Mitch Report
Antony Kaspi & Mark Ziemann
date generated: 2026-06-02
Background
Mitch performs unidimensional and multidimensional gene set enrichment analysis. The concept behind this dates to work by Cox and Mann (https://doi.org/10.1186/1471-2105-13-S16-S12). This implementation is suited to R based workflows of multi-omics datasets. This software was developed by Antony Kaspi and Mark Ziemann. Learn more about Mitch at the website: https://github.com/markziemann/Mitch
Input profiles
Here is the first few lines of the input profile.
| x | |
|---|---|
| 5_8S_rRNA | 0.8883357 |
| A1BG | -1.0618978 |
| A1BG-AS1 | 0.0763164 |
| A1CF | -0.2105187 |
| A2M | 1.3534789 |
| A2M-AS1 | 0.0585195 |
Here are some metrics about the input data profile:
| Profile metrics | |
|---|---|
| num_genesets | 10454 |
| num_genes_in_profile | 21253 |
| duplicated_genes_present | 0 |
| num_profile_genes_in_sets | 13736 |
| num_profile_genes_not_in_sets | 7517 |
Here is a plot of the input profiles. Note the dynamic ranges.
Here is the contour plot of the profile including all detected genes.
Input genesets
Here are some metrics about the gene sets used:
GMT file of genesets:| Gene sets metrics | |
|---|---|
| num_genesets | 10454 |
| num_genesets_excluded | 3980 |
| num_genesets_included | 6474 |
Differential pathway expression
Interactive enrichment scatterplot
Significance is calculated by -log10(p-value). All points shown are
FDR<0.05.
Significance is calculated by -log10(p-value). Top N sets shown
irrespective of FDR.
Results table
Top N= 50 gene sets| set | setSize | pANOVA | s.dist | p.adjustANOVA |
|---|---|---|---|---|
| GOBP REGULATION OF ENDOPLASMIC RETICULUM TUBULAR NETWORK ORGANIZATION | 6 | 2.54e-04 | 0.862 | 0.02850 |
| GOCC PHAGOCYTIC VESICLE LUMEN | 5 | 1.03e-03 | -0.848 | 0.07190 |
| GOBP ESTABLISHMENT OF MITOTIC SISTER CHROMATID COHESION | 7 | 1.08e-04 | 0.845 | 0.01620 |
| GOCC GLYCOPROTEIN IB IX V COMPLEX | 5 | 1.28e-03 | -0.831 | 0.08150 |
| GOBP ACROSOMAL VESICLE EXOCYTOSIS | 5 | 1.61e-03 | -0.814 | 0.09710 |
| GOCC SARCOPLASMIC RETICULUM LUMEN | 5 | 1.93e-03 | 0.801 | 0.10900 |
| GOBP REGULATION OF MATRIX METALLOPEPTIDASE SECRETION | 5 | 2.04e-03 | 0.797 | 0.11100 |
| GOBP INTERLEUKIN 27 MEDIATED SIGNALING PATHWAY | 7 | 2.65e-04 | 0.796 | 0.02890 |
| GOBP MEIOTIC CYTOKINESIS | 6 | 1.02e-03 | 0.774 | 0.07180 |
| GOMF HISTONE H2AX KINASE ACTIVITY | 5 | 3.89e-03 | 0.745 | 0.15000 |
| GOBP HYPOXIA INDUCIBLE FACTOR 1ALPHA SIGNALING PATHWAY | 5 | 3.99e-03 | 0.743 | 0.15100 |
| GOMF UBIQUITIN LIKE PROTEIN SPECIFIC ENDOPEPTIDASE ACTIVITY | 5 | 4.26e-03 | 0.738 | 0.15800 |
| GOCC TUBULAR ENDOSOME | 5 | 4.92e-03 | 0.726 | 0.17100 |
| GOBP INTERKINETIC NUCLEAR MIGRATION | 5 | 5.27e-03 | 0.721 | 0.17700 |
| GOMF C PALMITOYLTRANSFERASE ACTIVITY | 5 | 5.58e-03 | 0.716 | 0.17900 |
| GOBP PROTEIN FOLDING IN ENDOPLASMIC RETICULUM | 11 | 5.25e-05 | 0.704 | 0.00886 |
| GOCC BRCA1 C COMPLEX | 6 | 2.98e-03 | 0.700 | 0.12900 |
| GOBP ONCOGENE INDUCED CELL SENESCENCE | 5 | 7.03e-03 | -0.696 | 0.19400 |
| GOMF LIGAND GATED MONOATOMIC ION CHANNEL ACTIVITY INVOLVED IN REGULATION OF PRESYNAPTIC MEMBRANE POTENTIAL | 5 | 7.09e-03 | -0.695 | 0.19400 |
| GOBP NEGATIVE REGULATION OF FIBROBLAST APOPTOTIC PROCESS | 6 | 3.52e-03 | 0.688 | 0.14100 |
| GOBP REGULATION OF BLOOD VESSEL REMODELING | 6 | 3.60e-03 | -0.686 | 0.14200 |
| GOBP LOOP OF HENLE DEVELOPMENT | 5 | 7.89e-03 | -0.686 | 0.20400 |
| GOBP 7 METHYLGUANOSINE RNA CAPPING | 7 | 1.69e-03 | 0.685 | 0.10000 |
| GOBP REGULATION OF TOLL LIKE RECEPTOR 7 SIGNALING PATHWAY | 6 | 4.59e-03 | 0.668 | 0.16500 |
| GOBP HEPOXILIN METABOLIC PROCESS | 7 | 2.26e-03 | -0.667 | 0.11700 |
| GOCC TORC1 COMPLEX | 6 | 4.81e-03 | -0.665 | 0.16900 |
| GOCC MCRD MEDIATED MRNA STABILITY COMPLEX | 5 | 1.02e-02 | 0.664 | 0.22700 |
| GOBP INTERLEUKIN 5 MEDIATED SIGNALING PATHWAY | 5 | 1.12e-02 | 0.655 | 0.24000 |
| GOBP MAINTENANCE OF PROTEIN LOCATION IN EXTRACELLULAR REGION | 6 | 5.56e-03 | -0.654 | 0.17900 |
| GOBP LOW DENSITY LIPOPROTEIN RECEPTOR PARTICLE METABOLIC PROCESS | 6 | 5.71e-03 | -0.652 | 0.18000 |
| GOBP CHROMOSOME MOVEMENT TOWARDS SPINDLE POLE | 6 | 5.81e-03 | 0.650 | 0.18000 |
| GOBP REGULATION OF TOOTH MINERALIZATION | 5 | 1.20e-02 | -0.649 | 0.24300 |
| GOCC SIGNAL PEPTIDASE COMPLEX | 5 | 1.25e-02 | 0.645 | 0.24900 |
| GOCC MMXD COMPLEX | 5 | 1.27e-02 | -0.643 | 0.24900 |
| GOBP RENAL WATER ABSORPTION | 5 | 1.38e-02 | -0.636 | 0.25400 |
| GOBP REGULATION OF CELLULAR RESPONSE TO MACROPHAGE COLONY STIMULATING FACTOR STIMULUS | 5 | 1.42e-02 | 0.633 | 0.25700 |
| GOBP REGULATION OF PRESYNAPTIC MEMBRANE POTENTIAL | 9 | 1.01e-03 | -0.633 | 0.07180 |
| GOBP VESICLE FUSION WITH GOLGI APPARATUS | 8 | 2.12e-03 | 0.627 | 0.11300 |
| GOMF CTPASE ACTIVITY | 6 | 8.06e-03 | 0.625 | 0.20600 |
| GOMF SUPEROXIDE GENERATING NADPH OXIDASE ACTIVATOR ACTIVITY | 9 | 1.36e-03 | -0.617 | 0.08580 |
| GOCC POSTSYNAPTIC ACTIN CYTOSKELETON | 6 | 9.00e-03 | -0.616 | 0.21900 |
| GOBP SEBACEOUS GLAND DEVELOPMENT | 7 | 4.92e-03 | 0.614 | 0.17100 |
| GOCC CRD MEDIATED MRNA STABILITY COMPLEX | 5 | 1.77e-02 | 0.613 | 0.28800 |
| GOBP BRANCHING INVOLVED IN PROSTATE GLAND MORPHOGENESIS | 5 | 1.86e-02 | 0.608 | 0.29700 |
| GOMF NADPLUS NUCLEOTIDASE CYCLIC ADP RIBOSE GENERATING | 13 | 1.49e-04 | 0.607 | 0.02040 |
| GOCC GROWTH FACTOR COMPLEX | 5 | 1.87e-02 | -0.607 | 0.29800 |
| GOBP POSITIVE REGULATION OF PROTEIN LOCALIZATION TO SYNAPSE | 5 | 1.90e-02 | -0.605 | 0.30100 |
| GOBP PHOSPHATIDYLINOSITOL ACYL CHAIN REMODELING | 5 | 1.95e-02 | 0.603 | 0.30600 |
| GOBP PROTEIN O LINKED FUCOSYLATION | 5 | 1.97e-02 | -0.602 | 0.30600 |
| GOBP POSITIVE REGULATION OF TOLL LIKE RECEPTOR 7 SIGNALING PATHWAY | 5 | 1.97e-02 | 0.602 | 0.30600 |
Results (complete table)
Click HERE to show results for all gene sets
| set | setSize | pANOVA | s.dist | p.adjustANOVA |
|---|---|---|---|---|
| GOBP REGULATION OF ENDOPLASMIC RETICULUM TUBULAR NETWORK ORGANIZATION | 6 | 2.54e-04 | 8.62e-01 | 2.85e-02 |
| GOCC PHAGOCYTIC VESICLE LUMEN | 5 | 1.03e-03 | -8.48e-01 | 7.19e-02 |
| GOBP ESTABLISHMENT OF MITOTIC SISTER CHROMATID COHESION | 7 | 1.08e-04 | 8.45e-01 | 1.62e-02 |
| GOCC GLYCOPROTEIN IB IX V COMPLEX | 5 | 1.28e-03 | -8.31e-01 | 8.15e-02 |
| GOBP ACROSOMAL VESICLE EXOCYTOSIS | 5 | 1.61e-03 | -8.14e-01 | 9.71e-02 |
| GOCC SARCOPLASMIC RETICULUM LUMEN | 5 | 1.93e-03 | 8.01e-01 | 1.09e-01 |
| GOBP REGULATION OF MATRIX METALLOPEPTIDASE SECRETION | 5 | 2.04e-03 | 7.97e-01 | 1.11e-01 |
| GOBP INTERLEUKIN 27 MEDIATED SIGNALING PATHWAY | 7 | 2.65e-04 | 7.96e-01 | 2.89e-02 |
| GOBP MEIOTIC CYTOKINESIS | 6 | 1.02e-03 | 7.74e-01 | 7.18e-02 |
| GOMF HISTONE H2AX KINASE ACTIVITY | 5 | 3.89e-03 | 7.45e-01 | 1.50e-01 |
| GOBP HYPOXIA INDUCIBLE FACTOR 1ALPHA SIGNALING PATHWAY | 5 | 3.99e-03 | 7.43e-01 | 1.51e-01 |
| GOMF UBIQUITIN LIKE PROTEIN SPECIFIC ENDOPEPTIDASE ACTIVITY | 5 | 4.26e-03 | 7.38e-01 | 1.58e-01 |
| GOCC TUBULAR ENDOSOME | 5 | 4.92e-03 | 7.26e-01 | 1.71e-01 |
| GOBP INTERKINETIC NUCLEAR MIGRATION | 5 | 5.27e-03 | 7.21e-01 | 1.77e-01 |
| GOMF C PALMITOYLTRANSFERASE ACTIVITY | 5 | 5.58e-03 | 7.16e-01 | 1.79e-01 |
| GOBP PROTEIN FOLDING IN ENDOPLASMIC RETICULUM | 11 | 5.25e-05 | 7.04e-01 | 8.86e-03 |
| GOCC BRCA1 C COMPLEX | 6 | 2.98e-03 | 7.00e-01 | 1.29e-01 |
| GOBP ONCOGENE INDUCED CELL SENESCENCE | 5 | 7.03e-03 | -6.96e-01 | 1.94e-01 |
| GOMF LIGAND GATED MONOATOMIC ION CHANNEL ACTIVITY INVOLVED IN REGULATION OF PRESYNAPTIC MEMBRANE POTENTIAL | 5 | 7.09e-03 | -6.95e-01 | 1.94e-01 |
| GOBP NEGATIVE REGULATION OF FIBROBLAST APOPTOTIC PROCESS | 6 | 3.52e-03 | 6.88e-01 | 1.41e-01 |
| GOBP REGULATION OF BLOOD VESSEL REMODELING | 6 | 3.60e-03 | -6.86e-01 | 1.42e-01 |
| GOBP LOOP OF HENLE DEVELOPMENT | 5 | 7.89e-03 | -6.86e-01 | 2.04e-01 |
| GOBP 7 METHYLGUANOSINE RNA CAPPING | 7 | 1.69e-03 | 6.85e-01 | 1.00e-01 |
| GOBP REGULATION OF TOLL LIKE RECEPTOR 7 SIGNALING PATHWAY | 6 | 4.59e-03 | 6.68e-01 | 1.65e-01 |
| GOBP HEPOXILIN METABOLIC PROCESS | 7 | 2.26e-03 | -6.67e-01 | 1.17e-01 |
| GOCC TORC1 COMPLEX | 6 | 4.81e-03 | -6.65e-01 | 1.69e-01 |
| GOCC MCRD MEDIATED MRNA STABILITY COMPLEX | 5 | 1.02e-02 | 6.64e-01 | 2.27e-01 |
| GOBP INTERLEUKIN 5 MEDIATED SIGNALING PATHWAY | 5 | 1.12e-02 | 6.55e-01 | 2.40e-01 |
| GOBP MAINTENANCE OF PROTEIN LOCATION IN EXTRACELLULAR REGION | 6 | 5.56e-03 | -6.54e-01 | 1.79e-01 |
| GOBP LOW DENSITY LIPOPROTEIN RECEPTOR PARTICLE METABOLIC PROCESS | 6 | 5.71e-03 | -6.52e-01 | 1.80e-01 |
| GOBP CHROMOSOME MOVEMENT TOWARDS SPINDLE POLE | 6 | 5.81e-03 | 6.50e-01 | 1.80e-01 |
| GOBP REGULATION OF TOOTH MINERALIZATION | 5 | 1.20e-02 | -6.49e-01 | 2.43e-01 |
| GOCC SIGNAL PEPTIDASE COMPLEX | 5 | 1.25e-02 | 6.45e-01 | 2.49e-01 |
| GOCC MMXD COMPLEX | 5 | 1.27e-02 | -6.43e-01 | 2.49e-01 |
| GOBP RENAL WATER ABSORPTION | 5 | 1.38e-02 | -6.36e-01 | 2.54e-01 |
| GOBP REGULATION OF CELLULAR RESPONSE TO MACROPHAGE COLONY STIMULATING FACTOR STIMULUS | 5 | 1.42e-02 | 6.33e-01 | 2.57e-01 |
| GOBP REGULATION OF PRESYNAPTIC MEMBRANE POTENTIAL | 9 | 1.01e-03 | -6.33e-01 | 7.18e-02 |
| GOBP VESICLE FUSION WITH GOLGI APPARATUS | 8 | 2.12e-03 | 6.27e-01 | 1.13e-01 |
| GOMF CTPASE ACTIVITY | 6 | 8.06e-03 | 6.25e-01 | 2.06e-01 |
| GOMF SUPEROXIDE GENERATING NADPH OXIDASE ACTIVATOR ACTIVITY | 9 | 1.36e-03 | -6.17e-01 | 8.58e-02 |
| GOCC POSTSYNAPTIC ACTIN CYTOSKELETON | 6 | 9.00e-03 | -6.16e-01 | 2.19e-01 |
| GOBP SEBACEOUS GLAND DEVELOPMENT | 7 | 4.92e-03 | 6.14e-01 | 1.71e-01 |
| GOCC CRD MEDIATED MRNA STABILITY COMPLEX | 5 | 1.77e-02 | 6.13e-01 | 2.88e-01 |
| GOBP BRANCHING INVOLVED IN PROSTATE GLAND MORPHOGENESIS | 5 | 1.86e-02 | 6.08e-01 | 2.97e-01 |
| GOMF NADPLUS NUCLEOTIDASE CYCLIC ADP RIBOSE GENERATING | 13 | 1.49e-04 | 6.07e-01 | 2.04e-02 |
| GOCC GROWTH FACTOR COMPLEX | 5 | 1.87e-02 | -6.07e-01 | 2.98e-01 |
| GOBP POSITIVE REGULATION OF PROTEIN LOCALIZATION TO SYNAPSE | 5 | 1.90e-02 | -6.05e-01 | 3.01e-01 |
| GOBP PHOSPHATIDYLINOSITOL ACYL CHAIN REMODELING | 5 | 1.95e-02 | 6.03e-01 | 3.06e-01 |
| GOBP PROTEIN O LINKED FUCOSYLATION | 5 | 1.97e-02 | -6.02e-01 | 3.06e-01 |
| GOBP POSITIVE REGULATION OF TOLL LIKE RECEPTOR 7 SIGNALING PATHWAY | 5 | 1.97e-02 | 6.02e-01 | 3.06e-01 |
| GOMF NADPLUS NUCLEOSIDASE ACTIVITY | 8 | 3.30e-03 | 6.00e-01 | 1.35e-01 |
| GOBP POSITIVE REGULATION OF MAINTENANCE OF SISTER CHROMATID COHESION | 6 | 1.16e-02 | 5.95e-01 | 2.43e-01 |
| GOCC CHROMATOID BODY | 7 | 6.55e-03 | 5.93e-01 | 1.89e-01 |
| GOMF OLIGOSACCHARYL TRANSFERASE ACTIVITY | 5 | 2.19e-02 | 5.92e-01 | 3.22e-01 |
| GOBP METANEPHRIC GLOMERULUS VASCULATURE DEVELOPMENT | 6 | 1.24e-02 | -5.90e-01 | 2.49e-01 |
| GOBP NEGATIVE REGULATION OF PROTEIN LOCALIZATION TO CHROMATIN | 6 | 1.24e-02 | -5.90e-01 | 2.49e-01 |
| GOMF 1 PHOSPHATIDYLINOSITOL 4 5 BISPHOSPHATE 3 KINASE ACTIVITY | 7 | 7.05e-03 | 5.88e-01 | 1.94e-01 |
| GOBP POSITIVE REGULATION OF NITRIC OXIDE SYNTHASE BIOSYNTHETIC PROCESS | 14 | 1.47e-04 | 5.86e-01 | 2.04e-02 |
| GOBP PEPTIDYL LYSINE DEACETYLATION | 6 | 1.32e-02 | -5.84e-01 | 2.49e-01 |
| GOMF MORPHOGEN ACTIVITY | 5 | 2.36e-02 | -5.84e-01 | 3.33e-01 |
| GOBP RESPONSE TO FOLIC ACID | 7 | 7.45e-03 | -5.84e-01 | 1.98e-01 |
| GOBP NEGATIVE REGULATION OF IRE1 MEDIATED UNFOLDED PROTEIN RESPONSE | 5 | 2.42e-02 | 5.82e-01 | 3.38e-01 |
| GOBP PERIPHERAL NERVOUS SYSTEM MYELIN MAINTENANCE | 7 | 8.00e-03 | -5.79e-01 | 2.06e-01 |
| GOCC SPERM PLASMA MEMBRANE | 6 | 1.42e-02 | 5.78e-01 | 2.57e-01 |
| GOCC GATOR1 COMPLEX | 5 | 2.57e-02 | -5.76e-01 | 3.47e-01 |
| GOBP CAMP BIOSYNTHETIC PROCESS | 7 | 8.50e-03 | -5.74e-01 | 2.13e-01 |
| GOBP NEGATIVE REGULATION OF MUSCLE TISSUE DEVELOPMENT | 7 | 8.50e-03 | -5.74e-01 | 2.13e-01 |
| GOMF RDNA BINDING | 9 | 2.88e-03 | -5.74e-01 | 1.28e-01 |
| GOBP REGULATION OF NEUTROPHIL DEGRANULATION | 8 | 5.02e-03 | -5.73e-01 | 1.72e-01 |
| GOCC DNA DEPENDENT PROTEIN KINASE DNA LIGASE 4 COMPLEX | 7 | 9.04e-03 | 5.70e-01 | 2.19e-01 |
| GOBP POSITIVE REGULATION OF PROTEIN K63 LINKED UBIQUITINATION | 8 | 5.30e-03 | 5.69e-01 | 1.77e-01 |
| GOBP PROTEIN RETENTION IN GOLGI APPARATUS | 5 | 2.76e-02 | 5.69e-01 | 3.57e-01 |
| GOBP REGULATION OF CONNECTIVE TISSUE REPLACEMENT | 5 | 2.77e-02 | 5.68e-01 | 3.57e-01 |
| GOMF CYCLIC NUCLEOTIDE ACTIVATED MONOATOMIC ION CHANNEL ACTIVITY | 5 | 2.79e-02 | -5.68e-01 | 3.58e-01 |
| GOBP VESICLE TETHERING TO GOLGI | 5 | 2.80e-02 | 5.67e-01 | 3.58e-01 |
| GOBP POSITIVE REGULATION OF MITOCHONDRIAL OUTER MEMBRANE PERMEABILIZATION INVOLVED IN APOPTOTIC SIGNALING PATHWAY | 8 | 5.48e-03 | -5.67e-01 | 1.79e-01 |
| GOBP ANTIGEN PROCESSING AND PRESENTATION ENDOGENOUS LIPID ANTIGEN VIA MHC CLASS IB | 5 | 2.82e-02 | -5.67e-01 | 3.58e-01 |
| GOMF LIPID ANTIGEN BINDING | 5 | 2.82e-02 | -5.67e-01 | 3.58e-01 |
| GOBP CRD MEDIATED MRNA STABILIZATION | 10 | 1.98e-03 | 5.65e-01 | 1.09e-01 |
| GOBP L LYSINE TRANSMEMBRANE TRANSPORT | 5 | 2.88e-02 | -5.65e-01 | 3.59e-01 |
| GOMF L LYSINE TRANSMEMBRANE TRANSPORTER ACTIVITY | 5 | 2.88e-02 | -5.65e-01 | 3.59e-01 |
| GOCC ENDOPLASMIC RETICULUM TUBULAR NETWORK MEMBRANE | 5 | 2.90e-02 | 5.64e-01 | 3.59e-01 |
| GOBP RENAL WATER TRANSPORT | 6 | 1.74e-02 | -5.61e-01 | 2.87e-01 |
| GOBP CHORIONIC TROPHOBLAST CELL DIFFERENTIATION | 5 | 3.01e-02 | -5.60e-01 | 3.64e-01 |
| GOCC MITOTIC COHESIN COMPLEX | 7 | 1.04e-02 | 5.59e-01 | 2.29e-01 |
| GOBP AMINOPHOSPHOLIPID TRANSPORT | 9 | 3.67e-03 | 5.59e-01 | 1.43e-01 |
| GOBP VESTIBULOCOCHLEAR NERVE MORPHOGENESIS | 5 | 3.11e-02 | 5.57e-01 | 3.71e-01 |
| GOBP MONOUBIQUITINATED PROTEIN DEUBIQUITINATION | 9 | 3.87e-03 | 5.56e-01 | 1.50e-01 |
| GOBP NEGATIVE REGULATION OF MYELINATION | 8 | 6.65e-03 | 5.54e-01 | 1.89e-01 |
| GOBP NEGATIVE REGULATION OF ESTABLISHMENT OF PROTEIN LOCALIZATION TO MITOCHONDRION | 6 | 1.89e-02 | 5.53e-01 | 3.00e-01 |
| GOMF MHC CLASS IB RECEPTOR ACTIVITY | 8 | 6.76e-03 | 5.53e-01 | 1.91e-01 |
| GOMF COLLAGEN BINDING INVOLVED IN CELL MATRIX ADHESION | 5 | 3.23e-02 | 5.53e-01 | 3.77e-01 |
| GOBP SERINE PHOSPHORYLATION OF STAT PROTEIN | 5 | 3.30e-02 | 5.50e-01 | 3.79e-01 |
| GOBP RIBOSOMAL LARGE SUBUNIT EXPORT FROM NUCLEUS | 7 | 1.18e-02 | 5.50e-01 | 2.43e-01 |
| GOBP SNRNA CATABOLIC PROCESS | 5 | 3.38e-02 | 5.48e-01 | 3.83e-01 |
| GOBP REGULATION OF REMOVAL OF SUPEROXIDE RADICALS | 6 | 2.03e-02 | 5.47e-01 | 3.11e-01 |
| GOBP CELLULAR RESPONSE TO SALT | 5 | 3.49e-02 | -5.45e-01 | 3.88e-01 |
| GOBP CELLULAR RESPONSE TO SODIUM ARSENITE | 5 | 3.49e-02 | -5.45e-01 | 3.88e-01 |
| GOBP CHOLINE TRANSPORT | 5 | 3.53e-02 | 5.43e-01 | 3.88e-01 |
| GOBP GENITALIA MORPHOGENESIS | 7 | 1.28e-02 | 5.43e-01 | 2.49e-01 |
| GOBP TRNA THIO MODIFICATION | 5 | 3.57e-02 | -5.43e-01 | 3.89e-01 |
| GOBP NEGATIVE REGULATION OF ERYTHROCYTE DIFFERENTIATION | 7 | 1.30e-02 | -5.42e-01 | 2.49e-01 |
| GOBP NEGATIVE REGULATION OF HEPATOCYTE APOPTOTIC PROCESS | 6 | 2.15e-02 | 5.42e-01 | 3.21e-01 |
| GOBP AMINO ACID BETAINE BIOSYNTHETIC PROCESS | 5 | 3.58e-02 | 5.42e-01 | 3.89e-01 |
| GOBP PROLINE TRANSMEMBRANE TRANSPORT | 7 | 1.31e-02 | 5.41e-01 | 2.49e-01 |
| GOMF INHIBITORY MHC CLASS I RECEPTOR ACTIVITY | 8 | 8.03e-03 | 5.41e-01 | 2.06e-01 |
| GOBP RESPONSE TO INTERFERON ALPHA | 18 | 7.33e-05 | 5.40e-01 | 1.20e-02 |
| GOMF INOSITOL POLYPHOSPHATE 5 PHOSPHATASE ACTIVITY | 6 | 2.22e-02 | -5.39e-01 | 3.24e-01 |
| GOBP ANTERIOR COMMISSURE MORPHOGENESIS | 5 | 3.72e-02 | 5.38e-01 | 3.92e-01 |
| GOBP PYRIMIDINE CONTAINING COMPOUND SALVAGE | 6 | 2.27e-02 | -5.37e-01 | 3.27e-01 |
| GOBP POSITIVE REGULATION OF PROTEIN POLYUBIQUITINATION | 16 | 2.00e-04 | 5.37e-01 | 2.45e-02 |
| GOBP PROSTATE GLAND GROWTH | 8 | 8.83e-03 | 5.35e-01 | 2.17e-01 |
| GOBP PROTEIN LOCALIZATION TO MOTILE CILIUM | 5 | 3.93e-02 | 5.32e-01 | 3.98e-01 |
| GOBP PROTEIN LOCALIZATION TO CYTOPLASMIC STRESS GRANULE | 8 | 9.15e-03 | 5.32e-01 | 2.20e-01 |
| GOBP NUCLEAR MIGRATION ALONG MICROTUBULE | 5 | 3.94e-02 | -5.32e-01 | 3.98e-01 |
| GOBP REGULATION OF MAINTENANCE OF SISTER CHROMATID COHESION | 9 | 5.77e-03 | 5.31e-01 | 1.80e-01 |
| GOBP NEGATIVE REGULATION OF TYROSINE PHOSPHORYLATION OF STAT PROTEIN | 8 | 9.43e-03 | 5.30e-01 | 2.22e-01 |
| GOBP INHIBITION OF NEUROEPITHELIAL CELL DIFFERENTIATION | 5 | 4.03e-02 | -5.30e-01 | 4.01e-01 |
| GOBP REGULATION OF CARDIAC MUSCLE CELL MEMBRANE POTENTIAL | 5 | 4.05e-02 | -5.29e-01 | 4.01e-01 |
| GOBP SUCKLING BEHAVIOR | 8 | 9.71e-03 | 5.28e-01 | 2.23e-01 |
| GOBP NUCLEAR PORE COMPLEX ASSEMBLY | 11 | 2.43e-03 | 5.28e-01 | 1.20e-01 |
| GOBP REGULATION OF HEPATOCYTE APOPTOTIC PROCESS | 7 | 1.57e-02 | 5.27e-01 | 2.71e-01 |
| GOBP POSITIVE REGULATION OF CHONDROCYTE PROLIFERATION | 5 | 4.25e-02 | -5.24e-01 | 4.07e-01 |
| GOCC TRAMP COMPLEX | 5 | 4.27e-02 | 5.23e-01 | 4.07e-01 |
| GOCC PROCENTRIOLE REPLICATION COMPLEX | 6 | 2.65e-02 | 5.23e-01 | 3.52e-01 |
| GOMF RNA POLYMERASE III TRANSCRIPTION REGULATORY REGION SEQUENCE SPECIFIC DNA BINDING | 8 | 1.04e-02 | -5.23e-01 | 2.29e-01 |
| GOBP REGULATION OF COMPLEMENT ACTIVATION CLASSICAL PATHWAY | 7 | 1.67e-02 | 5.23e-01 | 2.82e-01 |
| GOBP ENDOTHELIAL CELL MATRIX ADHESION | 5 | 4.39e-02 | -5.20e-01 | 4.11e-01 |
| GOBP POSITIVE REGULATION OF ENDOTHELIAL CELL MATRIX ADHESION VIA FIBRONECTIN | 5 | 4.39e-02 | -5.20e-01 | 4.11e-01 |
| GOBP PARENTAL BEHAVIOR | 7 | 1.72e-02 | 5.20e-01 | 2.85e-01 |
| GOBP TELOMERASE HOLOENZYME COMPLEX ASSEMBLY | 6 | 2.74e-02 | 5.20e-01 | 3.56e-01 |
| GOMF UDP GLUCOSYLTRANSFERASE ACTIVITY | 9 | 7.03e-03 | 5.19e-01 | 1.94e-01 |
| GOBP CHOLESTEROL CATABOLIC PROCESS | 6 | 2.80e-02 | -5.18e-01 | 3.58e-01 |
| GOCC ATP BINDING CASSETTE ABC TRANSPORTER COMPLEX | 5 | 4.51e-02 | -5.17e-01 | 4.13e-01 |
| GOBP POSITIVE REGULATION OF RIG I SIGNALING PATHWAY | 8 | 1.14e-02 | 5.17e-01 | 2.42e-01 |
| GOBP SUGAR MEDIATED SIGNALING PATHWAY | 6 | 2.86e-02 | -5.16e-01 | 3.59e-01 |
| GOBP RESPONSE TO CORTICOSTERONE | 11 | 3.09e-03 | -5.15e-01 | 1.31e-01 |
| GOMF NAADP SENSITIVE CALCIUM RELEASE CHANNEL ACTIVITY | 5 | 4.61e-02 | -5.15e-01 | 4.17e-01 |
| GOBP RESPONSE TO PHORBOL 13 ACETATE 12 MYRISTATE | 6 | 2.89e-02 | -5.15e-01 | 3.59e-01 |
| GOBP VESTIBULOCOCHLEAR NERVE DEVELOPMENT | 7 | 1.83e-02 | 5.15e-01 | 2.94e-01 |
| GOBP TOLL LIKE RECEPTOR 8 SIGNALING PATHWAY | 5 | 4.65e-02 | 5.14e-01 | 4.19e-01 |
| GOBP RESPONSE TO SODIUM ARSENITE | 6 | 2.96e-02 | -5.13e-01 | 3.63e-01 |
| GOCC TRANSCRIPTION FACTOR AP 1 COMPLEX | 5 | 4.75e-02 | -5.12e-01 | 4.23e-01 |
| GOBP POSITIVE REGULATION OF PHOSPHOLIPID TRANSLOCATION | 5 | 4.81e-02 | 5.10e-01 | 4.25e-01 |
| GOBP LIPOXIN METABOLIC PROCESS | 5 | 4.84e-02 | -5.10e-01 | 4.25e-01 |
| GOBP REGULATION OF DNA TOPOISOMERASE ATP HYDROLYZING ACTIVITY | 5 | 4.89e-02 | 5.08e-01 | 4.25e-01 |
| GOBP COBALAMIN TRANSPORT | 8 | 1.29e-02 | -5.08e-01 | 2.49e-01 |
| GOCC SUPER ELONGATION COMPLEX | 6 | 3.14e-02 | 5.07e-01 | 3.73e-01 |
| GOMF 3 HYDROXYACYL COA DEHYDRATASE ACTIVITY | 8 | 1.30e-02 | 5.07e-01 | 2.49e-01 |
| GOMF CCR5 CHEMOKINE RECEPTOR BINDING | 6 | 3.16e-02 | 5.07e-01 | 3.73e-01 |
| GOBP RECEPTOR LOCALIZATION TO NON MOTILE CILIUM | 5 | 4.97e-02 | 5.07e-01 | 4.27e-01 |
| GOBP PROTEIN POLYUFMYLATION | 5 | 5.01e-02 | 5.06e-01 | 4.28e-01 |
| GOBP POSITIVE REGULATION OF NUCLEASE ACTIVITY | 6 | 3.19e-02 | -5.06e-01 | 3.76e-01 |
| GOBP POSITIVE REGULATION OF VESICLE TRANSPORT ALONG MICROTUBULE | 5 | 5.08e-02 | -5.04e-01 | 4.30e-01 |
| GOBP NEGATIVE REGULATION OF PROTEIN POLYUBIQUITINATION | 6 | 3.27e-02 | 5.03e-01 | 3.77e-01 |
| GOMF PHOSPHATIDYLINOSITOL MONOPHOSPHATE PHOSPHATASE ACTIVITY | 14 | 1.13e-03 | 5.03e-01 | 7.42e-02 |
| GOBP SPINAL CORD ASSOCIATION NEURON DIFFERENTIATION | 5 | 5.18e-02 | -5.02e-01 | 4.33e-01 |
| GOCC CDC73 PAF1 COMPLEX | 6 | 3.32e-02 | 5.02e-01 | 3.80e-01 |
| GOBP POSITIVE REGULATION OF PROTEIN CATABOLIC PROCESS IN THE VACUOLE | 6 | 3.37e-02 | -5.01e-01 | 3.83e-01 |
| GOBP SIRNA PROCESSING | 8 | 1.43e-02 | 5.00e-01 | 2.58e-01 |
| GOBP MIRNA MEDIATED GENE SILENCING BY MRNA DESTABILIZATION | 9 | 9.44e-03 | 5.00e-01 | 2.22e-01 |
| GOBP REGULATION OF T CIRCLE FORMATION | 7 | 2.21e-02 | -5.00e-01 | 3.23e-01 |
| GOBP PEPTIDYL LYSINE DIMETHYLATION | 5 | 5.38e-02 | -4.98e-01 | 4.36e-01 |
| GOCC MICROFIBRIL | 11 | 4.46e-03 | -4.95e-01 | 1.61e-01 |
| GOCC BARR BODY | 8 | 1.54e-02 | 4.95e-01 | 2.68e-01 |
| GOBP REGULATION OF PHOSPHATIDYLINOSITOL DEPHOSPHORYLATION | 6 | 3.59e-02 | 4.95e-01 | 3.89e-01 |
| GOMF L LEUCINE BINDING | 6 | 3.59e-02 | 4.95e-01 | 3.89e-01 |
| GOBP ATRIAL CARDIAC MUSCLE CELL MEMBRANE REPOLARIZATION | 6 | 3.67e-02 | -4.92e-01 | 3.91e-01 |
| GOBP REGULATION OF ATRIAL CARDIAC MUSCLE CELL MEMBRANE REPOLARIZATION | 6 | 3.67e-02 | -4.92e-01 | 3.91e-01 |
| GOBP MITOTIC DNA REPLICATION CHECKPOINT SIGNALING | 10 | 7.12e-03 | 4.91e-01 | 1.94e-01 |
| GOCC PROTEASOME CORE COMPLEX ALPHA SUBUNIT COMPLEX | 7 | 2.45e-02 | 4.91e-01 | 3.39e-01 |
| GOMF PHOSPHATIDYLSERINE FLIPPASE ACTIVITY | 5 | 5.76e-02 | 4.90e-01 | 4.46e-01 |
| GOBP POSITIVE REGULATION OF CYTOPLASMIC MRNA PROCESSING BODY ASSEMBLY | 6 | 3.81e-02 | 4.89e-01 | 3.96e-01 |
| GOMF 1 PHOSPHATIDYLINOSITOL BINDING | 13 | 2.27e-03 | 4.89e-01 | 1.17e-01 |
| GOBP TELOMERE LOCALIZATION | 7 | 2.52e-02 | 4.88e-01 | 3.44e-01 |
| GOBP MITOTIC SISTER CHROMATID COHESION | 31 | 2.51e-06 | 4.88e-01 | 1.11e-03 |
| GOBP MAINTENANCE OF SISTER CHROMATID COHESION | 13 | 2.31e-03 | 4.88e-01 | 1.18e-01 |
| GOMF DOUBLE STRANDED DNA 3 5 DNA EXONUCLEASE ACTIVITY | 6 | 3.85e-02 | -4.88e-01 | 3.98e-01 |
| GOMF XMP 5 NUCLEOSIDASE ACTIVITY | 6 | 3.86e-02 | 4.88e-01 | 3.98e-01 |
| GOBP BLOOD COAGULATION INTRINSIC PATHWAY | 7 | 2.56e-02 | -4.87e-01 | 3.47e-01 |
| GOBP PEPTIDYL LYSINE OXIDATION | 5 | 5.92e-02 | -4.87e-01 | 4.53e-01 |
| GOMF PROTEIN LYSINE 6 OXIDASE ACTIVITY | 5 | 5.92e-02 | -4.87e-01 | 4.53e-01 |
| GOBP SYNAPTIC VESICLE ENDOSOMAL PROCESSING | 9 | 1.14e-02 | 4.87e-01 | 2.42e-01 |
| GOCC MITOCHONDRIAL CRISTA | 8 | 1.73e-02 | 4.86e-01 | 2.86e-01 |
| GOBP T CELL ANTIGEN PROCESSING AND PRESENTATION | 6 | 3.93e-02 | -4.86e-01 | 3.98e-01 |
| GOBP COMPLEMENT DEPENDENT CYTOTOXICITY | 11 | 5.31e-03 | 4.85e-01 | 1.77e-01 |
| GOCC SMC5 SMC6 COMPLEX | 9 | 1.18e-02 | 4.85e-01 | 2.43e-01 |
| GOCC NONHOMOLOGOUS END JOINING COMPLEX | 9 | 1.18e-02 | 4.84e-01 | 2.43e-01 |
| GOCC FC RECEPTOR COMPLEX | 5 | 6.15e-02 | 4.83e-01 | 4.60e-01 |
| GOBP REGULATION OF CAVEOLIN MEDIATED ENDOCYTOSIS | 5 | 6.22e-02 | -4.81e-01 | 4.63e-01 |
| GOBP TRANSFORMING GROWTH FACTOR BETA2 PRODUCTION | 7 | 2.77e-02 | 4.81e-01 | 3.57e-01 |
| GOBP LIPOXYGENASE PATHWAY | 9 | 1.28e-02 | -4.79e-01 | 2.49e-01 |
| GOBP ACTIN POLYMERIZATION DEPENDENT CELL MOTILITY | 7 | 2.83e-02 | 4.79e-01 | 3.59e-01 |
| GOBP AMINOPHOSPHOLIPID TRANSLOCATION | 7 | 2.84e-02 | 4.78e-01 | 3.59e-01 |
| GOMF AMINOPHOSPHOLIPID FLIPPASE ACTIVITY | 7 | 2.84e-02 | 4.78e-01 | 3.59e-01 |
| GOBP NEGATIVE REGULATION OF T CELL MEDIATED CYTOTOXICITY | 9 | 1.31e-02 | 4.78e-01 | 2.49e-01 |
| GOBP PROXIMAL TUBULE DEVELOPMENT | 8 | 1.95e-02 | -4.77e-01 | 3.06e-01 |
| GOBP POSITIVE REGULATION OF SULFUR METABOLIC PROCESS | 5 | 6.51e-02 | 4.76e-01 | 4.66e-01 |
| GOBP POSITIVE REGULATION OF T CELL TOLERANCE INDUCTION | 8 | 1.97e-02 | 4.76e-01 | 3.06e-01 |
| GOMF INTRAMOLECULAR OXIDOREDUCTASE ACTIVITY INTERCONVERTING ALDOSES AND KETOSES | 6 | 4.37e-02 | -4.76e-01 | 4.11e-01 |
| GOBP REGULATION OF TERMINATION OF DNA TEMPLATED TRANSCRIPTION | 5 | 6.57e-02 | 4.75e-01 | 4.68e-01 |
| GOCC NMDA SELECTIVE GLUTAMATE RECEPTOR COMPLEX | 6 | 4.41e-02 | -4.74e-01 | 4.11e-01 |
| GOBP REGULATION OF PROTEIN K63 LINKED UBIQUITINATION | 13 | 3.07e-03 | 4.74e-01 | 1.31e-01 |
| GOBP DNA DOUBLE STRAND BREAK PROCESSING | 20 | 2.48e-04 | 4.73e-01 | 2.84e-02 |
| GOBP PLANAR CELL POLARITY PATHWAY INVOLVED IN NEURAL TUBE CLOSURE | 6 | 4.48e-02 | -4.73e-01 | 4.12e-01 |
| GOBP NEUTROPHIL CLEARANCE | 6 | 4.53e-02 | 4.72e-01 | 4.13e-01 |
| GOBP REGULATION OF RIBOSOME BIOGENESIS | 6 | 4.54e-02 | 4.72e-01 | 4.14e-01 |
| GOBP ASYMMETRIC NEUROBLAST DIVISION | 5 | 6.78e-02 | 4.72e-01 | 4.73e-01 |
| GOMF GUANINE NUCLEOTIDE TRANSMEMBRANE TRANSPORTER ACTIVITY | 5 | 6.79e-02 | -4.72e-01 | 4.73e-01 |
| GOMF GLUTAMATE RECEPTOR ACTIVITY | 10 | 9.87e-03 | -4.71e-01 | 2.25e-01 |
| GOMF FIBRINOGEN BINDING | 5 | 6.86e-02 | -4.70e-01 | 4.76e-01 |
| GOBP NEGATIVE REGULATION OF STEROL TRANSPORT | 6 | 4.61e-02 | -4.70e-01 | 4.17e-01 |
| GOBP NEGATIVE REGULATION OF NUCLEAR TRANSCRIBED MRNA CATABOLIC PROCESS DEADENYLATION DEPENDENT DECAY | 11 | 7.10e-03 | 4.69e-01 | 1.94e-01 |
| GOBP ENDOPLASMIC RETICULUM MEMBRANE ORGANIZATION | 12 | 5.02e-03 | 4.68e-01 | 1.72e-01 |
| GOBP POSITIVE REGULATION OF HELICASE ACTIVITY | 6 | 4.73e-02 | 4.68e-01 | 4.23e-01 |
| GOBP REGULATION OF RESPONSE TO REACTIVE OXYGEN SPECIES | 9 | 1.52e-02 | 4.67e-01 | 2.65e-01 |
| GOBP SPHINGOMYELIN BIOSYNTHETIC PROCESS | 10 | 1.05e-02 | 4.67e-01 | 2.30e-01 |
| GOMF TRANSLATION TERMINATION FACTOR ACTIVITY | 6 | 4.76e-02 | 4.67e-01 | 4.24e-01 |
| GOBP POSITIVE REGULATION OF ANOIKIS | 5 | 7.07e-02 | -4.67e-01 | 4.82e-01 |
| GOCC MPP7 DLG1 LIN7 COMPLEX | 5 | 7.13e-02 | 4.66e-01 | 4.84e-01 |
| GOBP DETECTION OF VIRUS | 5 | 7.21e-02 | 4.64e-01 | 4.86e-01 |
| GOBP POSITIVE REGULATION OF DEOXYRIBONUCLEASE ACTIVITY | 5 | 7.23e-02 | -4.64e-01 | 4.86e-01 |
| GOMF CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY INVOLVED IN EXECUTION PHASE OF APOPTOSIS | 5 | 7.23e-02 | 4.64e-01 | 4.86e-01 |
| GOBP NEGATIVE REGULATION OF FATTY ACID BETA OXIDATION | 6 | 4.91e-02 | -4.64e-01 | 4.25e-01 |
| GOBP REGULATION OF SULFUR METABOLIC PROCESS | 12 | 5.41e-03 | 4.64e-01 | 1.79e-01 |
| GOCC U2AF COMPLEX | 6 | 4.93e-02 | -4.63e-01 | 4.25e-01 |
| GOBP LYMPHOCYTE ANERGY | 8 | 2.33e-02 | 4.63e-01 | 3.31e-01 |
| GOBP PHENOTYPIC SWITCHING | 6 | 4.96e-02 | -4.63e-01 | 4.26e-01 |
| GOMF RNA POLYMERASE III TYPE 3 PROMOTER SEQUENCE SPECIFIC DNA BINDING | 6 | 4.97e-02 | -4.63e-01 | 4.26e-01 |
| GOBP REGULATION OF MYOFIBROBLAST DIFFERENTIATION | 6 | 5.01e-02 | 4.62e-01 | 4.28e-01 |
| GOBP NUCLEAR PORE ORGANIZATION | 15 | 1.97e-03 | 4.61e-01 | 1.09e-01 |
| GOBP POSITIVE REGULATION OF CELL SIZE | 9 | 1.65e-02 | 4.61e-01 | 2.81e-01 |
| GOMF FRUCTOSE 6 PHOSPHATE BINDING | 5 | 7.40e-02 | -4.61e-01 | 4.89e-01 |
| GOBP REGULATION OF RIBONUCLEASE ACTIVITY | 9 | 1.67e-02 | 4.61e-01 | 2.82e-01 |
| GOMF OXIDOREDUCTASE ACTIVITY ACTING ON CH OR CH2 GROUPS | 7 | 3.48e-02 | 4.61e-01 | 3.88e-01 |
| GOBP NITRIC OXIDE SYNTHASE BIOSYNTHETIC PROCESS | 17 | 1.01e-03 | 4.60e-01 | 7.18e-02 |
| GOMF SUMO POLYMER BINDING | 6 | 5.10e-02 | 4.60e-01 | 4.30e-01 |
| GOCC PTW PP1 PHOSPHATASE COMPLEX | 7 | 3.52e-02 | 4.60e-01 | 3.88e-01 |
| GOBP GLUTAMATE SECRETION NEUROTRANSMISSION | 7 | 3.54e-02 | 4.59e-01 | 3.88e-01 |
| GOMF UNMETHYLATED CPG BINDING | 10 | 1.19e-02 | -4.59e-01 | 2.43e-01 |
| GOCC MITOCHONDRIA ASSOCIATED ENDOPLASMIC RETICULUM MEMBRANE CONTACT SITE | 20 | 3.80e-04 | 4.59e-01 | 3.84e-02 |
| GOBP DENTINOGENESIS | 5 | 7.57e-02 | -4.59e-01 | 4.93e-01 |
| GOBP DNA STRAND RESECTION INVOLVED IN REPLICATION FORK PROCESSING | 10 | 1.20e-02 | 4.59e-01 | 2.45e-01 |
| GOMF UBIQUITIN LIGASE COMPLEX SCAFFOLD ACTIVITY | 6 | 5.19e-02 | 4.58e-01 | 4.33e-01 |
| GOMF PHOSPHATIDYLETHANOLAMINE FLIPPASE ACTIVITY | 5 | 7.61e-02 | 4.58e-01 | 4.93e-01 |
| GOBP POSITIVE REGULATION OF LYMPHOCYTE ANERGY | 5 | 7.62e-02 | 4.58e-01 | 4.93e-01 |
| GOBP REGULATION OF FC RECEPTOR MEDIATED STIMULATORY SIGNALING PATHWAY | 10 | 1.22e-02 | 4.58e-01 | 2.46e-01 |
| GOBP REGULATION OF OVARIAN FOLLICLE DEVELOPMENT | 6 | 5.24e-02 | -4.57e-01 | 4.33e-01 |
| GOCC DENDRITIC SPINE MEMBRANE | 9 | 1.77e-02 | -4.57e-01 | 2.88e-01 |
| GOBP GROWTH PLATE CARTILAGE CHONDROCYTE DIFFERENTIATION | 7 | 3.67e-02 | 4.56e-01 | 3.91e-01 |
| GOCC CALCINEURIN COMPLEX | 5 | 7.77e-02 | 4.56e-01 | 4.96e-01 |
| GOBP G QUADRUPLEX DNA UNWINDING | 7 | 3.70e-02 | 4.55e-01 | 3.91e-01 |
| GOBP INNATE IMMUNE RESPONSE IN MUCOSA | 18 | 8.33e-04 | -4.55e-01 | 6.56e-02 |
| GOMF FUCOSE BINDING | 6 | 5.37e-02 | -4.55e-01 | 4.36e-01 |
| GOCC SIGNAL RECOGNITION PARTICLE | 10 | 1.28e-02 | 4.55e-01 | 2.49e-01 |
| GOBP FORMATION OF TRANSLATION PREINITIATION COMPLEX | 7 | 3.73e-02 | 4.54e-01 | 3.93e-01 |
| GOMF NAD DEPENDENT HISTONE DEACETYLASE ACTIVITY | 5 | 7.92e-02 | -4.53e-01 | 4.97e-01 |
| GOBP TOLL LIKE RECEPTOR 7 SIGNALING PATHWAY | 11 | 9.31e-03 | 4.53e-01 | 2.21e-01 |
| GOBP SIALYLATION | 6 | 5.48e-02 | 4.53e-01 | 4.38e-01 |
| GOMF POLY A SPECIFIC RIBONUCLEASE ACTIVITY | 13 | 4.72e-03 | 4.53e-01 | 1.68e-01 |
| GOMF GUANYLATE CYCLASE ACTIVITY | 5 | 7.97e-02 | 4.53e-01 | 4.98e-01 |
| GOBP NEGATIVE REGULATION OF DENDRITIC CELL APOPTOTIC PROCESS | 6 | 5.53e-02 | 4.52e-01 | 4.40e-01 |
| GOBP NEGATIVE REGULATION OF PLASMINOGEN ACTIVATION | 7 | 3.87e-02 | -4.51e-01 | 3.98e-01 |
| GOBP L HISTIDINE TRANSMEMBRANE TRANSPORT | 5 | 8.06e-02 | -4.51e-01 | 5.01e-01 |
| GOBP REGULATION OF MONOATOMIC ANION TRANSMEMBRANE TRANSPORT | 5 | 8.08e-02 | 4.51e-01 | 5.01e-01 |
| GOBP REGULATION OF SKELETAL MUSCLE TISSUE REGENERATION | 5 | 8.10e-02 | -4.51e-01 | 5.01e-01 |
| GOBP MUCOSA ASSOCIATED LYMPHOID TISSUE DEVELOPMENT | 5 | 8.11e-02 | 4.51e-01 | 5.01e-01 |
| GOCC MRE11 COMPLEX | 5 | 8.13e-02 | 4.50e-01 | 5.02e-01 |
| GOBP POSITIVE REGULATION OF PROTEIN LOCALIZATION TO EARLY ENDOSOME | 9 | 1.95e-02 | 4.50e-01 | 3.06e-01 |
| GOBP MAINTENANCE OF DNA REPEAT ELEMENTS | 7 | 3.97e-02 | 4.49e-01 | 3.98e-01 |
| GOBP RNA SECONDARY STRUCTURE UNWINDING | 9 | 1.99e-02 | 4.48e-01 | 3.07e-01 |
| GOBP HIGH DENSITY LIPOPROTEIN PARTICLE ASSEMBLY | 10 | 1.42e-02 | -4.48e-01 | 2.57e-01 |
| GOBP TOXIN METABOLIC PROCESS | 8 | 2.87e-02 | 4.47e-01 | 3.59e-01 |
| GOMF N ACYLSPHINGOSINE AMIDOHYDROLASE ACTIVITY | 7 | 4.07e-02 | 4.47e-01 | 4.01e-01 |
| GOBP SPERMATID NUCLEUS DIFFERENTIATION | 19 | 7.58e-04 | 4.46e-01 | 6.12e-02 |
| GOCC MUSCLE MYOSIN COMPLEX | 6 | 5.86e-02 | -4.46e-01 | 4.51e-01 |
| GOBP CYTOSOL TO ENDOPLASMIC RETICULUM TRANSPORT | 5 | 8.44e-02 | -4.46e-01 | 5.09e-01 |
| GOMF N6 METHYLADENOSINE CONTAINING RNA READER ACTIVITY | 11 | 1.05e-02 | 4.45e-01 | 2.30e-01 |
| GOBP NAD BIOSYNTHESIS VIA NICOTINAMIDE RIBOSIDE SALVAGE PATHWAY | 7 | 4.14e-02 | 4.45e-01 | 4.04e-01 |
| GOBP REGULATION OF DEFENSE RESPONSE TO FUNGUS | 5 | 8.51e-02 | -4.45e-01 | 5.11e-01 |
| GOBP RETINA VASCULATURE MORPHOGENESIS IN CAMERA TYPE EYE | 6 | 5.95e-02 | 4.44e-01 | 4.53e-01 |
| GOBP ECTODERMAL CELL DIFFERENTIATION | 6 | 5.96e-02 | -4.44e-01 | 4.53e-01 |
| GOMF 1 PHOSPHATIDYLINOSITOL 4 PHOSPHATE 3 KINASE ACTIVITY | 7 | 4.22e-02 | 4.43e-01 | 4.05e-01 |
| GOCC MITOCHONDRIAL PERMEABILITY TRANSITION PORE COMPLEX | 6 | 6.04e-02 | -4.43e-01 | 4.55e-01 |
| GOBP FUCOSYLATION | 13 | 5.87e-03 | -4.41e-01 | 1.80e-01 |
| GOMF ORGANOPHOSPHATE PHOSPHATE ANTIPORTER ACTIVITY | 7 | 4.33e-02 | -4.41e-01 | 4.09e-01 |
| GOCC CKM COMPLEX | 5 | 8.80e-02 | 4.41e-01 | 5.19e-01 |
| GOBP PITUITARY GLAND DEVELOPMENT | 15 | 3.27e-03 | 4.39e-01 | 1.35e-01 |
| GOBP REGULATION OF TYPE B PANCREATIC CELL PROLIFERATION | 10 | 1.63e-02 | -4.39e-01 | 2.79e-01 |
| GOMF CASPASE BINDING | 10 | 1.63e-02 | 4.38e-01 | 2.79e-01 |
| GOBP KERATINOCYTE APOPTOTIC PROCESS | 6 | 6.30e-02 | -4.38e-01 | 4.63e-01 |
| GOCC CHYLOMICRON | 5 | 8.98e-02 | -4.38e-01 | 5.25e-01 |
| GOBP IMMUNE RESPONSE INHIBITING CELL SURFACE RECEPTOR SIGNALING PATHWAY | 7 | 4.49e-02 | 4.38e-01 | 4.12e-01 |
| GOCC RISC LOADING COMPLEX | 8 | 3.20e-02 | 4.38e-01 | 3.76e-01 |
| GOBP LNCRNA MEDIATED POST TRANSCRIPTIONAL GENE SILENCING | 6 | 6.36e-02 | 4.37e-01 | 4.64e-01 |
| GOMF HISTONE H3K27 METHYLTRANSFERASE ACTIVITY | 6 | 6.37e-02 | -4.37e-01 | 4.64e-01 |
| GOBP RISC COMPLEX ASSEMBLY | 10 | 1.68e-02 | 4.37e-01 | 2.83e-01 |
| GOBP TRYPTOPHAN TRANSPORT | 6 | 6.40e-02 | 4.37e-01 | 4.65e-01 |
| GOBP REGULATION OF CYCLIC NUCLEOTIDE PHOSPHODIESTERASE ACTIVITY | 6 | 6.49e-02 | 4.35e-01 | 4.66e-01 |
| GOBP REGULATION OF HELICASE ACTIVITY | 9 | 2.39e-02 | 4.35e-01 | 3.36e-01 |
| GOMF INTERLEUKIN 1 RECEPTOR ACTIVITY | 5 | 9.24e-02 | 4.35e-01 | 5.31e-01 |
| GOBP ATRIOVENTRICULAR CANAL DEVELOPMENT | 5 | 9.24e-02 | 4.35e-01 | 5.31e-01 |
| GOMF SPHINGOSINE 1 PHOSPHATE RECEPTOR ACTIVITY | 7 | 4.67e-02 | -4.34e-01 | 4.21e-01 |
| GOBP MAINTENANCE OF CENTROSOME LOCATION | 6 | 6.56e-02 | 4.34e-01 | 4.68e-01 |
| GOBP POSITIVE REGULATION OF TOLERANCE INDUCTION | 10 | 1.75e-02 | 4.34e-01 | 2.87e-01 |
| GOBP NEGATIVE REGULATION OF FATTY ACID TRANSPORT | 7 | 4.72e-02 | -4.33e-01 | 4.23e-01 |
| GOBP MAST CELL DIFFERENTIATION | 5 | 9.37e-02 | -4.33e-01 | 5.34e-01 |
| GOBP PHOSPHOLIPID EFFLUX | 7 | 4.76e-02 | -4.32e-01 | 4.24e-01 |
| GOMF TESTOSTERONE 17 BETA DEHYDROGENASE NADPPLUS ACTIVITY | 6 | 6.66e-02 | -4.32e-01 | 4.70e-01 |
| GOCC CCR4 NOT CORE COMPLEX | 6 | 6.72e-02 | 4.31e-01 | 4.71e-01 |
| GOMF PROTEIN GERANYLGERANYLTRANSFERASE ACTIVITY | 5 | 9.49e-02 | 4.31e-01 | 5.36e-01 |
| GOBP PROLINE TRANSPORT | 9 | 2.57e-02 | 4.29e-01 | 3.47e-01 |
| GOMF K63 LINKED DEUBIQUITINASE ACTIVITY | 15 | 3.98e-03 | 4.29e-01 | 1.51e-01 |
| GOMF C ACYLTRANSFERASE ACTIVITY | 18 | 1.62e-03 | 4.29e-01 | 9.71e-02 |
| GOBP REGULATION OF MRNA CIS SPLICING VIA SPLICEOSOME | 5 | 9.66e-02 | -4.29e-01 | 5.40e-01 |
| GOMF ADENYLATE KINASE ACTIVITY | 7 | 4.93e-02 | 4.29e-01 | 4.25e-01 |
| GOBP NEGATIVE REGULATION OF AUTOPHAGY OF MITOCHONDRION | 7 | 4.95e-02 | -4.29e-01 | 4.26e-01 |
| GOBP POSITIVE REGULATION OF LYSOSOMAL PROTEIN CATABOLIC PROCESS | 5 | 9.69e-02 | -4.29e-01 | 5.41e-01 |
| GOBP BLOOD COAGULATION FIBRIN CLOT FORMATION | 11 | 1.39e-02 | -4.28e-01 | 2.54e-01 |
| GOBP REGULATION OF SYNAPTIC VESICLE MEMBRANE ORGANIZATION | 8 | 3.60e-02 | -4.28e-01 | 3.89e-01 |
| GOBP POSITIVE REGULATION OF RAC PROTEIN SIGNAL TRANSDUCTION | 8 | 3.61e-02 | 4.28e-01 | 3.89e-01 |
| GOCC EQUATORIAL MICROTUBULE ORGANIZING CENTER | 5 | 9.76e-02 | -4.28e-01 | 5.43e-01 |
| GOBP FAS SIGNALING PATHWAY | 6 | 7.01e-02 | 4.27e-01 | 4.81e-01 |
| GOMF RETROMER COMPLEX BINDING | 9 | 2.66e-02 | 4.27e-01 | 3.52e-01 |
| GOBP REGULATION OF DOPAMINE RECEPTOR SIGNALING PATHWAY | 6 | 7.05e-02 | 4.26e-01 | 4.82e-01 |
| GOBP POSITIVE REGULATION OF MONOCYTE DIFFERENTIATION | 8 | 3.70e-02 | -4.26e-01 | 3.91e-01 |
| GOBP NEGATIVE REGULATION OF T CELL MIGRATION | 5 | 9.93e-02 | 4.26e-01 | 5.46e-01 |
| GOBP HYDROGEN SULFIDE METABOLIC PROCESS | 5 | 9.94e-02 | -4.25e-01 | 5.46e-01 |
| GOBP ESTABLISHMENT OR MAINTENANCE OF CYTOSKELETON POLARITY | 7 | 5.14e-02 | -4.25e-01 | 4.32e-01 |
| GOMF FRUCTOSE BINDING | 6 | 7.15e-02 | -4.25e-01 | 4.85e-01 |
| GOMF ACETYL COA C ACYLTRANSFERASE ACTIVITY | 7 | 5.16e-02 | 4.25e-01 | 4.33e-01 |
| GOCC IGA IMMUNOGLOBULIN COMPLEX | 7 | 5.18e-02 | -4.24e-01 | 4.33e-01 |
| GOBP RNA CAPPING | 15 | 4.43e-03 | 4.24e-01 | 1.61e-01 |
| GOBP REGULATION OF DNA DEMETHYLATION | 5 | 1.00e-01 | -4.24e-01 | 5.47e-01 |
| GOBP REGULATION OF FATTY ACID BETA OXIDATION | 17 | 2.46e-03 | -4.24e-01 | 1.20e-01 |
| GOBP BONE TRABECULA FORMATION | 7 | 5.26e-02 | -4.23e-01 | 4.33e-01 |
| GOMF HISTONE H2A UBIQUITIN LIGASE ACTIVITY | 6 | 7.27e-02 | 4.23e-01 | 4.87e-01 |
| GOCC THO COMPLEX | 6 | 7.30e-02 | 4.23e-01 | 4.87e-01 |
| GOBP REGULATION OF HISTAMINE SECRETION BY MAST CELL | 6 | 7.30e-02 | 4.23e-01 | 4.87e-01 |
| GOMF PHOSPHATIDYLINOSITOL 3 5 BISPHOSPHATE 3 PHOSPHATASE ACTIVITY | 11 | 1.52e-02 | 4.23e-01 | 2.65e-01 |
| GOBP PROTEIN GERANYLGERANYLATION | 6 | 7.33e-02 | 4.22e-01 | 4.87e-01 |
| GOBP SULFUR AMINO ACID CATABOLIC PROCESS | 6 | 7.40e-02 | -4.21e-01 | 4.89e-01 |
| GOBP REGULATION OF FIBROBLAST APOPTOTIC PROCESS | 16 | 3.54e-03 | 4.21e-01 | 1.41e-01 |
| GOBP REGULATION OF PROTEIN LIPIDATION | 9 | 2.89e-02 | 4.21e-01 | 3.59e-01 |
| GOMF PRIMARY AMINE OXIDASE ACTIVITY | 7 | 5.44e-02 | -4.20e-01 | 4.38e-01 |
| GOMF PHOSPHATIDYLINOSITOL 3 4 5 TRISPHOSPHATE 5 PHOSPHATASE ACTIVITY | 6 | 7.51e-02 | -4.20e-01 | 4.93e-01 |
| GOBP SOMITE ROSTRAL CAUDAL AXIS SPECIFICATION | 5 | 1.04e-01 | 4.19e-01 | 5.56e-01 |
| GOBP REGULATION OF MITOCHONDRIAL RNA CATABOLIC PROCESS | 5 | 1.05e-01 | 4.19e-01 | 5.56e-01 |
| GOBP ESTABLISHMENT OF SISTER CHROMATID COHESION | 10 | 2.17e-02 | 4.19e-01 | 3.22e-01 |
| GOCC CYTOPLASMIC SIDE OF ENDOSOME MEMBRANE | 6 | 7.57e-02 | 4.19e-01 | 4.93e-01 |
| GOMF CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY INVOLVED IN APOPTOTIC PROCESS | 11 | 1.62e-02 | 4.18e-01 | 2.79e-01 |
| GOBP NEURAL PLATE REGIONALIZATION | 6 | 7.64e-02 | -4.18e-01 | 4.93e-01 |
| GOCC ENDOPLASMIC RETICULUM PALMITOYLTRANSFERASE COMPLEX | 8 | 4.10e-02 | 4.17e-01 | 4.02e-01 |
| GOBP PROTEIN LOCALIZATION TO NON MOTILE CILIUM | 10 | 2.25e-02 | 4.17e-01 | 3.26e-01 |
| GOBP NEGATIVE REGULATION OF INTERFERON ALPHA PRODUCTION | 6 | 7.77e-02 | 4.16e-01 | 4.96e-01 |
| GOMF SELENIUM BINDING | 8 | 4.16e-02 | 4.16e-01 | 4.05e-01 |
| GOBP PROTEIN LOCALIZATION TO EARLY ENDOSOME | 13 | 9.44e-03 | 4.16e-01 | 2.22e-01 |
| GOBP NEURON NEURON SYNAPTIC TRANSMISSION | 6 | 7.78e-02 | 4.16e-01 | 4.96e-01 |
| GOMF K48 LINKED POLYUBIQUITIN MODIFICATION DEPENDENT PROTEIN BINDING | 10 | 2.28e-02 | -4.16e-01 | 3.28e-01 |
| GOCC UNIPLEX COMPLEX | 6 | 7.81e-02 | 4.15e-01 | 4.96e-01 |
| GOBP NEGATIVE REGULATION OF COMPLEMENT ACTIVATION | 12 | 1.32e-02 | 4.13e-01 | 2.49e-01 |
| GOMF APOLIPOPROTEIN RECEPTOR BINDING | 5 | 1.10e-01 | -4.13e-01 | 5.63e-01 |
| GOBP FAT PAD DEVELOPMENT | 9 | 3.23e-02 | 4.12e-01 | 3.77e-01 |
| GOCC INTERCHROMATIN GRANULE | 5 | 1.11e-01 | 4.12e-01 | 5.64e-01 |
| GOBP COLLECTING DUCT DEVELOPMENT | 7 | 5.94e-02 | -4.12e-01 | 4.53e-01 |
| GOMF NEUROPEPTIDE ACTIVITY | 9 | 3.26e-02 | -4.11e-01 | 3.77e-01 |
| GOMF DIACYLGLYCEROL BINDING | 11 | 1.82e-02 | -4.11e-01 | 2.94e-01 |
| GOCC B WICH COMPLEX | 7 | 5.98e-02 | 4.11e-01 | 4.53e-01 |
| GOBP SUCCINATE METABOLIC PROCESS | 5 | 1.12e-01 | 4.11e-01 | 5.66e-01 |
| GOMF IMMUNOGLOBULIN RECEPTOR ACTIVITY | 11 | 1.84e-02 | 4.11e-01 | 2.94e-01 |
| GOMF NAD DEPENDENT PROTEIN LYSINE DEACETYLASE ACTIVITY | 7 | 6.07e-02 | -4.09e-01 | 4.56e-01 |
| GOBP REGULATION OF PROTEIN POLYUBIQUITINATION | 24 | 5.18e-04 | 4.09e-01 | 4.68e-02 |
| GOBP DOUBLE STRAND BREAK REPAIR VIA CLASSICAL NONHOMOLOGOUS END JOINING | 9 | 3.35e-02 | 4.09e-01 | 3.83e-01 |
| GOBP ANTIBACTERIAL PEPTIDE PRODUCTION | 5 | 1.14e-01 | -4.09e-01 | 5.70e-01 |
| GOBP ANTIMICROBIAL PEPTIDE PRODUCTION | 5 | 1.14e-01 | -4.09e-01 | 5.70e-01 |
| GOMF PYRUVATE DEHYDROGENASE ACTIVITY | 5 | 1.14e-01 | 4.08e-01 | 5.70e-01 |
| GOMF KINETOCHORE BINDING | 6 | 8.33e-02 | 4.08e-01 | 5.05e-01 |
| GOCC UBIQUITIN CONJUGATING ENZYME COMPLEX | 8 | 4.56e-02 | 4.08e-01 | 4.15e-01 |
| GOBP ERROR PRONE TRANSLESION SYNTHESIS | 12 | 1.44e-02 | 4.08e-01 | 2.58e-01 |
| GOBP RECEPTOR MEDIATED ENDOCYTOSIS OF VIRUS BY HOST CELL | 9 | 3.42e-02 | 4.08e-01 | 3.84e-01 |
| GOBP RRNA 5 END PROCESSING | 5 | 1.15e-01 | -4.07e-01 | 5.72e-01 |
| GOBP FIBROBLAST APOPTOTIC PROCESS | 22 | 9.46e-04 | 4.07e-01 | 6.98e-02 |
| GOBP VESICLE TETHERING INVOLVED IN EXOCYTOSIS | 9 | 3.45e-02 | 4.07e-01 | 3.85e-01 |
| GOMF RETINOIC ACID BINDING | 7 | 6.25e-02 | -4.07e-01 | 4.63e-01 |
| GOBP PROTEIN N LINKED GLYCOSYLATION VIA ASPARAGINE | 23 | 7.49e-04 | 4.06e-01 | 6.10e-02 |
| GOBP REGULATION OF COLLAGEN FIBRIL ORGANIZATION | 8 | 4.70e-02 | -4.05e-01 | 4.22e-01 |
| GOMF CALCIUM DEPENDENT CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY | 13 | 1.14e-02 | -4.05e-01 | 2.42e-01 |
| GOBP POSITIVE REGULATION OF FATTY ACID OXIDATION | 13 | 1.14e-02 | -4.05e-01 | 2.42e-01 |
| GOBP MANNOSE METABOLIC PROCESS | 9 | 3.53e-02 | -4.05e-01 | 3.88e-01 |
| GOBP REGULATION OF SKELETAL MUSCLE ACETYLCHOLINE GATED CHANNEL CLUSTERING | 5 | 1.18e-01 | 4.04e-01 | 5.78e-01 |
| GOBP RESPONSE TO BLUE LIGHT | 5 | 1.18e-01 | -4.04e-01 | 5.78e-01 |
| GOBP FRUCTOSE TRANSMEMBRANE TRANSPORT | 7 | 6.44e-02 | -4.04e-01 | 4.66e-01 |
| GOMF FRUCTOSE TRANSMEMBRANE TRANSPORTER ACTIVITY | 7 | 6.44e-02 | -4.04e-01 | 4.66e-01 |
| GOMF PLATELET DERIVED GROWTH FACTOR BINDING | 6 | 8.71e-02 | -4.03e-01 | 5.17e-01 |
| GOMF CO SMAD BINDING | 9 | 3.62e-02 | 4.03e-01 | 3.89e-01 |
| GOMF PROTEIN CYSTEINE S STEAROYLTRANSFERASE ACTIVITY | 7 | 6.50e-02 | 4.03e-01 | 4.66e-01 |
| GOBP BASE EXCISION REPAIR GAP FILLING | 14 | 9.13e-03 | -4.02e-01 | 2.20e-01 |
| GOCC PRESYNAPTIC ACTIVE ZONE CYTOPLASMIC COMPONENT | 11 | 2.12e-02 | -4.01e-01 | 3.18e-01 |
| GOBP NEGATIVE REGULATION OF CYTOKINESIS | 5 | 1.20e-01 | -4.01e-01 | 5.83e-01 |
| GOCC PHOSPHATIDYLINOSITOL 3 KINASE COMPLEX CLASS III | 7 | 6.61e-02 | 4.01e-01 | 4.68e-01 |
| GOCC DNA REPAIR COMPLEX | 22 | 1.13e-03 | 4.01e-01 | 7.42e-02 |
| GOBP NAD CATABOLIC PROCESS | 19 | 2.54e-03 | -4.00e-01 | 1.20e-01 |
| GOBP DELAMINATION | 5 | 1.22e-01 | -3.99e-01 | 5.85e-01 |
| GOBP DEVELOPMENT OF SECONDARY FEMALE SEXUAL CHARACTERISTICS | 6 | 9.04e-02 | -3.99e-01 | 5.25e-01 |
| GOMF HISTONE UBIQUITIN LIGASE ACTIVITY | 11 | 2.19e-02 | 3.99e-01 | 3.22e-01 |
| GOBP UV PROTECTION | 11 | 2.23e-02 | -3.98e-01 | 3.25e-01 |
| GOBP NEGATIVE REGULATION OF T HELPER 17 TYPE IMMUNE RESPONSE | 10 | 2.94e-02 | -3.98e-01 | 3.62e-01 |
| GOCC NLS DEPENDENT PROTEIN NUCLEAR IMPORT COMPLEX | 9 | 3.89e-02 | 3.98e-01 | 3.98e-01 |
| GOBP REGULATION OF RECEPTOR BINDING | 12 | 1.71e-02 | -3.97e-01 | 2.85e-01 |
| GOMF PYRIMIDINE NUCLEOBASE TRANSMEMBRANE TRANSPORTER ACTIVITY | 6 | 9.27e-02 | 3.96e-01 | 5.32e-01 |
| GOCC DNA REPLICATION FACTOR A COMPLEX | 12 | 1.74e-02 | 3.96e-01 | 2.87e-01 |
| GOBP EXTRACELLULAR REGULATION OF SIGNAL TRANSDUCTION | 11 | 2.29e-02 | -3.96e-01 | 3.29e-01 |
| GOBP CANNABINOID SIGNALING PATHWAY | 6 | 9.33e-02 | -3.96e-01 | 5.33e-01 |
| GOBP FOLATE TRANSMEMBRANE TRANSPORT | 5 | 1.26e-01 | -3.95e-01 | 5.91e-01 |
| GOBP R LOOP PROCESSING | 9 | 4.03e-02 | 3.95e-01 | 4.01e-01 |
| GOBP DISTAL TUBULE DEVELOPMENT | 7 | 7.07e-02 | -3.95e-01 | 4.82e-01 |
| GOBP REGULATION OF GLUTAMATE SECRETION NEUROTRANSMISSION | 5 | 1.27e-01 | 3.94e-01 | 5.92e-01 |
| GOBP CAMP CATABOLIC PROCESS | 8 | 5.38e-02 | 3.94e-01 | 4.36e-01 |
| GOCC MICROTUBULE BUNDLE | 6 | 9.49e-02 | -3.94e-01 | 5.36e-01 |
| GOMF 3 5 RNA HELICASE ACTIVITY | 5 | 1.28e-01 | 3.93e-01 | 5.93e-01 |
| GOBP PLUS END DIRECTED ORGANELLE TRANSPORT ALONG MICROTUBULE | 7 | 7.18e-02 | 3.93e-01 | 4.86e-01 |
| GOBP METANEPHRIC GLOMERULUS DEVELOPMENT | 9 | 4.15e-02 | -3.92e-01 | 4.04e-01 |
| GOCC NUCLEOTIDE ACTIVATED PROTEIN KINASE COMPLEX | 8 | 5.46e-02 | 3.92e-01 | 4.38e-01 |
| GOBP TRNA TRANSCRIPTION | 13 | 1.43e-02 | -3.92e-01 | 2.58e-01 |
| GOMF C X3 C CHEMOKINE BINDING | 5 | 1.29e-01 | 3.92e-01 | 5.94e-01 |
| GOBP CONSTITUTIVE SECRETORY PATHWAY | 7 | 7.24e-02 | 3.92e-01 | 4.86e-01 |
| GOMF ADENINE TRANSMEMBRANE TRANSPORTER ACTIVITY | 5 | 1.29e-01 | -3.92e-01 | 5.94e-01 |
| GOBP DOUBLE STRAND BREAK REPAIR VIA ALTERNATIVE NONHOMOLOGOUS END JOINING | 8 | 5.49e-02 | 3.92e-01 | 4.38e-01 |
| GOBP G1 TO G0 TRANSITION | 17 | 5.17e-03 | -3.92e-01 | 1.75e-01 |
| GOMF BETA 2 MICROGLOBULIN BINDING | 9 | 4.20e-02 | -3.92e-01 | 4.05e-01 |
| GOBP POSITIVE REGULATION OF DNA METHYLATION DEPENDENT HETEROCHROMATIN FORMATION | 11 | 2.46e-02 | 3.91e-01 | 3.39e-01 |
| GOBP EPOXIDE METABOLIC PROCESS | 5 | 1.30e-01 | -3.91e-01 | 5.94e-01 |
| GOBP POST TRANSLATIONAL PROTEIN TARGETING TO MEMBRANE TRANSLOCATION | 7 | 7.31e-02 | 3.91e-01 | 4.87e-01 |
| GOBP INTERLEUKIN 33 MEDIATED SIGNALING PATHWAY | 8 | 5.54e-02 | 3.91e-01 | 4.40e-01 |
| GOBP LONG CHAIN FATTY ACID BIOSYNTHETIC PROCESS | 20 | 2.50e-03 | -3.90e-01 | 1.20e-01 |
| GOBP HORMONE CATABOLIC PROCESS | 7 | 7.39e-02 | 3.90e-01 | 4.89e-01 |
| GOBP OLIGODENDROCYTE APOPTOTIC PROCESS | 5 | 1.31e-01 | 3.90e-01 | 5.95e-01 |
| GOBP ISG15 PROTEIN CONJUGATION | 6 | 9.85e-02 | 3.89e-01 | 5.45e-01 |
| GOBP OSTEOCLAST PROLIFERATION | 7 | 7.46e-02 | -3.89e-01 | 4.90e-01 |
| GOBP NEGATIVE REGULATION OF POTASSIUM ION TRANSMEMBRANE TRANSPORTER ACTIVITY | 12 | 1.97e-02 | 3.89e-01 | 3.06e-01 |
| GOBP HIGH DENSITY LIPOPROTEIN PARTICLE REMODELING | 12 | 1.97e-02 | -3.89e-01 | 3.06e-01 |
| GOBP NEGATIVE REGULATION OF MAST CELL ACTIVATION | 10 | 3.34e-02 | 3.89e-01 | 3.81e-01 |
| GOMF AMP ACTIVATED PROTEIN KINASE ACTIVITY | 5 | 1.32e-01 | 3.88e-01 | 5.98e-01 |
| GOCC SYNAPSE ASSOCIATED EXTRACELLULAR MATRIX | 5 | 1.33e-01 | -3.88e-01 | 5.98e-01 |
| GOBP POSITIVE REGULATION OF TRIGLYCERIDE BIOSYNTHETIC PROCESS | 12 | 1.99e-02 | -3.88e-01 | 3.07e-01 |
| GOBP POSITIVE REGULATION OF FATTY ACID BETA OXIDATION | 9 | 4.39e-02 | -3.88e-01 | 4.11e-01 |
| GOBP PROTEIN POLY ADP RIBOSYLATION | 10 | 3.37e-02 | 3.88e-01 | 3.83e-01 |
| GOMF RRNA ADENINE METHYLTRANSFERASE ACTIVITY | 7 | 7.61e-02 | 3.87e-01 | 4.93e-01 |
| GOMF 7S RNA BINDING | 7 | 7.63e-02 | 3.87e-01 | 4.93e-01 |
| GOBP INTERNAL PEPTIDYL LYSINE ACETYLATION | 7 | 7.66e-02 | -3.87e-01 | 4.93e-01 |
| GOBP REGULATION OF COMPLEMENT DEPENDENT CYTOTOXICITY | 8 | 5.85e-02 | 3.86e-01 | 4.51e-01 |
| GOCC CIA COMPLEX | 5 | 1.35e-01 | -3.86e-01 | 5.99e-01 |
| GOBP CAVEOLIN MEDIATED ENDOCYTOSIS | 9 | 4.48e-02 | -3.86e-01 | 4.12e-01 |
| GOBP POSITIVE REGULATION OF SISTER CHROMATID COHESION | 9 | 4.49e-02 | 3.86e-01 | 4.12e-01 |
| GOBP COPPER ION TRANSMEMBRANE TRANSPORT | 7 | 7.71e-02 | 3.86e-01 | 4.95e-01 |
| GOMF COPPER ION TRANSMEMBRANE TRANSPORTER ACTIVITY | 7 | 7.71e-02 | 3.86e-01 | 4.95e-01 |
| GOMF SIGNAL RECOGNITION PARTICLE BINDING | 8 | 5.89e-02 | 3.86e-01 | 4.53e-01 |
| GOCC NUCLEAR LAMINA | 12 | 2.09e-02 | -3.85e-01 | 3.16e-01 |
| GOCC ALVEOLAR LAMELLAR BODY | 7 | 7.79e-02 | -3.85e-01 | 4.96e-01 |
| GOBP NEGATIVE REGULATION OF TOLL LIKE RECEPTOR 9 SIGNALING PATHWAY | 5 | 1.36e-01 | 3.85e-01 | 6.02e-01 |
| GOBP NEGATIVE REGULATION OF BLOOD VESSEL ENDOTHELIAL CELL PROLIFERATION INVOLVED IN SPROUTING ANGIOGENESIS | 5 | 1.37e-01 | -3.84e-01 | 6.02e-01 |
| GOMF GLYCOLIPID MANNOSYLTRANSFERASE ACTIVITY | 5 | 1.37e-01 | 3.84e-01 | 6.03e-01 |
| GOBP LYMPHOCYTE MIGRATION INTO LYMPHOID ORGANS | 8 | 6.01e-02 | 3.84e-01 | 4.54e-01 |
| GOCC HOST CELLULAR COMPONENT | 8 | 6.01e-02 | 3.84e-01 | 4.54e-01 |
| GOBP PEPTIDOGLYCAN METABOLIC PROCESS | 5 | 1.38e-01 | -3.83e-01 | 6.04e-01 |
| GOMF 1 PHOSPHATIDYLINOSITOL 3 KINASE ACTIVITY | 10 | 3.70e-02 | 3.81e-01 | 3.91e-01 |
| GOBP NERVE GROWTH FACTOR SIGNALING PATHWAY | 10 | 3.70e-02 | 3.81e-01 | 3.91e-01 |
| GOCC BOX C D RNP COMPLEX | 5 | 1.40e-01 | -3.81e-01 | 6.07e-01 |
| GOBP POSITIVE REGULATION OF FILOPODIUM ASSEMBLY | 25 | 9.88e-04 | 3.81e-01 | 7.18e-02 |
| GOBP SPHINGOID BIOSYNTHETIC PROCESS | 13 | 1.75e-02 | 3.81e-01 | 2.87e-01 |
| GOBP REGULATION OF ASPARTIC TYPE PEPTIDASE ACTIVITY | 7 | 8.14e-02 | -3.80e-01 | 5.02e-01 |
| GOBP REGULATION BY VIRUS OF VIRAL PROTEIN LEVELS IN HOST CELL | 7 | 8.14e-02 | 3.80e-01 | 5.02e-01 |
| GOMF PROTEIN PHOSPHATASE 2B BINDING | 5 | 1.41e-01 | 3.80e-01 | 6.09e-01 |
| GOBP TRIGLYCERIDE RICH LIPOPROTEIN PARTICLE REMODELING | 6 | 1.07e-01 | -3.80e-01 | 5.61e-01 |
| GOMF GLUTAMATE GATED RECEPTOR ACTIVITY | 8 | 6.31e-02 | -3.79e-01 | 4.63e-01 |
| GOCC GOLGI TRANS CISTERNA | 10 | 3.78e-02 | 3.79e-01 | 3.94e-01 |
| GOBP DIAPEDESIS | 6 | 1.08e-01 | 3.79e-01 | 5.61e-01 |
| GOBP POSITIVE REGULATION OF EPITHELIAL TUBE FORMATION | 5 | 1.42e-01 | -3.79e-01 | 6.09e-01 |
| GOBP ENDOTHELIAL CELL MORPHOGENESIS | 6 | 1.08e-01 | 3.79e-01 | 5.61e-01 |
| GOBP MESENDODERM DEVELOPMENT | 6 | 1.08e-01 | -3.79e-01 | 5.61e-01 |
| GOBP REGULATION OF MEMBRANE TUBULATION | 5 | 1.42e-01 | 3.79e-01 | 6.09e-01 |
| GOBP CHIASMA ASSEMBLY | 6 | 1.08e-01 | 3.79e-01 | 5.61e-01 |
| GOBP NEGATIVE REGULATION OF RECEPTOR BINDING | 9 | 4.92e-02 | -3.79e-01 | 4.25e-01 |
| GOBP NEGATIVE REGULATION OF CD4 POSITIVE ALPHA BETA T CELL PROLIFERATION | 12 | 2.32e-02 | 3.79e-01 | 3.30e-01 |
| GOMF ROUNDABOUT BINDING | 5 | 1.43e-01 | -3.79e-01 | 6.10e-01 |
| GOCC POSTSYNAPTIC CYTOSKELETON | 10 | 3.82e-02 | -3.78e-01 | 3.97e-01 |
| GOBP POSITIVE REGULATION OF CENTRIOLE ELONGATION | 5 | 1.43e-01 | 3.78e-01 | 6.10e-01 |
| GOBP G PROTEIN COUPLED GLUTAMATE RECEPTOR SIGNALING PATHWAY | 7 | 8.30e-02 | -3.78e-01 | 5.05e-01 |
| GOBP OPSONIZATION | 8 | 6.44e-02 | -3.78e-01 | 4.66e-01 |
| GOMF IGG RECEPTOR ACTIVITY | 6 | 1.10e-01 | 3.77e-01 | 5.63e-01 |
| GOBP CHROMATIN LOOPING | 14 | 1.46e-02 | 3.77e-01 | 2.59e-01 |
| GOCC WASH COMPLEX | 14 | 1.47e-02 | 3.77e-01 | 2.59e-01 |
| GOBP LOCALIZATION OF CELL | 6 | 1.10e-01 | -3.77e-01 | 5.63e-01 |
| GOBP POSITIVE REGULATION OF MUSCLE HYPERTROPHY | 21 | 2.81e-03 | 3.77e-01 | 1.27e-01 |
| GOBP RESPONSE TO DISACCHARIDE | 5 | 1.45e-01 | -3.77e-01 | 6.12e-01 |
| GOMF BIS 5 ADENOSYL PENTAPHOSPHATASE ACTIVITY | 5 | 1.45e-01 | 3.76e-01 | 6.12e-01 |
| GOBP NEGATIVE REGULATION OF RESPIRATORY BURST | 5 | 1.46e-01 | -3.76e-01 | 6.13e-01 |
| GOBP PROTEIN O LINKED GLYCOSYLATION VIA SERINE | 8 | 6.58e-02 | 3.76e-01 | 4.68e-01 |
| GOMF PYRUVATE DEHYDROGENASE ACETYL TRANSFERRING PHOSPHATASE ACTIVITY | 5 | 1.46e-01 | 3.76e-01 | 6.13e-01 |
| GOMF POLY G BINDING | 8 | 6.60e-02 | 3.75e-01 | 4.68e-01 |
| GOCC CEREBELLAR CLIMBING FIBER TO PURKINJE CELL SYNAPSE | 5 | 1.46e-01 | 3.75e-01 | 6.13e-01 |
| GOBP NEGATIVE REGULATION OF MEIOTIC NUCLEAR DIVISION | 6 | 1.12e-01 | 3.75e-01 | 5.67e-01 |
| GOBP REGULATION OF NK T CELL DIFFERENTIATION | 6 | 1.12e-01 | 3.75e-01 | 5.67e-01 |
| GOBP ANTIGEN PROCESSING AND PRESENTATION OF LIPID ANTIGEN VIA MHC CLASS IB | 7 | 8.66e-02 | -3.74e-01 | 5.15e-01 |
| GOBP GLYCOLYTIC PROCESS THROUGH GLUCOSE 6 PHOSPHATE | 18 | 6.01e-03 | -3.74e-01 | 1.82e-01 |
| GOBP MICROTUBULE NUCLEATION BY MICROTUBULE ORGANIZING CENTER | 5 | 1.48e-01 | 3.74e-01 | 6.13e-01 |
| GOBP SEQUESTERING OF EXTRACELLULAR LIGAND FROM RECEPTOR | 9 | 5.23e-02 | -3.74e-01 | 4.33e-01 |
| GOBP SYNAPTIC VESICLE DOCKING | 6 | 1.14e-01 | -3.73e-01 | 5.70e-01 |
| GOBP AXONOGENESIS INVOLVED IN INNERVATION | 7 | 8.80e-02 | 3.72e-01 | 5.19e-01 |
| GOMF ISOPRENOID BINDING | 13 | 2.02e-02 | -3.72e-01 | 3.10e-01 |
| GOBP REGULATION OF TRANSLATIONAL INITIATION BY EIF2 ALPHA PHOSPHORYLATION | 12 | 2.56e-02 | 3.72e-01 | 3.47e-01 |
| GOBP NEGATIVE REGULATION OF CATECHOLAMINE SECRETION | 7 | 8.83e-02 | -3.72e-01 | 5.19e-01 |
| GOMF NUCLEAR THYROID HORMONE RECEPTOR BINDING | 27 | 8.22e-04 | 3.72e-01 | 6.53e-02 |
| GOBP POSITIVE REGULATION OF APOPTOTIC PROCESS INVOLVED IN DEVELOPMENT | 5 | 1.50e-01 | -3.72e-01 | 6.13e-01 |
| GOBP POSITIVE REGULATION OF APOPTOTIC PROCESS INVOLVED IN MORPHOGENESIS | 5 | 1.50e-01 | -3.72e-01 | 6.13e-01 |
| GOBP CENTRIOLE ELONGATION | 8 | 6.88e-02 | 3.72e-01 | 4.77e-01 |
| GOBP REGULATION OF ANAPHASE PROMOTING COMPLEX DEPENDENT CATABOLIC PROCESS | 5 | 1.50e-01 | -3.71e-01 | 6.13e-01 |
| GOMF CYTOSKELETON NUCLEAR MEMBRANE ANCHOR ACTIVITY | 5 | 1.51e-01 | -3.71e-01 | 6.13e-01 |
| GOBP SPERMIDINE METABOLIC PROCESS | 8 | 6.95e-02 | -3.71e-01 | 4.79e-01 |
| GOBP FATTY ACYL COA CATABOLIC PROCESS | 6 | 1.16e-01 | -3.70e-01 | 5.74e-01 |
| GOMF LIGAND GATED SODIUM CHANNEL ACTIVITY | 9 | 5.44e-02 | -3.70e-01 | 4.38e-01 |
| GOMF MITOGEN ACTIVATED PROTEIN KINASE KINASE BINDING | 10 | 4.26e-02 | -3.70e-01 | 4.07e-01 |
| GOBP HEPATOCYTE GROWTH FACTOR RECEPTOR SIGNALING PATHWAY | 9 | 5.45e-02 | 3.70e-01 | 4.38e-01 |
| GOBP REGULATION OF CELL COMMUNICATION BY ELECTRICAL COUPLING | 9 | 5.46e-02 | 3.70e-01 | 4.38e-01 |
| GOBP REGULATION OF MITOCHONDRIAL ATP SYNTHESIS COUPLED ELECTRON TRANSPORT | 6 | 1.17e-01 | 3.70e-01 | 5.76e-01 |
| GOMF TYPE 5 METABOTROPIC GLUTAMATE RECEPTOR BINDING | 6 | 1.17e-01 | 3.70e-01 | 5.76e-01 |
| GOBP NEGATIVE REGULATION OF DELAYED RECTIFIER POTASSIUM CHANNEL ACTIVITY | 7 | 9.02e-02 | 3.70e-01 | 5.25e-01 |
| GOBP UBIQUITIN DEPENDENT ENDOCYTOSIS | 6 | 1.17e-01 | -3.70e-01 | 5.76e-01 |
| GOBP LEPTIN MEDIATED SIGNALING PATHWAY | 8 | 7.03e-02 | 3.69e-01 | 4.82e-01 |
| GOBP POSITIVE REGULATION OF MITOTIC SISTER CHROMATID SEGREGATION | 6 | 1.17e-01 | -3.69e-01 | 5.77e-01 |
| GOBP METANEPHRIC NEPHRON TUBULE MORPHOGENESIS | 5 | 1.53e-01 | -3.69e-01 | 6.16e-01 |
| GOBP CELLULAR RESPONSE TO INTERFERON ALPHA | 8 | 7.06e-02 | 3.69e-01 | 4.82e-01 |
| GOBP ATTACHMENT OF MITOTIC SPINDLE MICROTUBULES TO KINETOCHORE | 24 | 1.74e-03 | 3.69e-01 | 1.02e-01 |
| GOBP SKELETAL MUSCLE SATELLITE CELL PROLIFERATION | 13 | 2.12e-02 | 3.69e-01 | 3.18e-01 |
| GOCC INHIBITORY SYNAPSE | 6 | 1.18e-01 | -3.69e-01 | 5.78e-01 |
| GOBP NEGATIVE REGULATION OF VASOCONSTRICTION | 8 | 7.09e-02 | 3.69e-01 | 4.84e-01 |
| GOBP TETRAPYRROLE CATABOLIC PROCESS | 9 | 5.55e-02 | -3.69e-01 | 4.40e-01 |
| GOBP EXCITATORY CHEMICAL SYNAPTIC TRANSMISSION | 5 | 1.54e-01 | -3.69e-01 | 6.16e-01 |
| GOBP REGULATION OF CARDIAC MUSCLE CELL ACTION POTENTIAL INVOLVED IN REGULATION OF CONTRACTION | 5 | 1.54e-01 | 3.68e-01 | 6.17e-01 |
| GOBP REGULATION OF TOLERANCE INDUCTION | 18 | 6.84e-03 | 3.68e-01 | 1.93e-01 |
| GOBP REGULATION OF IRE1 MEDIATED UNFOLDED PROTEIN RESPONSE | 13 | 2.16e-02 | 3.68e-01 | 3.21e-01 |
| GOMF INOSITOL 1 3 4 5 TETRAKISPHOSPHATE BINDING | 5 | 1.54e-01 | -3.68e-01 | 6.17e-01 |
| GOBP NUCLEOSIDE MONOPHOSPHATE PHOSPHORYLATION | 9 | 5.60e-02 | 3.68e-01 | 4.42e-01 |
| GOBP WYBUTOSINE METABOLIC PROCESS | 6 | 1.19e-01 | 3.68e-01 | 5.81e-01 |
| GOCC VACUOLAR PROTON TRANSPORTING V TYPE ATPASE V0 DOMAIN | 9 | 5.60e-02 | -3.68e-01 | 4.42e-01 |
| GOCC POST MRNA RELEASE SPLICEOSOMAL COMPLEX | 10 | 4.42e-02 | 3.67e-01 | 4.11e-01 |
| GOBP NEGATIVE REGULATION OF T CELL CYTOKINE PRODUCTION | 9 | 5.63e-02 | -3.67e-01 | 4.43e-01 |
| GOMF GDP BINDING | 64 | 3.85e-07 | 3.67e-01 | 4.62e-04 |
| GOBP ACTIVATION OF JANUS KINASE ACTIVITY | 10 | 4.46e-02 | 3.67e-01 | 4.12e-01 |
| GOMF UBIQUINOL CYTOCHROME C REDUCTASE ACTIVITY | 7 | 9.30e-02 | -3.67e-01 | 5.32e-01 |
| GOBP REGULATION OF VASCULAR ASSOCIATED SMOOTH MUSCLE CONTRACTION | 7 | 9.32e-02 | 3.66e-01 | 5.33e-01 |
| GOBP INNER DYNEIN ARM ASSEMBLY | 12 | 2.80e-02 | -3.66e-01 | 3.58e-01 |
| GOBP REGULATION OF CELL PROLIFERATION INVOLVED IN KIDNEY DEVELOPMENT | 11 | 3.55e-02 | -3.66e-01 | 3.89e-01 |
| GOBP FOREBRAIN MORPHOGENESIS | 9 | 5.74e-02 | 3.66e-01 | 4.46e-01 |
| GOCC SPERM ANNULUS | 6 | 1.21e-01 | 3.65e-01 | 5.84e-01 |
| GOBP RESPONSE TO SORBITOL | 6 | 1.21e-01 | 3.65e-01 | 5.84e-01 |
| GOMF OXIDOREDUCTASE ACTIVITY ACTING ON THE CH NH2 GROUP OF DONORS OXYGEN AS ACCEPTOR | 14 | 1.79e-02 | -3.65e-01 | 2.91e-01 |
| GOBP OXYGEN TRANSPORT | 10 | 4.56e-02 | 3.65e-01 | 4.15e-01 |
| GOBP IRE1 MEDIATED UNFOLDED PROTEIN RESPONSE | 19 | 5.90e-03 | 3.65e-01 | 1.80e-01 |
| GOCC NUCLEAR PORE NUCLEAR BASKET | 12 | 2.88e-02 | 3.65e-01 | 3.59e-01 |
| GOCC CCR4 NOT COMPLEX | 16 | 1.16e-02 | 3.64e-01 | 2.43e-01 |
| GOBP BRANCHED CHAIN AMINO ACID BIOSYNTHETIC PROCESS | 5 | 1.59e-01 | -3.64e-01 | 6.24e-01 |
| GOBP REGULATION OF TRANSLATIONAL INITIATION IN RESPONSE TO STRESS | 15 | 1.47e-02 | 3.64e-01 | 2.59e-01 |
| GOBP NEGATIVE REGULATION OF PROTEIN SUMOYLATION | 8 | 7.48e-02 | -3.64e-01 | 4.91e-01 |
| GOBP REGULATION OF LIPID KINASE ACTIVITY | 7 | 9.56e-02 | 3.64e-01 | 5.38e-01 |
| GOMF DNA REPLICATION ORIGIN BINDING | 16 | 1.18e-02 | 3.64e-01 | 2.43e-01 |
| GOMF IGE BINDING | 5 | 1.60e-01 | 3.63e-01 | 6.26e-01 |
| GOBP CELLULAR RESPONSE TO HYDROPEROXIDE | 7 | 9.62e-02 | 3.63e-01 | 5.39e-01 |
| GOBP GLIAL CELL FATE COMMITMENT | 6 | 1.24e-01 | -3.63e-01 | 5.86e-01 |
| GOMF OXIDOREDUCTASE ACTIVITY ACTING ON DIPHENOLS AND RELATED SUBSTANCES AS DONORS | 9 | 5.94e-02 | -3.63e-01 | 4.53e-01 |
| GOBP CELLULAR RESPONSE TO ELECTRICAL STIMULUS | 9 | 5.98e-02 | 3.62e-01 | 4.53e-01 |
| GOBP REVERSIBLE DIFFERENTIATION | 5 | 1.61e-01 | -3.62e-01 | 6.27e-01 |
| GOBP PROTEIN LOCALIZATION TO CILIARY MEMBRANE | 12 | 2.99e-02 | 3.62e-01 | 3.64e-01 |
| GOBP NEGATIVE REGULATION OF ACTIN NUCLEATION | 7 | 9.76e-02 | -3.62e-01 | 5.43e-01 |
| GOBP METANEPHRIC COLLECTING DUCT DEVELOPMENT | 6 | 1.25e-01 | -3.62e-01 | 5.88e-01 |
| GOBP CARBOHYDRATE IMPORT ACROSS PLASMA MEMBRANE | 5 | 1.62e-01 | -3.61e-01 | 6.28e-01 |
| GOMF ALDOSE REDUCTASE NADPH ACTIVITY | 8 | 7.72e-02 | -3.61e-01 | 4.95e-01 |
| GOBP DENDRITIC CELL APOPTOTIC PROCESS | 9 | 6.11e-02 | 3.60e-01 | 4.59e-01 |
| GOMF DOUBLE STRANDED DNA EXODEOXYRIBONUCLEASE ACTIVITY | 8 | 7.76e-02 | -3.60e-01 | 4.96e-01 |
| GOBP INNERVATION | 16 | 1.26e-02 | 3.60e-01 | 2.49e-01 |
| GOBP ASYMMETRIC CELL DIVISION | 17 | 1.01e-02 | 3.60e-01 | 2.27e-01 |
| GOBP N ACYLPHOSPHATIDYLETHANOLAMINE METABOLIC PROCESS | 6 | 1.27e-01 | -3.60e-01 | 5.92e-01 |
| GOBP ADAPTIVE IMMUNE MEMORY RESPONSE | 6 | 1.27e-01 | -3.60e-01 | 5.92e-01 |
| GOBP REGULATION OF CELL COMMUNICATION BY ELECTRICAL COUPLING INVOLVED IN CARDIAC CONDUCTION | 7 | 9.94e-02 | 3.60e-01 | 5.46e-01 |
| GOBP AUTOPHAGOSOME MEMBRANE DOCKING | 7 | 9.95e-02 | 3.60e-01 | 5.46e-01 |
| GOBP TETRAHYDROFOLATE BIOSYNTHETIC PROCESS | 8 | 7.83e-02 | 3.60e-01 | 4.96e-01 |
| GOBP POSITIVE REGULATION OF PROTEIN NEDDYLATION | 5 | 1.64e-01 | 3.59e-01 | 6.30e-01 |
| GOMF PHOSPHOFRUCTOKINASE ACTIVITY | 7 | 1.00e-01 | -3.59e-01 | 5.47e-01 |
| GOBP DENDRITIC TRANSPORT | 11 | 3.94e-02 | 3.59e-01 | 3.98e-01 |
| GOBP REGULATION OF NK T CELL PROLIFERATION | 6 | 1.28e-01 | -3.58e-01 | 5.93e-01 |
| GOBP SERINE FAMILY AMINO ACID CATABOLIC PROCESS | 10 | 4.97e-02 | -3.58e-01 | 4.26e-01 |
| GOBP REGULATION OF FIBRINOLYSIS | 12 | 3.16e-02 | -3.58e-01 | 3.73e-01 |
| GOBP SINGLE STRAND BREAK REPAIR | 10 | 4.98e-02 | 3.58e-01 | 4.27e-01 |
| GOCC CUL4A RING E3 UBIQUITIN LIGASE COMPLEX | 14 | 2.03e-02 | 3.58e-01 | 3.11e-01 |
| GOBP POSITIVE REGULATION OF MICROGLIAL CELL ACTIVATION | 5 | 1.66e-01 | 3.58e-01 | 6.30e-01 |
| GOBP SOMATIC DIVERSIFICATION OF IMMUNE RECEPTORS VIA SOMATIC MUTATION | 14 | 2.05e-02 | 3.58e-01 | 3.12e-01 |
| GOBP ESTABLISHMENT OF PROTEIN LOCALIZATION TO ENDOPLASMIC RETICULUM | 42 | 6.08e-05 | 3.58e-01 | 1.01e-02 |
| GOBP POSITIVE REGULATION OF NEURON PROJECTION ARBORIZATION | 7 | 1.01e-01 | -3.57e-01 | 5.50e-01 |
| GOMF G PROTEIN COUPLED RECEPTOR KINASE ACTIVITY | 6 | 1.30e-01 | -3.57e-01 | 5.94e-01 |
| GOBP POSITIVE REGULATION OF VASCULAR PERMEABILITY | 16 | 1.34e-02 | -3.57e-01 | 2.50e-01 |
| GOBP SRP DEPENDENT COTRANSLATIONAL PROTEIN TARGETING TO MEMBRANE SIGNAL SEQUENCE RECOGNITION | 8 | 8.07e-02 | 3.57e-01 | 5.01e-01 |
| GOBP POSITIVE REGULATION OF EXECUTION PHASE OF APOPTOSIS | 11 | 4.06e-02 | -3.57e-01 | 4.01e-01 |
| GOMF DOUBLE STRANDED METHYLATED DNA BINDING | 5 | 1.68e-01 | -3.56e-01 | 6.33e-01 |
| GOBP MICROGLIAL CELL MIGRATION | 6 | 1.31e-01 | 3.56e-01 | 5.95e-01 |
| GOBP INTRACELLULAR TRANSPORT OF VIRUS | 9 | 6.44e-02 | 3.56e-01 | 4.66e-01 |
| GOBP PROTEIN DEMETHYLATION | 9 | 6.45e-02 | -3.56e-01 | 4.66e-01 |
| GOMF INTERLEUKIN 6 RECEPTOR BINDING | 6 | 1.31e-01 | 3.56e-01 | 5.95e-01 |
| GOMF SERINE TYPE CARBOXYPEPTIDASE ACTIVITY | 5 | 1.69e-01 | 3.55e-01 | 6.34e-01 |
| GOBP NEGATIVE REGULATION OF VASCULAR ASSOCIATED SMOOTH MUSCLE CELL DIFFERENTIATION | 7 | 1.04e-01 | -3.55e-01 | 5.55e-01 |
| GOMF PHOSPHOTRANSFERASE ACTIVITY NITROGENOUS GROUP AS ACCEPTOR | 5 | 1.69e-01 | 3.55e-01 | 6.36e-01 |
| GOBP HISTAMINE SECRETION | 12 | 3.33e-02 | 3.55e-01 | 3.81e-01 |
| GOBP REGULATION OF PROTEIN LOCALIZATION TO ENDOSOME | 13 | 2.68e-02 | 3.55e-01 | 3.53e-01 |
| GOMF DNA BINDING BENDING | 11 | 4.17e-02 | 3.55e-01 | 4.05e-01 |
| GOCC NURF COMPLEX | 6 | 1.33e-01 | 3.54e-01 | 5.98e-01 |
| GOBP NEGATIVE REGULATION OF CAMP DEPENDENT PROTEIN KINASE ACTIVITY | 7 | 1.05e-01 | 3.54e-01 | 5.57e-01 |
| GOBP ADENOSINE METABOLIC PROCESS | 10 | 5.26e-02 | 3.54e-01 | 4.33e-01 |
| GOBP PROTEIN DEPALMITOYLATION | 8 | 8.30e-02 | 3.54e-01 | 5.05e-01 |
| GOMF ATP TRANSMEMBRANE TRANSPORTER ACTIVITY | 12 | 3.41e-02 | -3.53e-01 | 3.84e-01 |
| GOBP N TERMINAL PEPTIDYL METHIONINE ACETYLATION | 5 | 1.71e-01 | 3.53e-01 | 6.38e-01 |
| GOBP POSITIVE REGULATION OF AMINO ACID TRANSPORT | 18 | 9.49e-03 | 3.53e-01 | 2.22e-01 |
| GOBP SNRNA TRANSCRIPTION BY RNA POLYMERASE III | 9 | 6.66e-02 | 3.53e-01 | 4.70e-01 |
| GOBP NEGATIVE REGULATION OF IMMUNOGLOBULIN PRODUCTION | 11 | 4.26e-02 | 3.53e-01 | 4.07e-01 |
| GOBP POSITIVE REGULATION OF FEEDING BEHAVIOR | 7 | 1.06e-01 | -3.53e-01 | 5.59e-01 |
| GOBP REGULATION OF PHOSPHOLIPID TRANSLOCATION | 6 | 1.35e-01 | 3.53e-01 | 5.99e-01 |
| GOBP REGULATION OF STRESS GRANULE ASSEMBLY | 10 | 5.34e-02 | 3.53e-01 | 4.36e-01 |
| GOBP REGULATION OF SYNAPTIC VESICLE PRIMING | 8 | 8.41e-02 | -3.53e-01 | 5.08e-01 |
| GOBP AGGRESOME ASSEMBLY | 5 | 1.72e-01 | -3.53e-01 | 6.40e-01 |
| GOBP POSITIVE REGULATION OF CD8 POSITIVE ALPHA BETA T CELL DIFFERENTIATION | 5 | 1.72e-01 | 3.52e-01 | 6.40e-01 |
| GOBP ENDOPLASMIC RETICULUM TUBULAR NETWORK ORGANIZATION | 20 | 6.38e-03 | 3.52e-01 | 1.87e-01 |
| GOBP TYPE II HYPERSENSITIVITY | 9 | 6.75e-02 | 3.52e-01 | 4.72e-01 |
| GOMF OXIDOREDUCTASE ACTIVITY ACTING ON CH OR CH2 GROUPS DISULFIDE AS ACCEPTOR | 5 | 1.73e-01 | 3.52e-01 | 6.40e-01 |
| GOBP ALDITOL PHOSPHATE METABOLIC PROCESS | 10 | 5.40e-02 | 3.52e-01 | 4.36e-01 |
| GOBP REGULATION OF MITOCHONDRIAL OUTER MEMBRANE PERMEABILIZATION INVOLVED IN APOPTOTIC SIGNALING PATHWAY | 20 | 6.48e-03 | -3.52e-01 | 1.89e-01 |
| GOBP ENDOCARDIUM DEVELOPMENT | 7 | 1.08e-01 | 3.51e-01 | 5.61e-01 |
| GOCC PROTEIN PHOSPHATASE 4 COMPLEX | 5 | 1.74e-01 | 3.51e-01 | 6.41e-01 |
| GOMF ENOYL COA HYDRATASE ACTIVITY | 12 | 3.55e-02 | 3.51e-01 | 3.89e-01 |
| GOBP NEUTROPHIL APOPTOTIC PROCESS | 6 | 1.37e-01 | 3.50e-01 | 6.03e-01 |
| GOBP REGULATION OF CYTOPLASMIC MRNA PROCESSING BODY ASSEMBLY | 8 | 8.62e-02 | 3.50e-01 | 5.14e-01 |
| GOBP L ASPARTATE IMPORT ACROSS PLASMA MEMBRANE | 5 | 1.75e-01 | 3.50e-01 | 6.43e-01 |
| GOBP NEGATIVE REGULATION OF B CELL RECEPTOR SIGNALING PATHWAY | 7 | 1.09e-01 | 3.50e-01 | 5.62e-01 |
| GOMF HISTONE KINASE ACTIVITY | 21 | 5.53e-03 | 3.50e-01 | 1.79e-01 |
| GOBP LINOLEIC ACID METABOLIC PROCESS | 13 | 2.91e-02 | -3.50e-01 | 3.60e-01 |
| GOMF MONOCARBOXYLATE SODIUM SYMPORTER ACTIVITY | 6 | 1.38e-01 | -3.49e-01 | 6.04e-01 |
| GOBP MUCOCILIARY CLEARANCE | 6 | 1.38e-01 | 3.49e-01 | 6.04e-01 |
| GOBP MECHANOSENSORY BEHAVIOR | 8 | 8.73e-02 | 3.49e-01 | 5.17e-01 |
| GOBP POSITIVE REGULATION OF ACTIVIN RECEPTOR SIGNALING PATHWAY | 7 | 1.10e-01 | -3.49e-01 | 5.63e-01 |
| GOMF HISTONE DEACETYLASE REGULATOR ACTIVITY | 6 | 1.39e-01 | -3.49e-01 | 6.05e-01 |
| GOBP COTRANSLATIONAL PROTEIN TARGETING TO MEMBRANE | 25 | 2.56e-03 | 3.49e-01 | 1.20e-01 |
| GOBP T FOLLICULAR HELPER CELL DIFFERENTIATION | 5 | 1.77e-01 | 3.48e-01 | 6.48e-01 |
| GOBP NLS BEARING PROTEIN IMPORT INTO NUCLEUS | 19 | 8.57e-03 | 3.48e-01 | 2.14e-01 |
| GOBP POSITIVE REGULATION OF FIBROBLAST APOPTOTIC PROCESS | 7 | 1.11e-01 | 3.48e-01 | 5.64e-01 |
| GOCC PROTON TRANSPORTING V TYPE ATPASE V1 DOMAIN | 10 | 5.70e-02 | 3.48e-01 | 4.45e-01 |
| GOBP POSITIVE REGULATION OF ISOTYPE SWITCHING TO IGG ISOTYPES | 10 | 5.73e-02 | 3.47e-01 | 4.46e-01 |
| GOBP LEARNED VOCALIZATION BEHAVIOR OR VOCAL LEARNING | 7 | 1.12e-01 | 3.47e-01 | 5.67e-01 |
| GOCC SEMAPHORIN RECEPTOR COMPLEX | 13 | 3.05e-02 | -3.46e-01 | 3.66e-01 |
| GOBP ISOLEUCINE METABOLIC PROCESS | 7 | 1.13e-01 | -3.46e-01 | 5.69e-01 |
| GOBP PROTEIN DESUMOYLATION | 9 | 7.27e-02 | 3.45e-01 | 4.87e-01 |
| GOBP AUDITORY RECEPTOR CELL MORPHOGENESIS | 15 | 2.07e-02 | -3.45e-01 | 3.13e-01 |
| GOBP CALCIUM ION EXPORT ACROSS PLASMA MEMBRANE | 8 | 9.12e-02 | 3.45e-01 | 5.27e-01 |
| GOBP CELLULAR RESPONSE TO TESTOSTERONE STIMULUS | 11 | 4.77e-02 | 3.45e-01 | 4.24e-01 |
| GOBP NEGATIVE REGULATION OF UBIQUITIN PROTEIN LIGASE ACTIVITY | 9 | 7.33e-02 | 3.45e-01 | 4.87e-01 |
| GOBP GLYCEROL 3 PHOSPHATE METABOLIC PROCESS | 8 | 9.13e-02 | 3.45e-01 | 5.27e-01 |
| GOBP REGULATION OF TRANSLATION INITIATION IN RESPONSE TO ENDOPLASMIC RETICULUM STRESS | 8 | 9.14e-02 | 3.45e-01 | 5.28e-01 |
| GOBP STRESS GRANULE ASSEMBLY | 32 | 7.41e-04 | 3.45e-01 | 6.10e-02 |
| GOCC TOR COMPLEX | 12 | 3.89e-02 | -3.44e-01 | 3.98e-01 |
| GOBP T CELL TOLERANCE INDUCTION | 14 | 2.58e-02 | 3.44e-01 | 3.47e-01 |
| GOBP SNRNA TRANSPORT | 6 | 1.45e-01 | 3.44e-01 | 6.12e-01 |
| GOMF GLUCOSIDASE ACTIVITY | 10 | 5.97e-02 | -3.44e-01 | 4.53e-01 |
| GOCC ARP2 3 PROTEIN COMPLEX | 9 | 7.42e-02 | 3.44e-01 | 4.89e-01 |
| GOBP NUCLEOSIDE TRIPHOSPHATE CATABOLIC PROCESS | 11 | 4.88e-02 | 3.43e-01 | 4.25e-01 |
| GOBP NEGATIVE REGULATION OF FIBRINOLYSIS | 9 | 7.47e-02 | -3.43e-01 | 4.91e-01 |
| GOBP HEXOSE PHOSPHATE TRANSPORT | 6 | 1.46e-01 | -3.43e-01 | 6.13e-01 |
| GOBP RRNA PSEUDOURIDINE SYNTHESIS | 8 | 9.29e-02 | -3.43e-01 | 5.32e-01 |
| GOBP CAMKK AMPK SIGNALING CASCADE | 6 | 1.46e-01 | 3.43e-01 | 6.13e-01 |
| GOBP DIADENOSINE POLYPHOSPHATE METABOLIC PROCESS | 7 | 1.16e-01 | 3.43e-01 | 5.75e-01 |
| GOBP POLYKETIDE METABOLIC PROCESS | 7 | 1.16e-01 | -3.43e-01 | 5.75e-01 |
| GOBP PHOSPHATIDYLINOSITOL 3 PHOSPHATE BIOSYNTHETIC PROCESS | 22 | 5.45e-03 | 3.42e-01 | 1.79e-01 |
| GOBP FARNESYL DIPHOSPHATE METABOLIC PROCESS | 5 | 1.85e-01 | 3.42e-01 | 6.59e-01 |
| GOBP ISOTYPE SWITCHING TO IGG ISOTYPES | 15 | 2.18e-02 | 3.42e-01 | 3.22e-01 |
| GOBP PYRIMIDINE NUCLEOBASE CATABOLIC PROCESS | 5 | 1.86e-01 | 3.42e-01 | 6.60e-01 |
| GOBP NUCLEOTIDE EXCISION REPAIR DNA GAP FILLING | 6 | 1.48e-01 | 3.41e-01 | 6.13e-01 |
| GOCC SUMO LIGASE COMPLEX | 13 | 3.31e-02 | 3.41e-01 | 3.80e-01 |
| GOMF HEMOGLOBIN BINDING | 7 | 1.18e-01 | 3.41e-01 | 5.80e-01 |
| GOBP ENDONUCLEOLYTIC CLEAVAGE IN ITS1 TO SEPARATE SSU RRNA FROM 5 8S RRNA AND LSU RRNA FROM TRICISTRONIC RRNA TRANSCRIPT SSU RRNA 5 8S RRNA LSU RRNA | 9 | 7.67e-02 | -3.41e-01 | 4.93e-01 |
| GOBP NEGATIVE REGULATION OF P38MAPK CASCADE | 6 | 1.48e-01 | 3.41e-01 | 6.13e-01 |
| GOBP ANGIOTENSIN ACTIVATED SIGNALING PATHWAY | 12 | 4.10e-02 | 3.41e-01 | 4.02e-01 |
| GOBP NEGATIVE REGULATION OF HUMORAL IMMUNE RESPONSE MEDIATED BY CIRCULATING IMMUNOGLOBULIN | 10 | 6.21e-02 | 3.41e-01 | 4.62e-01 |
| GOMF MIRNA INHIBITOR ACTIVITY VIA BASE PAIRING | 5 | 1.87e-01 | 3.40e-01 | 6.62e-01 |
| GOBP NEGATIVE REGULATION OF NUCLEOCYTOPLASMIC TRANSPORT | 21 | 6.99e-03 | 3.40e-01 | 1.94e-01 |
| GOBP INTRACELLULAR OXYGEN HOMEOSTASIS | 7 | 1.19e-01 | 3.40e-01 | 5.82e-01 |
| GOBP ADP TRANSPORT | 10 | 6.28e-02 | -3.40e-01 | 4.63e-01 |
| GOBP NEGATIVE REGULATION OF LIPID TRANSPORT | 21 | 7.03e-03 | -3.40e-01 | 1.94e-01 |
| GOCC ISWI TYPE COMPLEX | 13 | 3.41e-02 | 3.39e-01 | 3.84e-01 |
| GOBP REGULATION OF PROTEIN MONOUBIQUITINATION | 6 | 1.50e-01 | 3.39e-01 | 6.13e-01 |
| GOBP REGULATION OF T HELPER 17 CELL LINEAGE COMMITMENT | 8 | 9.66e-02 | -3.39e-01 | 5.40e-01 |
| GOCC PRESYNAPTIC ACTIVE ZONE MEMBRANE | 22 | 5.91e-03 | -3.39e-01 | 1.80e-01 |
| GOMF PROTEIN TYROSINE THREONINE PHOSPHATASE ACTIVITY | 9 | 7.83e-02 | -3.39e-01 | 4.96e-01 |
| GOMF CROSSOVER JUNCTION DNA ENDONUCLEASE ACTIVITY | 9 | 7.84e-02 | -3.39e-01 | 4.97e-01 |
| GOMF CAMP DEPENDENT PROTEIN KINASE REGULATOR ACTIVITY | 10 | 6.37e-02 | 3.39e-01 | 4.64e-01 |
| GOBP POSITIVE REGULATION OF FC RECEPTOR MEDIATED STIMULATORY SIGNALING PATHWAY | 5 | 1.91e-01 | 3.38e-01 | 6.63e-01 |
| GOBP CARBOHYDRATE MEDIATED SIGNALING | 8 | 9.84e-02 | -3.37e-01 | 5.45e-01 |
| GOMF MHC CLASS I RECEPTOR ACTIVITY | 12 | 4.30e-02 | 3.37e-01 | 4.07e-01 |
| GOCC N TERMINAL PROTEIN ACETYLTRANSFERASE COMPLEX | 9 | 7.98e-02 | 3.37e-01 | 4.98e-01 |
| GOMF SEMAPHORIN RECEPTOR BINDING | 17 | 1.61e-02 | -3.37e-01 | 2.77e-01 |
| GOBP DEADENYLATION DEPENDENT DECAPPING OF NUCLEAR TRANSCRIBED MRNA | 11 | 5.30e-02 | 3.37e-01 | 4.35e-01 |
| GOBP INTESTINAL EPITHELIAL STRUCTURE MAINTENANCE | 5 | 1.92e-01 | 3.37e-01 | 6.65e-01 |
| GOBP RIBOSOME ASSOCIATED UBIQUITIN DEPENDENT PROTEIN CATABOLIC PROCESS | 7 | 1.23e-01 | 3.36e-01 | 5.86e-01 |
| GOCC ENDOLYSOSOME LUMEN | 5 | 1.94e-01 | 3.36e-01 | 6.67e-01 |
| GOMF HISTONE H3K4 TRIMETHYLTRANSFERASE ACTIVITY | 8 | 1.00e-01 | -3.35e-01 | 5.47e-01 |
| GOBP MOTOR LEARNING | 5 | 1.94e-01 | -3.35e-01 | 6.67e-01 |
| GOCC LAMIN FILAMENT | 5 | 1.94e-01 | -3.35e-01 | 6.67e-01 |
| GOBP CELLULAR RESPONSE TO UV B | 12 | 4.44e-02 | -3.35e-01 | 4.11e-01 |
| GOCC LATE ENDOSOME LUMEN | 7 | 1.25e-01 | -3.35e-01 | 5.88e-01 |
| GOMF OXIDOREDUCTASE ACTIVITY ACTING ON THE CH NH2 GROUP OF DONORS | 17 | 1.68e-02 | -3.35e-01 | 2.83e-01 |
| GOCC PALMITOYLTRANSFERASE COMPLEX | 11 | 5.44e-02 | 3.35e-01 | 4.38e-01 |
| GOMF INTRACELLULARLY LIGAND GATED MONOATOMIC ION CHANNEL ACTIVITY | 23 | 5.44e-03 | -3.35e-01 | 1.79e-01 |
| GOMF EUKARYOTIC TRANSLATION INITIATION FACTOR 2ALPHA KINASE ACTIVITY | 6 | 1.56e-01 | 3.34e-01 | 6.20e-01 |
| GOBP REGULATION OF MODIFICATION OF POSTSYNAPTIC ACTIN CYTOSKELETON | 5 | 1.96e-01 | -3.34e-01 | 6.68e-01 |
| GOBP REGULATION OF T CELL MEDIATED IMMUNE RESPONSE TO TUMOR CELL | 10 | 6.81e-02 | 3.33e-01 | 4.73e-01 |
| GOBP NEGATIVE REGULATION OF PROTEIN IMPORT INTO NUCLEUS | 13 | 3.75e-02 | 3.33e-01 | 3.93e-01 |
| GOCC MYELIN SHEATH ABAXONAL REGION | 6 | 1.58e-01 | 3.33e-01 | 6.24e-01 |
| GOMF DEATH RECEPTOR ACTIVITY | 12 | 4.61e-02 | -3.32e-01 | 4.17e-01 |
| GOBP GDP MANNOSE METABOLIC PROCESS | 8 | 1.04e-01 | -3.32e-01 | 5.56e-01 |
| GOBP SUCCINYL COA CATABOLIC PROCESS | 6 | 1.59e-01 | 3.32e-01 | 6.25e-01 |
| GOBP SUPEROXIDE ANION GENERATION | 32 | 1.16e-03 | -3.32e-01 | 7.54e-02 |
| GOBP MEIOTIC CELL CYCLE CHECKPOINT SIGNALING | 9 | 8.48e-02 | 3.32e-01 | 5.10e-01 |
| GOBP SHORT TERM MEMORY | 8 | 1.04e-01 | 3.32e-01 | 5.56e-01 |
| GOBP POSITIVE REGULATION OF MYOTUBE DIFFERENTIATION | 7 | 1.29e-01 | -3.31e-01 | 5.94e-01 |
| GOBP MAMMARY GLAND INVOLUTION | 5 | 1.99e-01 | -3.31e-01 | 6.71e-01 |
| GOBP REGULATION OF LONG CHAIN FATTY ACID IMPORT ACROSS PLASMA MEMBRANE | 6 | 1.60e-01 | -3.31e-01 | 6.27e-01 |
| GOBP SMOOTH MUSCLE CELL MATRIX ADHESION | 5 | 2.00e-01 | -3.31e-01 | 6.71e-01 |
| GOBP CELL AGGREGATION | 9 | 8.56e-02 | -3.31e-01 | 5.12e-01 |
| GOBP NEGATIVE REGULATION OF FATTY ACID OXIDATION | 11 | 5.74e-02 | -3.31e-01 | 4.46e-01 |
| GOBP PYRIMIDINE CONTAINING COMPOUND TRANSMEMBRANE TRANSPORT | 13 | 3.92e-02 | 3.30e-01 | 3.98e-01 |
| GOMF LIPASE ACTIVATOR ACTIVITY | 16 | 2.23e-02 | 3.30e-01 | 3.25e-01 |
| GOCC ASTER | 10 | 7.11e-02 | 3.30e-01 | 4.84e-01 |
| GOBP NEGATIVE REGULATION OF HORMONE METABOLIC PROCESS | 10 | 7.18e-02 | 3.29e-01 | 4.86e-01 |
| GOBP TRANSFERRIN TRANSPORT | 9 | 8.77e-02 | -3.29e-01 | 5.18e-01 |
| GOBP ELASTIC FIBER ASSEMBLY | 9 | 8.78e-02 | -3.29e-01 | 5.19e-01 |
| GOBP NEGATIVE REGULATION OF INSULIN SECRETION INVOLVED IN CELLULAR RESPONSE TO GLUCOSE STIMULUS | 9 | 8.78e-02 | 3.29e-01 | 5.19e-01 |
| GOBP MDA 5 SIGNALING PATHWAY | 10 | 7.21e-02 | 3.28e-01 | 4.86e-01 |
| GOBP ORGAN OR TISSUE SPECIFIC IMMUNE RESPONSE | 27 | 3.14e-03 | -3.28e-01 | 1.32e-01 |
| GOBP REGULATION OF GROWTH HORMONE RECEPTOR SIGNALING PATHWAY | 6 | 1.64e-01 | 3.28e-01 | 6.30e-01 |
| GOBP RESPONSE TO PEPTIDOGLYCAN | 10 | 7.23e-02 | -3.28e-01 | 4.86e-01 |
| GOBP HIGH DENSITY LIPOPROTEIN PARTICLE CLEARANCE | 7 | 1.33e-01 | -3.28e-01 | 5.98e-01 |
| GOBP POSITIVE REGULATION OF DNA DAMAGE CHECKPOINT | 5 | 2.05e-01 | -3.27e-01 | 6.80e-01 |
| GOMF 3 PHOSPHOADENOSINE 5 PHOSPHOSULFATE BINDING | 5 | 2.05e-01 | -3.27e-01 | 6.80e-01 |
| GOBP CALMODULIN DEPENDENT KINASE SIGNALING PATHWAY | 8 | 1.09e-01 | 3.27e-01 | 5.62e-01 |
| GOBP POSITIVE REGULATION OF DEFENSE RESPONSE TO BACTERIUM | 10 | 7.33e-02 | -3.27e-01 | 4.87e-01 |
| GOBP NEGATIVE REGULATION OF LYMPHOCYTE MIGRATION | 13 | 4.12e-02 | 3.27e-01 | 4.03e-01 |
| GOBP PHOSPHATE ION TRANSMEMBRANE TRANSPORT | 13 | 4.13e-02 | -3.27e-01 | 4.03e-01 |
| GOCC ENDOPLASMIC RETICULUM CHAPERONE COMPLEX | 11 | 6.05e-02 | 3.27e-01 | 4.56e-01 |
| GOMF MAP KINASE PHOSPHATASE ACTIVITY | 12 | 5.08e-02 | -3.26e-01 | 4.30e-01 |
| GOBP DENDRITIC TRANSPORT OF RIBONUCLEOPROTEIN COMPLEX | 5 | 2.08e-01 | 3.25e-01 | 6.82e-01 |
| GOMF HEXOSAMINIDASE ACTIVITY | 13 | 4.24e-02 | -3.25e-01 | 4.07e-01 |
| GOCC FILTRATION DIAPHRAGM | 7 | 1.36e-01 | 3.25e-01 | 6.02e-01 |
| GOCC HAPTOGLOBIN HEMOGLOBIN COMPLEX | 9 | 9.15e-02 | 3.25e-01 | 5.28e-01 |
| GOCC SYNAPTIC CLEFT | 11 | 6.21e-02 | -3.25e-01 | 4.62e-01 |
| GOBP MAINTENANCE OF PROTEIN LOCATION IN MITOCHONDRION | 5 | 2.09e-01 | -3.25e-01 | 6.82e-01 |
| GOBP HYPOTONIC RESPONSE | 10 | 7.54e-02 | 3.25e-01 | 4.93e-01 |
| GOBP NEGATIVE REGULATION OF CELL FATE COMMITMENT | 5 | 2.09e-01 | -3.25e-01 | 6.82e-01 |
| GOMF PHOSPHATIDYLSERINE FLOPPASE ACTIVITY | 9 | 9.17e-02 | 3.25e-01 | 5.29e-01 |
| GOCC NADPH OXIDASE COMPLEX | 13 | 4.27e-02 | -3.25e-01 | 4.07e-01 |
| GOBP REGULATION OF ER TO GOLGI VESICLE MEDIATED TRANSPORT | 10 | 7.56e-02 | 3.24e-01 | 4.93e-01 |
| GOBP NEGATIVE REGULATION OF PROTEIN EXIT FROM ENDOPLASMIC RETICULUM | 10 | 7.57e-02 | 3.24e-01 | 4.93e-01 |
| GOBP POSITIVE REGULATION OF GLYCOGEN METABOLIC PROCESS | 12 | 5.17e-02 | -3.24e-01 | 4.33e-01 |
| GOMF GLUCOSYLTRANSFERASE ACTIVITY | 17 | 2.08e-02 | 3.24e-01 | 3.14e-01 |
| GOMF SEMAPHORIN RECEPTOR ACTIVITY | 11 | 6.30e-02 | -3.24e-01 | 4.63e-01 |
| GOBP MATERNAL PROCESS INVOLVED IN PARTURITION | 5 | 2.10e-01 | -3.23e-01 | 6.83e-01 |
| GOCC MICROVESICLE | 5 | 2.11e-01 | 3.23e-01 | 6.83e-01 |
| GOMF PROTEIN CARBOXYL O METHYLTRANSFERASE ACTIVITY | 6 | 1.71e-01 | 3.23e-01 | 6.38e-01 |
| GOBP CD8 POSITIVE ALPHA BETA T CELL PROLIFERATION | 8 | 1.15e-01 | -3.22e-01 | 5.72e-01 |
| GOBP MITOCHONDRIAL RNA CATABOLIC PROCESS | 6 | 1.72e-01 | 3.22e-01 | 6.39e-01 |
| GOBP NEGATIVE REGULATION OF VIRAL GENOME REPLICATION | 50 | 8.18e-05 | 3.22e-01 | 1.27e-02 |
| GOBP HISTAMINE TRANSPORT | 13 | 4.47e-02 | 3.22e-01 | 4.12e-01 |
| GOBP NEGATIVE REGULATION OF DIGESTIVE SYSTEM PROCESS | 10 | 7.89e-02 | 3.21e-01 | 4.97e-01 |
| GOBP INTERLEUKIN 4 MEDIATED SIGNALING PATHWAY | 10 | 7.91e-02 | 3.21e-01 | 4.97e-01 |
| GOMF PROTEIN TYROSINE KINASE INHIBITOR ACTIVITY | 6 | 1.74e-01 | 3.20e-01 | 6.41e-01 |
| GOBP GLYCERALDEHYDE 3 PHOSPHATE METABOLIC PROCESS | 10 | 7.93e-02 | -3.20e-01 | 4.98e-01 |
| GOBP REGULATION OF RETROGRADE TRANSPORT ENDOSOME TO GOLGI | 7 | 1.42e-01 | 3.20e-01 | 6.09e-01 |
| GOMF FUCOSYLTRANSFERASE ACTIVITY | 9 | 9.65e-02 | -3.20e-01 | 5.40e-01 |
| GOBP POSITIVE REGULATION OF CELLULAR SENESCENCE | 11 | 6.63e-02 | 3.20e-01 | 4.68e-01 |
| GOBP REGULATION OF LIPOPROTEIN METABOLIC PROCESS | 12 | 5.52e-02 | 3.20e-01 | 4.39e-01 |
| GOBP COPPER ION TRANSPORT | 15 | 3.21e-02 | 3.20e-01 | 3.76e-01 |
| GOBP AMINOGLYCOSIDE ANTIBIOTIC METABOLIC PROCESS | 8 | 1.18e-01 | -3.19e-01 | 5.78e-01 |
| GOMF UBIQUITIN MODIFIED HISTONE READER ACTIVITY | 7 | 1.44e-01 | 3.19e-01 | 6.12e-01 |
| GOBP ADP BIOSYNTHETIC PROCESS | 5 | 2.16e-01 | 3.19e-01 | 6.92e-01 |
| GOBP CELLULAR RESPONSE TO NITROSATIVE STRESS | 5 | 2.17e-01 | 3.19e-01 | 6.92e-01 |
| GOBP POSITIVE REGULATION OF CYTOPLASMIC TRANSLATION | 14 | 3.87e-02 | 3.19e-01 | 3.98e-01 |
| GOCC ENDODEOXYRIBONUCLEASE COMPLEX | 5 | 2.17e-01 | -3.19e-01 | 6.92e-01 |
| GOBP POST EMBRYONIC HEMOPOIESIS | 5 | 2.17e-01 | -3.19e-01 | 6.92e-01 |
| GOBP MITOCHONDRIAL TRANSLATIONAL ELONGATION | 5 | 2.17e-01 | 3.19e-01 | 6.92e-01 |
| GOBP ENGULFMENT OF APOPTOTIC CELL | 11 | 6.72e-02 | -3.19e-01 | 4.71e-01 |
| GOBP GLUCOSE CATABOLIC PROCESS | 23 | 8.20e-03 | -3.18e-01 | 2.09e-01 |
| GOBP KILLING BY HOST OF SYMBIONT CELLS | 16 | 2.77e-02 | -3.18e-01 | 3.57e-01 |
| GOBP MAGNESIUM ION HOMEOSTASIS | 8 | 1.19e-01 | -3.18e-01 | 5.82e-01 |
| GOCC EUKARYOTIC TRANSLATION INITIATION FACTOR 2B COMPLEX | 5 | 2.19e-01 | -3.18e-01 | 6.93e-01 |
| GOBP PROTEIN O LINKED GLYCOSYLATION VIA THREONINE | 9 | 9.92e-02 | 3.17e-01 | 5.46e-01 |
| GOBP REGULATION OF L GLUTAMATE IMPORT ACROSS PLASMA MEMBRANE | 6 | 1.79e-01 | 3.17e-01 | 6.50e-01 |
| GOCC PROTON TRANSPORTING V TYPE ATPASE V0 DOMAIN | 10 | 8.27e-02 | -3.17e-01 | 5.05e-01 |
| GOMF AP 2 ADAPTOR COMPLEX BINDING | 10 | 8.28e-02 | 3.17e-01 | 5.05e-01 |
| GOCC ACTIVIN RECEPTOR COMPLEX | 6 | 1.79e-01 | 3.17e-01 | 6.51e-01 |
| GOBP NEGATIVE REGULATION OF HORMONE BIOSYNTHETIC PROCESS | 8 | 1.21e-01 | 3.17e-01 | 5.84e-01 |
| GOBP G PROTEIN COUPLED OPIOID RECEPTOR SIGNALING PATHWAY | 7 | 1.47e-01 | -3.16e-01 | 6.13e-01 |
| GOMF RNA POLYMERASE I TRANSCRIPTION REGULATORY REGION SEQUENCE SPECIFIC DNA BINDING | 9 | 1.00e-01 | -3.16e-01 | 5.47e-01 |
| GOMF CALCIUM CHANNEL INHIBITOR ACTIVITY | 10 | 8.36e-02 | 3.16e-01 | 5.06e-01 |
| GOCC ZONULA ADHERENS | 8 | 1.22e-01 | -3.16e-01 | 5.85e-01 |
| GOBP NEUTROPHIL DEGRANULATION | 14 | 4.07e-02 | -3.16e-01 | 4.01e-01 |
| GOBP HEPARAN SULFATE PROTEOGLYCAN CATABOLIC PROCESS | 9 | 1.01e-01 | -3.16e-01 | 5.49e-01 |
| GOBP REGULATION OF LENS FIBER CELL DIFFERENTIATION | 7 | 1.48e-01 | 3.16e-01 | 6.13e-01 |
| GOMF ARRESTIN FAMILY PROTEIN BINDING | 6 | 1.81e-01 | -3.15e-01 | 6.54e-01 |
| GOCC NUCLEAR PORE OUTER RING | 10 | 8.43e-02 | 3.15e-01 | 5.09e-01 |
| GOMF RNA DIRECTED DNA POLYMERASE ACTIVITY | 7 | 1.49e-01 | 3.15e-01 | 6.13e-01 |
| GOBP POINTED END ACTIN FILAMENT CAPPING | 5 | 2.22e-01 | 3.15e-01 | 6.97e-01 |
| GOBP OXIDATIVE DEMETHYLATION | 6 | 1.82e-01 | 3.15e-01 | 6.54e-01 |
| GOBP MANCHETTE ASSEMBLY | 6 | 1.83e-01 | -3.14e-01 | 6.55e-01 |
| GOCC PROTEIN COMPLEX INVOLVED IN CELL MATRIX ADHESION | 16 | 2.96e-02 | -3.14e-01 | 3.63e-01 |
| GOBP MAMMARY GLAND BRANCHING INVOLVED IN PREGNANCY | 6 | 1.83e-01 | 3.14e-01 | 6.55e-01 |
| GOBP TYROSINE CATABOLIC PROCESS | 5 | 2.24e-01 | -3.14e-01 | 6.97e-01 |
| GOBP NEGATIVE REGULATION OF HUMORAL IMMUNE RESPONSE | 15 | 3.53e-02 | 3.14e-01 | 3.88e-01 |
| GOBP NEGATIVE REGULATION OF MEMBRANE PROTEIN ECTODOMAIN PROTEOLYSIS | 6 | 1.83e-01 | 3.14e-01 | 6.56e-01 |
| GOBP RESPONSE TO HYDROSTATIC PRESSURE | 7 | 1.51e-01 | 3.14e-01 | 6.13e-01 |
| GOBP GLOMERULAR MESANGIUM DEVELOPMENT | 11 | 7.18e-02 | -3.14e-01 | 4.86e-01 |
| GOBP INTERFERON ALPHA PRODUCTION | 27 | 4.82e-03 | 3.13e-01 | 1.69e-01 |
| GOBP MAST CELL PROLIFERATION | 6 | 1.84e-01 | 3.13e-01 | 6.56e-01 |
| GOCC PHOSPHOLIPID TRANSLOCATING ATPASE COMPLEX | 13 | 5.05e-02 | 3.13e-01 | 4.29e-01 |
| GOBP COLLAGEN BIOSYNTHETIC PROCESS | 29 | 3.53e-03 | -3.13e-01 | 1.41e-01 |
| GOMF DNA N GLYCOSYLASE ACTIVITY | 13 | 5.09e-02 | -3.13e-01 | 4.30e-01 |
| GOBP ETHANOL METABOLIC PROCESS | 8 | 1.26e-01 | -3.13e-01 | 5.90e-01 |
| GOMF VERY LONG CHAIN FATTY ACID COA LIGASE ACTIVITY | 8 | 1.26e-01 | -3.13e-01 | 5.90e-01 |
| GOBP VASCULAR ASSOCIATED SMOOTH MUSCLE CONTRACTION | 16 | 3.04e-02 | 3.13e-01 | 3.66e-01 |
| GOMF CHROMO SHADOW DOMAIN BINDING | 6 | 1.85e-01 | 3.12e-01 | 6.58e-01 |
| GOCC EXTRINSIC COMPONENT OF SYNAPTIC VESICLE MEMBRANE | 11 | 7.31e-02 | 3.12e-01 | 4.87e-01 |
| GOBP REGULATION OF NUCLEAR TRANSCRIBED MRNA CATABOLIC PROCESS DEADENYLATION DEPENDENT DECAY | 22 | 1.13e-02 | 3.12e-01 | 2.41e-01 |
| GOBP IRON COORDINATION ENTITY TRANSPORT | 12 | 6.13e-02 | -3.12e-01 | 4.59e-01 |
| GOMF PHOSPHODIESTERASE I ACTIVITY | 5 | 2.27e-01 | 3.12e-01 | 7.00e-01 |
| GOBP NEURAL PLATE PATTERN SPECIFICATION | 8 | 1.27e-01 | -3.12e-01 | 5.92e-01 |
| GOMF PROTEIN LYSINE DEACETYLASE ACTIVITY | 23 | 9.65e-03 | -3.12e-01 | 2.22e-01 |
| GOBP STRESS GRANULE DISASSEMBLY | 7 | 1.53e-01 | 3.12e-01 | 6.16e-01 |
| GOBP DENSE CORE GRANULE TRANSPORT | 8 | 1.27e-01 | -3.12e-01 | 5.92e-01 |
| GOCC CYTOPLASMIC DYNEIN COMPLEX | 22 | 1.14e-02 | 3.12e-01 | 2.42e-01 |
| GOBP CELL CELL JUNCTION MAINTENANCE | 16 | 3.10e-02 | -3.11e-01 | 3.70e-01 |
| GOBP PROTEIN TARGETING TO LYSOSOME | 31 | 2.69e-03 | 3.11e-01 | 1.24e-01 |
| GOBP NEGATIVE REGULATION OF GLUCONEOGENESIS | 15 | 3.71e-02 | -3.11e-01 | 3.91e-01 |
| GOMF GLYCEROL 3 PHOSPHATE O ACYLTRANSFERASE ACTIVITY | 5 | 2.29e-01 | 3.11e-01 | 7.01e-01 |
| GOBP UBIQUITIN DEPENDENT GLYCOPROTEIN ERAD PATHWAY | 7 | 1.54e-01 | 3.11e-01 | 6.17e-01 |
| GOMF MANNOSYL OLIGOSACCHARIDE 1 2 ALPHA MANNOSIDASE ACTIVITY | 7 | 1.54e-01 | 3.11e-01 | 6.17e-01 |
| GOMF VINCULIN BINDING | 11 | 7.43e-02 | -3.11e-01 | 4.89e-01 |
| GOBP ABSCISSION | 5 | 2.29e-01 | -3.11e-01 | 7.01e-01 |
| GOMF CYTIDYLYLTRANSFERASE ACTIVITY | 10 | 8.89e-02 | 3.11e-01 | 5.22e-01 |
| GOBP TRANSLATIONAL READTHROUGH | 8 | 1.28e-01 | 3.10e-01 | 5.93e-01 |
| GOBP VESICLE CARGO LOADING | 32 | 2.37e-03 | 3.10e-01 | 1.19e-01 |
| GOBP NEGATIVE REGULATION OF VOLTAGE GATED POTASSIUM CHANNEL ACTIVITY | 8 | 1.29e-01 | 3.10e-01 | 5.94e-01 |
| GOBP GLOMERULUS MORPHOGENESIS | 7 | 1.55e-01 | 3.10e-01 | 6.18e-01 |
| GOMF C ACETYLTRANSFERASE ACTIVITY | 7 | 1.55e-01 | 3.10e-01 | 6.18e-01 |
| GOBP REGULATION OF TOLL LIKE RECEPTOR 9 SIGNALING PATHWAY | 12 | 6.29e-02 | 3.10e-01 | 4.63e-01 |
| GOCC NUCLEAR INCLUSION BODY | 12 | 6.30e-02 | 3.10e-01 | 4.63e-01 |
| GOBP NEGATIVE REGULATION OF SUBSTRATE ADHESION DEPENDENT CELL SPREADING | 12 | 6.31e-02 | -3.10e-01 | 4.63e-01 |
| GOBP SRP DEPENDENT COTRANSLATIONAL PROTEIN TARGETING TO MEMBRANE | 20 | 1.65e-02 | 3.10e-01 | 2.81e-01 |
| GOBP CELLULAR HYPOTONIC RESPONSE | 9 | 1.08e-01 | 3.09e-01 | 5.61e-01 |
| GOBP ATTACHMENT OF SPINDLE MICROTUBULES TO KINETOCHORE | 51 | 1.34e-04 | 3.09e-01 | 1.92e-02 |
| GOBP NEGATIVE REGULATION OF INTRACELLULAR PROTEIN TRANSPORT | 29 | 3.97e-03 | 3.09e-01 | 1.51e-01 |
| GOCC ANNULATE LAMELLAE | 5 | 2.32e-01 | 3.09e-01 | 7.04e-01 |
| GOCC ATG12 ATG5 ATG16 COMPLEX | 6 | 1.91e-01 | 3.09e-01 | 6.63e-01 |
| GOBP POSITIVE REGULATION OF TRIGLYCERIDE METABOLIC PROCESS | 15 | 3.86e-02 | -3.08e-01 | 3.98e-01 |
| GOBP DAMP METABOLIC PROCESS | 6 | 1.91e-01 | 3.08e-01 | 6.63e-01 |
| GOMF CYCLOHYDROLASE ACTIVITY | 5 | 2.33e-01 | 3.08e-01 | 7.05e-01 |
| GOCC LAMELLAR BODY | 9 | 1.09e-01 | -3.08e-01 | 5.63e-01 |
| GOMF PH DOMAIN BINDING | 8 | 1.31e-01 | -3.08e-01 | 5.95e-01 |
| GOMF G PROTEIN ACTIVITY | 41 | 6.42e-04 | 3.08e-01 | 5.47e-02 |
| GOMF N ACETYLLACTOSAMINE SYNTHASE ACTIVITY | 5 | 2.33e-01 | 3.08e-01 | 7.05e-01 |
| GOBP ANTIGEN PROCESSING AND PRESENTATION OF EXOGENOUS PEPTIDE ANTIGEN VIA MHC CLASS I | 9 | 1.10e-01 | 3.08e-01 | 5.63e-01 |
| GOBP DENDRITE SELF AVOIDANCE | 5 | 2.34e-01 | 3.08e-01 | 7.05e-01 |
| GOBP REGULATION OF COMPLEMENT ACTIVATION | 17 | 2.82e-02 | 3.07e-01 | 3.58e-01 |
| GOMF CCR CHEMOKINE RECEPTOR BINDING | 14 | 4.65e-02 | 3.07e-01 | 4.19e-01 |
| GOMF MAP KINASE TYROSINE SERINE THREONINE PHOSPHATASE ACTIVITY | 11 | 7.77e-02 | -3.07e-01 | 4.96e-01 |
| GOMF C METHYLTRANSFERASE ACTIVITY | 7 | 1.59e-01 | -3.07e-01 | 6.26e-01 |
| GOMF ACTIVIN RECEPTOR ACTIVITY | 9 | 1.11e-01 | 3.07e-01 | 5.64e-01 |
| GOMF DOUBLE STRANDED RNA BINDING | 70 | 9.00e-06 | 3.07e-01 | 3.06e-03 |
| GOBP GLOMERULAR MESANGIAL CELL PROLIFERATION | 8 | 1.33e-01 | -3.07e-01 | 5.98e-01 |
| GOBP ESTABLISHMENT OR MAINTENANCE OF TRANSMEMBRANE ELECTROCHEMICAL GRADIENT | 8 | 1.33e-01 | -3.07e-01 | 5.98e-01 |
| GOBP RESPONSE TO SELENIUM ION | 8 | 1.33e-01 | -3.06e-01 | 5.99e-01 |
| GOBP ESCRT COMPLEX DISASSEMBLY | 10 | 9.35e-02 | 3.06e-01 | 5.33e-01 |
| GOMF CAMP BINDING | 17 | 2.88e-02 | -3.06e-01 | 3.59e-01 |
| GOCC NUCLEAR CYCLIN DEPENDENT PROTEIN KINASE HOLOENZYME COMPLEX | 14 | 4.73e-02 | 3.06e-01 | 4.23e-01 |
| GOBP POSITIVE REGULATION OF MYELOID CELL APOPTOTIC PROCESS | 8 | 1.34e-01 | 3.06e-01 | 5.99e-01 |
| GOCC CCAAT BINDING FACTOR COMPLEX | 5 | 2.36e-01 | 3.06e-01 | 7.07e-01 |
| GOBP BILE ACID SECRETION | 6 | 1.95e-01 | 3.06e-01 | 6.68e-01 |
| GOBP ZINC ION IMPORT INTO ORGANELLE | 8 | 1.34e-01 | 3.06e-01 | 5.99e-01 |
| GOMF PHOTORECEPTOR ACTIVITY | 8 | 1.34e-01 | -3.06e-01 | 5.99e-01 |
| GOBP NEGATIVE REGULATION OF CARDIAC MUSCLE CELL PROLIFERATION | 8 | 1.35e-01 | -3.06e-01 | 5.99e-01 |
| GOBP NEGATIVE REGULATION OF DENDRITIC SPINE DEVELOPMENT | 11 | 7.94e-02 | 3.05e-01 | 4.98e-01 |
| GOCC FILOPODIUM TIP | 17 | 2.93e-02 | 3.05e-01 | 3.61e-01 |
| GOCC AMPA GLUTAMATE RECEPTOR COMPLEX | 14 | 4.80e-02 | -3.05e-01 | 4.25e-01 |
| GOBP DNA ALKYLATION REPAIR | 12 | 6.72e-02 | 3.05e-01 | 4.71e-01 |
| GOMF MYRISTOYLTRANSFERASE ACTIVITY | 11 | 7.97e-02 | 3.05e-01 | 4.98e-01 |
| GOCC MICROTUBULE ORGANIZING CENTER ATTACHMENT SITE | 8 | 1.35e-01 | -3.05e-01 | 6.00e-01 |
| GOBP POSITIVE REGULATION OF MICROTUBULE NUCLEATION | 8 | 1.35e-01 | -3.05e-01 | 6.01e-01 |
| GOMF 2 ACYLGLYCEROL 3 PHOSPHATE O ACYLTRANSFERASE ACTIVITY | 9 | 1.13e-01 | 3.05e-01 | 5.70e-01 |
| GOMF CENTROMERIC DNA BINDING | 6 | 1.96e-01 | 3.05e-01 | 6.68e-01 |
| GOBP POSITIVE REGULATION OF PROTEIN LOCALIZATION TO CELL SURFACE | 16 | 3.49e-02 | -3.05e-01 | 3.88e-01 |
| GOBP CELLULAR RESPONSE TO FOLLICLE STIMULATING HORMONE STIMULUS | 7 | 1.63e-01 | -3.05e-01 | 6.30e-01 |
| GOBP NEGATIVE REGULATION OF ADENYLATE CYCLASE ACTIVATING ADRENERGIC RECEPTOR SIGNALING PATHWAY | 5 | 2.39e-01 | 3.04e-01 | 7.08e-01 |
| GOBP CELLULAR RESPONSE TO ACIDIC PH | 10 | 9.57e-02 | -3.04e-01 | 5.38e-01 |
| GOBP NEGATIVE REGULATION OF NERVOUS SYSTEM PROCESS | 11 | 8.07e-02 | 3.04e-01 | 5.01e-01 |
| GOBP HEPATIC STELLATE CELL ACTIVATION | 7 | 1.64e-01 | 3.04e-01 | 6.30e-01 |
| GOBP GABAERGIC NEURON DIFFERENTIATION | 7 | 1.64e-01 | -3.04e-01 | 6.30e-01 |
| GOCC BRCA1 A COMPLEX | 8 | 1.37e-01 | 3.04e-01 | 6.03e-01 |
| GOCC NEUROTRANSMITTER RECEPTOR COMPLEX | 24 | 1.00e-02 | -3.04e-01 | 2.27e-01 |
| GOMF SINGLE STRANDED DNA 3 5 DNA EXONUCLEASE ACTIVITY | 5 | 2.40e-01 | -3.04e-01 | 7.09e-01 |
| GOCC MYOSIN FILAMENT | 11 | 8.13e-02 | -3.04e-01 | 5.02e-01 |
| GOMF THREONINE TYPE ENDOPEPTIDASE ACTIVITY | 7 | 1.65e-01 | -3.03e-01 | 6.30e-01 |
| GOCC PLATELET DENSE TUBULAR NETWORK | 10 | 9.68e-02 | -3.03e-01 | 5.41e-01 |
| GOMF OXYGEN CARRIER ACTIVITY | 9 | 1.15e-01 | 3.03e-01 | 5.73e-01 |
| GOBP PRE MIRNA PROCESSING | 15 | 4.22e-02 | 3.03e-01 | 4.05e-01 |
| GOMF CALCIUM ACTIVATED POTASSIUM CHANNEL ACTIVITY | 7 | 1.65e-01 | -3.03e-01 | 6.30e-01 |
| GOBP NEGATIVE REGULATION OF GRANULOCYTE DIFFERENTIATION | 7 | 1.65e-01 | -3.03e-01 | 6.30e-01 |
| GOBP POSITIVE REGULATION OF NUCLEOBASE CONTAINING COMPOUND TRANSPORT | 6 | 1.99e-01 | 3.03e-01 | 6.71e-01 |
| GOBP REGULATION OF PENTOSE PHOSPHATE SHUNT | 6 | 1.99e-01 | -3.02e-01 | 6.71e-01 |
| GOBP NEGATIVE REGULATION OF CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY INVOLVED IN APOPTOTIC SIGNALING PATHWAY | 5 | 2.42e-01 | -3.02e-01 | 7.12e-01 |
| GOBP RESPONSE TO CGMP | 7 | 1.67e-01 | -3.02e-01 | 6.31e-01 |
| GOMF RNA POLYMERASE II ACTIVITY | 11 | 8.29e-02 | -3.02e-01 | 5.05e-01 |
| GOBP POSITIVE REGULATION OF INTERFERON BETA PRODUCTION | 39 | 1.13e-03 | 3.01e-01 | 7.42e-02 |
| GOBP POSITIVE REGULATION OF PYROPTOSIS | 5 | 2.44e-01 | 3.01e-01 | 7.13e-01 |
| GOBP RECEPTOR DIFFUSION TRAPPING | 5 | 2.44e-01 | -3.01e-01 | 7.14e-01 |
| GOBP POSITIVE REGULATION OF LAMELLIPODIUM MORPHOGENESIS | 7 | 1.69e-01 | -3.00e-01 | 6.34e-01 |
| GOBP POSITIVE REGULATION OF DENDRITIC CELL DIFFERENTIATION | 6 | 2.03e-01 | -3.00e-01 | 6.76e-01 |
| GOMF DNA ENDONUCLEASE ACTIVITY PRODUCING 3 PHOSPHOMONOESTERS | 10 | 1.00e-01 | -3.00e-01 | 5.47e-01 |
| GOBP PROTEIN ACTIVATION CASCADE | 15 | 4.41e-02 | -3.00e-01 | 4.11e-01 |
| GOCC U2 TYPE CATALYTIC STEP 2 SPLICEOSOME | 30 | 4.44e-03 | 3.00e-01 | 1.61e-01 |
| GOBP HEME B METABOLIC PROCESS | 9 | 1.19e-01 | -3.00e-01 | 5.82e-01 |
| GOMF PROTEIN PRENYLTRANSFERASE ACTIVITY | 7 | 1.70e-01 | 3.00e-01 | 6.36e-01 |
| GOBP DE NOVO PYRIMIDINE NUCLEOBASE BIOSYNTHETIC PROCESS | 5 | 2.46e-01 | -3.00e-01 | 7.16e-01 |
| GOBP PRIMARY ALCOHOL CATABOLIC PROCESS | 9 | 1.20e-01 | -2.99e-01 | 5.83e-01 |
| GOMF CYCLIN DEPENDENT PROTEIN SERINE THREONINE KINASE ACTIVATOR ACTIVITY | 14 | 5.27e-02 | 2.99e-01 | 4.33e-01 |
| GOBP NEGATIVE REGULATION OF SEQUESTERING OF TRIGLYCERIDE | 5 | 2.47e-01 | 2.99e-01 | 7.16e-01 |
| GOBP ECTODERM DEVELOPMENT | 14 | 5.28e-02 | -2.99e-01 | 4.33e-01 |
| GOBP INTRACELLULAR MONOATOMIC ANION HOMEOSTASIS | 7 | 1.71e-01 | 2.99e-01 | 6.38e-01 |
| GOMF RNA DNA HYBRID RIBONUCLEASE ACTIVITY | 6 | 2.05e-01 | -2.99e-01 | 6.80e-01 |
| GOBP REGULATION OF PROTEIN NEDDYLATION | 19 | 2.42e-02 | 2.99e-01 | 3.38e-01 |
| GOCC POLYPRENYL DIPHOSPHATE SYNTHASE COMPLEX | 11 | 8.64e-02 | 2.99e-01 | 5.15e-01 |
| GOBP REGULATION OF TRANSLATION AT SYNAPSE MODULATING SYNAPTIC TRANSMISSION | 6 | 2.05e-01 | 2.99e-01 | 6.80e-01 |
| GOBP EMBRYONIC CLEAVAGE | 8 | 1.44e-01 | 2.98e-01 | 6.12e-01 |
| GOBP PHENOL CONTAINING COMPOUND CATABOLIC PROCESS | 9 | 1.21e-01 | -2.98e-01 | 5.85e-01 |
| GOBP MYOFIBROBLAST DIFFERENTIATION | 9 | 1.22e-01 | 2.98e-01 | 5.85e-01 |
| GOCC SEX CHROMOSOME | 33 | 3.11e-03 | 2.97e-01 | 1.31e-01 |
| GOBP PYRIMIDINE RIBONUCLEOTIDE CATABOLIC PROCESS | 7 | 1.73e-01 | 2.97e-01 | 6.40e-01 |
| GOBP POSITIVE REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY IN RESPONSE TO DNA DAMAGE | 7 | 1.73e-01 | -2.97e-01 | 6.40e-01 |
| GOBP ANTIBACTERIAL INNATE IMMUNE RESPONSE | 7 | 1.73e-01 | -2.97e-01 | 6.40e-01 |
| GOBP NEGATIVE REGULATION OF B CELL MEDIATED IMMUNITY | 14 | 5.43e-02 | 2.97e-01 | 4.38e-01 |
| GOBP REGULATION OF HEART RATE BY CHEMICAL SIGNAL | 5 | 2.50e-01 | -2.97e-01 | 7.18e-01 |
| GOMF NEDD8 TRANSFERASE ACTIVITY | 7 | 1.74e-01 | 2.97e-01 | 6.41e-01 |
| GOBP REGULATION OF SKELETAL MUSCLE SATELLITE CELL PROLIFERATION | 9 | 1.23e-01 | 2.97e-01 | 5.86e-01 |
| GOBP POSITIVE REGULATION OF HYPERSENSITIVITY | 6 | 2.08e-01 | 2.97e-01 | 6.82e-01 |
| GOBP POSITIVE REGULATION OF VIRAL GENOME REPLICATION | 29 | 5.67e-03 | 2.97e-01 | 1.80e-01 |
| GOBP AMYLOID BETA CLEARANCE BY CELLULAR CATABOLIC PROCESS | 6 | 2.08e-01 | 2.97e-01 | 6.82e-01 |
| GOBP EGG ACTIVATION | 6 | 2.08e-01 | -2.97e-01 | 6.82e-01 |
| GOBP TRIPEPTIDE TRANSPORT | 9 | 1.23e-01 | 2.97e-01 | 5.86e-01 |
| GOCC AXONEMAL OUTER DOUBLET | 10 | 1.05e-01 | -2.96e-01 | 5.56e-01 |
| GOBP POSITIVE REGULATION BY HOST OF VIRAL GENOME REPLICATION | 10 | 1.05e-01 | 2.96e-01 | 5.56e-01 |
| GOBP REGULATION OF FATTY ACID OXIDATION | 28 | 6.65e-03 | -2.96e-01 | 1.89e-01 |
| GOBP POSITIVE REGULATION OF RECEPTOR CLUSTERING | 9 | 1.24e-01 | 2.96e-01 | 5.88e-01 |
| GOBP DEVELOPMENT OF SECONDARY SEXUAL CHARACTERISTICS | 8 | 1.47e-01 | -2.96e-01 | 6.13e-01 |
| GOBP ENDODERMAL CELL FATE COMMITMENT | 10 | 1.05e-01 | 2.96e-01 | 5.58e-01 |
| GOCC ELASTIC FIBER | 5 | 2.53e-01 | -2.95e-01 | 7.22e-01 |
| GOBP CELLULAR RESPONSE TO CGMP | 6 | 2.10e-01 | -2.95e-01 | 6.83e-01 |
| GOBP REGULATION OF MAST CELL ACTIVATION | 17 | 3.51e-02 | 2.95e-01 | 3.88e-01 |
| GOBP IODIDE TRANSPORT | 5 | 2.53e-01 | -2.95e-01 | 7.22e-01 |
| GOBP SPERM DNA CONDENSATION | 11 | 9.02e-02 | 2.95e-01 | 5.25e-01 |
| GOCC MITOCHONDRIAL RESPIRATORY CHAIN COMPLEX III | 15 | 4.82e-02 | -2.95e-01 | 4.25e-01 |
| GOBP REGULATION OF INTERLEUKIN 1 MEDIATED SIGNALING PATHWAY | 7 | 1.77e-01 | 2.94e-01 | 6.48e-01 |
| GOBP BLEB ASSEMBLY | 11 | 9.10e-02 | 2.94e-01 | 5.27e-01 |
| GOBP RENAL WATER HOMEOSTASIS | 15 | 4.85e-02 | -2.94e-01 | 4.25e-01 |
| GOBP RESPONSE TO HEPATOCYTE GROWTH FACTOR | 15 | 4.85e-02 | 2.94e-01 | 4.25e-01 |
| GOCC RNA N6 METHYLADENOSINE METHYLTRANSFERASE COMPLEX | 9 | 1.27e-01 | 2.94e-01 | 5.92e-01 |
| GOBP POSITIVE REGULATION OF CENTRIOLE REPLICATION | 9 | 1.27e-01 | 2.94e-01 | 5.92e-01 |
| GOBP CATECHOL CONTAINING COMPOUND CATABOLIC PROCESS | 8 | 1.50e-01 | -2.94e-01 | 6.13e-01 |
| GOBP INTERLEUKIN 11 MEDIATED SIGNALING PATHWAY | 5 | 2.55e-01 | 2.94e-01 | 7.25e-01 |
| GOBP POSITIVE REGULATION OF NON CANONICAL WNT SIGNALING PATHWAY | 10 | 1.08e-01 | -2.94e-01 | 5.61e-01 |
| GOBP SYMPATHETIC NERVOUS SYSTEM DEVELOPMENT | 9 | 1.27e-01 | 2.94e-01 | 5.92e-01 |
| GOBP PURINE DEOXYRIBONUCLEOSIDE TRIPHOSPHATE METABOLIC PROCESS | 7 | 1.78e-01 | 2.94e-01 | 6.50e-01 |
| GOMF PURINE RIBONUCLEOTIDE TRANSMEMBRANE TRANSPORTER ACTIVITY | 20 | 2.30e-02 | -2.94e-01 | 3.29e-01 |
| GOMF GLYCINE BINDING | 5 | 2.56e-01 | -2.94e-01 | 7.25e-01 |
| GOBP REGULATION OF XENOPHAGY | 9 | 1.27e-01 | -2.94e-01 | 5.92e-01 |
| GOBP ESTABLISHMENT OF CENTROSOME LOCALIZATION | 8 | 1.51e-01 | 2.93e-01 | 6.13e-01 |
| GOMF ACID AMINO ACID LIGASE ACTIVITY | 19 | 2.68e-02 | -2.93e-01 | 3.53e-01 |
| GOBP RANDOM INACTIVATION OF X CHROMOSOME | 8 | 1.51e-01 | 2.93e-01 | 6.13e-01 |
| GOBP CENTRAL NERVOUS SYSTEM MATURATION | 6 | 2.13e-01 | 2.93e-01 | 6.88e-01 |
| GOBP RESPONSE TO VASOPRESSIN | 6 | 2.14e-01 | -2.93e-01 | 6.88e-01 |
| GOBP ACETYL COA BIOSYNTHETIC PROCESS FROM PYRUVATE | 10 | 1.09e-01 | 2.93e-01 | 5.62e-01 |
| GOBP SEQUESTERING OF IRON ION | 5 | 2.57e-01 | -2.93e-01 | 7.26e-01 |
| GOMF DYNACTIN BINDING | 12 | 7.90e-02 | 2.93e-01 | 4.97e-01 |
| GOBP NEGATIVE REGULATION OF SMOOTH MUSCLE CELL DIFFERENTIATION | 13 | 6.75e-02 | -2.93e-01 | 4.72e-01 |
| GOBP MEIOTIC SPINDLE ASSEMBLY | 11 | 9.29e-02 | 2.93e-01 | 5.32e-01 |
| GOBP CALCIUM INDEPENDENT CELL CELL ADHESION VIA PLASMA MEMBRANE CELL ADHESION MOLECULES | 8 | 1.52e-01 | -2.93e-01 | 6.15e-01 |
| GOBP REGULATION OF ASPARTIC TYPE ENDOPEPTIDASE ACTIVITY INVOLVED IN AMYLOID PRECURSOR PROTEIN CATABOLIC PROCESS | 6 | 2.15e-01 | -2.93e-01 | 6.91e-01 |
| GOCC XY BODY | 13 | 6.81e-02 | 2.92e-01 | 4.73e-01 |
| GOMF OXIDOREDUCTASE ACTIVITY ACTING ON A SULFUR GROUP OF DONORS NAD P AS ACCEPTOR | 11 | 9.33e-02 | 2.92e-01 | 5.33e-01 |
| GOBP LONG CHAIN FATTY ACID IMPORT ACROSS PLASMA MEMBRANE | 10 | 1.10e-01 | -2.92e-01 | 5.63e-01 |
| GOMF CAMP RESPONSE ELEMENT BINDING PROTEIN BINDING | 9 | 1.29e-01 | -2.92e-01 | 5.94e-01 |
| GOBP REGULATION OF MEMBRANE INVAGINATION | 14 | 5.85e-02 | 2.92e-01 | 4.51e-01 |
| GOBP HEPARAN SULFATE PROTEOGLYCAN BIOSYNTHETIC PROCESS POLYSACCHARIDE CHAIN BIOSYNTHETIC PROCESS | 6 | 2.15e-01 | 2.92e-01 | 6.91e-01 |
| GOBP REGULATION OF I KAPPAB PHOSPHORYLATION | 6 | 2.16e-01 | -2.92e-01 | 6.91e-01 |
| GOBP REGULATION OF SISTER CHROMATID COHESION | 17 | 3.72e-02 | 2.92e-01 | 3.92e-01 |
| GOBP MAINTENANCE OF ORGANELLE LOCATION | 12 | 8.01e-02 | 2.92e-01 | 4.99e-01 |
| GOMF EXTRACELLULAR MATRIX STRUCTURAL CONSTITUENT CONFERRING COMPRESSION RESISTANCE | 8 | 1.53e-01 | 2.92e-01 | 6.16e-01 |
| GOBP POSITIVE REGULATION OF CELL PROLIFERATION INVOLVED IN KIDNEY DEVELOPMENT | 8 | 1.53e-01 | -2.92e-01 | 6.16e-01 |
| GOBP POSITIVE REGULATION OF ENDOTHELIAL CELL DEVELOPMENT | 6 | 2.16e-01 | -2.92e-01 | 6.92e-01 |
| GOMF STRUCTURAL CONSTITUENT OF EYE LENS | 6 | 2.16e-01 | -2.92e-01 | 6.92e-01 |
| GOBP SKELETAL MUSCLE FIBER DIFFERENTIATION | 6 | 2.16e-01 | -2.92e-01 | 6.92e-01 |
| GOMF CALMODULIN DEPENDENT PROTEIN PHOSPHATASE ACTIVITY | 5 | 2.59e-01 | 2.92e-01 | 7.27e-01 |
| GOMF THIOESTERASE BINDING | 10 | 1.10e-01 | -2.92e-01 | 5.64e-01 |
| GOBP DOLICHYL DIPHOSPHATE METABOLIC PROCESS | 5 | 2.59e-01 | 2.91e-01 | 7.27e-01 |
| GOBP POSITIVE REGULATION OF GRANULOCYTE DIFFERENTIATION | 7 | 1.82e-01 | 2.91e-01 | 6.54e-01 |
| GOBP PHOSPHATIDYLETHANOLAMINE BIOSYNTHETIC PROCESS | 10 | 1.11e-01 | -2.91e-01 | 5.64e-01 |
| GOBP POSITIVE REGULATION OF INTERLEUKIN 18 PRODUCTION | 7 | 1.82e-01 | 2.91e-01 | 6.54e-01 |
| GOBP POSITIVE REGULATION OF MONOCYTE EXTRAVASATION | 5 | 2.59e-01 | -2.91e-01 | 7.28e-01 |
| GOCC PLATELET DENSE TUBULAR NETWORK MEMBRANE | 9 | 1.30e-01 | -2.91e-01 | 5.94e-01 |
| GOBP POSITIVE REGULATION OF ASPARTIC TYPE ENDOPEPTIDASE ACTIVITY INVOLVED IN AMYLOID PRECURSOR PROTEIN CATABOLIC PROCESS | 5 | 2.59e-01 | -2.91e-01 | 7.28e-01 |
| GOBP RESPONSE TO GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR | 8 | 1.54e-01 | -2.91e-01 | 6.17e-01 |
| GOMF TESTOSTERONE DEHYDROGENASE NAD P ACTIVITY | 8 | 1.54e-01 | -2.91e-01 | 6.17e-01 |
| GOBP HISTONE MRNA CATABOLIC PROCESS | 15 | 5.10e-02 | 2.91e-01 | 4.30e-01 |
| GOBP NEGATIVE REGULATION OF EXTRACELLULAR MATRIX ORGANIZATION | 11 | 9.46e-02 | -2.91e-01 | 5.36e-01 |
| GOBP POSITIVE REGULATION OF DENDRITIC SPINE MORPHOGENESIS | 15 | 5.10e-02 | 2.91e-01 | 4.30e-01 |
| GOBP COMPLEMENT ACTIVATION LECTIN PATHWAY | 5 | 2.60e-01 | 2.91e-01 | 7.28e-01 |
| GOMF GAMMA CATENIN BINDING | 8 | 1.54e-01 | 2.91e-01 | 6.17e-01 |
| GOMF POLY A RNA POLYMERASE ACTIVITY | 9 | 1.31e-01 | 2.91e-01 | 5.95e-01 |
| GOBP DIOL BIOSYNTHETIC PROCESS | 21 | 2.13e-02 | 2.90e-01 | 3.19e-01 |
| GOBP PORE COMPLEX ASSEMBLY | 20 | 2.47e-02 | 2.90e-01 | 3.39e-01 |
| GOMF HISTONE H3K9 MONOMETHYLTRANSFERASE ACTIVITY | 5 | 2.62e-01 | 2.90e-01 | 7.29e-01 |
| GOBP NEGATIVE REGULATION OF EXECUTION PHASE OF APOPTOSIS | 6 | 2.19e-01 | 2.90e-01 | 6.93e-01 |
| GOBP VITAMIN TRANSMEMBRANE TRANSPORT | 15 | 5.19e-02 | -2.90e-01 | 4.33e-01 |
| GOBP PYRIMIDINE RIBONUCLEOSIDE MONOPHOSPHATE BIOSYNTHETIC PROCESS | 11 | 9.61e-02 | -2.90e-01 | 5.39e-01 |
| GOCC PREFOLDIN COMPLEX | 7 | 1.84e-01 | 2.90e-01 | 6.57e-01 |
| GOMF PHOSPHATIDYLINOSITOL 3 5 BISPHOSPHATE PHOSPHATASE ACTIVITY | 15 | 5.21e-02 | 2.90e-01 | 4.33e-01 |
| GOBP REGULATION OF VIRAL GENOME REPLICATION | 78 | 1.00e-05 | 2.89e-01 | 3.21e-03 |
| GOMF GABA RECEPTOR BINDING | 11 | 9.68e-02 | 2.89e-01 | 5.41e-01 |
| GOBP BRANCHING MORPHOGENESIS OF A NERVE | 9 | 1.33e-01 | 2.89e-01 | 5.98e-01 |
| GOMF ANDROSTAN 3 ALPHA 17 BETA DIOL DEHYDROGENASE ACTIVITY | 7 | 1.86e-01 | -2.89e-01 | 6.60e-01 |
| GOBP LIPID TRANSPORT ACROSS BLOOD BRAIN BARRIER | 6 | 2.21e-01 | -2.89e-01 | 6.94e-01 |
| GOBP CD4 POSITIVE ALPHA BETA T CELL PROLIFERATION | 21 | 2.20e-02 | 2.89e-01 | 3.23e-01 |
| GOBP NEGATIVE REGULATION OF CYTOPLASMIC TRANSLATION | 9 | 1.34e-01 | 2.88e-01 | 5.99e-01 |
| GOCC EXTERNAL SIDE OF APICAL PLASMA MEMBRANE | 5 | 2.64e-01 | 2.88e-01 | 7.31e-01 |
| GOBP POSITIVE REGULATION OF MONOCYTE CHEMOTAXIS | 14 | 6.18e-02 | 2.88e-01 | 4.61e-01 |
| GOBP BEHAVIORAL RESPONSE TO PAIN | 13 | 7.22e-02 | -2.88e-01 | 4.86e-01 |
| GOBP CELLULAR RESPONSE TO PH | 17 | 3.99e-02 | -2.88e-01 | 3.99e-01 |
| GOMF 3 5 DNA EXONUCLEASE ACTIVITY | 15 | 5.37e-02 | -2.88e-01 | 4.36e-01 |
| GOBP HYALURONAN BIOSYNTHETIC PROCESS | 12 | 8.45e-02 | -2.88e-01 | 5.09e-01 |
| GOBP GLUTATHIONE TRANSPORT | 8 | 1.59e-01 | 2.88e-01 | 6.25e-01 |
| GOBP NEGATIVE REGULATION OF PLATELET ACTIVATION | 15 | 5.43e-02 | -2.87e-01 | 4.38e-01 |
| GOBP POSITIVE REGULATION OF CALCIUM ION IMPORT ACROSS PLASMA MEMBRANE | 8 | 1.60e-01 | 2.87e-01 | 6.27e-01 |
| GOBP DORSAL SPINAL CORD DEVELOPMENT | 8 | 1.60e-01 | -2.87e-01 | 6.27e-01 |
| GOCC ORIGIN RECOGNITION COMPLEX | 8 | 1.61e-01 | 2.86e-01 | 6.27e-01 |
| GOBP SULFATE TRANSPORT | 10 | 1.17e-01 | -2.86e-01 | 5.76e-01 |
| GOMF ACIDIC AMINO ACID TRANSMEMBRANE TRANSPORTER ACTIVITY | 14 | 6.35e-02 | 2.86e-01 | 4.64e-01 |
| GOMF G QUADRUPLEX RNA BINDING | 8 | 1.61e-01 | 2.86e-01 | 6.28e-01 |
| GOCC AXON HILLOCK | 7 | 1.90e-01 | 2.86e-01 | 6.62e-01 |
| GOBP PARAXIAL MESODERM MORPHOGENESIS | 6 | 2.25e-01 | 2.86e-01 | 6.98e-01 |
| GOBP POSITIVE REGULATION OF ARTERY MORPHOGENESIS | 5 | 2.68e-01 | -2.86e-01 | 7.33e-01 |
| GOBP REGULATION OF ARTERY MORPHOGENESIS | 5 | 2.68e-01 | -2.86e-01 | 7.33e-01 |
| GOBP SPINDLE ASSEMBLY INVOLVED IN FEMALE MEIOSIS | 8 | 1.61e-01 | 2.86e-01 | 6.28e-01 |
| GOMF C X C CHEMOKINE BINDING | 5 | 2.68e-01 | 2.86e-01 | 7.33e-01 |
| GOBP SODIUM INDEPENDENT ORGANIC ANION TRANSPORT | 5 | 2.68e-01 | -2.86e-01 | 7.33e-01 |
| GOBP RESPONSE TO INDOLE 3 METHANOL | 6 | 2.26e-01 | 2.86e-01 | 6.98e-01 |
| GOMF RIBOSOMAL SMALL SUBUNIT BINDING | 17 | 4.15e-02 | 2.86e-01 | 4.04e-01 |
| GOMF PHOSPHOLIPASE ACTIVATOR ACTIVITY | 15 | 5.55e-02 | 2.86e-01 | 4.40e-01 |
| GOBP GROWTH PLATE CARTILAGE DEVELOPMENT | 12 | 8.69e-02 | 2.85e-01 | 5.16e-01 |
| GOBP FORMATE METABOLIC PROCESS | 5 | 2.69e-01 | 2.85e-01 | 7.34e-01 |
| GOMF K48 LINKED DEUBIQUITINASE ACTIVITY | 17 | 4.18e-02 | 2.85e-01 | 4.05e-01 |
| GOBP DETOXIFICATION OF INORGANIC COMPOUND | 12 | 8.73e-02 | 2.85e-01 | 5.17e-01 |
| GOMF RNA POLYMERASE I ACTIVITY | 10 | 1.19e-01 | -2.85e-01 | 5.81e-01 |
| GOMF FATTY ACID ELONGASE ACTIVITY | 6 | 2.27e-01 | -2.85e-01 | 7.00e-01 |
| GOMF ALDO KETO REDUCTASE NADPH ACTIVITY | 24 | 1.57e-02 | -2.85e-01 | 2.72e-01 |
| GOBP INTERLEUKIN 3 MEDIATED SIGNALING PATHWAY | 6 | 2.28e-01 | 2.84e-01 | 7.01e-01 |
| GOBP REGULATION OF ORGANELLE TRANSPORT ALONG MICROTUBULE | 9 | 1.40e-01 | -2.84e-01 | 6.06e-01 |
| GOBP P BODY ASSEMBLY | 23 | 1.83e-02 | 2.84e-01 | 2.94e-01 |
| GOMF AMP BINDING | 13 | 7.62e-02 | -2.84e-01 | 4.93e-01 |
| GOBP REGULATION OF DENDRITIC SPINE MAINTENANCE | 10 | 1.20e-01 | 2.84e-01 | 5.82e-01 |
| GOBP POSITIVE REGULATION OF INTERFERON ALPHA PRODUCTION | 21 | 2.43e-02 | 2.84e-01 | 3.38e-01 |
| GOBP REGULATION OF URINE VOLUME | 15 | 5.69e-02 | -2.84e-01 | 4.45e-01 |
| GOBP POSITIVE REGULATION OF CHROMATIN ORGANIZATION | 14 | 6.60e-02 | 2.84e-01 | 4.68e-01 |
| GOBP REGULATION OF SUPEROXIDE ANION GENERATION | 17 | 4.29e-02 | -2.84e-01 | 4.07e-01 |
| GOBP POSITIVE REGULATION OF URINE VOLUME | 8 | 1.65e-01 | -2.84e-01 | 6.30e-01 |
| GOMF CAMP DEPENDENT PROTEIN KINASE INHIBITOR ACTIVITY | 8 | 1.65e-01 | 2.84e-01 | 6.30e-01 |
| GOBP NEURON FATE SPECIFICATION | 9 | 1.41e-01 | -2.84e-01 | 6.08e-01 |
| GOBP EMBRYONIC BODY MORPHOGENESIS | 11 | 1.04e-01 | -2.83e-01 | 5.55e-01 |
| GOMF MISMATCH REPAIR COMPLEX BINDING | 11 | 1.04e-01 | 2.83e-01 | 5.55e-01 |
| GOBP POSITIVE REGULATION OF GLYCOGEN BIOSYNTHETIC PROCESS | 11 | 1.04e-01 | -2.83e-01 | 5.55e-01 |
| GOMF SUPERCOILED DNA BINDING | 6 | 2.30e-01 | 2.83e-01 | 7.02e-01 |
| GOCC F ACTIN CAPPING PROTEIN COMPLEX | 7 | 1.95e-01 | 2.83e-01 | 6.68e-01 |
| GOBP NEGATIVE REGULATION OF NOTCH SIGNALING PATHWAY | 26 | 1.25e-02 | -2.83e-01 | 2.49e-01 |
| GOMF L ALANINE TRANSMEMBRANE TRANSPORTER ACTIVITY | 7 | 1.95e-01 | 2.83e-01 | 6.68e-01 |
| GOBP NUCLEOTIDE SALVAGE | 16 | 5.02e-02 | -2.83e-01 | 4.28e-01 |
| GOBP RENAL PROTEIN ABSORPTION | 7 | 1.96e-01 | -2.82e-01 | 6.68e-01 |
| GOBP PROTEIN UFMYLATION | 6 | 2.31e-01 | 2.82e-01 | 7.04e-01 |
| GOBP RESPONSE TO MURAMYL DIPEPTIDE | 21 | 2.53e-02 | -2.82e-01 | 3.45e-01 |
| GOBP POSITIVE REGULATION OF APOPTOTIC CELL CLEARANCE | 6 | 2.32e-01 | -2.82e-01 | 7.04e-01 |
| GOBP MELANOCYTE DIFFERENTIATION | 14 | 6.79e-02 | 2.82e-01 | 4.73e-01 |
| GOMF INTERLEUKIN 1 BINDING | 8 | 1.68e-01 | 2.82e-01 | 6.33e-01 |
| GOBP RESPONSE TO REDOX STATE | 13 | 7.89e-02 | 2.81e-01 | 4.97e-01 |
| GOBP CELLULAR RESPONSE TO OXYGEN RADICAL | 18 | 3.88e-02 | 2.81e-01 | 3.98e-01 |
| GOBP POSITIVE REGULATION OF OSTEOBLAST PROLIFERATION | 10 | 1.24e-01 | -2.81e-01 | 5.86e-01 |
| GOBP REGULATION OF DNA DAMAGE CHECKPOINT | 21 | 2.58e-02 | 2.81e-01 | 3.47e-01 |
| GOBP CELLULAR RESPONSE TO THYROID HORMONE STIMULUS | 11 | 1.07e-01 | 2.81e-01 | 5.59e-01 |
| GOBP POSTREPLICATION REPAIR | 36 | 3.55e-03 | 2.81e-01 | 1.41e-01 |
| GOBP DEOXYRIBONUCLEOTIDE BIOSYNTHETIC PROCESS | 14 | 6.90e-02 | 2.81e-01 | 4.77e-01 |
| GOMF TELOMERASE ACTIVITY | 6 | 2.34e-01 | 2.81e-01 | 7.05e-01 |
| GOMF PROTEIN DISULFIDE ISOMERASE ACTIVITY | 18 | 3.94e-02 | 2.80e-01 | 3.98e-01 |
| GOBP PLASMA MEMBRANE FUSION | 11 | 1.07e-01 | -2.80e-01 | 5.61e-01 |
| GOBP PROTEASOME ASSEMBLY | 13 | 8.03e-02 | 2.80e-01 | 4.99e-01 |
| GOBP BONE GROWTH | 20 | 3.01e-02 | 2.80e-01 | 3.64e-01 |
| GOBP RESPONSE TO X RAY | 26 | 1.34e-02 | 2.80e-01 | 2.50e-01 |
| GOBP PROGESTERONE RECEPTOR SIGNALING PATHWAY | 9 | 1.46e-01 | 2.80e-01 | 6.13e-01 |
| GOBP BRAINSTEM DEVELOPMENT | 5 | 2.79e-01 | 2.80e-01 | 7.40e-01 |
| GOBP NEGATIVE REGULATION OF G0 TO G1 TRANSITION | 5 | 2.79e-01 | -2.79e-01 | 7.41e-01 |
| GOBP GLIAL CELL APOPTOTIC PROCESS | 15 | 6.13e-02 | 2.79e-01 | 4.59e-01 |
| GOBP REGULATION OF RESPIRATORY BURST INVOLVED IN INFLAMMATORY RESPONSE | 6 | 2.37e-01 | -2.79e-01 | 7.08e-01 |
| GOCC HIGH DENSITY LIPOPROTEIN PARTICLE | 12 | 9.44e-02 | -2.79e-01 | 5.35e-01 |
| GOBP GASTRIC ACID SECRETION | 9 | 1.48e-01 | 2.78e-01 | 6.13e-01 |
| GOBP NK T CELL PROLIFERATION | 8 | 1.73e-01 | -2.78e-01 | 6.40e-01 |
| GOCC WNT SIGNALOSOME | 12 | 9.51e-02 | 2.78e-01 | 5.36e-01 |
| GOBP PURINE NUCLEOSIDE TRANSMEMBRANE TRANSPORT | 5 | 2.81e-01 | 2.78e-01 | 7.43e-01 |
| GOBP REGULATION OF CENTROMERE COMPLEX ASSEMBLY | 6 | 2.38e-01 | 2.78e-01 | 7.08e-01 |
| GOBP PROTEIN K63 LINKED DEUBIQUITINATION | 30 | 8.38e-03 | 2.78e-01 | 2.13e-01 |
| GOCC GID COMPLEX | 5 | 2.82e-01 | 2.78e-01 | 7.43e-01 |
| GOBP REGULATION OF T HELPER 17 CELL DIFFERENTIATION | 20 | 3.14e-02 | -2.78e-01 | 3.72e-01 |
| GOBP POSITIVE REGULATION OF GLOMERULAR MESANGIAL CELL PROLIFERATION | 6 | 2.38e-01 | -2.78e-01 | 7.08e-01 |
| GOCC FLEMMING BODY | 30 | 8.42e-03 | 2.78e-01 | 2.13e-01 |
| GOBP URIDINE TRANSMEMBRANE TRANSPORT | 5 | 2.82e-01 | 2.78e-01 | 7.43e-01 |
| GOBP POSITIVE REGULATION OF TRANSCRIPTION OF NUCLEOLAR LARGE RRNA BY RNA POLYMERASE I | 10 | 1.28e-01 | -2.78e-01 | 5.93e-01 |
| GOBP NEGATIVE REGULATION OF MACROPHAGE APOPTOTIC PROCESS | 7 | 2.03e-01 | 2.78e-01 | 6.77e-01 |
| GOBP LEUKOCYTE MIGRATION INVOLVED IN INFLAMMATORY RESPONSE | 14 | 7.20e-02 | -2.78e-01 | 4.86e-01 |
| GOBP XENOBIOTIC TRANSPORT ACROSS BLOOD BRAIN BARRIER | 5 | 2.83e-01 | -2.77e-01 | 7.43e-01 |
| GOBP REGULATION OF GTP BINDING | 8 | 1.75e-01 | 2.77e-01 | 6.42e-01 |
| GOBP RESPONSE TO MERCURY ION | 7 | 2.04e-01 | -2.77e-01 | 6.79e-01 |
| GOBP NEGATIVE REGULATION OF NITRIC OXIDE METABOLIC PROCESS | 10 | 1.29e-01 | -2.77e-01 | 5.94e-01 |
| GOBP RESPONSE TO FUNGICIDE | 6 | 2.40e-01 | -2.77e-01 | 7.10e-01 |
| GOBP REGULATION OF DNA METHYLATION DEPENDENT HETEROCHROMATIN FORMATION | 16 | 5.53e-02 | 2.77e-01 | 4.40e-01 |
| GOBP ALANINE TRANSPORT | 12 | 9.71e-02 | 2.77e-01 | 5.41e-01 |
| GOBP REGULATION OF CALCIUM ION IMPORT ACROSS PLASMA MEMBRANE | 10 | 1.30e-01 | 2.77e-01 | 5.94e-01 |
| GOBP BEHAVIORAL RESPONSE TO COCAINE | 10 | 1.30e-01 | -2.76e-01 | 5.94e-01 |
| GOCC KINETOCHORE MICROTUBULE | 19 | 3.71e-02 | 2.76e-01 | 3.91e-01 |
| GOBP L PHENYLALANINE METABOLIC PROCESS | 6 | 2.41e-01 | -2.76e-01 | 7.11e-01 |
| GOBP PREPULSE INHIBITION | 7 | 2.06e-01 | 2.76e-01 | 6.81e-01 |
| GOBP B CELL PROLIFERATION INVOLVED IN IMMUNE RESPONSE | 6 | 2.42e-01 | 2.76e-01 | 7.11e-01 |
| GOBP RESPONSE TO MAGNESIUM ION | 16 | 5.60e-02 | -2.76e-01 | 4.42e-01 |
| GOBP PURINE NUCLEOSIDE TRIPHOSPHATE CATABOLIC PROCESS | 5 | 2.85e-01 | 2.76e-01 | 7.45e-01 |
| GOBP NEGATIVE REGULATION OF LOW DENSITY LIPOPROTEIN PARTICLE CLEARANCE | 7 | 2.06e-01 | -2.76e-01 | 6.81e-01 |
| GOBP MEIOTIC METAPHASE CHROMOSOME ALIGNMENT | 5 | 2.86e-01 | 2.76e-01 | 7.45e-01 |
| GOMF WNT PROTEIN BINDING | 19 | 3.75e-02 | 2.76e-01 | 3.93e-01 |
| GOBP MICROTUBULE BASED PROTEIN TRANSPORT | 14 | 7.42e-02 | -2.76e-01 | 4.89e-01 |
| GOBP REGULATION OF TRANSLATION IN RESPONSE TO STRESS | 21 | 2.88e-02 | 2.76e-01 | 3.59e-01 |
| GOMF INTRAMOLECULAR PHOSPHOTRANSFERASE ACTIVITY | 9 | 1.52e-01 | 2.75e-01 | 6.16e-01 |
| GOBP GALACTOSE CATABOLIC PROCESS VIA UDP GALACTOSE | 5 | 2.87e-01 | -2.75e-01 | 7.46e-01 |
| GOBP GLYCOLYTIC PROCESS THROUGH FRUCTOSE 6 PHOSPHATE | 22 | 2.57e-02 | -2.75e-01 | 3.47e-01 |
| GOBP CELLULAR RESPONSE TO WATER STIMULUS | 5 | 2.87e-01 | -2.75e-01 | 7.47e-01 |
| GOBP CARDIOBLAST DIFFERENTIATION | 11 | 1.15e-01 | 2.75e-01 | 5.72e-01 |
| GOMF 3 HYDROXYACYL COA DEHYDROGENASE ACTIVITY | 6 | 2.44e-01 | 2.75e-01 | 7.14e-01 |
| GOMF HIGH VOLTAGE GATED CALCIUM CHANNEL ACTIVITY | 11 | 1.15e-01 | -2.75e-01 | 5.72e-01 |
| GOMF NUCLEOSIDE MONOPHOSPHATE KINASE ACTIVITY | 19 | 3.84e-02 | 2.74e-01 | 3.98e-01 |
| GOMF CAMP DEPENDENT PROTEIN KINASE ACTIVITY | 5 | 2.88e-01 | 2.74e-01 | 7.47e-01 |
| GOBP REGULATION OF MICROVILLUS ASSEMBLY | 6 | 2.45e-01 | 2.74e-01 | 7.14e-01 |
| GOBP OSMOSENSORY SIGNALING PATHWAY | 8 | 1.79e-01 | 2.74e-01 | 6.51e-01 |
| GOBP METAPHASE ANAPHASE TRANSITION OF MEIOTIC CELL CYCLE | 5 | 2.88e-01 | 2.74e-01 | 7.47e-01 |
| GOBP HYPERSENSITIVITY | 17 | 5.04e-02 | 2.74e-01 | 4.29e-01 |
| GOMF IMPORTIN ALPHA FAMILY PROTEIN BINDING | 9 | 1.55e-01 | 2.74e-01 | 6.17e-01 |
| GOBP CARDIOLIPIN BIOSYNTHETIC PROCESS | 7 | 2.09e-01 | -2.74e-01 | 6.83e-01 |
| GOCC DNA REPLICATION FACTOR C COMPLEX | 5 | 2.89e-01 | 2.74e-01 | 7.47e-01 |
| GOBP INTRACELLULAR SPHINGOLIPID HOMEOSTASIS | 5 | 2.90e-01 | -2.73e-01 | 7.47e-01 |
| GOMF SODIUM BICARBONATE SYMPORTER ACTIVITY | 5 | 2.90e-01 | 2.73e-01 | 7.47e-01 |
| GOBP HAIR CELL DIFFERENTIATION | 34 | 5.82e-03 | -2.73e-01 | 1.80e-01 |
| GOBP ECTODERMAL PLACODE DEVELOPMENT | 6 | 2.46e-01 | 2.73e-01 | 7.16e-01 |
| GOBP CORONARY ARTERY MORPHOGENESIS | 7 | 2.11e-01 | 2.73e-01 | 6.83e-01 |
| GOBP RESPONSE TO LIPOTEICHOIC ACID | 8 | 1.81e-01 | 2.73e-01 | 6.54e-01 |
| GOBP ESTABLISHMENT OF PLANAR POLARITY INVOLVED IN NEURAL TUBE CLOSURE | 7 | 2.11e-01 | -2.73e-01 | 6.84e-01 |
| GOCC MESSENGER RIBONUCLEOPROTEIN COMPLEX | 6 | 2.47e-01 | 2.73e-01 | 7.17e-01 |
| GOBP ANTIMICROBIAL HUMORAL IMMUNE RESPONSE MEDIATED BY ANTIMICROBIAL PEPTIDE | 52 | 6.70e-04 | -2.73e-01 | 5.61e-02 |
| GOBP UBIQUITIN DEPENDENT PROTEIN CATABOLIC PROCESS VIA THE C END DEGRON RULE PATHWAY | 12 | 1.02e-01 | 2.73e-01 | 5.51e-01 |
| GOBP COPPER ION IMPORT | 6 | 2.48e-01 | 2.73e-01 | 7.17e-01 |
| GOMF DNA INSERTION OR DELETION BINDING | 6 | 2.48e-01 | 2.73e-01 | 7.17e-01 |
| GOBP FOLIC ACID CONTAINING COMPOUND BIOSYNTHETIC PROCESS | 10 | 1.36e-01 | 2.72e-01 | 6.02e-01 |
| GOBP IMMUNE RESPONSE INHIBITING SIGNAL TRANSDUCTION | 9 | 1.57e-01 | 2.72e-01 | 6.22e-01 |
| GOBP REGULATION OF ODONTOGENESIS OF DENTIN CONTAINING TOOTH | 6 | 2.49e-01 | 2.72e-01 | 7.17e-01 |
| GOBP HEMATOPOIETIC STEM CELL MIGRATION TO BONE MARROW | 5 | 2.93e-01 | 2.72e-01 | 7.50e-01 |
| GOMF SEQUENCE SPECIFIC MRNA BINDING | 11 | 1.19e-01 | 2.72e-01 | 5.81e-01 |
| GOMF MITOGEN ACTIVATED PROTEIN KINASE P38 BINDING | 7 | 2.13e-01 | -2.72e-01 | 6.88e-01 |
| GOBP NEUTROPHIL MEDIATED KILLING OF SYMBIONT CELL | 9 | 1.59e-01 | -2.71e-01 | 6.24e-01 |
| GOMF HYDROLASE ACTIVITY ACTING ON ETHER BONDS | 10 | 1.37e-01 | -2.71e-01 | 6.03e-01 |
| GOBP DIAPHRAGM DEVELOPMENT | 5 | 2.93e-01 | -2.71e-01 | 7.50e-01 |
| GOBP MESENCHYMAL EPITHELIAL CELL SIGNALING | 5 | 2.94e-01 | -2.71e-01 | 7.50e-01 |
| GOBP RESPONSE TO BILE ACID | 6 | 2.50e-01 | -2.71e-01 | 7.18e-01 |
| GOBP POSITIVE REGULATION OF CAMP MEDIATED SIGNALING | 6 | 2.50e-01 | -2.71e-01 | 7.18e-01 |
| GOBP L GLUTAMATE IMPORT ACROSS PLASMA MEMBRANE | 12 | 1.04e-01 | 2.71e-01 | 5.56e-01 |
| GOMF PRIMARY MIRNA BINDING | 9 | 1.59e-01 | 2.71e-01 | 6.26e-01 |
| GOBP NEGATIVE REGULATION OF MONOCYTE CHEMOTAXIS | 6 | 2.51e-01 | -2.71e-01 | 7.19e-01 |
| GOMF 5 3 DNA EXONUCLEASE ACTIVITY | 9 | 1.60e-01 | 2.70e-01 | 6.27e-01 |
| GOBP CENTRAL NERVOUS SYSTEM NEURON AXONOGENESIS | 29 | 1.19e-02 | 2.70e-01 | 2.43e-01 |
| GOBP MITOCHONDRIAL ATP TRANSMEMBRANE TRANSPORT | 5 | 2.96e-01 | -2.70e-01 | 7.53e-01 |
| GOCC FASCIA ADHERENS | 5 | 2.96e-01 | -2.70e-01 | 7.53e-01 |
| GOBP RESPONSE TO LECTIN | 23 | 2.51e-02 | 2.70e-01 | 3.44e-01 |
| GOBP SYNAPTIC VESICLE MEMBRANE ORGANIZATION | 22 | 2.85e-02 | -2.70e-01 | 3.59e-01 |
| GOMF POLY ADP D RIBOSE BINDING | 6 | 2.53e-01 | 2.70e-01 | 7.22e-01 |
| GOBP TOOTH MINERALIZATION | 18 | 4.78e-02 | -2.69e-01 | 4.24e-01 |
| GOBP POSITIVE REGULATION OF NATURAL KILLER CELL DIFFERENTIATION | 8 | 1.87e-01 | 2.69e-01 | 6.61e-01 |
| GOBP NUCLEOSIDE TRANSPORT | 9 | 1.62e-01 | 2.69e-01 | 6.28e-01 |
| GOBP OSTEOCLAST FUSION | 5 | 2.97e-01 | -2.69e-01 | 7.53e-01 |
| GOBP CELL MIGRATION INVOLVED IN GASTRULATION | 8 | 1.88e-01 | -2.69e-01 | 6.62e-01 |
| GOBP REGULATION OF T CELL CHEMOTAXIS | 11 | 1.23e-01 | 2.69e-01 | 5.86e-01 |
| GOBP SUBSTRATE DEPENDENT CELL MIGRATION CELL EXTENSION | 9 | 1.63e-01 | 2.69e-01 | 6.29e-01 |
| GOBP PYRUVATE TRANSPORT | 6 | 2.54e-01 | 2.69e-01 | 7.23e-01 |
| GOBP POSITIVE REGULATION OF EXCITATORY POSTSYNAPTIC POTENTIAL | 23 | 2.57e-02 | -2.69e-01 | 3.47e-01 |
| GOBP PURINE DEOXYRIBONUCLEOTIDE BIOSYNTHETIC PROCESS | 5 | 2.98e-01 | 2.69e-01 | 7.54e-01 |
| GOCC MRNA EDITING COMPLEX | 5 | 2.99e-01 | -2.68e-01 | 7.55e-01 |
| GOBP SEMAPHORIN PLEXIN SIGNALING PATHWAY | 36 | 5.31e-03 | -2.68e-01 | 1.77e-01 |
| GOBP PHOSPHATIDYLINOSITOL DEPHOSPHORYLATION | 29 | 1.24e-02 | 2.68e-01 | 2.49e-01 |
| GOBP HEPATOCYTE APOPTOTIC PROCESS | 18 | 4.88e-02 | 2.68e-01 | 4.25e-01 |
| GOBP NEGATIVE REGULATION OF INTERLEUKIN 8 PRODUCTION | 16 | 6.32e-02 | -2.68e-01 | 4.63e-01 |
| GOBP IMMUNOGLOBULIN V D J RECOMBINATION | 8 | 1.89e-01 | 2.68e-01 | 6.62e-01 |
| GOBP POSITIVE REGULATION OF CREB TRANSCRIPTION FACTOR ACTIVITY | 10 | 1.42e-01 | -2.68e-01 | 6.09e-01 |
| GOBP INTRACILIARY TRANSPORT INVOLVED IN CILIUM ASSEMBLY | 6 | 2.56e-01 | 2.68e-01 | 7.25e-01 |
| GOBP MICROTUBULE SEVERING | 8 | 1.90e-01 | -2.68e-01 | 6.62e-01 |
| GOBP POSITIVE REGULATION OF ENDOPLASMIC RETICULUM STRESS INDUCED INTRINSIC APOPTOTIC SIGNALING PATHWAY | 8 | 1.90e-01 | 2.68e-01 | 6.62e-01 |
| GOCC PERINUCLEAR ENDOPLASMIC RETICULUM | 18 | 4.92e-02 | 2.68e-01 | 4.25e-01 |
| GOMF ADP TRANSMEMBRANE TRANSPORTER ACTIVITY | 9 | 1.64e-01 | -2.68e-01 | 6.30e-01 |
| GOBP POSITIVE REGULATION OF EARLY ENDOSOME TO LATE ENDOSOME TRANSPORT | 9 | 1.64e-01 | 2.68e-01 | 6.30e-01 |
| GOBP NEGATIVE REGULATION OF LIPOPROTEIN PARTICLE CLEARANCE | 8 | 1.90e-01 | -2.68e-01 | 6.62e-01 |
| GOBP LIPID GLYCOSYLATION | 8 | 1.90e-01 | -2.68e-01 | 6.62e-01 |
| GOBP NEGATIVE REGULATION OF WOUND HEALING SPREADING OF EPIDERMAL CELLS | 5 | 3.00e-01 | 2.68e-01 | 7.56e-01 |
| GOMF HISTONE H4 METHYLTRANSFERASE ACTIVITY | 14 | 8.32e-02 | -2.67e-01 | 5.05e-01 |
| GOBP CHONDROCYTE DIFFERENTIATION INVOLVED IN ENDOCHONDRAL BONE MORPHOGENESIS | 11 | 1.25e-01 | 2.67e-01 | 5.88e-01 |
| GOBP REGULATION OF INFLAMMATORY RESPONSE TO WOUNDING | 9 | 1.65e-01 | -2.67e-01 | 6.30e-01 |
| GOBP PROTEIN LINEAR POLYUBIQUITINATION | 5 | 3.01e-01 | -2.67e-01 | 7.57e-01 |
| GOMF OXIDOREDUCTASE ACTIVITY ACTING ON SINGLE DONORS WITH INCORPORATION OF MOLECULAR OXYGEN | 19 | 4.40e-02 | -2.67e-01 | 4.11e-01 |
| GOBP TRIPEPTIDE TRANSMEMBRANE TRANSPORT | 8 | 1.91e-01 | 2.67e-01 | 6.63e-01 |
| GOBP ANTEROGRADE NEURONAL DENSE CORE VESICLE TRANSPORT | 6 | 2.58e-01 | -2.67e-01 | 7.27e-01 |
| GOMF ACETYLESTERASE ACTIVITY | 5 | 3.02e-01 | 2.67e-01 | 7.57e-01 |
| GOBP RESPONSE TO HYDROPEROXIDE | 17 | 5.70e-02 | 2.67e-01 | 4.45e-01 |
| GOBP REGULATION OF INNER EAR AUDITORY RECEPTOR CELL DIFFERENTIATION | 5 | 3.02e-01 | -2.67e-01 | 7.57e-01 |
| GOBP POSITIVE REGULATION OF ORGANIC ACID TRANSPORT | 32 | 9.04e-03 | 2.67e-01 | 2.19e-01 |
| GOBP VITAMIN TRANSPORT | 35 | 6.35e-03 | -2.67e-01 | 1.87e-01 |
| GOBP POSITIVE REGULATION OF INTERLEUKIN 1 ALPHA PRODUCTION | 5 | 3.02e-01 | 2.67e-01 | 7.57e-01 |
| GOBP ARF PROTEIN SIGNAL TRANSDUCTION | 20 | 3.91e-02 | -2.66e-01 | 3.98e-01 |
| GOBP REGULATION OF RESPIRATORY BURST | 16 | 6.50e-02 | -2.66e-01 | 4.66e-01 |
| GOBP MEMBRANOUS SEPTUM MORPHOGENESIS | 7 | 2.22e-01 | 2.66e-01 | 6.97e-01 |
| GOBP POSITIVE REGULATION OF RYANODINE SENSITIVE CALCIUM RELEASE CHANNEL ACTIVITY | 7 | 2.23e-01 | 2.66e-01 | 6.97e-01 |
| GOBP REGULATION OF CHOLESTEROL EFFLUX | 27 | 1.66e-02 | -2.66e-01 | 2.82e-01 |
| GOMF ADP PHOSPHATASE ACTIVITY | 6 | 2.59e-01 | -2.66e-01 | 7.27e-01 |
| GOBP AIM2 INFLAMMASOME COMPLEX ASSEMBLY | 5 | 3.03e-01 | 2.66e-01 | 7.58e-01 |
| GOBP METANEPHRIC TUBULE MORPHOGENESIS | 6 | 2.59e-01 | -2.66e-01 | 7.27e-01 |
| GOBP AUDITORY RECEPTOR CELL DEVELOPMENT | 20 | 3.95e-02 | -2.66e-01 | 3.98e-01 |
| GOBP NEGATIVE REGULATION OF DEPHOSPHORYLATION | 27 | 1.68e-02 | 2.66e-01 | 2.83e-01 |
| GOBP NEGATIVE REGULATION OF DNA TEMPLATED TRANSCRIPTION INITIATION | 6 | 2.60e-01 | -2.66e-01 | 7.28e-01 |
| GOBP POSITIVE REGULATION OF OXIDATIVE STRESS INDUCED INTRINSIC APOPTOTIC SIGNALING PATHWAY | 6 | 2.60e-01 | 2.66e-01 | 7.28e-01 |
| GOCC MITOTIC SPINDLE ASTRAL MICROTUBULE | 7 | 2.24e-01 | 2.66e-01 | 6.97e-01 |
| GOBP REGULATION OF ADHERENS JUNCTION ORGANIZATION | 5 | 3.04e-01 | -2.66e-01 | 7.59e-01 |
| GOBP OUTFLOW TRACT SEPTUM MORPHOGENESIS | 16 | 6.60e-02 | 2.65e-01 | 4.68e-01 |
| GOBP ENDONUCLEOLYTIC CLEAVAGE OF TRICISTRONIC RRNA TRANSCRIPT SSU RRNA 5 8S RRNA LSU RRNA | 16 | 6.60e-02 | -2.65e-01 | 4.68e-01 |
| GOBP POSITIVE REGULATION OF PROTEIN GLYCOSYLATION | 6 | 2.60e-01 | -2.65e-01 | 7.28e-01 |
| GOBP ARACHIDONIC ACID METABOLIC PROCESS | 38 | 4.66e-03 | -2.65e-01 | 1.67e-01 |
| GOCC TRNA SPLICING LIGASE COMPLEX | 8 | 1.94e-01 | 2.65e-01 | 6.67e-01 |
| GOBP POSITIVE REGULATION OF STRIATED MUSCLE CELL DIFFERENTIATION | 23 | 2.78e-02 | -2.65e-01 | 3.58e-01 |
| GOBP NEGATIVE REGULATION OF GLIAL CELL DIFFERENTIATION | 15 | 7.57e-02 | -2.65e-01 | 4.93e-01 |
| GOBP POSITIVE REGULATION OF HUMORAL IMMUNE RESPONSE MEDIATED BY CIRCULATING IMMUNOGLOBULIN | 6 | 2.62e-01 | -2.64e-01 | 7.29e-01 |
| GOBP REGULATION OF CHROMOSOME CONDENSATION | 13 | 9.88e-02 | 2.64e-01 | 5.45e-01 |
| GOBP PROTEIN NEDDYLATION | 28 | 1.55e-02 | 2.64e-01 | 2.68e-01 |
| GOBP PROTEIN LOCALIZATION TO BASOLATERAL PLASMA MEMBRANE | 6 | 2.62e-01 | 2.64e-01 | 7.29e-01 |
| GOBP GOLGI TO ENDOSOME TRANSPORT | 17 | 5.92e-02 | 2.64e-01 | 4.53e-01 |
| GOBP MYELOID DENDRITIC CELL CYTOKINE PRODUCTION | 6 | 2.62e-01 | 2.64e-01 | 7.29e-01 |
| GOCC COPII VESICLE COAT | 16 | 6.73e-02 | 2.64e-01 | 4.71e-01 |
| GOBP CENTRAL NERVOUS SYSTEM PROJECTION NEURON AXONOGENESIS | 22 | 3.20e-02 | 2.64e-01 | 3.76e-01 |
| GOBP CAMP PKA SIGNAL TRANSDUCTION | 5 | 3.07e-01 | 2.64e-01 | 7.61e-01 |
| GOMF PLUS END DIRECTED MICROTUBULE MOTOR ACTIVITY | 15 | 7.67e-02 | 2.64e-01 | 4.93e-01 |
| GOBP NEGATIVE REGULATION OF COLLATERAL SPROUTING | 9 | 1.70e-01 | 2.64e-01 | 6.37e-01 |
| GOBP VACUOLAR PROTON TRANSPORTING V TYPE ATPASE COMPLEX ASSEMBLY | 5 | 3.07e-01 | 2.64e-01 | 7.62e-01 |
| GOBP SYNAPTIC VESICLE CLUSTERING | 11 | 1.30e-01 | -2.64e-01 | 5.94e-01 |
| GOBP SYNAPTIC MEMBRANE ADHESION | 14 | 8.75e-02 | -2.64e-01 | 5.18e-01 |
| GOMF MANNOSYL OLIGOSACCHARIDE MANNOSIDASE ACTIVITY | 9 | 1.71e-01 | 2.64e-01 | 6.38e-01 |
| GOBP ER OVERLOAD RESPONSE | 11 | 1.30e-01 | 2.64e-01 | 5.94e-01 |
| GOBP RESPONSE TO IRON II ION | 5 | 3.08e-01 | 2.63e-01 | 7.62e-01 |
| GOBP SERTOLI CELL DEVELOPMENT | 11 | 1.31e-01 | 2.63e-01 | 5.94e-01 |
| GOBP CELLULAR RESPONSE TO LEPTIN STIMULUS | 13 | 1.00e-01 | 2.63e-01 | 5.47e-01 |
| GOBP REGULATION OF TRANSCRIPTION OF NUCLEOLAR LARGE RRNA BY RNA POLYMERASE I | 15 | 7.80e-02 | -2.63e-01 | 4.96e-01 |
| GOMF FIBROBLAST GROWTH FACTOR BINDING | 19 | 4.74e-02 | -2.63e-01 | 4.23e-01 |
| GOBP TRANSPORT OF VIRUS | 20 | 4.21e-02 | 2.63e-01 | 4.05e-01 |
| GOBP NEPHRON TUBULE EPITHELIAL CELL DIFFERENTIATION | 8 | 1.99e-01 | 2.62e-01 | 6.71e-01 |
| GOCC ACETYLCHOLINE GATED CHANNEL COMPLEX | 8 | 1.99e-01 | 2.62e-01 | 6.71e-01 |
| GOCC PICLN SM PROTEIN COMPLEX | 6 | 2.66e-01 | 2.62e-01 | 7.33e-01 |
| GOBP REGULATION OF PROTEIN K48 LINKED UBIQUITINATION | 6 | 2.66e-01 | 2.62e-01 | 7.33e-01 |
| GOBP REGULATION OF VASCULAR ASSOCIATED SMOOTH MUSCLE CELL DIFFERENTIATION | 13 | 1.02e-01 | -2.62e-01 | 5.51e-01 |
| GOBP PYRIMIDINE NUCLEOSIDE MONOPHOSPHATE BIOSYNTHETIC PROCESS | 14 | 9.00e-02 | -2.62e-01 | 5.25e-01 |
| GOMF PHOSPHATIDYLINOSITOL PHOSPHATE 4 PHOSPHATASE ACTIVITY | 9 | 1.74e-01 | 2.62e-01 | 6.41e-01 |
| GOCC NUCLEOLAR EXOSOME RNASE COMPLEX | 10 | 1.52e-01 | -2.62e-01 | 6.15e-01 |
| GOCC NF KAPPAB COMPLEX | 5 | 3.11e-01 | -2.62e-01 | 7.65e-01 |
| GOMF SPHINGOSINE N ACYLTRANSFERASE ACTIVITY | 5 | 3.11e-01 | -2.62e-01 | 7.65e-01 |
| GOCC RNA CAP BINDING COMPLEX | 15 | 7.95e-02 | 2.62e-01 | 4.98e-01 |
| GOBP BLASTOCYST GROWTH | 20 | 4.29e-02 | 2.61e-01 | 4.07e-01 |
| GOBP MEGAKARYOCYTE DEVELOPMENT | 22 | 3.38e-02 | -2.61e-01 | 3.83e-01 |
| GOBP AUTOPHAGIC CELL DEATH | 8 | 2.01e-01 | 2.61e-01 | 6.72e-01 |
| GOCC PERICENTRIOLAR MATERIAL | 22 | 3.38e-02 | 2.61e-01 | 3.83e-01 |
| GOBP SKELETAL MUSCLE CELL PROLIFERATION | 19 | 4.86e-02 | 2.61e-01 | 4.25e-01 |
| GOBP POSITIVE REGULATION OF RNA EXPORT FROM NUCLEUS | 5 | 3.12e-01 | 2.61e-01 | 7.65e-01 |
| GOMF RNA POLYMERASE II CORE PROMOTER SEQUENCE SPECIFIC DNA BINDING | 19 | 4.87e-02 | 2.61e-01 | 4.25e-01 |
| GOBP CARDIAC VASCULAR SMOOTH MUSCLE CELL DIFFERENTIATION | 5 | 3.12e-01 | -2.61e-01 | 7.65e-01 |
| GOBP MITOCHONDRIAL RESPIRASOME ASSEMBLY | 7 | 2.32e-01 | 2.61e-01 | 7.04e-01 |
| GOBP DNA REPLICATION CHECKPOINT SIGNALING | 19 | 4.90e-02 | 2.61e-01 | 4.25e-01 |
| GOBP NUCLEOBASE CATABOLIC PROCESS | 6 | 2.69e-01 | 2.61e-01 | 7.33e-01 |
| GOBP NEPHRIC DUCT DEVELOPMENT | 7 | 2.32e-01 | -2.61e-01 | 7.05e-01 |
| GOCC DNA DEPENDENT PROTEIN KINASE COMPLEX | 5 | 3.13e-01 | 2.61e-01 | 7.65e-01 |
| GOCC COPI COATED VESICLE MEMBRANE | 18 | 5.55e-02 | 2.61e-01 | 4.40e-01 |
| GOBP ANDROGEN METABOLIC PROCESS | 19 | 4.91e-02 | 2.61e-01 | 4.25e-01 |
| GOBP NEGATIVE REGULATION OF LENS FIBER CELL DIFFERENTIATION | 5 | 3.13e-01 | 2.61e-01 | 7.65e-01 |
| GOBP REGULATION OF MESENCHYMAL STEM CELL DIFFERENTIATION | 9 | 1.76e-01 | 2.60e-01 | 6.46e-01 |
| GOMF ENDONUCLEASE ACTIVITY ACTIVE WITH EITHER RIBO OR DEOXYRIBONUCLEIC ACIDS AND PRODUCING 3 PHOSPHOMONOESTERS | 17 | 6.33e-02 | -2.60e-01 | 4.63e-01 |
| GOMF RETINAL DEHYDROGENASE ACTIVITY | 6 | 2.70e-01 | -2.60e-01 | 7.35e-01 |
| GOBP REGULATION OF CENTRIOLE REPLICATION | 22 | 3.48e-02 | 2.60e-01 | 3.88e-01 |
| GOCC FILAMENTOUS ACTIN | 25 | 2.46e-02 | -2.60e-01 | 3.39e-01 |
| GOMF PHOSPHATIDATE PHOSPHATASE ACTIVITY | 10 | 1.55e-01 | -2.60e-01 | 6.18e-01 |
| GOBP LIPOPROTEIN CATABOLIC PROCESS | 13 | 1.05e-01 | 2.60e-01 | 5.57e-01 |
| GOCC OUTER KINETOCHORE | 18 | 5.65e-02 | 2.60e-01 | 4.44e-01 |
| GOBP MONOSACCHARIDE CATABOLIC PROCESS | 42 | 3.60e-03 | -2.60e-01 | 1.42e-01 |
| GOMF BMP BINDING | 10 | 1.55e-01 | -2.60e-01 | 6.18e-01 |
| GOBP POSITIVE REGULATION OF TOLL LIKE RECEPTOR 2 SIGNALING PATHWAY | 6 | 2.71e-01 | 2.59e-01 | 7.35e-01 |
| GOBP POSITIVE REGULATION OF CHOLESTEROL BIOSYNTHETIC PROCESS | 5 | 3.15e-01 | -2.59e-01 | 7.67e-01 |
| GOBP AMYLOID BETA CLEARANCE BY TRANSCYTOSIS | 7 | 2.35e-01 | 2.59e-01 | 7.06e-01 |
| GOBP INTERLEUKIN 6 MEDIATED SIGNALING PATHWAY | 15 | 8.24e-02 | 2.59e-01 | 5.05e-01 |
| GOBP REGULATION OF CILIUM BEAT FREQUENCY INVOLVED IN CILIARY MOTILITY | 7 | 2.35e-01 | -2.59e-01 | 7.07e-01 |
| GOMF PEPTIDOGLYCAN MURALYTIC ACTIVITY | 6 | 2.72e-01 | -2.59e-01 | 7.36e-01 |
| GOBP POSITIVE REGULATION OF TISSUE REMODELING | 7 | 2.36e-01 | 2.59e-01 | 7.07e-01 |
| GOMF PHOSPHATIDYLINOSITOL 3 KINASE INHIBITOR ACTIVITY | 6 | 2.72e-01 | -2.59e-01 | 7.36e-01 |
| GOMF OPSONIN RECEPTOR ACTIVITY | 5 | 3.17e-01 | -2.59e-01 | 7.68e-01 |
| GOBP REGULATION OF AUTOPHAGY OF MITOCHONDRION IN RESPONSE TO MITOCHONDRIAL DEPOLARIZATION | 14 | 9.38e-02 | -2.59e-01 | 5.34e-01 |
| GOBP POSITIVE REGULATION OF PHOSPHATASE ACTIVITY | 23 | 3.19e-02 | 2.58e-01 | 3.75e-01 |
| GOBP POSITIVE REGULATION OF FEAR RESPONSE | 5 | 3.17e-01 | -2.58e-01 | 7.68e-01 |
| GOBP REGULATION OF MONOCYTE EXTRAVASATION | 6 | 2.73e-01 | -2.58e-01 | 7.36e-01 |
| GOBP NEGATIVE REGULATION OF EXCITATORY POSTSYNAPTIC POTENTIAL | 7 | 2.37e-01 | 2.58e-01 | 7.08e-01 |
| GOBP B 1 B CELL DIFFERENTIATION | 5 | 3.18e-01 | 2.58e-01 | 7.69e-01 |
| GOBP RIBOSOME DISASSEMBLY | 37 | 6.61e-03 | 2.58e-01 | 1.89e-01 |
| GOBP POSITIVE REGULATION OF PLATELET ACTIVATION | 12 | 1.22e-01 | -2.58e-01 | 5.85e-01 |
| GOBP DIADENOSINE POLYPHOSPHATE CATABOLIC PROCESS | 5 | 3.19e-01 | 2.58e-01 | 7.70e-01 |
| GOBP DERMATAN SULFATE METABOLIC PROCESS | 9 | 1.81e-01 | -2.58e-01 | 6.54e-01 |
| GOMF PROTEIN KINASE C BINDING | 46 | 2.52e-03 | -2.57e-01 | 1.20e-01 |
| GOBP REGULATION OF PHOSPHATIDYLCHOLINE METABOLIC PROCESS | 9 | 1.81e-01 | -2.57e-01 | 6.54e-01 |
| GOBP GTP BIOSYNTHETIC PROCESS | 9 | 1.82e-01 | -2.57e-01 | 6.54e-01 |
| GOCC MULTIVESICULAR BODY LUMEN | 6 | 2.76e-01 | -2.57e-01 | 7.38e-01 |
| GOBP COLLAGEN CATABOLIC PROCESS | 31 | 1.33e-02 | -2.57e-01 | 2.50e-01 |
| GOMF MRNA 5 UTR BINDING | 22 | 3.71e-02 | 2.57e-01 | 3.91e-01 |
| GOMF NEUROPEPTIDE RECEPTOR BINDING | 11 | 1.40e-01 | -2.57e-01 | 6.07e-01 |
| GOMF SULFATE TRANSMEMBRANE TRANSPORTER ACTIVITY | 9 | 1.82e-01 | -2.57e-01 | 6.55e-01 |
| GOBP NEGATIVE REGULATION OF CALCINEURIN MEDIATED SIGNALING | 13 | 1.09e-01 | -2.57e-01 | 5.62e-01 |
| GOBP CEREBROSPINAL FLUID CIRCULATION | 9 | 1.82e-01 | 2.57e-01 | 6.55e-01 |
| GOBP AMMONIUM TRANSMEMBRANE TRANSPORT | 7 | 2.40e-01 | -2.57e-01 | 7.09e-01 |
| GOBP MRNA MODIFICATION | 19 | 5.30e-02 | 2.56e-01 | 4.35e-01 |
| GOBP PARTURITION | 10 | 1.60e-01 | -2.56e-01 | 6.27e-01 |
| GOBP REGULATION OF NEURON MATURATION | 8 | 2.09e-01 | 2.56e-01 | 6.83e-01 |
| GOBP ERYTHROSE 4 PHOSPHATE PHOSPHOENOLPYRUVATE FAMILY AMINO ACID METABOLIC PROCESS | 11 | 1.41e-01 | -2.56e-01 | 6.08e-01 |
| GOBP POSITIVE REGULATION OF POST TRANSCRIPTIONAL GENE SILENCING | 11 | 1.41e-01 | 2.56e-01 | 6.08e-01 |
| GOMF INSULIN LIKE GROWTH FACTOR RECEPTOR BINDING | 11 | 1.42e-01 | -2.56e-01 | 6.09e-01 |
| GOBP NEGATIVE REGULATION OF CYTOSOLIC CALCIUM ION CONCENTRATION | 6 | 2.78e-01 | 2.56e-01 | 7.39e-01 |
| GOMF RNA POLYMERASE II CTD HEPTAPEPTIDE REPEAT PHOSPHATASE ACTIVITY | 7 | 2.41e-01 | -2.56e-01 | 7.11e-01 |
| GOBP TRIGEMINAL NERVE DEVELOPMENT | 6 | 2.78e-01 | 2.56e-01 | 7.40e-01 |
| GOBP INSULIN PROCESSING | 5 | 3.22e-01 | 2.56e-01 | 7.74e-01 |
| GOBP ACTIVATION OF ADENYLATE CYCLASE ACTIVITY | 11 | 1.42e-01 | -2.56e-01 | 6.09e-01 |
| GOBP REGULATION OF COLLAGEN METABOLIC PROCESS | 25 | 2.70e-02 | -2.56e-01 | 3.53e-01 |
| GOMF METAL DEPENDENT DEUBIQUITINASE ACTIVITY | 12 | 1.25e-01 | 2.55e-01 | 5.89e-01 |
| GOBP POSITIVE REGULATION OF UNSATURATED FATTY ACID BIOSYNTHETIC PROCESS | 6 | 2.79e-01 | -2.55e-01 | 7.40e-01 |
| GOMF NUCLEAR LOCALIZATION SEQUENCE BINDING | 23 | 3.41e-02 | 2.55e-01 | 3.84e-01 |
| GOCC PRP19 COMPLEX | 14 | 9.83e-02 | 2.55e-01 | 5.45e-01 |
| GOBP NEGATIVE REGULATION OF ORGANIC ACID TRANSPORT | 16 | 7.73e-02 | -2.55e-01 | 4.95e-01 |
| GOBP POSITIVE REGULATION OF T HELPER 2 CELL CYTOKINE PRODUCTION | 8 | 2.12e-01 | 2.55e-01 | 6.86e-01 |
| GOCC NBAF COMPLEX | 14 | 9.88e-02 | -2.55e-01 | 5.45e-01 |
| GOBP SYNAPTIC VESICLE LUMEN ACIDIFICATION | 14 | 9.90e-02 | 2.55e-01 | 5.46e-01 |
| GOBP PROTEIN CONTAINING COMPLEX REMODELING | 20 | 4.87e-02 | -2.55e-01 | 4.25e-01 |
| GOBP GLOMERULAR EPITHELIAL CELL DEVELOPMENT | 10 | 1.63e-01 | -2.55e-01 | 6.30e-01 |
| GOBP REGULATION OF RNA BINDING | 7 | 2.44e-01 | 2.54e-01 | 7.13e-01 |
| GOBP BONE TRABECULA MORPHOGENESIS | 10 | 1.64e-01 | -2.54e-01 | 6.30e-01 |
| GOBP CARTILAGE CONDENSATION | 7 | 2.44e-01 | -2.54e-01 | 7.14e-01 |
| GOBP MALE MEIOTIC NUCLEAR DIVISION | 33 | 1.15e-02 | 2.54e-01 | 2.43e-01 |
| GOBP INNER CELL MASS CELL DIFFERENTIATION | 5 | 3.25e-01 | 2.54e-01 | 7.76e-01 |
| GOBP REGULATION OF BRANCHING INVOLVED IN URETERIC BUD MORPHOGENESIS | 12 | 1.28e-01 | -2.54e-01 | 5.93e-01 |
| GOBP SEX CHROMOSOME DOSAGE COMPENSATION | 17 | 7.01e-02 | 2.54e-01 | 4.81e-01 |
| GOCC LEWY BODY | 8 | 2.14e-01 | -2.54e-01 | 6.89e-01 |
| GOBP GLYCINE TRANSPORT | 7 | 2.45e-01 | 2.54e-01 | 7.15e-01 |
| GOMF ACTIVIN RECEPTOR BINDING | 7 | 2.46e-01 | -2.53e-01 | 7.16e-01 |
| GOBP REGULATION OF SPHINGOLIPID BIOSYNTHETIC PROCESS | 10 | 1.66e-01 | -2.53e-01 | 6.30e-01 |
| GOBP CELL PROLIFERATION INVOLVED IN KIDNEY DEVELOPMENT | 14 | 1.01e-01 | -2.53e-01 | 5.49e-01 |
| GOBP NEGATIVE REGULATION OF INTRACELLULAR TRANSPORT | 40 | 5.61e-03 | 2.53e-01 | 1.79e-01 |
| GOBP INTERNAL PROTEIN AMINO ACID ACETYLATION | 10 | 1.67e-01 | -2.53e-01 | 6.31e-01 |
| GOMF INTRAMOLECULAR OXIDOREDUCTASE ACTIVITY TRANSPOSING C C BONDS | 12 | 1.30e-01 | -2.53e-01 | 5.94e-01 |
| GOMF ZINC ION TRANSMEMBRANE TRANSPORTER ACTIVITY | 19 | 5.69e-02 | 2.52e-01 | 4.45e-01 |
| GOBP MITOCHONDRIAL RIBOSOME ASSEMBLY | 12 | 1.30e-01 | -2.52e-01 | 5.94e-01 |
| GOBP GLUTATHIONE TRANSMEMBRANE TRANSPORT | 7 | 2.48e-01 | 2.52e-01 | 7.17e-01 |
| GOMF E BOX BINDING | 32 | 1.35e-02 | -2.52e-01 | 2.50e-01 |
| GOBP RIBOSOMAL SMALL SUBUNIT EXPORT FROM NUCLEUS | 8 | 2.17e-01 | 2.52e-01 | 6.92e-01 |
| GOBP CORNIFIED ENVELOPE ASSEMBLY | 6 | 2.85e-01 | -2.52e-01 | 7.45e-01 |
| GOBP CELL ADHESION INVOLVED IN HEART MORPHOGENESIS | 7 | 2.49e-01 | 2.52e-01 | 7.17e-01 |
| GOBP RIG I SIGNALING PATHWAY | 24 | 3.27e-02 | 2.52e-01 | 3.77e-01 |
| GOBP REGULATION OF MONOATOMIC ANION TRANSPORT | 11 | 1.48e-01 | 2.52e-01 | 6.13e-01 |
| GOMF INTRACELLULARLY GATED CALCIUM CHANNEL ACTIVITY | 17 | 7.25e-02 | -2.52e-01 | 4.86e-01 |
| GOBP REGULATION OF RIG I SIGNALING PATHWAY | 18 | 6.46e-02 | 2.52e-01 | 4.66e-01 |
| GOBP LEUKOCYTE CHEMOTAXIS INVOLVED IN INFLAMMATORY RESPONSE | 6 | 2.86e-01 | -2.52e-01 | 7.45e-01 |
| GOBP TRABECULA FORMATION | 15 | 9.17e-02 | -2.52e-01 | 5.29e-01 |
| GOCC NSL COMPLEX | 11 | 1.49e-01 | -2.51e-01 | 6.13e-01 |
| GOMF CARBONATE DEHYDRATASE ACTIVITY | 11 | 1.49e-01 | -2.51e-01 | 6.13e-01 |
| GOBP NEGATIVE REGULATION OF TUMOR NECROSIS FACTOR MEDIATED SIGNALING PATHWAY | 20 | 5.20e-02 | 2.51e-01 | 4.33e-01 |
| GOBP NEGATIVE REGULATION OF MONOCYTE DIFFERENTIATION | 5 | 3.31e-01 | -2.51e-01 | 7.82e-01 |
| GOMF AP 1 ADAPTOR COMPLEX BINDING | 5 | 3.31e-01 | 2.51e-01 | 7.82e-01 |
| GOBP G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY INVOLVED IN HEART PROCESS | 5 | 3.31e-01 | 2.51e-01 | 7.82e-01 |
| GOBP DEPYRIMIDINATION | 8 | 2.19e-01 | -2.51e-01 | 6.94e-01 |
| GOBP N TERMINAL PROTEIN LIPIDATION | 5 | 3.32e-01 | 2.51e-01 | 7.82e-01 |
| GOBP ELASTIN METABOLIC PROCESS | 6 | 2.88e-01 | 2.51e-01 | 7.47e-01 |
| GOMF ARYL SULFOTRANSFERASE ACTIVITY | 5 | 3.32e-01 | -2.51e-01 | 7.82e-01 |
| GOMF PROTEIN GLUTAMIC ACID LIGASE ACTIVITY | 8 | 2.20e-01 | -2.51e-01 | 6.94e-01 |
| GOBP NEGATIVE REGULATION OF KERATINOCYTE PROLIFERATION | 19 | 5.86e-02 | 2.51e-01 | 4.51e-01 |
| GOMF ALDEHYDE LYASE ACTIVITY | 8 | 2.20e-01 | 2.51e-01 | 6.94e-01 |
| GOBP POSITIVE REGULATION OF MITOCHONDRIAL CALCIUM ION CONCENTRATION | 9 | 1.93e-01 | 2.50e-01 | 6.67e-01 |
| GOMF CHEMOKINE BINDING | 31 | 1.59e-02 | 2.50e-01 | 2.74e-01 |
| GOCC CLATHRIN COMPLEX | 7 | 2.52e-01 | 2.50e-01 | 7.20e-01 |
| GOBP MITOCHONDRIAL DNA REPAIR | 6 | 2.89e-01 | 2.50e-01 | 7.47e-01 |
| GOBP NEGATIVE REGULATION OF LOW DENSITY LIPOPROTEIN RECEPTOR ACTIVITY | 5 | 3.33e-01 | -2.50e-01 | 7.83e-01 |
| GOBP TUBULIN COMPLEX ASSEMBLY | 8 | 2.21e-01 | 2.50e-01 | 6.94e-01 |
| GOBP CORTICOSPINAL TRACT MORPHOGENESIS | 6 | 2.89e-01 | 2.50e-01 | 7.47e-01 |
| GOBP NEGATIVE REGULATION OF CELL VOLUME | 5 | 3.33e-01 | 2.50e-01 | 7.83e-01 |
| GOBP COMMON MYELOID PROGENITOR CELL PROLIFERATION | 8 | 2.21e-01 | -2.50e-01 | 6.94e-01 |
| GOBP REGULATION OF MACROPHAGE APOPTOTIC PROCESS | 10 | 1.71e-01 | 2.50e-01 | 6.38e-01 |
| GOBP FUCOSE CATABOLIC PROCESS | 6 | 2.90e-01 | -2.50e-01 | 7.47e-01 |
| GOCC SEH1 ASSOCIATED COMPLEX | 14 | 1.06e-01 | -2.50e-01 | 5.59e-01 |
| GOBP RESPONSE TO L LEUCINE | 14 | 1.06e-01 | 2.49e-01 | 5.59e-01 |
| GOBP COLLAGEN METABOLIC PROCESS | 73 | 2.30e-04 | -2.49e-01 | 2.70e-02 |
| GOCC CYTOLYTIC GRANULE | 14 | 1.06e-01 | 2.49e-01 | 5.59e-01 |
| GOBP 5 PHOSPHORIBOSE 1 DIPHOSPHATE METABOLIC PROCESS | 5 | 3.35e-01 | 2.49e-01 | 7.84e-01 |
| GOBP REGULATION OF RECEPTOR CLUSTERING | 13 | 1.20e-01 | 2.49e-01 | 5.82e-01 |
| GOBP HEMIDESMOSOME ASSEMBLY | 5 | 3.35e-01 | -2.49e-01 | 7.84e-01 |
| GOBP ZINC ION IMPORT ACROSS PLASMA MEMBRANE | 8 | 2.22e-01 | 2.49e-01 | 6.97e-01 |
| GOBP INTERLEUKIN 10 MEDIATED SIGNALING PATHWAY | 11 | 1.53e-01 | 2.49e-01 | 6.16e-01 |
| GOMF STEROID HYDROXYLASE ACTIVITY | 10 | 1.73e-01 | 2.49e-01 | 6.40e-01 |
| GOBP REGULATION OF B CELL RECEPTOR SIGNALING PATHWAY | 21 | 4.87e-02 | 2.49e-01 | 4.25e-01 |
| GOBP POSITIVE REGULATION OF EMBRYONIC DEVELOPMENT | 15 | 9.56e-02 | -2.49e-01 | 5.38e-01 |
| GOCC ENDOPLASMIC RETICULUM QUALITY CONTROL COMPARTMENT | 15 | 9.56e-02 | 2.49e-01 | 5.38e-01 |
| GOBP POSITIVE REGULATION OF RELEASE OF CYTOCHROME C FROM MITOCHONDRIA | 24 | 3.51e-02 | -2.48e-01 | 3.88e-01 |
| GOMF HISTONE H4K20 METHYLTRANSFERASE ACTIVITY | 8 | 2.24e-01 | -2.48e-01 | 6.97e-01 |
| GOBP METANEPHRIC NEPHRON DEVELOPMENT | 21 | 4.90e-02 | -2.48e-01 | 4.25e-01 |
| GOBP PHOSPHATIDYLETHANOLAMINE METABOLIC PROCESS | 23 | 3.95e-02 | -2.48e-01 | 3.98e-01 |
| GOBP AMELOGENESIS | 16 | 8.59e-02 | -2.48e-01 | 5.13e-01 |
| GOBP PONS DEVELOPMENT | 7 | 2.56e-01 | 2.48e-01 | 7.25e-01 |
| GOBP HEMATOPOIETIC STEM CELL MIGRATION | 9 | 1.98e-01 | 2.48e-01 | 6.70e-01 |
| GOBP MODULATION OF MICROTUBULE CYTOSKELETON INVOLVED IN CEREBRAL CORTEX RADIAL GLIA GUIDED MIGRATION | 5 | 3.37e-01 | -2.48e-01 | 7.86e-01 |
| GOBP PROTEIN IMPORT | 9 | 1.98e-01 | -2.48e-01 | 6.70e-01 |
| GOBP CARDIAC MUSCLE CELL MYOBLAST DIFFERENTIATION | 8 | 2.25e-01 | 2.48e-01 | 6.98e-01 |
| GOCC CYTOPLASMIC UBIQUITIN LIGASE COMPLEX | 8 | 2.25e-01 | 2.47e-01 | 6.98e-01 |
| GOBP REGULATION OF DEFENSE RESPONSE TO BACTERIUM | 14 | 1.09e-01 | -2.47e-01 | 5.62e-01 |
| GOBP ACTIVATION OF CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY | 12 | 1.38e-01 | 2.47e-01 | 6.04e-01 |
| GOBP VENTRICULAR TRABECULA MYOCARDIUM MORPHOGENESIS | 10 | 1.76e-01 | 2.47e-01 | 6.45e-01 |
| GOBP POSITIVE REGULATION OF CHOLESTEROL EFFLUX | 18 | 6.95e-02 | -2.47e-01 | 4.79e-01 |
| GOMF G PROTEIN BETA SUBUNIT BINDING | 14 | 1.09e-01 | 2.47e-01 | 5.63e-01 |
| GOBP PIGMENT CATABOLIC PROCESS | 7 | 2.58e-01 | -2.47e-01 | 7.27e-01 |
| GOBP CELLULAR RESPONSE TO LEUCINE STARVATION | 12 | 1.39e-01 | 2.47e-01 | 6.04e-01 |
| GOMF ALCOHOL DEHYDROGENASE NADPPLUS ACTIVITY | 17 | 7.81e-02 | -2.47e-01 | 4.96e-01 |
| GOBP SNRNA TRANSCRIPTION | 19 | 6.26e-02 | 2.47e-01 | 4.63e-01 |
| GOBP SA NODE CELL TO ATRIAL CARDIAC MUSCLE CELL COMMUNICATION | 6 | 2.95e-01 | 2.47e-01 | 7.52e-01 |
| GOBP NK T CELL DIFFERENTIATION | 11 | 1.57e-01 | 2.47e-01 | 6.21e-01 |
| GOBP MONOACYLGLYCEROL CATABOLIC PROCESS | 7 | 2.59e-01 | -2.46e-01 | 7.27e-01 |
| GOBP RESPONSE TO ODORANT | 5 | 3.40e-01 | 2.46e-01 | 7.88e-01 |
| GOBP POSITIVE REGULATION OF RESPONSE TO TUMOR CELL | 11 | 1.57e-01 | 2.46e-01 | 6.22e-01 |
| GOBP REGULATION OF AMINO ACID TRANSMEMBRANE TRANSPORT | 12 | 1.40e-01 | 2.46e-01 | 6.07e-01 |
| GOBP L LEUCINE CATABOLIC PROCESS | 5 | 3.41e-01 | 2.46e-01 | 7.88e-01 |
| GOBP POSITIVE REGULATION OF ENDOPLASMIC RETICULUM UNFOLDED PROTEIN RESPONSE | 12 | 1.40e-01 | 2.46e-01 | 6.07e-01 |
| GOBP REGULATION OF SKELETAL MUSCLE ADAPTATION | 7 | 2.60e-01 | -2.46e-01 | 7.28e-01 |
| GOBP PLATELET DERIVED GROWTH FACTOR RECEPTOR ALPHA SIGNALING PATHWAY | 6 | 2.98e-01 | 2.45e-01 | 7.53e-01 |
| GOBP FRUCTOSE METABOLIC PROCESS | 13 | 1.26e-01 | -2.45e-01 | 5.89e-01 |
| GOBP PHAGOCYTOSIS RECOGNITION | 17 | 7.99e-02 | -2.45e-01 | 4.98e-01 |
| GOBP REGULATION OF EXTRACELLULAR MATRIX DISASSEMBLY | 12 | 1.41e-01 | -2.45e-01 | 6.08e-01 |
| GOMF DEACETYLASE ACTIVITY | 35 | 1.21e-02 | -2.45e-01 | 2.45e-01 |
| GOBP NEGATIVE REGULATION OF DOUBLE STRAND BREAK REPAIR VIA NONHOMOLOGOUS END JOINING | 7 | 2.62e-01 | -2.45e-01 | 7.29e-01 |
| GOBP RESPONSE TO PROSTAGLANDIN D | 5 | 3.43e-01 | -2.45e-01 | 7.89e-01 |
| GOBP REGULATION OF SREBP SIGNALING PATHWAY | 7 | 2.62e-01 | 2.45e-01 | 7.29e-01 |
| GOBP POSITIVE REGULATION OF DENDRITIC SPINE DEVELOPMENT | 34 | 1.35e-02 | 2.45e-01 | 2.50e-01 |
| GOBP BIOLOGICAL PHASE | 5 | 3.43e-01 | 2.45e-01 | 7.89e-01 |
| GOMF STEROID HORMONE BINDING | 5 | 3.44e-01 | -2.45e-01 | 7.89e-01 |
| GOBP GAS TRANSPORT | 12 | 1.43e-01 | 2.44e-01 | 6.10e-01 |
| GOBP CELL DIFFERENTIATION IN HINDBRAIN | 15 | 1.01e-01 | 2.44e-01 | 5.49e-01 |
| GOBP NEGATIVE REGULATION OF RUFFLE ASSEMBLY | 7 | 2.63e-01 | -2.44e-01 | 7.30e-01 |
| GOBP NUCLEAR TRANSCRIBED MRNA CATABOLIC PROCESS DEADENYLATION DEPENDENT DECAY | 60 | 1.07e-03 | 2.44e-01 | 7.42e-02 |
| GOBP REGULATION OF FEMALE GONAD DEVELOPMENT | 5 | 3.44e-01 | 2.44e-01 | 7.89e-01 |
| GOBP TELOMERIC LOOP DISASSEMBLY | 11 | 1.61e-01 | -2.44e-01 | 6.28e-01 |
| GOBP POSITIVE REGULATION OF STRESS GRANULE ASSEMBLY | 7 | 2.64e-01 | 2.44e-01 | 7.31e-01 |
| GOBP ACTIN CROSSLINK FORMATION | 11 | 1.61e-01 | -2.44e-01 | 6.28e-01 |
| GOBP REGULATION OF ATTACHMENT OF MITOTIC SPINDLE MICROTUBULES TO KINETOCHORE | 9 | 2.05e-01 | 2.44e-01 | 6.80e-01 |
| GOBP POSITIVE REGULATION OF RETINOIC ACID RECEPTOR SIGNALING PATHWAY | 5 | 3.45e-01 | -2.44e-01 | 7.89e-01 |
| GOMF DIPHOSPHOTRANSFERASE ACTIVITY | 5 | 3.45e-01 | 2.44e-01 | 7.89e-01 |
| GOBP RESPONSE TO IMMOBILIZATION STRESS | 18 | 7.34e-02 | -2.44e-01 | 4.88e-01 |
| GOBP GANGLIOSIDE CATABOLIC PROCESS | 5 | 3.45e-01 | -2.44e-01 | 7.90e-01 |
| GOBP PRO B CELL DIFFERENTIATION | 11 | 1.62e-01 | 2.44e-01 | 6.28e-01 |
| GOMF MHC CLASS I PROTEIN COMPLEX BINDING | 7 | 2.65e-01 | 2.44e-01 | 7.31e-01 |
| GOMF TRANSMEMBRANE RECEPTOR PROTEIN SERINE THREONINE KINASE BINDING | 15 | 1.02e-01 | -2.44e-01 | 5.53e-01 |
| GOMF HORMONE ACTIVITY | 40 | 7.71e-03 | -2.43e-01 | 2.02e-01 |
| GOCC LATERAL ELEMENT | 11 | 1.62e-01 | 2.43e-01 | 6.29e-01 |
| GOBP PROTEIN LOCALIZATION TO ENDOSOME | 28 | 2.60e-02 | 2.43e-01 | 3.49e-01 |
| GOBP ENDOTHELIN RECEPTOR SIGNALING PATHWAY | 7 | 2.66e-01 | -2.43e-01 | 7.33e-01 |
| GOMF AMMONIUM TRANSMEMBRANE TRANSPORTER ACTIVITY | 6 | 3.03e-01 | -2.43e-01 | 7.58e-01 |
| GOBP NEGATIVE REGULATION OF ARP2 3 COMPLEX MEDIATED ACTIN NUCLEATION | 5 | 3.47e-01 | -2.43e-01 | 7.91e-01 |
| GOBP REGULATION OF PROSTAGLANDIN SECRETION | 9 | 2.07e-01 | 2.43e-01 | 6.81e-01 |
| GOBP ANTIFUNGAL INNATE IMMUNE RESPONSE | 14 | 1.16e-01 | 2.43e-01 | 5.74e-01 |
| GOMF C3HC4 TYPE RING FINGER DOMAIN BINDING | 6 | 3.03e-01 | -2.43e-01 | 7.58e-01 |
| GOMF RETINAL BINDING | 5 | 3.47e-01 | -2.43e-01 | 7.91e-01 |
| GOBP BASE EXCISION REPAIR AP SITE FORMATION | 11 | 1.64e-01 | -2.42e-01 | 6.30e-01 |
| GOBP REGULATION OF ACYL COA BIOSYNTHETIC PROCESS | 5 | 3.48e-01 | 2.42e-01 | 7.92e-01 |
| GOBP MAST CELL CYTOKINE PRODUCTION | 6 | 3.05e-01 | 2.42e-01 | 7.60e-01 |
| GOCC CYTOSOLIC PROTEASOME COMPLEX | 5 | 3.49e-01 | 2.42e-01 | 7.92e-01 |
| GOBP SURFACTANT HOMEOSTASIS | 14 | 1.17e-01 | -2.42e-01 | 5.77e-01 |
| GOBP POSITIVE REGULATION OF TOLL LIKE RECEPTOR 3 SIGNALING PATHWAY | 7 | 2.68e-01 | 2.42e-01 | 7.33e-01 |
| GOCC KINOCILIUM | 8 | 2.37e-01 | -2.41e-01 | 7.08e-01 |
| GOBP MITOCHONDRIAL PROTON TRANSPORTING ATP SYNTHASE COMPLEX ASSEMBLY | 8 | 2.37e-01 | -2.41e-01 | 7.08e-01 |
| GOMF HAPTOGLOBIN BINDING | 8 | 2.37e-01 | 2.41e-01 | 7.08e-01 |
| GOBP PROTEIN DEUBIQUITINATION INVOLVED IN UBIQUITIN DEPENDENT PROTEIN CATABOLIC PROCESS | 6 | 3.06e-01 | 2.41e-01 | 7.61e-01 |
| GOBP POSITIVE REGULATION OF RECEPTOR RECYCLING | 12 | 1.48e-01 | 2.41e-01 | 6.13e-01 |
| GOMF LOW DENSITY LIPOPROTEIN PARTICLE BINDING | 15 | 1.06e-01 | -2.41e-01 | 5.59e-01 |
| GOBP RECEPTOR MEDIATED ENDOCYTOSIS INVOLVED IN CHOLESTEROL TRANSPORT | 5 | 3.51e-01 | -2.41e-01 | 7.93e-01 |
| GOCC CELL CORTEX REGION | 28 | 2.74e-02 | -2.41e-01 | 3.55e-01 |
| GOBP METANEPHRIC MESENCHYME DEVELOPMENT | 6 | 3.07e-01 | 2.41e-01 | 7.62e-01 |
| GOBP MRNA 3 END PROCESSING | 39 | 9.31e-03 | 2.41e-01 | 2.21e-01 |
| GOMF UNIPORTER ACTIVITY | 5 | 3.52e-01 | 2.41e-01 | 7.94e-01 |
| GOMF NUCLEAR IMPORT SIGNAL RECEPTOR ACTIVITY | 19 | 6.95e-02 | 2.41e-01 | 4.79e-01 |
| GOBP NEGATIVE REGULATION OF MITOCHONDRIAL OUTER MEMBRANE PERMEABILIZATION INVOLVED IN APOPTOTIC SIGNALING PATHWAY | 12 | 1.49e-01 | -2.40e-01 | 6.13e-01 |
| GOBP POSITIVE REGULATION OF LYMPHOCYTE CHEMOTAXIS | 14 | 1.19e-01 | 2.40e-01 | 5.82e-01 |
| GOBP CELLULAR RESPONSE TO NITROGEN LEVELS | 9 | 2.12e-01 | 2.40e-01 | 6.85e-01 |
| GOBP CELLULAR RESPONSE TO MINERALOCORTICOID STIMULUS | 10 | 1.88e-01 | -2.40e-01 | 6.62e-01 |
| GOBP AUTOPHAGOSOME LYSOSOME FUSION | 11 | 1.68e-01 | -2.40e-01 | 6.33e-01 |
| GOBP SYNAPTIC VESICLE RECYCLING VIA ENDOSOME | 5 | 3.52e-01 | 2.40e-01 | 7.94e-01 |
| GOBP NEGATIVE REGULATION OF PLATELET AGGREGATION | 9 | 2.12e-01 | -2.40e-01 | 6.86e-01 |
| GOBP RESPONSE TO ERYTHROPOIETIN | 6 | 3.08e-01 | 2.40e-01 | 7.62e-01 |
| GOBP MYELIN MAINTENANCE | 15 | 1.07e-01 | -2.40e-01 | 5.61e-01 |
| GOBP OVIDUCT DEVELOPMENT | 5 | 3.53e-01 | 2.40e-01 | 7.94e-01 |
| GOBP REGULATION OF PIGMENT CELL DIFFERENTIATION | 5 | 3.53e-01 | 2.40e-01 | 7.94e-01 |
| GOBP CELLULAR RESPONSE TO ETHER | 6 | 3.10e-01 | -2.39e-01 | 7.64e-01 |
| GOBP PROTEIN LOCALIZATION TO ENDOPLASMIC RETICULUM | 71 | 4.86e-04 | 2.39e-01 | 4.48e-02 |
| GOBP REGULATION OF TELOMERE MAINTENANCE IN RESPONSE TO DNA DAMAGE | 19 | 7.11e-02 | -2.39e-01 | 4.84e-01 |
| GOBP REGULATION OF PHOSPHATE TRANSPORT | 7 | 2.73e-01 | -2.39e-01 | 7.36e-01 |
| GOMF RNA ENDONUCLEASE ACTIVITY PRODUCING 3 PHOSPHOMONOESTERS | 6 | 3.11e-01 | -2.39e-01 | 7.64e-01 |
| GOBP NUCLEAR TRANSCRIBED MRNA CATABOLIC PROCESS DEADENYLATION INDEPENDENT DECAY | 7 | 2.74e-01 | -2.39e-01 | 7.36e-01 |
| GOCC NUCLEAR OUTER MEMBRANE | 26 | 3.50e-02 | -2.39e-01 | 3.88e-01 |
| GOBP GTP METABOLIC PROCESS | 22 | 5.25e-02 | 2.39e-01 | 4.33e-01 |
| GOMF RIBOSOMAL LARGE SUBUNIT BINDING | 14 | 1.22e-01 | 2.39e-01 | 5.85e-01 |
| GOBP REGULATION OF SKELETAL MUSCLE CELL PROLIFERATION | 11 | 1.70e-01 | 2.39e-01 | 6.37e-01 |
| GOCC TROPONIN COMPLEX | 5 | 3.55e-01 | -2.39e-01 | 7.96e-01 |
| GOBP NEGATIVE REGULATION OF B CELL PROLIFERATION | 16 | 9.84e-02 | 2.39e-01 | 5.45e-01 |
| GOMF CXCR CHEMOKINE RECEPTOR BINDING | 11 | 1.71e-01 | -2.39e-01 | 6.38e-01 |
| GOBP CELLULAR RESPONSE TO ALDOSTERONE | 6 | 3.12e-01 | -2.39e-01 | 7.65e-01 |
| GOBP PURINE NUCLEOBASE TRANSMEMBRANE TRANSPORT | 7 | 2.75e-01 | 2.38e-01 | 7.38e-01 |
| GOBP PHOSPHATE ION TRANSPORT | 21 | 5.86e-02 | -2.38e-01 | 4.51e-01 |
| GOBP OTIC VESICLE DEVELOPMENT | 7 | 2.75e-01 | 2.38e-01 | 7.38e-01 |
| GOBP MATURATION OF 5 8S RRNA FROM TRICISTRONIC RRNA TRANSCRIPT SSU RRNA 5 8S RRNA LSU RRNA | 24 | 4.33e-02 | -2.38e-01 | 4.09e-01 |
| GOBP IONOTROPIC GLUTAMATE RECEPTOR SIGNALING PATHWAY | 14 | 1.23e-01 | -2.38e-01 | 5.86e-01 |
| GOBP POSITIVE REGULATION OF MEGAKARYOCYTE DIFFERENTIATION | 10 | 1.92e-01 | 2.38e-01 | 6.64e-01 |
| GOMF AMIDINE LYASE ACTIVITY | 6 | 3.12e-01 | 2.38e-01 | 7.65e-01 |
| GOBP VIRAL RELEASE FROM HOST CELL | 27 | 3.22e-02 | 2.38e-01 | 3.76e-01 |
| GOBP REGULATION OF GASTRULATION | 13 | 1.37e-01 | -2.38e-01 | 6.03e-01 |
| GOBP LATE ENDOSOME TO LYSOSOME TRANSPORT | 21 | 5.93e-02 | 2.38e-01 | 4.53e-01 |
| GOBP PURINE DEOXYRIBONUCLEOTIDE METABOLIC PROCESS | 15 | 1.11e-01 | 2.38e-01 | 5.65e-01 |
| GOBP POSITIVE REGULATION OF SPINDLE CHECKPOINT | 13 | 1.38e-01 | 2.38e-01 | 6.04e-01 |
| GOBP REGULATION OF CELLULAR RESPONSE TO OSMOTIC STRESS | 11 | 1.72e-01 | -2.38e-01 | 6.40e-01 |
| GOCC ZONA PELLUCIDA RECEPTOR COMPLEX | 7 | 2.76e-01 | 2.38e-01 | 7.39e-01 |
| GOCC GAMMA SECRETASE COMPLEX | 7 | 2.77e-01 | 2.37e-01 | 7.39e-01 |
| GOMF CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY INVOLVED IN APOPTOTIC SIGNALING PATHWAY | 6 | 3.14e-01 | 2.37e-01 | 7.66e-01 |
| GOCC RNA POLYMERASE I COMPLEX | 13 | 1.39e-01 | -2.37e-01 | 6.04e-01 |
| GOCC APICAL DENDRITE | 13 | 1.39e-01 | -2.37e-01 | 6.04e-01 |
| GOBP REGULATION OF TOLL LIKE RECEPTOR 3 SIGNALING PATHWAY | 13 | 1.39e-01 | 2.37e-01 | 6.04e-01 |
| GOBP POSITIVE REGULATION OF COLLATERAL SPROUTING | 7 | 2.77e-01 | -2.37e-01 | 7.39e-01 |
| GOMF PROTEIN KINASE B BINDING | 9 | 2.18e-01 | 2.37e-01 | 6.93e-01 |
| GOBP AMINOACYL TRNA METABOLISM INVOLVED IN TRANSLATIONAL FIDELITY | 13 | 1.39e-01 | -2.37e-01 | 6.05e-01 |
| GOMF AMINOACYL TRNA EDITING ACTIVITY | 13 | 1.39e-01 | -2.37e-01 | 6.05e-01 |
| GOBP POSITIVE REGULATION OF INFLAMMASOME MEDIATED SIGNALING PATHWAY | 21 | 6.03e-02 | 2.37e-01 | 4.55e-01 |
| GOMF OLFACTORY RECEPTOR ACTIVITY | 48 | 4.54e-03 | 2.37e-01 | 1.64e-01 |
| GOBP REGULATION OF PROTEIN KINASE A SIGNALING | 13 | 1.39e-01 | 2.37e-01 | 6.06e-01 |
| GOBP SIGNAL PEPTIDE PROCESSING | 13 | 1.40e-01 | 2.36e-01 | 6.07e-01 |
| GOBP SECRETORY GRANULE LOCALIZATION | 15 | 1.13e-01 | -2.36e-01 | 5.69e-01 |
| GOBP GANGLION DEVELOPMENT | 7 | 2.79e-01 | 2.36e-01 | 7.40e-01 |
| GOBP T CELL MEDIATED IMMUNE RESPONSE TO TUMOR CELL | 11 | 1.75e-01 | 2.36e-01 | 6.42e-01 |
| GOBP MITOTIC G2 M TRANSITION CHECKPOINT | 54 | 2.67e-03 | 2.36e-01 | 1.24e-01 |
| GOCC POLAR MICROTUBULE | 5 | 3.61e-01 | -2.36e-01 | 8.01e-01 |
| GOBP DEFENSE RESPONSE TO GRAM NEGATIVE BACTERIUM | 47 | 5.13e-03 | -2.36e-01 | 1.75e-01 |
| GOMF CARBOXYLESTERASE ACTIVITY | 5 | 3.61e-01 | -2.36e-01 | 8.01e-01 |
| GOBP ANTEROGRADE DENDRITIC TRANSPORT | 8 | 2.48e-01 | 2.36e-01 | 7.17e-01 |
| GOCC DEATH INDUCING SIGNALING COMPLEX | 9 | 2.21e-01 | 2.36e-01 | 6.95e-01 |
| GOMF PEPTIDE ALPHA N ACETYLTRANSFERASE ACTIVITY | 7 | 2.81e-01 | -2.36e-01 | 7.42e-01 |
| GOBP SPHINGOLIPID MEDIATED SIGNALING PATHWAY | 17 | 9.29e-02 | -2.35e-01 | 5.32e-01 |
| GOBP POSITIVE REGULATION OF MITOCHONDRIAL MEMBRANE PERMEABILITY | 36 | 1.46e-02 | -2.35e-01 | 2.59e-01 |
| GOBP NEGATIVE REGULATION OF CARDIOCYTE DIFFERENTIATION | 8 | 2.49e-01 | 2.35e-01 | 7.18e-01 |
| GOBP CHONDROITIN SULFATE BIOSYNTHETIC PROCESS | 16 | 1.04e-01 | -2.35e-01 | 5.55e-01 |
| GOMF BMP RECEPTOR BINDING | 8 | 2.50e-01 | -2.35e-01 | 7.18e-01 |
| GOMF INOSITOL BISPHOSPHATE PHOSPHATASE ACTIVITY | 7 | 2.82e-01 | 2.35e-01 | 7.43e-01 |
| GOBP NEGATIVE REGULATION OF REACTIVE OXYGEN SPECIES BIOSYNTHETIC PROCESS | 14 | 1.28e-01 | 2.35e-01 | 5.93e-01 |
| GOBP REGULATION OF DENDRITIC SPINE DEVELOPMENT | 49 | 4.46e-03 | 2.35e-01 | 1.61e-01 |
| GOBP TRANSCRIPTION INITIATION AT RNA POLYMERASE III PROMOTER | 8 | 2.50e-01 | -2.35e-01 | 7.18e-01 |
| GOMF PHOSPHATIDYLINOSITOL TRANSFER ACTIVITY | 10 | 1.99e-01 | -2.35e-01 | 6.71e-01 |
| GOBP AXONAL TRANSPORT OF MITOCHONDRION | 14 | 1.29e-01 | 2.35e-01 | 5.94e-01 |
| GOBP FLAVONOID METABOLIC PROCESS | 5 | 3.64e-01 | -2.34e-01 | 8.02e-01 |
| GOBP POSITIVE REGULATION OF CELLULAR RESPIRATION | 13 | 1.43e-01 | 2.34e-01 | 6.11e-01 |
| GOBP REGULATION OF TRANSLATIONAL FIDELITY | 18 | 8.52e-02 | -2.34e-01 | 5.11e-01 |
| GOBP POSITIVE REGULATION OF MUCUS SECRETION | 5 | 3.64e-01 | -2.34e-01 | 8.02e-01 |
| GOBP RESPONSE TO UV B | 19 | 7.71e-02 | -2.34e-01 | 4.95e-01 |
| GOBP REGULATION OF AMYLOID FIBRIL FORMATION | 13 | 1.44e-01 | 2.34e-01 | 6.12e-01 |
| GOBP EXTRAEMBRYONIC MEMBRANE DEVELOPMENT | 9 | 2.24e-01 | -2.34e-01 | 6.97e-01 |
| GOMF ACTIVIN RECEPTOR ACTIVITY TYPE I | 5 | 3.65e-01 | 2.34e-01 | 8.03e-01 |
| GOMF CYSTEINE TYPE ENDOPEPTIDASE INHIBITOR ACTIVITY INVOLVED IN APOPTOTIC PROCESS | 17 | 9.48e-02 | 2.34e-01 | 5.36e-01 |
| GOBP DNA STRAND INVASION | 5 | 3.65e-01 | 2.34e-01 | 8.03e-01 |
| GOBP U4 SNRNA 3 END PROCESSING | 8 | 2.52e-01 | -2.34e-01 | 7.21e-01 |
| GOCC PROTEASOME CORE COMPLEX BETA SUBUNIT COMPLEX | 10 | 2.01e-01 | -2.34e-01 | 6.72e-01 |
| GOMF OXIDOREDUCTASE ACTIVITY ACTING ON OTHER NITROGENOUS COMPOUNDS AS DONORS | 10 | 2.01e-01 | -2.34e-01 | 6.72e-01 |
| GOBP PROTEIN KINASE C ACTIVATING G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY | 17 | 9.54e-02 | -2.34e-01 | 5.38e-01 |
| GOBP RESPONSE TO ZINC ION STARVATION | 8 | 2.53e-01 | -2.34e-01 | 7.22e-01 |
| GOBP POSITIVE REGULATION OF GLIAL CELL PROLIFERATION | 18 | 8.65e-02 | 2.33e-01 | 5.15e-01 |
| GOCC BBAF COMPLEX | 9 | 2.25e-01 | -2.33e-01 | 6.98e-01 |
| GOCC PLATELET DENSE GRANULE MEMBRANE | 6 | 3.22e-01 | 2.33e-01 | 7.74e-01 |
| GOMF SODIUM ION BINDING | 6 | 3.23e-01 | -2.33e-01 | 7.74e-01 |
| GOBP NEGATIVE REGULATION OF AUTOPHAGOSOME MATURATION | 5 | 3.67e-01 | -2.33e-01 | 8.04e-01 |
| GOBP REGULATION OF PROTEIN SUMOYLATION | 20 | 7.12e-02 | -2.33e-01 | 4.84e-01 |
| GOBP NEGATIVE REGULATION OF PROTEIN DEPHOSPHORYLATION | 23 | 5.31e-02 | 2.33e-01 | 4.35e-01 |
| GOBP POSITIVE REGULATION OF PEPTIDYL LYSINE ACETYLATION | 5 | 3.67e-01 | 2.33e-01 | 8.04e-01 |
| GOCC EUKARYOTIC TRANSLATION INITIATION FACTOR 4F COMPLEX | 12 | 1.63e-01 | 2.33e-01 | 6.29e-01 |
| GOBP ADHERENS JUNCTION ASSEMBLY | 12 | 1.63e-01 | -2.33e-01 | 6.29e-01 |
| GOBP REVERSE CHOLESTEROL TRANSPORT | 13 | 1.47e-01 | -2.33e-01 | 6.13e-01 |
| GOBP AMINO SUGAR CATABOLIC PROCESS | 13 | 1.47e-01 | -2.33e-01 | 6.13e-01 |
| GOCC PRESYNAPTIC ACTIVE ZONE | 55 | 2.87e-03 | -2.32e-01 | 1.28e-01 |
| GOBP POSITIVE REGULATION OF ANTIGEN PROCESSING AND PRESENTATION | 6 | 3.25e-01 | -2.32e-01 | 7.75e-01 |
| GOBP POSITIVE REGULATION BY HOST OF VIRAL PROCESS | 21 | 6.55e-02 | 2.32e-01 | 4.68e-01 |
| GOMF BHLH TRANSCRIPTION FACTOR BINDING | 22 | 5.95e-02 | -2.32e-01 | 4.53e-01 |
| GOBP T HELPER CELL LINEAGE COMMITMENT | 20 | 7.24e-02 | -2.32e-01 | 4.86e-01 |
| GOBP POSITIVE REGULATION OF PLATELET AGGREGATION | 9 | 2.28e-01 | -2.32e-01 | 7.01e-01 |
| GOCC DNA RECOMBINASE MEDIATOR COMPLEX | 7 | 2.88e-01 | -2.32e-01 | 7.47e-01 |
| GOMF TUMOR NECROSIS FACTOR RECEPTOR ACTIVITY | 9 | 2.29e-01 | -2.31e-01 | 7.02e-01 |
| GOBP DEOXYRIBONUCLEOSIDE TRIPHOSPHATE METABOLIC PROCESS | 9 | 2.30e-01 | 2.31e-01 | 7.02e-01 |
| GOBP DIACYLGLYCEROL CATABOLIC PROCESS | 5 | 3.71e-01 | -2.31e-01 | 8.07e-01 |
| GOBP DIACYLGLYCEROL METABOLIC PROCESS | 23 | 5.50e-02 | -2.31e-01 | 4.38e-01 |
| GOMF U4 SNRNA BINDING | 6 | 3.27e-01 | -2.31e-01 | 7.78e-01 |
| GOBP REGULATION OF T CELL ACTIVATION VIA T CELL RECEPTOR CONTACT WITH ANTIGEN BOUND TO MHC MOLECULE ON ANTIGEN PRESENTING CELL | 6 | 3.27e-01 | -2.31e-01 | 7.78e-01 |
| GOBP POSITIVE REGULATION OF DNA DAMAGE RESPONSE SIGNAL TRANSDUCTION BY P53 CLASS MEDIATOR RESULTING IN TRANSCRIPTION OF P21 CLASS MEDIATOR | 5 | 3.71e-01 | -2.31e-01 | 8.08e-01 |
| GOBP FOLIC ACID TRANSPORT | 8 | 2.58e-01 | -2.31e-01 | 7.27e-01 |
| GOBP POSITIVE REGULATION OF ADENYLATE CYCLASE ACTIVITY | 16 | 1.10e-01 | -2.31e-01 | 5.63e-01 |
| GOBP MITOTIC SISTER CHROMATID COHESION CENTROMERIC | 5 | 3.71e-01 | 2.31e-01 | 8.08e-01 |
| GOBP MYD88 DEPENDENT TOLL LIKE RECEPTOR SIGNALING PATHWAY | 19 | 8.17e-02 | 2.31e-01 | 5.02e-01 |
| GOBP RRNA BASE METHYLATION | 10 | 2.07e-01 | -2.31e-01 | 6.81e-01 |
| GOBP PYRIMIDINE RIBONUCLEOSIDE TRIPHOSPHATE BIOSYNTHETIC PROCESS | 13 | 1.50e-01 | -2.31e-01 | 6.13e-01 |
| GOBP PEPTIDYL TYROSINE AUTOPHOSPHORYLATION | 12 | 1.67e-01 | -2.31e-01 | 6.32e-01 |
| GOBP NEGATIVE REGULATION OF SISTER CHROMATID COHESION | 5 | 3.72e-01 | 2.30e-01 | 8.08e-01 |
| GOCC NUCLEOCYTOPLASMIC TRANSPORT COMPLEX | 11 | 1.86e-01 | 2.30e-01 | 6.61e-01 |
| GOMF TOXIN TRANSMEMBRANE TRANSPORTER ACTIVITY | 6 | 3.29e-01 | 2.30e-01 | 7.80e-01 |
| GOMF NON MEMBRANE SPANNING PROTEIN TYROSINE PHOSPHATASE ACTIVITY | 12 | 1.68e-01 | 2.30e-01 | 6.33e-01 |
| GOMF HYALURONONGLUCOSAMINIDASE ACTIVITY | 6 | 3.29e-01 | -2.30e-01 | 7.81e-01 |
| GOBP POSITIVE REGULATION OF PROTEIN LOCALIZATION TO NUCLEOLUS | 5 | 3.73e-01 | 2.30e-01 | 8.09e-01 |
| GOBP NEGATIVE REGULATION OF EPIDERMAL GROWTH FACTOR ACTIVATED RECEPTOR ACTIVITY | 12 | 1.68e-01 | 2.30e-01 | 6.33e-01 |
| GOMF TRANSLATION INITIATION FACTOR ACTIVITY | 49 | 5.39e-03 | 2.30e-01 | 1.79e-01 |
| GOBP NEGATIVE REGULATION OF PROTEIN EXPORT FROM NUCLEUS | 6 | 3.30e-01 | 2.30e-01 | 7.81e-01 |
| GOBP POSITIVE REGULATION OF MORPHOGENESIS OF AN EPITHELIUM | 25 | 4.68e-02 | -2.30e-01 | 4.21e-01 |
| GOBP FREE UBIQUITIN CHAIN POLYMERIZATION | 9 | 2.33e-01 | -2.30e-01 | 7.05e-01 |
| GOBP PROTEIN LOCALIZATION TO PRESYNAPSE | 11 | 1.87e-01 | -2.30e-01 | 6.62e-01 |
| GOCC COPI COATED VESICLE | 25 | 4.69e-02 | 2.30e-01 | 4.21e-01 |
| GOMF GTPASE ACTIVATING PROTEIN BINDING | 11 | 1.88e-01 | -2.29e-01 | 6.62e-01 |
| GOMF TRANSPORTER INHIBITOR ACTIVITY | 33 | 2.25e-02 | 2.29e-01 | 3.26e-01 |
| GOMF 1 ACYLGLYCEROPHOSPHOCHOLINE O ACYLTRANSFERASE ACTIVITY | 7 | 2.93e-01 | 2.29e-01 | 7.50e-01 |
| GOBP HISTONE MRNA METABOLIC PROCESS | 24 | 5.18e-02 | 2.29e-01 | 4.33e-01 |
| GOBP GOLGI VESICLE BUDDING | 10 | 2.09e-01 | 2.29e-01 | 6.83e-01 |
| GOBP TERMINATION OF RNA POLYMERASE II TRANSCRIPTION | 10 | 2.09e-01 | 2.29e-01 | 6.83e-01 |
| GOBP MITOTIC METAPHASE CHROMOSOME ALIGNMENT | 61 | 1.96e-03 | 2.29e-01 | 1.09e-01 |
| GOBP FUCOSE METABOLIC PROCESS | 13 | 1.53e-01 | -2.29e-01 | 6.16e-01 |
| GOMF INOSITOL 1 4 5 TRISPHOSPHATE BINDING | 9 | 2.34e-01 | 2.29e-01 | 7.05e-01 |
| GOBP DIACYLGLYCEROL BIOSYNTHETIC PROCESS | 7 | 2.94e-01 | -2.29e-01 | 7.51e-01 |
| GOBP REGULATION OF CDC42 PROTEIN SIGNAL TRANSDUCTION | 5 | 3.75e-01 | 2.29e-01 | 8.09e-01 |
| GOBP NUCLEOSIDE TRANSMEMBRANE TRANSPORT | 7 | 2.95e-01 | 2.29e-01 | 7.51e-01 |
| GOBP TETRAHYDROFOLATE METABOLIC PROCESS | 18 | 9.29e-02 | 2.29e-01 | 5.32e-01 |
| GOBP POSITIVE REGULATION OF MEMBRANE PERMEABILITY | 39 | 1.34e-02 | -2.29e-01 | 2.50e-01 |
| GOBP REGULATION OF PROTEIN LOCALIZATION TO CELL CORTEX | 8 | 2.63e-01 | -2.29e-01 | 7.30e-01 |
| GOMF METALLOENDOPEPTIDASE INHIBITOR ACTIVITY | 8 | 2.63e-01 | 2.29e-01 | 7.30e-01 |
| GOBP ENDOLYSOSOMAL TOLL LIKE RECEPTOR SIGNALING PATHWAY | 48 | 6.12e-03 | 2.29e-01 | 1.83e-01 |
| GOBP CELLULAR RESPONSE TO PEPTIDE | 12 | 1.70e-01 | -2.29e-01 | 6.37e-01 |
| GOMF NUCLEOCYTOPLASMIC CARRIER ACTIVITY | 31 | 2.76e-02 | 2.29e-01 | 3.57e-01 |
| GOBP ASTRAL MICROTUBULE ORGANIZATION | 10 | 2.11e-01 | 2.29e-01 | 6.83e-01 |
| GOBP GLUCOSYLCERAMIDE METABOLIC PROCESS | 5 | 3.76e-01 | 2.28e-01 | 8.10e-01 |
| GOMF ORGANOPHOSPHATE ESTER TRANSMEMBRANE TRANSPORTER ACTIVITY | 34 | 2.12e-02 | -2.28e-01 | 3.18e-01 |
| GOBP POSITIVE REGULATION OF INTERLEUKIN 5 PRODUCTION | 8 | 2.63e-01 | 2.28e-01 | 7.31e-01 |
| GOBP CHORION DEVELOPMENT | 8 | 2.63e-01 | -2.28e-01 | 7.31e-01 |
| GOBP NEGATIVE REGULATION OF SIGNALING RECEPTOR ACTIVITY | 22 | 6.39e-02 | 2.28e-01 | 4.65e-01 |
| GOBP REGULATION OF RRNA PROCESSING | 16 | 1.14e-01 | 2.28e-01 | 5.70e-01 |
| GOBP VESICLE FUSION TO PLASMA MEMBRANE | 17 | 1.03e-01 | -2.28e-01 | 5.55e-01 |
| GOBP NEUROFILAMENT CYTOSKELETON ORGANIZATION | 9 | 2.36e-01 | 2.28e-01 | 7.07e-01 |
| GOBP MICROGLIAL CELL MEDIATED CYTOTOXICITY | 5 | 3.77e-01 | -2.28e-01 | 8.10e-01 |
| GOCC AMINOACYL TRNA SYNTHETASE MULTIENZYME COMPLEX | 11 | 1.91e-01 | 2.28e-01 | 6.63e-01 |
| GOMF PROTEIN KINASE A REGULATORY SUBUNIT BINDING | 23 | 5.86e-02 | 2.28e-01 | 4.51e-01 |
| GOBP REGULATION OF PROTEIN EXIT FROM ENDOPLASMIC RETICULUM | 24 | 5.34e-02 | 2.28e-01 | 4.36e-01 |
| GOBP REGULATION OF BONE DEVELOPMENT | 6 | 3.34e-01 | -2.28e-01 | 7.84e-01 |
| GOBP REGULATION OF RELEASE OF SEQUESTERED CALCIUM ION INTO CYTOSOL BY SARCOPLASMIC RETICULUM | 22 | 6.47e-02 | 2.28e-01 | 4.66e-01 |
| GOBP REGULATORY NCRNA PROCESSING | 57 | 2.98e-03 | 2.27e-01 | 1.29e-01 |
| GOBP REGULATION OF ENDOSOME ORGANIZATION | 5 | 3.79e-01 | 2.27e-01 | 8.12e-01 |
| GOCC TORC2 COMPLEX | 9 | 2.38e-01 | -2.27e-01 | 7.08e-01 |
| GOBP RESPONSE TO NITROSATIVE STRESS | 9 | 2.38e-01 | 2.27e-01 | 7.08e-01 |
| GOCC CD95 DEATH INDUCING SIGNALING COMPLEX | 6 | 3.35e-01 | 2.27e-01 | 7.84e-01 |
| GOMF ADENYLYLTRANSFERASE ACTIVITY | 27 | 4.10e-02 | 2.27e-01 | 4.02e-01 |
| GOCC DYNEIN AXONEMAL PARTICLE | 14 | 1.41e-01 | -2.27e-01 | 6.08e-01 |
| GOBP UDP N ACETYLGLUCOSAMINE TRANSMEMBRANE TRANSPORT | 5 | 3.79e-01 | 2.27e-01 | 8.12e-01 |
| GOMF UDP N ACETYLGLUCOSAMINE TRANSMEMBRANE TRANSPORTER ACTIVITY | 5 | 3.79e-01 | 2.27e-01 | 8.12e-01 |
| GOMF OXIDOREDUCTASE ACTIVITY ACTING ON THE CH CH GROUP OF DONORS WITH A FLAVIN AS ACCEPTOR | 13 | 1.57e-01 | -2.27e-01 | 6.21e-01 |
| GOBP PROTEIN MONOUBIQUITINATION | 48 | 6.54e-03 | 2.27e-01 | 1.89e-01 |
| GOBP HEPARAN SULFATE PROTEOGLYCAN BIOSYNTHETIC PROCESS ENZYMATIC MODIFICATION | 8 | 2.67e-01 | 2.27e-01 | 7.33e-01 |
| GOMF HEPARAN SULFATE SULFOTRANSFERASE ACTIVITY | 8 | 2.67e-01 | 2.27e-01 | 7.33e-01 |
| GOMF ARYL HYDROCARBON RECEPTOR BINDING | 6 | 3.36e-01 | -2.27e-01 | 7.86e-01 |
| GOBP REGULATION OF MUSCLE ORGAN DEVELOPMENT | 17 | 1.06e-01 | 2.27e-01 | 5.59e-01 |
| GOCC PROTEIN PHOSPHATASE TYPE 1 COMPLEX | 17 | 1.06e-01 | 2.26e-01 | 5.59e-01 |
| GOBP POSITIVE REGULATION OF TOLL LIKE RECEPTOR 9 SIGNALING PATHWAY | 6 | 3.37e-01 | 2.26e-01 | 7.86e-01 |
| GOBP PROTEIN LOCALIZATION TO CHROMOSOME TELOMERIC REGION | 31 | 2.93e-02 | 2.26e-01 | 3.61e-01 |
| GOBP INFLAMMATORY CELL APOPTOTIC PROCESS | 21 | 7.29e-02 | 2.26e-01 | 4.87e-01 |
| GOCC GOLGI LUMEN | 57 | 3.16e-03 | -2.26e-01 | 1.32e-01 |
| GOBP NUCLEAR TRANSCRIBED MRNA POLY A TAIL SHORTENING | 32 | 2.69e-02 | 2.26e-01 | 3.53e-01 |
| GOBP NEUTROPHIL HOMEOSTASIS | 19 | 8.82e-02 | 2.26e-01 | 5.19e-01 |
| GOBP REGULATION OF STORE OPERATED CALCIUM CHANNEL ACTIVITY | 6 | 3.38e-01 | 2.26e-01 | 7.87e-01 |
| GOBP PHOTOPERIODISM | 24 | 5.55e-02 | -2.26e-01 | 4.40e-01 |
| GOBP FAT SOLUBLE VITAMIN CATABOLIC PROCESS | 5 | 3.82e-01 | 2.26e-01 | 8.14e-01 |
| GOMF AROMATASE ACTIVITY | 11 | 1.95e-01 | 2.26e-01 | 6.68e-01 |
| GOBP UDP GLUCOSE METABOLIC PROCESS | 6 | 3.39e-01 | 2.25e-01 | 7.87e-01 |
| GOMF NUCLEAR VITAMIN D RECEPTOR BINDING | 15 | 1.31e-01 | 2.25e-01 | 5.94e-01 |
| GOBP MITOCHONDRIAL ELECTRON TRANSPORT UBIQUINOL TO CYTOCHROME C | 14 | 1.44e-01 | -2.25e-01 | 6.12e-01 |
| GOBP REGULATION OF MDA 5 SIGNALING PATHWAY | 6 | 3.39e-01 | 2.25e-01 | 7.87e-01 |
| GOMF RNA POLYMERASE II GENERAL TRANSCRIPTION INITIATION FACTOR ACTIVITY | 36 | 1.93e-02 | 2.25e-01 | 3.05e-01 |
| GOBP PROTEIN DEUBIQUITINATION | 82 | 4.20e-04 | 2.25e-01 | 4.02e-02 |
| GOMF PURINE NUCLEOTIDE TRANSMEMBRANE TRANSPORTER ACTIVITY | 25 | 5.12e-02 | -2.25e-01 | 4.31e-01 |
| GOCC CYCLIN CDK POSITIVE TRANSCRIPTION ELONGATION FACTOR COMPLEX | 8 | 2.70e-01 | 2.25e-01 | 7.35e-01 |
| GOBP PROTEIN MODIFICATION BY SMALL PROTEIN REMOVAL | 102 | 8.62e-05 | 2.25e-01 | 1.31e-02 |
| GOMF L GLUTAMATE TRANSMEMBRANE TRANSPORTER ACTIVITY | 10 | 2.18e-01 | 2.25e-01 | 6.93e-01 |
| GOBP POSITIVE REGULATION OF NUCLEOTIDE CATABOLIC PROCESS | 15 | 1.32e-01 | 2.25e-01 | 5.97e-01 |
| GOMF CALMODULIN DEPENDENT PROTEIN KINASE ACTIVITY | 19 | 9.01e-02 | -2.25e-01 | 5.25e-01 |
| GOBP ENDOPLASMIC RETICULUM TO GOLGI VESICLE MEDIATED TRANSPORT | 132 | 8.38e-06 | 2.25e-01 | 3.00e-03 |
| GOBP PROTEIN TARGETING TO VACUOLE | 45 | 9.17e-03 | 2.24e-01 | 2.20e-01 |
| GOBP FRUCTOSE 1 6 BISPHOSPHATE METABOLIC PROCESS | 8 | 2.72e-01 | -2.24e-01 | 7.36e-01 |
| GOBP DTMP METABOLIC PROCESS | 6 | 3.42e-01 | -2.24e-01 | 7.89e-01 |
| GOMF ICOSANOID TRANSMEMBRANE TRANSPORTER ACTIVITY | 6 | 3.42e-01 | -2.24e-01 | 7.89e-01 |
| GOMF FATTY ACYL COA SYNTHASE ACTIVITY | 5 | 3.86e-01 | 2.24e-01 | 8.15e-01 |
| GOBP HARD PALATE DEVELOPMENT | 5 | 3.86e-01 | 2.24e-01 | 8.15e-01 |
| GOBP REGULATION OF ISOMERASE ACTIVITY | 7 | 3.05e-01 | 2.24e-01 | 7.60e-01 |
| GOCC CHROMOSOME CENTROMERIC CORE DOMAIN | 8 | 2.73e-01 | -2.24e-01 | 7.36e-01 |
| GOBP RESPIRATORY BURST INVOLVED IN INFLAMMATORY RESPONSE | 8 | 2.73e-01 | -2.24e-01 | 7.36e-01 |
| GOCC INSULIN RESPONSIVE COMPARTMENT | 6 | 3.43e-01 | 2.24e-01 | 7.89e-01 |
| GOBP INTERNEURON MIGRATION | 5 | 3.87e-01 | 2.24e-01 | 8.16e-01 |
| GOBP PEPTIDYL THREONINE DEPHOSPHORYLATION | 16 | 1.22e-01 | 2.23e-01 | 5.85e-01 |
| GOBP REGULATION OF NUCLEOBASE CONTAINING COMPOUND TRANSPORT | 19 | 9.19e-02 | 2.23e-01 | 5.29e-01 |
| GOBP POLY N ACETYLLACTOSAMINE METABOLIC PROCESS | 7 | 3.06e-01 | -2.23e-01 | 7.61e-01 |
| GOMF PHOSPHATIDYL PHOSPHOLIPASE B ACTIVITY | 10 | 2.21e-01 | -2.23e-01 | 6.96e-01 |
| GOMF SCAVENGER RECEPTOR ACTIVITY | 22 | 6.98e-02 | -2.23e-01 | 4.80e-01 |
| GOBP POSITIVE REGULATION OF RUFFLE ASSEMBLY | 13 | 1.63e-01 | -2.23e-01 | 6.30e-01 |
| GOBP CELLULAR RESPONSE TO X RAY | 9 | 2.46e-01 | 2.23e-01 | 7.16e-01 |
| GOBP REGULATION OF MYOTUBE DIFFERENTIATION | 30 | 3.45e-02 | -2.23e-01 | 3.85e-01 |
| GOBP EOSINOPHIL DIFFERENTIATION | 5 | 3.88e-01 | 2.23e-01 | 8.17e-01 |
| GOBP TONGUE MORPHOGENESIS | 5 | 3.90e-01 | 2.22e-01 | 8.18e-01 |
| GOCC IGG IMMUNOGLOBULIN COMPLEX | 10 | 2.24e-01 | -2.22e-01 | 6.97e-01 |
| GOBP FC EPSILON RECEPTOR SIGNALING PATHWAY | 25 | 5.45e-02 | 2.22e-01 | 4.38e-01 |
| GOBP ERBB3 SIGNALING PATHWAY | 9 | 2.48e-01 | -2.22e-01 | 7.17e-01 |
| GOMF VITAMIN TRANSMEMBRANE TRANSPORTER ACTIVITY | 23 | 6.52e-02 | -2.22e-01 | 4.67e-01 |
| GOBP REGULATION OF OPSONIZATION | 5 | 3.90e-01 | -2.22e-01 | 8.18e-01 |
| GOBP MATURATION OF LSU RRNA FROM TRICISTRONIC RRNA TRANSCRIPT SSU RRNA 5 8S RRNA LSU RRNA | 16 | 1.24e-01 | 2.22e-01 | 5.88e-01 |
| GOCC SMAD PROTEIN COMPLEX | 8 | 2.77e-01 | 2.22e-01 | 7.39e-01 |
| GOMF GLYCINE TRANSMEMBRANE TRANSPORTER ACTIVITY | 6 | 3.47e-01 | 2.22e-01 | 7.91e-01 |
| GOBP REGULATION OF RESPONSE TO OSMOTIC STRESS | 14 | 1.51e-01 | -2.21e-01 | 6.13e-01 |
| GOBP INDUCTION OF POSITIVE CHEMOTAXIS | 7 | 3.10e-01 | -2.21e-01 | 7.64e-01 |
| GOBP CELL JUNCTION MAINTENANCE | 36 | 2.15e-02 | -2.21e-01 | 3.21e-01 |
| GOCC ENDOPLASMIC RETICULUM EXIT SITE | 30 | 3.60e-02 | 2.21e-01 | 3.89e-01 |
| GOBP REGULATION OF MONOCYTE DIFFERENTIATION | 15 | 1.38e-01 | -2.21e-01 | 6.04e-01 |
| GOMF PHOSPHATIDYLINOSITOL TRISPHOSPHATE PHOSPHATASE ACTIVITY | 7 | 3.11e-01 | -2.21e-01 | 7.65e-01 |
| GOBP INTERLEUKIN 5 PRODUCTION | 15 | 1.38e-01 | 2.21e-01 | 6.04e-01 |
| GOBP COPII COATED VESICLE CARGO LOADING | 18 | 1.05e-01 | 2.21e-01 | 5.56e-01 |
| GOBP CARDIOBLAST PROLIFERATION | 6 | 3.49e-01 | -2.21e-01 | 7.92e-01 |
| GOMF PROTEIN RNA ADAPTOR ACTIVITY | 20 | 8.73e-02 | 2.21e-01 | 5.17e-01 |
| GOBP CGMP BIOSYNTHETIC PROCESS | 6 | 3.49e-01 | 2.21e-01 | 7.92e-01 |
| GOMF NADPLUS PROTEIN ADP RIBOSYLTRANSFERASE ACTIVITY | 24 | 6.13e-02 | 2.21e-01 | 4.59e-01 |
| GOBP POSITIVE REGULATION OF DNA DAMAGE RESPONSE SIGNAL TRANSDUCTION BY P53 CLASS MEDIATOR | 14 | 1.53e-01 | 2.21e-01 | 6.16e-01 |
| GOBP CELLULAR RESPONSE TO INDOLE 3 METHANOL | 5 | 3.93e-01 | 2.20e-01 | 8.20e-01 |
| GOBP PURINE NUCLEOBASE BIOSYNTHETIC PROCESS | 10 | 2.28e-01 | 2.20e-01 | 7.01e-01 |
| GOBP POSITIVE REGULATION OF ADIPOSE TISSUE DEVELOPMENT | 9 | 2.53e-01 | 2.20e-01 | 7.22e-01 |
| GOBP NEGATIVE REGULATION OF ERAD PATHWAY | 7 | 3.14e-01 | 2.20e-01 | 7.66e-01 |
| GOBP MESENCHYMAL STEM CELL DIFFERENTIATION | 10 | 2.29e-01 | 2.20e-01 | 7.01e-01 |
| GOBP NEGATIVE REGULATION OF CYTOKINE PRODUCTION INVOLVED IN INFLAMMATORY RESPONSE | 20 | 8.89e-02 | -2.20e-01 | 5.22e-01 |
| GOBP RESPONSE TO LUTEINIZING HORMONE | 5 | 3.95e-01 | 2.20e-01 | 8.20e-01 |
| GOBP SULFATION | 12 | 1.88e-01 | -2.20e-01 | 6.62e-01 |
| GOMF LNCRNA BINDING | 16 | 1.28e-01 | 2.20e-01 | 5.93e-01 |
| GOBP NEGATIVE REGULATION OF AMYLOID BETA CLEARANCE | 7 | 3.14e-01 | 2.20e-01 | 7.66e-01 |
| GOMF METAL CATION PROTON ANTIPORTER ACTIVITY | 19 | 9.76e-02 | 2.20e-01 | 5.43e-01 |
| GOMF PEPTIDE TRANSMEMBRANE TRANSPORTER ACTIVITY | 8 | 2.82e-01 | -2.19e-01 | 7.43e-01 |
| GOMF MITOCHONDRION TARGETING SEQUENCE BINDING | 5 | 3.95e-01 | 2.19e-01 | 8.20e-01 |
| GOCC SITE OF DOUBLE STRAND BREAK | 94 | 2.36e-04 | 2.19e-01 | 2.74e-02 |
| GOBP MITOCHONDRIAL OUTER MEMBRANE PERMEABILIZATION | 28 | 4.45e-02 | -2.19e-01 | 4.11e-01 |
| GOBP TRANSCRIPTION ELONGATION COUPLED CHROMATIN REMODELING | 9 | 2.54e-01 | -2.19e-01 | 7.23e-01 |
| GOBP NEGATIVE REGULATION OF POTASSIUM ION TRANSMEMBRANE TRANSPORT | 15 | 1.41e-01 | 2.19e-01 | 6.08e-01 |
| GOBP REGULATION OF FEAR RESPONSE | 8 | 2.83e-01 | -2.19e-01 | 7.43e-01 |
| GOCC AXONEMAL A TUBULE INNER SHEATH | 5 | 3.96e-01 | -2.19e-01 | 8.21e-01 |
| GOBP REGULATION OF GASTRIC ACID SECRETION | 5 | 3.96e-01 | 2.19e-01 | 8.21e-01 |
| GOCC GLYCOSYLPHOSPHATIDYLINOSITOL N ACETYLGLUCOSAMINYLTRANSFERASE GPI GNT COMPLEX | 7 | 3.15e-01 | -2.19e-01 | 7.67e-01 |
| GOBP MIRNA PROCESSING | 41 | 1.52e-02 | 2.19e-01 | 2.65e-01 |
| GOBP SCHWANN CELL DIFFERENTIATION | 43 | 1.30e-02 | -2.19e-01 | 2.49e-01 |
| GOBP HEART VALVE FORMATION | 8 | 2.83e-01 | -2.19e-01 | 7.44e-01 |
| GOBP L SERINE BIOSYNTHETIC PROCESS | 6 | 3.53e-01 | 2.19e-01 | 7.94e-01 |
| GOCC NURD COMPLEX | 16 | 1.30e-01 | -2.19e-01 | 5.94e-01 |
| GOBP RESPONSE TO INTERLEUKIN 9 | 7 | 3.16e-01 | 2.19e-01 | 7.67e-01 |
| GOBP RESPONSE TO SALT | 21 | 8.28e-02 | -2.19e-01 | 5.05e-01 |
| GOBP DETOXIFICATION OF COPPER ION | 6 | 3.54e-01 | 2.19e-01 | 7.95e-01 |
| GOMF INSULIN RECEPTOR SUBSTRATE BINDING | 12 | 1.90e-01 | 2.19e-01 | 6.62e-01 |
| GOMF POLY PURINE TRACT BINDING | 26 | 5.37e-02 | 2.19e-01 | 4.36e-01 |
| GOMF ATPASE ACTIVATOR ACTIVITY | 26 | 5.38e-02 | 2.19e-01 | 4.36e-01 |
| GOBP LEUKOTRIENE TRANSPORT | 7 | 3.17e-01 | -2.19e-01 | 7.68e-01 |
| GOBP REGULATION OF NK T CELL ACTIVATION | 9 | 2.56e-01 | -2.19e-01 | 7.26e-01 |
| GOBP THYMOCYTE MIGRATION | 7 | 3.17e-01 | -2.18e-01 | 7.68e-01 |
| GOBP PERICYTE CELL DIFFERENTIATION | 7 | 3.17e-01 | -2.18e-01 | 7.68e-01 |
| GOMF AMINOACYL TRNA HYDROLASE ACTIVITY | 5 | 3.98e-01 | 2.18e-01 | 8.22e-01 |
| GOMF LIGAND GATED CALCIUM CHANNEL ACTIVITY | 24 | 6.45e-02 | -2.18e-01 | 4.66e-01 |
| GOBP TROPHOBLAST GIANT CELL DIFFERENTIATION | 6 | 3.55e-01 | -2.18e-01 | 7.96e-01 |
| GOMF G PROTEIN COUPLED ADENOSINE RECEPTOR ACTIVITY | 5 | 3.99e-01 | 2.18e-01 | 8.22e-01 |
| GOBP POLY A DEPENDENT SNORNA 3 END PROCESSING | 8 | 2.86e-01 | -2.18e-01 | 7.45e-01 |
| GOBP N ACETYLNEURAMINATE CATABOLIC PROCESS | 6 | 3.55e-01 | -2.18e-01 | 7.97e-01 |
| GOBP REGULATION OF TRANSLATION IN RESPONSE TO ENDOPLASMIC RETICULUM STRESS | 12 | 1.91e-01 | 2.18e-01 | 6.63e-01 |
| GOBP NEGATIVE REGULATION OF MACROPHAGE ACTIVATION | 13 | 1.74e-01 | -2.18e-01 | 6.41e-01 |
| GOMF ATP DEPENDENT CHROMATIN REMODELER ACTIVITY | 35 | 2.58e-02 | 2.18e-01 | 3.47e-01 |
| GOBP REGULATION OF PLASMINOGEN ACTIVATION | 17 | 1.20e-01 | -2.18e-01 | 5.83e-01 |
| GOBP SENSORY PERCEPTION OF SOUR TASTE | 5 | 3.99e-01 | -2.18e-01 | 8.22e-01 |
| GOBP MESENCHYMAL TO EPITHELIAL TRANSITION INVOLVED IN METANEPHROS MORPHOGENESIS | 5 | 3.99e-01 | 2.18e-01 | 8.22e-01 |
| GOBP POST EMBRYONIC CAMERA TYPE EYE DEVELOPMENT | 7 | 3.19e-01 | -2.18e-01 | 7.70e-01 |
| GOBP VOCALIZATION BEHAVIOR | 9 | 2.58e-01 | 2.18e-01 | 7.27e-01 |
| GOMF ATP DEPENDENT PROTEIN FOLDING CHAPERONE | 31 | 3.60e-02 | 2.18e-01 | 3.89e-01 |
| GOCC X CHROMOSOME | 13 | 1.75e-01 | 2.17e-01 | 6.42e-01 |
| GOBP MITOCHONDRIAL RNA 3 END PROCESSING | 7 | 3.19e-01 | 2.17e-01 | 7.70e-01 |
| GOBP SIGNAL COMPLEX ASSEMBLY | 8 | 2.87e-01 | -2.17e-01 | 7.47e-01 |
| GOBP REGULATION OF CEREBELLAR GRANULE CELL PRECURSOR PROLIFERATION | 5 | 4.00e-01 | -2.17e-01 | 8.23e-01 |
| GOBP INTRACELLULAR CORTICOSTEROID RECEPTOR SIGNALING PATHWAY | 11 | 2.12e-01 | 2.17e-01 | 6.86e-01 |
| GOBP REGULATION OF GLIAL CELL APOPTOTIC PROCESS | 10 | 2.34e-01 | 2.17e-01 | 7.05e-01 |
| GOBP SEMINIFEROUS TUBULE DEVELOPMENT | 14 | 1.59e-01 | 2.17e-01 | 6.26e-01 |
| GOBP REGULATION OF CELL FATE COMMITMENT | 29 | 4.30e-02 | -2.17e-01 | 4.07e-01 |
| GOBP LIPOPROTEIN LOCALIZATION | 18 | 1.11e-01 | 2.17e-01 | 5.64e-01 |
| GOMF IGG BINDING | 8 | 2.88e-01 | 2.17e-01 | 7.47e-01 |
| GOBP POSITIVE REGULATION OF HAIR FOLLICLE DEVELOPMENT | 6 | 3.57e-01 | -2.17e-01 | 7.98e-01 |
| GOBP PROTEIN AUTO ADP RIBOSYLATION | 11 | 2.13e-01 | 2.17e-01 | 6.87e-01 |
| GOBP CORTICOTROPIN SECRETION | 5 | 4.01e-01 | -2.17e-01 | 8.23e-01 |
| GOBP PLASMINOGEN ACTIVATION | 20 | 9.41e-02 | -2.16e-01 | 5.34e-01 |
| GOBP REGULATION OF HYALURONAN BIOSYNTHETIC PROCESS | 7 | 3.22e-01 | -2.16e-01 | 7.74e-01 |
| GOCC PROTEASOME ACCESSORY COMPLEX | 24 | 6.69e-02 | 2.16e-01 | 4.71e-01 |
| GOBP NEGATIVE REGULATION OF PHOSPHATASE ACTIVITY | 17 | 1.23e-01 | 2.16e-01 | 5.86e-01 |
| GOBP ACROSOME ASSEMBLY | 17 | 1.23e-01 | 2.16e-01 | 5.86e-01 |
| GOMF NUCLEAR RETINOID X RECEPTOR BINDING | 14 | 1.62e-01 | -2.16e-01 | 6.28e-01 |
| GOBP FEMALE MEIOTIC NUCLEAR DIVISION | 30 | 4.07e-02 | 2.16e-01 | 4.01e-01 |
| GOBP BEHAVIORAL RESPONSE TO ETHANOL | 7 | 3.23e-01 | 2.16e-01 | 7.74e-01 |
| GOBP RELAXATION OF CARDIAC MUSCLE | 13 | 1.78e-01 | 2.16e-01 | 6.50e-01 |
| GOBP PROSTAGLANDIN SECRETION | 11 | 2.16e-01 | 2.16e-01 | 6.91e-01 |
| GOMF MICROFILAMENT MOTOR ACTIVITY | 26 | 5.71e-02 | -2.16e-01 | 4.45e-01 |
| GOBP ADENYLATE CYCLASE ACTIVATING DOPAMINE RECEPTOR SIGNALING PATHWAY | 5 | 4.04e-01 | -2.15e-01 | 8.25e-01 |
| GOMF PROTEIN KINASE A BINDING | 44 | 1.35e-02 | 2.15e-01 | 2.50e-01 |
| GOMF FRIZZLED BINDING | 26 | 5.76e-02 | -2.15e-01 | 4.46e-01 |
| GOCC PROTEASOME REGULATORY PARTICLE BASE SUBCOMPLEX | 12 | 1.97e-01 | 2.15e-01 | 6.69e-01 |
| GOMF DYSTROGLYCAN BINDING | 9 | 2.64e-01 | -2.15e-01 | 7.31e-01 |
| GOMF LIPOPROTEIN PARTICLE RECEPTOR ACTIVITY | 17 | 1.25e-01 | -2.15e-01 | 5.88e-01 |
| GOBP RESPONSE TO GROWTH HORMONE | 28 | 4.90e-02 | 2.15e-01 | 4.25e-01 |
| GOCC GOLGI MEDIAL CISTERNA | 12 | 1.97e-01 | 2.15e-01 | 6.70e-01 |
| GOBP SNRNA TRANSCRIPTION BY RNA POLYMERASE II | 15 | 1.50e-01 | 2.15e-01 | 6.13e-01 |
| GOBP POSITIVE REGULATION OF ACUTE INFLAMMATORY RESPONSE | 21 | 8.83e-02 | 2.15e-01 | 5.19e-01 |
| GOMF 5 DEOXYRIBOSE 5 PHOSPHATE LYASE ACTIVITY | 6 | 3.62e-01 | 2.15e-01 | 8.01e-01 |
| GOBP PRIMARY AMINO COMPOUND BIOSYNTHETIC PROCESS | 5 | 4.06e-01 | -2.15e-01 | 8.26e-01 |
| GOBP INNER EAR RECEPTOR CELL STEREOCILIUM ORGANIZATION | 27 | 5.37e-02 | -2.15e-01 | 4.36e-01 |
| GOBP MESODERMAL CELL FATE SPECIFICATION | 5 | 4.06e-01 | -2.14e-01 | 8.26e-01 |
| GOBP UTP BIOSYNTHETIC PROCESS | 8 | 2.94e-01 | -2.14e-01 | 7.50e-01 |
| GOBP TOLL LIKE RECEPTOR 9 SIGNALING PATHWAY | 19 | 1.06e-01 | 2.14e-01 | 5.59e-01 |
| GOBP REGULATION OF PROTEIN GLYCOSYLATION | 9 | 2.66e-01 | -2.14e-01 | 7.33e-01 |
| GOMF PROTEIN SERINE THREONINE KINASE BINDING | 10 | 2.41e-01 | 2.14e-01 | 7.11e-01 |
| GOBP NEGATIVE REGULATION OF DENDRITIC CELL DIFFERENTIATION | 5 | 4.07e-01 | 2.14e-01 | 8.26e-01 |
| GOBP CHOLANGIOCYTE PROLIFERATION | 5 | 4.07e-01 | -2.14e-01 | 8.26e-01 |
| GOMF MINOR GROOVE OF ADENINE THYMINE RICH DNA BINDING | 8 | 2.95e-01 | 2.14e-01 | 7.51e-01 |
| GOMF METAL ION SENSOR ACTIVITY | 7 | 3.27e-01 | 2.14e-01 | 7.78e-01 |
| GOBP POSITIVE REGULATION OF MITOPHAGY IN RESPONSE TO MITOCHONDRIAL DEPOLARIZATION | 10 | 2.42e-01 | -2.14e-01 | 7.12e-01 |
| GOBP LACTONE METABOLIC PROCESS | 10 | 2.42e-01 | -2.14e-01 | 7.12e-01 |
| GOBP CYCLIC NUCLEOTIDE CATABOLIC PROCESS | 12 | 2.01e-01 | 2.13e-01 | 6.72e-01 |
| GOBP REGULATION OF EPIDERMAL GROWTH FACTOR ACTIVATED RECEPTOR ACTIVITY | 16 | 1.40e-01 | 2.13e-01 | 6.06e-01 |
| GOBP L GLUTAMATE IMPORT | 31 | 3.99e-02 | 2.13e-01 | 3.99e-01 |
| GOBP NEGATIVE REGULATION OF MYOSIN LIGHT CHAIN PHOSPHATASE ACTIVITY | 5 | 4.10e-01 | 2.13e-01 | 8.26e-01 |
| GOBP POSITIVE REGULATION OF DNA TEMPLATED DNA REPLICATION | 13 | 1.84e-01 | -2.13e-01 | 6.56e-01 |
| GOMF SIRNA BINDING | 10 | 2.44e-01 | 2.13e-01 | 7.13e-01 |
| GOCC PROTON TRANSPORTING TWO SECTOR ATPASE COMPLEX CATALYTIC DOMAIN | 16 | 1.41e-01 | 2.13e-01 | 6.08e-01 |
| GOBP NEGATIVE REGULATION OF INTERLEUKIN 5 PRODUCTION | 5 | 4.11e-01 | 2.12e-01 | 8.26e-01 |
| GOBP CELLULAR METABOLIC COMPOUND SALVAGE | 28 | 5.17e-02 | -2.12e-01 | 4.33e-01 |
| GOMF UBIQUITIN CONJUGATING ENZYME BINDING | 27 | 5.61e-02 | 2.12e-01 | 4.42e-01 |
| GOBP RESPONSE TO INTERLEUKIN 18 | 11 | 2.23e-01 | 2.12e-01 | 6.97e-01 |
| GOMF DYNEIN COMPLEX BINDING | 22 | 8.47e-02 | 2.12e-01 | 5.09e-01 |
| GOBP REGULATION OF RELAXATION OF MUSCLE | 9 | 2.70e-01 | 2.12e-01 | 7.35e-01 |
| GOBP ANDROGEN BIOSYNTHETIC PROCESS | 5 | 4.12e-01 | 2.12e-01 | 8.27e-01 |
| GOBP REGULATION OF FILOPODIUM ASSEMBLY | 42 | 1.75e-02 | 2.12e-01 | 2.87e-01 |
| GOMF CYSTEINE TYPE EXOPEPTIDASE ACTIVITY | 6 | 3.69e-01 | 2.12e-01 | 8.06e-01 |
| GOBP HETEROPHILIC CELL CELL ADHESION VIA PLASMA MEMBRANE CELL ADHESION MOLECULES | 30 | 4.47e-02 | -2.12e-01 | 4.12e-01 |
| GOBP SISTER CHROMATID COHESION | 55 | 6.61e-03 | 2.12e-01 | 1.89e-01 |
| GOMF AMINOACYLASE ACTIVITY | 5 | 4.12e-01 | 2.12e-01 | 8.28e-01 |
| GOCC ORGANELLE MEMBRANE CONTACT SITE | 46 | 1.30e-02 | 2.12e-01 | 2.49e-01 |
| GOBP CELLULAR RESPONSE TO LAMINAR FLUID SHEAR STRESS | 6 | 3.70e-01 | -2.12e-01 | 8.06e-01 |
| GOMF OXYGEN BINDING | 14 | 1.71e-01 | 2.12e-01 | 6.38e-01 |
| GOBP STEM CELL DIVISION | 28 | 5.27e-02 | 2.12e-01 | 4.33e-01 |
| GOMF STRUCTURAL CONSTITUENT OF MUSCLE | 30 | 4.50e-02 | -2.11e-01 | 4.13e-01 |
| GOBP NEGATIVE REGULATION OF MOTOR NEURON APOPTOTIC PROCESS | 10 | 2.47e-01 | 2.11e-01 | 7.16e-01 |
| GOBP MODULATION OF EXCITATORY POSTSYNAPTIC POTENTIAL | 33 | 3.56e-02 | -2.11e-01 | 3.89e-01 |
| GOBP NEGATIVE REGULATION OF SODIUM ION TRANSMEMBRANE TRANSPORT | 8 | 3.01e-01 | 2.11e-01 | 7.57e-01 |
| GOBP CELLULAR MODIFIED AMINO ACID BIOSYNTHETIC PROCESS | 39 | 2.26e-02 | 2.11e-01 | 3.26e-01 |
| GOBP VIRAL GENOME REPLICATION | 117 | 8.08e-05 | 2.11e-01 | 1.27e-02 |
| GOMF RETINYL PALMITATE ESTERASE ACTIVITY | 5 | 4.14e-01 | -2.11e-01 | 8.29e-01 |
| GOBP TRAIL ACTIVATED APOPTOTIC SIGNALING PATHWAY | 9 | 2.73e-01 | -2.11e-01 | 7.36e-01 |
| GOCC UBIQUINONE BIOSYNTHESIS COMPLEX | 6 | 3.71e-01 | -2.11e-01 | 8.08e-01 |
| GOBP NATURAL KILLER CELL CHEMOTAXIS | 8 | 3.02e-01 | 2.11e-01 | 7.57e-01 |
| GOBP POSITIVE REGULATION OF RRNA PROCESSING | 10 | 2.48e-01 | 2.11e-01 | 7.17e-01 |
| GOBP REGULATION OF MITOTIC SISTER CHROMATID SEGREGATION | 54 | 7.34e-03 | 2.11e-01 | 1.96e-01 |
| GOBP PROXIMAL DISTAL PATTERN FORMATION | 12 | 2.06e-01 | -2.11e-01 | 6.81e-01 |
| GOBP NEGATIVE REGULATION OF CELL MIGRATION INVOLVED IN SPROUTING ANGIOGENESIS | 12 | 2.06e-01 | -2.11e-01 | 6.81e-01 |
| GOBP DOPAMINE BIOSYNTHETIC PROCESS | 7 | 3.34e-01 | 2.11e-01 | 7.84e-01 |
| GOBP ACTIN MYOSIN FILAMENT SLIDING | 6 | 3.72e-01 | -2.11e-01 | 8.08e-01 |
| GOCC AP 2 ADAPTOR COMPLEX | 9 | 2.74e-01 | -2.11e-01 | 7.37e-01 |
| GOBP RENAL TUBULAR SECRETION | 9 | 2.74e-01 | -2.10e-01 | 7.37e-01 |
| GOBP PLATELET ACTIVATING FACTOR METABOLIC PROCESS | 7 | 3.35e-01 | 2.10e-01 | 7.84e-01 |
| GOBP POSITIVE REGULATION OF MUSCLE TISSUE DEVELOPMENT | 15 | 1.59e-01 | 2.10e-01 | 6.24e-01 |
| GOBP CYTOPLASM ORGANIZATION | 13 | 1.90e-01 | 2.10e-01 | 6.62e-01 |
| GOBP CORPUS CALLOSUM MORPHOGENESIS | 6 | 3.73e-01 | 2.10e-01 | 8.09e-01 |
| GOMF PHOSPHOSERINE RESIDUE BINDING | 10 | 2.50e-01 | 2.10e-01 | 7.18e-01 |
| GOBP POSITIVE REGULATION OF DNA LIGATION | 5 | 4.16e-01 | 2.10e-01 | 8.30e-01 |
| GOBP NEGATIVE REGULATION OF JUN KINASE ACTIVITY | 11 | 2.28e-01 | 2.10e-01 | 7.01e-01 |
| GOBP POSITIVE REGULATION OF TYPE I INTERFERON PRODUCTION | 70 | 2.41e-03 | 2.10e-01 | 1.19e-01 |
| GOCC DENDRITE CYTOPLASM | 23 | 8.17e-02 | 2.10e-01 | 5.02e-01 |
| GOCC POSTSYNAPTIC SPECIALIZATION INTRACELLULAR COMPONENT | 16 | 1.46e-01 | -2.10e-01 | 6.13e-01 |
| GOMF DNA TOPOISOMERASE ACTIVITY | 6 | 3.74e-01 | 2.10e-01 | 8.09e-01 |
| GOBP REGULATION OF SECONDARY HEART FIELD CARDIOBLAST PROLIFERATION | 5 | 4.17e-01 | -2.10e-01 | 8.30e-01 |
| GOBP REGULATION OF PROTEIN FOLDING | 9 | 2.77e-01 | -2.09e-01 | 7.39e-01 |
| GOBP EPOXYGENASE P450 PATHWAY | 6 | 3.74e-01 | 2.09e-01 | 8.09e-01 |
| GOBP RESPONSE TO FOOD | 23 | 8.22e-02 | -2.09e-01 | 5.04e-01 |
| GOCC CHROMOSOME CENTROMERIC REGION | 242 | 2.01e-08 | 2.09e-01 | 6.24e-05 |
| GOBP POSITIVE REGULATION OF I KAPPAB PHOSPHORYLATION | 5 | 4.18e-01 | -2.09e-01 | 8.30e-01 |
| GOBP POSITIVE REGULATION OF PROTEIN MONOUBIQUITINATION | 5 | 4.18e-01 | 2.09e-01 | 8.30e-01 |
| GOCC CATSPER COMPLEX | 9 | 2.77e-01 | -2.09e-01 | 7.39e-01 |
| GOBP POSITIVE REGULATION OF RESPIRATORY BURST | 7 | 3.38e-01 | -2.09e-01 | 7.87e-01 |
| GOBP POSITIVE REGULATION OF T HELPER 1 CELL DIFFERENTIATION | 5 | 4.18e-01 | 2.09e-01 | 8.30e-01 |
| GOMF NUCLEAR EXPORT SIGNAL RECEPTOR ACTIVITY | 12 | 2.10e-01 | 2.09e-01 | 6.83e-01 |
| GOBP POSITIVE REGULATION OF NEUROINFLAMMATORY RESPONSE | 11 | 2.30e-01 | 2.09e-01 | 7.03e-01 |
| GOBP ERBB2 EGFR SIGNALING PATHWAY | 6 | 3.75e-01 | -2.09e-01 | 8.09e-01 |
| GOCC BASEMENT MEMBRANE COLLAGEN TRIMER | 5 | 4.19e-01 | -2.09e-01 | 8.30e-01 |
| GOMF C C CHEMOKINE BINDING | 23 | 8.30e-02 | 2.09e-01 | 5.05e-01 |
| GOBP VITAMIN B6 METABOLIC PROCESS | 5 | 4.19e-01 | -2.09e-01 | 8.30e-01 |
| GOBP NEGATIVE REGULATION OF PROTEIN TARGETING TO MEMBRANE | 5 | 4.19e-01 | -2.09e-01 | 8.30e-01 |
| GOBP CELLULAR RESPONSE TO DSRNA | 19 | 1.15e-01 | 2.09e-01 | 5.73e-01 |
| GOMF DNA CLAMP LOADER ACTIVITY | 9 | 2.78e-01 | 2.09e-01 | 7.40e-01 |
| GOBP RETINOIC ACID RECEPTOR SIGNALING PATHWAY | 22 | 9.02e-02 | -2.09e-01 | 5.25e-01 |
| GOBP POSITIVE REGULATION OF LYASE ACTIVITY | 21 | 9.80e-02 | -2.09e-01 | 5.44e-01 |
| GOMF EUKARYOTIC INITIATION FACTOR 4E BINDING | 9 | 2.79e-01 | -2.09e-01 | 7.40e-01 |
| GOBP CELL PROLIFERATION IN FOREBRAIN | 16 | 1.49e-01 | 2.09e-01 | 6.13e-01 |
| GOBP ANTIBACTERIAL HUMORAL RESPONSE | 46 | 1.44e-02 | -2.08e-01 | 2.58e-01 |
| GOMF EPIDERMAL GROWTH FACTOR RECEPTOR BINDING | 27 | 6.09e-02 | 2.08e-01 | 4.58e-01 |
| GOBP MITOTIC SPINDLE ASSEMBLY | 73 | 2.08e-03 | 2.08e-01 | 1.12e-01 |
| GOBP PROTEIN DELIPIDATION | 5 | 4.20e-01 | -2.08e-01 | 8.30e-01 |
| GOBP NEGATIVE REGULATION OF DNA DAMAGE RESPONSE SIGNAL TRANSDUCTION BY P53 CLASS MEDIATOR | 13 | 1.94e-01 | 2.08e-01 | 6.67e-01 |
| GOMF CARNITINE O ACYLTRANSFERASE ACTIVITY | 6 | 3.78e-01 | -2.08e-01 | 8.10e-01 |
| GOCC TIM23 MITOCHONDRIAL IMPORT INNER MEMBRANE TRANSLOCASE COMPLEX | 16 | 1.50e-01 | -2.08e-01 | 6.13e-01 |
| GOMF GLYCOSPHINGOLIPID BINDING | 8 | 3.09e-01 | 2.08e-01 | 7.62e-01 |
| GOMF RNA CAP BINDING | 18 | 1.27e-01 | 2.08e-01 | 5.92e-01 |
| GOBP PROTEIN K48 LINKED UBIQUITINATION | 97 | 4.10e-04 | 2.08e-01 | 4.01e-02 |
| GOBP RESPONSE TO NEMATODE | 5 | 4.22e-01 | 2.08e-01 | 8.30e-01 |
| GOMF NUCLEOSIDE BINDING | 8 | 3.10e-01 | 2.07e-01 | 7.64e-01 |
| GOBP CYCLIC NUCLEOTIDE BIOSYNTHETIC PROCESS | 13 | 1.95e-01 | -2.07e-01 | 6.68e-01 |
| GOBP NEURONAL SIGNAL TRANSDUCTION | 5 | 4.22e-01 | -2.07e-01 | 8.30e-01 |
| GOMF CYCLOSPORIN A BINDING | 16 | 1.51e-01 | 2.07e-01 | 6.13e-01 |
| GOBP NEGATIVE REGULATION OF TROPHOBLAST CELL MIGRATION | 5 | 4.22e-01 | 2.07e-01 | 8.30e-01 |
| GOBP POSITIVE REGULATION OF CELL CELL ADHESION MEDIATED BY INTEGRIN | 5 | 4.22e-01 | -2.07e-01 | 8.30e-01 |
| GOBP REGULATION OF ACROSOME REACTION | 7 | 3.43e-01 | 2.07e-01 | 7.89e-01 |
| GOCC PROTON TRANSPORTING TWO SECTOR ATPASE COMPLEX PROTON TRANSPORTING DOMAIN | 23 | 8.56e-02 | -2.07e-01 | 5.12e-01 |
| GOMF MYOSIN V BINDING | 13 | 1.96e-01 | 2.07e-01 | 6.68e-01 |
| GOCC MYOSIN COMPLEX | 40 | 2.35e-02 | -2.07e-01 | 3.32e-01 |
| GOBP GANGLIOSIDE BIOSYNTHETIC PROCESS VIA LACTOSYLCERAMIDE | 5 | 4.23e-01 | 2.07e-01 | 8.30e-01 |
| GOBP POSITIVE REGULATION OF ENDOCYTIC RECYCLING | 6 | 3.80e-01 | 2.07e-01 | 8.13e-01 |
| GOBP CELLULAR RESPONSE TO COCAINE | 7 | 3.44e-01 | 2.07e-01 | 7.89e-01 |
| GOMF DESUMOYLASE ACTIVITY | 7 | 3.44e-01 | 2.07e-01 | 7.89e-01 |
| GOBP POSITIVE REGULATION OF LONG TERM NEURONAL SYNAPTIC PLASTICITY | 8 | 3.12e-01 | 2.07e-01 | 7.65e-01 |
| GOBP RNA POLYMERASE I PREINITIATION COMPLEX ASSEMBLY | 9 | 2.84e-01 | -2.06e-01 | 7.44e-01 |
| GOBP MYOBLAST MIGRATION | 9 | 2.84e-01 | 2.06e-01 | 7.44e-01 |
| GOBP REGULATION OF CELL CYCLE CHECKPOINT | 44 | 1.80e-02 | 2.06e-01 | 2.91e-01 |
| GOMF METHYL CPG BINDING | 22 | 9.44e-02 | -2.06e-01 | 5.35e-01 |
| GOBP PIGMENT GRANULE ORGANIZATION | 36 | 3.25e-02 | 2.06e-01 | 3.77e-01 |
| GOBP PROTEIN C LINKED GLYCOSYLATION | 6 | 3.82e-01 | 2.06e-01 | 8.14e-01 |
| GOBP REGULATION OF GOLGI TO PLASMA MEMBRANE PROTEIN TRANSPORT | 8 | 3.13e-01 | 2.06e-01 | 7.66e-01 |
| GOBP DETERMINATION OF DORSAL VENTRAL ASYMMETRY | 9 | 2.85e-01 | -2.06e-01 | 7.45e-01 |
| GOBP RESPONSE TO GONADOTROPIN RELEASING HORMONE | 6 | 3.83e-01 | 2.06e-01 | 8.15e-01 |
| GOMF TRNA CYTIDINE 5 METHYLTRANSFERASE ACTIVITY | 5 | 4.26e-01 | 2.06e-01 | 8.33e-01 |
| GOBP NEGATIVE REGULATION OF TYPE I INTERFERON MEDIATED SIGNALING PATHWAY | 22 | 9.50e-02 | 2.06e-01 | 5.36e-01 |
| GOCC UNCONVENTIONAL MYOSIN COMPLEX | 8 | 3.14e-01 | -2.06e-01 | 7.66e-01 |
| GOBP EXTRACELLULAR MATRIX DISASSEMBLY | 45 | 1.71e-02 | -2.05e-01 | 2.85e-01 |
| GOCC NUCLEAR PORE CENTRAL TRANSPORT CHANNEL | 6 | 3.84e-01 | -2.05e-01 | 8.15e-01 |
| GOBP REGULATION OF RUFFLE ASSEMBLY | 28 | 6.02e-02 | -2.05e-01 | 4.55e-01 |
| GOBP FATTY ACID BETA OXIDATION USING ACYL COA OXIDASE | 12 | 2.19e-01 | 2.05e-01 | 6.93e-01 |
| GOCC NLRP3 INFLAMMASOME COMPLEX | 8 | 3.15e-01 | 2.05e-01 | 7.67e-01 |
| GOBP POSITIVE REGULATION OF RECEPTOR SIGNALING PATHWAY VIA STAT | 35 | 3.57e-02 | 2.05e-01 | 3.89e-01 |
| GOBP COMMISSURAL NEURON AXON GUIDANCE | 11 | 2.39e-01 | 2.05e-01 | 7.08e-01 |
| GOBP V D J RECOMBINATION | 18 | 1.32e-01 | 2.05e-01 | 5.97e-01 |
| GOBP RESPONSE TO OXYGEN RADICAL | 22 | 9.61e-02 | 2.05e-01 | 5.39e-01 |
| GOBP TOLERANCE INDUCTION | 27 | 6.53e-02 | 2.05e-01 | 4.67e-01 |
| GOBP PROTEOGLYCAN CATABOLIC PROCESS | 10 | 2.62e-01 | -2.05e-01 | 7.29e-01 |
| GOBP PEPTIDE ANTIGEN ASSEMBLY WITH MHC CLASS I PROTEIN COMPLEX | 6 | 3.85e-01 | 2.05e-01 | 8.15e-01 |
| GOBP EPITHELIAL CELL CELL ADHESION | 14 | 1.85e-01 | -2.05e-01 | 6.57e-01 |
| GOBP NEGATIVE REGULATION OF OLIGODENDROCYTE DIFFERENTIATION | 6 | 3.85e-01 | -2.05e-01 | 8.15e-01 |
| GOBP MAMMARY GLAND ALVEOLUS DEVELOPMENT | 15 | 1.70e-01 | 2.05e-01 | 6.36e-01 |
| GOBP ERYTHROCYTE MATURATION | 19 | 1.22e-01 | -2.05e-01 | 5.86e-01 |
| GOBP POSITIVE REGULATION OF CELL MATURATION | 6 | 3.85e-01 | 2.05e-01 | 8.15e-01 |
| GOBP CARDIAC RIGHT VENTRICLE MORPHOGENESIS | 12 | 2.20e-01 | -2.05e-01 | 6.94e-01 |
| GOBP INTRA GOLGI VESICLE MEDIATED TRANSPORT | 32 | 4.51e-02 | 2.05e-01 | 4.13e-01 |
| GOBP EXOCRINE SYSTEM DEVELOPMENT | 34 | 3.90e-02 | 2.05e-01 | 3.98e-01 |
| GOMF ADP RIBOSE DIPHOSPHATASE ACTIVITY | 6 | 3.85e-01 | -2.05e-01 | 8.15e-01 |
| GOBP NEURONAL STEM CELL POPULATION MAINTENANCE | 19 | 1.23e-01 | 2.05e-01 | 5.86e-01 |
| GOBP REGULATION OF NON MOTILE CILIUM ASSEMBLY | 9 | 2.88e-01 | 2.05e-01 | 7.47e-01 |
| GOBP ALCOHOL CATABOLIC PROCESS | 25 | 7.67e-02 | -2.05e-01 | 4.93e-01 |
| GOBP DEOXYRIBONUCLEOSIDE CATABOLIC PROCESS | 5 | 4.29e-01 | 2.04e-01 | 8.34e-01 |
| GOBP PEPTIDE MODIFICATION | 6 | 3.87e-01 | 2.04e-01 | 8.16e-01 |
| GOBP L ASPARTATE TRANSMEMBRANE TRANSPORT | 9 | 2.89e-01 | 2.04e-01 | 7.47e-01 |
| GOBP PERIPHERAL NERVOUS SYSTEM AXON ENSHEATHMENT | 23 | 9.06e-02 | -2.04e-01 | 5.27e-01 |
| GOMF PHOSPHATIDYLINOSITOL 4 PHOSPHATE BINDING | 27 | 6.68e-02 | 2.04e-01 | 4.71e-01 |
| GOBP AXONEMAL DYNEIN COMPLEX ASSEMBLY | 25 | 7.79e-02 | -2.04e-01 | 4.96e-01 |
| GOBP REGULATION OF CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY INVOLVED IN APOPTOTIC SIGNALING PATHWAY | 10 | 2.65e-01 | -2.04e-01 | 7.32e-01 |
| GOMF PROTEIN TYROSINE SERINE THREONINE PHOSPHATASE ACTIVITY | 21 | 1.06e-01 | -2.04e-01 | 5.59e-01 |
| GOBP RESPONSE TO LEAD ION | 19 | 1.25e-01 | 2.04e-01 | 5.88e-01 |
| GOBP REGULATION OF VIRAL PROCESS | 143 | 2.66e-05 | 2.03e-01 | 5.36e-03 |
| GOBP MONOACYLGLYCEROL METABOLIC PROCESS | 13 | 2.04e-01 | -2.03e-01 | 6.78e-01 |
| GOBP QUINOLINATE METABOLIC PROCESS | 5 | 4.31e-01 | 2.03e-01 | 8.35e-01 |
| GOBP PEPTIDYL SERINE DEPHOSPHORYLATION | 14 | 1.88e-01 | 2.03e-01 | 6.62e-01 |
| GOBP NEGATIVE REGULATION OF SYNAPSE ORGANIZATION | 5 | 4.31e-01 | 2.03e-01 | 8.35e-01 |
| GOBP REGULATION OF PROTEIN LOCALIZATION TO CELL SURFACE | 34 | 4.02e-02 | -2.03e-01 | 4.01e-01 |
| GOBP ADENINE TRANSPORT | 6 | 3.89e-01 | -2.03e-01 | 8.17e-01 |
| GOBP ALDEHYDE CATABOLIC PROCESS | 10 | 2.66e-01 | -2.03e-01 | 7.33e-01 |
| GOCC GLIAL CELL PROJECTION | 25 | 7.87e-02 | 2.03e-01 | 4.97e-01 |
| GOCC RNA POLYMERASE II CORE COMPLEX | 15 | 1.73e-01 | -2.03e-01 | 6.40e-01 |
| GOBP MEIOTIC SISTER CHROMATID COHESION | 12 | 2.23e-01 | 2.03e-01 | 6.97e-01 |
| GOBP ENUCLEATE ERYTHROCYTE DEVELOPMENT | 6 | 3.89e-01 | -2.03e-01 | 8.18e-01 |
| GOMF DISULFIDE OXIDOREDUCTASE ACTIVITY | 38 | 3.05e-02 | 2.03e-01 | 3.66e-01 |
| GOBP REGULATION OF SOMATIC STEM CELL POPULATION MAINTENANCE | 7 | 3.53e-01 | -2.03e-01 | 7.94e-01 |
| GOMF ADENYLATE CYCLASE BINDING | 9 | 2.92e-01 | 2.03e-01 | 7.49e-01 |
| GOMF UBIQUITIN LIKE MODIFIER ACTIVATING ENZYME ACTIVITY | 10 | 2.67e-01 | 2.03e-01 | 7.33e-01 |
| GOBP NEGATIVE REGULATION OF CELL SUBSTRATE JUNCTION ORGANIZATION | 14 | 1.89e-01 | -2.03e-01 | 6.62e-01 |
| GOBP NEGATIVE REGULATION OF NEUROINFLAMMATORY RESPONSE | 10 | 2.67e-01 | 2.03e-01 | 7.33e-01 |
| GOBP B CELL HOMEOSTASIS | 34 | 4.09e-02 | 2.03e-01 | 4.02e-01 |
| GOBP POSITIVE REGULATION OF PINOCYTOSIS | 7 | 3.53e-01 | 2.03e-01 | 7.95e-01 |
| GOBP NADH METABOLIC PROCESS | 30 | 5.49e-02 | -2.02e-01 | 4.38e-01 |
| GOBP NOTCH RECEPTOR PROCESSING | 8 | 3.21e-01 | 2.02e-01 | 7.73e-01 |
| GOBP NONRIBOSOMAL PEPTIDE BIOSYNTHETIC PROCESS | 14 | 1.90e-01 | 2.02e-01 | 6.62e-01 |
| GOBP POST CHAPERONIN TUBULIN FOLDING PATHWAY | 7 | 3.54e-01 | 2.02e-01 | 7.96e-01 |
| GOBP HYALURONAN CATABOLIC PROCESS | 14 | 1.91e-01 | -2.02e-01 | 6.63e-01 |
| GOMF POLY A BINDING | 20 | 1.18e-01 | 2.02e-01 | 5.78e-01 |
| GOCC CANONICAL INFLAMMASOME COMPLEX | 16 | 1.62e-01 | 2.02e-01 | 6.28e-01 |
| GOBP PROTEIN TRIMERIZATION | 13 | 2.08e-01 | 2.02e-01 | 6.82e-01 |
| GOBP PML BODY ORGANIZATION | 7 | 3.55e-01 | 2.02e-01 | 7.96e-01 |
| GOBP RESPONSE TO GRAM POSITIVE BACTERIUM | 5 | 4.35e-01 | 2.02e-01 | 8.37e-01 |
| GOBP REGULATION OF RELEASE OF CYTOCHROME C FROM MITOCHONDRIA | 42 | 2.38e-02 | -2.02e-01 | 3.35e-01 |
| GOMF UBIQUITIN LIKE PROTEIN PEPTIDASE ACTIVITY | 106 | 3.36e-04 | 2.02e-01 | 3.47e-02 |
| GOBP POSITIVE REGULATION OF AUTOPHAGOSOME ASSEMBLY | 19 | 1.28e-01 | 2.02e-01 | 5.93e-01 |
| GOMF THIOREDOXIN DISULFIDE REDUCTASE NADPH ACTIVITY | 6 | 3.93e-01 | 2.02e-01 | 8.20e-01 |
| GOMF TESTOSTERONE DEHYDROGENASE NADPLUS ACTIVITY | 6 | 3.93e-01 | -2.01e-01 | 8.20e-01 |
| GOBP NEGATIVE REGULATION OF MICROGLIAL CELL ACTIVATION | 6 | 3.93e-01 | -2.01e-01 | 8.20e-01 |
| GOMF UBIQUINONE BINDING | 6 | 3.93e-01 | 2.01e-01 | 8.20e-01 |
| GOBP POSITIVE REGULATION OF BMP SIGNALING PATHWAY | 20 | 1.19e-01 | -2.01e-01 | 5.82e-01 |
| GOCC SORTING ENDOSOME | 5 | 4.36e-01 | 2.01e-01 | 8.37e-01 |
| GOMF CYCLIC NUCLEOTIDE BINDING | 26 | 7.60e-02 | -2.01e-01 | 4.93e-01 |
| GOBP POSITIVE REGULATION OF NK T CELL ACTIVATION | 7 | 3.57e-01 | -2.01e-01 | 7.98e-01 |
| GOBP NEGATIVE REGULATION OF VIRAL PROCESS | 77 | 2.29e-03 | 2.01e-01 | 1.17e-01 |
| GOBP MYELOID DENDRITIC CELL DIFFERENTIATION | 16 | 1.64e-01 | 2.01e-01 | 6.30e-01 |
| GOBP AMYLOID BETA CLEARANCE | 31 | 5.27e-02 | 2.01e-01 | 4.33e-01 |
| GOBP NEUROMUSCULAR PROCESS CONTROLLING POSTURE | 12 | 2.28e-01 | -2.01e-01 | 7.01e-01 |
| GOBP RIBOSOMAL SMALL SUBUNIT ASSEMBLY | 18 | 1.40e-01 | -2.01e-01 | 6.07e-01 |
| GOBP CELLULAR RESPONSE TO GONADOTROPIN STIMULUS | 12 | 2.28e-01 | -2.01e-01 | 7.01e-01 |
| GOMF MDM2 MDM4 FAMILY PROTEIN BINDING | 10 | 2.71e-01 | -2.01e-01 | 7.36e-01 |
| GOBP DICHOTOMOUS SUBDIVISION OF AN EPITHELIAL TERMINAL UNIT | 7 | 3.58e-01 | -2.01e-01 | 7.98e-01 |
| GOMF CORECEPTOR ACTIVITY | 47 | 1.72e-02 | 2.01e-01 | 2.86e-01 |
| GOBP CELLULAR RESPONSE TO GROWTH HORMONE STIMULUS | 21 | 1.11e-01 | 2.01e-01 | 5.65e-01 |
| GOBP PROTEIN LOCALIZATION TO PHAGOPHORE ASSEMBLY SITE | 16 | 1.65e-01 | -2.01e-01 | 6.30e-01 |
| GOBP RENAL VESICLE FORMATION | 6 | 3.95e-01 | -2.01e-01 | 8.20e-01 |
| GOMF GLYCERALDEHYDE 3 PHOSPHATE DEHYDROGENASE NADPLUS NON PHOSPHORYLATING ACTIVITY | 6 | 3.95e-01 | -2.01e-01 | 8.20e-01 |
| GOBP SKELETAL MUSCLE TISSUE GROWTH | 6 | 3.95e-01 | 2.01e-01 | 8.20e-01 |
| GOBP RESPONSE TO GLYCOPROTEIN | 9 | 2.98e-01 | 2.00e-01 | 7.53e-01 |
| GOBP POSITIVE REGULATION OF ATP DEPENDENT ACTIVITY | 36 | 3.74e-02 | 2.00e-01 | 3.93e-01 |
| GOBP RIBOSOMAL SUBUNIT EXPORT FROM NUCLEUS | 15 | 1.79e-01 | 2.00e-01 | 6.51e-01 |
| GOBP DEFENSE RESPONSE TO TUMOR CELL | 12 | 2.30e-01 | -2.00e-01 | 7.02e-01 |
| GOBP REGULATION OF IRON ION TRANSPORT | 7 | 3.59e-01 | 2.00e-01 | 7.99e-01 |
| GOBP NEGATIVE REGULATION OF CAMP MEDIATED SIGNALING | 7 | 3.59e-01 | -2.00e-01 | 7.99e-01 |
| GOMF C2H2 ZINC FINGER DOMAIN BINDING | 12 | 2.30e-01 | -2.00e-01 | 7.03e-01 |
| GOBP MODULATION OF INHIBITORY POSTSYNAPTIC POTENTIAL | 5 | 4.39e-01 | -2.00e-01 | 8.39e-01 |
| GOBP POSITIVE REGULATION OF NATURAL KILLER CELL MEDIATED IMMUNITY | 30 | 5.80e-02 | 2.00e-01 | 4.49e-01 |
| GOCC DENDRITIC SHAFT | 32 | 5.03e-02 | -2.00e-01 | 4.28e-01 |
| GOBP ACTIVATION OF CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY INVOLVED IN APOPTOTIC PROCESS BY CYTOCHROME C | 5 | 4.39e-01 | -2.00e-01 | 8.39e-01 |
| GOMF THREONINE TYPE PEPTIDASE ACTIVITY | 13 | 2.12e-01 | -2.00e-01 | 6.86e-01 |
| GOBP ESTABLISHMENT OF PROTEIN LOCALIZATION TO VACUOLE | 58 | 8.51e-03 | 2.00e-01 | 2.13e-01 |
| GOBP REGULATION OF PIGMENTATION | 12 | 2.31e-01 | 2.00e-01 | 7.04e-01 |
| GOCC B CELL RECEPTOR COMPLEX | 5 | 4.39e-01 | -2.00e-01 | 8.39e-01 |
| GOBP REGULATION OF PEPTIDYL LYSINE ACETYLATION | 9 | 3.00e-01 | 1.99e-01 | 7.56e-01 |
| GOCC EXTRINSIC COMPONENT OF ORGANELLE MEMBRANE | 24 | 9.07e-02 | 1.99e-01 | 5.27e-01 |
| GOBP GLYCOSAMINOGLYCAN CATABOLIC PROCESS | 25 | 8.43e-02 | -1.99e-01 | 5.09e-01 |
| GOMF HISTONE H2A DEUBIQUITINASE ACTIVITY | 6 | 3.98e-01 | 1.99e-01 | 8.22e-01 |
| GOBP POSITIVE REGULATION OF IRE1 MEDIATED UNFOLDED PROTEIN RESPONSE | 6 | 3.98e-01 | 1.99e-01 | 8.22e-01 |
| GOMF CYCLIC NUCLEOTIDE DEPENDENT PROTEIN KINASE ACTIVITY | 7 | 3.62e-01 | 1.99e-01 | 8.01e-01 |
| GOBP OXALATE TRANSPORT | 5 | 4.41e-01 | -1.99e-01 | 8.40e-01 |
| GOBP TRANSCRIPTION INITIATION AT RNA POLYMERASE I PROMOTER | 14 | 1.97e-01 | -1.99e-01 | 6.70e-01 |
| GOBP THYROID GLAND DEVELOPMENT | 18 | 1.44e-01 | -1.99e-01 | 6.12e-01 |
| GOMF L SERINE TRANSMEMBRANE TRANSPORTER ACTIVITY | 8 | 3.30e-01 | 1.99e-01 | 7.81e-01 |
| GOBP RETINAL CONE CELL DEVELOPMENT | 6 | 3.99e-01 | -1.99e-01 | 8.22e-01 |
| GOMF SINGLE STRANDED DNA ENDODEOXYRIBONUCLEASE ACTIVITY | 11 | 2.54e-01 | 1.99e-01 | 7.22e-01 |
| GOBP REGULATION OF NUCLEOTIDE BINDING DOMAIN LEUCINE RICH REPEAT CONTAINING RECEPTOR SIGNALING PATHWAY | 14 | 1.98e-01 | 1.99e-01 | 6.70e-01 |
| GOBP TRANSLESION SYNTHESIS | 26 | 7.94e-02 | 1.99e-01 | 4.98e-01 |
| GOMF UBIQUITIN LIKE PROTEIN CONJUGATING ENZYME ACTIVITY | 37 | 3.65e-02 | 1.99e-01 | 3.90e-01 |
| GOBP REGULATION OF MITOCHONDRIAL TRANSCRIPTION | 8 | 3.30e-01 | -1.99e-01 | 7.82e-01 |
| GOBP REGULATION OF NATURAL KILLER CELL CHEMOTAXIS | 6 | 4.00e-01 | 1.99e-01 | 8.22e-01 |
| GOBP DISRUPTION OF ANATOMICAL STRUCTURE IN ANOTHER ORGANISM | 54 | 1.16e-02 | -1.99e-01 | 2.43e-01 |
| GOBP REGULATION OF PHOSPHATASE ACTIVITY | 47 | 1.86e-02 | 1.98e-01 | 2.97e-01 |
| GOBP REGULATION OF SYNAPTIC VESICLE EXOCYTOSIS | 35 | 4.22e-02 | 1.98e-01 | 4.05e-01 |
| GOBP NEUTROPHIL MEDIATED IMMUNITY | 32 | 5.21e-02 | -1.98e-01 | 4.33e-01 |
| GOBP POSITIVE REGULATION OF SYNAPSE MATURATION | 5 | 4.43e-01 | 1.98e-01 | 8.41e-01 |
| GOMF HEXOSE TRANSMEMBRANE TRANSPORTER ACTIVITY | 18 | 1.45e-01 | -1.98e-01 | 6.13e-01 |
| GOMF COMPLEMENT COMPONENT C3B BINDING | 5 | 4.43e-01 | -1.98e-01 | 8.41e-01 |
| GOBP REGULATION OF AUTOPHAGY OF MITOCHONDRION | 42 | 2.62e-02 | -1.98e-01 | 3.50e-01 |
| GOBP POSITIVE REGULATION OF CARDIOCYTE DIFFERENTIATION | 7 | 3.64e-01 | -1.98e-01 | 8.02e-01 |
| GOBP NEGATIVE REGULATION OF REGULATORY T CELL DIFFERENTIATION | 5 | 4.43e-01 | -1.98e-01 | 8.41e-01 |
| GOBP REGULATION OF REACTIVE OXYGEN SPECIES BIOSYNTHETIC PROCESS | 33 | 4.91e-02 | 1.98e-01 | 4.25e-01 |
| GOCC MEDIATOR COMPLEX | 37 | 3.77e-02 | 1.97e-01 | 3.94e-01 |
| GOBP CONNECTIVE TISSUE REPLACEMENT | 10 | 2.80e-01 | 1.97e-01 | 7.41e-01 |
| GOBP MEMBRANE FISSION | 42 | 2.69e-02 | 1.97e-01 | 3.53e-01 |
| GOBP HYPOTHALAMUS CELL DIFFERENTIATION | 5 | 4.45e-01 | -1.97e-01 | 8.41e-01 |
| GOBP HYPOTHALAMUS GONADOTROPHIN RELEASING HORMONE NEURON DIFFERENTIATION | 5 | 4.45e-01 | -1.97e-01 | 8.41e-01 |
| GOMF ATP DEPENDENT PEPTIDASE ACTIVITY | 7 | 3.66e-01 | -1.97e-01 | 8.04e-01 |
| GOMF MOLECULAR TAG ACTIVITY | 13 | 2.18e-01 | 1.97e-01 | 6.93e-01 |
| GOBP ENTERIC NERVOUS SYSTEM DEVELOPMENT | 7 | 3.66e-01 | -1.97e-01 | 8.04e-01 |
| GOBP MODULATION BY HOST OF VIRAL GENOME REPLICATION | 23 | 1.02e-01 | 1.97e-01 | 5.51e-01 |
| GOBP GLUTAMINE TRANSPORT | 8 | 3.35e-01 | 1.97e-01 | 7.84e-01 |
| GOMF L GLUTAMINE TRANSMEMBRANE TRANSPORTER ACTIVITY | 8 | 3.35e-01 | 1.97e-01 | 7.84e-01 |
| GOBP HEPATOCYTE DIFFERENTIATION | 7 | 3.67e-01 | -1.97e-01 | 8.04e-01 |
| GOBP REGULATION OF T CELL COSTIMULATION | 5 | 4.46e-01 | 1.97e-01 | 8.41e-01 |
| GOBP DOPAMINERGIC NEURON DIFFERENTIATION | 17 | 1.60e-01 | 1.97e-01 | 6.27e-01 |
| GOBP REGULATION OF POTASSIUM ION TRANSMEMBRANE TRANSPORTER ACTIVITY | 35 | 4.39e-02 | 1.97e-01 | 4.11e-01 |
| GOMF VOLTAGE GATED SODIUM CHANNEL ACTIVITY INVOLVED IN CARDIAC MUSCLE CELL ACTION POTENTIAL | 5 | 4.47e-01 | 1.97e-01 | 8.42e-01 |
| GOMF ARACHIDONATE COA LIGASE ACTIVITY | 9 | 3.07e-01 | 1.96e-01 | 7.62e-01 |
| GOBP RESPONSE TO DSRNA | 36 | 4.14e-02 | 1.96e-01 | 4.04e-01 |
| GOCC COPI VESICLE COAT | 13 | 2.20e-01 | 1.96e-01 | 6.94e-01 |
| GOBP REGULATION OF HETEROCHROMATIN FORMATION | 22 | 1.11e-01 | 1.96e-01 | 5.65e-01 |
| GOMF PROTEASOME ACTIVATING ACTIVITY | 6 | 4.06e-01 | 1.96e-01 | 8.26e-01 |
| GOBP REGULATION OF NUCLEAR CELL CYCLE DNA REPLICATION | 14 | 2.04e-01 | 1.96e-01 | 6.79e-01 |
| GOBP LATERAL MESODERM DEVELOPMENT | 12 | 2.40e-01 | -1.96e-01 | 7.10e-01 |
| GOBP 7 METHYLGUANOSINE CAP HYPERMETHYLATION | 8 | 3.37e-01 | 1.96e-01 | 7.86e-01 |
| GOMF PHOSPHATIDYLINOSITOL KINASE ACTIVITY | 26 | 8.39e-02 | 1.96e-01 | 5.07e-01 |
| GOBP IRON IMPORT INTO CELL | 8 | 3.38e-01 | 1.96e-01 | 7.86e-01 |
| GOBP REGULATION OF RESPONSE TO FOOD | 10 | 2.84e-01 | -1.96e-01 | 7.44e-01 |
| GOBP POSITIVE REGULATION OF SYNAPTIC TRANSMISSION GABAERGIC | 9 | 3.09e-01 | 1.96e-01 | 7.64e-01 |
| GOBP ETHANOLAMINE CONTAINING COMPOUND METABOLIC PROCESS | 7 | 3.70e-01 | 1.96e-01 | 8.07e-01 |
| GOCC PHOTORECEPTOR RIBBON SYNAPSE | 7 | 3.70e-01 | 1.96e-01 | 8.07e-01 |
| GOBP ISOPRENOID BIOSYNTHETIC PROCESS | 22 | 1.13e-01 | 1.95e-01 | 5.69e-01 |
| GOBP NEGATIVE REGULATION OF AUTOPHAGOSOME ASSEMBLY | 13 | 2.23e-01 | 1.95e-01 | 6.97e-01 |
| GOBP POSITIVE REGULATION OF ODONTOGENESIS | 6 | 4.08e-01 | -1.95e-01 | 8.26e-01 |
| GOBP L KYNURENINE METABOLIC PROCESS | 6 | 4.08e-01 | 1.95e-01 | 8.26e-01 |
| GOBP PROTEIN REPAIR | 7 | 3.72e-01 | -1.95e-01 | 8.08e-01 |
| GOCC SITE OF DNA DAMAGE | 125 | 1.68e-04 | 1.95e-01 | 2.18e-02 |
| GOBP SPHINGOSINE 1 PHOSPHATE RECEPTOR SIGNALING PATHWAY | 14 | 2.07e-01 | -1.95e-01 | 6.81e-01 |
| GOBP OLIGOSACCHARIDE LIPID INTERMEDIATE BIOSYNTHETIC PROCESS | 22 | 1.14e-01 | 1.95e-01 | 5.70e-01 |
| GOBP 4 HYDROXYPROLINE METABOLIC PROCESS | 10 | 2.86e-01 | -1.95e-01 | 7.46e-01 |
| GOBP MICROTUBULE ORGANIZING CENTER LOCALIZATION | 30 | 6.49e-02 | 1.95e-01 | 4.66e-01 |
| GOBP TRNA TRANSPORT | 5 | 4.51e-01 | 1.95e-01 | 8.43e-01 |
| GOCC EXTRINSIC COMPONENT OF POSTSYNAPTIC SPECIALIZATION MEMBRANE | 5 | 4.51e-01 | 1.95e-01 | 8.43e-01 |
| GOBP IRIS MORPHOGENESIS | 6 | 4.09e-01 | 1.95e-01 | 8.26e-01 |
| GOBP PHARYNGEAL ARCH ARTERY MORPHOGENESIS | 6 | 4.09e-01 | 1.95e-01 | 8.26e-01 |
| GOBP NEGATIVE REGULATION OF MEMBRANE PERMEABILITY | 18 | 1.53e-01 | -1.95e-01 | 6.16e-01 |
| GOBP PEPTIDYL GLUTAMIC ACID MODIFICATION | 19 | 1.42e-01 | -1.94e-01 | 6.09e-01 |
| GOBP POSITIVE REGULATION OF DOUBLE STRAND BREAK REPAIR VIA NONHOMOLOGOUS END JOINING | 14 | 2.08e-01 | 1.94e-01 | 6.82e-01 |
| GOMF MUTLALPHA COMPLEX BINDING | 7 | 3.73e-01 | 1.94e-01 | 8.09e-01 |
| GOMF PHOSPHATIDYLINOSITOL 3 5 BISPHOSPHATE 5 PHOSPHATASE ACTIVITY | 6 | 4.10e-01 | 1.94e-01 | 8.26e-01 |
| GOBP ANTIMICROBIAL HUMORAL RESPONSE | 81 | 2.49e-03 | -1.94e-01 | 1.20e-01 |
| GOBP REGULATION OF MAMMARY GLAND EPITHELIAL CELL PROLIFERATION | 14 | 2.08e-01 | -1.94e-01 | 6.82e-01 |
| GOBP NEGATIVE REGULATION OF DNA REPLICATION | 21 | 1.23e-01 | 1.94e-01 | 5.86e-01 |
| GOBP CHROMOSOME LOCALIZATION | 112 | 3.87e-04 | 1.94e-01 | 3.86e-02 |
| GOBP REGULATION OF AMPA RECEPTOR ACTIVITY | 12 | 2.44e-01 | -1.94e-01 | 7.14e-01 |
| GOMF BILE ACID TRANSMEMBRANE TRANSPORTER ACTIVITY | 8 | 3.42e-01 | -1.94e-01 | 7.89e-01 |
| GOBP RESPONSE TO YEAST | 7 | 3.74e-01 | -1.94e-01 | 8.09e-01 |
| GOBP VENTRICULAR CARDIAC MUSCLE CELL DEVELOPMENT | 5 | 4.53e-01 | 1.94e-01 | 8.43e-01 |
| GOBP KINETOCHORE ORGANIZATION | 20 | 1.33e-01 | 1.94e-01 | 5.98e-01 |
| GOCC PROTEASOME COMPLEX | 60 | 9.42e-03 | 1.94e-01 | 2.22e-01 |
| GOBP EMBRYONIC DIGESTIVE TRACT MORPHOGENESIS | 6 | 4.11e-01 | 1.94e-01 | 8.27e-01 |
| GOCC CHAPERONIN CONTAINING T COMPLEX | 9 | 3.14e-01 | 1.94e-01 | 7.66e-01 |
| GOBP MITOCHONDRIAL PROTEIN CATABOLIC PROCESS | 9 | 3.14e-01 | -1.94e-01 | 7.66e-01 |
| GOBP PROTEIN REFOLDING | 23 | 1.08e-01 | 1.94e-01 | 5.61e-01 |
| GOBP EATING BEHAVIOR | 20 | 1.34e-01 | 1.94e-01 | 5.99e-01 |
| GOBP GLYCOSYLCERAMIDE BIOSYNTHETIC PROCESS | 7 | 3.75e-01 | 1.94e-01 | 8.09e-01 |
| GOBP ENDONUCLEOLYTIC CLEAVAGE IN 5 ETS OF TRICISTRONIC RRNA TRANSCRIPT SSU RRNA 5 8S RRNA LSU RRNA | 7 | 3.75e-01 | -1.93e-01 | 8.09e-01 |
| GOBP POSITIVE REGULATION OF G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY | 19 | 1.44e-01 | 1.93e-01 | 6.12e-01 |
| GOBP ENAMEL MINERALIZATION | 12 | 2.46e-01 | -1.93e-01 | 7.16e-01 |
| GOMF MAP KINASE KINASE KINASE KINASE ACTIVITY | 6 | 4.12e-01 | 1.93e-01 | 8.28e-01 |
| GOBP ENDOCARDIAL CUSHION FORMATION | 15 | 1.95e-01 | 1.93e-01 | 6.68e-01 |
| GOBP FEMALE GENITALIA DEVELOPMENT | 11 | 2.67e-01 | 1.93e-01 | 7.33e-01 |
| GOBP NEURAL PLATE DEVELOPMENT | 7 | 3.76e-01 | -1.93e-01 | 8.10e-01 |
| GOBP POSITIVE REGULATION OF FATTY ACID TRANSPORT | 16 | 1.81e-01 | 1.93e-01 | 6.54e-01 |
| GOBP GLYCOSIDE METABOLIC PROCESS | 15 | 1.95e-01 | -1.93e-01 | 6.68e-01 |
| GOBP LONG TERM SYNAPTIC DEPRESSION | 24 | 1.02e-01 | -1.93e-01 | 5.51e-01 |
| GOBP NOREPINEPHRINE SECRETION | 10 | 2.91e-01 | -1.93e-01 | 7.48e-01 |
| GOBP POSITIVE REGULATION OF CALCIUM ION DEPENDENT EXOCYTOSIS | 9 | 3.16e-01 | -1.93e-01 | 7.67e-01 |
| GOBP ANTIGEN PROCESSING AND PRESENTATION VIA MHC CLASS IB | 19 | 1.45e-01 | -1.93e-01 | 6.13e-01 |
| GOMF MONOATOMIC CATION BICARBONATE SYMPORTER ACTIVITY | 11 | 2.68e-01 | 1.93e-01 | 7.33e-01 |
| GOBP RESPONSE TO FLUID SHEAR STRESS | 28 | 7.73e-02 | -1.93e-01 | 4.95e-01 |
| GOBP NEGATIVE REGULATION OF EPIDERMAL GROWTH FACTOR RECEPTOR SIGNALING PATHWAY | 24 | 1.02e-01 | 1.93e-01 | 5.51e-01 |
| GOBP REGULATION OF THE FORCE OF HEART CONTRACTION | 16 | 1.82e-01 | 1.93e-01 | 6.54e-01 |
| GOMF MICROFIBRIL BINDING | 5 | 4.55e-01 | -1.93e-01 | 8.44e-01 |
| GOBP NEGATIVE REGULATION OF TRIGLYCERIDE METABOLIC PROCESS | 11 | 2.68e-01 | 1.93e-01 | 7.33e-01 |
| GOMF AXON GUIDANCE RECEPTOR ACTIVITY | 7 | 3.77e-01 | 1.93e-01 | 8.10e-01 |
| GOMF CHEMOREPELLENT ACTIVITY | 20 | 1.36e-01 | -1.93e-01 | 6.02e-01 |
| GOCC JUNCTIONAL SARCOPLASMIC RETICULUM MEMBRANE | 6 | 4.14e-01 | 1.93e-01 | 8.29e-01 |
| GOBP REGULATION OF CYTOPLASMIC TRANSLATION | 32 | 5.94e-02 | 1.93e-01 | 4.53e-01 |
| GOBP REGULATORY NCRNA MEDIATED GENE SILENCING | 135 | 1.12e-04 | 1.93e-01 | 1.65e-02 |
| GOCC ENDOPLASMIC RETICULUM TUBULAR NETWORK | 27 | 8.33e-02 | 1.93e-01 | 5.05e-01 |
| GOCC SPINDLE MICROTUBULE | 77 | 3.49e-03 | 1.93e-01 | 1.41e-01 |
| GOMF PROTEIN SERINE THREONINE KINASE ACTIVATOR ACTIVITY | 65 | 7.27e-03 | 1.93e-01 | 1.95e-01 |
| GOBP REGULATION OF EARLY ENDOSOME TO LATE ENDOSOME TRANSPORT | 19 | 1.47e-01 | 1.92e-01 | 6.13e-01 |
| GOCC GABA ERGIC SYNAPSE | 37 | 4.30e-02 | -1.92e-01 | 4.07e-01 |
| GOBP NEGATIVE REGULATION OF PROTEIN LOCALIZATION TO CELL PERIPHERY | 24 | 1.03e-01 | 1.92e-01 | 5.55e-01 |
| GOBP SERINE TRANSPORT | 9 | 3.19e-01 | 1.92e-01 | 7.70e-01 |
| GOBP HISTIDINE METABOLIC PROCESS | 8 | 3.47e-01 | 1.92e-01 | 7.91e-01 |
| GOBP GERM CELL PROLIFERATION | 8 | 3.47e-01 | 1.92e-01 | 7.91e-01 |
| GOCC ATG1 ULK1 KINASE COMPLEX | 9 | 3.19e-01 | 1.92e-01 | 7.70e-01 |
| GOMF IMMUNOGLOBULIN BINDING | 19 | 1.48e-01 | 1.92e-01 | 6.13e-01 |
| GOBP NEGATIVE REGULATION OF ORGANELLE ASSEMBLY | 45 | 2.61e-02 | 1.92e-01 | 3.49e-01 |
| GOBP NEGATIVE REGULATION OF B CELL ACTIVATION | 29 | 7.40e-02 | 1.92e-01 | 4.89e-01 |
| GOCC TRANSLATION PREINITIATION COMPLEX | 19 | 1.48e-01 | 1.92e-01 | 6.13e-01 |
| GOBP RESPONSE TO PEPTIDE | 19 | 1.48e-01 | -1.92e-01 | 6.13e-01 |
| GOCC LSM1 7 PAT1 COMPLEX | 5 | 4.58e-01 | 1.92e-01 | 8.46e-01 |
| GOBP REGULATION OF RETROGRADE PROTEIN TRANSPORT ER TO CYTOSOL | 13 | 2.32e-01 | 1.92e-01 | 7.04e-01 |
| GOBP REGULATION OF PROTEIN EXPORT FROM NUCLEUS | 34 | 5.32e-02 | 1.92e-01 | 4.36e-01 |
| GOBP SA NODE CELL TO ATRIAL CARDIAC MUSCLE CELL SIGNALING | 5 | 4.58e-01 | 1.92e-01 | 8.46e-01 |
| GOCC STEREOCILIUM BASE | 6 | 4.17e-01 | -1.91e-01 | 8.30e-01 |
| GOBP TRANS SYNAPTIC SIGNALING MODULATING SYNAPTIC TRANSMISSION | 7 | 3.80e-01 | -1.91e-01 | 8.13e-01 |
| GOBP GROWTH HORMONE RECEPTOR SIGNALING PATHWAY VIA JAK STAT | 10 | 2.95e-01 | 1.91e-01 | 7.51e-01 |
| GOBP REGULATION OF MYOSIN LIGHT CHAIN PHOSPHATASE ACTIVITY | 7 | 3.80e-01 | 1.91e-01 | 8.13e-01 |
| GOBP PROTEIN TO MEMBRANE DOCKING | 5 | 4.59e-01 | 1.91e-01 | 8.47e-01 |
| GOBP PLASMA MEMBRANE RAFT ASSEMBLY | 5 | 4.59e-01 | 1.91e-01 | 8.47e-01 |
| GOMF CELL MATRIX ADHESION MEDIATOR ACTIVITY | 8 | 3.49e-01 | 1.91e-01 | 7.92e-01 |
| GOBP RESPONSE TO VITAMIN A | 7 | 3.81e-01 | 1.91e-01 | 8.14e-01 |
| GOBP REGULATION OF LYMPHOCYTE CHEMOTAXIS | 19 | 1.49e-01 | 1.91e-01 | 6.13e-01 |
| GOBP SPLICEOSOMAL CONFORMATIONAL CHANGES TO GENERATE CATALYTIC CONFORMATION | 5 | 4.59e-01 | -1.91e-01 | 8.47e-01 |
| GOBP REGULATION OF FEVER GENERATION | 8 | 3.49e-01 | 1.91e-01 | 7.92e-01 |
| GOBP TYROSINE PHOSPHORYLATION OF STAT PROTEIN | 48 | 2.20e-02 | 1.91e-01 | 3.23e-01 |
| GOBP DERMATAN SULFATE PROTEOGLYCAN METABOLIC PROCESS | 12 | 2.52e-01 | -1.91e-01 | 7.20e-01 |
| GOBP POSITIVE REGULATION OF FIBROBLAST GROWTH FACTOR RECEPTOR SIGNALING PATHWAY | 6 | 4.18e-01 | -1.91e-01 | 8.30e-01 |
| GOBP EPITHELIAL STRUCTURE MAINTENANCE | 21 | 1.30e-01 | -1.91e-01 | 5.94e-01 |
| GOBP REGULATION OF ENDOPLASMIC RETICULUM STRESS INDUCED INTRINSIC APOPTOTIC SIGNALING PATHWAY | 28 | 8.03e-02 | 1.91e-01 | 4.99e-01 |
| GOBP BONE MINERALIZATION INVOLVED IN BONE MATURATION | 8 | 3.50e-01 | -1.91e-01 | 7.93e-01 |
| GOMF FLIPPASE ACTIVITY | 14 | 2.16e-01 | 1.91e-01 | 6.92e-01 |
| GOMF RNA POLYMERASE II INTRONIC TRANSCRIPTION REGULATORY REGION SEQUENCE SPECIFIC DNA BINDING | 6 | 4.18e-01 | 1.91e-01 | 8.30e-01 |
| GOBP NEGATIVE REGULATION OF MUSCLE ORGAN DEVELOPMENT | 5 | 4.60e-01 | -1.91e-01 | 8.47e-01 |
| GOCC A BAND | 29 | 7.55e-02 | 1.91e-01 | 4.93e-01 |
| GOMF ADENYLATE CYCLASE ACTIVITY | 11 | 2.74e-01 | -1.91e-01 | 7.36e-01 |
| GOMF 5 3 EXONUCLEASE ACTIVITY | 18 | 1.62e-01 | 1.91e-01 | 6.28e-01 |
| GOBP DITERPENOID BIOSYNTHETIC PROCESS | 6 | 4.19e-01 | 1.91e-01 | 8.30e-01 |
| GOBP POSITIVE REGULATION OF NON MOTILE CILIUM ASSEMBLY | 6 | 4.19e-01 | 1.91e-01 | 8.30e-01 |
| GOBP RESPONSE TO BACTERIAL LIPOPROTEIN | 8 | 3.51e-01 | 1.90e-01 | 7.93e-01 |
| GOBP EXCRETION | 14 | 2.17e-01 | -1.90e-01 | 6.92e-01 |
| GOBP SKELETAL MUSCLE CELL DIFFERENTIATION | 51 | 1.87e-02 | -1.90e-01 | 2.97e-01 |
| GOBP POSITIVE REGULATION OF FIBROBLAST PROLIFERATION | 44 | 2.89e-02 | -1.90e-01 | 3.59e-01 |
| GOBP METANEPHRIC EPITHELIUM DEVELOPMENT | 14 | 2.18e-01 | -1.90e-01 | 6.93e-01 |
| GOBP MULTIVESICULAR BODY ORGANIZATION | 30 | 7.13e-02 | 1.90e-01 | 4.84e-01 |
| GOMF CALCIUM CHANNEL REGULATOR ACTIVITY | 34 | 5.49e-02 | 1.90e-01 | 4.38e-01 |
| GOBP ESTROGEN BIOSYNTHETIC PROCESS | 9 | 3.24e-01 | 1.90e-01 | 7.75e-01 |
| GOBP ORGANIC HYDROXY COMPOUND CATABOLIC PROCESS | 39 | 4.00e-02 | -1.90e-01 | 3.99e-01 |
| GOMF U2 SNRNA BINDING | 6 | 4.20e-01 | 1.90e-01 | 8.30e-01 |
| GOMF PRE MRNA INTRONIC BINDING | 11 | 2.75e-01 | 1.90e-01 | 7.38e-01 |
| GOBP POSITIVE REGULATION OF TYPE I INTERFERON MEDIATED SIGNALING PATHWAY | 17 | 1.75e-01 | -1.90e-01 | 6.43e-01 |
| GOBP BUNDLE OF HIS CELL TO PURKINJE MYOCYTE COMMUNICATION | 8 | 3.52e-01 | -1.90e-01 | 7.94e-01 |
| GOBP CELLULAR RESPONSE TO UV A | 5 | 4.62e-01 | 1.90e-01 | 8.48e-01 |
| GOBP REGULATION OF LAMELLIPODIUM MORPHOGENESIS | 10 | 2.98e-01 | -1.90e-01 | 7.55e-01 |
| GOBP REGULATION OF MYELOID CELL APOPTOTIC PROCESS | 26 | 9.39e-02 | 1.90e-01 | 5.34e-01 |
| GOBP POSITIVE REGULATION OF KIDNEY DEVELOPMENT | 6 | 4.21e-01 | 1.90e-01 | 8.30e-01 |
| GOBP REGULATION OF MACROPHAGE PROLIFERATION | 5 | 4.63e-01 | 1.90e-01 | 8.48e-01 |
| GOCC BRAHMA COMPLEX | 13 | 2.36e-01 | -1.90e-01 | 7.07e-01 |
| GOBP REGULATION OF MITOCHONDRIAL MEMBRANE PERMEABILITY INVOLVED IN APOPTOTIC PROCESS | 37 | 4.59e-02 | -1.90e-01 | 4.17e-01 |
| GOBP NEGATIVE REGULATION OF T HELPER CELL DIFFERENTIATION | 16 | 1.89e-01 | -1.90e-01 | 6.62e-01 |
| GOBP REGULATION OF T HELPER 17 TYPE IMMUNE RESPONSE | 30 | 7.24e-02 | -1.90e-01 | 4.86e-01 |
| GOBP FATTY ACID TRANSMEMBRANE TRANSPORT | 18 | 1.64e-01 | -1.89e-01 | 6.30e-01 |
| GOMF MUTSALPHA COMPLEX BINDING | 7 | 3.85e-01 | 1.89e-01 | 8.15e-01 |
| GOBP RESPONSE TO INTERFERON BETA | 30 | 7.26e-02 | 1.89e-01 | 4.86e-01 |
| GOBP POSITIVE REGULATION OF CHONDROCYTE DIFFERENTIATION | 12 | 2.56e-01 | -1.89e-01 | 7.25e-01 |
| GOBP CELLULAR RESPONSE TO INTERFERON BETA | 23 | 1.16e-01 | 1.89e-01 | 5.74e-01 |
| GOBP POSITIVE REGULATION OF NATURAL KILLER CELL MEDIATED CYTOTOXICITY | 26 | 9.48e-02 | 1.89e-01 | 5.36e-01 |
| GOBP REGULATION OF MITOCHONDRIAL MEMBRANE PERMEABILITY | 49 | 2.19e-02 | -1.89e-01 | 3.22e-01 |
| GOBP COPI COATED VESICLE BUDDING | 6 | 4.22e-01 | 1.89e-01 | 8.30e-01 |
| GOBP HEME A METABOLIC PROCESS | 10 | 3.00e-01 | -1.89e-01 | 7.56e-01 |
| GOBP AMINO ACID IMPORT ACROSS PLASMA MEMBRANE | 32 | 6.42e-02 | 1.89e-01 | 4.66e-01 |
| GOBP RESPONSE TO COBALT ION | 10 | 3.01e-01 | 1.89e-01 | 7.57e-01 |
| GOBP REGULATION OF ICOSANOID SECRETION | 13 | 2.38e-01 | 1.89e-01 | 7.08e-01 |
| GOBP DNA LIGATION | 16 | 1.91e-01 | 1.89e-01 | 6.63e-01 |
| GOBP MULTINUCLEAR OSTEOCLAST DIFFERENTIATION | 6 | 4.24e-01 | -1.89e-01 | 8.31e-01 |
| GOBP CELLULAR RESPONSE TO VIRUS | 53 | 1.75e-02 | 1.89e-01 | 2.87e-01 |
| GOBP POSITIVE REGULATION BY SYMBIONT OF ENTRY INTO HOST | 13 | 2.39e-01 | -1.89e-01 | 7.08e-01 |
| GOBP POSITIVE REGULATION OF VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR SIGNALING PATHWAY | 11 | 2.79e-01 | -1.89e-01 | 7.40e-01 |
| GOBP NEGATIVE REGULATION OF ERBB SIGNALING PATHWAY | 28 | 8.42e-02 | 1.89e-01 | 5.09e-01 |
| GOBP METAPHASE CHROMOSOME ALIGNMENT | 98 | 1.27e-03 | 1.88e-01 | 8.11e-02 |
| GOBP REGULATION OF DEVELOPMENT HETEROCHRONIC | 10 | 3.02e-01 | -1.88e-01 | 7.57e-01 |
| GOCC INO80 COMPLEX | 16 | 1.92e-01 | -1.88e-01 | 6.64e-01 |
| GOMF RNA EXONUCLEASE ACTIVITY PRODUCING 5 PHOSPHOMONOESTERS | 40 | 3.93e-02 | 1.88e-01 | 3.98e-01 |
| GOBP NEGATIVE REGULATION OF PEPTIDYL TYROSINE PHOSPHORYLATION | 36 | 5.06e-02 | 1.88e-01 | 4.29e-01 |
| GOMF TFIID CLASS TRANSCRIPTION FACTOR COMPLEX BINDING | 10 | 3.03e-01 | -1.88e-01 | 7.58e-01 |
| GOBP NEGATIVE REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY BY P53 CLASS MEDIATOR | 21 | 1.35e-01 | 1.88e-01 | 6.00e-01 |
| GOMF BASIC AMINO ACID TRANSMEMBRANE TRANSPORTER ACTIVITY | 12 | 2.59e-01 | -1.88e-01 | 7.27e-01 |
| GOMF POTASSIUM ION BINDING | 7 | 3.89e-01 | -1.88e-01 | 8.17e-01 |
| GOMF UBIQUITIN PROTEIN TRANSFERASE ACTIVATOR ACTIVITY | 15 | 2.07e-01 | 1.88e-01 | 6.82e-01 |
| GOBP REACTIVE GLIOSIS | 5 | 4.67e-01 | -1.88e-01 | 8.52e-01 |
| GOBP NUCLEOLAR CHROMATIN ORGANIZATION | 11 | 2.80e-01 | -1.88e-01 | 7.41e-01 |
| GOMF 1 PHOSPHATIDYLINOSITOL 3 KINASE REGULATOR ACTIVITY | 14 | 2.23e-01 | -1.88e-01 | 6.97e-01 |
| GOBP RESCUE OF STALLED RIBOSOME | 29 | 7.99e-02 | 1.88e-01 | 4.98e-01 |
| GOBP NEUROBLAST DIVISION | 13 | 2.41e-01 | 1.88e-01 | 7.11e-01 |
| GOBP POSITIVE REGULATION OF NUCLEOTIDE BINDING DOMAIN LEUCINE RICH REPEAT CONTAINING RECEPTOR SIGNALING PATHWAY | 7 | 3.89e-01 | -1.88e-01 | 8.18e-01 |
| GOBP NEGATIVE REGULATION OF ASTROCYTE DIFFERENTIATION | 9 | 3.29e-01 | -1.88e-01 | 7.80e-01 |
| GOBP ENDOTHELIAL CELL ACTIVATION | 8 | 3.58e-01 | 1.88e-01 | 7.98e-01 |
| GOMF HISTONE H3 KINASE ACTIVITY | 11 | 2.81e-01 | 1.88e-01 | 7.43e-01 |
| GOCC CONDENSED CHROMOSOME | 259 | 2.03e-07 | 1.88e-01 | 3.69e-04 |
| GOCC PWP2P CONTAINING SUBCOMPLEX OF 90S PRERIBOSOME | 5 | 4.68e-01 | 1.87e-01 | 8.53e-01 |
| GOBP VITAMIN CATABOLIC PROCESS | 8 | 3.59e-01 | 1.87e-01 | 7.99e-01 |
| GOBP DOPAMINE RECEPTOR SIGNALING PATHWAY | 28 | 8.65e-02 | -1.87e-01 | 5.15e-01 |
| GOMF 14 3 3 PROTEIN BINDING | 32 | 6.69e-02 | -1.87e-01 | 4.71e-01 |
| GOBP NEGATIVE REGULATION OF MACROPHAGE CYTOKINE PRODUCTION | 10 | 3.05e-01 | -1.87e-01 | 7.61e-01 |
| GOMF QUATERNARY AMMONIUM GROUP TRANSMEMBRANE TRANSPORTER ACTIVITY | 8 | 3.59e-01 | -1.87e-01 | 7.99e-01 |
| GOBP POSITIVE REGULATION OF VITAMIN D RECEPTOR SIGNALING PATHWAY | 6 | 4.27e-01 | -1.87e-01 | 8.34e-01 |
| GOCC PORE COMPLEX | 20 | 1.47e-01 | -1.87e-01 | 6.13e-01 |
| GOBP POSITIVE REGULATION OF MACROPHAGE ACTIVATION | 20 | 1.47e-01 | 1.87e-01 | 6.13e-01 |
| GOCC CONDENSED CHROMOSOME CENTROMERIC REGION | 176 | 1.85e-05 | 1.87e-01 | 4.65e-03 |
| GOBP RESPONSE TO LITHIUM ION | 11 | 2.83e-01 | 1.87e-01 | 7.43e-01 |
| GOCC TRANSCRIPTION EXPORT COMPLEX | 12 | 2.62e-01 | 1.87e-01 | 7.29e-01 |
| GOCC ANKYRIN 1 COMPLEX | 5 | 4.69e-01 | 1.87e-01 | 8.53e-01 |
| GOMF PYRIMIDINE NUCLEOTIDE SUGAR TRANSMEMBRANE TRANSPORTER ACTIVITY | 10 | 3.06e-01 | 1.87e-01 | 7.61e-01 |
| GOBP PRENYLATION | 10 | 3.06e-01 | 1.87e-01 | 7.61e-01 |
| GOBP PYRIMIDINE RIBONUCLEOSIDE MONOPHOSPHATE METABOLIC PROCESS | 14 | 2.26e-01 | -1.87e-01 | 6.98e-01 |
| GOBP REGULATION OF ACTIVATION OF JANUS KINASE ACTIVITY | 5 | 4.69e-01 | 1.87e-01 | 8.54e-01 |
| GOBP RESPONSE TO LAMINAR FLUID SHEAR STRESS | 13 | 2.44e-01 | -1.87e-01 | 7.13e-01 |
| GOBP PROTEIN TRANSPORT WITHIN LIPID BILAYER | 6 | 4.28e-01 | -1.87e-01 | 8.34e-01 |
| GOMF VOLTAGE GATED CALCIUM CHANNEL ACTIVITY | 31 | 7.20e-02 | -1.87e-01 | 4.86e-01 |
| GOBP POSITIVE REGULATION OF TELOMERE MAINTENANCE VIA TELOMERE LENGTHENING | 36 | 5.27e-02 | 1.87e-01 | 4.33e-01 |
| GOBP RESPONSE TO TYPE III INTERFERON | 8 | 3.61e-01 | 1.87e-01 | 8.01e-01 |
| GOBP NEUROMUSCULAR PROCESS CONTROLLING BALANCE | 38 | 4.66e-02 | -1.87e-01 | 4.20e-01 |
| GOBP DETERMINATION OF DIGESTIVE TRACT LEFT RIGHT ASYMMETRY | 5 | 4.70e-01 | -1.87e-01 | 8.54e-01 |
| GOMF 5 N 7 METHYLGUANOSINE 5 TRIPHOSPHO MRNA HYDROLASE ACTIVITY | 10 | 3.07e-01 | 1.87e-01 | 7.62e-01 |
| GOBP ENDOSOME TO LYSOSOME TRANSPORT | 65 | 9.30e-03 | 1.87e-01 | 2.21e-01 |
| GOBP L ALANINE TRANSPORT | 8 | 3.61e-01 | 1.86e-01 | 8.01e-01 |
| GOBP MIDBODY ABSCISSION | 17 | 1.83e-01 | 1.86e-01 | 6.55e-01 |
| GOMF SINGLE STRANDED RNA BINDING | 74 | 5.59e-03 | 1.86e-01 | 1.79e-01 |
| GOBP TRIPARTITE REGIONAL SUBDIVISION | 11 | 2.85e-01 | 1.86e-01 | 7.45e-01 |
| GOMF RNA POLYMERASE III ACTIVITY | 10 | 3.08e-01 | -1.86e-01 | 7.62e-01 |
| GOBP RELEASE OF SEQUESTERED CALCIUM ION INTO CYTOSOL BY ENDOPLASMIC RETICULUM | 29 | 8.29e-02 | 1.86e-01 | 5.05e-01 |
| GOBP ENDOCYTOSIS INVOLVED IN VIRAL ENTRY INTO HOST CELL | 11 | 2.86e-01 | 1.86e-01 | 7.45e-01 |
| GOBP KYNURENINE METABOLIC PROCESS | 9 | 3.34e-01 | 1.86e-01 | 7.84e-01 |
| GOBP POSITIVE REGULATION OF SECONDARY METABOLITE BIOSYNTHETIC PROCESS | 7 | 3.94e-01 | 1.86e-01 | 8.20e-01 |
| GOMF MEDIUM CHAIN FATTY ACID COA LIGASE ACTIVITY | 8 | 3.63e-01 | 1.86e-01 | 8.02e-01 |
| GOBP CELLULAR RESPONSE TO FLUID SHEAR STRESS | 15 | 2.13e-01 | -1.86e-01 | 6.87e-01 |
| GOBP ENDOCARDIAL CUSHION MORPHOGENESIS | 23 | 1.23e-01 | 1.86e-01 | 5.86e-01 |
| GOBP POSITIVE REGULATION OF PROTEIN ACETYLATION | 11 | 2.86e-01 | 1.86e-01 | 7.46e-01 |
| GOMF PHOSPHATIDYLINOSITOL PHOSPHATE PHOSPHATASE ACTIVITY | 27 | 9.50e-02 | 1.86e-01 | 5.36e-01 |
| GOBP PROTEIN LOCALIZATION TO NUCLEAR ENVELOPE | 13 | 2.47e-01 | 1.86e-01 | 7.16e-01 |
| GOCC GOLGI ASSOCIATED VESICLE | 80 | 4.11e-03 | 1.86e-01 | 1.53e-01 |
| GOCC TRANS GOLGI NETWORK TRANSPORT VESICLE | 33 | 6.51e-02 | 1.86e-01 | 4.66e-01 |
| GOBP POSITIVE REGULATION OF T HELPER 17 CELL LINEAGE COMMITMENT | 6 | 4.31e-01 | -1.86e-01 | 8.35e-01 |
| GOBP NEGATIVE REGULATION OF LIPOPOLYSACCHARIDE MEDIATED SIGNALING PATHWAY | 10 | 3.10e-01 | -1.85e-01 | 7.64e-01 |
| GOBP FERROPTOSIS | 10 | 3.10e-01 | -1.85e-01 | 7.64e-01 |
| GOBP REGULATION OF NADP METABOLIC PROCESS | 8 | 3.64e-01 | -1.85e-01 | 8.02e-01 |
| GOMF COMPLEMENT COMPONENT C1Q COMPLEX BINDING | 5 | 4.73e-01 | -1.85e-01 | 8.55e-01 |
| GOCC RDNA HETEROCHROMATIN | 5 | 4.73e-01 | -1.85e-01 | 8.55e-01 |
| GOBP RESPONSE TO MINERALOCORTICOID | 30 | 7.91e-02 | -1.85e-01 | 4.97e-01 |
| GOBP REGULATION OF RNA EXPORT FROM NUCLEUS | 16 | 2.00e-01 | 1.85e-01 | 6.71e-01 |
| GOCC PRERIBOSOME LARGE SUBUNIT PRECURSOR | 19 | 1.62e-01 | -1.85e-01 | 6.29e-01 |
| GOCC INTEGRATOR COMPLEX | 16 | 2.00e-01 | 1.85e-01 | 6.71e-01 |
| GOBP PYRIMIDINE NUCLEOSIDE BIOSYNTHETIC PROCESS | 5 | 4.74e-01 | -1.85e-01 | 8.55e-01 |
| GOBP ATP TRANSPORT | 17 | 1.87e-01 | -1.85e-01 | 6.61e-01 |
| GOBP POSITIVE REGULATION OF TRANSCRIPTION BY RNA POLYMERASE III | 18 | 1.74e-01 | 1.85e-01 | 6.42e-01 |
| GOBP CALCIUM IMPORT INTO THE MITOCHONDRION | 16 | 2.01e-01 | 1.85e-01 | 6.72e-01 |
| GOBP POSITIVE REGULATION OF PROTEIN EXIT FROM ENDOPLASMIC RETICULUM | 12 | 2.68e-01 | 1.85e-01 | 7.33e-01 |
| GOBP NEUTROPHIL ACTIVATION INVOLVED IN IMMUNE RESPONSE | 20 | 1.53e-01 | -1.85e-01 | 6.16e-01 |
| GOBP AUTOPHAGOSOME MATURATION | 65 | 1.01e-02 | 1.85e-01 | 2.27e-01 |
| GOBP NEGATIVE REGULATION OF DEFENSE RESPONSE TO VIRUS | 17 | 1.88e-01 | 1.85e-01 | 6.62e-01 |
| GOBP POST GOLGI VESICLE MEDIATED TRANSPORT | 103 | 1.22e-03 | 1.84e-01 | 7.86e-02 |
| GOBP NEUTROPHIL MEDIATED CYTOTOXICITY | 11 | 2.90e-01 | -1.84e-01 | 7.47e-01 |
| GOBP MITOCHONDRIAL FISSION | 38 | 4.93e-02 | 1.84e-01 | 4.25e-01 |
| GOMF GLUTATHIONE DISULFIDE OXIDOREDUCTASE ACTIVITY | 5 | 4.75e-01 | 1.84e-01 | 8.56e-01 |
| GOBP PROTEIN LOCALIZATION TO CONDENSED CHROMOSOME | 15 | 2.17e-01 | 1.84e-01 | 6.92e-01 |
| GOBP POSITIVE REGULATION OF RESPONSE TO ENDOPLASMIC RETICULUM STRESS | 34 | 6.31e-02 | 1.84e-01 | 4.63e-01 |
| GOBP REGULATION OF RESPIRATORY GASEOUS EXCHANGE | 17 | 1.89e-01 | -1.84e-01 | 6.62e-01 |
| GOMF PRENYLTRANSFERASE ACTIVITY | 17 | 1.89e-01 | 1.84e-01 | 6.62e-01 |
| GOCC HAUS COMPLEX | 8 | 3.67e-01 | 1.84e-01 | 8.04e-01 |
| GOBP REGULATION OF PROTEIN LOCALIZATION TO CHROMOSOME TELOMERIC REGION | 14 | 2.33e-01 | 1.84e-01 | 7.05e-01 |
| GOBP PROTEIN PEPTIDYL PROLYL ISOMERIZATION | 16 | 2.02e-01 | 1.84e-01 | 6.76e-01 |
| GOBP REGULATION OF EXTRACELLULAR MATRIX ASSEMBLY | 17 | 1.89e-01 | -1.84e-01 | 6.62e-01 |
| GOBP POSITIVE REGULATION OF CATECHOLAMINE METABOLIC PROCESS | 5 | 4.76e-01 | 1.84e-01 | 8.57e-01 |
| GOBP PEXOPHAGY | 7 | 3.99e-01 | 1.84e-01 | 8.22e-01 |
| GOBP NEGATIVE REGULATION OF CELLULAR EXTRAVASATION | 5 | 4.77e-01 | -1.84e-01 | 8.57e-01 |
| GOBP POSITIVE REGULATION OF MULTICELLULAR ORGANISM GROWTH | 21 | 1.45e-01 | 1.84e-01 | 6.12e-01 |
| GOBP SOMATIC STEM CELL DIVISION | 9 | 3.40e-01 | -1.84e-01 | 7.88e-01 |
| GOBP NEGATIVE REGULATION OF PROTEASOMAL PROTEIN CATABOLIC PROCESS | 50 | 2.47e-02 | 1.84e-01 | 3.39e-01 |
| GOCC ENDOPLASMIC RETICULUM PROTEIN CONTAINING COMPLEX | 119 | 5.43e-04 | 1.84e-01 | 4.81e-02 |
| GOBP DETERMINATION OF LEFT RIGHT ASYMMETRY IN LATERAL MESODERM | 7 | 4.01e-01 | -1.83e-01 | 8.23e-01 |
| GOMF MHC CLASS II PROTEIN BINDING | 6 | 4.37e-01 | -1.83e-01 | 8.38e-01 |
| GOBP HEART FIELD SPECIFICATION | 9 | 3.41e-01 | 1.83e-01 | 7.88e-01 |
| GOBP POSITIVE REGULATION OF GOLGI TO PLASMA MEMBRANE PROTEIN TRANSPORT | 5 | 4.78e-01 | 1.83e-01 | 8.58e-01 |
| GOBP PROTOPORPHYRINOGEN IX BIOSYNTHETIC PROCESS | 9 | 3.41e-01 | -1.83e-01 | 7.88e-01 |
| GOBP REGULATION OF MEMBRANE PERMEABILITY | 58 | 1.58e-02 | -1.83e-01 | 2.74e-01 |
| GOBP NEGATIVE REGULATION OF INFLAMMASOME MEDIATED SIGNALING PATHWAY | 12 | 2.72e-01 | -1.83e-01 | 7.36e-01 |
| GOBP APOPTOTIC PROCESS INVOLVED IN MORPHOGENESIS | 15 | 2.20e-01 | -1.83e-01 | 6.94e-01 |
| GOMF MICROTUBULE PLUS END BINDING | 21 | 1.46e-01 | 1.83e-01 | 6.13e-01 |
| GOBP BASE CONVERSION OR SUBSTITUTION EDITING | 15 | 2.20e-01 | 1.83e-01 | 6.94e-01 |
| GOBP CELL CYCLE CHECKPOINT SIGNALING | 187 | 1.62e-05 | 1.83e-01 | 4.51e-03 |
| GOMF OXO ACID LYASE ACTIVITY | 5 | 4.79e-01 | 1.83e-01 | 8.58e-01 |
| GOBP INTRACELLULAR AMINO ACID HOMEOSTASIS | 7 | 4.03e-01 | -1.83e-01 | 8.23e-01 |
| GOBP EPITHELIAL TUBE BRANCHING INVOLVED IN LUNG MORPHOGENESIS | 17 | 1.93e-01 | -1.82e-01 | 6.65e-01 |
| GOBP BASEMENT MEMBRANE ASSEMBLY | 8 | 3.72e-01 | -1.82e-01 | 8.08e-01 |
| GOMF REGULATORY RNA BINDING | 46 | 3.24e-02 | 1.82e-01 | 3.77e-01 |
| GOBP RESPONSE TO ELECTRICAL STIMULUS | 32 | 7.44e-02 | 1.82e-01 | 4.90e-01 |
| GOBP NEGATIVE REGULATION OF AMYLOID FIBRIL FORMATION | 9 | 3.44e-01 | 1.82e-01 | 7.89e-01 |
| GOMF TRANSPORTER ACTIVATOR ACTIVITY | 6 | 4.40e-01 | -1.82e-01 | 8.40e-01 |
| GOBP PROTEIN LOCALIZATION TO CELL CORTEX | 10 | 3.19e-01 | -1.82e-01 | 7.70e-01 |
| GOCC OLIGOSACCHARYLTRANSFERASE COMPLEX | 13 | 2.55e-01 | 1.82e-01 | 7.25e-01 |
| GOBP HEPARAN SULFATE PROTEOGLYCAN BIOSYNTHETIC PROCESS | 25 | 1.15e-01 | 1.82e-01 | 5.73e-01 |
| GOMF CALCIUM DEPENDENT PROTEIN SERINE THREONINE PHOSPHATASE ACTIVITY | 7 | 4.04e-01 | 1.82e-01 | 8.25e-01 |
| GOBP RESPONSE TO CATECHOLAMINE | 41 | 4.39e-02 | -1.82e-01 | 4.11e-01 |
| GOBP PYRIMIDINE NUCLEOSIDE MONOPHOSPHATE METABOLIC PROCESS | 19 | 1.70e-01 | -1.82e-01 | 6.37e-01 |
| GOBP VITAMIN D RECEPTOR SIGNALING PATHWAY | 10 | 3.19e-01 | -1.82e-01 | 7.70e-01 |
| GOBP PERIPHERAL NERVOUS SYSTEM NEURON DIFFERENTIATION | 6 | 4.41e-01 | 1.82e-01 | 8.40e-01 |
| GOBP PROTEIN IMPORT INTO MITOCHONDRIAL MATRIX | 19 | 1.70e-01 | -1.82e-01 | 6.37e-01 |
| GOCC H3 HISTONE ACETYLTRANSFERASE COMPLEX | 8 | 3.73e-01 | -1.82e-01 | 8.09e-01 |
| GOBP POSITIVE REGULATION OF FIBROBLAST MIGRATION | 14 | 2.39e-01 | -1.82e-01 | 7.09e-01 |
| GOBP PORPHYRIN CONTAINING COMPOUND METABOLIC PROCESS | 47 | 3.12e-02 | -1.82e-01 | 3.72e-01 |
| GOMF IMMUNE RECEPTOR ACTIVITY | 124 | 4.78e-04 | 1.82e-01 | 4.48e-02 |
| GOBP PRIMARY AMINO COMPOUND METABOLIC PROCESS | 11 | 2.97e-01 | -1.82e-01 | 7.53e-01 |
| GOBP MATERNAL PLACENTA DEVELOPMENT | 26 | 1.09e-01 | -1.82e-01 | 5.62e-01 |
| GOCC PRC1 COMPLEX | 16 | 2.09e-01 | -1.82e-01 | 6.82e-01 |
| GOBP T CELL ACTIVATION VIA T CELL RECEPTOR CONTACT WITH ANTIGEN BOUND TO MHC MOLECULE ON ANTIGEN PRESENTING CELL | 10 | 3.20e-01 | -1.81e-01 | 7.72e-01 |
| GOCC 90S PRERIBOSOME | 26 | 1.10e-01 | -1.81e-01 | 5.63e-01 |
| GOBP THROMBIN ACTIVATED RECEPTOR SIGNALING PATHWAY | 12 | 2.77e-01 | 1.81e-01 | 7.39e-01 |
| GOBP PROTEIN LOCALIZATION TO MICROTUBULE ORGANIZING CENTER | 37 | 5.66e-02 | 1.81e-01 | 4.44e-01 |
| GOBP SPINAL CORD MOTOR NEURON DIFFERENTIATION | 16 | 2.10e-01 | -1.81e-01 | 6.83e-01 |
| GOBP MYELOID DENDRITIC CELL ACTIVATION | 25 | 1.17e-01 | 1.81e-01 | 5.77e-01 |
| GOBP SPINAL CORD PATTERNING | 6 | 4.43e-01 | -1.81e-01 | 8.41e-01 |
| GOBP PROTEIN INSERTION INTO MITOCHONDRIAL MEMBRANE | 7 | 4.07e-01 | -1.81e-01 | 8.26e-01 |
| GOMF INTRONIC TRANSCRIPTION REGULATORY REGION SEQUENCE SPECIFIC DNA BINDING | 7 | 4.07e-01 | 1.81e-01 | 8.26e-01 |
| GOBP OLEFINIC COMPOUND METABOLIC PROCESS | 102 | 1.60e-03 | -1.81e-01 | 9.70e-02 |
| GOMF G PROTEIN COUPLED NEUROTRANSMITTER RECEPTOR ACTIVITY | 5 | 4.84e-01 | 1.81e-01 | 8.60e-01 |
| GOBP CARTILAGE DEVELOPMENT INVOLVED IN ENDOCHONDRAL BONE MORPHOGENESIS | 20 | 1.62e-01 | 1.81e-01 | 6.28e-01 |
| GOBP T CELL CHEMOTAXIS | 20 | 1.62e-01 | 1.81e-01 | 6.28e-01 |
| GOMF LIPID TRANSMEMBRANE TRANSPORTER ACTIVITY | 27 | 1.04e-01 | -1.81e-01 | 5.56e-01 |
| GOBP FATTY ACID ELONGATION SATURATED FATTY ACID | 7 | 4.08e-01 | -1.81e-01 | 8.26e-01 |
| GOBP REGULATION OF CRISTAE FORMATION | 5 | 4.85e-01 | -1.80e-01 | 8.60e-01 |
| GOMF OXIDOREDUCTASE ACTIVITY ACTING ON A SULFUR GROUP OF DONORS | 53 | 2.30e-02 | 1.80e-01 | 3.29e-01 |
| GOCC DERLIN 1 RETROTRANSLOCATION COMPLEX | 8 | 3.77e-01 | 1.80e-01 | 8.10e-01 |
| GOBP EXTRACELLULAR EXOSOME ASSEMBLY | 6 | 4.44e-01 | 1.80e-01 | 8.41e-01 |
| GOBP OXALOACETATE METABOLIC PROCESS | 7 | 4.08e-01 | -1.80e-01 | 8.26e-01 |
| GOMF TRNA GUANINE METHYLTRANSFERASE ACTIVITY | 12 | 2.79e-01 | 1.80e-01 | 7.41e-01 |
| GOBP REGULATION OF VASCULAR PERMEABILITY | 34 | 6.88e-02 | -1.80e-01 | 4.77e-01 |
| GOBP GALACTOSE CATABOLIC PROCESS | 6 | 4.44e-01 | -1.80e-01 | 8.41e-01 |
| GOBP PERIPHERAL NERVOUS SYSTEM DEVELOPMENT | 63 | 1.34e-02 | -1.80e-01 | 2.50e-01 |
| GOBP NEGATIVE REGULATION OF ANOIKIS | 14 | 2.43e-01 | 1.80e-01 | 7.13e-01 |
| GOBP MULTIVESICULAR BODY SORTING PATHWAY | 47 | 3.27e-02 | 1.80e-01 | 3.77e-01 |
| GOCC MYOSIN II COMPLEX | 14 | 2.44e-01 | -1.80e-01 | 7.13e-01 |
| GOBP CELLULAR RESPONSE TO DEXAMETHASONE STIMULUS | 20 | 1.63e-01 | 1.80e-01 | 6.30e-01 |
| GOBP NEGATIVE REGULATION OF NUCLEAR TRANSCRIBED MRNA CATABOLIC PROCESS NONSENSE MEDIATED DECAY | 7 | 4.10e-01 | -1.80e-01 | 8.26e-01 |
| GOMF MICROTUBULE MINUS END BINDING | 14 | 2.44e-01 | -1.80e-01 | 7.14e-01 |
| GOBP VIRAL TRANSLATIONAL TERMINATION REINITIATION | 5 | 4.86e-01 | -1.80e-01 | 8.60e-01 |
| GOMF UBIQUITIN LIKE PROTEIN CONJUGATING ENZYME BINDING | 33 | 7.39e-02 | 1.80e-01 | 4.89e-01 |
| GOBP REGULATION OF TRIGLYCERIDE CATABOLIC PROCESS | 7 | 4.10e-01 | 1.80e-01 | 8.26e-01 |
| GOCC PYRUVATE DEHYDROGENASE COMPLEX | 6 | 4.46e-01 | 1.80e-01 | 8.42e-01 |
| GOMF DEUBIQUITINASE ACTIVITY | 93 | 2.78e-03 | 1.79e-01 | 1.26e-01 |
| GOCC TRANSCRIPTION FACTOR TFIID COMPLEX | 32 | 7.89e-02 | 1.79e-01 | 4.97e-01 |
| GOBP REGULATION OF ACTIVIN RECEPTOR SIGNALING PATHWAY | 20 | 1.65e-01 | -1.79e-01 | 6.30e-01 |
| GOCC NUCLEAR ENVELOPE LUMEN | 10 | 3.26e-01 | 1.79e-01 | 7.77e-01 |
| GOBP CYTOPLASMIC TRANSLATIONAL ELONGATION | 5 | 4.87e-01 | 1.79e-01 | 8.60e-01 |
| GOBP METHYLGLYOXAL METABOLIC PROCESS | 6 | 4.47e-01 | -1.79e-01 | 8.42e-01 |
| GOBP CELLULAR LIPID BIOSYNTHETIC PROCESS | 12 | 2.82e-01 | 1.79e-01 | 7.43e-01 |
| GOCC DYSTROPHIN ASSOCIATED GLYCOPROTEIN COMPLEX | 14 | 2.46e-01 | 1.79e-01 | 7.16e-01 |
| GOBP ACTIVATION OF NF KAPPAB INDUCING KINASE ACTIVITY | 9 | 3.52e-01 | -1.79e-01 | 7.94e-01 |
| GOBP REGULATION OF TORC2 SIGNALING | 6 | 4.48e-01 | -1.79e-01 | 8.43e-01 |
| GOMF OUTWARD RECTIFIER POTASSIUM CHANNEL ACTIVITY | 16 | 2.15e-01 | -1.79e-01 | 6.91e-01 |
| GOBP SUBTELOMERIC HETEROCHROMATIN FORMATION | 9 | 3.53e-01 | 1.79e-01 | 7.94e-01 |
| GOBP ASPARTATE TRANSMEMBRANE TRANSPORT | 16 | 2.15e-01 | 1.79e-01 | 6.91e-01 |
| GOBP MRNA METHYLGUANOSINE CAP DECAPPING | 16 | 2.16e-01 | 1.79e-01 | 6.91e-01 |
| GOBP MEIOTIC CHROMOSOME SEPARATION | 8 | 3.81e-01 | -1.79e-01 | 8.14e-01 |
| GOBP NEGATIVE REGULATION OF GLUCOSE IMPORT | 11 | 3.05e-01 | -1.79e-01 | 7.60e-01 |
| GOBP NEGATIVE REGULATION OF CILIUM ASSEMBLY | 20 | 1.66e-01 | 1.79e-01 | 6.31e-01 |
| GOBP NEGATIVE REGULATION OF CHROMOSOME SEGREGATION | 49 | 3.04e-02 | 1.79e-01 | 3.66e-01 |
| GOBP MAINTENANCE OF PROTEIN LOCALIZATION IN ENDOPLASMIC RETICULUM | 11 | 3.05e-01 | 1.79e-01 | 7.60e-01 |
| GOCC CUL2 RING UBIQUITIN LIGASE COMPLEX | 21 | 1.56e-01 | 1.79e-01 | 6.21e-01 |
| GOMF ADENYL NUCLEOTIDE EXCHANGE FACTOR ACTIVITY | 15 | 2.31e-01 | 1.79e-01 | 7.04e-01 |
| GOBP CELL DIFFERENTIATION IN SPINAL CORD | 25 | 1.23e-01 | -1.78e-01 | 5.86e-01 |
| GOBP ESTABLISHMENT OF MITOTIC SPINDLE LOCALIZATION | 35 | 6.78e-02 | 1.78e-01 | 4.73e-01 |
| GOMF TRANSCRIPTION COREPRESSOR BINDING | 46 | 3.64e-02 | -1.78e-01 | 3.90e-01 |
| GOBP POSITIVE REGULATION OF P38MAPK CASCADE | 21 | 1.57e-01 | -1.78e-01 | 6.22e-01 |
| GOBP COBALT ION TRANSPORT | 7 | 4.14e-01 | 1.78e-01 | 8.29e-01 |
| GOMF PHOSPHATIDYLINOSITOL 3 KINASE REGULATORY SUBUNIT BINDING | 10 | 3.29e-01 | 1.78e-01 | 7.80e-01 |
| GOBP DETOXIFICATION OF NITROGEN COMPOUND | 5 | 4.91e-01 | -1.78e-01 | 8.62e-01 |
| GOBP NEGATIVE REGULATION OF MONOATOMIC ION TRANSMEMBRANE TRANSPORT | 63 | 1.45e-02 | 1.78e-01 | 2.59e-01 |
| GOMF BH DOMAIN BINDING | 10 | 3.30e-01 | -1.78e-01 | 7.81e-01 |
| GOBP NEGATIVE REGULATION OF PROTEIN CATABOLIC PROCESS IN THE VACUOLE | 5 | 4.91e-01 | 1.78e-01 | 8.62e-01 |
| GOBP ENDOPLASMIC RETICULUM UNFOLDED PROTEIN RESPONSE | 70 | 1.01e-02 | 1.78e-01 | 2.27e-01 |
| GOBP SULFUR COMPOUND CATABOLIC PROCESS | 36 | 6.48e-02 | -1.78e-01 | 4.66e-01 |
| GOBP POSITIVE REGULATION OF AMINE TRANSPORT | 28 | 1.03e-01 | 1.78e-01 | 5.55e-01 |
| GOBP POSITIVE REGULATION OF PSEUDOPODIUM ASSEMBLY | 11 | 3.07e-01 | 1.78e-01 | 7.62e-01 |
| GOCC RETROMER COMPLEX | 20 | 1.69e-01 | 1.78e-01 | 6.34e-01 |
| GOBP POSITIVE REGULATION OF CYCLASE ACTIVITY | 21 | 1.59e-01 | -1.78e-01 | 6.24e-01 |
| GOCC PHOSPHATASE COMPLEX | 49 | 3.15e-02 | 1.78e-01 | 3.73e-01 |
| GOBP PROTEIN OXIDATION | 10 | 3.31e-01 | -1.77e-01 | 7.82e-01 |
| GOBP DERMATAN SULFATE BIOSYNTHETIC PROCESS | 5 | 4.92e-01 | -1.77e-01 | 8.62e-01 |
| GOMF HISTONE ACETYLTRANSFERASE BINDING | 22 | 1.50e-01 | 1.77e-01 | 6.13e-01 |
| GOMF INSULIN BINDING | 5 | 4.93e-01 | 1.77e-01 | 8.62e-01 |
| GOBP POSITIVE REGULATION OF LEUKOCYTE APOPTOTIC PROCESS | 25 | 1.25e-01 | 1.77e-01 | 5.89e-01 |
| GOBP NUCLEOLAR LARGE RRNA TRANSCRIPTION BY RNA POLYMERASE I | 24 | 1.33e-01 | -1.77e-01 | 5.98e-01 |
| GOMF U1 SNRNP BINDING | 6 | 4.53e-01 | 1.77e-01 | 8.43e-01 |
| GOBP REGULATION OF RESPONSE TO NUTRIENT LEVELS | 22 | 1.51e-01 | -1.77e-01 | 6.13e-01 |
| GOBP REGULATION OF CILIUM BEAT FREQUENCY | 12 | 2.88e-01 | -1.77e-01 | 7.47e-01 |
| GOBP FIBRINOLYSIS | 18 | 1.94e-01 | -1.77e-01 | 6.67e-01 |
| GOBP POSITIVE REGULATION OF VIRAL PROCESS | 61 | 1.68e-02 | 1.77e-01 | 2.83e-01 |
| GOBP PLATELET DENSE GRANULE ORGANIZATION | 24 | 1.34e-01 | 1.77e-01 | 5.99e-01 |
| GOBP GOLGI TO PLASMA MEMBRANE TRANSPORT | 60 | 1.79e-02 | 1.77e-01 | 2.90e-01 |
| GOMF SODIUM CHANNEL ACTIVITY | 33 | 7.90e-02 | -1.77e-01 | 4.97e-01 |
| GOBP MYOBLAST PROLIFERATION | 17 | 2.07e-01 | -1.77e-01 | 6.82e-01 |
| GOBP NEGATIVE REGULATION OF AMYLOID PRECURSOR PROTEIN BIOSYNTHETIC PROCESS | 7 | 4.19e-01 | 1.77e-01 | 8.30e-01 |
| GOBP NEURON PROJECTION MAINTENANCE | 10 | 3.34e-01 | -1.76e-01 | 7.84e-01 |
| GOBP REGULATION OF DNA LIGATION | 6 | 4.54e-01 | 1.76e-01 | 8.43e-01 |
| GOCC CATALYTIC STEP 2 SPLICEOSOME | 89 | 4.02e-03 | 1.76e-01 | 1.51e-01 |
| GOBP WATER TRANSPORT | 14 | 2.53e-01 | -1.76e-01 | 7.22e-01 |
| GOBP RIBOSOMAL LARGE SUBUNIT ASSEMBLY | 21 | 1.62e-01 | -1.76e-01 | 6.29e-01 |
| GOBP HEART TRABECULA MORPHOGENESIS | 20 | 1.73e-01 | 1.76e-01 | 6.40e-01 |
| GOMF S ACYLTRANSFERASE ACTIVITY | 29 | 1.01e-01 | -1.76e-01 | 5.48e-01 |
| GOBP CYTOKINE PRODUCTION INVOLVED IN INFLAMMATORY RESPONSE | 46 | 3.89e-02 | -1.76e-01 | 3.98e-01 |
| GOBP PRESYNAPSE ORGANIZATION | 29 | 1.01e-01 | -1.76e-01 | 5.49e-01 |
| GOBP STRESS INDUCED PREMATURE SENESCENCE | 7 | 4.20e-01 | 1.76e-01 | 8.30e-01 |
| GOBP REGULATION OF PRESYNAPSE ORGANIZATION | 19 | 1.84e-01 | -1.76e-01 | 6.57e-01 |
| GOBP MOTOR NEURON APOPTOTIC PROCESS | 19 | 1.85e-01 | 1.76e-01 | 6.57e-01 |
| GOBP NEGATIVE REGULATION OF AMYLOID PRECURSOR PROTEIN CATABOLIC PROCESS | 17 | 2.10e-01 | -1.76e-01 | 6.83e-01 |
| GOMF NADPH BINDING | 17 | 2.10e-01 | 1.76e-01 | 6.83e-01 |
| GOBP NECROPTOTIC SIGNALING PATHWAY | 8 | 3.90e-01 | 1.76e-01 | 8.18e-01 |
| GOBP INNER CELL MASS CELL PROLIFERATION | 14 | 2.55e-01 | 1.76e-01 | 7.25e-01 |
| GOBP POSITIVE REGULATION OF DENDRITIC CELL ANTIGEN PROCESSING AND PRESENTATION | 5 | 4.97e-01 | -1.76e-01 | 8.62e-01 |
| GOBP REGULATION OF SODIUM DEPENDENT PHOSPHATE TRANSPORT | 5 | 4.97e-01 | -1.76e-01 | 8.62e-01 |
| GOBP NEGATIVE REGULATION OF PROTEASOMAL UBIQUITIN DEPENDENT PROTEIN CATABOLIC PROCESS | 34 | 7.65e-02 | 1.76e-01 | 4.93e-01 |
| GOBP SENSORY PERCEPTION OF SMELL | 65 | 1.44e-02 | 1.76e-01 | 2.58e-01 |
| GOBP CADMIUM ION TRANSMEMBRANE TRANSPORT | 5 | 4.97e-01 | 1.75e-01 | 8.62e-01 |
| GOBP CELLULAR RESPONSE TO SALT STRESS | 13 | 2.73e-01 | -1.75e-01 | 7.36e-01 |
| GOBP REGULATION OF MITOCHONDRIAL DNA METABOLIC PROCESS | 5 | 4.97e-01 | -1.75e-01 | 8.62e-01 |
| GOBP REGULATION OF WNT PROTEIN SECRETION | 5 | 4.97e-01 | 1.75e-01 | 8.62e-01 |
| GOMF ADENYLATE CYCLASE REGULATOR ACTIVITY | 7 | 4.22e-01 | 1.75e-01 | 8.30e-01 |
| GOBP NATURAL KILLER CELL MEDIATED IMMUNE RESPONSE TO TUMOR CELL | 10 | 3.37e-01 | -1.75e-01 | 7.86e-01 |
| GOMF MIRNA BINDING | 37 | 6.50e-02 | 1.75e-01 | 4.66e-01 |
| GOBP REGULATION OF NUCLEOCYTOPLASMIC TRANSPORT | 105 | 1.91e-03 | 1.75e-01 | 1.09e-01 |
| GOBP POSITIVE REGULATION OF LEUKOCYTE ADHESION TO VASCULAR ENDOTHELIAL CELL | 21 | 1.64e-01 | -1.75e-01 | 6.30e-01 |
| GOBP ESTABLISHMENT OF MITOCHONDRION LOCALIZATION MICROTUBULE MEDIATED | 22 | 1.55e-01 | 1.75e-01 | 6.18e-01 |
| GOMF RNA POLYMERASE BINDING | 56 | 2.34e-02 | 1.75e-01 | 3.32e-01 |
| GOMF MYOSIN LIGHT CHAIN BINDING | 5 | 4.98e-01 | -1.75e-01 | 8.62e-01 |
| GOBP INNER EAR RECEPTOR CELL DEVELOPMENT | 37 | 6.54e-02 | -1.75e-01 | 4.67e-01 |
| GOBP NEUROTRANSMITTER RECEPTOR LOCALIZATION TO POSTSYNAPTIC SPECIALIZATION MEMBRANE | 16 | 2.26e-01 | -1.75e-01 | 6.98e-01 |
| GOBP REGULATION OF AMINO ACID TRANSPORT | 30 | 9.73e-02 | 1.75e-01 | 5.42e-01 |
| GOCC VOLTAGE GATED SODIUM CHANNEL COMPLEX | 11 | 3.15e-01 | 1.75e-01 | 7.67e-01 |
| GOBP CLATHRIN COATED VESICLE CARGO LOADING | 7 | 4.23e-01 | 1.75e-01 | 8.30e-01 |
| GOMF HISTONE CHAPERONE ACTIVITY | 11 | 3.16e-01 | 1.75e-01 | 7.67e-01 |
| GOBP DNA TOPOLOGICAL CHANGE | 9 | 3.64e-01 | 1.75e-01 | 8.02e-01 |
| GOMF ANNEALING ACTIVITY | 10 | 3.39e-01 | 1.75e-01 | 7.87e-01 |
| GOBP POSITIVE REGULATION OF STRESS ACTIVATED PROTEIN KINASE SIGNALING CASCADE | 18 | 2.00e-01 | 1.75e-01 | 6.71e-01 |
| GOBP CD8 POSITIVE ALPHA BETA T CELL DIFFERENTIATION | 14 | 2.58e-01 | 1.75e-01 | 7.27e-01 |
| GOBP INTERFERON BETA PRODUCTION | 57 | 2.27e-02 | 1.74e-01 | 3.27e-01 |
| GOMF S METHYLTRANSFERASE ACTIVITY | 6 | 4.59e-01 | 1.74e-01 | 8.47e-01 |
| GOBP VITAMIN K METABOLIC PROCESS | 10 | 3.40e-01 | -1.74e-01 | 7.88e-01 |
| GOBP SARCOPLASMIC RETICULUM CALCIUM ION TRANSPORT | 30 | 9.84e-02 | 1.74e-01 | 5.45e-01 |
| GOBP REGULATION OF POSTSYNAPTIC NEUROTRANSMITTER RECEPTOR INTERNALIZATION | 16 | 2.27e-01 | 1.74e-01 | 7.01e-01 |
| GOBP REGULATION OF DNA DAMAGE RESPONSE SIGNAL TRANSDUCTION BY P53 CLASS MEDIATOR | 33 | 8.33e-02 | 1.74e-01 | 5.05e-01 |
| GOBP POSITIVE REGULATION OF MRNA CATABOLIC PROCESS | 101 | 2.49e-03 | 1.74e-01 | 1.20e-01 |
| GOBP SPINAL CORD DEVELOPMENT | 61 | 1.87e-02 | -1.74e-01 | 2.97e-01 |
| GOCC COHESIN COMPLEX | 10 | 3.40e-01 | 1.74e-01 | 7.88e-01 |
| GOBP REGULATION OF LONG CHAIN FATTY ACID IMPORT INTO CELL | 8 | 3.94e-01 | -1.74e-01 | 8.20e-01 |
| GOMF STEROL ESTERASE ACTIVITY | 7 | 4.25e-01 | -1.74e-01 | 8.32e-01 |
| GOBP DOUBLE STRAND BREAK REPAIR VIA NONHOMOLOGOUS END JOINING | 70 | 1.18e-02 | 1.74e-01 | 2.43e-01 |
| GOBP POSITIVE REGULATION OF G1 S TRANSITION OF MITOTIC CELL CYCLE | 41 | 5.38e-02 | 1.74e-01 | 4.36e-01 |
| GOBP REGULATION OF WNT SIGNALING PATHWAY PLANAR CELL POLARITY PATHWAY | 10 | 3.41e-01 | -1.74e-01 | 7.88e-01 |
| GOBP REGULATION OF CELL FATE SPECIFICATION | 20 | 1.78e-01 | -1.74e-01 | 6.50e-01 |
| GOBP REGULATION OF POLYSACCHARIDE BIOSYNTHETIC PROCESS | 28 | 1.11e-01 | -1.74e-01 | 5.65e-01 |
| GOMF INSULIN LIKE GROWTH FACTOR II BINDING | 5 | 5.01e-01 | 1.74e-01 | 8.64e-01 |
| GOBP MELANOSOME ASSEMBLY | 19 | 1.89e-01 | 1.74e-01 | 6.62e-01 |
| GOCC CHROMOSOMAL REGION | 370 | 9.39e-09 | 1.74e-01 | 4.36e-05 |
| GOCC LSM2 8 COMPLEX | 7 | 4.26e-01 | 1.74e-01 | 8.33e-01 |
| GOMF CUPROUS ION BINDING | 6 | 4.61e-01 | 1.74e-01 | 8.48e-01 |
| GOBP LIGAND GATED ION CHANNEL SIGNALING PATHWAY | 22 | 1.58e-01 | -1.74e-01 | 6.24e-01 |
| GOBP THYROID HORMONE GENERATION | 14 | 2.60e-01 | -1.74e-01 | 7.28e-01 |
| GOBP SUPEROXIDE METABOLIC PROCESS | 53 | 2.87e-02 | -1.74e-01 | 3.59e-01 |
| GOBP LOW DENSITY LIPOPROTEIN PARTICLE REMODELING | 8 | 3.95e-01 | -1.74e-01 | 8.20e-01 |
| GOMF LIGAND GATED MONOATOMIC CATION CHANNEL ACTIVITY | 77 | 8.45e-03 | -1.74e-01 | 2.13e-01 |
| GOBP AMINOGLYCAN CATABOLIC PROCESS | 30 | 1.00e-01 | -1.74e-01 | 5.47e-01 |
| GOBP NUCLEOTIDE BINDING DOMAIN LEUCINE RICH REPEAT CONTAINING RECEPTOR SIGNALING PATHWAY | 28 | 1.12e-01 | 1.73e-01 | 5.67e-01 |
| GOBP NEGATIVE REGULATION OF RECEPTOR INTERNALIZATION | 14 | 2.62e-01 | -1.73e-01 | 7.29e-01 |
| GOBP TOLL LIKE RECEPTOR 3 SIGNALING PATHWAY | 26 | 1.26e-01 | 1.73e-01 | 5.91e-01 |
| GOBP MRNA 3 SPLICE SITE RECOGNITION | 6 | 4.62e-01 | -1.73e-01 | 8.48e-01 |
| GOBP ADRENAL GLAND DEVELOPMENT | 17 | 2.17e-01 | 1.73e-01 | 6.92e-01 |
| GOBP REGULATION OF NON CANONICAL WNT SIGNALING PATHWAY | 19 | 1.91e-01 | -1.73e-01 | 6.63e-01 |
| GOBP RESPONSE TO FRUCTOSE | 9 | 3.69e-01 | -1.73e-01 | 8.05e-01 |
| GOBP RESPONSE TO HYPEROXIA | 13 | 2.80e-01 | 1.73e-01 | 7.41e-01 |
| GOBP REGULATION OF GERMINAL CENTER FORMATION | 8 | 3.97e-01 | 1.73e-01 | 8.21e-01 |
| GOBP FATTY ACID ALPHA OXIDATION | 6 | 4.63e-01 | 1.73e-01 | 8.49e-01 |
| GOBP CELLULAR RESPONSE TO ANGIOTENSIN | 24 | 1.43e-01 | 1.73e-01 | 6.11e-01 |
| GOBP INSULIN METABOLIC PROCESS | 12 | 3.00e-01 | 1.73e-01 | 7.56e-01 |
| GOBP OSTEOBLAST DEVELOPMENT | 9 | 3.70e-01 | -1.73e-01 | 8.06e-01 |
| GOBP NEGATIVE REGULATION OF HYDROGEN PEROXIDE METABOLIC PROCESS | 5 | 5.04e-01 | 1.73e-01 | 8.66e-01 |
| GOMF RNA POLYMERASE II CTD HEPTAPEPTIDE REPEAT KINASE ACTIVITY | 10 | 3.45e-01 | 1.73e-01 | 7.89e-01 |
| GOBP REGULATION OF CARDIAC MUSCLE CELL ACTION POTENTIAL | 21 | 1.71e-01 | 1.73e-01 | 6.38e-01 |
| GOMF ANGIOTENSIN RECEPTOR BINDING | 8 | 3.98e-01 | -1.73e-01 | 8.22e-01 |
| GOBP NEGATIVE REGULATION OF COAGULATION | 38 | 6.59e-02 | -1.72e-01 | 4.68e-01 |
| GOBP MITOTIC SISTER CHROMATID SEGREGATION | 187 | 4.80e-05 | 1.72e-01 | 8.33e-03 |
| GOMF RNA POLYMERASE CORE ENZYME BINDING | 41 | 5.62e-02 | 1.72e-01 | 4.43e-01 |
| GOBP POSITIVE REGULATION OF COLLAGEN METABOLIC PROCESS | 19 | 1.93e-01 | -1.72e-01 | 6.67e-01 |
| GOBP SCF DEPENDENT PROTEASOMAL UBIQUITIN DEPENDENT PROTEIN CATABOLIC PROCESS | 42 | 5.34e-02 | 1.72e-01 | 4.36e-01 |
| GOBP POSITIVE REGULATION OF BONE RESORPTION | 13 | 2.82e-01 | -1.72e-01 | 7.43e-01 |
| GOBP LAYER FORMATION IN CEREBRAL CORTEX | 10 | 3.46e-01 | 1.72e-01 | 7.90e-01 |
| GOBP PYRIMIDINE NUCLEOSIDE DIPHOSPHATE METABOLIC PROCESS | 9 | 3.71e-01 | 1.72e-01 | 8.08e-01 |
| GOBP DNA INTEGRITY CHECKPOINT SIGNALING | 132 | 6.39e-04 | 1.72e-01 | 5.47e-02 |
| GOCC NEUROFILAMENT | 5 | 5.05e-01 | 1.72e-01 | 8.66e-01 |
| GOMF BASAL TRANSCRIPTION MACHINERY BINDING | 58 | 2.35e-02 | 1.72e-01 | 3.32e-01 |
| GOBP SPINDLE ASSEMBLY | 126 | 8.63e-04 | 1.72e-01 | 6.64e-02 |
| GOBP ENTRAINMENT OF CIRCADIAN CLOCK | 24 | 1.45e-01 | -1.72e-01 | 6.12e-01 |
| GOBP POSITIVE REGULATION OF PHOSPHOLIPID BIOSYNTHETIC PROCESS | 5 | 5.06e-01 | 1.72e-01 | 8.67e-01 |
| GOMF VASOPRESSIN RECEPTOR ACTIVITY | 5 | 5.06e-01 | -1.72e-01 | 8.67e-01 |
| GOBP MITOTIC INTRA S DNA DAMAGE CHECKPOINT SIGNALING | 16 | 2.35e-01 | 1.72e-01 | 7.05e-01 |
| GOMF ADP D RIBOSE MODIFICATION DEPENDENT PROTEIN BINDING | 7 | 4.32e-01 | 1.72e-01 | 8.35e-01 |
| GOBP THIAMINE TRANSPORT | 6 | 4.67e-01 | 1.71e-01 | 8.52e-01 |
| GOBP SMOOTH MUSCLE CELL CHEMOTAXIS | 7 | 4.32e-01 | -1.71e-01 | 8.36e-01 |
| GOBP RUFFLE ORGANIZATION | 51 | 3.42e-02 | -1.71e-01 | 3.84e-01 |
| GOBP QUATERNARY AMMONIUM GROUP TRANSPORT | 12 | 3.04e-01 | -1.71e-01 | 7.59e-01 |
| GOBP RESPONSE TO HISTAMINE | 6 | 4.68e-01 | -1.71e-01 | 8.53e-01 |
| GOBP REGULATION OF VITAMIN D RECEPTOR SIGNALING PATHWAY | 9 | 3.74e-01 | -1.71e-01 | 8.09e-01 |
| GOBP CHONDROITIN SULFATE PROTEOGLYCAN BIOSYNTHETIC PROCESS | 21 | 1.75e-01 | -1.71e-01 | 6.42e-01 |
| GOMF HEPARIN BINDING | 107 | 2.23e-03 | -1.71e-01 | 1.17e-01 |
| GOBP NEGATIVE REGULATION OF T HELPER 1 TYPE IMMUNE RESPONSE | 8 | 4.02e-01 | 1.71e-01 | 8.23e-01 |
| GOBP NEGATIVE REGULATION OF CARDIAC MUSCLE CELL DIFFERENTIATION | 7 | 4.33e-01 | 1.71e-01 | 8.36e-01 |
| GOBP PIGMENT CELL DIFFERENTIATION | 25 | 1.39e-01 | 1.71e-01 | 6.04e-01 |
| GOBP GLIAL CELL DERIVED NEUROTROPHIC FACTOR RECEPTOR SIGNALING PATHWAY | 7 | 4.33e-01 | -1.71e-01 | 8.36e-01 |
| GOMF SERINE HYDROLASE ACTIVITY | 112 | 1.77e-03 | -1.71e-01 | 1.02e-01 |
| GOBP EXTRACELLULAR MATRIX ASSEMBLY | 37 | 7.19e-02 | -1.71e-01 | 4.86e-01 |
| GOBP DEFENSE RESPONSE TO VIRUS | 264 | 1.74e-06 | 1.71e-01 | 8.50e-04 |
| GOBP REGULATION OF SKELETAL MUSCLE CONTRACTION BY REGULATION OF RELEASE OF SEQUESTERED CALCIUM ION | 5 | 5.08e-01 | 1.71e-01 | 8.69e-01 |
| GOBP LATE ENDOSOME TO VACUOLE TRANSPORT | 34 | 8.47e-02 | 1.71e-01 | 5.09e-01 |
| GOCC PRESYNAPTIC CYTOSOL | 12 | 3.06e-01 | 1.71e-01 | 7.61e-01 |
| GOBP POSITIVE REGULATION OF MAST CELL ACTIVATION | 5 | 5.09e-01 | -1.71e-01 | 8.69e-01 |
| GOBP POSITIVE REGULATION OF LIPID CATABOLIC PROCESS | 18 | 2.10e-01 | -1.71e-01 | 6.83e-01 |
| GOBP NEGATIVE REGULATION OF OXIDATIVE STRESS INDUCED NEURON INTRINSIC APOPTOTIC SIGNALING PATHWAY | 12 | 3.06e-01 | -1.71e-01 | 7.61e-01 |
| GOMF TAP BINDING | 7 | 4.35e-01 | -1.71e-01 | 8.36e-01 |
| GOCC STEREOCILIUM TIP | 17 | 2.24e-01 | -1.70e-01 | 6.97e-01 |
| GOBP POSITIVE REGULATION OF REACTIVE OXYGEN SPECIES BIOSYNTHETIC PROCESS | 13 | 2.87e-01 | 1.70e-01 | 7.47e-01 |
| GOBP AORTA MORPHOGENESIS | 20 | 1.87e-01 | -1.70e-01 | 6.62e-01 |
| GOBP REGULATION OF PROTEIN LOCALIZATION TO CHROMATIN | 9 | 3.76e-01 | -1.70e-01 | 8.10e-01 |
| GOBP RNA 5 END PROCESSING | 37 | 7.30e-02 | 1.70e-01 | 4.87e-01 |
| GOBP NEGATIVE REGULATION OF EXOCYTOSIS | 29 | 1.13e-01 | 1.70e-01 | 5.68e-01 |
| GOMF MRF BINDING | 5 | 5.11e-01 | -1.70e-01 | 8.70e-01 |
| GOBP NON LYTIC VIRAL RELEASE | 14 | 2.71e-01 | 1.70e-01 | 7.35e-01 |
| GOCC MITOTIC SPINDLE POLE | 38 | 7.03e-02 | 1.70e-01 | 4.82e-01 |
| GOBP B CELL CHEMOTAXIS | 6 | 4.72e-01 | -1.70e-01 | 8.54e-01 |
| GOBP REGULATION OF BRANCHING MORPHOGENESIS OF A NERVE | 5 | 5.11e-01 | 1.70e-01 | 8.70e-01 |
| GOMF TOLL LIKE RECEPTOR BINDING | 14 | 2.72e-01 | 1.70e-01 | 7.36e-01 |
| GOBP CELLULAR RESPONSE TO MURAMYL DIPEPTIDE | 9 | 3.79e-01 | -1.70e-01 | 8.12e-01 |
| GOBP PHOSPHOLIPID HOMEOSTASIS | 13 | 2.90e-01 | -1.69e-01 | 7.47e-01 |
| GOMF POLY PYRIMIDINE TRACT BINDING | 24 | 1.51e-01 | 1.69e-01 | 6.13e-01 |
| GOBP REGULATION OF CHROMOSOME SEGREGATION | 124 | 1.13e-03 | 1.69e-01 | 7.42e-02 |
| GOBP PURINE NUCLEOSIDE DIPHOSPHATE BIOSYNTHETIC PROCESS | 6 | 4.73e-01 | 1.69e-01 | 8.55e-01 |
| GOBP REGULATION OF AUTOPHAGOSOME ASSEMBLY | 47 | 4.48e-02 | 1.69e-01 | 4.12e-01 |
| GOBP PHASIC SMOOTH MUSCLE CONTRACTION | 11 | 3.31e-01 | 1.69e-01 | 7.82e-01 |
| GOBP PYRIMIDINE RIBONUCLEOSIDE DIPHOSPHATE METABOLIC PROCESS | 7 | 4.38e-01 | 1.69e-01 | 8.39e-01 |
| GOBP CO TRANSCRIPTIONAL RNA 3 END PROCESSING CLEAVAGE AND POLYADENYLATION PATHWAY | 10 | 3.55e-01 | 1.69e-01 | 7.96e-01 |
| GOBP EPITHELIAL CELL MORPHOGENESIS | 23 | 1.61e-01 | 1.69e-01 | 6.28e-01 |
| GOMF JUN KINASE KINASE KINASE ACTIVITY | 11 | 3.32e-01 | 1.69e-01 | 7.83e-01 |
| GOMF PROTEIN DISULFIDE REDUCTASE NAD P H ACTIVITY | 8 | 4.08e-01 | 1.69e-01 | 8.26e-01 |
| GOMF POLY ADP D RIBOSE MODIFICATION DEPENDENT PROTEIN BINDING | 5 | 5.14e-01 | 1.69e-01 | 8.71e-01 |
| GOBP POSITIVE REGULATION OF INTERLEUKIN 10 PRODUCTION | 36 | 7.98e-02 | 1.69e-01 | 4.98e-01 |
| GOCC MISMATCH REPAIR COMPLEX | 10 | 3.56e-01 | 1.69e-01 | 7.97e-01 |
| GOBP DETECTION OF CELL DENSITY | 7 | 4.40e-01 | 1.69e-01 | 8.40e-01 |
| GOBP POSITIVE REGULATION OF ATP METABOLIC PROCESS | 23 | 1.62e-01 | 1.69e-01 | 6.28e-01 |
| GOMF LYSOPHOSPHOLIPID ACYLTRANSFERASE ACTIVITY | 20 | 1.92e-01 | 1.69e-01 | 6.64e-01 |
| GOBP MACROMOLECULE DEPALMITOYLATION | 14 | 2.75e-01 | 1.69e-01 | 7.38e-01 |
| GOMF PALMITOYL HYDROLASE ACTIVITY | 14 | 2.75e-01 | 1.69e-01 | 7.38e-01 |
| GOMF SULFOTRANSFERASE ACTIVITY | 30 | 1.10e-01 | -1.69e-01 | 5.63e-01 |
| GOMF MRNA REGULATORY ELEMENT BINDING TRANSLATION REPRESSOR ACTIVITY | 15 | 2.58e-01 | 1.69e-01 | 7.27e-01 |
| GOMF CYCLASE ACTIVITY | 15 | 2.59e-01 | -1.68e-01 | 7.27e-01 |
| GOMF STRUCTURAL CONSTITUENT OF SKIN EPIDERMIS | 10 | 3.56e-01 | 1.68e-01 | 7.97e-01 |
| GOBP INOSITOL TRISPHOSPHATE BIOSYNTHETIC PROCESS | 5 | 5.14e-01 | -1.68e-01 | 8.71e-01 |
| GOBP DNA LIGATION INVOLVED IN DNA REPAIR | 5 | 5.14e-01 | 1.68e-01 | 8.71e-01 |
| GOBP REGULATION OF TRANSLATIONAL INITIATION | 78 | 1.01e-02 | 1.68e-01 | 2.27e-01 |
| GOBP NEGATIVE REGULATION OF DENDRITE DEVELOPMENT | 6 | 4.75e-01 | -1.68e-01 | 8.56e-01 |
| GOBP L ASCORBIC ACID METABOLIC PROCESS | 9 | 3.82e-01 | -1.68e-01 | 8.14e-01 |
| GOBP NEGATIVE REGULATION OF INTERLEUKIN 4 PRODUCTION | 6 | 4.75e-01 | -1.68e-01 | 8.56e-01 |
| GOBP REGULATION OF ESTABLISHMENT OR MAINTENANCE OF CELL POLARITY | 24 | 1.53e-01 | 1.68e-01 | 6.16e-01 |
| GOCC OMEGASOME | 5 | 5.15e-01 | 1.68e-01 | 8.71e-01 |
| GOBP PROGRAMMED CELL DEATH INVOLVED IN CELL DEVELOPMENT | 17 | 2.31e-01 | 1.68e-01 | 7.03e-01 |
| GOBP POSITIVE REGULATION OF SODIUM PROTON ANTIPORTER ACTIVITY | 5 | 5.16e-01 | 1.68e-01 | 8.71e-01 |
| GOBP PYRIDINE NUCLEOTIDE BIOSYNTHETIC PROCESS | 24 | 1.54e-01 | 1.68e-01 | 6.17e-01 |
| GOBP REGULATION OF SYNAPTIC TRANSMISSION DOPAMINERGIC | 7 | 4.42e-01 | -1.68e-01 | 8.41e-01 |
| GOCC EARLY PHAGOSOME | 11 | 3.35e-01 | 1.68e-01 | 7.84e-01 |
| GOBP IMMUNOGLOBULIN PRODUCTION INVOLVED IN IMMUNOGLOBULIN MEDIATED IMMUNE RESPONSE | 56 | 2.98e-02 | 1.68e-01 | 3.64e-01 |
| GOBP NEGATIVE REGULATION OF GLIOGENESIS | 27 | 1.31e-01 | -1.68e-01 | 5.95e-01 |
| GOMF SINGLE STRANDED DNA BINDING | 114 | 1.97e-03 | 1.68e-01 | 1.09e-01 |
| GOBP SPECIFICATION OF ANIMAL ORGAN IDENTITY | 18 | 2.18e-01 | 1.68e-01 | 6.93e-01 |
| GOMF CLASS I DNA APURINIC OR APYRIMIDINIC SITE ENDONUCLEASE ACTIVITY | 7 | 4.43e-01 | -1.68e-01 | 8.41e-01 |
| GOMF SIGNALING RECEPTOR COMPLEX ADAPTOR ACTIVITY | 47 | 4.68e-02 | -1.68e-01 | 4.21e-01 |
| GOBP REGULATION OF PRO B CELL DIFFERENTIATION | 7 | 4.43e-01 | 1.68e-01 | 8.41e-01 |
| GOBP RENAL SYSTEM PROCESS INVOLVED IN REGULATION OF BLOOD VOLUME | 10 | 3.59e-01 | 1.67e-01 | 7.99e-01 |
| GOBP POSITIVE REGULATION OF MUSCLE CONTRACTION | 36 | 8.22e-02 | -1.67e-01 | 5.04e-01 |
| GOCC CORTICAL ENDOPLASMIC RETICULUM | 7 | 4.43e-01 | -1.67e-01 | 8.41e-01 |
| GOBP INTESTINAL EPITHELIAL CELL DEVELOPMENT | 12 | 3.15e-01 | 1.67e-01 | 7.67e-01 |
| GOCC POSTSYNAPTIC DENSITY MEMBRANE | 60 | 2.50e-02 | -1.67e-01 | 3.43e-01 |
| GOBP FOREBRAIN NEUROBLAST DIVISION | 5 | 5.17e-01 | 1.67e-01 | 8.72e-01 |
| GOBP REGULATION OF VESICLE FUSION | 18 | 2.20e-01 | -1.67e-01 | 6.94e-01 |
| GOBP REGULATION OF MAST CELL ACTIVATION INVOLVED IN IMMUNE RESPONSE | 5 | 5.18e-01 | 1.67e-01 | 8.73e-01 |
| GOBP MITOTIC CELL CYCLE CHECKPOINT SIGNALING | 141 | 6.21e-04 | 1.67e-01 | 5.40e-02 |
| GOBP PODOCYTE CELL MIGRATION | 7 | 4.44e-01 | -1.67e-01 | 8.41e-01 |
| GOBP ESTABLISHMENT OF PROTEIN LOCALIZATION TO TELOMERE | 18 | 2.21e-01 | 1.67e-01 | 6.94e-01 |
| GOCC PML BODY | 103 | 3.46e-03 | 1.67e-01 | 1.40e-01 |
| GOBP CHOLESTEROL EFFLUX | 40 | 6.81e-02 | -1.67e-01 | 4.73e-01 |
| GOBP BRANCHIOMOTOR NEURON AXON GUIDANCE | 5 | 5.19e-01 | 1.66e-01 | 8.74e-01 |
| GOBP REGULATION OF SYNAPTIC TRANSMISSION GABAERGIC | 23 | 1.67e-01 | 1.66e-01 | 6.32e-01 |
| GOBP REGULATION OF NATURAL KILLER CELL MEDIATED IMMUNE RESPONSE TO TUMOR CELL | 9 | 3.87e-01 | -1.66e-01 | 8.17e-01 |
| GOBP NOTOCHORD DEVELOPMENT | 13 | 2.99e-01 | 1.66e-01 | 7.55e-01 |
| GOBP REGULATION OF SKELETAL MUSCLE CONTRACTION | 13 | 2.99e-01 | -1.66e-01 | 7.55e-01 |
| GOBP RESPONSE TO NITRIC OXIDE | 15 | 2.65e-01 | 1.66e-01 | 7.32e-01 |
| GOBP ESTABLISHMENT OF SKIN BARRIER | 19 | 2.10e-01 | -1.66e-01 | 6.83e-01 |
| GOMF LIGAND GATED CHANNEL ACTIVITY | 99 | 4.28e-03 | -1.66e-01 | 1.58e-01 |
| GOBP ESTABLISHMENT OF EPITHELIAL CELL POLARITY | 28 | 1.28e-01 | -1.66e-01 | 5.93e-01 |
| GOBP EPITHELIAL CELL PROLIFERATION INVOLVED IN LUNG MORPHOGENESIS | 6 | 4.81e-01 | 1.66e-01 | 8.59e-01 |
| GOBP COENZYME A BIOSYNTHETIC PROCESS | 10 | 3.63e-01 | -1.66e-01 | 8.02e-01 |
| GOBP POSITIVE REGULATION OF ERYTHROCYTE DIFFERENTIATION | 31 | 1.10e-01 | 1.66e-01 | 5.63e-01 |
| GOMF 1 4 ALPHA OLIGOGLUCAN PHOSPHORYLASE ACTIVITY | 5 | 5.21e-01 | -1.66e-01 | 8.74e-01 |
| GOBP MICROVILLUS ASSEMBLY | 21 | 1.88e-01 | 1.66e-01 | 6.62e-01 |
| GOBP BEHAVIORAL RESPONSE TO NICOTINE | 5 | 5.21e-01 | 1.66e-01 | 8.74e-01 |
| GOBP ACTIVATION OF GTPASE ACTIVITY | 90 | 6.61e-03 | -1.66e-01 | 1.89e-01 |
| GOCC CYTOPLASMIC STRESS GRANULE | 82 | 9.55e-03 | 1.66e-01 | 2.22e-01 |
| GOMF FATTY ACID TRANSMEMBRANE TRANSPORTER ACTIVITY | 14 | 2.84e-01 | -1.66e-01 | 7.44e-01 |
| GOBP PSEUDOPODIUM ORGANIZATION | 13 | 3.02e-01 | 1.65e-01 | 7.57e-01 |
| GOMF MHC CLASS II RECEPTOR ACTIVITY | 9 | 3.90e-01 | 1.65e-01 | 8.18e-01 |
| GOBP UNSATURATED FATTY ACID METABOLIC PROCESS | 82 | 9.59e-03 | -1.65e-01 | 2.22e-01 |
| GOMF G QUADRUPLEX DNA BINDING | 11 | 3.42e-01 | 1.65e-01 | 7.89e-01 |
| GOBP PROTEIN LOCALIZATION TO SITE OF DOUBLE STRAND BREAK | 15 | 2.68e-01 | 1.65e-01 | 7.33e-01 |
| GOBP NOREPINEPHRINE TRANSPORT | 15 | 2.68e-01 | -1.65e-01 | 7.33e-01 |
| GOBP HOMOLOGOUS RECOMBINATION | 50 | 4.34e-02 | 1.65e-01 | 4.09e-01 |
| GOBP NEGATIVE REGULATION OF MYOBLAST DIFFERENTIATION | 17 | 2.39e-01 | -1.65e-01 | 7.08e-01 |
| GOBP POSITIVE REGULATION OF EPIDERMIS DEVELOPMENT | 24 | 1.62e-01 | -1.65e-01 | 6.28e-01 |
| GOBP OUTER DYNEIN ARM ASSEMBLY | 14 | 2.85e-01 | -1.65e-01 | 7.45e-01 |
| GOBP DTTP METABOLIC PROCESS | 5 | 5.23e-01 | 1.65e-01 | 8.75e-01 |
| GOCC TRANSCRIPTION PREINITIATION COMPLEX | 13 | 3.03e-01 | 1.65e-01 | 7.58e-01 |
| GOBP TERTIARY ALCOHOL METABOLIC PROCESS | 13 | 3.03e-01 | -1.65e-01 | 7.58e-01 |
| GOBP BRAIN MORPHOGENESIS | 29 | 1.24e-01 | 1.65e-01 | 5.88e-01 |
| GOBP REGULATION OF EOSINOPHIL MIGRATION | 5 | 5.23e-01 | 1.65e-01 | 8.75e-01 |
| GOBP POSITIVE REGULATION OF SKELETAL MUSCLE TISSUE DEVELOPMENT | 12 | 3.23e-01 | 1.65e-01 | 7.74e-01 |
| GOBP REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY BY P53 CLASS MEDIATOR | 31 | 1.12e-01 | 1.65e-01 | 5.68e-01 |
| GOMF TRNA CYTIDINE METHYLTRANSFERASE ACTIVITY | 10 | 3.67e-01 | 1.65e-01 | 8.04e-01 |
| GOMF P TYPE TRANSMEMBRANE TRANSPORTER ACTIVITY | 18 | 2.26e-01 | -1.65e-01 | 7.00e-01 |
| GOBP NEGATIVE REGULATION OF PROTEIN BINDING | 59 | 2.87e-02 | -1.65e-01 | 3.59e-01 |
| GOBP L ARGININE TRANSMEMBRANE TRANSPORT | 10 | 3.67e-01 | -1.65e-01 | 8.04e-01 |
| GOBP REGULATION OF CAMP MEDIATED SIGNALING | 14 | 2.86e-01 | -1.65e-01 | 7.46e-01 |
| GOBP POSITIVE REGULATION OF MEMORY T CELL DIFFERENTIATION | 6 | 4.85e-01 | 1.65e-01 | 8.60e-01 |
| GOMF CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY | 75 | 1.38e-02 | 1.65e-01 | 2.53e-01 |
| GOCC SPECIFIC GRANULE LUMEN | 61 | 2.63e-02 | -1.65e-01 | 3.50e-01 |
| GOBP B CELL LINEAGE COMMITMENT | 5 | 5.24e-01 | -1.64e-01 | 8.76e-01 |
| GOMF INTERLEUKIN 1 RECEPTOR BINDING | 10 | 3.68e-01 | 1.64e-01 | 8.05e-01 |
| GOBP BRANCHING INVOLVED IN LABYRINTHINE LAYER MORPHOGENESIS | 10 | 3.68e-01 | 1.64e-01 | 8.05e-01 |
| GOBP DNA TEMPLATED TRANSCRIPTION TERMINATION | 24 | 1.64e-01 | 1.64e-01 | 6.30e-01 |
| GOBP NEGATIVE REGULATION OF FILOPODIUM ASSEMBLY | 5 | 5.25e-01 | 1.64e-01 | 8.76e-01 |
| GOBP ENDOPLASMIC RETICULUM ORGANIZATION | 93 | 6.21e-03 | 1.64e-01 | 1.84e-01 |
| GOBP CELL MOTILITY INVOLVED IN CEREBRAL CORTEX RADIAL GLIA GUIDED MIGRATION | 7 | 4.52e-01 | -1.64e-01 | 8.43e-01 |
| GOMF TRNA SPECIFIC ADENOSINE DEAMINASE ACTIVITY | 6 | 4.86e-01 | 1.64e-01 | 8.60e-01 |
| GOBP REGULATION OF HYDROGEN PEROXIDE BIOSYNTHETIC PROCESS | 5 | 5.25e-01 | 1.64e-01 | 8.76e-01 |
| GOMF OXIDATIVE RNA DEMETHYLASE ACTIVITY | 5 | 5.25e-01 | 1.64e-01 | 8.76e-01 |
| GOBP NADH OXIDATION | 6 | 4.86e-01 | 1.64e-01 | 8.60e-01 |
| GOBP REGULATION OF POLYSACCHARIDE METABOLIC PROCESS | 33 | 1.03e-01 | -1.64e-01 | 5.55e-01 |
| GOMF CARBOHYDRATE DERIVATIVE TRANSMEMBRANE TRANSPORTER ACTIVITY | 51 | 4.28e-02 | -1.64e-01 | 4.07e-01 |
| GOBP PARANODAL JUNCTION ASSEMBLY | 6 | 4.87e-01 | 1.64e-01 | 8.60e-01 |
| GOCC PSEUDOPODIUM | 14 | 2.89e-01 | -1.64e-01 | 7.47e-01 |
| GOCC MULTIVESICULAR BODY INTERNAL VESICLE | 5 | 5.26e-01 | -1.64e-01 | 8.76e-01 |
| GOBP SECRETORY GRANULE ORGANIZATION | 53 | 3.94e-02 | 1.64e-01 | 3.98e-01 |
| GOMF OLIGOSACCHARIDE BINDING | 9 | 3.95e-01 | -1.64e-01 | 8.20e-01 |
| GOBP TETRAHYDROBIOPTERIN METABOLIC PROCESS | 9 | 3.96e-01 | 1.64e-01 | 8.21e-01 |
| GOBP ESTABLISHMENT OF PLANAR POLARITY OF EMBRYONIC EPITHELIUM | 9 | 3.96e-01 | -1.63e-01 | 8.21e-01 |
| GOBP NEGATIVE REGULATION OF MYOTUBE DIFFERENTIATION | 13 | 3.08e-01 | -1.63e-01 | 7.62e-01 |
| GOMF TRIPEPTIDE TRANSMEMBRANE TRANSPORTER ACTIVITY | 7 | 4.54e-01 | 1.63e-01 | 8.43e-01 |
| GOBP PROTEIN KINASE A SIGNALING | 27 | 1.42e-01 | 1.63e-01 | 6.09e-01 |
| GOBP NEUROEPITHELIAL CELL DIFFERENTIATION | 25 | 1.58e-01 | -1.63e-01 | 6.23e-01 |
| GOBP NEGATIVE REGULATION OF CELL KILLING | 26 | 1.50e-01 | 1.63e-01 | 6.13e-01 |
| GOCC POSTSYNAPTIC ENDOSOME MEMBRANE | 5 | 5.28e-01 | -1.63e-01 | 8.76e-01 |
| GOBP GOLGI DISASSEMBLY | 6 | 4.89e-01 | -1.63e-01 | 8.61e-01 |
| GOBP NOSE DEVELOPMENT | 7 | 4.55e-01 | 1.63e-01 | 8.44e-01 |
| GOBP SISTER CHROMATID SEGREGATION | 224 | 2.65e-05 | 1.63e-01 | 5.36e-03 |
| GOBP POSITIVE REGULATION OF ACUTE INFLAMMATORY RESPONSE TO ANTIGENIC STIMULUS | 8 | 4.25e-01 | 1.63e-01 | 8.32e-01 |
| GOBP REGULATION OF RESPONSE TO ENDOPLASMIC RETICULUM STRESS | 77 | 1.35e-02 | 1.63e-01 | 2.50e-01 |
| GOMF SIGNAL SEQUENCE BINDING | 44 | 6.19e-02 | 1.63e-01 | 4.61e-01 |
| GOBP ALDEHYDE BIOSYNTHETIC PROCESS | 13 | 3.10e-01 | -1.63e-01 | 7.64e-01 |
| GOMF COMPLEMENT BINDING | 16 | 2.60e-01 | -1.63e-01 | 7.28e-01 |
| GOBP PEPTIDYL L CYSTEINE S PALMITOYLATION | 22 | 1.87e-01 | -1.63e-01 | 6.61e-01 |
| GOMF CARBOXY LYASE ACTIVITY | 28 | 1.36e-01 | -1.63e-01 | 6.02e-01 |
| GOBP DETECTION OF MECHANICAL STIMULUS INVOLVED IN SENSORY PERCEPTION OF PAIN | 8 | 4.26e-01 | 1.63e-01 | 8.33e-01 |
| GOBP NITROGEN CYCLE METABOLIC PROCESS | 7 | 4.56e-01 | -1.63e-01 | 8.44e-01 |
| GOBP UREA CYCLE | 7 | 4.56e-01 | -1.63e-01 | 8.44e-01 |
| GOBP EMBRYONIC AXIS SPECIFICATION | 26 | 1.51e-01 | 1.63e-01 | 6.13e-01 |
| GOMF DYNEIN LIGHT INTERMEDIATE CHAIN BINDING | 26 | 1.51e-01 | -1.63e-01 | 6.13e-01 |
| GOBP RESPONSE TO LEUKEMIA INHIBITORY FACTOR | 86 | 9.21e-03 | 1.62e-01 | 2.20e-01 |
| GOBP TELOMERE MAINTENANCE IN RESPONSE TO DNA DAMAGE | 33 | 1.07e-01 | -1.62e-01 | 5.59e-01 |
| GOBP MULTICELLULAR ORGANISMAL LEVEL WATER HOMEOSTASIS | 19 | 2.21e-01 | -1.62e-01 | 6.94e-01 |
| GOCC U2 TYPE SPLICEOSOMAL COMPLEX | 92 | 7.14e-03 | 1.62e-01 | 1.94e-01 |
| GOCC GROWTH CONE MEMBRANE | 6 | 4.91e-01 | -1.62e-01 | 8.62e-01 |
| GOBP POSITIVE REGULATION OF GLIAL CELL MIGRATION | 9 | 4.00e-01 | 1.62e-01 | 8.22e-01 |
| GOBP RUFFLE ASSEMBLY | 40 | 7.60e-02 | -1.62e-01 | 4.93e-01 |
| GOBP OLEFINIC COMPOUND BIOSYNTHETIC PROCESS | 19 | 2.21e-01 | -1.62e-01 | 6.95e-01 |
| GOMF OLEATE TRANSMEMBRANE TRANSPORTER ACTIVITY | 5 | 5.31e-01 | -1.62e-01 | 8.78e-01 |
| GOBP TRANSLATIONAL INITIATION | 115 | 2.71e-03 | 1.62e-01 | 1.24e-01 |
| GOBP MRNA PSEUDOURIDINE SYNTHESIS | 9 | 4.00e-01 | 1.62e-01 | 8.23e-01 |
| GOMF MAP KINASE KINASE ACTIVITY | 14 | 2.94e-01 | 1.62e-01 | 7.51e-01 |
| GOBP PROTECTION FROM NON HOMOLOGOUS END JOINING AT TELOMERE | 9 | 4.01e-01 | -1.62e-01 | 8.23e-01 |
| GOBP REGULATION OF MONOCYTE CHEMOTAXIS | 21 | 1.99e-01 | 1.62e-01 | 6.71e-01 |
| GOBP SOMATIC DIVERSIFICATION OF IMMUNE RECEPTORS | 76 | 1.48e-02 | 1.62e-01 | 2.61e-01 |
| GOBP CENTRAL NERVOUS SYSTEM NEURON DEVELOPMENT | 57 | 3.50e-02 | 1.61e-01 | 3.88e-01 |
| GOBP SPHINGOMYELIN METABOLIC PROCESS | 18 | 2.36e-01 | 1.61e-01 | 7.07e-01 |
| GOMF HISTONE DECROTONYLASE ACTIVITY | 5 | 5.32e-01 | 1.61e-01 | 8.79e-01 |
| GOMF PRE MIRNA BINDING | 9 | 4.02e-01 | 1.61e-01 | 8.23e-01 |
| GOBP RELAXATION OF VASCULAR ASSOCIATED SMOOTH MUSCLE | 5 | 5.32e-01 | 1.61e-01 | 8.79e-01 |
| GOMF TUMOR NECROSIS FACTOR BINDING | 7 | 4.60e-01 | -1.61e-01 | 8.47e-01 |
| GOMF EXTRACELLULAR MATRIX STRUCTURAL CONSTITUENT | 93 | 7.23e-03 | -1.61e-01 | 1.95e-01 |
| GOMF HISTONE H3K4 MONOMETHYLTRANSFERASE ACTIVITY | 8 | 4.30e-01 | -1.61e-01 | 8.35e-01 |
| GOBP C21 STEROID HORMONE BIOSYNTHETIC PROCESS | 13 | 3.14e-01 | -1.61e-01 | 7.66e-01 |
| GOBP ANTIGEN PROCESSING AND PRESENTATION OF PEPTIDE ANTIGEN VIA MHC CLASS I | 32 | 1.15e-01 | 1.61e-01 | 5.72e-01 |
| GOMF ODORANT BINDING | 10 | 3.78e-01 | 1.61e-01 | 8.11e-01 |
| GOBP POSITIVE REGULATION OF SMALL GTPASE MEDIATED SIGNAL TRANSDUCTION | 58 | 3.41e-02 | 1.61e-01 | 3.84e-01 |
| GOBP REGULATION OF APOPTOTIC PROCESS INVOLVED IN DEVELOPMENT | 7 | 4.61e-01 | -1.61e-01 | 8.48e-01 |
| GOMF O ACETYLTRANSFERASE ACTIVITY | 6 | 4.95e-01 | 1.61e-01 | 8.62e-01 |
| GOBP REGULATION OF CARDIAC MUSCLE CONTRACTION BY REGULATION OF THE RELEASE OF SEQUESTERED CALCIUM ION | 16 | 2.66e-01 | 1.61e-01 | 7.33e-01 |
| GOBP CATECHOLAMINE UPTAKE | 9 | 4.04e-01 | -1.61e-01 | 8.25e-01 |
| GOBP POSITIVE REGULATION OF DEVELOPMENTAL PIGMENTATION | 6 | 4.96e-01 | 1.61e-01 | 8.62e-01 |
| GOBP TYPE B PANCREATIC CELL DEVELOPMENT | 15 | 2.82e-01 | -1.61e-01 | 7.43e-01 |
| GOBP POSITIVE REGULATION OF ESTABLISHMENT OF PROTEIN LOCALIZATION TO TELOMERE | 10 | 3.79e-01 | 1.61e-01 | 8.12e-01 |
| GOBP EPITHELIAL CELL DIFFERENTIATION INVOLVED IN PROSTATE GLAND DEVELOPMENT | 7 | 4.62e-01 | 1.61e-01 | 8.48e-01 |
| GOMF GUANYLYLTRANSFERASE ACTIVITY | 7 | 4.62e-01 | 1.60e-01 | 8.48e-01 |
| GOBP REGULATION OF APOPTOTIC DNA FRAGMENTATION | 8 | 4.32e-01 | -1.60e-01 | 8.36e-01 |
| GOBP NUCLEUS ORGANIZATION | 139 | 1.13e-03 | 1.60e-01 | 7.42e-02 |
| GOBP SHORT CHAIN FATTY ACID CATABOLIC PROCESS | 6 | 4.97e-01 | -1.60e-01 | 8.62e-01 |
| GOBP RRNA TRANSCRIPTION | 40 | 8.00e-02 | -1.60e-01 | 4.99e-01 |
| GOBP REGULATION OF 3 UTR MEDIATED MRNA STABILIZATION | 5 | 5.36e-01 | 1.60e-01 | 8.79e-01 |
| GOBP POSITIVE REGULATION OF LIPID STORAGE | 19 | 2.28e-01 | -1.60e-01 | 7.01e-01 |
| GOBP RESPONSE TO RAPAMYCIN | 5 | 5.36e-01 | 1.60e-01 | 8.79e-01 |
| GOMF G PROTEIN COUPLED AMINE RECEPTOR ACTIVITY | 12 | 3.38e-01 | -1.60e-01 | 7.87e-01 |
| GOBP REGULATION OF GLYCOGEN BIOSYNTHETIC PROCESS | 21 | 2.05e-01 | -1.60e-01 | 6.80e-01 |
| GOCC DENDRITIC GROWTH CONE | 9 | 4.07e-01 | -1.60e-01 | 8.26e-01 |
| GOBP COLLAGEN ACTIVATED TYROSINE KINASE RECEPTOR SIGNALING PATHWAY | 8 | 4.34e-01 | -1.60e-01 | 8.36e-01 |
| GOBP POSITIVE REGULATION OF CARTILAGE DEVELOPMENT | 18 | 2.41e-01 | -1.60e-01 | 7.11e-01 |
| GOMF LIPID PHOSPHATASE ACTIVITY | 15 | 2.84e-01 | -1.60e-01 | 7.45e-01 |
| GOCC NUCLEAR REPLICATION FORK | 40 | 8.09e-02 | 1.60e-01 | 5.01e-01 |
| GOBP REGULATION OF LYASE ACTIVITY | 34 | 1.08e-01 | -1.59e-01 | 5.61e-01 |
| GOMF OXYSTEROL BINDING | 15 | 2.85e-01 | 1.59e-01 | 7.45e-01 |
| GOBP POSITIVE REGULATION OF STEM CELL DIFFERENTIATION | 12 | 3.39e-01 | 1.59e-01 | 7.87e-01 |
| GOBP CHAPERONE MEDIATED PROTEIN COMPLEX ASSEMBLY | 21 | 2.06e-01 | 1.59e-01 | 6.81e-01 |
| GOMF N ACETYLLACTOSAMINIDE BETA 1 3 N ACETYLGLUCOSAMINYLTRANSFERASE ACTIVITY | 5 | 5.37e-01 | -1.59e-01 | 8.79e-01 |
| GOMF DEOXYNUCLEOSIDE KINASE ACTIVITY | 5 | 5.37e-01 | 1.59e-01 | 8.79e-01 |
| GOMF NUCLEOTIDE TRANSMEMBRANE TRANSPORTER ACTIVITY | 29 | 1.38e-01 | -1.59e-01 | 6.04e-01 |
| GOBP COCHLEA DEVELOPMENT | 28 | 1.45e-01 | 1.59e-01 | 6.12e-01 |
| GOCC PROXIMAL DENDRITE | 5 | 5.38e-01 | 1.59e-01 | 8.79e-01 |
| GOBP NEGATIVE REGULATION OF EPIDERMIS DEVELOPMENT | 6 | 5.00e-01 | -1.59e-01 | 8.64e-01 |
| GOBP FATTY ACID DERIVATIVE CATABOLIC PROCESS | 16 | 2.71e-01 | -1.59e-01 | 7.35e-01 |
| GOBP NEGATIVE REGULATION OF DNA REPAIR | 39 | 8.57e-02 | -1.59e-01 | 5.12e-01 |
| GOBP STRIATED MUSCLE ADAPTATION | 28 | 1.45e-01 | -1.59e-01 | 6.13e-01 |
| GOBP BLASTODERM SEGMENTATION | 14 | 3.03e-01 | 1.59e-01 | 7.58e-01 |
| GOBP NEGATIVE REGULATION OF CELL CYCLE G2 M PHASE TRANSITION | 67 | 2.46e-02 | 1.59e-01 | 3.39e-01 |
| GOBP NEGATIVE REGULATION OF LONG TERM SYNAPTIC POTENTIATION | 11 | 3.62e-01 | -1.59e-01 | 8.01e-01 |
| GOBP INTRACELLULAR TRIGLYCERIDE HOMEOSTASIS | 9 | 4.10e-01 | 1.59e-01 | 8.26e-01 |
| GOCC NUCLEOTIDE EXCISION REPAIR COMPLEX | 12 | 3.41e-01 | -1.59e-01 | 7.88e-01 |
| GOBP REGULATION OF ATTACHMENT OF SPINDLE MICROTUBULES TO KINETOCHORE | 22 | 1.98e-01 | 1.59e-01 | 6.70e-01 |
| GOBP ENERGY COUPLED PROTON TRANSMEMBRANE TRANSPORT AGAINST ELECTROCHEMICAL GRADIENT | 5 | 5.39e-01 | -1.59e-01 | 8.80e-01 |
| GOCC AUTOPHAGOSOME MEMBRANE | 50 | 5.23e-02 | 1.59e-01 | 4.33e-01 |
| GOMF DOUBLE STRANDED TELOMERIC DNA BINDING | 9 | 4.10e-01 | 1.59e-01 | 8.26e-01 |
| GOMF ACYL COA HYDROLASE ACTIVITY | 21 | 2.09e-01 | 1.58e-01 | 6.82e-01 |
| GOCC ROUGH ENDOPLASMIC RETICULUM MEMBRANE | 25 | 1.71e-01 | 1.58e-01 | 6.38e-01 |
| GOBP NEGATIVE REGULATION OF VITAMIN METABOLIC PROCESS | 6 | 5.02e-01 | 1.58e-01 | 8.66e-01 |
| GOBP REGULATION OF PROTEIN LOCALIZATION TO SYNAPSE | 19 | 2.33e-01 | -1.58e-01 | 7.05e-01 |
| GOBP NEGATIVE REGULATION OF PROGRAMMED NECROTIC CELL DEATH | 16 | 2.74e-01 | -1.58e-01 | 7.37e-01 |
| GOBP REGULATION OF B CELL PROLIFERATION | 59 | 3.59e-02 | 1.58e-01 | 3.89e-01 |
| GOBP COLLAGEN FIBRIL ORGANIZATION | 45 | 6.69e-02 | -1.58e-01 | 4.71e-01 |
| GOBP RNA STABILIZATION | 59 | 3.59e-02 | 1.58e-01 | 3.89e-01 |
| GOMF NADPLUS PROTEIN LYSINE ADP RIBOSYLTRANSFERASE ACTIVITY | 5 | 5.41e-01 | 1.58e-01 | 8.81e-01 |
| GOBP BRANCH ELONGATION OF AN EPITHELIUM | 9 | 4.13e-01 | -1.58e-01 | 8.28e-01 |
| GOBP REGULATION OF SEQUESTERING OF TRIGLYCERIDE | 12 | 3.44e-01 | 1.58e-01 | 7.89e-01 |
| GOBP CGAS STING SIGNALING PATHWAY | 18 | 2.47e-01 | -1.58e-01 | 7.16e-01 |
| GOBP SPLICEOSOMAL TRI SNRNP COMPLEX ASSEMBLY | 15 | 2.91e-01 | -1.58e-01 | 7.48e-01 |
| GOCC EXTERNAL ENCAPSULATING STRUCTURE | 345 | 4.97e-07 | -1.58e-01 | 4.62e-04 |
| GOCC PARALLEL FIBER TO PURKINJE CELL SYNAPSE | 8 | 4.41e-01 | -1.57e-01 | 8.40e-01 |
| GOBP NEGATIVE REGULATION OF CHEMOKINE PRODUCTION | 20 | 2.23e-01 | 1.57e-01 | 6.97e-01 |
| GOBP MONOCYTE CHEMOTACTIC PROTEIN 1 PRODUCTION | 16 | 2.76e-01 | 1.57e-01 | 7.39e-01 |
| GOBP MALE MEIOSIS I | 17 | 2.62e-01 | 1.57e-01 | 7.29e-01 |
| GOBP POSITIVE REGULATION OF FEVER GENERATION | 6 | 5.05e-01 | 1.57e-01 | 8.66e-01 |
| GOBP REGULATION OF MODIFICATION OF SYNAPTIC STRUCTURE | 13 | 3.26e-01 | -1.57e-01 | 7.77e-01 |
| GOMF MONOATOMIC ION GATED CHANNEL ACTIVITY | 20 | 2.24e-01 | -1.57e-01 | 6.97e-01 |
| GOMF SMALL RIBOSOMAL SUBUNIT RRNA BINDING | 8 | 4.41e-01 | 1.57e-01 | 8.41e-01 |
| GOBP RESPONSE TO SALT STRESS | 19 | 2.36e-01 | -1.57e-01 | 7.07e-01 |
| GOBP NEGATIVE REGULATION OF PROTEIN LOCALIZATION TO NUCLEUS | 31 | 1.30e-01 | 1.57e-01 | 5.94e-01 |
| GOBP REGULATION OF SISTER CHROMATID SEGREGATION | 100 | 6.71e-03 | 1.57e-01 | 1.90e-01 |
| GOBP VENTRICULAR CARDIAC MUSCLE CELL DIFFERENTIATION | 7 | 4.72e-01 | 1.57e-01 | 8.55e-01 |
| GOMF PROTEINASE ACTIVATED RECEPTOR ACTIVITY | 5 | 5.44e-01 | -1.57e-01 | 8.82e-01 |
| GOBP NEGATIVE REGULATION OF SIGNAL TRANSDUCTION BY P53 CLASS MEDIATOR | 30 | 1.37e-01 | 1.57e-01 | 6.03e-01 |
| GOMF BETA TUBULIN BINDING | 36 | 1.04e-01 | 1.57e-01 | 5.55e-01 |
| GOBP NEURONAL ACTION POTENTIAL | 18 | 2.50e-01 | -1.57e-01 | 7.18e-01 |
| GOBP REGULATION OF NEURON PROJECTION ARBORIZATION | 13 | 3.28e-01 | -1.57e-01 | 7.78e-01 |
| GOBP RESOLUTION OF MEIOTIC RECOMBINATION INTERMEDIATES | 14 | 3.10e-01 | 1.57e-01 | 7.64e-01 |
| GOMF CYCLIN DEPENDENT PROTEIN SERINE THREONINE KINASE REGULATOR ACTIVITY | 46 | 6.60e-02 | 1.57e-01 | 4.68e-01 |
| GOBP PROTEIN RNA COMPLEX DISASSEMBLY | 10 | 3.91e-01 | 1.57e-01 | 8.18e-01 |
| GOMF SUGAR TRANSMEMBRANE TRANSPORTER ACTIVITY | 22 | 2.03e-01 | -1.57e-01 | 6.77e-01 |
| GOBP CARNITINE TRANSPORT | 7 | 4.73e-01 | -1.57e-01 | 8.55e-01 |
| GOBP NEGATIVE REGULATION OF CIRCADIAN RHYTHM | 9 | 4.17e-01 | -1.56e-01 | 8.30e-01 |
| GOCC BASEMENT MEMBRANE | 63 | 3.18e-02 | -1.56e-01 | 3.75e-01 |
| GOBP AORTA DEVELOPMENT | 43 | 7.60e-02 | -1.56e-01 | 4.93e-01 |
| GOBP REGULATION OF CELL PROJECTION SIZE | 10 | 3.92e-01 | -1.56e-01 | 8.19e-01 |
| GOBP REGULATION OF RECEPTOR SIGNALING PATHWAY VIA STAT | 66 | 2.81e-02 | 1.56e-01 | 3.58e-01 |
| GOBP POSITIVE REGULATION OF POTASSIUM ION TRANSMEMBRANE TRANSPORTER ACTIVITY | 12 | 3.49e-01 | 1.56e-01 | 7.92e-01 |
| GOBP LOCOMOTOR RHYTHM | 11 | 3.70e-01 | -1.56e-01 | 8.06e-01 |
| GOCC NEUROMUSCULAR JUNCTION | 58 | 3.97e-02 | -1.56e-01 | 3.98e-01 |
| GOBP RENAL SODIUM ION ABSORPTION | 9 | 4.17e-01 | 1.56e-01 | 8.30e-01 |
| GOBP RENAL SODIUM ION TRANSPORT | 9 | 4.17e-01 | 1.56e-01 | 8.30e-01 |
| GOBP GLUCOCORTICOID BIOSYNTHETIC PROCESS | 8 | 4.45e-01 | 1.56e-01 | 8.41e-01 |
| GOBP REGULATION OF CELL MATURATION | 15 | 2.96e-01 | 1.56e-01 | 7.53e-01 |
| GOBP ERAD PATHWAY | 105 | 5.78e-03 | 1.56e-01 | 1.80e-01 |
| GOCC EXTRINSIC COMPONENT OF POSTSYNAPTIC MEMBRANE | 8 | 4.45e-01 | 1.56e-01 | 8.41e-01 |
| GOBP GOLGI VESICLE TRANSPORT | 288 | 5.41e-06 | 1.56e-01 | 2.01e-03 |
| GOCC SPLICEOSOMAL COMPLEX | 194 | 1.83e-04 | 1.56e-01 | 2.30e-02 |
| GOCC POSTSYNAPTIC SPECIALIZATION MEMBRANE | 74 | 2.05e-02 | -1.56e-01 | 3.12e-01 |
| GOBP POSITIVE REGULATION OF RNA BINDING | 5 | 5.47e-01 | 1.56e-01 | 8.84e-01 |
| GOMF MISMATCHED DNA BINDING | 14 | 3.13e-01 | 1.56e-01 | 7.66e-01 |
| GOBP NEGATIVE REGULATION OF UBIQUITIN PROTEIN TRANSFERASE ACTIVITY | 15 | 2.97e-01 | 1.56e-01 | 7.53e-01 |
| GOBP REGULATION OF STEROID HORMONE SECRETION | 15 | 2.97e-01 | 1.56e-01 | 7.53e-01 |
| GOMF DNA POLYMERASE BINDING | 20 | 2.29e-01 | -1.56e-01 | 7.01e-01 |
| GOBP PERK MEDIATED UNFOLDED PROTEIN RESPONSE | 19 | 2.41e-01 | 1.56e-01 | 7.11e-01 |
| GOBP REGULATION OF LIPOPHAGY | 5 | 5.47e-01 | 1.55e-01 | 8.84e-01 |
| GOBP MECHANORECEPTOR DIFFERENTIATION | 48 | 6.24e-02 | -1.55e-01 | 4.63e-01 |
| GOBP POSITIVE REGULATION OF CELL CYCLE G1 S PHASE TRANSITION | 51 | 5.49e-02 | 1.55e-01 | 4.38e-01 |
| GOBP REGULATION OF CELLULAR SENESCENCE | 40 | 8.95e-02 | 1.55e-01 | 5.24e-01 |
| GOBP PURINE NUCLEOBASE METABOLIC PROCESS | 17 | 2.68e-01 | 1.55e-01 | 7.33e-01 |
| GOBP ESTABLISHMENT OF MITOCHONDRION LOCALIZATION | 28 | 1.56e-01 | 1.55e-01 | 6.19e-01 |
| GOBP EPITHELIAL CELL FATE COMMITMENT | 6 | 5.11e-01 | 1.55e-01 | 8.70e-01 |
| GOBP SCHWANN CELL MIGRATION | 5 | 5.49e-01 | 1.55e-01 | 8.84e-01 |
| GOBP RESPONSE TO MITOCHONDRIAL DEPOLARISATION | 20 | 2.31e-01 | -1.55e-01 | 7.04e-01 |
| GOBP THYROID HORMONE MEDIATED SIGNALING PATHWAY | 6 | 5.12e-01 | -1.55e-01 | 8.70e-01 |
| GOBP EMBRYONIC EYE MORPHOGENESIS | 16 | 2.84e-01 | -1.55e-01 | 7.44e-01 |
| GOCC MICROBODY MEMBRANE | 61 | 3.68e-02 | 1.55e-01 | 3.91e-01 |
| GOBP ENDOSOME TO PLASMA MEMBRANE PROTEIN TRANSPORT | 16 | 2.84e-01 | 1.55e-01 | 7.45e-01 |
| GOMF GALACTOSIDASE ACTIVITY | 6 | 5.12e-01 | -1.55e-01 | 8.70e-01 |
| GOBP POSITIVE REGULATION OF FATTY ACID METABOLIC PROCESS | 29 | 1.50e-01 | -1.54e-01 | 6.13e-01 |
| GOBP RESPONSE TO TOPOLOGICALLY INCORRECT PROTEIN | 138 | 1.76e-03 | 1.54e-01 | 1.02e-01 |
| GOBP NEGATIVE REGULATION OF CALCIUM ION TRANSMEMBRANE TRANSPORT | 32 | 1.31e-01 | 1.54e-01 | 5.95e-01 |
| GOBP REGULATION OF PEPTIDYL THREONINE PHOSPHORYLATION | 36 | 1.09e-01 | -1.54e-01 | 5.63e-01 |
| GOBP RELAXATION OF SMOOTH MUSCLE | 8 | 4.50e-01 | 1.54e-01 | 8.43e-01 |
| GOBP RNA 3 END PROCESSING | 85 | 1.41e-02 | 1.54e-01 | 2.56e-01 |
| GOBP NEGATIVE REGULATION OF BLOOD VESSEL ENDOTHELIAL CELL MIGRATION | 29 | 1.51e-01 | -1.54e-01 | 6.13e-01 |
| GOMF KINASE ACTIVATOR ACTIVITY | 122 | 3.30e-03 | 1.54e-01 | 1.35e-01 |
| GOBP NEGATIVE REGULATION OF CELL SIZE | 8 | 4.51e-01 | -1.54e-01 | 8.43e-01 |
| GOBP POSITIVE REGULATION OF AXON EXTENSION INVOLVED IN AXON GUIDANCE | 5 | 5.51e-01 | 1.54e-01 | 8.85e-01 |
| GOBP POSITIVE REGULATION OF HETEROTYPIC CELL CELL ADHESION | 10 | 3.99e-01 | -1.54e-01 | 8.22e-01 |
| GOMF 2 IRON 2 SULFUR CLUSTER BINDING | 25 | 1.83e-01 | 1.54e-01 | 6.55e-01 |
| GOBP ODONTOGENESIS OF DENTIN CONTAINING TOOTH | 52 | 5.49e-02 | -1.54e-01 | 4.38e-01 |
| GOMF LIGAND ACTIVATED TRANSCRIPTION FACTOR ACTIVITY | 39 | 9.64e-02 | -1.54e-01 | 5.40e-01 |
| GOBP INTERLEUKIN 10 PRODUCTION | 53 | 5.27e-02 | 1.54e-01 | 4.33e-01 |
| GOBP REGULATION OF RAB PROTEIN SIGNAL TRANSDUCTION | 7 | 4.81e-01 | -1.54e-01 | 8.59e-01 |
| GOBP NEURAL NUCLEUS DEVELOPMENT | 51 | 5.75e-02 | 1.54e-01 | 4.46e-01 |
| GOMF PROTEIN LIPID COMPLEX BINDING | 24 | 1.93e-01 | -1.54e-01 | 6.65e-01 |
| GOBP POSITIVE REGULATION OF ENDOTHELIAL CELL DIFFERENTIATION | 8 | 4.52e-01 | -1.54e-01 | 8.43e-01 |
| GOBP PROTEIN LIPID COMPLEX ORGANIZATION | 35 | 1.16e-01 | -1.54e-01 | 5.74e-01 |
| GOMF LARGE RIBOSOMAL SUBUNIT RRNA BINDING | 5 | 5.52e-01 | -1.54e-01 | 8.86e-01 |
| GOBP REGULATION OF BICELLULAR TIGHT JUNCTION ASSEMBLY | 17 | 2.73e-01 | -1.54e-01 | 7.36e-01 |
| GOBP PEPTIDYL LYSINE HYDROXYLATION | 8 | 4.52e-01 | -1.54e-01 | 8.43e-01 |
| GOCC NLRP1 INFLAMMASOME COMPLEX | 5 | 5.52e-01 | 1.54e-01 | 8.86e-01 |
| GOBP STEROID CATABOLIC PROCESS | 14 | 3.20e-01 | -1.54e-01 | 7.71e-01 |
| GOBP CHONDROCYTE DEVELOPMENT | 20 | 2.35e-01 | 1.53e-01 | 7.06e-01 |
| GOMF HISTONE READER ACTIVITY | 18 | 2.60e-01 | -1.53e-01 | 7.28e-01 |
| GOMF G PROTEIN COUPLED CHEMOATTRACTANT RECEPTOR ACTIVITY | 25 | 1.84e-01 | 1.53e-01 | 6.57e-01 |
| GOBP ROSTROCAUDAL NEURAL TUBE PATTERNING | 7 | 4.82e-01 | -1.53e-01 | 8.59e-01 |
| GOBP REGULATION OF CHROMATIN ORGANIZATION | 33 | 1.27e-01 | 1.53e-01 | 5.92e-01 |
| GOBP CELLULAR PIGMENTATION | 57 | 4.52e-02 | 1.53e-01 | 4.13e-01 |
| GOBP STRESS ACTIVATED PROTEIN KINASE SIGNALING CASCADE | 50 | 6.08e-02 | 1.53e-01 | 4.57e-01 |
| GOBP MONOACYLGLYCEROL BIOSYNTHETIC PROCESS | 6 | 5.16e-01 | -1.53e-01 | 8.72e-01 |
| GOBP DNA CONFORMATION CHANGE | 88 | 1.30e-02 | 1.53e-01 | 2.49e-01 |
| GOBP CALCIUM ION REGULATED EXOCYTOSIS OF NEUROTRANSMITTER | 13 | 3.39e-01 | -1.53e-01 | 7.87e-01 |
| GOBP INDOLE CONTAINING COMPOUND CATABOLIC PROCESS | 8 | 4.53e-01 | 1.53e-01 | 8.43e-01 |
| GOBP PROTEIN MATURATION BY PROTEIN FOLDING | 8 | 4.53e-01 | 1.53e-01 | 8.43e-01 |
| GOBP INTRACELLULAR LIPID TRANSPORT | 45 | 7.56e-02 | 1.53e-01 | 4.93e-01 |
| GOBP POSITIVE REGULATION OF SMOOTH MUSCLE CONTRACTION | 21 | 2.25e-01 | -1.53e-01 | 6.98e-01 |
| GOMF TRANSCRIPTION COREGULATOR BINDING | 103 | 7.27e-03 | -1.53e-01 | 1.95e-01 |
| GOBP PURINE RIBONUCLEOSIDE METABOLIC PROCESS | 21 | 2.25e-01 | 1.53e-01 | 6.98e-01 |
| GOBP POSITIVE REGULATION OF VASCULAR ASSOCIATED SMOOTH MUSCLE CELL DIFFERENTIATION | 6 | 5.16e-01 | -1.53e-01 | 8.72e-01 |
| GOBP STABILIZATION OF MEMBRANE POTENTIAL | 9 | 4.27e-01 | -1.53e-01 | 8.33e-01 |
| GOBP EMBRYONIC DIGIT MORPHOGENESIS | 34 | 1.23e-01 | 1.53e-01 | 5.86e-01 |
| GOMF WW DOMAIN BINDING | 18 | 2.61e-01 | 1.53e-01 | 7.29e-01 |
| GOBP NEGATIVE REGULATION OF NUCLEAR DIVISION | 56 | 4.80e-02 | 1.53e-01 | 4.25e-01 |
| GOMF XENOBIOTIC TRANSMEMBRANE TRANSPORTER ACTIVITY | 24 | 1.95e-01 | -1.53e-01 | 6.68e-01 |
| GOMF ANKYRIN BINDING | 13 | 3.41e-01 | 1.53e-01 | 7.88e-01 |
| GOBP PARAXIAL MESODERM DEVELOPMENT | 11 | 3.81e-01 | 1.53e-01 | 8.13e-01 |
| GOBP KETONE BIOSYNTHETIC PROCESS | 38 | 1.03e-01 | -1.53e-01 | 5.55e-01 |
| GOMF ICOSANOID BINDING | 7 | 4.85e-01 | -1.53e-01 | 8.60e-01 |
| GOBP MIRNA MEDIATED GENE SILENCING BY INHIBITION OF TRANSLATION | 19 | 2.50e-01 | 1.52e-01 | 7.18e-01 |
| GOBP PROTEIN POLYUBIQUITINATION | 251 | 3.21e-05 | 1.52e-01 | 6.15e-03 |
| GOBP GOLGI TO PLASMA MEMBRANE PROTEIN TRANSPORT | 39 | 9.97e-02 | 1.52e-01 | 5.47e-01 |
| GOBP SYNAPTIC VESICLE TRANSPORT | 40 | 9.55e-02 | 1.52e-01 | 5.38e-01 |
| GOBP POSITIVE REGULATION OF PROTEIN LOCALIZATION TO CENTROSOME | 7 | 4.85e-01 | -1.52e-01 | 8.60e-01 |
| GOBP POSITIVE REGULATION OF MESENCHYMAL CELL PROLIFERATION | 14 | 3.24e-01 | 1.52e-01 | 7.75e-01 |
| GOBP NEGATIVE REGULATION OF CELL CELL ADHESION MEDIATED BY CADHERIN | 9 | 4.29e-01 | -1.52e-01 | 8.34e-01 |
| GOBP NEGATIVE REGULATION OF STEROID METABOLIC PROCESS | 18 | 2.64e-01 | 1.52e-01 | 7.31e-01 |
| GOBP PROTEIN LOCALIZATION TO CILIARY TRANSITION ZONE | 7 | 4.86e-01 | 1.52e-01 | 8.60e-01 |
| GOBP VIRAL PROTEIN PROCESSING | 30 | 1.49e-01 | 1.52e-01 | 6.13e-01 |
| GOMF SODIUM PROTON ANTIPORTER ACTIVITY | 11 | 3.83e-01 | 1.52e-01 | 8.15e-01 |
| GOBP REGULATION OF PROTEIN IMPORT INTO NUCLEUS | 50 | 6.29e-02 | 1.52e-01 | 4.63e-01 |
| GOBP POSITIVE REGULATION OF NUCLEOTIDE METABOLIC PROCESS | 26 | 1.80e-01 | 1.52e-01 | 6.53e-01 |
| GOBP CELL VOLUME HOMEOSTASIS | 31 | 1.43e-01 | -1.52e-01 | 6.11e-01 |
| GOMF NADPLUS PROTEIN CYSTEINE ADP RIBOSYLTRANSFERASE ACTIVITY | 6 | 5.19e-01 | 1.52e-01 | 8.74e-01 |
| GOBP ASTROCYTE ACTIVATION | 19 | 2.52e-01 | -1.52e-01 | 7.20e-01 |
| GOBP SOMATIC DIVERSIFICATION OF IMMUNOGLOBULINS | 65 | 3.43e-02 | 1.52e-01 | 3.84e-01 |
| GOBP VESICLE TETHERING | 32 | 1.37e-01 | 1.52e-01 | 6.03e-01 |
| GOBP MITOTIC SISTER CHROMATID SEPARATION | 62 | 3.87e-02 | 1.52e-01 | 3.98e-01 |
| GOBP TRYPTOPHAN METABOLIC PROCESS | 10 | 4.06e-01 | 1.52e-01 | 8.26e-01 |
| GOMF TOXIC SUBSTANCE BINDING | 6 | 5.20e-01 | 1.52e-01 | 8.74e-01 |
| GOCC PHAGOLYSOSOME | 7 | 4.87e-01 | -1.52e-01 | 8.60e-01 |
| GOCC COLLAGEN CONTAINING EXTRACELLULAR MATRIX | 265 | 2.13e-05 | -1.52e-01 | 5.08e-03 |
| GOMF GLYCOLIPID BINDING | 23 | 2.08e-01 | 1.52e-01 | 6.82e-01 |
| GOBP O GLYCAN PROCESSING | 36 | 1.15e-01 | 1.52e-01 | 5.73e-01 |
| GOBP PROTEIN N LINKED GLYCOSYLATION | 64 | 3.60e-02 | 1.52e-01 | 3.89e-01 |
| GOBP ERBB4 SIGNALING PATHWAY | 6 | 5.20e-01 | -1.52e-01 | 8.74e-01 |
| GOBP 3 PHOSPHOADENOSINE 5 PHOSPHOSULFATE METABOLIC PROCESS | 13 | 3.44e-01 | -1.51e-01 | 7.89e-01 |
| GOMF MOLECULAR CARRIER ACTIVITY | 88 | 1.40e-02 | 1.51e-01 | 2.56e-01 |
| GOBP NEGATIVE REGULATION OF SMOOTH MUSCLE CELL APOPTOTIC PROCESS | 11 | 3.85e-01 | -1.51e-01 | 8.15e-01 |
| GOCC CIS GOLGI NETWORK | 60 | 4.27e-02 | 1.51e-01 | 4.07e-01 |
| GOBP NEGATIVE REGULATION OF CARBOHYDRATE METABOLIC PROCESS | 48 | 6.99e-02 | -1.51e-01 | 4.80e-01 |
| GOCC AXONEMAL DYNEIN COMPLEX | 15 | 3.11e-01 | -1.51e-01 | 7.64e-01 |
| GOBP NUCLEAR TRANSCRIBED MRNA CATABOLIC PROCESS | 121 | 4.08e-03 | 1.51e-01 | 1.52e-01 |
| GOBP PEPTIDYL HISTIDINE MODIFICATION | 9 | 4.32e-01 | 1.51e-01 | 8.36e-01 |
| GOBP POSITIVE REGULATION OF B CELL PROLIFERATION | 40 | 9.81e-02 | 1.51e-01 | 5.45e-01 |
| GOBP PHOSPHOLIPASE C ACTIVATING G PROTEIN COUPLED ACETYLCHOLINE RECEPTOR SIGNALING PATHWAY | 6 | 5.22e-01 | -1.51e-01 | 8.75e-01 |
| GOBP RESPONSE TO GRAVITY | 6 | 5.22e-01 | -1.51e-01 | 8.75e-01 |
| GOBP POSITIVE REGULATION OF VASCULAR ENDOTHELIAL GROWTH FACTOR SIGNALING PATHWAY | 5 | 5.59e-01 | 1.51e-01 | 8.88e-01 |
| GOBP MACROPHAGE PROLIFERATION | 7 | 4.89e-01 | 1.51e-01 | 8.61e-01 |
| GOMF TRANSITION METAL ION TRANSMEMBRANE TRANSPORTER ACTIVITY | 38 | 1.07e-01 | 1.51e-01 | 5.61e-01 |
| GOBP LOCOMOTION INVOLVED IN LOCOMOTORY BEHAVIOR | 10 | 4.09e-01 | 1.51e-01 | 8.26e-01 |
| GOBP POSTSYNAPTIC DENSITY PROTEIN 95 CLUSTERING | 7 | 4.89e-01 | 1.51e-01 | 8.61e-01 |
| GOBP REGULATION OF MITOPHAGY | 35 | 1.22e-01 | -1.51e-01 | 5.86e-01 |
| GOBP CONVERGENT EXTENSION INVOLVED IN GASTRULATION | 7 | 4.89e-01 | -1.51e-01 | 8.61e-01 |
| GOBP CELLULAR RESPONSE TO ESTROGEN STIMULUS | 16 | 2.96e-01 | 1.51e-01 | 7.53e-01 |
| GOBP POSITIVE REGULATION OF HIPPO SIGNALING | 9 | 4.33e-01 | 1.51e-01 | 8.36e-01 |
| GOBP CELL PROLIFERATION IN HINDBRAIN | 9 | 4.33e-01 | -1.51e-01 | 8.36e-01 |
| GOBP SPERM CAPACITATION | 11 | 3.87e-01 | -1.51e-01 | 8.16e-01 |
| GOBP MEMBRANE TUBULATION | 5 | 5.59e-01 | 1.51e-01 | 8.88e-01 |
| GOBP FLOOR PLATE DEVELOPMENT | 7 | 4.90e-01 | -1.51e-01 | 8.61e-01 |
| GOMF SIALIC ACID BINDING | 16 | 2.96e-01 | -1.51e-01 | 7.53e-01 |
| GOBP DECIDUALIZATION | 18 | 2.69e-01 | -1.51e-01 | 7.33e-01 |
| GOBP IMMUNOLOGICAL MEMORY FORMATION PROCESS | 10 | 4.10e-01 | 1.51e-01 | 8.26e-01 |
| GOBP POSITIVE REGULATION OF STEROL TRANSPORT | 26 | 1.84e-01 | -1.51e-01 | 6.56e-01 |
| GOBP SEQUESTERING OF TRIGLYCERIDE | 15 | 3.13e-01 | 1.51e-01 | 7.65e-01 |
| GOBP NEGATIVE REGULATION OF PROTEIN AUTOPHOSPHORYLATION | 7 | 4.91e-01 | 1.50e-01 | 8.62e-01 |
| GOMF HISTONE DEACETYLASE BINDING | 102 | 8.65e-03 | -1.50e-01 | 2.15e-01 |
| GOBP REGULATION OF NATURAL KILLER CELL PROLIFERATION | 9 | 4.35e-01 | 1.50e-01 | 8.36e-01 |
| GOBP SCHWANN CELL PROLIFERATION | 8 | 4.61e-01 | 1.50e-01 | 8.48e-01 |
| GOBP MAST CELL ACTIVATION | 60 | 4.40e-02 | 1.50e-01 | 4.11e-01 |
| GOBP L PROLINE BIOSYNTHETIC PROCESS | 6 | 5.24e-01 | 1.50e-01 | 8.76e-01 |
| GOBP POSITIVE REGULATION OF SYNAPSE ASSEMBLY | 38 | 1.09e-01 | -1.50e-01 | 5.62e-01 |
| GOBP REGULATION OF SNARE COMPLEX ASSEMBLY | 13 | 3.48e-01 | -1.50e-01 | 7.92e-01 |
| GOBP DETECTION OF BACTERIUM | 15 | 3.14e-01 | -1.50e-01 | 7.66e-01 |
| GOBP MATURATION OF LSU RRNA | 24 | 2.03e-01 | 1.50e-01 | 6.76e-01 |
| GOCC SCF UBIQUITIN LIGASE COMPLEX | 59 | 4.61e-02 | 1.50e-01 | 4.17e-01 |
| GOBP REGULATION OF TRANSLATION AT POSTSYNAPSE | 5 | 5.61e-01 | -1.50e-01 | 8.88e-01 |
| GOCC DYSTROGLYCAN COMPLEX | 5 | 5.61e-01 | -1.50e-01 | 8.88e-01 |
| GOBP HEMOGLOBIN BIOSYNTHETIC PROCESS | 11 | 3.89e-01 | 1.50e-01 | 8.17e-01 |
| GOCC MICOS COMPLEX | 9 | 4.36e-01 | -1.50e-01 | 8.37e-01 |
| GOBP VESICLE MEDIATED TRANSPORT BETWEEN ENDOSOMAL COMPARTMENTS | 49 | 6.92e-02 | 1.50e-01 | 4.78e-01 |
| GOBP POSITIVE REGULATION OF TRANSMEMBRANE RECEPTOR PROTEIN SERINE THREONINE KINASE SIGNALING PATHWAY | 73 | 2.67e-02 | -1.50e-01 | 3.53e-01 |
| GOCC EXOCYST | 15 | 3.15e-01 | 1.50e-01 | 7.67e-01 |
| GOBP PIGMENT METABOLIC PROCESS | 58 | 4.83e-02 | -1.50e-01 | 4.25e-01 |
| GOBP REGULATION OF GLYCOGEN METABOLIC PROCESS | 26 | 1.86e-01 | -1.50e-01 | 6.60e-01 |
| GOBP NEGATIVE REGULATION OF ION TRANSMEMBRANE TRANSPORTER ACTIVITY | 36 | 1.20e-01 | 1.50e-01 | 5.82e-01 |
| GOMF FLAP ENDONUCLEASE ACTIVITY | 8 | 4.63e-01 | -1.50e-01 | 8.49e-01 |
| GOBP GLANDULAR EPITHELIAL CELL MATURATION | 7 | 4.93e-01 | 1.50e-01 | 8.62e-01 |
| GOCC TIM22 MITOCHONDRIAL IMPORT INNER MEMBRANE INSERTION COMPLEX | 7 | 4.93e-01 | 1.50e-01 | 8.62e-01 |
| GOBP REGULATION OF STEROL TRANSPORT | 43 | 8.95e-02 | -1.50e-01 | 5.24e-01 |
| GOBP CEREBELLAR PURKINJE CELL LAYER FORMATION | 10 | 4.13e-01 | 1.50e-01 | 8.28e-01 |
| GOBP REGULATION OF CHAPERONE MEDIATED AUTOPHAGY | 8 | 4.64e-01 | -1.49e-01 | 8.50e-01 |
| GOBP CRANIAL NERVE DEVELOPMENT | 39 | 1.06e-01 | 1.49e-01 | 5.59e-01 |
| GOBP CORPUS CALLOSUM DEVELOPMENT | 25 | 1.96e-01 | 1.49e-01 | 6.68e-01 |
| GOMF PHOSPHOLIPASE INHIBITOR ACTIVITY | 7 | 4.94e-01 | 1.49e-01 | 8.62e-01 |
| GOBP REGULATION OF BILE ACID BIOSYNTHETIC PROCESS | 6 | 5.26e-01 | 1.49e-01 | 8.76e-01 |
| GOBP MYOSIN FILAMENT ORGANIZATION | 6 | 5.27e-01 | -1.49e-01 | 8.76e-01 |
| GOBP REGULATION OF RECEPTOR RECYCLING | 21 | 2.36e-01 | 1.49e-01 | 7.07e-01 |
| GOMF MINUS END DIRECTED MICROTUBULE MOTOR ACTIVITY | 14 | 3.34e-01 | -1.49e-01 | 7.84e-01 |
| GOBP PLATELET DEGRANULATION | 7 | 4.95e-01 | 1.49e-01 | 8.62e-01 |
| GOBP NEGATIVE REGULATION OF T CELL DIFFERENTIATION IN THYMUS | 6 | 5.27e-01 | 1.49e-01 | 8.76e-01 |
| GOBP NEGATIVE REGULATION OF FERROPTOSIS | 8 | 4.66e-01 | -1.49e-01 | 8.51e-01 |
| GOBP MAINTENANCE OF SYNAPSE STRUCTURE | 20 | 2.49e-01 | -1.49e-01 | 7.18e-01 |
| GOMF ABC TYPE XENOBIOTIC TRANSPORTER ACTIVITY | 11 | 3.93e-01 | -1.49e-01 | 8.20e-01 |
| GOMF SIALYLTRANSFERASE ACTIVITY | 16 | 3.03e-01 | 1.49e-01 | 7.58e-01 |
| GOMF TRANSLATION FACTOR ACTIVITY RNA BINDING | 82 | 1.99e-02 | 1.49e-01 | 3.07e-01 |
| GOBP GLIAL CELL DEVELOPMENT | 103 | 9.16e-03 | -1.49e-01 | 2.20e-01 |
| GOCC CASPASE COMPLEX | 9 | 4.40e-01 | -1.49e-01 | 8.40e-01 |
| GOBP NEGATIVE T CELL SELECTION | 11 | 3.94e-01 | 1.49e-01 | 8.20e-01 |
| GOMF PROTEIN ANTIGEN BINDING | 8 | 4.67e-01 | 1.49e-01 | 8.52e-01 |
| GOBP 4FE 4S CLUSTER ASSEMBLY | 5 | 5.65e-01 | -1.49e-01 | 8.90e-01 |
| GOMF SUMO BINDING | 17 | 2.89e-01 | 1.49e-01 | 7.47e-01 |
| GOBP AMP SALVAGE | 5 | 5.65e-01 | 1.49e-01 | 8.90e-01 |
| GOBP REGULATION OF PLATELET DERIVED GROWTH FACTOR RECEPTOR SIGNALING PATHWAY | 17 | 2.89e-01 | 1.48e-01 | 7.47e-01 |
| GOBP WHITE FAT CELL DIFFERENTIATION | 12 | 3.73e-01 | 1.48e-01 | 8.09e-01 |
| GOCC DENDRITE MEMBRANE | 20 | 2.50e-01 | -1.48e-01 | 7.18e-01 |
| GOMF INORGANIC DIPHOSPHATE PHOSPHATASE ACTIVITY | 5 | 5.66e-01 | 1.48e-01 | 8.90e-01 |
| GOBP TYPE B PANCREATIC CELL DIFFERENTIATION | 17 | 2.89e-01 | -1.48e-01 | 7.47e-01 |
| GOBP EPITHELIAL TO MESENCHYMAL TRANSITION INVOLVED IN ENDOCARDIAL CUSHION FORMATION | 10 | 4.17e-01 | 1.48e-01 | 8.30e-01 |
| GOMF PROTEASOME BINDING | 16 | 3.04e-01 | 1.48e-01 | 7.60e-01 |
| GOCC INTRACILIARY TRANSPORT PARTICLE A | 8 | 4.68e-01 | -1.48e-01 | 8.53e-01 |
| GOBP REGULATION OF PLATELET ACTIVATION | 44 | 8.91e-02 | -1.48e-01 | 5.22e-01 |
| GOBP NEGATIVE REGULATION OF CYTOKINE PRODUCTION INVOLVED IN IMMUNE RESPONSE | 29 | 1.68e-01 | -1.48e-01 | 6.33e-01 |
| GOBP INTERLEUKIN 17 MEDIATED SIGNALING PATHWAY | 9 | 4.42e-01 | -1.48e-01 | 8.41e-01 |
| GOMF LEUCINE ZIPPER DOMAIN BINDING | 11 | 3.95e-01 | -1.48e-01 | 8.20e-01 |
| GOCC CYCLIN DEPENDENT PROTEIN KINASE HOLOENZYME COMPLEX | 53 | 6.24e-02 | 1.48e-01 | 4.63e-01 |
| GOBP ACTIVATION OF INNATE IMMUNE RESPONSE | 274 | 2.49e-05 | 1.48e-01 | 5.36e-03 |
| GOBP POSITIVE REGULATION OF NUCLEAR TRANSCRIBED MRNA CATABOLIC PROCESS DEADENYLATION DEPENDENT DECAY | 12 | 3.75e-01 | 1.48e-01 | 8.09e-01 |
| GOMF ALANINE TRANSMEMBRANE TRANSPORTER ACTIVITY | 12 | 3.75e-01 | 1.48e-01 | 8.09e-01 |
| GOBP DEVELOPMENTAL PIGMENTATION | 33 | 1.42e-01 | 1.48e-01 | 6.09e-01 |
| GOBP NEGATIVE REGULATION OF ESTABLISHMENT OF PROTEIN LOCALIZATION | 105 | 8.91e-03 | 1.48e-01 | 2.18e-01 |
| GOCC RNAI EFFECTOR COMPLEX | 31 | 1.55e-01 | 1.48e-01 | 6.17e-01 |
| GOBP OBSERVATIONAL LEARNING | 5 | 5.67e-01 | 1.48e-01 | 8.90e-01 |
| GOBP RHODOPSIN MEDIATED SIGNALING PATHWAY | 8 | 4.70e-01 | 1.48e-01 | 8.54e-01 |
| GOBP PROTEIN HYDROXYLATION | 22 | 2.31e-01 | -1.48e-01 | 7.04e-01 |
| GOBP POSITIVE REGULATION OF TROPHOBLAST CELL MIGRATION | 5 | 5.68e-01 | 1.48e-01 | 8.90e-01 |
| GOMF TBP CLASS PROTEIN BINDING | 24 | 2.11e-01 | 1.48e-01 | 6.83e-01 |
| GOMF RNA STEM LOOP BINDING | 15 | 3.23e-01 | 1.48e-01 | 7.74e-01 |
| GOBP REGULATION OF LEUKOCYTE TETHERING OR ROLLING | 12 | 3.77e-01 | -1.47e-01 | 8.10e-01 |
| GOBP REGULATION OF GLUCOCORTICOID BIOSYNTHETIC PROCESS | 7 | 5.00e-01 | 1.47e-01 | 8.64e-01 |
| GOBP ACTIVATION OF PHOSPHOLIPASE C ACTIVITY | 16 | 3.08e-01 | -1.47e-01 | 7.62e-01 |
| GOBP NEGATIVE REGULATION OF MITOCHONDRIAL FUSION | 8 | 4.71e-01 | -1.47e-01 | 8.54e-01 |
| GOBP REGULATION OF EXIT FROM MITOSIS | 15 | 3.24e-01 | -1.47e-01 | 7.75e-01 |
| GOBP REGULATION OF ENDOPLASMIC RETICULUM UNFOLDED PROTEIN RESPONSE | 28 | 1.78e-01 | 1.47e-01 | 6.50e-01 |
| GOBP FRUCTOSE 2 6 BISPHOSPHATE METABOLIC PROCESS | 5 | 5.69e-01 | 1.47e-01 | 8.90e-01 |
| GOMF FRUCTOSE 2 6 BISPHOSPHATE 2 PHOSPHATASE ACTIVITY | 5 | 5.69e-01 | 1.47e-01 | 8.90e-01 |
| GOMF ENDOPEPTIDASE ACTIVATOR ACTIVITY | 18 | 2.80e-01 | 1.47e-01 | 7.41e-01 |
| GOBP NUCLEAR BODY ORGANIZATION | 18 | 2.80e-01 | 1.47e-01 | 7.41e-01 |
| GOBP TOLL LIKE RECEPTOR SIGNALING PATHWAY | 74 | 2.88e-02 | 1.47e-01 | 3.59e-01 |
| GOCC NEUROFIBRILLARY TANGLE | 5 | 5.69e-01 | 1.47e-01 | 8.90e-01 |
| GOBP REGULATION OF CILIUM MOVEMENT | 20 | 2.55e-01 | -1.47e-01 | 7.25e-01 |
| GOMF COENZYME A DIPHOSPHATASE ACTIVITY | 5 | 5.70e-01 | -1.47e-01 | 8.90e-01 |
| GOBP NEGATIVE REGULATION OF CELL ADHESION MEDIATED BY INTEGRIN | 10 | 4.21e-01 | 1.47e-01 | 8.30e-01 |
| GOCC IGM IMMUNOGLOBULIN COMPLEX | 8 | 4.72e-01 | -1.47e-01 | 8.54e-01 |
| GOBP NEGATIVE REGULATION OF ACUTE INFLAMMATORY RESPONSE | 8 | 4.72e-01 | 1.47e-01 | 8.54e-01 |
| GOBP NEGATIVE REGULATION OF RESPONSE TO NUTRIENT LEVELS | 9 | 4.46e-01 | -1.47e-01 | 8.41e-01 |
| GOBP REGULATION OF MORPHOGENESIS OF AN EPITHELIUM | 39 | 1.13e-01 | -1.47e-01 | 5.68e-01 |
| GOBP PEPTIDYL METHIONINE MODIFICATION | 10 | 4.22e-01 | 1.47e-01 | 8.30e-01 |
| GOBP PROTON TRANSPORTING TWO SECTOR ATPASE COMPLEX ASSEMBLY | 15 | 3.26e-01 | -1.47e-01 | 7.76e-01 |
| GOBP NEGATIVE REGULATION OF CELL MATURATION | 5 | 5.70e-01 | 1.47e-01 | 8.90e-01 |
| GOCC GOLGI ASSOCIATED VESICLE MEMBRANE | 49 | 7.60e-02 | 1.47e-01 | 4.93e-01 |
| GOBP REGULATION OF NUCLEAR TRANSCRIBED MRNA POLY A TAIL SHORTENING | 15 | 3.26e-01 | 1.46e-01 | 7.77e-01 |
| GOCC NEURON PROJECTION CYTOPLASM | 78 | 2.54e-02 | 1.46e-01 | 3.45e-01 |
| GOBP HEME TRANSPORT | 9 | 4.47e-01 | -1.46e-01 | 8.42e-01 |
| GOMF HEME TRANSMEMBRANE TRANSPORTER ACTIVITY | 9 | 4.47e-01 | -1.46e-01 | 8.42e-01 |
| GOBP DNA REPAIR DEPENDENT CHROMATIN REMODELING | 22 | 2.35e-01 | 1.46e-01 | 7.05e-01 |
| GOBP REGULATION OF T HELPER 1 TYPE IMMUNE RESPONSE | 28 | 1.80e-01 | 1.46e-01 | 6.53e-01 |
| GOBP NEGATIVE REGULATION OF AMINE TRANSPORT | 15 | 3.27e-01 | -1.46e-01 | 7.77e-01 |
| GOCC AP 3 ADAPTOR COMPLEX | 11 | 4.01e-01 | 1.46e-01 | 8.23e-01 |
| GOBP DENDRITIC CELL CYTOKINE PRODUCTION | 16 | 3.11e-01 | 1.46e-01 | 7.65e-01 |
| GOBP REGULATION OF PROTEIN LOCALIZATION TO CENTROSOME | 12 | 3.81e-01 | -1.46e-01 | 8.13e-01 |
| GOBP REGULATION OF RESPONSE TO TUMOR CELL | 21 | 2.47e-01 | 1.46e-01 | 7.16e-01 |
| GOBP POSITIVE REGULATION OF VASCULAR ENDOTHELIAL GROWTH FACTOR PRODUCTION | 23 | 2.25e-01 | 1.46e-01 | 6.98e-01 |
| GOMF MONOATOMIC ANION MONOATOMIC CATION SYMPORTER ACTIVITY | 18 | 2.84e-01 | -1.46e-01 | 7.44e-01 |
| GOCC POSTSYNAPTIC RECYCLING ENDOSOME | 8 | 4.75e-01 | 1.46e-01 | 8.56e-01 |
| GOBP POSITIVE REGULATION OF PROTEIN UBIQUITINATION | 97 | 1.31e-02 | 1.46e-01 | 2.49e-01 |
| GOBP REGULATION OF PEPTIDYL SERINE DEPHOSPHORYLATION | 7 | 5.04e-01 | 1.46e-01 | 8.66e-01 |
| GOCC FILOPODIUM | 83 | 2.17e-02 | 1.46e-01 | 3.22e-01 |
| GOBP DENDRITIC CELL CHEMOTAXIS | 22 | 2.37e-01 | 1.46e-01 | 7.08e-01 |
| GOMF GROWTH FACTOR ACTIVITY | 77 | 2.70e-02 | -1.46e-01 | 3.53e-01 |
| GOBP G1 TO G0 TRANSITION INVOLVED IN CELL DIFFERENTIATION | 5 | 5.73e-01 | -1.46e-01 | 8.92e-01 |
| GOBP REGULATION OF SYNAPTIC VESICLE CYCLE | 12 | 3.82e-01 | 1.46e-01 | 8.14e-01 |
| GOBP PROTEIN LOCALIZATION TO POSTSYNAPSE | 33 | 1.48e-01 | -1.46e-01 | 6.13e-01 |
| GOBP NUCLEAR CHROMOSOME SEGREGATION | 287 | 2.21e-05 | 1.46e-01 | 5.12e-03 |
| GOBP CELLULAR RESPONSE TO OXIDISED LOW DENSITY LIPOPROTEIN PARTICLE STIMULUS | 11 | 4.03e-01 | 1.45e-01 | 8.24e-01 |
| GOMF ACYLGLYCEROL LIPASE ACTIVITY | 14 | 3.46e-01 | -1.45e-01 | 7.90e-01 |
| GOCC CLATHRIN SCULPTED GAMMA AMINOBUTYRIC ACID TRANSPORT VESICLE | 5 | 5.74e-01 | -1.45e-01 | 8.92e-01 |
| GOBP TETRAPYRROLE METABOLIC PROCESS | 56 | 6.01e-02 | -1.45e-01 | 4.54e-01 |
| GOMF ADP BINDING | 35 | 1.37e-01 | -1.45e-01 | 6.03e-01 |
| GOBP LIVER MORPHOGENESIS | 18 | 2.87e-01 | 1.45e-01 | 7.46e-01 |
| GOBP REGULATION OF ALTERNATIVE MRNA SPLICING VIA SPLICEOSOME | 47 | 8.53e-02 | 1.45e-01 | 5.11e-01 |
| GOMF PYRUVATE TRANSMEMBRANE TRANSPORTER ACTIVITY | 5 | 5.74e-01 | 1.45e-01 | 8.92e-01 |
| GOBP U2 TYPE PRESPLICEOSOME ASSEMBLY | 25 | 2.10e-01 | 1.45e-01 | 6.83e-01 |
| GOBP REGULATION OF LEUKOCYTE ADHESION TO VASCULAR ENDOTHELIAL CELL | 24 | 2.19e-01 | -1.45e-01 | 6.93e-01 |
| GOBP REGULATION OF POSTSYNAPTIC DENSITY ASSEMBLY | 8 | 4.78e-01 | -1.45e-01 | 8.57e-01 |
| GOBP POSTSYNAPTIC MODULATION OF CHEMICAL SYNAPTIC TRANSMISSION | 20 | 2.62e-01 | 1.45e-01 | 7.29e-01 |
| GOBP BILE ACID BIOSYNTHETIC PROCESS | 27 | 1.93e-01 | 1.45e-01 | 6.65e-01 |
| GOBP REGULATION OF CATECHOLAMINE METABOLIC PROCESS | 13 | 3.66e-01 | -1.45e-01 | 8.04e-01 |
| GOMF TRANSMEMBRANE RECEPTOR PROTEIN TYROSINE KINASE ACTIVATOR ACTIVITY | 11 | 4.06e-01 | -1.45e-01 | 8.26e-01 |
| GOBP DIPEPTIDE TRANSMEMBRANE TRANSPORT | 7 | 5.07e-01 | 1.45e-01 | 8.68e-01 |
| GOBP NEGATIVE REGULATION OF RNA CATABOLIC PROCESS | 70 | 3.64e-02 | 1.45e-01 | 3.90e-01 |
| GOBP MACROPHAGE APOPTOTIC PROCESS | 13 | 3.67e-01 | 1.45e-01 | 8.04e-01 |
| GOBP MICROTUBULE CYTOSKELETON ORGANIZATION INVOLVED IN MITOSIS | 159 | 1.66e-03 | 1.45e-01 | 9.86e-02 |
| GOBP PHOSPHATIDYLGLYCEROL BIOSYNTHETIC PROCESS | 9 | 4.53e-01 | -1.45e-01 | 8.43e-01 |
| GOBP POSITIVE REGULATION OF PROTEIN EXPORT FROM NUCLEUS | 19 | 2.75e-01 | 1.45e-01 | 7.38e-01 |
| GOBP CYCLOOXYGENASE PATHWAY | 8 | 4.79e-01 | -1.44e-01 | 8.58e-01 |
| GOBP RESPONSE TO VIRUS | 345 | 4.03e-06 | 1.44e-01 | 1.63e-03 |
| GOBP NATURAL KILLER CELL DIFFERENTIATION | 24 | 2.21e-01 | 1.44e-01 | 6.94e-01 |
| GOBP GLUTAMATE RECEPTOR SIGNALING PATHWAY | 31 | 1.64e-01 | -1.44e-01 | 6.30e-01 |
| GOBP CELLULAR RESPONSE TO TOPOLOGICALLY INCORRECT PROTEIN | 95 | 1.51e-02 | 1.44e-01 | 2.64e-01 |
| GOBP PROTEIN K11 LINKED UBIQUITINATION | 36 | 1.34e-01 | 1.44e-01 | 5.99e-01 |
| GOBP POSITIVE REGULATION OF LEUKOCYTE TETHERING OR ROLLING | 11 | 4.07e-01 | -1.44e-01 | 8.26e-01 |
| GOBP REGULATION OF CILIUM DEPENDENT CELL MOTILITY | 12 | 3.87e-01 | -1.44e-01 | 8.17e-01 |
| GOBP REGULATION OF GLIAL CELL PROLIFERATION | 31 | 1.65e-01 | 1.44e-01 | 6.30e-01 |
| GOBP CELL CELL ADHESION INVOLVED IN GASTRULATION | 9 | 4.54e-01 | -1.44e-01 | 8.43e-01 |
| GOBP THYROID HORMONE TRANSPORT | 6 | 5.41e-01 | 1.44e-01 | 8.81e-01 |
| GOMF GTP DEPENDENT PROTEIN BINDING | 19 | 2.77e-01 | 1.44e-01 | 7.39e-01 |
| GOCC AXON INITIAL SEGMENT | 12 | 3.88e-01 | -1.44e-01 | 8.17e-01 |
| GOBP NEGATIVE REGULATION OF AMIDE METABOLIC PROCESS | 21 | 2.54e-01 | -1.44e-01 | 7.22e-01 |
| GOMF TRANSMEMBRANE RECEPTOR PROTEIN TYROSINE KINASE ADAPTOR ACTIVITY | 16 | 3.19e-01 | -1.44e-01 | 7.70e-01 |
| GOBP REGULATION OF METALLOPEPTIDASE ACTIVITY | 8 | 4.81e-01 | 1.44e-01 | 8.59e-01 |
| GOMF PEROXIREDOXIN ACTIVITY | 8 | 4.81e-01 | 1.44e-01 | 8.59e-01 |
| GOBP HEPARAN SULFATE PROTEOGLYCAN METABOLIC PROCESS | 10 | 4.31e-01 | 1.44e-01 | 8.35e-01 |
| GOBP POSITIVE REGULATION OF GLUCOSE TRANSMEMBRANE TRANSPORT | 33 | 1.53e-01 | 1.44e-01 | 6.16e-01 |
| GOCC TERTIARY GRANULE LUMEN | 51 | 7.58e-02 | -1.44e-01 | 4.93e-01 |
| GOBP POSITIVE REGULATION OF PEPTIDYL THREONINE PHOSPHORYLATION | 23 | 2.33e-01 | -1.44e-01 | 7.05e-01 |
| GOMF PENTOSYLTRANSFERASE ACTIVITY | 48 | 8.51e-02 | 1.44e-01 | 5.11e-01 |
| GOBP PEPTIDYL LYSINE MONOMETHYLATION | 9 | 4.56e-01 | -1.44e-01 | 8.44e-01 |
| GOBP NEGATIVE REGULATION OF RESPONSE TO CYTOKINE STIMULUS | 68 | 4.06e-02 | 1.44e-01 | 4.01e-01 |
| GOBP HEAT ACCLIMATION | 6 | 5.43e-01 | -1.44e-01 | 8.82e-01 |
| GOMF L ARGININE TRANSMEMBRANE TRANSPORTER ACTIVITY | 8 | 4.83e-01 | -1.43e-01 | 8.60e-01 |
| GOBP ADHESION OF SYMBIONT TO HOST CELL | 7 | 5.11e-01 | 1.43e-01 | 8.70e-01 |
| GOBP ZINC ION TRANSPORT | 22 | 2.45e-01 | 1.43e-01 | 7.14e-01 |
| GOBP BASIC AMINO ACID TRANSPORT | 15 | 3.37e-01 | -1.43e-01 | 7.86e-01 |
| GOBP CELL DIVISION | 565 | 5.90e-09 | 1.43e-01 | 4.36e-05 |
| GOMF OXIDOREDUCTASE ACTIVITY ACTING ON THE CH CH GROUP OF DONORS OXYGEN AS ACCEPTOR | 10 | 4.33e-01 | -1.43e-01 | 8.36e-01 |
| GOBP PURINE RIBONUCLEOSIDE CATABOLIC PROCESS | 5 | 5.79e-01 | 1.43e-01 | 8.92e-01 |
| GOBP CLEAVAGE FURROW FORMATION | 7 | 5.12e-01 | 1.43e-01 | 8.70e-01 |
| GOBP SYNAPSE PRUNING | 10 | 4.34e-01 | -1.43e-01 | 8.36e-01 |
| GOBP ATRIAL SEPTUM DEVELOPMENT | 13 | 3.73e-01 | 1.43e-01 | 8.09e-01 |
| GOMF VOLTAGE GATED CHLORIDE CHANNEL ACTIVITY | 8 | 4.84e-01 | -1.43e-01 | 8.60e-01 |
| GOCC APICAL JUNCTION COMPLEX | 113 | 8.77e-03 | -1.43e-01 | 2.17e-01 |
| GOBP INTRACELLULAR STEROL TRANSPORT | 32 | 1.62e-01 | 1.43e-01 | 6.29e-01 |
| GOBP SKELETAL MUSCLE TISSUE REGENERATION | 34 | 1.50e-01 | -1.43e-01 | 6.13e-01 |
| GOBP NK T CELL ACTIVATION | 13 | 3.74e-01 | -1.43e-01 | 8.09e-01 |
| GOBP REGULATION OF UBIQUITIN PROTEIN LIGASE ACTIVITY | 18 | 2.95e-01 | 1.43e-01 | 7.52e-01 |
| GOBP POSITIVE REGULATION OF MRNA METABOLIC PROCESS | 129 | 5.21e-03 | 1.42e-01 | 1.76e-01 |
| GOMF TRNA METHYLTRANSFERASE ACTIVITY | 34 | 1.51e-01 | 1.42e-01 | 6.13e-01 |
| GOCC EUKARYOTIC TRANSLATION INITIATION FACTOR 3 COMPLEX | 16 | 3.24e-01 | 1.42e-01 | 7.75e-01 |
| GOBP NEGATIVE REGULATION OF CHROMOSOME ORGANIZATION | 94 | 1.71e-02 | 1.42e-01 | 2.85e-01 |
| GOBP HYALURONAN METABOLIC PROCESS | 29 | 1.85e-01 | -1.42e-01 | 6.58e-01 |
| GOBP TESTOSTERONE BIOSYNTHETIC PROCESS | 8 | 4.86e-01 | -1.42e-01 | 8.60e-01 |
| GOBP PROTEIN LOCALIZATION TO BICELLULAR TIGHT JUNCTION | 5 | 5.82e-01 | -1.42e-01 | 8.93e-01 |
| GOBP POSITIVE REGULATION OF INTERLEUKIN 17 PRODUCTION | 20 | 2.71e-01 | -1.42e-01 | 7.35e-01 |
| GOBP MITRAL VALVE DEVELOPMENT | 11 | 4.14e-01 | -1.42e-01 | 8.29e-01 |
| GOMF CARBOHYDRATE PHOSPHATASE ACTIVITY | 8 | 4.87e-01 | 1.42e-01 | 8.60e-01 |
| GOCC EARP COMPLEX | 5 | 5.82e-01 | -1.42e-01 | 8.93e-01 |
| GOBP POLYAMINE METABOLIC PROCESS | 18 | 2.97e-01 | -1.42e-01 | 7.53e-01 |
| GOBP NEGATIVE REGULATION OF TYPE 2 IMMUNE RESPONSE | 12 | 3.94e-01 | -1.42e-01 | 8.20e-01 |
| GOMF ALL TRANS RETINOL DEHYDROGENASE NADPPLUS ACTIVITY | 11 | 4.15e-01 | -1.42e-01 | 8.29e-01 |
| GOBP CELLULAR RESPONSE TO L LEUCINE | 12 | 3.95e-01 | 1.42e-01 | 8.20e-01 |
| GOBP ASPARTATE METABOLIC PROCESS | 6 | 5.47e-01 | 1.42e-01 | 8.84e-01 |
| GOMF ATPASE REGULATOR ACTIVITY | 47 | 9.24e-02 | 1.42e-01 | 5.31e-01 |
| GOBP NEGATIVE REGULATION OF FATTY ACID BIOSYNTHETIC PROCESS | 15 | 3.42e-01 | 1.42e-01 | 7.89e-01 |
| GOBP VENOUS BLOOD VESSEL MORPHOGENESIS | 6 | 5.47e-01 | -1.42e-01 | 8.84e-01 |
| GOCC AXON CYTOPLASM | 58 | 6.18e-02 | 1.42e-01 | 4.61e-01 |
| GOBP CELL CELL ADHESION VIA PLASMA MEMBRANE ADHESION MOLECULES | 148 | 2.94e-03 | -1.42e-01 | 1.29e-01 |
| GOBP ENDOSOME TRANSPORT VIA MULTIVESICULAR BODY SORTING PATHWAY | 39 | 1.26e-01 | 1.42e-01 | 5.90e-01 |
| GOBP EPITHELIAL FLUID TRANSPORT | 6 | 5.48e-01 | -1.42e-01 | 8.84e-01 |
| GOBP NEGATIVE REGULATION OF LEUKOCYTE DEGRANULATION | 11 | 4.16e-01 | -1.42e-01 | 8.30e-01 |
| GOBP CELLULAR DEFENSE RESPONSE | 43 | 1.08e-01 | 1.42e-01 | 5.62e-01 |
| GOCC HOPS COMPLEX | 14 | 3.59e-01 | 1.41e-01 | 7.99e-01 |
| GOBP B CELL PROLIFERATION | 79 | 2.98e-02 | 1.41e-01 | 3.64e-01 |
| GOMF NUCLEASE INHIBITOR ACTIVITY | 6 | 5.49e-01 | -1.41e-01 | 8.84e-01 |
| GOMF TRIGLYCERIDE LIPASE ACTIVITY | 15 | 3.43e-01 | 1.41e-01 | 7.89e-01 |
| GOBP ESTABLISHMENT OF RNA LOCALIZATION | 153 | 2.56e-03 | 1.41e-01 | 1.20e-01 |
| GOCC MICROBODY LUMEN | 43 | 1.09e-01 | 1.41e-01 | 5.62e-01 |
| GOBP DENDRITIC SPINE DEVELOPMENT | 83 | 2.61e-02 | 1.41e-01 | 3.49e-01 |
| GOBP NEGATIVE REGULATION OF PEPTIDYL CYSTEINE S NITROSYLATION | 6 | 5.49e-01 | 1.41e-01 | 8.84e-01 |
| GOMF INSULIN RECEPTOR BINDING | 18 | 3.00e-01 | 1.41e-01 | 7.56e-01 |
| GOBP PRIMITIVE HEMOPOIESIS | 9 | 4.63e-01 | 1.41e-01 | 8.49e-01 |
| GOBP MONOSACCHARIDE BIOSYNTHETIC PROCESS | 81 | 2.80e-02 | -1.41e-01 | 3.58e-01 |
| GOMF MITOGEN ACTIVATED PROTEIN KINASE KINASE KINASE BINDING | 15 | 3.44e-01 | -1.41e-01 | 7.89e-01 |
| GOBP RESPIRATORY BURST | 35 | 1.48e-01 | -1.41e-01 | 6.13e-01 |
| GOBP CELLULAR RESPONSE TO MAGNESIUM ION | 6 | 5.49e-01 | -1.41e-01 | 8.84e-01 |
| GOMF DOLICHYL PHOSPHATE MANNOSE PROTEIN MANNOSYLTRANSFERASE ACTIVITY | 8 | 4.90e-01 | 1.41e-01 | 8.61e-01 |
| GOMF TRANSLATION REGULATOR ACTIVITY NUCLEIC ACID BINDING | 100 | 1.48e-02 | 1.41e-01 | 2.61e-01 |
| GOBP SPINDLE LOCALIZATION | 50 | 8.46e-02 | 1.41e-01 | 5.09e-01 |
| GOBP NEGATIVE REGULATION OF MUSCLE ADAPTATION | 8 | 4.90e-01 | -1.41e-01 | 8.61e-01 |
| GOBP VIRAL PROCESS | 374 | 3.02e-06 | 1.41e-01 | 1.27e-03 |
| GOBP FOCAL ADHESION ASSEMBLY | 71 | 4.05e-02 | -1.41e-01 | 4.01e-01 |
| GOBP REGULATION OF MUSCLE HYPERTROPHY | 45 | 1.03e-01 | 1.41e-01 | 5.54e-01 |
| GOBP DE NOVO CENTRIOLE ASSEMBLY | 5 | 5.86e-01 | 1.41e-01 | 8.95e-01 |
| GOBP IMMUNOLOGICAL SYNAPSE FORMATION | 15 | 3.46e-01 | 1.40e-01 | 7.90e-01 |
| GOBP SODIUM ION EXPORT ACROSS PLASMA MEMBRANE | 11 | 4.20e-01 | -1.40e-01 | 8.30e-01 |
| GOBP DNA TEMPLATED DNA REPLICATION MAINTENANCE OF FIDELITY | 57 | 6.68e-02 | 1.40e-01 | 4.71e-01 |
| GOBP GLYCOSPHINGOLIPID BIOSYNTHETIC PROCESS | 29 | 1.91e-01 | 1.40e-01 | 6.63e-01 |
| GOBP INSULIN LIKE GROWTH FACTOR RECEPTOR SIGNALING PATHWAY | 40 | 1.25e-01 | -1.40e-01 | 5.88e-01 |
| GOMF GLUCURONOSYLTRANSFERASE ACTIVITY | 14 | 3.64e-01 | -1.40e-01 | 8.02e-01 |
| GOBP PROTEIN DEACETYLATION | 41 | 1.20e-01 | -1.40e-01 | 5.83e-01 |
| GOMF FLOPPASE ACTIVITY | 16 | 3.32e-01 | 1.40e-01 | 7.82e-01 |
| GOBP MODIFICATION OF POSTSYNAPTIC ACTIN CYTOSKELETON | 10 | 4.43e-01 | -1.40e-01 | 8.41e-01 |
| GOBP REGULATION OF POSTSYNAPSE ASSEMBLY | 5 | 5.87e-01 | 1.40e-01 | 8.95e-01 |
| GOMF OXIDOREDUCTASE ACTIVITY ACTING ON THE CH CH GROUP OF DONORS NAD OR NADP AS ACCEPTOR | 28 | 1.99e-01 | -1.40e-01 | 6.71e-01 |
| GOBP EYELID DEVELOPMENT IN CAMERA TYPE EYE | 6 | 5.52e-01 | 1.40e-01 | 8.86e-01 |
| GOBP PROTEIN LOCALIZATION TO VACUOLE | 78 | 3.25e-02 | 1.40e-01 | 3.77e-01 |
| GOBP POSITIVE REGULATION OF SYNAPTIC VESICLE ENDOCYTOSIS | 5 | 5.88e-01 | -1.40e-01 | 8.95e-01 |
| GOBP POSITIVE REGULATION OF INTERLEUKIN 13 PRODUCTION | 13 | 3.82e-01 | -1.40e-01 | 8.14e-01 |
| GOBP REGULATION OF SHORT TERM NEURONAL SYNAPTIC PLASTICITY | 11 | 4.22e-01 | -1.40e-01 | 8.30e-01 |
| GOBP REGULATION OF ESTABLISHMENT OF PROTEIN LOCALIZATION TO CHROMOSOME | 12 | 4.02e-01 | 1.40e-01 | 8.23e-01 |
| GOBP RELEASE OF CYTOCHROME C FROM MITOCHONDRIA | 52 | 8.15e-02 | -1.40e-01 | 5.02e-01 |
| GOBP PROTEIN LOCALIZATION TO LYSOSOME | 52 | 8.15e-02 | 1.40e-01 | 5.02e-01 |
| GOBP REGULATION OF VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR SIGNALING PATHWAY | 26 | 2.18e-01 | -1.40e-01 | 6.93e-01 |
| GOBP GDP METABOLIC PROCESS | 11 | 4.23e-01 | 1.40e-01 | 8.30e-01 |
| GOBP REGULATION OF ENDOSOME SIZE | 13 | 3.84e-01 | 1.40e-01 | 8.15e-01 |
| GOBP POSITIVE REGULATION OF MAST CELL DEGRANULATION | 12 | 4.03e-01 | 1.40e-01 | 8.23e-01 |
| GOBP PEPTIDYL SERINE AUTOPHOSPHORYLATION | 8 | 4.95e-01 | 1.39e-01 | 8.62e-01 |
| GOBP REGULATION OF INTRACELLULAR PROTEIN TRANSPORT | 136 | 5.01e-03 | 1.39e-01 | 1.72e-01 |
| GOBP REGULATION OF CYTOPLASMIC PATTERN RECOGNITION RECEPTOR SIGNALING PATHWAY | 106 | 1.32e-02 | 1.39e-01 | 2.49e-01 |
| GOBP SUCCINYL COA METABOLIC PROCESS | 10 | 4.45e-01 | 1.39e-01 | 8.41e-01 |
| GOBP REGULATION OF ESTABLISHMENT OF PLANAR POLARITY | 10 | 4.45e-01 | -1.39e-01 | 8.41e-01 |
| GOBP TYPE B PANCREATIC CELL PROLIFERATION | 22 | 2.58e-01 | -1.39e-01 | 7.27e-01 |
| GOBP NEGATIVE REGULATION OF PROTEIN KINASE ACTIVITY BY REGULATION OF PROTEIN PHOSPHORYLATION | 6 | 5.54e-01 | 1.39e-01 | 8.87e-01 |
| GOMF PHOSPHATE TRANSMEMBRANE TRANSPORTER ACTIVITY | 14 | 3.67e-01 | -1.39e-01 | 8.04e-01 |
| GOCC ACROSOMAL MEMBRANE | 18 | 3.06e-01 | -1.39e-01 | 7.61e-01 |
| GOBP TRIGLYCERIDE CATABOLIC PROCESS | 16 | 3.35e-01 | 1.39e-01 | 7.84e-01 |
| GOBP CELLULAR ALDEHYDE METABOLIC PROCESS | 57 | 6.91e-02 | -1.39e-01 | 4.77e-01 |
| GOBP REGULATION OF T CELL DIFFERENTIATION IN THYMUS | 21 | 2.70e-01 | 1.39e-01 | 7.35e-01 |
| GOBP BASOLATERAL PROTEIN SECRETION | 5 | 5.90e-01 | 1.39e-01 | 8.97e-01 |
| GOBP RNA 3 URIDYLATION | 5 | 5.90e-01 | 1.39e-01 | 8.97e-01 |
| GOBP CELLULAR RESPONSE TO VITAMIN D | 17 | 3.21e-01 | -1.39e-01 | 7.72e-01 |
| GOBP DE NOVO PROTEIN FOLDING | 42 | 1.19e-01 | 1.39e-01 | 5.81e-01 |
| GOBP ENDOPLASMIC RETICULUM TO CYTOSOL TRANSPORT | 28 | 2.03e-01 | 1.39e-01 | 6.76e-01 |
| GOMF PRE MRNA 3 SPLICE SITE BINDING | 6 | 5.55e-01 | -1.39e-01 | 8.87e-01 |
| GOMF RNA 7 METHYLGUANOSINE CAP BINDING | 12 | 4.05e-01 | 1.39e-01 | 8.25e-01 |
| GOMF DELTA CATENIN BINDING | 7 | 5.25e-01 | -1.39e-01 | 8.76e-01 |
| GOBP FLAVIN CONTAINING COMPOUND METABOLIC PROCESS | 5 | 5.91e-01 | -1.39e-01 | 8.97e-01 |
| GOBP MONOCYTE DIFFERENTIATION | 26 | 2.21e-01 | -1.39e-01 | 6.95e-01 |
| GOBP ATRIOVENTRICULAR VALVE FORMATION | 5 | 5.91e-01 | -1.39e-01 | 8.97e-01 |
| GOMF METALLODIPEPTIDASE ACTIVITY | 6 | 5.57e-01 | 1.39e-01 | 8.87e-01 |
| GOCC CYTOPLASMIC SIDE OF ROUGH ENDOPLASMIC RETICULUM MEMBRANE | 5 | 5.91e-01 | 1.39e-01 | 8.97e-01 |
| GOBP VIRAL LIFE CYCLE | 275 | 7.79e-05 | 1.38e-01 | 1.25e-02 |
| GOBP REGULATION OF INTRACELLULAR ESTROGEN RECEPTOR SIGNALING PATHWAY | 29 | 1.97e-01 | 1.38e-01 | 6.69e-01 |
| GOBP ENTEROENDOCRINE CELL DIFFERENTIATION | 21 | 2.72e-01 | -1.38e-01 | 7.36e-01 |
| GOBP EMBRYONIC CAMERA TYPE EYE DEVELOPMENT | 21 | 2.72e-01 | -1.38e-01 | 7.36e-01 |
| GOBP MACROPINOCYTOSIS | 10 | 4.49e-01 | -1.38e-01 | 8.43e-01 |
| GOBP CRANIAL NERVE MORPHOGENESIS | 19 | 2.97e-01 | 1.38e-01 | 7.53e-01 |
| GOBP MAINTENANCE OF LENS TRANSPARENCY | 6 | 5.58e-01 | 1.38e-01 | 8.88e-01 |
| GOBP AMINE CATABOLIC PROCESS | 17 | 3.24e-01 | -1.38e-01 | 7.75e-01 |
| GOMF TRANSLATION REGULATOR ACTIVITY | 132 | 6.15e-03 | 1.38e-01 | 1.83e-01 |
| GOMF TOLL LIKE RECEPTOR 4 BINDING | 5 | 5.93e-01 | 1.38e-01 | 8.99e-01 |
| GOBP PROTEIN LOCALIZATION TO NUCLEAR BODY | 12 | 4.08e-01 | 1.38e-01 | 8.26e-01 |
| GOBP SNARE COMPLEX ASSEMBLY | 20 | 2.86e-01 | -1.38e-01 | 7.45e-01 |
| GOBP REGULATION OF ACTIN NUCLEATION | 37 | 1.47e-01 | -1.38e-01 | 6.13e-01 |
| GOBP PROTEIN K6 LINKED UBIQUITINATION | 16 | 3.40e-01 | 1.38e-01 | 7.88e-01 |
| GOBP MAST CELL ACTIVATION INVOLVED IN IMMUNE RESPONSE | 48 | 9.85e-02 | 1.38e-01 | 5.45e-01 |
| GOBP REGULATION OF ENDOCYTIC RECYCLING | 17 | 3.25e-01 | -1.38e-01 | 7.76e-01 |
| GOBP TRANS SYNAPTIC SIGNALING BY LIPID | 6 | 5.59e-01 | -1.38e-01 | 8.88e-01 |
| GOBP INTERLEUKIN 18 MEDIATED SIGNALING PATHWAY | 10 | 4.51e-01 | 1.38e-01 | 8.43e-01 |
| GOBP DETECTION OF STIMULUS INVOLVED IN SENSORY PERCEPTION | 114 | 1.11e-02 | 1.38e-01 | 2.39e-01 |
| GOBP NEGATIVE REGULATION OF CELL DIVISION | 12 | 4.09e-01 | -1.38e-01 | 8.26e-01 |
| GOBP NEGATIVE CHEMOTAXIS | 33 | 1.71e-01 | -1.38e-01 | 6.38e-01 |
| GOBP GONADOTROPIN SECRETION | 6 | 5.60e-01 | 1.38e-01 | 8.88e-01 |
| GOMF CYSTEINE TYPE PEPTIDASE ACTIVITY | 150 | 3.66e-03 | 1.37e-01 | 1.43e-01 |
| GOBP DUMP METABOLIC PROCESS | 6 | 5.60e-01 | -1.37e-01 | 8.88e-01 |
| GOCC HFE TRANSFERRIN RECEPTOR COMPLEX | 6 | 5.60e-01 | 1.37e-01 | 8.88e-01 |
| GOBP LONG CHAIN FATTY ACID METABOLIC PROCESS | 81 | 3.25e-02 | -1.37e-01 | 3.77e-01 |
| GOBP NADPH REGENERATION | 21 | 2.76e-01 | -1.37e-01 | 7.38e-01 |
| GOBP REGULATION OF PHOSPHOPROTEIN PHOSPHATASE ACTIVITY | 36 | 1.54e-01 | 1.37e-01 | 6.16e-01 |
| GOBP REGULATION OF SPINDLE CHECKPOINT | 23 | 2.54e-01 | 1.37e-01 | 7.23e-01 |
| GOMF ATP DEPENDENT ACTIVITY ACTING ON DNA | 117 | 1.03e-02 | 1.37e-01 | 2.28e-01 |
| GOCC POSTSYNAPTIC CYTOSOL | 12 | 4.11e-01 | -1.37e-01 | 8.26e-01 |
| GOMF PHOSPHATIDYLSERINE 1 ACYLHYDROLASE ACTIVITY | 8 | 5.02e-01 | -1.37e-01 | 8.65e-01 |
| GOBP POSITIVE REGULATION OF PHOSPHOPROTEIN PHOSPHATASE ACTIVITY | 15 | 3.58e-01 | 1.37e-01 | 7.98e-01 |
| GOBP PROTEIN POLYGLUTAMYLATION | 10 | 4.53e-01 | -1.37e-01 | 8.43e-01 |
| GOBP FRUCTOSE 6 PHOSPHATE METABOLIC PROCESS | 11 | 4.31e-01 | -1.37e-01 | 8.35e-01 |
| GOBP REGULATION OF TRIGLYCERIDE BIOSYNTHETIC PROCESS | 18 | 3.14e-01 | -1.37e-01 | 7.66e-01 |
| GOBP ACTIN FILAMENT NETWORK FORMATION | 8 | 5.03e-01 | 1.37e-01 | 8.66e-01 |
| GOCC APICOLATERAL PLASMA MEMBRANE | 14 | 3.75e-01 | 1.37e-01 | 8.09e-01 |
| GOBP MARGINAL ZONE B CELL DIFFERENTIATION | 8 | 5.03e-01 | -1.37e-01 | 8.66e-01 |
| GOBP DNA REPLICATION INITIATION | 35 | 1.61e-01 | 1.37e-01 | 6.28e-01 |
| GOBP PURINE DEOXYRIBONUCLEOTIDE CATABOLIC PROCESS | 9 | 4.77e-01 | 1.37e-01 | 8.57e-01 |
| GOBP CELLULAR RESPONSE TO MANGANESE ION | 9 | 4.77e-01 | 1.37e-01 | 8.57e-01 |
| GOBP REGULATION OF ADENYLATE CYCLASE ACTIVITY | 26 | 2.27e-01 | -1.37e-01 | 7.01e-01 |
| GOBP CYTOPLASMIC PATTERN RECOGNITION RECEPTOR SIGNALING PATHWAY | 157 | 3.11e-03 | 1.37e-01 | 1.31e-01 |
| GOMF LONG CHAIN FATTY ACID BINDING | 12 | 4.12e-01 | -1.37e-01 | 8.28e-01 |
| GOBP AMYLOID PRECURSOR PROTEIN BIOSYNTHETIC PROCESS | 14 | 3.76e-01 | 1.37e-01 | 8.10e-01 |
| GOCC CARBOXY TERMINAL DOMAIN PROTEIN KINASE COMPLEX | 20 | 2.90e-01 | 1.37e-01 | 7.47e-01 |
| GOBP PANCREATIC JUICE SECRETION | 9 | 4.78e-01 | -1.37e-01 | 8.57e-01 |
| GOBP REGULATION OF ACUTE INFLAMMATORY RESPONSE | 38 | 1.45e-01 | 1.37e-01 | 6.12e-01 |
| GOBP PYROPTOSIS | 33 | 1.75e-01 | 1.36e-01 | 6.42e-01 |
| GOBP PROTEIN PALMITOYLATION | 30 | 1.96e-01 | -1.36e-01 | 6.68e-01 |
| GOBP RESPONSE TO MOLECULE OF FUNGAL ORIGIN | 5 | 5.98e-01 | 1.36e-01 | 9.02e-01 |
| GOCC IRON SULFUR CLUSTER ASSEMBLY COMPLEX | 12 | 4.14e-01 | -1.36e-01 | 8.29e-01 |
| GOBP MESENCHYME MORPHOGENESIS | 31 | 1.89e-01 | 1.36e-01 | 6.62e-01 |
| GOCC FAR SIN STRIPAK COMPLEX | 17 | 3.31e-01 | 1.36e-01 | 7.82e-01 |
| GOBP TRANSLATIONAL ELONGATION | 67 | 5.38e-02 | 1.36e-01 | 4.36e-01 |
| GOBP NEGATIVE REGULATION OF MITOTIC CELL CYCLE PHASE TRANSITION | 171 | 2.12e-03 | 1.36e-01 | 1.13e-01 |
| GOBP FEEDING BEHAVIOR | 49 | 9.92e-02 | 1.36e-01 | 5.46e-01 |
| GOBP POSITIVE REGULATION OF EXTRACELLULAR MATRIX ORGANIZATION | 25 | 2.39e-01 | -1.36e-01 | 7.08e-01 |
| GOBP POSITIVE REGULATION OF TRANSCRIPTION BY GLUCOSE | 6 | 5.64e-01 | -1.36e-01 | 8.90e-01 |
| GOBP POSITIVE REGULATION OF ACTIN FILAMENT POLYMERIZATION | 44 | 1.19e-01 | -1.36e-01 | 5.81e-01 |
| GOCC RNA POLYMERASE TRANSCRIPTION FACTOR SL1 COMPLEX | 5 | 5.99e-01 | 1.36e-01 | 9.02e-01 |
| GOMF BITTER TASTE RECEPTOR ACTIVITY | 6 | 5.64e-01 | 1.36e-01 | 8.90e-01 |
| GOBP TERPENOID BIOSYNTHETIC PROCESS | 10 | 4.57e-01 | 1.36e-01 | 8.45e-01 |
| GOBP NEGATIVE REGULATION OF ALPHA BETA T CELL PROLIFERATION | 16 | 3.47e-01 | 1.36e-01 | 7.91e-01 |
| GOBP IRES DEPENDENT VIRAL TRANSLATIONAL INITIATION | 11 | 4.36e-01 | 1.36e-01 | 8.37e-01 |
| GOBP HEPARIN BIOSYNTHETIC PROCESS | 9 | 4.81e-01 | 1.36e-01 | 8.59e-01 |
| GOCC GAMMA DELTA T CELL RECEPTOR COMPLEX | 6 | 5.65e-01 | 1.36e-01 | 8.90e-01 |
| GOMF BETA N ACETYLHEXOSAMINIDASE ACTIVITY | 5 | 6.00e-01 | -1.36e-01 | 9.03e-01 |
| GOBP CELLULAR RESPONSE TO STEROL | 20 | 2.94e-01 | 1.35e-01 | 7.51e-01 |
| GOCC U2 SNRNP | 25 | 2.41e-01 | 1.35e-01 | 7.11e-01 |
| GOBP PROGRAMMED CELL DEATH IN RESPONSE TO REACTIVE OXYGEN SPECIES | 13 | 3.98e-01 | 1.35e-01 | 8.22e-01 |
| GOBP NEURONAL ACTION POTENTIAL PROPAGATION | 6 | 5.66e-01 | -1.35e-01 | 8.90e-01 |
| GOMF PROTEIN TRANSMEMBRANE TRANSPORTER ACTIVITY | 25 | 2.41e-01 | 1.35e-01 | 7.11e-01 |
| GOCC RIBONUCLEOPROTEIN GRANULE | 237 | 3.35e-04 | 1.35e-01 | 3.47e-02 |
| GOBP REGULATION OF HYPERSENSITIVITY | 10 | 4.59e-01 | 1.35e-01 | 8.47e-01 |
| GOBP XYLULOSE 5 PHOSPHATE METABOLIC PROCESS | 6 | 5.66e-01 | -1.35e-01 | 8.90e-01 |
| GOCC NUCLEAR PORE | 94 | 2.35e-02 | 1.35e-01 | 3.32e-01 |
| GOBP REGULATION OF PLATELET AGGREGATION | 23 | 2.62e-01 | -1.35e-01 | 7.29e-01 |
| GOBP SUBSTANTIA NIGRA DEVELOPMENT | 38 | 1.49e-01 | 1.35e-01 | 6.13e-01 |
| GOBP CELLULAR RESPONSE TO IONIZING RADIATION | 64 | 6.15e-02 | 1.35e-01 | 4.60e-01 |
| GOBP NEGATIVE REGULATION OF TRANSPORTER ACTIVITY | 44 | 1.21e-01 | 1.35e-01 | 5.84e-01 |
| GOMF TRNA URIDINE METHYLTRANSFERASE ACTIVITY | 5 | 6.01e-01 | -1.35e-01 | 9.03e-01 |
| GOBP METANEPHRIC TUBULE DEVELOPMENT | 13 | 3.99e-01 | -1.35e-01 | 8.22e-01 |
| GOBP PROTEIN LOCALIZATION TO CHROMOSOME | 115 | 1.24e-02 | 1.35e-01 | 2.49e-01 |
| GOCC TIGHT JUNCTION | 96 | 2.22e-02 | -1.35e-01 | 3.24e-01 |
| GOBP NEGATIVE REGULATION OF INTERLEUKIN 10 PRODUCTION | 17 | 3.35e-01 | 1.35e-01 | 7.84e-01 |
| GOMF MAP KINASE SCAFFOLD ACTIVITY | 12 | 4.18e-01 | -1.35e-01 | 8.30e-01 |
| GOMF CILIARY NEUROTROPHIC FACTOR RECEPTOR BINDING | 5 | 6.01e-01 | 1.35e-01 | 9.03e-01 |
| GOBP OLFACTORY NERVE DEVELOPMENT | 6 | 5.67e-01 | 1.35e-01 | 8.90e-01 |
| GOBP REGULATION OF RESPIRATORY SYSTEM PROCESS | 11 | 4.39e-01 | -1.35e-01 | 8.39e-01 |
| GOBP REGULATION OF CYCLASE ACTIVITY | 32 | 1.87e-01 | -1.35e-01 | 6.61e-01 |
| GOBP FOREBRAIN REGIONALIZATION | 9 | 4.84e-01 | -1.35e-01 | 8.60e-01 |
| GOCC TOM COMPLEX | 7 | 5.37e-01 | 1.35e-01 | 8.79e-01 |
| GOBP METANEPHRIC NEPHRON MORPHOGENESIS | 13 | 4.01e-01 | -1.35e-01 | 8.23e-01 |
| GOBP REGULATION OF PLATELET DERIVED GROWTH FACTOR RECEPTOR BETA SIGNALING PATHWAY | 7 | 5.37e-01 | 1.35e-01 | 8.79e-01 |
| GOMF NAD P H DEHYDROGENASE QUINONE ACTIVITY | 5 | 6.03e-01 | 1.34e-01 | 9.03e-01 |
| GOCC GUANYL NUCLEOTIDE EXCHANGE FACTOR COMPLEX | 23 | 2.65e-01 | 1.34e-01 | 7.32e-01 |
| GOBP VACUOLAR TRANSPORT | 157 | 3.68e-03 | 1.34e-01 | 1.43e-01 |
| GOBP PTERIDINE CONTAINING COMPOUND BIOSYNTHETIC PROCESS | 15 | 3.68e-01 | 1.34e-01 | 8.05e-01 |
| GOBP CHONDROCYTE DEVELOPMENT INVOLVED IN ENDOCHONDRAL BONE MORPHOGENESIS | 7 | 5.38e-01 | 1.34e-01 | 8.79e-01 |
| GOBP PIGMENTATION | 88 | 2.95e-02 | 1.34e-01 | 3.62e-01 |
| GOBP REGULATION OF SYNAPSE MATURATION | 16 | 3.52e-01 | 1.34e-01 | 7.94e-01 |
| GOBP HOMEOSTASIS OF NUMBER OF CELLS WITHIN A TISSUE | 31 | 1.96e-01 | 1.34e-01 | 6.68e-01 |
| GOBP MEIOTIC CELL CYCLE PHASE TRANSITION | 11 | 4.41e-01 | 1.34e-01 | 8.41e-01 |
| GOBP LATE ENDOSOME TO VACUOLE TRANSPORT VIA MULTIVESICULAR BODY SORTING PATHWAY | 25 | 2.46e-01 | 1.34e-01 | 7.16e-01 |
| GOBP AMMONIUM ION METABOLIC PROCESS | 13 | 4.03e-01 | 1.34e-01 | 8.24e-01 |
| GOBP NUCLEOBASE TRANSPORT | 12 | 4.22e-01 | 1.34e-01 | 8.30e-01 |
| GOBP RESPONSE TO ENDOPLASMIC RETICULUM STRESS | 240 | 3.54e-04 | 1.34e-01 | 3.61e-02 |
| GOBP REGULATION OF ANTIGEN PROCESSING AND PRESENTATION | 17 | 3.39e-01 | -1.34e-01 | 7.88e-01 |
| GOBP REGULATION OF STRIATED MUSCLE CELL DIFFERENTIATION | 59 | 7.53e-02 | -1.34e-01 | 4.93e-01 |
| GOBP CENTROSOME DUPLICATION | 71 | 5.12e-02 | 1.34e-01 | 4.31e-01 |
| GOMF TRANSFERASE ACTIVITY TRANSFERRING SULPHUR CONTAINING GROUPS | 47 | 1.13e-01 | -1.34e-01 | 5.68e-01 |
| GOMF EXTRACELLULAR MATRIX STRUCTURAL CONSTITUENT CONFERRING TENSILE STRENGTH | 26 | 2.38e-01 | -1.34e-01 | 7.08e-01 |
| GOMF GLYCOSAMINOGLYCAN BINDING | 149 | 4.84e-03 | -1.34e-01 | 1.69e-01 |
| GOBP REGULATION OF INNATE IMMUNE RESPONSE | 399 | 4.59e-06 | 1.34e-01 | 1.78e-03 |
| GOBP METANEPHROS DEVELOPMENT | 45 | 1.21e-01 | -1.34e-01 | 5.84e-01 |
| GOBP AXO DENDRITIC TRANSPORT | 72 | 5.00e-02 | 1.34e-01 | 4.28e-01 |
| GOBP PYRIMIDINE DEOXYRIBONUCLEOTIDE BIOSYNTHETIC PROCESS | 6 | 5.71e-01 | 1.34e-01 | 8.91e-01 |
| GOBP REGULATION OF CELLULAR RESPIRATION | 44 | 1.25e-01 | 1.34e-01 | 5.89e-01 |
| GOBP MODULATION BY HOST OF VIRAL PROCESS | 45 | 1.21e-01 | 1.33e-01 | 5.84e-01 |
| GOBP COCHLEA MORPHOGENESIS | 10 | 4.65e-01 | 1.33e-01 | 8.51e-01 |
| GOBP CELLULAR COMPONENT DISASSEMBLY INVOLVED IN EXECUTION PHASE OF APOPTOSIS | 28 | 2.22e-01 | -1.33e-01 | 6.97e-01 |
| GOCC SNO S RNA CONTAINING RIBONUCLEOPROTEIN COMPLEX | 22 | 2.79e-01 | -1.33e-01 | 7.40e-01 |
| GOBP MITOTIC DNA INTEGRITY CHECKPOINT SIGNALING | 85 | 3.36e-02 | 1.33e-01 | 3.83e-01 |
| GOBP POSITIVE REGULATION OF INTERLEUKIN 1 PRODUCTION | 63 | 6.72e-02 | 1.33e-01 | 4.71e-01 |
| GOBP MICROTUBULE DEPOLYMERIZATION | 38 | 1.55e-01 | 1.33e-01 | 6.17e-01 |
| GOCC PRESYNAPTIC MEMBRANE | 101 | 2.06e-02 | -1.33e-01 | 3.13e-01 |
| GOCC CUTICULAR PLATE | 7 | 5.41e-01 | 1.33e-01 | 8.81e-01 |
| GOBP NEGATIVE REGULATION OF CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY INVOLVED IN APOPTOTIC PROCESS | 42 | 1.35e-01 | 1.33e-01 | 6.00e-01 |
| GOBP MEMBRANE PROTEIN INTRACELLULAR DOMAIN PROTEOLYSIS | 13 | 4.06e-01 | 1.33e-01 | 8.26e-01 |
| GOBP TOLERANCE INDUCTION TO SELF ANTIGEN | 6 | 5.72e-01 | 1.33e-01 | 8.92e-01 |
| GOCC EARLY ENDOSOME MEMBRANE | 172 | 2.61e-03 | 1.33e-01 | 1.22e-01 |
| GOBP NEGATIVE REGULATION OF VOLTAGE GATED CALCIUM CHANNEL ACTIVITY | 6 | 5.73e-01 | -1.33e-01 | 8.92e-01 |
| GOBP DIENCEPHALON DEVELOPMENT | 38 | 1.56e-01 | 1.33e-01 | 6.20e-01 |
| GOBP MATURATION OF SSU RRNA FROM TRICISTRONIC RRNA TRANSCRIPT SSU RRNA 5 8S RRNA LSU RRNA | 34 | 1.80e-01 | -1.33e-01 | 6.53e-01 |
| GOBP MONOSACCHARIDE METABOLIC PROCESS | 213 | 8.43e-04 | -1.33e-01 | 6.58e-02 |
| GOBP RNA SPLICING VIA ENDONUCLEOLYTIC CLEAVAGE AND LIGATION | 14 | 3.90e-01 | 1.33e-01 | 8.18e-01 |
| GOBP REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY IN RESPONSE TO DNA DAMAGE BY P53 CLASS MEDIATOR | 17 | 3.44e-01 | 1.33e-01 | 7.89e-01 |
| GOBP POSITIVE REGULATION OF DEFENSE RESPONSE TO VIRUS BY HOST | 27 | 2.33e-01 | 1.33e-01 | 7.05e-01 |
| GOBP PYRIMIDINE NUCLEOBASE METABOLIC PROCESS | 17 | 3.44e-01 | 1.32e-01 | 7.89e-01 |
| GOMF POLYPEPTIDE N ACETYLGALACTOSAMINYLTRANSFERASE ACTIVITY | 16 | 3.59e-01 | 1.32e-01 | 7.99e-01 |
| GOBP DNA MODIFICATION | 39 | 1.52e-01 | -1.32e-01 | 6.16e-01 |
| GOMF CYSTEINE TYPE ENDOPEPTIDASE INHIBITOR ACTIVITY | 15 | 3.75e-01 | 1.32e-01 | 8.09e-01 |
| GOBP POSITIVE REGULATION OF CYTOPLASMIC TRANSLATIONAL INITIATION | 5 | 6.08e-01 | -1.32e-01 | 9.03e-01 |
| GOBP REGULATION OF GERM CELL PROLIFERATION | 7 | 5.44e-01 | 1.32e-01 | 8.83e-01 |
| GOMF NUCLEAR GLUCOCORTICOID RECEPTOR BINDING | 12 | 4.27e-01 | -1.32e-01 | 8.34e-01 |
| GOCC ER UBIQUITIN LIGASE COMPLEX | 5 | 6.08e-01 | 1.32e-01 | 9.03e-01 |
| GOBP PYRIDINE CONTAINING COMPOUND BIOSYNTHETIC PROCESS | 27 | 2.34e-01 | 1.32e-01 | 7.05e-01 |
| GOBP SUCCINATE TRANSMEMBRANE TRANSPORT | 5 | 6.09e-01 | -1.32e-01 | 9.03e-01 |
| GOMF SUCCINATE TRANSMEMBRANE TRANSPORTER ACTIVITY | 5 | 6.09e-01 | -1.32e-01 | 9.03e-01 |
| GOBP REGULATION OF SPINDLE ASSEMBLY | 31 | 2.03e-01 | 1.32e-01 | 6.77e-01 |
| GOBP ANTERIOR POSTERIOR AXIS SPECIFICATION | 30 | 2.11e-01 | 1.32e-01 | 6.83e-01 |
| GOBP NEGATIVE REGULATION OF NEUROTRANSMITTER TRANSPORT | 9 | 4.93e-01 | 1.32e-01 | 8.62e-01 |
| GOBP PROTEIN LOCALIZATION TO CILIUM | 62 | 7.23e-02 | 1.32e-01 | 4.86e-01 |
| GOBP REGULATION OF VOLTAGE GATED CALCIUM CHANNEL ACTIVITY | 18 | 3.32e-01 | -1.32e-01 | 7.83e-01 |
| GOBP REGULATION OF ACTIN FILAMENT BASED MOVEMENT | 28 | 2.27e-01 | 1.32e-01 | 7.00e-01 |
| GOBP REGULATION OF TOLL LIKE RECEPTOR 2 SIGNALING PATHWAY | 10 | 4.70e-01 | 1.32e-01 | 8.54e-01 |
| GOBP DNA CYTOSINE DEAMINATION | 9 | 4.93e-01 | 1.32e-01 | 8.62e-01 |
| GOBP FC RECEPTOR SIGNALING PATHWAY | 55 | 9.09e-02 | 1.32e-01 | 5.27e-01 |
| GOBP CATECHOL CONTAINING COMPOUND BIOSYNTHETIC PROCESS | 13 | 4.11e-01 | 1.32e-01 | 8.26e-01 |
| GOBP REGULATION OF PLASMA LIPOPROTEIN PARTICLE LEVELS | 55 | 9.12e-02 | -1.32e-01 | 5.27e-01 |
| GOBP NUCLEOBASE METABOLIC PROCESS | 33 | 1.90e-01 | 1.32e-01 | 6.63e-01 |
| GOBP NEGATIVE REGULATION OF NEUROTRANSMITTER SECRETION | 6 | 5.76e-01 | 1.32e-01 | 8.92e-01 |
| GOCC GARP COMPLEX | 5 | 6.10e-01 | -1.32e-01 | 9.03e-01 |
| GOBP REGULATION OF GUANYL NUCLEOTIDE EXCHANGE FACTOR ACTIVITY | 6 | 5.77e-01 | 1.32e-01 | 8.92e-01 |
| GOBP DEHYDROASCORBIC ACID TRANSPORT | 7 | 5.46e-01 | -1.32e-01 | 8.84e-01 |
| GOMF DEHYDROASCORBIC ACID TRANSMEMBRANE TRANSPORTER ACTIVITY | 7 | 5.46e-01 | -1.32e-01 | 8.84e-01 |
| GOBP PROTEIN AUTOUBIQUITINATION | 70 | 5.70e-02 | 1.32e-01 | 4.45e-01 |
| GOMF ALPHA N ACETYLGALACTOSAMINIDE ALPHA 2 6 SIALYLTRANSFERASE ACTIVITY | 5 | 6.10e-01 | 1.32e-01 | 9.03e-01 |
| GOBP REGULATION OF EXCITATORY SYNAPSE ASSEMBLY | 11 | 4.50e-01 | -1.32e-01 | 8.43e-01 |
| GOBP FOREGUT MORPHOGENESIS | 6 | 5.77e-01 | -1.32e-01 | 8.92e-01 |
| GOBP VESICLE TARGETING | 65 | 6.69e-02 | 1.31e-01 | 4.71e-01 |
| GOBP VISUAL BEHAVIOR | 43 | 1.36e-01 | 1.31e-01 | 6.02e-01 |
| GOBP MOTOR NEURON AXON GUIDANCE | 18 | 3.35e-01 | -1.31e-01 | 7.84e-01 |
| GOBP RECEPTOR GUANYLYL CYCLASE SIGNALING PATHWAY | 6 | 5.78e-01 | 1.31e-01 | 8.92e-01 |
| GOMF PROTEIN KINASE A CATALYTIC SUBUNIT BINDING | 13 | 4.13e-01 | 1.31e-01 | 8.28e-01 |
| GOBP NEGATIVE REGULATION OF ADENYLATE CYCLASE ACTIVATING G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY | 10 | 4.73e-01 | 1.31e-01 | 8.55e-01 |
| GOMF AMINO ACID SODIUM SYMPORTER ACTIVITY | 12 | 4.32e-01 | 1.31e-01 | 8.35e-01 |
| GOBP REGULATION OF FOCAL ADHESION DISASSEMBLY | 6 | 5.78e-01 | 1.31e-01 | 8.92e-01 |
| GOBP REGULATION OF ENDOTHELIAL CELL CHEMOTAXIS | 11 | 4.52e-01 | -1.31e-01 | 8.43e-01 |
| GOBP PARALLEL ACTIN FILAMENT BUNDLE ASSEMBLY | 5 | 6.12e-01 | 1.31e-01 | 9.04e-01 |
| GOBP GLUCOSE 6 PHOSPHATE METABOLIC PROCESS | 27 | 2.39e-01 | -1.31e-01 | 7.08e-01 |
| GOBP NEGATIVE REGULATION OF MYELOID CELL APOPTOTIC PROCESS | 15 | 3.80e-01 | 1.31e-01 | 8.13e-01 |
| GOBP REGULATION OF RECEPTOR LOCALIZATION TO SYNAPSE | 19 | 3.23e-01 | -1.31e-01 | 7.74e-01 |
| GOBP MYELIN ASSEMBLY | 21 | 2.99e-01 | 1.31e-01 | 7.55e-01 |
| GOMF LRR DOMAIN BINDING | 16 | 3.65e-01 | -1.31e-01 | 8.03e-01 |
| GOBP CITRATE METABOLIC PROCESS | 5 | 6.12e-01 | -1.31e-01 | 9.04e-01 |
| GOBP CHROMOSOME ORGANIZATION INVOLVED IN MEIOTIC CELL CYCLE | 46 | 1.25e-01 | 1.31e-01 | 5.88e-01 |
| GOBP POSITIVE REGULATION OF GLUTAMATE SECRETION | 9 | 4.97e-01 | 1.31e-01 | 8.62e-01 |
| GOBP 3 UTR MEDIATED MRNA DESTABILIZATION | 18 | 3.37e-01 | -1.31e-01 | 7.86e-01 |
| GOBP CELLULAR RESPONSE TO BRAIN DERIVED NEUROTROPHIC FACTOR STIMULUS | 5 | 6.13e-01 | 1.31e-01 | 9.04e-01 |
| GOCC EUKARYOTIC 48S PREINITIATION COMPLEX | 17 | 3.51e-01 | 1.31e-01 | 7.93e-01 |
| GOBP MALE GENITALIA DEVELOPMENT | 11 | 4.53e-01 | -1.31e-01 | 8.43e-01 |
| GOBP TRANSFORMING GROWTH FACTOR BETA PRODUCTION | 26 | 2.49e-01 | 1.31e-01 | 7.17e-01 |
| GOBP PROTEIN AUTOPROCESSING | 17 | 3.51e-01 | -1.31e-01 | 7.93e-01 |
| GOBP PROTEIN LOCALIZATION TO NUCLEOPLASM | 14 | 3.98e-01 | 1.31e-01 | 8.22e-01 |
| GOBP OVULATION FROM OVARIAN FOLLICLE | 5 | 6.13e-01 | 1.31e-01 | 9.04e-01 |
| GOBP REGULATION OF MITOTIC SPINDLE ASSEMBLY | 22 | 2.89e-01 | 1.31e-01 | 7.47e-01 |
| GOCC GATOR2 COMPLEX | 10 | 4.75e-01 | -1.31e-01 | 8.56e-01 |
| GOBP REACTIVE OXYGEN SPECIES BIOSYNTHETIC PROCESS | 44 | 1.34e-01 | 1.31e-01 | 5.99e-01 |
| GOBP MIRNA CATABOLIC PROCESS | 16 | 3.66e-01 | 1.31e-01 | 8.04e-01 |
| GOMF RNA POLYMERASE II GENERAL TRANSCRIPTION INITIATION FACTOR BINDING | 23 | 2.79e-01 | 1.30e-01 | 7.40e-01 |
| GOBP AUTOPHAGY OF PEROXISOME | 16 | 3.67e-01 | 1.30e-01 | 8.04e-01 |
| GOBP NEGATIVE REGULATION OF TRANSLATIONAL INITIATION | 22 | 2.90e-01 | 1.30e-01 | 7.47e-01 |
| GOBP REGULATION OF LEUKOCYTE APOPTOTIC PROCESS | 79 | 4.52e-02 | 1.30e-01 | 4.13e-01 |
| GOBP LIPID EXPORT FROM CELL | 35 | 1.82e-01 | 1.30e-01 | 6.55e-01 |
| GOMF PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR BINDING | 9 | 4.98e-01 | 1.30e-01 | 8.63e-01 |
| GOMF CYCLIC NUCLEOTIDE PHOSPHODIESTERASE ACTIVITY | 21 | 3.01e-01 | 1.30e-01 | 7.57e-01 |
| GOBP VENTRAL SPINAL CORD DEVELOPMENT | 24 | 2.69e-01 | -1.30e-01 | 7.34e-01 |
| GOBP RESPONSE TO STEROL | 28 | 2.33e-01 | 1.30e-01 | 7.05e-01 |
| GOCC CAMP DEPENDENT PROTEIN KINASE COMPLEX | 6 | 5.81e-01 | 1.30e-01 | 8.93e-01 |
| GOCC NETWORK FORMING COLLAGEN TRIMER | 6 | 5.81e-01 | -1.30e-01 | 8.93e-01 |
| GOBP REGULATION OF POSTSYNAPTIC MEMBRANE POTENTIAL | 85 | 3.81e-02 | -1.30e-01 | 3.96e-01 |
| GOBP NEUROMUSCULAR JUNCTION DEVELOPMENT | 40 | 1.55e-01 | -1.30e-01 | 6.17e-01 |
| GOBP SALIVARY GLAND DEVELOPMENT | 29 | 2.25e-01 | 1.30e-01 | 6.98e-01 |
| GOMF RIBOSOME BINDING | 101 | 2.39e-02 | 1.30e-01 | 3.36e-01 |
| GOBP POSITIVE REGULATION OF VACUOLE ORGANIZATION | 24 | 2.70e-01 | 1.30e-01 | 7.35e-01 |
| GOCC REPLISOME | 23 | 2.81e-01 | 1.30e-01 | 7.42e-01 |
| GOMF ATP DEPENDENT PROTEIN BINDING | 6 | 5.82e-01 | -1.30e-01 | 8.93e-01 |
| GOBP POSITIVE REGULATION OF BIOMINERAL TISSUE DEVELOPMENT | 37 | 1.72e-01 | -1.30e-01 | 6.39e-01 |
| GOBP NEGATIVE REGULATION OF MEIOTIC CELL CYCLE | 11 | 4.56e-01 | 1.30e-01 | 8.44e-01 |
| GOBP RESPONSE TO ANGIOTENSIN | 30 | 2.18e-01 | 1.30e-01 | 6.93e-01 |
| GOMF OXIDOREDUCTASE ACTIVITY ACTING ON THE CH CH GROUP OF DONORS | 56 | 9.29e-02 | -1.30e-01 | 5.32e-01 |
| GOBP POSITIVE REGULATION OF KERATINOCYTE DIFFERENTIATION | 14 | 4.00e-01 | -1.30e-01 | 8.23e-01 |
| GOBP PROTEIN LOCALIZATION TO CELL SURFACE | 58 | 8.74e-02 | -1.30e-01 | 5.17e-01 |
| GOBP ESTROGEN METABOLIC PROCESS | 23 | 2.81e-01 | 1.30e-01 | 7.43e-01 |
| GOMF ANKYRIN REPEAT BINDING | 6 | 5.82e-01 | -1.30e-01 | 8.93e-01 |
| GOMF GENERAL TRANSCRIPTION INITIATION FACTOR ACTIVITY | 49 | 1.16e-01 | 1.30e-01 | 5.75e-01 |
| GOBP NODAL SIGNALING PATHWAY | 12 | 4.37e-01 | -1.30e-01 | 8.38e-01 |
| GOBP RENAL ABSORPTION | 23 | 2.82e-01 | -1.30e-01 | 7.43e-01 |
| GOBP RRNA MODIFICATION | 33 | 1.98e-01 | -1.29e-01 | 6.70e-01 |
| GOBP REPLICATION BORN DOUBLE STRAND BREAK REPAIR VIA SISTER CHROMATID EXCHANGE | 6 | 5.83e-01 | 1.29e-01 | 8.93e-01 |
| GOBP NEGATIVE REGULATION OF PROTEIN LOCALIZATION TO MEMBRANE | 29 | 2.28e-01 | 1.29e-01 | 7.01e-01 |
| GOBP REGULATION OF MICROTUBULE BASED MOVEMENT | 35 | 1.86e-01 | -1.29e-01 | 6.60e-01 |
| GOBP NEGATIVE REGULATION OF VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR SIGNALING PATHWAY | 11 | 4.58e-01 | -1.29e-01 | 8.46e-01 |
| GOMF RNA EXONUCLEASE ACTIVITY | 45 | 1.34e-01 | 1.29e-01 | 5.99e-01 |
| GOBP REGULATION OF TRANSLATION AT SYNAPSE | 8 | 5.27e-01 | 1.29e-01 | 8.76e-01 |
| GOBP NOREPINEPHRINE METABOLIC PROCESS | 8 | 5.27e-01 | 1.29e-01 | 8.76e-01 |
| GOBP ACUTE INFLAMMATORY RESPONSE TO ANTIGENIC STIMULUS | 26 | 2.54e-01 | 1.29e-01 | 7.23e-01 |
| GOMF CALCIUM MONOATOMIC CATION ANTIPORTER ACTIVITY | 10 | 4.80e-01 | -1.29e-01 | 8.59e-01 |
| GOBP MIDBRAIN DEVELOPMENT | 64 | 7.40e-02 | 1.29e-01 | 4.89e-01 |
| GOBP NEGATIVE REGULATION OF MUSCLE CELL APOPTOTIC PROCESS | 34 | 1.93e-01 | -1.29e-01 | 6.65e-01 |
| GOBP INNATE IMMUNE RESPONSE ACTIVATING CELL SURFACE RECEPTOR SIGNALING PATHWAY | 83 | 4.21e-02 | 1.29e-01 | 4.05e-01 |
| GOBP CEREBELLAR CORTEX FORMATION | 18 | 3.43e-01 | 1.29e-01 | 7.89e-01 |
| GOMF CYSTEINE TYPE ENDOPEPTIDASE REGULATOR ACTIVITY INVOLVED IN APOPTOTIC PROCESS | 38 | 1.69e-01 | 1.29e-01 | 6.34e-01 |
| GOMF GLUTATHIONE TRANSMEMBRANE TRANSPORTER ACTIVITY | 6 | 5.84e-01 | 1.29e-01 | 8.93e-01 |
| GOBP CELLULAR RESPONSE TO EXOGENOUS DSRNA | 14 | 4.03e-01 | 1.29e-01 | 8.24e-01 |
| GOBP REGULATION OF MITOCHONDRIAL FISSION | 28 | 2.37e-01 | 1.29e-01 | 7.08e-01 |
| GOBP GAP JUNCTION ASSEMBLY | 10 | 4.80e-01 | 1.29e-01 | 8.59e-01 |
| GOCC CHROMOSOME TELOMERIC REPEAT REGION | 13 | 4.21e-01 | 1.29e-01 | 8.30e-01 |
| GOCC MITOTIC SPINDLE MIDZONE | 13 | 4.21e-01 | 1.29e-01 | 8.30e-01 |
| GOBP MITOCHONDRION ENDOPLASMIC RETICULUM MEMBRANE TETHERING | 7 | 5.55e-01 | 1.29e-01 | 8.87e-01 |
| GOBP PLASMA LIPOPROTEIN PARTICLE CLEARANCE | 30 | 2.23e-01 | -1.29e-01 | 6.97e-01 |
| GOBP POSITIVE REGULATION OF COAGULATION | 24 | 2.76e-01 | -1.29e-01 | 7.38e-01 |
| GOBP GLUTAMINE METABOLIC PROCESS | 25 | 2.66e-01 | 1.29e-01 | 7.33e-01 |
| GOMF INTEGRIN BINDING | 115 | 1.73e-02 | -1.29e-01 | 2.86e-01 |
| GOBP CYTOKINESIS | 166 | 4.30e-03 | 1.28e-01 | 1.58e-01 |
| GOBP REGULATION OF T HELPER 1 CELL DIFFERENTIATION | 10 | 4.82e-01 | 1.28e-01 | 8.59e-01 |
| GOBP NEGATIVE REGULATION OF MACROAUTOPHAGY | 35 | 1.89e-01 | -1.28e-01 | 6.62e-01 |
| GOBP LYMPH NODE DEVELOPMENT | 17 | 3.59e-01 | 1.28e-01 | 7.99e-01 |
| GOBP REGULATION OF EXECUTION PHASE OF APOPTOSIS | 17 | 3.59e-01 | -1.28e-01 | 7.99e-01 |
| GOBP PROTEIN INSERTION INTO MITOCHONDRIAL OUTER MEMBRANE | 15 | 3.89e-01 | 1.28e-01 | 8.18e-01 |
| GOBP CAMERA TYPE EYE PHOTORECEPTOR CELL DIFFERENTIATION | 19 | 3.33e-01 | -1.28e-01 | 7.83e-01 |
| GOBP POSITIVE REGULATION OF TRANSCRIPTION OF NOTCH RECEPTOR TARGET | 7 | 5.57e-01 | -1.28e-01 | 8.87e-01 |
| GOBP SPONTANEOUS NEUROTRANSMITTER SECRETION | 7 | 5.57e-01 | -1.28e-01 | 8.87e-01 |
| GOBP RESPONSE TO L PHENYLALANINE DERIVATIVE | 5 | 6.19e-01 | 1.28e-01 | 9.07e-01 |
| GOBP NEGATIVE REGULATION OF CARDIAC MUSCLE TISSUE GROWTH | 18 | 3.46e-01 | -1.28e-01 | 7.90e-01 |
| GOBP RESPONSE TO THYROID HORMONE | 20 | 3.21e-01 | 1.28e-01 | 7.73e-01 |
| GOMF HISTONE H3K9ME2 METHYLTRANSFERASE ACTIVITY | 6 | 5.87e-01 | -1.28e-01 | 8.95e-01 |
| GOMF BIOACTIVE LIPID RECEPTOR ACTIVITY | 13 | 4.25e-01 | -1.28e-01 | 8.32e-01 |
| GOBP REGULATION OF VACUOLE ORGANIZATION | 58 | 9.22e-02 | 1.28e-01 | 5.31e-01 |
| GOBP NEGATIVE REGULATION OF DNA TEMPLATED TRANSCRIPTION ELONGATION | 22 | 3.00e-01 | -1.28e-01 | 7.56e-01 |
| GOBP KINETOCHORE ASSEMBLY | 16 | 3.77e-01 | 1.28e-01 | 8.10e-01 |
| GOBP LIPID PHOSPHORYLATION | 9 | 5.07e-01 | -1.28e-01 | 8.68e-01 |
| GOMF ATP DEPENDENT DIACYLGLYCEROL KINASE ACTIVITY | 9 | 5.07e-01 | -1.28e-01 | 8.68e-01 |
| GOBP PLATELET MORPHOGENESIS | 26 | 2.60e-01 | -1.28e-01 | 7.28e-01 |
| GOBP OSTEOBLAST PROLIFERATION | 26 | 2.60e-01 | -1.28e-01 | 7.28e-01 |
| GOMF PHOSPHOLIPID TRANSFER ACTIVITY | 23 | 2.90e-01 | -1.28e-01 | 7.47e-01 |
| GOBP PROTEIN LOCALIZATION TO ENDOPLASMIC RETICULUM EXIT SITE | 8 | 5.32e-01 | 1.28e-01 | 8.79e-01 |
| GOBP PHOSPHOLIPID DEPHOSPHORYLATION | 39 | 1.68e-01 | 1.28e-01 | 6.33e-01 |
| GOBP THIAMINE CONTAINING COMPOUND METABOLIC PROCESS | 7 | 5.59e-01 | 1.28e-01 | 8.88e-01 |
| GOBP REGULATION OF PLASMA CELL DIFFERENTIATION | 5 | 6.22e-01 | 1.27e-01 | 9.09e-01 |
| GOBP PURINE DEOXYRIBONUCLEOSIDE MONOPHOSPHATE METABOLIC PROCESS | 10 | 4.85e-01 | 1.27e-01 | 8.60e-01 |
| GOBP POSITIVE REGULATION OF ALPHA BETA T CELL PROLIFERATION | 23 | 2.90e-01 | -1.27e-01 | 7.47e-01 |
| GOMF POTASSIUM CHANNEL REGULATOR ACTIVITY | 36 | 1.86e-01 | 1.27e-01 | 6.60e-01 |
| GOMF BMP RECEPTOR ACTIVITY | 5 | 6.22e-01 | 1.27e-01 | 9.09e-01 |
| GOBP AMP BIOSYNTHETIC PROCESS | 13 | 4.27e-01 | 1.27e-01 | 8.33e-01 |
| GOBP CHROMOSOME SEGREGATION | 387 | 1.72e-05 | 1.27e-01 | 4.51e-03 |
| GOCC ER TO GOLGI TRANSPORT VESICLE MEMBRANE | 59 | 9.09e-02 | 1.27e-01 | 5.27e-01 |
| GOMF INOSITOL 1 4 5 TRISPHOSPHATE 5 PHOSPHATASE ACTIVITY | 6 | 5.89e-01 | -1.27e-01 | 8.96e-01 |
| GOBP MUSCLE HYPERTROPHY IN RESPONSE TO STRESS | 19 | 3.37e-01 | -1.27e-01 | 7.86e-01 |
| GOMF EXTRACELLULAR MATRIX CONSTITUENT CONFERRING ELASTICITY | 9 | 5.09e-01 | -1.27e-01 | 8.69e-01 |
| GOBP RNA LOCALIZATION | 191 | 2.45e-03 | 1.27e-01 | 1.20e-01 |
| GOBP NEGATIVE REGULATION OF EPITHELIAL TO MESENCHYMAL TRANSITION | 29 | 2.36e-01 | 1.27e-01 | 7.07e-01 |
| GOBP DNA CATABOLIC PROCESS | 27 | 2.53e-01 | -1.27e-01 | 7.22e-01 |
| GOBP RESPONSE TO INTERLEUKIN 6 | 25 | 2.72e-01 | 1.27e-01 | 7.36e-01 |
| GOCC TRIGLYCERIDE RICH PLASMA LIPOPROTEIN PARTICLE | 11 | 4.66e-01 | -1.27e-01 | 8.51e-01 |
| GOBP NEGATIVE REGULATION OF B CELL APOPTOTIC PROCESS | 14 | 4.10e-01 | -1.27e-01 | 8.26e-01 |
| GOBP REPRODUCTIVE BEHAVIOR | 28 | 2.45e-01 | 1.27e-01 | 7.14e-01 |
| GOBP NEGATIVE REGULATION OF INTERLEUKIN 1 PRODUCTION | 28 | 2.45e-01 | -1.27e-01 | 7.15e-01 |
| GOBP SNRNA METABOLIC PROCESS | 56 | 1.00e-01 | 1.27e-01 | 5.47e-01 |
| GOBP CELL SUBSTRATE JUNCTION ORGANIZATION | 88 | 3.97e-02 | -1.27e-01 | 3.98e-01 |
| GOBP ANTIVIRAL INNATE IMMUNE RESPONSE | 49 | 1.24e-01 | 1.27e-01 | 5.88e-01 |
| GOBP ANATOMICAL STRUCTURE REGRESSION | 8 | 5.34e-01 | 1.27e-01 | 8.79e-01 |
| GOBP NEGATIVE REGULATION OF MACROPHAGE CHEMOTAXIS | 7 | 5.61e-01 | 1.27e-01 | 8.88e-01 |
| GOBP B CELL ACTIVATION INVOLVED IN IMMUNE RESPONSE | 80 | 5.01e-02 | 1.27e-01 | 4.28e-01 |
| GOBP REGULATION OF FAT CELL DIFFERENTIATION | 94 | 3.39e-02 | -1.27e-01 | 3.84e-01 |
| GOBP CHEMOKINE C X C MOTIF LIGAND 2 PRODUCTION | 17 | 3.66e-01 | 1.27e-01 | 8.04e-01 |
| GOBP RENAL SODIUM EXCRETION | 7 | 5.62e-01 | -1.27e-01 | 8.89e-01 |
| GOBP REGULATION OF SMOOTH MUSCLE CELL DIFFERENTIATION | 30 | 2.31e-01 | -1.26e-01 | 7.03e-01 |
| GOBP NEGATIVE REGULATION OF SODIUM ION TRANSPORT | 9 | 5.11e-01 | 1.26e-01 | 8.70e-01 |
| GOMF TYPE 1 ANGIOTENSIN RECEPTOR BINDING | 5 | 6.24e-01 | -1.26e-01 | 9.09e-01 |
| GOBP POSITIVE REGULATION OF VASCULAR ASSOCIATED SMOOTH MUSCLE CELL APOPTOTIC PROCESS | 7 | 5.62e-01 | 1.26e-01 | 8.90e-01 |
| GOBP POSITIVE REGULATION OF GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR PRODUCTION | 9 | 5.12e-01 | -1.26e-01 | 8.70e-01 |
| GOBP NEGATIVE REGULATION OF SYNAPTIC TRANSMISSION | 35 | 1.96e-01 | -1.26e-01 | 6.68e-01 |
| GOBP RESPONSE TO ACETYLCHOLINE | 28 | 2.48e-01 | 1.26e-01 | 7.17e-01 |
| GOCC NUCLEAR STRESS GRANULE | 6 | 5.93e-01 | 1.26e-01 | 8.99e-01 |
| GOMF PHOSPHATIDIC ACID TRANSFER ACTIVITY | 7 | 5.64e-01 | 1.26e-01 | 8.90e-01 |
| GOMF HYDROLASE ACTIVITY ACTING ON CARBON NITROGEN BUT NOT PEPTIDE BONDS IN LINEAR AMIDINES | 7 | 5.64e-01 | -1.26e-01 | 8.90e-01 |
| GOCC CYTOCHROME COMPLEX | 35 | 1.97e-01 | -1.26e-01 | 6.69e-01 |
| GOMF MONOCARBOXYLIC ACID TRANSMEMBRANE TRANSPORTER ACTIVITY | 45 | 1.44e-01 | -1.26e-01 | 6.12e-01 |
| GOMF CALCIUM DEPENDENT PHOSPHOLIPASE A2 ACTIVITY | 8 | 5.38e-01 | -1.26e-01 | 8.79e-01 |
| GOBP SPHINGOMYELIN CATABOLIC PROCESS | 7 | 5.64e-01 | -1.26e-01 | 8.90e-01 |
| GOMF INOSITOL TRISPHOSPHATE PHOSPHATASE ACTIVITY | 12 | 4.51e-01 | -1.26e-01 | 8.43e-01 |
| GOBP NEGATIVE REGULATION OF PHAGOCYTOSIS | 20 | 3.30e-01 | 1.26e-01 | 7.81e-01 |
| GOBP RESPONSE TO LEPTIN | 17 | 3.69e-01 | 1.26e-01 | 8.06e-01 |
| GOBP REGULATION OF STRESS ACTIVATED PROTEIN KINASE SIGNALING CASCADE | 35 | 1.98e-01 | 1.26e-01 | 6.70e-01 |
| GOMF PROTEIN ARGININE OMEGA N ASYMMETRIC METHYLTRANSFERASE ACTIVITY | 6 | 5.94e-01 | -1.26e-01 | 9.00e-01 |
| GOMF S ADENOSYL L METHIONINE BINDING | 20 | 3.31e-01 | -1.26e-01 | 7.82e-01 |
| GOBP MITOTIC G2 DNA DAMAGE CHECKPOINT SIGNALING | 37 | 1.86e-01 | 1.26e-01 | 6.60e-01 |
| GOBP RESPONSE TO INTERLEUKIN 2 | 9 | 5.14e-01 | 1.26e-01 | 8.71e-01 |
| GOMF HORMONE RECEPTOR BINDING | 12 | 4.52e-01 | -1.26e-01 | 8.43e-01 |
| GOBP CYSTEINE METABOLIC PROCESS | 9 | 5.14e-01 | -1.26e-01 | 8.71e-01 |
| GOBP OPTIC NERVE DEVELOPMENT | 14 | 4.16e-01 | 1.25e-01 | 8.30e-01 |
| GOMF MACROMOLECULE TRANSMEMBRANE TRANSPORTER ACTIVITY | 30 | 2.34e-01 | 1.25e-01 | 7.05e-01 |
| GOMF OMEGA PEPTIDASE ACTIVITY | 10 | 4.92e-01 | -1.25e-01 | 8.62e-01 |
| GOBP REGULATION OF SUBSTRATE ADHESION DEPENDENT CELL SPREADING | 51 | 1.22e-01 | -1.25e-01 | 5.85e-01 |
| GOBP RESPONSE TO AMINO ACID STARVATION | 53 | 1.15e-01 | 1.25e-01 | 5.72e-01 |
| GOMF GTPASE INHIBITOR ACTIVITY | 11 | 4.72e-01 | 1.25e-01 | 8.54e-01 |
| GOBP POSITIVE REGULATION OF DENDRITIC CELL CYTOKINE PRODUCTION | 11 | 4.72e-01 | 1.25e-01 | 8.54e-01 |
| GOBP LEUKOCYTE HOMEOSTASIS | 100 | 3.05e-02 | 1.25e-01 | 3.66e-01 |
| GOBP PYRIMIDINE RIBONUCLEOTIDE BIOSYNTHETIC PROCESS | 21 | 3.21e-01 | -1.25e-01 | 7.72e-01 |
| GOBP POSITIVE REGULATION OF OLIGODENDROCYTE DIFFERENTIATION | 19 | 3.45e-01 | -1.25e-01 | 7.89e-01 |
| GOMF VOLTAGE GATED POTASSIUM CHANNEL ACTIVITY INVOLVED IN VENTRICULAR CARDIAC MUSCLE CELL ACTION POTENTIAL REPOLARIZATION | 8 | 5.40e-01 | 1.25e-01 | 8.80e-01 |
| GOBP HOST MEDIATED REGULATION OF INTESTINAL MICROBIOTA COMPOSITION | 6 | 5.96e-01 | -1.25e-01 | 9.01e-01 |
| GOMF ACETYLGALACTOSAMINYLTRANSFERASE ACTIVITY | 29 | 2.44e-01 | 1.25e-01 | 7.13e-01 |
| GOBP LABYRINTHINE LAYER MORPHOGENESIS | 14 | 4.18e-01 | 1.25e-01 | 8.30e-01 |
| GOBP RETINA HOMEOSTASIS | 37 | 1.88e-01 | 1.25e-01 | 6.62e-01 |
| GOBP RESPONSE TO L GLUTAMATE | 15 | 4.02e-01 | 1.25e-01 | 8.23e-01 |
| GOBP CHEMICAL SYNAPTIC TRANSMISSION POSTSYNAPTIC | 73 | 6.49e-02 | -1.25e-01 | 4.66e-01 |
| GOBP CERAMIDE CATABOLIC PROCESS | 17 | 3.73e-01 | 1.25e-01 | 8.08e-01 |
| GOBP SPHINGOID METABOLIC PROCESS | 21 | 3.22e-01 | 1.25e-01 | 7.74e-01 |
| GOBP RRNA CATABOLIC PROCESS | 14 | 4.19e-01 | -1.25e-01 | 8.30e-01 |
| GOBP COPII COATED VESICLE BUDDING | 44 | 1.53e-01 | 1.25e-01 | 6.16e-01 |
| GOBP OVARIAN FOLLICLE DEVELOPMENT | 39 | 1.78e-01 | -1.25e-01 | 6.50e-01 |
| GOMF HELICASE ACTIVITY | 146 | 9.37e-03 | 1.25e-01 | 2.22e-01 |
| GOBP HEMOGLOBIN METABOLIC PROCESS | 15 | 4.04e-01 | 1.25e-01 | 8.24e-01 |
| GOCC AP 1 ADAPTOR COMPLEX | 11 | 4.74e-01 | 1.25e-01 | 8.56e-01 |
| GOBP MITOTIC NUCLEAR MEMBRANE ORGANIZATION | 10 | 4.96e-01 | -1.24e-01 | 8.62e-01 |
| GOBP TYPE I INTERFERON PRODUCTION | 118 | 1.96e-02 | 1.24e-01 | 3.06e-01 |
| GOBP 5S CLASS RRNA TRANSCRIPTION BY RNA POLYMERASE III | 6 | 5.98e-01 | -1.24e-01 | 9.02e-01 |
| GOCC TRANSCRIPTION FACTOR TFIIIC COMPLEX | 6 | 5.98e-01 | -1.24e-01 | 9.02e-01 |
| GOBP NUCLEOTIDE SUGAR BIOSYNTHETIC PROCESS | 19 | 3.48e-01 | -1.24e-01 | 7.92e-01 |
| GOBP SODIUM ION HOMEOSTASIS | 30 | 2.39e-01 | 1.24e-01 | 7.08e-01 |
| GOBP NEGATIVE REGULATION OF CENTRIOLE REPLICATION | 7 | 5.69e-01 | 1.24e-01 | 8.90e-01 |
| GOBP NEGATIVE REGULATION OF PROTEIN LOCALIZATION TO CELL SURFACE | 10 | 4.96e-01 | 1.24e-01 | 8.62e-01 |
| GOCC ADHERENS JUNCTION | 149 | 8.84e-03 | -1.24e-01 | 2.17e-01 |
| GOBP NEGATIVE REGULATION OF PEPTIDYL SERINE PHOSPHORYLATION | 21 | 3.24e-01 | 1.24e-01 | 7.75e-01 |
| GOBP NEGATIVE REGULATION OF FAT CELL DIFFERENTIATION | 37 | 1.91e-01 | -1.24e-01 | 6.63e-01 |
| GOBP RESPONSE TO MANGANESE ION | 16 | 3.90e-01 | 1.24e-01 | 8.18e-01 |
| GOBP C4 DICARBOXYLATE TRANSPORT | 23 | 3.02e-01 | 1.24e-01 | 7.58e-01 |
| GOMF CALCIUM SODIUM ANTIPORTER ACTIVITY | 8 | 5.43e-01 | -1.24e-01 | 8.82e-01 |
| GOBP REGULATION OF DEPHOSPHORYLATION | 91 | 4.07e-02 | 1.24e-01 | 4.01e-01 |
| GOCC MIDBODY | 194 | 2.90e-03 | 1.24e-01 | 1.28e-01 |
| GOMF VOLTAGE GATED MONOATOMIC CATION CHANNEL ACTIVITY | 88 | 4.44e-02 | -1.24e-01 | 4.11e-01 |
| GOBP NEGATIVE REGULATION OF T CELL MEDIATED IMMUNE RESPONSE TO TUMOR CELL | 5 | 6.31e-01 | 1.24e-01 | 9.12e-01 |
| GOBP ODONTOBLAST DIFFERENTIATION | 10 | 4.97e-01 | -1.24e-01 | 8.62e-01 |
| GOBP REPLACEMENT OSSIFICATION | 21 | 3.26e-01 | -1.24e-01 | 7.76e-01 |
| GOBP POSITIVE REGULATION OF EXTRACELLULAR MATRIX ASSEMBLY | 13 | 4.39e-01 | -1.24e-01 | 8.39e-01 |
| GOMF DICARBOXYLIC ACID TRANSMEMBRANE TRANSPORTER ACTIVITY | 20 | 3.38e-01 | -1.24e-01 | 7.87e-01 |
| GOBP CARDIAC MUSCLE CELL ACTION POTENTIAL | 59 | 1.00e-01 | 1.24e-01 | 5.47e-01 |
| GOBP SINGLE STRANDED VIRAL RNA REPLICATION VIA DOUBLE STRANDED DNA INTERMEDIATE | 19 | 3.50e-01 | 1.24e-01 | 7.93e-01 |
| GOBP TRICARBOXYLIC ACID CYCLE | 28 | 2.57e-01 | 1.24e-01 | 7.27e-01 |
| GOBP ACID SECRETION | 28 | 2.57e-01 | 1.24e-01 | 7.27e-01 |
| GOBP POSITIVE REGULATION OF AXONOGENESIS | 61 | 9.47e-02 | -1.24e-01 | 5.36e-01 |
| GOCC PIGMENT GRANULE | 103 | 3.01e-02 | 1.24e-01 | 3.64e-01 |
| GOMF LONG CHAIN FATTY ACID TRANSMEMBRANE TRANSPORTER ACTIVITY | 13 | 4.40e-01 | -1.24e-01 | 8.40e-01 |
| GOCC ATPASE DEPENDENT TRANSMEMBRANE TRANSPORT COMPLEX | 16 | 3.92e-01 | -1.24e-01 | 8.19e-01 |
| GOBP NEGATIVE REGULATION OF CELL CYCLE PROCESS | 272 | 4.51e-04 | 1.24e-01 | 4.27e-02 |
| GOBP T HELPER 17 CELL DIFFERENTIATION | 30 | 2.41e-01 | -1.24e-01 | 7.11e-01 |
| GOBP RESPONSE TO DIETARY EXCESS | 23 | 3.05e-01 | 1.24e-01 | 7.60e-01 |
| GOCC SEPTIN CYTOSKELETON | 15 | 4.07e-01 | 1.24e-01 | 8.26e-01 |
| GOBP VACUOLAR TRANSMEMBRANE TRANSPORT | 7 | 5.71e-01 | -1.24e-01 | 8.91e-01 |
| GOBP DNA SYNTHESIS INVOLVED IN DNA REPAIR | 40 | 1.76e-01 | 1.24e-01 | 6.46e-01 |
| GOBP REGULATION OF STEM CELL DIVISION | 9 | 5.21e-01 | 1.23e-01 | 8.74e-01 |
| GOBP PHOTORECEPTOR CELL OUTER SEGMENT ORGANIZATION | 9 | 5.21e-01 | -1.23e-01 | 8.74e-01 |
| GOCC PRESYNAPTIC ENDOCYTIC ZONE | 8 | 5.46e-01 | 1.23e-01 | 8.84e-01 |
| GOBP MODIFICATION OF POSTSYNAPTIC STRUCTURE | 19 | 3.52e-01 | 1.23e-01 | 7.94e-01 |
| GOBP PROTEIN LIPID COMPLEX ASSEMBLY | 21 | 3.28e-01 | -1.23e-01 | 7.78e-01 |
| GOBP RESPONSE TO TYPE I INTERFERON | 68 | 7.87e-02 | 1.23e-01 | 4.97e-01 |
| GOBP REGULATION OF SMOOTH MUSCLE CELL CHEMOTAXIS | 5 | 6.33e-01 | -1.23e-01 | 9.13e-01 |
| GOBP POSITIVE REGULATION OF GLUCOSE METABOLIC PROCESS | 34 | 2.13e-01 | -1.23e-01 | 6.88e-01 |
| GOBP REGULATION OF VITAMIN D BIOSYNTHETIC PROCESS | 6 | 6.01e-01 | 1.23e-01 | 9.03e-01 |
| GOBP LYMPHANGIOGENESIS | 11 | 4.79e-01 | 1.23e-01 | 8.58e-01 |
| GOMF LONG CHAIN FATTY ACYL COA HYDROLASE ACTIVITY | 13 | 4.42e-01 | 1.23e-01 | 8.41e-01 |
| GOMF SHORT CHAIN CARBOXYLESTERASE ACTIVITY | 6 | 6.01e-01 | 1.23e-01 | 9.03e-01 |
| GOBP INTERFERON MEDIATED SIGNALING PATHWAY | 82 | 5.39e-02 | 1.23e-01 | 4.36e-01 |
| GOMF PROTEIN BINDING INVOLVED IN HETEROTYPIC CELL CELL ADHESION | 10 | 5.00e-01 | 1.23e-01 | 8.64e-01 |
| GOMF GUANYLATE KINASE ACTIVITY | 9 | 5.23e-01 | 1.23e-01 | 8.75e-01 |
| GOBP MRNA TRANSCRIPTION | 48 | 1.40e-01 | 1.23e-01 | 6.07e-01 |
| GOBP PHOSPHATIDYLINOSITOL PHOSPHATE BIOSYNTHETIC PROCESS | 61 | 9.65e-02 | 1.23e-01 | 5.40e-01 |
| GOBP POST ANAL TAIL MORPHOGENESIS | 12 | 4.61e-01 | 1.23e-01 | 8.48e-01 |
| GOMF LIGASE ACTIVITY FORMING CARBON CARBON BONDS | 7 | 5.73e-01 | 1.23e-01 | 8.92e-01 |
| GOMF DNA APURINIC OR APYRIMIDINIC SITE ENDONUCLEASE ACTIVITY | 11 | 4.81e-01 | -1.23e-01 | 8.59e-01 |
| GOCC PROTEASE INHIBITOR COMPLEX | 6 | 6.02e-01 | 1.23e-01 | 9.03e-01 |
| GOBP LYMPHOCYTE CHEMOTAXIS | 32 | 2.29e-01 | 1.23e-01 | 7.02e-01 |
| GOBP REGULATION OF CHROMATIN BINDING | 10 | 5.01e-01 | 1.23e-01 | 8.65e-01 |
| GOBP RESPONSE TO INCREASED OXYGEN LEVELS | 20 | 3.42e-01 | 1.23e-01 | 7.89e-01 |
| GOMF MANNOSYLTRANSFERASE ACTIVITY | 24 | 2.98e-01 | 1.23e-01 | 7.54e-01 |
| GOBP SKELETAL MUSCLE ACETYLCHOLINE GATED CHANNEL CLUSTERING | 10 | 5.02e-01 | -1.23e-01 | 8.65e-01 |
| GOBP DORSAL AORTA MORPHOGENESIS | 5 | 6.35e-01 | -1.23e-01 | 9.14e-01 |
| GOBP POSITIVE REGULATION OF MONOOXYGENASE ACTIVITY | 21 | 3.30e-01 | 1.23e-01 | 7.82e-01 |
| GOBP RESPONSE TO HYDROXYUREA | 11 | 4.81e-01 | 1.23e-01 | 8.59e-01 |
| GOBP NEGATIVE REGULATION OF SMOOTH MUSCLE CELL PROLIFERATION | 38 | 1.91e-01 | -1.23e-01 | 6.63e-01 |
| GOBP RESPONSE TO UV C | 13 | 4.44e-01 | 1.22e-01 | 8.41e-01 |
| GOMF TUMOR NECROSIS FACTOR RECEPTOR BINDING | 30 | 2.46e-01 | -1.22e-01 | 7.16e-01 |
| GOBP POSITIVE REGULATION OF LEUKOCYTE CHEMOTAXIS | 70 | 7.65e-02 | 1.22e-01 | 4.93e-01 |
| GOBP ACYLGLYCEROL TRANSPORT | 5 | 6.36e-01 | 1.22e-01 | 9.14e-01 |
| GOBP PURINE NUCLEOSIDE METABOLIC PROCESS | 26 | 2.80e-01 | 1.22e-01 | 7.41e-01 |
| GOCC PROTON TRANSPORTING ATP SYNTHASE COMPLEX COUPLING FACTOR F O | 13 | 4.45e-01 | -1.22e-01 | 8.41e-01 |
| GOMF PRE MRNA BINDING | 36 | 2.04e-01 | 1.22e-01 | 6.78e-01 |
| GOBP SHORT CHAIN FATTY ACID METABOLIC PROCESS | 14 | 4.28e-01 | -1.22e-01 | 8.34e-01 |
| GOMF LIGAND GATED MONOATOMIC ANION CHANNEL ACTIVITY | 20 | 3.44e-01 | -1.22e-01 | 7.89e-01 |
| GOBP TELOMERIC D LOOP DISASSEMBLY | 9 | 5.25e-01 | -1.22e-01 | 8.76e-01 |
| GOMF GAMMA TUBULIN BINDING | 33 | 2.24e-01 | -1.22e-01 | 6.97e-01 |
| GOCC P BODY | 96 | 3.85e-02 | 1.22e-01 | 3.98e-01 |
| GOBP NEGATIVE REGULATION OF TRANSLATION | 116 | 2.30e-02 | 1.22e-01 | 3.29e-01 |
| GOBP NEGATIVE REGULATION OF SPROUTING ANGIOGENESIS | 10 | 5.03e-01 | -1.22e-01 | 8.66e-01 |
| GOMF DNA SECONDARY STRUCTURE BINDING | 35 | 2.11e-01 | 1.22e-01 | 6.83e-01 |
| GOBP POSITIVE REGULATION OF STRIATED MUSCLE CONTRACTION | 11 | 4.83e-01 | -1.22e-01 | 8.60e-01 |
| GOBP REGULATION OF CHROMOSOME ORGANIZATION | 241 | 1.09e-03 | 1.22e-01 | 7.42e-02 |
| GOBP EMBRYONIC DIGESTIVE TRACT DEVELOPMENT | 15 | 4.13e-01 | 1.22e-01 | 8.28e-01 |
| GOBP DEOXYRIBONUCLEOSIDE METABOLIC PROCESS | 10 | 5.04e-01 | 1.22e-01 | 8.66e-01 |
| GOBP MRNA 5 SPLICE SITE RECOGNITION | 7 | 5.76e-01 | 1.22e-01 | 8.92e-01 |
| GOBP MYOTUBE DIFFERENTIATION INVOLVED IN SKELETAL MUSCLE REGENERATION | 6 | 6.04e-01 | -1.22e-01 | 9.03e-01 |
| GOCC RPAP3 R2TP PREFOLDIN LIKE COMPLEX | 11 | 4.84e-01 | -1.22e-01 | 8.60e-01 |
| GOBP PEPTIDE CATABOLIC PROCESS | 17 | 3.84e-01 | 1.22e-01 | 8.15e-01 |
| GOCC NUCLEOLAR RIBONUCLEASE P COMPLEX | 7 | 5.76e-01 | -1.22e-01 | 8.92e-01 |
| GOBP DETERMINATION OF LIVER LEFT RIGHT ASYMMETRY | 5 | 6.37e-01 | -1.22e-01 | 9.14e-01 |
| GOBP NEGATIVE REGULATION OF PHOSPHATIDYLINOSITOL 3 KINASE PROTEIN KINASE B SIGNAL TRANSDUCTION | 48 | 1.44e-01 | -1.22e-01 | 6.12e-01 |
| GOMF CARGO RECEPTOR ACTIVITY | 64 | 9.20e-02 | -1.22e-01 | 5.30e-01 |
| GOBP PROTEIN LOCALIZATION TO PERINUCLEAR REGION OF CYTOPLASM | 7 | 5.77e-01 | -1.22e-01 | 8.92e-01 |
| GOBP POSITIVE REGULATION OF VOLTAGE GATED POTASSIUM CHANNEL ACTIVITY | 6 | 6.06e-01 | 1.22e-01 | 9.03e-01 |
| GOBP POSITIVE REGULATION OF POST TRANSLATIONAL PROTEIN MODIFICATION | 119 | 2.18e-02 | 1.22e-01 | 3.22e-01 |
| GOMF GAMMA AMINOBUTYRIC ACID TRANSMEMBRANE TRANSPORTER ACTIVITY | 5 | 6.38e-01 | -1.22e-01 | 9.15e-01 |
| GOBP ATRIOVENTRICULAR VALVE DEVELOPMENT | 18 | 3.72e-01 | 1.22e-01 | 8.08e-01 |
| GOBP PROTEIN TARGETING TO VACUOLE INVOLVED IN AUTOPHAGY | 6 | 6.06e-01 | -1.22e-01 | 9.03e-01 |
| GOMF EPOXIDE HYDROLASE ACTIVITY | 8 | 5.52e-01 | -1.22e-01 | 8.86e-01 |
| GOBP NEGATIVE REGULATION OF MAP KINASE ACTIVITY | 36 | 2.07e-01 | 1.22e-01 | 6.81e-01 |
| GOBP EMBRYONIC PLACENTA MORPHOGENESIS | 17 | 3.86e-01 | 1.21e-01 | 8.16e-01 |
| GOBP MACROPHAGE COLONY STIMULATING FACTOR SIGNALING PATHWAY | 6 | 6.06e-01 | 1.21e-01 | 9.03e-01 |
| GOBP NEGATIVE REGULATION OF VASCULAR ASSOCIATED SMOOTH MUSCLE CELL MIGRATION | 7 | 5.78e-01 | 1.21e-01 | 8.92e-01 |
| GOBP NEGATIVE REGULATION OF LIPID LOCALIZATION | 34 | 2.21e-01 | -1.21e-01 | 6.94e-01 |
| GOBP CHROMOSOME ORGANIZATION | 567 | 7.80e-07 | 1.21e-01 | 5.61e-04 |
| GOBP POSITIVE REGULATION OF LONG TERM SYNAPTIC POTENTIATION | 15 | 4.16e-01 | 1.21e-01 | 8.30e-01 |
| GOBP REGULATION OF STRIATED MUSCLE TISSUE DEVELOPMENT | 14 | 4.32e-01 | 1.21e-01 | 8.36e-01 |
| GOBP REGULATION OF DEFENSE RESPONSE TO VIRUS | 57 | 1.13e-01 | 1.21e-01 | 5.69e-01 |
| GOCC CALYX OF HELD | 12 | 4.67e-01 | -1.21e-01 | 8.52e-01 |
| GOBP COMPLEMENT ACTIVATION ALTERNATIVE PATHWAY | 11 | 4.87e-01 | 1.21e-01 | 8.60e-01 |
| GOMF NADPLUS PROTEIN ASPARTATE ADP RIBOSYLTRANSFERASE ACTIVITY | 5 | 6.39e-01 | -1.21e-01 | 9.15e-01 |
| GOBP RESPONSE TO CAMP | 58 | 1.11e-01 | -1.21e-01 | 5.64e-01 |
| GOBP RETINAL CONE CELL DIFFERENTIATION | 8 | 5.53e-01 | -1.21e-01 | 8.86e-01 |
| GOBP MICROVILLUS ORGANIZATION | 27 | 2.76e-01 | 1.21e-01 | 7.39e-01 |
| GOMF RECEPTOR SERINE THREONINE KINASE BINDING | 18 | 3.74e-01 | -1.21e-01 | 8.09e-01 |
| GOBP CYTOSKELETON DEPENDENT CYTOKINESIS | 112 | 2.69e-02 | 1.21e-01 | 3.53e-01 |
| GOMF TELOMERASE RNA BINDING | 22 | 3.26e-01 | 1.21e-01 | 7.77e-01 |
| GOBP PROTEIN PROCESSING INVOLVED IN PROTEIN TARGETING TO MITOCHONDRION | 7 | 5.79e-01 | -1.21e-01 | 8.92e-01 |
| GOMF POTASSIUM CHANNEL ACTIVITY | 72 | 7.59e-02 | -1.21e-01 | 4.93e-01 |
| GOCC LATERAL PLASMA MEMBRANE | 50 | 1.39e-01 | -1.21e-01 | 6.05e-01 |
| GOBP DE NOVO NAD BIOSYNTHETIC PROCESS | 8 | 5.54e-01 | 1.21e-01 | 8.86e-01 |
| GOCC ACTIN FILAMENT | 94 | 4.28e-02 | -1.21e-01 | 4.07e-01 |
| GOBP INHIBITORY POSTSYNAPTIC POTENTIAL | 9 | 5.30e-01 | -1.21e-01 | 8.78e-01 |
| GOBP ADHERENS JUNCTION ORGANIZATION | 41 | 1.81e-01 | -1.21e-01 | 6.54e-01 |
| GOBP MITOCHONDRIAL ELECTRON TRANSPORT SUCCINATE TO UBIQUINONE | 5 | 6.40e-01 | 1.21e-01 | 9.15e-01 |
| GOBP ACETYL COA BIOSYNTHETIC PROCESS | 17 | 3.89e-01 | 1.21e-01 | 8.17e-01 |
| GOBP S ADENOSYLMETHIONINE CYCLE | 7 | 5.80e-01 | 1.21e-01 | 8.93e-01 |
| GOBP TRANSCRIPTION DEPENDENT TETHERING OF RNA POLYMERASE II GENE DNA AT NUCLEAR PERIPHERY | 7 | 5.80e-01 | 1.21e-01 | 8.93e-01 |
| GOCC SERINE TYPE ENDOPEPTIDASE COMPLEX | 6 | 6.09e-01 | -1.21e-01 | 9.03e-01 |
| GOCC SERINE TYPE PEPTIDASE COMPLEX | 6 | 6.09e-01 | -1.21e-01 | 9.03e-01 |
| GOMF ENDODEOXYRIBONUCLEASE ACTIVITY PRODUCING 5 PHOSPHOMONOESTERS | 14 | 4.34e-01 | -1.21e-01 | 8.36e-01 |
| GOMF EXTRACELLULAR MATRIX BINDING | 46 | 1.57e-01 | -1.21e-01 | 6.21e-01 |
| GOBP ERBB2 SIGNALING PATHWAY | 18 | 3.76e-01 | -1.21e-01 | 8.10e-01 |
| GOBP PROTEIN DENEDDYLATION | 11 | 4.89e-01 | 1.21e-01 | 8.61e-01 |
| GOBP PHARYNGEAL SYSTEM DEVELOPMENT | 13 | 4.52e-01 | 1.21e-01 | 8.43e-01 |
| GOBP REGULATION OF MONOOXYGENASE ACTIVITY | 28 | 2.70e-01 | 1.20e-01 | 7.35e-01 |
| GOMF SPHINGOSINE 1 PHOSPHATE PHOSPHATASE ACTIVITY | 7 | 5.81e-01 | -1.20e-01 | 8.93e-01 |
| GOBP POSITIVE REGULATION OF HOMOTYPIC CELL CELL ADHESION | 13 | 4.52e-01 | -1.20e-01 | 8.43e-01 |
| GOBP INTRACELLULAR POTASSIUM ION HOMEOSTASIS | 11 | 4.89e-01 | 1.20e-01 | 8.61e-01 |
| GOMF ACID PHOSPHATASE ACTIVITY | 8 | 5.56e-01 | 1.20e-01 | 8.87e-01 |
| GOMF THIOREDOXIN DEPENDENT PEROXIREDOXIN ACTIVITY | 6 | 6.10e-01 | 1.20e-01 | 9.03e-01 |
| GOBP DEOXYRIBONUCLEOTIDE METABOLIC PROCESS | 39 | 1.94e-01 | 1.20e-01 | 6.67e-01 |
| GOCC VOLTAGE GATED CALCIUM CHANNEL COMPLEX | 31 | 2.46e-01 | -1.20e-01 | 7.16e-01 |
| GOBP MITOTIC RECOMBINATION | 23 | 3.18e-01 | 1.20e-01 | 7.69e-01 |
| GOCC CYTOPLASMIC EXOSOME RNASE COMPLEX | 16 | 4.05e-01 | -1.20e-01 | 8.25e-01 |
| GOBP MITOTIC SPINDLE ORGANIZATION | 130 | 1.79e-02 | 1.20e-01 | 2.90e-01 |
| GOBP REGULATION OF BLOOD BRAIN BARRIER PERMEABILITY | 8 | 5.56e-01 | 1.20e-01 | 8.87e-01 |
| GOMF VOLTAGE GATED MONOATOMIC ANION CHANNEL ACTIVITY | 13 | 4.53e-01 | 1.20e-01 | 8.43e-01 |
| GOMF VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR ACTIVITY | 6 | 6.10e-01 | 1.20e-01 | 9.03e-01 |
| GOBP REGULATION OF OPSIN MEDIATED SIGNALING PATHWAY | 7 | 5.82e-01 | 1.20e-01 | 8.93e-01 |
| GOBP INTRACELLULAR PHOSPHATE ION HOMEOSTASIS | 6 | 6.10e-01 | 1.20e-01 | 9.03e-01 |
| GOMF LIPASE INHIBITOR ACTIVITY | 9 | 5.33e-01 | 1.20e-01 | 8.79e-01 |
| GOBP REGULATION OF EXTRACELLULAR MATRIX ORGANIZATION | 53 | 1.30e-01 | -1.20e-01 | 5.94e-01 |
| GOBP POSITIVE REGULATION OF GASTRO INTESTINAL SYSTEM SMOOTH MUSCLE CONTRACTION | 5 | 6.42e-01 | -1.20e-01 | 9.15e-01 |
| GOBP REGULATION OF MYELOID DENDRITIC CELL ACTIVATION | 5 | 6.42e-01 | 1.20e-01 | 9.15e-01 |
| GOBP CENTRIOLE ASSEMBLY | 45 | 1.64e-01 | 1.20e-01 | 6.30e-01 |
| GOBP SUBSTRATE DEPENDENT CELL MIGRATION | 22 | 3.30e-01 | 1.20e-01 | 7.82e-01 |
| GOMF LYSOPHOSPHATIDIC ACID PHOSPHATASE ACTIVITY | 5 | 6.43e-01 | 1.20e-01 | 9.15e-01 |
| GOBP MESONEPHRIC TUBULE MORPHOGENESIS | 40 | 1.90e-01 | -1.20e-01 | 6.62e-01 |
| GOBP POSITIVE REGULATION OF MUSCLE CELL DIFFERENTIATION | 48 | 1.51e-01 | -1.20e-01 | 6.13e-01 |
| GOBP CARBON DIOXIDE TRANSPORT | 8 | 5.57e-01 | 1.20e-01 | 8.88e-01 |
| GOMF ATP DEPENDENT ACTIVITY ACTING ON RNA | 72 | 7.89e-02 | 1.20e-01 | 4.97e-01 |
| GOBP REGULATION OF MESENCHYMAL CELL PROLIFERATION | 19 | 3.66e-01 | 1.20e-01 | 8.04e-01 |
| GOBP INTERMEMBRANE LIPID TRANSFER | 28 | 2.73e-01 | -1.20e-01 | 7.36e-01 |
| GOMF RAGE RECEPTOR BINDING | 9 | 5.34e-01 | 1.20e-01 | 8.79e-01 |
| GOBP GLUCOSAMINE CONTAINING COMPOUND CATABOLIC PROCESS | 8 | 5.58e-01 | -1.20e-01 | 8.88e-01 |
| GOCC OXOGLUTARATE DEHYDROGENASE COMPLEX | 10 | 5.12e-01 | -1.20e-01 | 8.70e-01 |
| GOBP REGULATION OF RESPONSE TO BIOTIC STIMULUS | 468 | 9.22e-06 | 1.20e-01 | 3.06e-03 |
| GOBP PROTEIN LOCALIZATION TO CHROMOSOME CENTROMERIC REGION | 29 | 2.65e-01 | 1.20e-01 | 7.32e-01 |
| GOBP MEIOTIC CHROMOSOME SEGREGATION | 68 | 8.81e-02 | 1.20e-01 | 5.19e-01 |
| GOMF TRANSLATION REPRESSOR ACTIVITY | 37 | 2.08e-01 | 1.20e-01 | 6.82e-01 |
| GOBP PSEUDOURIDINE SYNTHESIS | 18 | 3.80e-01 | -1.20e-01 | 8.13e-01 |
| GOBP REGULATION OF MRNA 3 END PROCESSING | 9 | 5.35e-01 | 1.19e-01 | 8.79e-01 |
| GOBP NEGATIVE REGULATION OF INTERLEUKIN 17 PRODUCTION | 13 | 4.56e-01 | -1.19e-01 | 8.44e-01 |
| GOCC PERICHROMATIN FIBRILS | 6 | 6.12e-01 | 1.19e-01 | 9.04e-01 |
| GOCC SPERM CONNECTING PIECE | 9 | 5.35e-01 | 1.19e-01 | 8.79e-01 |
| GOBP RESPONSE TO DEXAMETHASONE | 30 | 2.58e-01 | 1.19e-01 | 7.27e-01 |
| GOBP POSITIVE REGULATION OF BASEMENT MEMBRANE ASSEMBLY INVOLVED IN EMBRYONIC BODY MORPHOGENESIS | 5 | 6.44e-01 | -1.19e-01 | 9.15e-01 |
| GOBP ANGIOGENESIS INVOLVED IN CORONARY VASCULAR MORPHOGENESIS | 5 | 6.44e-01 | 1.19e-01 | 9.15e-01 |
| GOBP REGULATION OF PHOSPHOLIPASE A2 ACTIVITY | 6 | 6.13e-01 | 1.19e-01 | 9.04e-01 |
| GOBP EXTERNAL ENCAPSULATING STRUCTURE ORGANIZATION | 223 | 2.15e-03 | -1.19e-01 | 1.14e-01 |
| GOBP REGULATION OF MEMBRANE REPOLARIZATION DURING ACTION POTENTIAL | 6 | 6.13e-01 | -1.19e-01 | 9.04e-01 |
| GOBP INSEMINATION | 8 | 5.59e-01 | 1.19e-01 | 8.88e-01 |
| GOBP NEGATIVE REGULATION OF MITOTIC CELL CYCLE | 211 | 2.85e-03 | 1.19e-01 | 1.28e-01 |
| GOBP FILOPODIUM ASSEMBLY | 57 | 1.20e-01 | 1.19e-01 | 5.82e-01 |
| GOCC RNA POLYMERASE III TRANSCRIPTION REGULATOR COMPLEX | 9 | 5.36e-01 | -1.19e-01 | 8.79e-01 |
| GOBP REGULATION OF ANTIGEN RECEPTOR MEDIATED SIGNALING PATHWAY | 66 | 9.43e-02 | 1.19e-01 | 5.35e-01 |
| GOBP GAMMA AMINOBUTYRIC ACID METABOLIC PROCESS | 6 | 6.13e-01 | 1.19e-01 | 9.04e-01 |
| GOBP MEIOTIC CELL CYCLE PROCESS | 153 | 1.10e-02 | 1.19e-01 | 2.38e-01 |
| GOBP GROWTH HORMONE SECRETION | 9 | 5.36e-01 | 1.19e-01 | 8.79e-01 |
| GOBP AMINO ACID BETAINE TRANSPORT | 11 | 4.94e-01 | -1.19e-01 | 8.62e-01 |
| GOBP SIGNAL TRANSDUCTION IN RESPONSE TO DNA DAMAGE | 181 | 5.76e-03 | 1.19e-01 | 1.80e-01 |
| GOBP ZYMOGEN INHIBITION | 7 | 5.86e-01 | 1.19e-01 | 8.94e-01 |
| GOBP MEMBRANE HYPERPOLARIZATION | 5 | 6.45e-01 | -1.19e-01 | 9.15e-01 |
| GOMF SIGNALING RECEPTOR REGULATOR ACTIVITY | 261 | 9.44e-04 | -1.19e-01 | 6.98e-02 |
| GOBP REGULATION OF GLIAL CELL MIGRATION | 17 | 3.96e-01 | 1.19e-01 | 8.21e-01 |
| GOCC DENDRITIC SPINE HEAD | 5 | 6.46e-01 | -1.19e-01 | 9.15e-01 |
| GOBP VESICLE MEDIATED CHOLESTEROL TRANSPORT | 8 | 5.61e-01 | 1.19e-01 | 8.88e-01 |
| GOBP LEUKOTRIENE D4 BIOSYNTHETIC PROCESS | 5 | 6.46e-01 | 1.19e-01 | 9.15e-01 |
| GOBP SYNAPTIC VESICLE CYTOSKELETAL TRANSPORT | 19 | 3.70e-01 | 1.19e-01 | 8.07e-01 |
| GOBP UBIQUINONE METABOLIC PROCESS | 18 | 3.84e-01 | -1.19e-01 | 8.15e-01 |
| GOBP CELLULAR RESPONSE TO PROSTAGLANDIN STIMULUS | 19 | 3.71e-01 | -1.19e-01 | 8.08e-01 |
| GOBP MRNA EXPORT FROM NUCLEUS | 67 | 9.35e-02 | 1.18e-01 | 5.33e-01 |
| GOBP POSITIVE REGULATION OF TYPE 2 IMMUNE RESPONSE | 17 | 3.98e-01 | 1.18e-01 | 8.22e-01 |
| GOBP DETECTION OF STIMULUS INVOLVED IN SENSORY PERCEPTION OF PAIN | 18 | 3.84e-01 | 1.18e-01 | 8.15e-01 |
| GOBP POSITIVE REGULATION OF T CELL CYTOKINE PRODUCTION | 25 | 3.06e-01 | 1.18e-01 | 7.61e-01 |
| GOBP MHC CLASS II BIOSYNTHETIC PROCESS | 19 | 3.72e-01 | 1.18e-01 | 8.08e-01 |
| GOBP PROTEIN LOCALIZATION TO CENP A CONTAINING CHROMATIN | 7 | 5.88e-01 | -1.18e-01 | 8.95e-01 |
| GOCC ACROSOMAL VESICLE | 86 | 5.80e-02 | -1.18e-01 | 4.49e-01 |
| GOBP UBIQUITIN RECYCLING | 13 | 4.60e-01 | 1.18e-01 | 8.47e-01 |
| GOBP ASPARTATE FAMILY AMINO ACID CATABOLIC PROCESS | 11 | 4.97e-01 | -1.18e-01 | 8.62e-01 |
| GOBP VASCULAR ASSOCIATED SMOOTH MUSCLE CELL DIFFERENTIATION | 22 | 3.37e-01 | -1.18e-01 | 7.86e-01 |
| GOBP NEGATIVE REGULATION OF LIPID STORAGE | 17 | 3.99e-01 | 1.18e-01 | 8.22e-01 |
| GOBP PRIMARY ALCOHOL METABOLIC PROCESS | 63 | 1.05e-01 | -1.18e-01 | 5.57e-01 |
| GOBP DENDRITE ARBORIZATION | 7 | 5.88e-01 | -1.18e-01 | 8.95e-01 |
| GOBP CARDIOLIPIN METABOLIC PROCESS | 14 | 4.44e-01 | -1.18e-01 | 8.41e-01 |
| GOBP REGULATION OF HETEROTYPIC CELL CELL ADHESION | 18 | 3.86e-01 | -1.18e-01 | 8.16e-01 |
| GOBP L LEUCINE TRANSPORT | 9 | 5.40e-01 | -1.18e-01 | 8.80e-01 |
| GOBP ORGAN INDUCTION | 9 | 5.40e-01 | 1.18e-01 | 8.80e-01 |
| GOBP ALLANTOIN METABOLIC PROCESS | 6 | 6.17e-01 | 1.18e-01 | 9.06e-01 |
| GOBP REGULATION OF OSTEOBLAST PROLIFERATION | 22 | 3.38e-01 | -1.18e-01 | 7.87e-01 |
| GOMF GROWTH FACTOR RECEPTOR BINDING | 91 | 5.20e-02 | 1.18e-01 | 4.33e-01 |
| GOBP MALONYL COA METABOLIC PROCESS | 6 | 6.17e-01 | -1.18e-01 | 9.06e-01 |
| GOBP CDP DIACYLGLYCEROL BIOSYNTHETIC PROCESS | 13 | 4.62e-01 | 1.18e-01 | 8.48e-01 |
| GOBP POSITIVE REGULATION OF EXTRACELLULAR MATRIX DISASSEMBLY | 6 | 6.18e-01 | -1.18e-01 | 9.06e-01 |
| GOBP REGULATION OF DEFENSE RESPONSE TO VIRUS BY HOST | 37 | 2.16e-01 | 1.18e-01 | 6.91e-01 |
| GOBP REGULATION OF CALCIUM ION EXPORT ACROSS PLASMA MEMBRANE | 5 | 6.49e-01 | 1.18e-01 | 9.17e-01 |
| GOMF CALCIUM INDEPENDENT PHOSPHOLIPASE A2 ACTIVITY | 8 | 5.65e-01 | 1.18e-01 | 8.90e-01 |
| GOCC TRNA METHYLTRANSFERASE COMPLEX | 7 | 5.90e-01 | -1.18e-01 | 8.97e-01 |
| GOMF CARBOHYDRATE TRANSMEMBRANE TRANSPORTER ACTIVITY | 31 | 2.57e-01 | -1.18e-01 | 7.27e-01 |
| GOBP HEMATOPOIETIC STEM CELL PROLIFERATION | 28 | 2.82e-01 | -1.17e-01 | 7.43e-01 |
| GOBP RESPONSE TO FORSKOLIN | 10 | 5.20e-01 | -1.17e-01 | 8.74e-01 |
| GOBP T HELPER 17 TYPE IMMUNE RESPONSE | 43 | 1.83e-01 | -1.17e-01 | 6.55e-01 |
| GOCC PHOSPHATIDYLINOSITOL 3 KINASE COMPLEX | 28 | 2.83e-01 | 1.17e-01 | 7.43e-01 |
| GOBP NEGATIVE REGULATION OF ENDOPLASMIC RETICULUM STRESS INDUCED INTRINSIC APOPTOTIC SIGNALING PATHWAY | 17 | 4.03e-01 | 1.17e-01 | 8.23e-01 |
| GOBP ESTABLISHMENT OF PROTEIN LOCALIZATION TO PLASMA MEMBRANE | 61 | 1.13e-01 | 1.17e-01 | 5.69e-01 |
| GOBP MRNA 3 END PROCESSING BY STEM LOOP BINDING AND CLEAVAGE | 6 | 6.19e-01 | 1.17e-01 | 9.07e-01 |
| GOCC CILIARY ROOTLET | 14 | 4.48e-01 | 1.17e-01 | 8.42e-01 |
| GOBP NEGATIVE REGULATION OF NEURON DIFFERENTIATION | 44 | 1.78e-01 | 1.17e-01 | 6.50e-01 |
| GOMF ACETYLCHOLINE RECEPTOR ACTIVITY | 10 | 5.21e-01 | 1.17e-01 | 8.74e-01 |
| GOMF K63 LINKED POLYUBIQUITIN MODIFICATION DEPENDENT PROTEIN BINDING | 26 | 3.01e-01 | -1.17e-01 | 7.57e-01 |
| GOMF ACETYLCHOLINE GATED MONOATOMIC CATION SELECTIVE CHANNEL ACTIVITY | 8 | 5.66e-01 | 1.17e-01 | 8.90e-01 |
| GOBP REGULATION OF ELECTRON TRANSFER ACTIVITY | 5 | 6.50e-01 | -1.17e-01 | 9.17e-01 |
| GOBP TRACHEA DEVELOPMENT | 12 | 4.83e-01 | -1.17e-01 | 8.60e-01 |
| GOBP MICROTUBULE ANCHORING | 24 | 3.21e-01 | 1.17e-01 | 7.73e-01 |
| GOBP POSITIVE REGULATION OF BROWN FAT CELL DIFFERENTIATION | 12 | 4.83e-01 | -1.17e-01 | 8.60e-01 |
| GOBP POSITIVE REGULATION OF HORMONE METABOLIC PROCESS | 13 | 4.66e-01 | -1.17e-01 | 8.52e-01 |
| GOBP NUCLEOTIDE BINDING OLIGOMERIZATION DOMAIN CONTAINING 1 SIGNALING PATHWAY | 8 | 5.68e-01 | 1.17e-01 | 8.90e-01 |
| GOCC PRECATALYTIC SPLICEOSOME | 52 | 1.46e-01 | 1.17e-01 | 6.13e-01 |
| GOBP NEGATIVE REGULATION OF AMINO ACID TRANSPORT | 9 | 5.45e-01 | -1.16e-01 | 8.83e-01 |
| GOBP CARDIAC MUSCLE CELL CONTRACTION | 58 | 1.25e-01 | 1.16e-01 | 5.89e-01 |
| GOBP FOLIC ACID METABOLIC PROCESS | 14 | 4.51e-01 | 1.16e-01 | 8.43e-01 |
| GOBP POSITIVE REGULATION OF WOUND HEALING | 44 | 1.82e-01 | -1.16e-01 | 6.54e-01 |
| GOBP NEGATIVE REGULATION OF OSTEOCLAST DIFFERENTIATION | 26 | 3.05e-01 | 1.16e-01 | 7.60e-01 |
| GOMF ACTIN FILAMENT BINDING | 177 | 7.64e-03 | -1.16e-01 | 2.02e-01 |
| GOBP INTRACELLULAR GLUTAMATE HOMEOSTASIS | 5 | 6.53e-01 | -1.16e-01 | 9.18e-01 |
| GOCC CHROMOSOME TELOMERIC REGION | 150 | 1.40e-02 | 1.16e-01 | 2.56e-01 |
| GOBP MONOCYTE EXTRAVASATION | 10 | 5.25e-01 | -1.16e-01 | 8.76e-01 |
| GOBP NEGATIVE REGULATION OF ALCOHOL BIOSYNTHETIC PROCESS | 12 | 4.86e-01 | 1.16e-01 | 8.60e-01 |
| GOBP REGULATION OF PROTEIN DEUBIQUITINATION | 10 | 5.25e-01 | 1.16e-01 | 8.76e-01 |
| GOBP NEGATIVE REGULATION OF RIG I SIGNALING PATHWAY | 8 | 5.70e-01 | -1.16e-01 | 8.90e-01 |
| GOBP AV NODE CELL TO BUNDLE OF HIS CELL SIGNALING | 6 | 6.22e-01 | -1.16e-01 | 9.09e-01 |
| GOBP RESPONSE TO VITAMIN D | 27 | 2.96e-01 | -1.16e-01 | 7.53e-01 |
| GOMF PHOSPHATASE REGULATOR ACTIVITY | 88 | 5.99e-02 | 1.16e-01 | 4.54e-01 |
| GOMF HISTONE H3K36 METHYLTRANSFERASE ACTIVITY | 11 | 5.05e-01 | 1.16e-01 | 8.66e-01 |
| GOCC MRNA CLEAVAGE FACTOR COMPLEX | 22 | 3.46e-01 | 1.16e-01 | 7.90e-01 |
| GOBP NEGATIVE REGULATION OF T HELPER 2 CELL DIFFERENTIATION | 5 | 6.53e-01 | -1.16e-01 | 9.18e-01 |
| GOBP CELL CYCLE DNA REPLICATION | 44 | 1.83e-01 | 1.16e-01 | 6.55e-01 |
| GOBP MESENCHYMAL CELL MIGRATION | 33 | 2.49e-01 | -1.16e-01 | 7.18e-01 |
| GOMF CDP ALCOHOL PHOSPHATIDYLTRANSFERASE ACTIVITY | 8 | 5.70e-01 | 1.16e-01 | 8.90e-01 |
| GOBP REGULATION OF VESICLE SIZE | 20 | 3.70e-01 | 1.16e-01 | 8.06e-01 |
| GOCC HEMOGLOBIN COMPLEX | 10 | 5.26e-01 | 1.16e-01 | 8.76e-01 |
| GOBP REGULATION OF GLUTAMATE SECRETION | 14 | 4.53e-01 | 1.16e-01 | 8.43e-01 |
| GOMF STRUCTURAL CONSTITUENT OF CHROMATIN | 46 | 1.74e-01 | -1.16e-01 | 6.42e-01 |
| GOBP REGULATION OF MAST CELL DEGRANULATION | 24 | 3.26e-01 | 1.16e-01 | 7.77e-01 |
| GOBP REGULATION OF CELLULAR PH REDUCTION | 6 | 6.24e-01 | 1.16e-01 | 9.09e-01 |
| GOBP POSITIVE REGULATION OF SYNCYTIUM FORMATION BY PLASMA MEMBRANE FUSION | 17 | 4.09e-01 | -1.16e-01 | 8.26e-01 |
| GOMF WNT RECEPTOR ACTIVITY | 13 | 4.70e-01 | 1.16e-01 | 8.54e-01 |
| GOBP INFLAMMATORY RESPONSE TO WOUNDING | 22 | 3.48e-01 | -1.16e-01 | 7.92e-01 |
| GOBP NEGATIVE REGULATION OF NUCLEOTIDE METABOLIC PROCESS | 25 | 3.17e-01 | -1.16e-01 | 7.68e-01 |
| GOBP EMBRYONIC NEUROCRANIUM MORPHOGENESIS | 7 | 5.97e-01 | -1.16e-01 | 9.01e-01 |
| GOMF CHITIN BINDING | 6 | 6.24e-01 | -1.15e-01 | 9.09e-01 |
| GOBP REGULATION OF GENE SILENCING BY REGULATORY NCRNA | 24 | 3.27e-01 | 1.15e-01 | 7.78e-01 |
| GOBP NITRIC OXIDE CGMP MEDIATED SIGNALING | 7 | 5.97e-01 | 1.15e-01 | 9.02e-01 |
| GOBP REGULATION OF SKELETAL MUSCLE FIBER DEVELOPMENT | 6 | 6.24e-01 | -1.15e-01 | 9.09e-01 |
| GOBP CAMP MEDIATED SIGNALING | 40 | 2.07e-01 | 1.15e-01 | 6.81e-01 |
| GOCC CAJAL BODY | 61 | 1.19e-01 | 1.15e-01 | 5.82e-01 |
| GOBP EXIT FROM MITOSIS | 27 | 3.00e-01 | -1.15e-01 | 7.56e-01 |
| GOBP NEGATIVE REGULATION OF SMAD PROTEIN SIGNAL TRANSDUCTION | 18 | 3.97e-01 | -1.15e-01 | 8.22e-01 |
| GOBP POSITIVE REGULATION OF BICELLULAR TIGHT JUNCTION ASSEMBLY | 5 | 6.55e-01 | -1.15e-01 | 9.18e-01 |
| GOMF SECONDARY ACTIVE SULFATE TRANSMEMBRANE TRANSPORTER ACTIVITY | 7 | 5.98e-01 | -1.15e-01 | 9.02e-01 |
| GOMF HYDROLASE ACTIVITY HYDROLYZING N GLYCOSYL COMPOUNDS | 36 | 2.32e-01 | 1.15e-01 | 7.04e-01 |
| GOBP POSITIVE REGULATION OF ACTIN NUCLEATION | 13 | 4.72e-01 | -1.15e-01 | 8.54e-01 |
| GOBP STRIATED MUSCLE CELL PROLIFERATION | 54 | 1.43e-01 | 1.15e-01 | 6.11e-01 |
| GOBP OLIGOSACCHARIDE CATABOLIC PROCESS | 10 | 5.28e-01 | -1.15e-01 | 8.76e-01 |
| GOBP REGULATION OF TRANSLATIONAL ELONGATION | 12 | 4.90e-01 | 1.15e-01 | 8.61e-01 |
| GOBP NEGATIVE REGULATION OF EPITHELIAL CELL APOPTOTIC PROCESS | 41 | 2.03e-01 | 1.15e-01 | 6.76e-01 |
| GOBP RESPONSE TO PROSTAGLANDIN | 26 | 3.10e-01 | -1.15e-01 | 7.64e-01 |
| GOCC BBSOME | 8 | 5.74e-01 | -1.15e-01 | 8.92e-01 |
| GOBP CELL CYCLE G1 S PHASE TRANSITION | 212 | 3.96e-03 | 1.15e-01 | 1.51e-01 |
| GOBP RETROGRADE AXONAL TRANSPORT | 17 | 4.13e-01 | 1.15e-01 | 8.28e-01 |
| GOBP POSITIVE REGULATION OF GLUCOSE IMPORT | 28 | 2.94e-01 | 1.15e-01 | 7.50e-01 |
| GOBP MITOTIC CYTOKINESIS | 87 | 6.47e-02 | 1.15e-01 | 4.66e-01 |
| GOBP FOLIC ACID CONTAINING COMPOUND METABOLIC PROCESS | 26 | 3.12e-01 | 1.15e-01 | 7.65e-01 |
| GOMF SUMO TRANSFERASE ACTIVITY | 24 | 3.31e-01 | -1.15e-01 | 7.82e-01 |
| GOCC NUCLEAR INNER MEMBRANE | 49 | 1.66e-01 | 1.14e-01 | 6.30e-01 |
| GOCC M BAND | 21 | 3.64e-01 | 1.14e-01 | 8.02e-01 |
| GOBP POSITIVE REGULATION OF MITOCHONDRIAL TRANSLATION | 16 | 4.28e-01 | -1.14e-01 | 8.34e-01 |
| GOCC PLATELET DENSE GRANULE | 16 | 4.28e-01 | 1.14e-01 | 8.34e-01 |
| GOBP RHYTHMIC BEHAVIOR | 30 | 2.78e-01 | -1.14e-01 | 7.40e-01 |
| GOBP EOSINOPHIL ACTIVATION | 9 | 5.53e-01 | 1.14e-01 | 8.86e-01 |
| GOMF POTASSIUM CHLORIDE SYMPORTER ACTIVITY | 8 | 5.75e-01 | -1.14e-01 | 8.92e-01 |
| GOBP RENAL RESPONSE TO BLOOD FLOW INVOLVED IN CIRCULATORY RENIN ANGIOTENSIN REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE | 6 | 6.28e-01 | -1.14e-01 | 9.11e-01 |
| GOBP PHOTORECEPTOR CELL MAINTENANCE | 30 | 2.79e-01 | 1.14e-01 | 7.40e-01 |
| GOMF NUCLEAR ANDROGEN RECEPTOR BINDING | 24 | 3.33e-01 | 1.14e-01 | 7.83e-01 |
| GOCC RNA POLYMERASE II HOLOENZYME | 70 | 9.84e-02 | 1.14e-01 | 5.45e-01 |
| GOMF BH3 DOMAIN BINDING | 6 | 6.28e-01 | -1.14e-01 | 9.11e-01 |
| GOBP THREONINE METABOLIC PROCESS | 5 | 6.58e-01 | -1.14e-01 | 9.19e-01 |
| GOMF RIBONUCLEOPROTEIN COMPLEX BINDING | 160 | 1.28e-02 | 1.14e-01 | 2.49e-01 |
| GOBP POSITIVE REGULATION OF GLIAL CELL DIFFERENTIATION | 32 | 2.64e-01 | -1.14e-01 | 7.31e-01 |
| GOBP POSITIVE REGULATION OF LIPID METABOLIC PROCESS | 89 | 6.29e-02 | -1.14e-01 | 4.63e-01 |
| GOBP REGULATION OF HUMORAL IMMUNE RESPONSE MEDIATED BY CIRCULATING IMMUNOGLOBULIN | 16 | 4.31e-01 | 1.14e-01 | 8.35e-01 |
| GOMF HEPARAN SULFATE PROTEOGLYCAN BINDING | 13 | 4.78e-01 | 1.14e-01 | 8.57e-01 |
| GOCC FLOTILLIN COMPLEX | 8 | 5.78e-01 | 1.14e-01 | 8.92e-01 |
| GOBP PYRIMIDINE NUCLEOSIDE CATABOLIC PROCESS | 15 | 4.46e-01 | 1.14e-01 | 8.41e-01 |
| GOCC PINOSOME | 9 | 5.55e-01 | 1.14e-01 | 8.87e-01 |
| GOBP NEGATIVE REGULATION OF MONOATOMIC ION TRANSPORT | 79 | 8.07e-02 | 1.14e-01 | 5.01e-01 |
| GOMF PROTEIN PHOSPHATASE 2A BINDING | 26 | 3.16e-01 | 1.14e-01 | 7.67e-01 |
| GOBP TOLL LIKE RECEPTOR 4 SIGNALING PATHWAY | 53 | 1.52e-01 | 1.14e-01 | 6.16e-01 |
| GOBP POSITIVE REGULATION OF CELLULAR RESPONSE TO TRANSFORMING GROWTH FACTOR BETA STIMULUS | 25 | 3.25e-01 | -1.14e-01 | 7.76e-01 |
| GOBP FACIAL NERVE STRUCTURAL ORGANIZATION | 6 | 6.30e-01 | -1.14e-01 | 9.11e-01 |
| GOBP POSITIVE REGULATION OF VOLTAGE GATED CALCIUM CHANNEL ACTIVITY | 5 | 6.60e-01 | -1.14e-01 | 9.20e-01 |
| GOBP GLUCOSE METABOLIC PROCESS | 161 | 1.29e-02 | -1.14e-01 | 2.49e-01 |
| GOBP ER NUCLEUS SIGNALING PATHWAY | 46 | 1.83e-01 | 1.14e-01 | 6.55e-01 |
| GOCC POLE PLASM | 16 | 4.32e-01 | 1.14e-01 | 8.35e-01 |
| GOBP RESPONSE TO INTERLEUKIN 15 | 12 | 4.96e-01 | 1.14e-01 | 8.62e-01 |
| GOMF TRANSLATION ACTIVATOR ACTIVITY | 7 | 6.03e-01 | 1.14e-01 | 9.03e-01 |
| GOCC RSC TYPE COMPLEX | 14 | 4.62e-01 | 1.13e-01 | 8.48e-01 |
| GOCC COPII COATED ER TO GOLGI TRANSPORT VESICLE | 90 | 6.29e-02 | 1.13e-01 | 4.63e-01 |
| GOBP PHOSPHATE ION HOMEOSTASIS | 12 | 4.96e-01 | 1.13e-01 | 8.62e-01 |
| GOMF NUCLEOTIDE SUGAR TRANSMEMBRANE TRANSPORTER ACTIVITY | 12 | 4.97e-01 | 1.13e-01 | 8.62e-01 |
| GOBP NUCLEOSIDE SALVAGE | 11 | 5.16e-01 | -1.13e-01 | 8.71e-01 |
| GOBP REGULATION OF CYTOKINETIC PROCESS | 7 | 6.04e-01 | -1.13e-01 | 9.03e-01 |
| GOBP MEMBRANE DEPOLARIZATION DURING CARDIAC MUSCLE CELL ACTION POTENTIAL | 16 | 4.33e-01 | 1.13e-01 | 8.36e-01 |
| GOBP DENDRITIC CELL DIFFERENTIATION | 40 | 2.15e-01 | 1.13e-01 | 6.91e-01 |
| GOBP BASE EXCISION REPAIR | 42 | 2.04e-01 | -1.13e-01 | 6.79e-01 |
| GOBP GLYCOLIPID TRANSPORT | 8 | 5.80e-01 | -1.13e-01 | 8.92e-01 |
| GOBP INTERLEUKIN 2 MEDIATED SIGNALING PATHWAY | 8 | 5.80e-01 | 1.13e-01 | 8.93e-01 |
| GOBP URATE METABOLIC PROCESS | 7 | 6.05e-01 | 1.13e-01 | 9.03e-01 |
| GOBP NEGATIVE REGULATION OF PROTEIN LOCALIZATION | 176 | 9.72e-03 | 1.13e-01 | 2.23e-01 |
| GOBP CELL SURFACE RECEPTOR SIGNALING PATHWAY VIA STAT | 116 | 3.56e-02 | 1.13e-01 | 3.89e-01 |
| GOMF PHOSPHATASE INHIBITOR ACTIVITY | 35 | 2.48e-01 | 1.13e-01 | 7.17e-01 |
| GOBP EARLY ENDOSOME TO RECYCLING ENDOSOME TRANSPORT | 7 | 6.05e-01 | 1.13e-01 | 9.03e-01 |
| GOBP RECEPTOR CLUSTERING | 45 | 1.90e-01 | -1.13e-01 | 6.63e-01 |
| GOBP REGULATION OF LOW DENSITY LIPOPROTEIN PARTICLE CLEARANCE | 11 | 5.17e-01 | -1.13e-01 | 8.73e-01 |
| GOCC DYNACTIN COMPLEX | 8 | 5.81e-01 | 1.13e-01 | 8.93e-01 |
| GOBP RESPIRATORY BURST INVOLVED IN DEFENSE RESPONSE | 14 | 4.66e-01 | -1.13e-01 | 8.51e-01 |
| GOMF VOLTAGE GATED CHANNEL ACTIVITY | 107 | 4.41e-02 | -1.13e-01 | 4.11e-01 |
| GOBP REGULATION OF NITRIC OXIDE SYNTHASE ACTIVITY | 17 | 4.21e-01 | 1.13e-01 | 8.30e-01 |
| GOBP CHROMOSOME SEPARATION | 79 | 8.36e-02 | 1.13e-01 | 5.06e-01 |
| GOMF SULFUR COMPOUND BINDING | 190 | 7.45e-03 | -1.13e-01 | 1.98e-01 |
| GOBP REGULATION OF CYCLIN DEPENDENT PROTEIN KINASE ACTIVITY | 66 | 1.14e-01 | 1.13e-01 | 5.70e-01 |
| GOBP NEGATIVE REGULATION OF ALPHA BETA T CELL DIFFERENTIATION | 22 | 3.61e-01 | -1.12e-01 | 8.01e-01 |
| GOBP POSITIVE REGULATION OF B CELL DIFFERENTIATION | 16 | 4.36e-01 | -1.12e-01 | 8.37e-01 |
| GOBP RESPONSE TO WATER | 11 | 5.19e-01 | 1.12e-01 | 8.74e-01 |
| GOBP BIOLOGICAL PROCESS INVOLVED IN INTRASPECIES INTERACTION BETWEEN ORGANISMS | 36 | 2.43e-01 | -1.12e-01 | 7.13e-01 |
| GOBP PLATELET AGGREGATION | 63 | 1.23e-01 | -1.12e-01 | 5.86e-01 |
| GOBP PRIMARY ALCOHOL BIOSYNTHETIC PROCESS | 10 | 5.38e-01 | -1.12e-01 | 8.79e-01 |
| GOMF COLLAGEN BINDING | 54 | 1.53e-01 | -1.12e-01 | 6.16e-01 |
| GOBP SECONDARY PALATE DEVELOPMENT | 19 | 3.97e-01 | 1.12e-01 | 8.21e-01 |
| GOBP NON CANONICAL WNT SIGNALING PATHWAY | 53 | 1.57e-01 | -1.12e-01 | 6.22e-01 |
| GOBP REGULATION OF ISOTYPE SWITCHING TO IGE ISOTYPES | 7 | 6.07e-01 | 1.12e-01 | 9.03e-01 |
| GOCC LAMININ COMPLEX | 7 | 6.07e-01 | -1.12e-01 | 9.03e-01 |
| GOCC TRAPPII PROTEIN COMPLEX | 12 | 5.01e-01 | -1.12e-01 | 8.64e-01 |
| GOCC ENDOPEPTIDASE COMPLEX | 78 | 8.66e-02 | 1.12e-01 | 5.15e-01 |
| GOMF LIGASE ACTIVITY FORMING PHOSPHORIC ESTER BONDS | 5 | 6.64e-01 | 1.12e-01 | 9.22e-01 |
| GOBP ACIDIC AMINO ACID TRANSPORT | 48 | 1.79e-01 | 1.12e-01 | 6.51e-01 |
| GOBP NEGATIVE REGULATION OF TOLL LIKE RECEPTOR SIGNALING PATHWAY | 19 | 3.97e-01 | -1.12e-01 | 8.22e-01 |
| GOBP POSITIVE REGULATION OF RESPONSE TO BIOTIC STIMULUS | 347 | 3.33e-04 | 1.12e-01 | 3.47e-02 |
| GOBP POSITIVE REGULATION OF RECEPTOR MEDIATED ENDOCYTOSIS | 41 | 2.14e-01 | 1.12e-01 | 6.90e-01 |
| GOBP POSITIVE REGULATION OF VASCULAR ENDOTHELIAL CELL PROLIFERATION | 14 | 4.68e-01 | -1.12e-01 | 8.53e-01 |
| GOBP REGULATION OF CELL ADHESION MEDIATED BY INTEGRIN | 40 | 2.20e-01 | 1.12e-01 | 6.94e-01 |
| GOBP NEGATIVE REGULATION OF MEMBRANE POTENTIAL | 11 | 5.20e-01 | -1.12e-01 | 8.74e-01 |
| GOBP REGULATION OF PROTEIN UBIQUITINATION | 180 | 9.61e-03 | 1.12e-01 | 2.22e-01 |
| GOBP MUSCLE HYPERTROPHY | 66 | 1.16e-01 | 1.12e-01 | 5.74e-01 |
| GOMF COLLAGEN RECEPTOR ACTIVITY | 6 | 6.35e-01 | 1.12e-01 | 9.14e-01 |
| GOBP HUMORAL IMMUNE RESPONSE | 166 | 1.29e-02 | -1.12e-01 | 2.49e-01 |
| GOMF VOLTAGE GATED SODIUM CHANNEL ACTIVITY | 18 | 4.12e-01 | -1.12e-01 | 8.27e-01 |
| GOBP REGULATION OF GLUCOSE TRANSMEMBRANE TRANSPORT | 60 | 1.34e-01 | 1.12e-01 | 5.99e-01 |
| GOBP POSITIVE REGULATION OF SYNAPTIC PLASTICITY | 7 | 6.09e-01 | -1.12e-01 | 9.03e-01 |
| GOBP EMBRYONIC PATTERN SPECIFICATION | 46 | 1.90e-01 | 1.12e-01 | 6.62e-01 |
| GOBP NEGATIVE REGULATION OF PROTEIN MATURATION | 23 | 3.54e-01 | -1.12e-01 | 7.95e-01 |
| GOBP POSITIVE REGULATION OF T HELPER 1 TYPE IMMUNE RESPONSE | 16 | 4.39e-01 | 1.12e-01 | 8.39e-01 |
| GOBP REGULATION OF DENDRITIC SPINE MORPHOGENESIS | 35 | 2.53e-01 | 1.12e-01 | 7.22e-01 |
| GOBP ALTERNATIVE MRNA SPLICING VIA SPLICEOSOME | 65 | 1.20e-01 | 1.12e-01 | 5.82e-01 |
| GOBP POSITIVE REGULATION OF ORGANELLE ASSEMBLY | 81 | 8.26e-02 | 1.12e-01 | 5.05e-01 |
| GOBP REGULATION OF HEPATIC STELLATE CELL ACTIVATION | 5 | 6.66e-01 | 1.11e-01 | 9.22e-01 |
| GOBP REGULATION OF FIBROBLAST MIGRATION | 35 | 2.54e-01 | -1.11e-01 | 7.22e-01 |
| GOCC ESC E Z COMPLEX | 15 | 4.55e-01 | 1.11e-01 | 8.44e-01 |
| GOBP CONVERGENT EXTENSION | 11 | 5.22e-01 | -1.11e-01 | 8.75e-01 |
| GOCC U1 SNRNP | 19 | 4.01e-01 | 1.11e-01 | 8.23e-01 |
| GOCC PROTEIN KINASE COMPLEX | 136 | 2.50e-02 | 1.11e-01 | 3.43e-01 |
| GOBP REGULATION OF PROTEIN CATABOLIC PROCESS IN THE VACUOLE | 12 | 5.04e-01 | -1.11e-01 | 8.66e-01 |
| GOMF SOLUTE PROTON SYMPORTER ACTIVITY | 19 | 4.01e-01 | -1.11e-01 | 8.23e-01 |
| GOBP NATURAL KILLER CELL DEGRANULATION | 11 | 5.23e-01 | 1.11e-01 | 8.75e-01 |
| GOBP CELLULAR RESPONSE TO PURINE CONTAINING COMPOUND | 12 | 5.05e-01 | -1.11e-01 | 8.66e-01 |
| GOBP REGULATION OF PROTEIN ACETYLATION | 18 | 4.14e-01 | 1.11e-01 | 8.29e-01 |
| GOBP KERATAN SULFATE METABOLIC PROCESS | 15 | 4.56e-01 | 1.11e-01 | 8.44e-01 |
| GOBP NEGATIVE REGULATION OF OXIDATIVE STRESS INDUCED INTRINSIC APOPTOTIC SIGNALING PATHWAY | 26 | 3.26e-01 | -1.11e-01 | 7.77e-01 |
| GOBP RENAL TUBULE DEVELOPMENT | 60 | 1.36e-01 | -1.11e-01 | 6.02e-01 |
| GOBP POSITIVE REGULATION OF INSULIN SECRETION INVOLVED IN CELLULAR RESPONSE TO GLUCOSE STIMULUS | 22 | 3.67e-01 | -1.11e-01 | 8.04e-01 |
| GOMF ACTININ BINDING | 22 | 3.67e-01 | -1.11e-01 | 8.04e-01 |
| GOCC SIN3 TYPE COMPLEX | 22 | 3.67e-01 | 1.11e-01 | 8.04e-01 |
| GOMF SULFATE BINDING | 6 | 6.37e-01 | 1.11e-01 | 9.15e-01 |
| GOMF PHOSPHOLIPASE D ACTIVITY | 5 | 6.67e-01 | 1.11e-01 | 9.22e-01 |
| GOBP POSITIVE REGULATION OF NITRIC OXIDE SYNTHASE ACTIVITY | 12 | 5.06e-01 | 1.11e-01 | 8.67e-01 |
| GOBP MICROTUBULE ORGANIZING CENTER ORGANIZATION | 142 | 2.24e-02 | 1.11e-01 | 3.25e-01 |
| GOBP REGULATION OF DNA REPLICATION | 118 | 3.74e-02 | 1.11e-01 | 3.93e-01 |
| GOBP T CELL HOMEOSTASIS | 43 | 2.08e-01 | 1.11e-01 | 6.82e-01 |
| GOBP NEGATIVE REGULATION BY HOST OF VIRAL TRANSCRIPTION | 12 | 5.06e-01 | 1.11e-01 | 8.67e-01 |
| GOMF ORGANIC ANION TRANSMEMBRANE TRANSPORTER ACTIVITY | 184 | 9.50e-03 | -1.11e-01 | 2.22e-01 |
| GOMF SINGLE STRANDED DNA HELICASE ACTIVITY | 23 | 3.58e-01 | 1.11e-01 | 7.98e-01 |
| GOMF UBIQUITIN LIKE PROTEIN LIGASE BINDING | 301 | 9.47e-04 | 1.11e-01 | 6.98e-02 |
| GOBP LACTATION | 30 | 2.94e-01 | 1.11e-01 | 7.50e-01 |
| GOCC SPINDLE POLE | 171 | 1.25e-02 | 1.11e-01 | 2.49e-01 |
| GOMF CYCLIN BINDING | 30 | 2.94e-01 | -1.11e-01 | 7.50e-01 |
| GOCC ASYMMETRIC GLUTAMATERGIC EXCITATORY SYNAPSE | 9 | 5.65e-01 | -1.11e-01 | 8.90e-01 |
| GOMF UDP XYLOSYLTRANSFERASE ACTIVITY | 10 | 5.44e-01 | 1.11e-01 | 8.83e-01 |
| GOBP REGULATION OF INFLAMMASOME MEDIATED SIGNALING PATHWAY | 34 | 2.64e-01 | 1.11e-01 | 7.31e-01 |
| GOBP PROTEIN FOLDING | 195 | 7.71e-03 | 1.11e-01 | 2.02e-01 |
| GOBP NEPHRON MORPHOGENESIS | 45 | 1.99e-01 | -1.11e-01 | 6.71e-01 |
| GOBP POSITIVE REGULATION OF PROTEIN POLYMERIZATION | 78 | 9.11e-02 | -1.11e-01 | 5.27e-01 |
| GOBP FAT SOLUBLE VITAMIN BIOSYNTHETIC PROCESS | 10 | 5.45e-01 | -1.11e-01 | 8.83e-01 |
| GOMF SYNTAXIN 1 BINDING | 15 | 4.59e-01 | 1.11e-01 | 8.47e-01 |
| GOMF BILE ACID BINDING | 6 | 6.39e-01 | -1.10e-01 | 9.15e-01 |
| GOBP AMINOGLYCAN BIOSYNTHETIC PROCESS | 65 | 1.24e-01 | -1.10e-01 | 5.86e-01 |
| GOBP MYELOID CELL APOPTOTIC PROCESS | 32 | 2.80e-01 | 1.10e-01 | 7.41e-01 |
| GOMF UNFOLDED PROTEIN BINDING | 99 | 5.76e-02 | 1.10e-01 | 4.46e-01 |
| GOBP POSITIVE REGULATION OF CYTOKINE PRODUCTION INVOLVED IN INFLAMMATORY RESPONSE | 20 | 3.93e-01 | -1.10e-01 | 8.20e-01 |
| GOBP POSITIVE REGULATION OF T HELPER 17 CELL DIFFERENTIATION | 9 | 5.66e-01 | -1.10e-01 | 8.90e-01 |
| GOMF ER RETENTION SEQUENCE BINDING | 5 | 6.69e-01 | -1.10e-01 | 9.22e-01 |
| GOBP ACTIN FILAMENT SEVERING | 16 | 4.45e-01 | -1.10e-01 | 8.41e-01 |
| GOBP CARBOHYDRATE PHOSPHORYLATION | 23 | 3.60e-01 | -1.10e-01 | 8.00e-01 |
| GOBP CELL CYCLE PHASE TRANSITION | 484 | 3.24e-05 | 1.10e-01 | 6.15e-03 |
| GOMF PHOSPHORYLATION DEPENDENT PROTEIN BINDING | 9 | 5.67e-01 | 1.10e-01 | 8.90e-01 |
| GOMF CYTOKINE ACTIVITY | 116 | 4.02e-02 | -1.10e-01 | 4.01e-01 |
| GOBP MULTICELLULAR ORGANISMAL LEVEL CHEMICAL HOMEOSTASIS | 55 | 1.57e-01 | -1.10e-01 | 6.22e-01 |
| GOBP RNA DECAPPING | 19 | 4.06e-01 | 1.10e-01 | 8.26e-01 |
| GOBP NEGATIVE REGULATION OF STEM CELL POPULATION MAINTENANCE | 21 | 3.82e-01 | 1.10e-01 | 8.14e-01 |
| GOBP GLYCOSYLCERAMIDE METABOLIC PROCESS | 14 | 4.76e-01 | 1.10e-01 | 8.57e-01 |
| GOBP PROTEIN EXIT FROM ENDOPLASMIC RETICULUM | 47 | 1.92e-01 | 1.10e-01 | 6.64e-01 |
| GOMF GALACTOSIDE BINDING | 7 | 6.14e-01 | 1.10e-01 | 9.04e-01 |
| GOCC SNARE COMPLEX | 44 | 2.07e-01 | 1.10e-01 | 6.81e-01 |
| GOMF POTASSIUM PROTON ANTIPORTER ACTIVITY | 9 | 5.68e-01 | 1.10e-01 | 8.90e-01 |
| GOBP REGULATION OF APPETITE | 13 | 4.92e-01 | -1.10e-01 | 8.62e-01 |
| GOBP CELLULAR MODIFIED AMINO ACID CATABOLIC PROCESS | 21 | 3.83e-01 | 1.10e-01 | 8.15e-01 |
| GOBP REGULATION OF RAC PROTEIN SIGNAL TRANSDUCTION | 22 | 3.72e-01 | 1.10e-01 | 8.08e-01 |
| GOBP RESPONSE TO TYPE II INTERFERON | 103 | 5.39e-02 | 1.10e-01 | 4.36e-01 |
| GOBP RIBONUCLEOSIDE MONOPHOSPHATE CATABOLIC PROCESS | 13 | 4.93e-01 | 1.10e-01 | 8.62e-01 |
| GOCC MICROTUBULE PLUS END | 22 | 3.72e-01 | -1.10e-01 | 8.08e-01 |
| GOBP LYSOSOMAL MEMBRANE ORGANIZATION | 13 | 4.93e-01 | 1.10e-01 | 8.62e-01 |
| GOBP REGULATION OF GLUCOSE METABOLIC PROCESS | 84 | 8.20e-02 | -1.10e-01 | 5.03e-01 |
| GOMF UBIQUITIN UBIQUITIN LIGASE ACTIVITY | 14 | 4.77e-01 | 1.10e-01 | 8.57e-01 |
| GOBP REGULATION OF FIBROBLAST PROLIFERATION | 76 | 9.81e-02 | -1.10e-01 | 5.45e-01 |
| GOBP OLIGOPEPTIDE TRANSPORT | 15 | 4.62e-01 | 1.10e-01 | 8.48e-01 |
| GOBP CELLULAR RESPONSE TO CAMP | 37 | 2.49e-01 | -1.10e-01 | 7.17e-01 |
| GOMF NUCLEAR RETINOIC ACID RECEPTOR BINDING | 21 | 3.85e-01 | -1.10e-01 | 8.15e-01 |
| GOBP NEGATIVE REGULATION OF INTERLEUKIN 2 PRODUCTION | 28 | 3.16e-01 | -1.10e-01 | 7.67e-01 |
| GOMF NUCLEOBASE TRANSMEMBRANE TRANSPORTER ACTIVITY | 10 | 5.49e-01 | 1.09e-01 | 8.84e-01 |
| GOBP REGULATION OF HEAT GENERATION | 11 | 5.30e-01 | 1.09e-01 | 8.78e-01 |
| GOBP RENAL SYSTEM VASCULATURE MORPHOGENESIS | 6 | 6.43e-01 | 1.09e-01 | 9.15e-01 |
| GOMF SOLUTE POTASSIUM ANTIPORTER ACTIVITY | 13 | 4.95e-01 | 1.09e-01 | 8.62e-01 |
| GOBP NEPHRON TUBULE FORMATION | 8 | 5.92e-01 | -1.09e-01 | 8.98e-01 |
| GOBP ICOSANOID METABOLIC PROCESS | 84 | 8.32e-02 | -1.09e-01 | 5.05e-01 |
| GOBP MORPHOGENESIS OF AN EPITHELIAL SHEET | 49 | 1.85e-01 | -1.09e-01 | 6.60e-01 |
| GOBP NEGATIVE REGULATION OF DNA BINDING | 25 | 3.44e-01 | 1.09e-01 | 7.89e-01 |
| GOCC GAP JUNCTION | 11 | 5.30e-01 | 1.09e-01 | 8.78e-01 |
| GOBP POSITIVE REGULATION OF PROGRAMMED NECROTIC CELL DEATH | 8 | 5.93e-01 | -1.09e-01 | 8.99e-01 |
| GOBP IMP BIOSYNTHETIC PROCESS | 10 | 5.50e-01 | -1.09e-01 | 8.84e-01 |
| GOCC CLEAVAGE FURROW | 47 | 1.95e-01 | 1.09e-01 | 6.68e-01 |
| GOMF MACROLIDE BINDING | 11 | 5.31e-01 | -1.09e-01 | 8.78e-01 |
| GOBP MESENCHYMAL TO EPITHELIAL TRANSITION | 10 | 5.50e-01 | 1.09e-01 | 8.84e-01 |
| GOBP CELLULAR RESPONSE TO ARSENIC CONTAINING SUBSTANCE | 17 | 4.36e-01 | -1.09e-01 | 8.37e-01 |
| GOBP POSITIVE REGULATION OF TRANSCRIPTION REGULATORY REGION DNA BINDING | 13 | 4.96e-01 | 1.09e-01 | 8.62e-01 |
| GOMF PROSTANOID RECEPTOR ACTIVITY | 10 | 5.50e-01 | 1.09e-01 | 8.84e-01 |
| GOCC TRANSPORT VESICLE | 341 | 5.37e-04 | 1.09e-01 | 4.80e-02 |
| GOBP GLIAL CELL DIFFERENTIATION | 187 | 1.01e-02 | -1.09e-01 | 2.27e-01 |
| GOBP EXCITATORY SYNAPSE ASSEMBLY | 24 | 3.55e-01 | -1.09e-01 | 7.96e-01 |
| GOBP POSITIVE REGULATION OF EPITHELIAL CELL DIFFERENTIATION | 43 | 2.16e-01 | -1.09e-01 | 6.92e-01 |
| GOBP PYRIMIDINE DEOXYRIBONUCLEOSIDE METABOLIC PROCESS | 5 | 6.73e-01 | 1.09e-01 | 9.23e-01 |
| GOBP INTRACELLULAR ZINC ION HOMEOSTASIS | 24 | 3.56e-01 | 1.09e-01 | 7.97e-01 |
| GOBP PROTEIN LIPOYLATION | 5 | 6.73e-01 | 1.09e-01 | 9.23e-01 |
| GOBP REGULATION OF MITOCHONDRION ORGANIZATION | 139 | 2.69e-02 | -1.09e-01 | 3.53e-01 |
| GOBP POLYOL BIOSYNTHETIC PROCESS | 49 | 1.88e-01 | 1.09e-01 | 6.62e-01 |
| GOCC TRANSCRIPTION EXPORT COMPLEX 2 | 5 | 6.74e-01 | 1.09e-01 | 9.23e-01 |
| GOMF CGMP BINDING | 9 | 5.72e-01 | -1.09e-01 | 8.92e-01 |
| GOMF PROTEIN FOLDING CHAPERONE BINDING | 119 | 4.06e-02 | 1.09e-01 | 4.01e-01 |
| GOBP MRNA METABOLIC PROCESS | 674 | 1.53e-06 | 1.09e-01 | 8.36e-04 |
| GOBP RNA TEMPLATED DNA BIOSYNTHETIC PROCESS | 69 | 1.19e-01 | 1.09e-01 | 5.82e-01 |
| GOBP REGULATION OF SYNAPTIC VESICLE ENDOCYTOSIS | 17 | 4.39e-01 | 1.09e-01 | 8.39e-01 |
| GOBP CELL FATE SPECIFICATION | 50 | 1.84e-01 | -1.08e-01 | 6.57e-01 |
| GOBP DENDRITIC CELL MIGRATION | 29 | 3.12e-01 | 1.08e-01 | 7.65e-01 |
| GOBP REGULATION OF COAGULATION | 54 | 1.68e-01 | -1.08e-01 | 6.33e-01 |
| GOBP MICROTUBULE BUNDLE FORMATION | 90 | 7.54e-02 | -1.08e-01 | 4.93e-01 |
| GOBP POST EMBRYONIC DEVELOPMENT | 77 | 1.00e-01 | 1.08e-01 | 5.47e-01 |
| GOMF PHOSPHATIDYLINOSITOL 3 KINASE REGULATOR ACTIVITY | 11 | 5.34e-01 | -1.08e-01 | 8.79e-01 |
| GOBP GLYCEROL TRANSMEMBRANE TRANSPORT | 6 | 6.46e-01 | -1.08e-01 | 9.15e-01 |
| GOMF GLYCEROL TRANSMEMBRANE TRANSPORTER ACTIVITY | 6 | 6.46e-01 | -1.08e-01 | 9.15e-01 |
| GOBP MYD88 INDEPENDENT TOLL LIKE RECEPTOR SIGNALING PATHWAY | 16 | 4.53e-01 | 1.08e-01 | 8.43e-01 |
| GOBP POSITIVE REGULATION OF MHC CLASS II BIOSYNTHETIC PROCESS | 14 | 4.83e-01 | 1.08e-01 | 8.60e-01 |
| GOBP LYMPH VESSEL MORPHOGENESIS | 14 | 4.83e-01 | 1.08e-01 | 8.60e-01 |
| GOBP POSITIVE REGULATION OF LIPID BIOSYNTHETIC PROCESS | 63 | 1.37e-01 | -1.08e-01 | 6.03e-01 |
| GOCC NUCLEAR CHROMOSOME | 218 | 5.91e-03 | 1.08e-01 | 1.80e-01 |
| GOBP NEURONAL ION CHANNEL CLUSTERING | 9 | 5.74e-01 | -1.08e-01 | 8.92e-01 |
| GOBP PHOSPHATIDYLETHANOLAMINE ACYL CHAIN REMODELING | 9 | 5.74e-01 | -1.08e-01 | 8.92e-01 |
| GOBP RESPONSE TO STIMULUS INVOLVED IN REGULATION OF MUSCLE ADAPTATION | 11 | 5.35e-01 | -1.08e-01 | 8.79e-01 |
| GOBP NEURON PROJECTION ARBORIZATION | 26 | 3.41e-01 | -1.08e-01 | 7.88e-01 |
| GOBP POSITIVE REGULATION OF G0 TO G1 TRANSITION | 5 | 6.76e-01 | 1.08e-01 | 9.24e-01 |
| GOBP SPINDLE ORGANIZATION | 192 | 9.92e-03 | 1.08e-01 | 2.25e-01 |
| GOCC PHOTORECEPTOR OUTER SEGMENT | 60 | 1.49e-01 | 1.08e-01 | 6.13e-01 |
| GOBP ADHERENS JUNCTION MAINTENANCE | 6 | 6.48e-01 | -1.08e-01 | 9.16e-01 |
| GOMF NUCLEOTIDYLTRANSFERASE ACTIVITY | 132 | 3.25e-02 | 1.08e-01 | 3.77e-01 |
| GOBP DERMATAN SULFATE PROTEOGLYCAN BIOSYNTHETIC PROCESS | 8 | 5.98e-01 | -1.08e-01 | 9.02e-01 |
| GOBP NEGATIVE REGULATION OF TRANSFORMING GROWTH FACTOR BETA1 PRODUCTION | 5 | 6.77e-01 | -1.08e-01 | 9.24e-01 |
| GOBP POSITIVE REGULATION OF CELL CYCLE | 268 | 2.41e-03 | 1.08e-01 | 1.19e-01 |
| GOBP UNSATURATED FATTY ACID BIOSYNTHETIC PROCESS | 40 | 2.39e-01 | -1.08e-01 | 7.08e-01 |
| GOMF ALPHA ACTININ BINDING | 17 | 4.42e-01 | -1.08e-01 | 8.41e-01 |
| GOMF PROMOTER ENHANCER LOOP ANCHORING ACTIVITY | 5 | 6.77e-01 | -1.08e-01 | 9.24e-01 |
| GOBP NEURON FATE COMMITMENT | 26 | 3.42e-01 | -1.08e-01 | 7.89e-01 |
| GOBP POSITIVE REGULATION OF INTERLEUKIN 1 BETA PRODUCTION | 54 | 1.71e-01 | 1.08e-01 | 6.38e-01 |
| GOBP INTERLEUKIN 17 PRODUCTION | 32 | 2.92e-01 | -1.08e-01 | 7.49e-01 |
| GOBP SEROTONIN METABOLIC PROCESS | 7 | 6.22e-01 | -1.08e-01 | 9.09e-01 |
| GOBP POSITIVE REGULATION OF TYROSINE PHOSPHORYLATION OF STAT PROTEIN | 38 | 2.51e-01 | 1.08e-01 | 7.20e-01 |
| GOCC TRANSCRIPTION ELONGATION FACTOR COMPLEX | 50 | 1.88e-01 | 1.08e-01 | 6.62e-01 |
| GOBP RENAL SYSTEM VASCULATURE DEVELOPMENT | 22 | 3.83e-01 | -1.08e-01 | 8.15e-01 |
| GOBP NEGATIVE REGULATION OF PLATELET DERIVED GROWTH FACTOR RECEPTOR SIGNALING PATHWAY | 9 | 5.77e-01 | 1.07e-01 | 8.92e-01 |
| GOBP REGULATION OF NITRIC OXIDE MEDIATED SIGNAL TRANSDUCTION | 5 | 6.77e-01 | -1.07e-01 | 9.24e-01 |
| GOBP MYOTUBE DIFFERENTIATION | 100 | 6.33e-02 | -1.07e-01 | 4.63e-01 |
| GOBP POSITIVE REGULATION OF ESTABLISHMENT OF PROTEIN LOCALIZATION TO MITOCHONDRION | 32 | 2.93e-01 | -1.07e-01 | 7.50e-01 |
| GOCC CORTICAL GRANULE | 5 | 6.77e-01 | 1.07e-01 | 9.24e-01 |
| GOMF COPPER CHAPERONE ACTIVITY | 7 | 6.23e-01 | 1.07e-01 | 9.09e-01 |
| GOBP GENITALIA DEVELOPMENT | 27 | 3.34e-01 | 1.07e-01 | 7.84e-01 |
| GOBP INTERLEUKIN 8 PRODUCTION | 67 | 1.29e-01 | -1.07e-01 | 5.94e-01 |
| GOBP NEGATIVE REGULATION OF HOMOTYPIC CELL CELL ADHESION | 11 | 5.38e-01 | -1.07e-01 | 8.79e-01 |
| GOBP CHONDROITIN SULFATE METABOLIC PROCESS | 22 | 3.84e-01 | -1.07e-01 | 8.15e-01 |
| GOCC GABA RECEPTOR COMPLEX | 6 | 6.50e-01 | -1.07e-01 | 9.17e-01 |
| GOMF GABA RECEPTOR ACTIVITY | 6 | 6.50e-01 | -1.07e-01 | 9.17e-01 |
| GOBP CELLULAR RESPONSE TO FATTY ACID | 24 | 3.64e-01 | -1.07e-01 | 8.02e-01 |
| GOBP POSITIVE REGULATION OF WNT SIGNALING PATHWAY PLANAR CELL POLARITY PATHWAY | 6 | 6.50e-01 | -1.07e-01 | 9.17e-01 |
| GOBP POSITIVE REGULATION OF RESPONSE TO WOUNDING | 55 | 1.70e-01 | -1.07e-01 | 6.36e-01 |
| GOBP REGULATION OF MIRNA CATABOLIC PROCESS | 7 | 6.24e-01 | 1.07e-01 | 9.09e-01 |
| GOBP FIBROBLAST GROWTH FACTOR PRODUCTION | 7 | 6.24e-01 | 1.07e-01 | 9.09e-01 |
| GOCC SMOOTH ENDOPLASMIC RETICULUM | 25 | 3.55e-01 | 1.07e-01 | 7.96e-01 |
| GOBP CEREBELLAR PURKINJE CELL LAYER MORPHOGENESIS | 14 | 4.88e-01 | 1.07e-01 | 8.61e-01 |
| GOBP L GLUTAMATE TRANSMEMBRANE TRANSPORT | 22 | 3.85e-01 | 1.07e-01 | 8.15e-01 |
| GOBP REGULATION OF TRANSCRIPTION BY GLUCOSE | 9 | 5.79e-01 | -1.07e-01 | 8.92e-01 |
| GOCC CHROMAFFIN GRANULE MEMBRANE | 9 | 5.79e-01 | 1.07e-01 | 8.92e-01 |
| GOMF AROMATIC AMINO ACID TRANSMEMBRANE TRANSPORTER ACTIVITY | 9 | 5.79e-01 | -1.07e-01 | 8.92e-01 |
| GOBP TAIL ANCHORED MEMBRANE PROTEIN INSERTION INTO ER MEMBRANE | 17 | 4.46e-01 | -1.07e-01 | 8.41e-01 |
| GOBP RETINAL CELL PROGRAMMED CELL DEATH | 5 | 6.79e-01 | -1.07e-01 | 9.24e-01 |
| GOBP PIGMENT GRANULE LOCALIZATION | 21 | 3.97e-01 | 1.07e-01 | 8.21e-01 |
| GOBP ENDOSOME TO LYSOSOME TRANSPORT VIA MULTIVESICULAR BODY SORTING PATHWAY | 16 | 4.60e-01 | 1.07e-01 | 8.47e-01 |
| GOCC MATRIX SIDE OF MITOCHONDRIAL INNER MEMBRANE | 6 | 6.51e-01 | -1.07e-01 | 9.17e-01 |
| GOCC LATE ENDOSOME MEMBRANE | 160 | 1.99e-02 | 1.07e-01 | 3.07e-01 |
| GOBP CELLULAR OXIDANT DETOXIFICATION | 81 | 9.69e-02 | 1.07e-01 | 5.41e-01 |
| GOMF POLYUBIQUITIN MODIFICATION DEPENDENT PROTEIN BINDING | 56 | 1.67e-01 | -1.07e-01 | 6.33e-01 |
| GOBP CENTROMERIC SISTER CHROMATID COHESION | 10 | 5.59e-01 | 1.07e-01 | 8.88e-01 |
| GOBP EXTRACELLULAR MATRIX CONSTITUENT SECRETION | 10 | 5.59e-01 | 1.07e-01 | 8.88e-01 |
| GOBP MEIOTIC CELL CYCLE | 211 | 7.68e-03 | 1.06e-01 | 2.02e-01 |
| GOBP INTERLEUKIN 12 MEDIATED SIGNALING PATHWAY | 8 | 6.02e-01 | -1.06e-01 | 9.03e-01 |
| GOMF THIAMINE TRANSMEMBRANE TRANSPORTER ACTIVITY | 5 | 6.80e-01 | 1.06e-01 | 9.24e-01 |
| GOMF SECONDARY ACTIVE MONOCARBOXYLATE TRANSMEMBRANE TRANSPORTER ACTIVITY | 9 | 5.80e-01 | -1.06e-01 | 8.93e-01 |
| GOBP REGULATION OF CAMP DEPENDENT PROTEIN KINASE ACTIVITY | 11 | 5.41e-01 | 1.06e-01 | 8.81e-01 |
| GOBP NEGATIVE REGULATION OF CHROMATIN ORGANIZATION | 5 | 6.80e-01 | 1.06e-01 | 9.24e-01 |
| GOBP REGULATION OF CARTILAGE DEVELOPMENT | 41 | 2.39e-01 | -1.06e-01 | 7.08e-01 |
| GOBP ASPARAGINE METABOLIC PROCESS | 5 | 6.81e-01 | -1.06e-01 | 9.24e-01 |
| GOCC 3M COMPLEX | 5 | 6.81e-01 | -1.06e-01 | 9.24e-01 |
| GOBP TETRAPYRROLE BIOSYNTHETIC PROCESS | 33 | 2.91e-01 | -1.06e-01 | 7.48e-01 |
| GOBP DORSAL AORTA DEVELOPMENT | 7 | 6.27e-01 | -1.06e-01 | 9.11e-01 |
| GOBP PENILE ERECTION | 6 | 6.52e-01 | 1.06e-01 | 9.18e-01 |
| GOBP REGULATION OF CARDIAC MUSCLE CELL DIFFERENTIATION | 11 | 5.42e-01 | -1.06e-01 | 8.82e-01 |
| GOBP NEGATIVE REGULATION OF MONOOXYGENASE ACTIVITY | 7 | 6.27e-01 | 1.06e-01 | 9.11e-01 |
| GOCC ESCRT COMPLEX | 27 | 3.40e-01 | 1.06e-01 | 7.88e-01 |
| GOBP RELAXATION OF MUSCLE | 26 | 3.49e-01 | 1.06e-01 | 7.92e-01 |
| GOBP CD8 POSITIVE ALPHA BETA T CELL ACTIVATION | 26 | 3.49e-01 | 1.06e-01 | 7.92e-01 |
| GOBP ENDOCARDIAL CUSHION DEVELOPMENT | 28 | 3.32e-01 | 1.06e-01 | 7.82e-01 |
| GOMF AMINOACYLTRANSFERASE ACTIVITY | 429 | 1.69e-04 | 1.06e-01 | 2.18e-02 |
| GOBP REGULATION OF CALCIUM ION DEPENDENT EXOCYTOSIS | 24 | 3.69e-01 | -1.06e-01 | 8.06e-01 |
| GOCC CD40 RECEPTOR COMPLEX | 11 | 5.43e-01 | -1.06e-01 | 8.82e-01 |
| GOBP CELLULAR RESPONSE TO ANTIBIOTIC | 12 | 5.26e-01 | 1.06e-01 | 8.76e-01 |
| GOBP DNA METHYLATION DEPENDENT HETEROCHROMATIN FORMATION | 29 | 3.24e-01 | 1.06e-01 | 7.75e-01 |
| GOBP NUCLEOBASE CONTAINING COMPOUND TRANSPORT | 213 | 7.80e-03 | 1.06e-01 | 2.04e-01 |
| GOCC U5 SNRNP | 19 | 4.25e-01 | -1.06e-01 | 8.32e-01 |
| GOBP REGULATION OF NEUROTRANSMITTER RECEPTOR ACTIVITY | 26 | 3.51e-01 | -1.06e-01 | 7.93e-01 |
| GOBP REGULATION OF RENAL SYSTEM PROCESS | 13 | 5.10e-01 | 1.06e-01 | 8.69e-01 |
| GOBP VIRAL GENE EXPRESSION | 96 | 7.36e-02 | 1.06e-01 | 4.88e-01 |
| GOBP POSITIVE REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY VIA DEATH DOMAIN RECEPTORS | 9 | 5.83e-01 | 1.06e-01 | 8.93e-01 |
| GOCC EXTRINSIC COMPONENT OF MITOCHONDRIAL INNER MEMBRANE | 6 | 6.54e-01 | -1.06e-01 | 9.18e-01 |
| GOBP POLYPRENOL METABOLIC PROCESS | 25 | 3.61e-01 | 1.06e-01 | 8.01e-01 |
| GOCC MHC CLASS I PEPTIDE LOADING COMPLEX | 8 | 6.05e-01 | 1.06e-01 | 9.03e-01 |
| GOCC LATE ENDOSOME | 281 | 2.33e-03 | 1.06e-01 | 1.18e-01 |
| GOMF AMINOPEPTIDASE ACTIVITY | 35 | 2.80e-01 | -1.06e-01 | 7.41e-01 |
| GOBP LEUKOCYTE APOPTOTIC PROCESS | 105 | 6.17e-02 | 1.06e-01 | 4.61e-01 |
| GOCC RIBONUCLEASE MRP COMPLEX | 9 | 5.84e-01 | -1.05e-01 | 8.93e-01 |
| GOBP PODOSOME ASSEMBLY | 18 | 4.39e-01 | -1.05e-01 | 8.39e-01 |
| GOMF SINGLE STRANDED DNA 5 3 DNA EXONUCLEASE ACTIVITY | 5 | 6.83e-01 | 1.05e-01 | 9.24e-01 |
| GOBP NEGATIVE REGULATION OF CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY | 49 | 2.02e-01 | 1.05e-01 | 6.74e-01 |
| GOBP PROTEIN DE ADP RIBOSYLATION | 5 | 6.83e-01 | 1.05e-01 | 9.24e-01 |
| GOBP INTERLEUKIN 18 PRODUCTION | 11 | 5.45e-01 | 1.05e-01 | 8.83e-01 |
| GOBP MITOPHAGY | 66 | 1.39e-01 | -1.05e-01 | 6.04e-01 |
| GOBP I KAPPAB PHOSPHORYLATION | 14 | 4.95e-01 | 1.05e-01 | 8.62e-01 |
| GOBP POSITIVE REGULATION OF T CELL APOPTOTIC PROCESS | 12 | 5.27e-01 | 1.05e-01 | 8.76e-01 |
| GOBP WALKING BEHAVIOR | 22 | 3.92e-01 | -1.05e-01 | 8.20e-01 |
| GOBP MULTI PASS TRANSMEMBRANE PROTEIN INSERTION INTO ER MEMBRANE | 9 | 5.84e-01 | 1.05e-01 | 8.93e-01 |
| GOCC MULTI PASS TRANSLOCON COMPLEX | 9 | 5.84e-01 | 1.05e-01 | 8.93e-01 |
| GOMF NADPLUS BINDING | 17 | 4.52e-01 | 1.05e-01 | 8.43e-01 |
| GOMF NEUROPEPTIDE BINDING | 12 | 5.28e-01 | 1.05e-01 | 8.76e-01 |
| GOBP REGULATION OF INTESTINAL ABSORPTION | 6 | 6.55e-01 | -1.05e-01 | 9.18e-01 |
| GOBP CELL SURFACE PATTERN RECOGNITION RECEPTOR SIGNALING PATHWAY | 63 | 1.48e-01 | 1.05e-01 | 6.13e-01 |
| GOBP POSITIVE REGULATION OF INSULIN LIKE GROWTH FACTOR RECEPTOR SIGNALING PATHWAY | 7 | 6.30e-01 | 1.05e-01 | 9.11e-01 |
| GOMF LOW DENSITY LIPOPROTEIN PARTICLE RECEPTOR ACTIVITY | 14 | 4.95e-01 | -1.05e-01 | 8.62e-01 |
| GOBP POSITIVE REGULATION OF CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY INVOLVED IN APOPTOTIC SIGNALING PATHWAY | 5 | 6.84e-01 | -1.05e-01 | 9.25e-01 |
| GOBP NEGATIVE REGULATION OF CALCIUM ION DEPENDENT EXOCYTOSIS | 6 | 6.56e-01 | 1.05e-01 | 9.18e-01 |
| GOBP NUCLEAR RNA SURVEILLANCE | 15 | 4.81e-01 | -1.05e-01 | 8.59e-01 |
| GOBP POSITIVE REGULATION OF MITOTIC CYTOKINESIS | 13 | 5.12e-01 | -1.05e-01 | 8.70e-01 |
| GOBP GOLGI RIBBON FORMATION | 11 | 5.46e-01 | 1.05e-01 | 8.84e-01 |
| GOBP POSITIVE REGULATION OF CD4 POSITIVE ALPHA BETA T CELL PROLIFERATION | 10 | 5.65e-01 | 1.05e-01 | 8.90e-01 |
| GOBP NEGATIVE REGULATION OF GLYCOPROTEIN METABOLIC PROCESS | 13 | 5.12e-01 | -1.05e-01 | 8.70e-01 |
| GOMF STRUCTURAL CONSTITUENT OF NUCLEAR PORE | 24 | 3.73e-01 | 1.05e-01 | 8.09e-01 |
| GOBP POSITIVE REGULATION OF INTRACELLULAR STEROID HORMONE RECEPTOR SIGNALING PATHWAY | 8 | 6.07e-01 | 1.05e-01 | 9.03e-01 |
| GOBP CARDIAC ATRIUM DEVELOPMENT | 20 | 4.17e-01 | 1.05e-01 | 8.30e-01 |
| GOBP LOW DENSITY LIPOPROTEIN PARTICLE CLEARANCE | 21 | 4.06e-01 | -1.05e-01 | 8.26e-01 |
| GOBP NEGATIVE REGULATION OF ORGAN GROWTH | 26 | 3.55e-01 | -1.05e-01 | 7.96e-01 |
| GOBP LYSOSOMAL TRANSPORT | 124 | 4.40e-02 | 1.05e-01 | 4.11e-01 |
| GOBP REGULATION OF AXON EXTENSION | 63 | 1.50e-01 | -1.05e-01 | 6.13e-01 |
| GOMF GDP PHOSPHATASE ACTIVITY | 8 | 6.08e-01 | 1.05e-01 | 9.03e-01 |
| GOBP ESTABLISHMENT OF ORGANELLE LOCALIZATION | 422 | 2.25e-04 | 1.05e-01 | 2.70e-02 |
| GOMF JUN KINASE BINDING | 11 | 5.48e-01 | -1.05e-01 | 8.84e-01 |
| GOBP FC RECEPTOR MEDIATED STIMULATORY SIGNALING PATHWAY | 30 | 3.21e-01 | 1.05e-01 | 7.73e-01 |
| GOMF ABC TYPE TRANSPORTER ACTIVITY | 39 | 2.58e-01 | -1.05e-01 | 7.27e-01 |
| GOMF DNA DAMAGE SENSOR ACTIVITY | 22 | 3.95e-01 | -1.05e-01 | 8.20e-01 |
| GOBP NEGATIVE REGULATION OF MEGAKARYOCYTE DIFFERENTIATION | 10 | 5.67e-01 | -1.05e-01 | 8.90e-01 |
| GOBP PYRIMIDINE DEOXYRIBONUCLEOSIDE TRIPHOSPHATE METABOLIC PROCESS | 6 | 6.57e-01 | 1.05e-01 | 9.19e-01 |
| GOBP TRANSCRIPTION COUPLED NUCLEOTIDE EXCISION REPAIR | 10 | 5.67e-01 | -1.05e-01 | 8.90e-01 |
| GOBP REGULATION OF PHOSPHOLIPID TRANSPORT | 14 | 4.98e-01 | -1.05e-01 | 8.63e-01 |
| GOMF GATED CHANNEL ACTIVITY | 187 | 1.37e-02 | -1.05e-01 | 2.52e-01 |
| GOBP BOX C D SNORNP ASSEMBLY | 8 | 6.09e-01 | -1.05e-01 | 9.03e-01 |
| GOCC POTASSIUM CHANNEL COMPLEX | 62 | 1.55e-01 | -1.04e-01 | 6.17e-01 |
| GOBP REGULATION OF B CELL DIFFERENTIATION | 32 | 3.06e-01 | -1.04e-01 | 7.61e-01 |
| GOBP REGULATION OF TRANSLATION | 335 | 1.02e-03 | 1.04e-01 | 7.18e-02 |
| GOBP GOLGI ORGANIZATION | 145 | 3.00e-02 | 1.04e-01 | 3.64e-01 |
| GOBP REGULATION OF PERK MEDIATED UNFOLDED PROTEIN RESPONSE | 11 | 5.49e-01 | 1.04e-01 | 8.84e-01 |
| GOBP NEGATIVE REGULATION OF NEURAL PRECURSOR CELL PROLIFERATION | 19 | 4.31e-01 | -1.04e-01 | 8.35e-01 |
| GOBP POSITIVE REGULATION OF CYTOKINESIS | 38 | 2.66e-01 | 1.04e-01 | 7.33e-01 |
| GOBP SERINE FAMILY AMINO ACID METABOLIC PROCESS | 26 | 3.57e-01 | -1.04e-01 | 7.98e-01 |
| GOBP NEGATIVE REGULATION OF INNATE IMMUNE RESPONSE | 80 | 1.07e-01 | 1.04e-01 | 5.60e-01 |
| GOBP TRICARBOXYLIC ACID METABOLIC PROCESS | 14 | 4.99e-01 | -1.04e-01 | 8.64e-01 |
| GOMF 1 PHOSPHATIDYLINOSITOL 4 PHOSPHATE 5 KINASE ACTIVITY | 9 | 5.88e-01 | 1.04e-01 | 8.95e-01 |
| GOBP REGULATION OF MRNA CATABOLIC PROCESS | 167 | 2.02e-02 | 1.04e-01 | 3.11e-01 |
| GOBP REGULATION OF DEOXYRIBONUCLEASE ACTIVITY | 10 | 5.69e-01 | -1.04e-01 | 8.90e-01 |
| GOBP MEMBRANE DOCKING | 75 | 1.19e-01 | 1.04e-01 | 5.82e-01 |
| GOBP NEGATIVE REGULATION OF JNK CASCADE | 32 | 3.08e-01 | 1.04e-01 | 7.62e-01 |
| GOBP PROTEIN LOCALIZATION TO ADHERENS JUNCTION | 6 | 6.59e-01 | -1.04e-01 | 9.19e-01 |
| GOBP NEGATIVE REGULATION OF RELEASE OF CYTOCHROME C FROM MITOCHONDRIA | 18 | 4.45e-01 | -1.04e-01 | 8.41e-01 |
| GOBP RECEPTOR RECYCLING | 42 | 2.44e-01 | 1.04e-01 | 7.13e-01 |
| GOBP REGULATION OF NUCLEASE ACTIVITY | 21 | 4.10e-01 | 1.04e-01 | 8.26e-01 |
| GOBP NEGATIVE REGULATION OF MICROTUBULE POLYMERIZATION | 12 | 5.33e-01 | -1.04e-01 | 8.79e-01 |
| GOBP RNA SPLICING VIA TRANSESTERIFICATION REACTIONS | 289 | 2.36e-03 | 1.04e-01 | 1.19e-01 |
| GOBP POSITIVE REGULATION OF VASCULAR ASSOCIATED SMOOTH MUSCLE CELL MIGRATION | 13 | 5.16e-01 | 1.04e-01 | 8.72e-01 |
| GOCC UBIQUITIN LIGASE COMPLEX | 291 | 2.29e-03 | 1.04e-01 | 1.17e-01 |
| GOBP POSITIVE REGULATION OF NEURON APOPTOTIC PROCESS | 51 | 1.99e-01 | 1.04e-01 | 6.71e-01 |
| GOBP RRNA 3 END PROCESSING | 10 | 5.69e-01 | -1.04e-01 | 8.90e-01 |
| GOBP CARDIAC NEURAL CREST CELL DEVELOPMENT INVOLVED IN OUTFLOW TRACT MORPHOGENESIS | 6 | 6.59e-01 | -1.04e-01 | 9.20e-01 |
| GOBP PROTEIN CONTAINING COMPLEX DISASSEMBLY | 233 | 6.32e-03 | 1.04e-01 | 1.87e-01 |
| GOBP MITOCHONDRIAL DNA REPLICATION | 14 | 5.01e-01 | 1.04e-01 | 8.65e-01 |
| GOBP GANGLIOSIDE BIOSYNTHETIC PROCESS | 12 | 5.33e-01 | 1.04e-01 | 8.79e-01 |
| GOMF VOLTAGE GATED POTASSIUM CHANNEL ACTIVITY INVOLVED IN CARDIAC MUSCLE CELL ACTION POTENTIAL REPOLARIZATION | 10 | 5.70e-01 | 1.04e-01 | 8.90e-01 |
| GOBP POSITIVE REGULATION OF GENE EXPRESSION EPIGENETIC | 52 | 1.95e-01 | -1.04e-01 | 6.68e-01 |
| GOMF LYSINE N ACETYLTRANSFERASE ACTIVITY ACTING ON ACETYL PHOSPHATE AS DONOR | 5 | 6.88e-01 | -1.04e-01 | 9.27e-01 |
| GOMF HISTONE DEUBIQUITINASE ACTIVITY | 8 | 6.11e-01 | 1.04e-01 | 9.04e-01 |
| GOMF PATTERN RECOGNITION RECEPTOR ACTIVITY | 31 | 3.18e-01 | 1.04e-01 | 7.69e-01 |
| GOBP NEUROPEPTIDE SIGNALING PATHWAY | 44 | 2.34e-01 | -1.04e-01 | 7.05e-01 |
| GOBP MEMBRANE REPOLARIZATION DURING VENTRICULAR CARDIAC MUSCLE CELL ACTION POTENTIAL | 11 | 5.52e-01 | 1.04e-01 | 8.86e-01 |
| GOCC PLATELET ALPHA GRANULE MEMBRANE | 16 | 4.73e-01 | 1.04e-01 | 8.55e-01 |
| GOMF NEUTRAL L AMINO ACID TRANSMEMBRANE TRANSPORTER ACTIVITY | 29 | 3.34e-01 | 1.04e-01 | 7.84e-01 |
| GOMF TITIN BINDING | 9 | 5.91e-01 | -1.04e-01 | 8.97e-01 |
| GOBP RIBONUCLEOPROTEIN COMPLEX LOCALIZATION | 12 | 5.35e-01 | 1.04e-01 | 8.79e-01 |
| GOBP CELLULAR COMPONENT MAINTENANCE | 56 | 1.80e-01 | -1.03e-01 | 6.53e-01 |
| GOCC MITOCHONDRIAL CRISTA JUNCTION | 8 | 6.12e-01 | 1.03e-01 | 9.04e-01 |
| GOMF PYRIMIDINE NUCLEOTIDE BINDING | 5 | 6.89e-01 | 1.03e-01 | 9.27e-01 |
| GOBP CALCIUM ION TRANSMEMBRANE IMPORT INTO CYTOSOL | 133 | 3.94e-02 | -1.03e-01 | 3.98e-01 |
| GOBP REGULATION OF HEMATOPOIETIC STEM CELL PROLIFERATION | 11 | 5.52e-01 | -1.03e-01 | 8.86e-01 |
| GOBP DETECTION OF MECHANICAL STIMULUS INVOLVED IN SENSORY PERCEPTION | 24 | 3.81e-01 | 1.03e-01 | 8.13e-01 |
| GOBP TROPHECTODERMAL CELL DIFFERENTIATION | 14 | 5.03e-01 | -1.03e-01 | 8.66e-01 |
| GOMF NITRIC OXIDE SYNTHASE BINDING | 9 | 5.91e-01 | -1.03e-01 | 8.97e-01 |
| GOBP DEFENSE RESPONSE TO FUNGUS | 38 | 2.70e-01 | -1.03e-01 | 7.35e-01 |
| GOBP AZOLE TRANSMEMBRANE TRANSPORT | 11 | 5.53e-01 | -1.03e-01 | 8.86e-01 |
| GOBP MESENCHYMAL CELL PROLIFERATION | 22 | 4.02e-01 | 1.03e-01 | 8.23e-01 |
| GOMF NAD BINDING | 51 | 2.02e-01 | -1.03e-01 | 6.75e-01 |
| GOMF ASPARTIC TYPE ENDOPEPTIDASE INHIBITOR ACTIVITY | 6 | 6.61e-01 | 1.03e-01 | 9.21e-01 |
| GOBP RIBONUCLEOSIDE METABOLIC PROCESS | 34 | 2.97e-01 | 1.03e-01 | 7.53e-01 |
| GOBP L LEUCINE METABOLIC PROCESS | 7 | 6.36e-01 | 1.03e-01 | 9.14e-01 |
| GOBP VENTRICULAR COMPACT MYOCARDIUM MORPHOGENESIS | 7 | 6.36e-01 | 1.03e-01 | 9.14e-01 |
| GOMF GALACTOSYLTRANSFERASE ACTIVITY | 26 | 3.63e-01 | -1.03e-01 | 8.02e-01 |
| GOBP NATURAL KILLER CELL ACTIVATION | 72 | 1.31e-01 | 1.03e-01 | 5.94e-01 |
| GOBP REGULATION OF TYPE B PANCREATIC CELL DEVELOPMENT | 7 | 6.37e-01 | -1.03e-01 | 9.14e-01 |
| GOBP PROTEIN K63 LINKED UBIQUITINATION | 65 | 1.51e-01 | 1.03e-01 | 6.13e-01 |
| GOMF ARYLSULFATASE ACTIVITY | 10 | 5.73e-01 | -1.03e-01 | 8.92e-01 |
| GOBP REGULATION OF MRNA EXPORT FROM NUCLEUS | 10 | 5.73e-01 | 1.03e-01 | 8.92e-01 |
| GOBP MITOCHONDRIAL DEPOLARIZATION | 18 | 4.49e-01 | -1.03e-01 | 8.43e-01 |
| GOBP TROPHOBLAST CELL MIGRATION | 13 | 5.20e-01 | 1.03e-01 | 8.74e-01 |
| GOBP REGULATION OF ACUTE INFLAMMATORY RESPONSE TO ANTIGENIC STIMULUS | 14 | 5.05e-01 | 1.03e-01 | 8.66e-01 |
| GOBP POSITIVE REGULATION OF PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR SIGNALING PATHWAY | 5 | 6.90e-01 | 1.03e-01 | 9.27e-01 |
| GOBP CYTOPLASMIC SEQUESTERING OF TRANSCRIPTION FACTOR | 8 | 6.14e-01 | -1.03e-01 | 9.05e-01 |
| GOBP POSITIVE REGULATION OF AUTOPHAGY OF MITOCHONDRION | 18 | 4.50e-01 | -1.03e-01 | 8.43e-01 |
| GOBP CD4 POSITIVE OR CD8 POSITIVE ALPHA BETA T CELL LINEAGE COMMITMENT | 26 | 3.64e-01 | -1.03e-01 | 8.02e-01 |
| GOBP AXONAL TRANSPORT | 61 | 1.65e-01 | 1.03e-01 | 6.30e-01 |
| GOBP RAP PROTEIN SIGNAL TRANSDUCTION | 13 | 5.21e-01 | 1.03e-01 | 8.74e-01 |
| GOBP MALE SEX DETERMINATION | 6 | 6.63e-01 | -1.03e-01 | 9.21e-01 |
| GOBP POSITIVE REGULATION OF METAPHASE ANAPHASE TRANSITION OF CELL CYCLE | 14 | 5.06e-01 | 1.03e-01 | 8.67e-01 |
| GOMF OPSONIN BINDING | 12 | 5.38e-01 | -1.03e-01 | 8.79e-01 |
| GOBP REGULATION OF LIPID CATABOLIC PROCESS | 45 | 2.34e-01 | -1.03e-01 | 7.05e-01 |
| GOBP OLIGODENDROCYTE DIFFERENTIATION | 75 | 1.25e-01 | -1.03e-01 | 5.88e-01 |
| GOBP ESTABLISHMENT OF BLOOD BRAIN BARRIER | 13 | 5.22e-01 | -1.03e-01 | 8.75e-01 |
| GOBP CENTROMERE COMPLEX ASSEMBLY | 29 | 3.39e-01 | 1.03e-01 | 7.88e-01 |
| GOBP T CELL MEDIATED CYTOTOXICITY | 52 | 2.01e-01 | 1.02e-01 | 6.73e-01 |
| GOMF SERINE TYPE ENDOPEPTIDASE INHIBITOR ACTIVITY | 51 | 2.06e-01 | 1.02e-01 | 6.81e-01 |
| GOBP CARDIAC MYOFIBRIL ASSEMBLY | 12 | 5.39e-01 | 1.02e-01 | 8.80e-01 |
| GOBP REGULATION OF CENTROSOME CYCLE | 51 | 2.06e-01 | 1.02e-01 | 6.81e-01 |
| GOCC TRANSFERASE COMPLEX | 789 | 1.02e-06 | 1.02e-01 | 6.31e-04 |
| GOBP CHONDROCYTE PROLIFERATION | 15 | 4.92e-01 | -1.02e-01 | 8.62e-01 |
| GOBP RESPONSE TO IONIZING RADIATION | 127 | 4.65e-02 | 1.02e-01 | 4.19e-01 |
| GOBP GLUCURONATE CATABOLIC PROCESS TO XYLULOSE 5 PHOSPHATE | 5 | 6.92e-01 | -1.02e-01 | 9.27e-01 |
| GOMF SMALL PROTEIN ACTIVATING ENZYME BINDING | 5 | 6.92e-01 | 1.02e-01 | 9.27e-01 |
| GOBP NEGATIVE REGULATION BY HOST OF VIRAL GENOME REPLICATION | 9 | 5.95e-01 | 1.02e-01 | 9.01e-01 |
| GOBP POSITIVE REGULATION OF NUCLEOCYTOPLASMIC TRANSPORT | 58 | 1.78e-01 | 1.02e-01 | 6.50e-01 |
| GOMF DINUCLEOTIDE PHOSPHATASE ACTIVITY | 7 | 6.40e-01 | -1.02e-01 | 9.15e-01 |
| GOBP REGULATION OF T HELPER CELL DIFFERENTIATION | 40 | 2.63e-01 | -1.02e-01 | 7.31e-01 |
| GOBP NEUROTRANSMITTER RECEPTOR TRANSPORT TO PLASMA MEMBRANE | 14 | 5.08e-01 | -1.02e-01 | 8.69e-01 |
| GOBP REGULATION OF MITOCHONDRIAL MRNA STABILITY | 7 | 6.40e-01 | 1.02e-01 | 9.15e-01 |
| GOBP REGULATION OF MORPHOGENESIS OF A BRANCHING STRUCTURE | 33 | 3.10e-01 | -1.02e-01 | 7.64e-01 |
| GOBP CELLULAR RESPONSE TO COLD | 10 | 5.77e-01 | 1.02e-01 | 8.92e-01 |
| GOBP BRANCHING INVOLVED IN MAMMARY GLAND DUCT MORPHOGENESIS | 17 | 4.67e-01 | 1.02e-01 | 8.52e-01 |
| GOMF PEPTIDOGLYCAN BINDING | 11 | 5.58e-01 | -1.02e-01 | 8.88e-01 |
| GOMF PHOSPHOLIPASE BINDING | 21 | 4.19e-01 | 1.02e-01 | 8.30e-01 |
| GOBP IRON ION TRANSPORT | 49 | 2.17e-01 | -1.02e-01 | 6.92e-01 |
| GOMF CARDIOLIPIN BINDING | 9 | 5.97e-01 | 1.02e-01 | 9.02e-01 |
| GOMF ADENOSINE DEAMINASE ACTIVITY | 11 | 5.59e-01 | 1.02e-01 | 8.88e-01 |
| GOBP REGULATION OF ODONTOBLAST DIFFERENTIATION | 6 | 6.66e-01 | -1.02e-01 | 9.22e-01 |
| GOBP ENDOSOMAL VESICLE FUSION | 15 | 4.95e-01 | -1.02e-01 | 8.62e-01 |
| GOMF 7SK SNRNA BINDING | 9 | 5.97e-01 | -1.02e-01 | 9.02e-01 |
| GOMF ACYLGLYCEROL O ACYLTRANSFERASE ACTIVITY | 25 | 3.79e-01 | 1.02e-01 | 8.12e-01 |
| GOBP POSITIVE REGULATION OF TRANSLATION IN RESPONSE TO STRESS | 6 | 6.67e-01 | 1.02e-01 | 9.22e-01 |
| GOBP MULTI CILIATED EPITHELIAL CELL DIFFERENTIATION | 6 | 6.67e-01 | -1.02e-01 | 9.22e-01 |
| GOBP MITOTIC CELL CYCLE PHASE TRANSITION | 397 | 5.18e-04 | 1.02e-01 | 4.68e-02 |
| GOBP REGULATION OF PHOSPHOLIPASE C ACTIVITY | 27 | 3.61e-01 | -1.01e-01 | 8.01e-01 |
| GOBP REGULATION OF CELL CELL ADHESION MEDIATED BY CADHERIN | 16 | 4.82e-01 | -1.01e-01 | 8.59e-01 |
| GOBP REGULATION OF GONAD DEVELOPMENT | 8 | 6.19e-01 | 1.01e-01 | 9.07e-01 |
| GOMF UBIQUITIN SPECIFIC PROTEASE BINDING | 17 | 4.69e-01 | 1.01e-01 | 8.54e-01 |
| GOBP REGULATION OF TRANSLATIONAL TERMINATION | 9 | 5.98e-01 | -1.01e-01 | 9.02e-01 |
| GOBP APOLIPOPROTEIN A I MEDIATED SIGNALING PATHWAY | 5 | 6.95e-01 | 1.01e-01 | 9.27e-01 |
| GOBP RESPONSE TO INTERLEUKIN 3 | 7 | 6.42e-01 | 1.01e-01 | 9.15e-01 |
| GOBP PEPTIDE METABOLIC PROCESS | 65 | 1.58e-01 | 1.01e-01 | 6.23e-01 |
| GOBP REGULATION OF CELL CYCLE PHASE TRANSITION | 391 | 5.87e-04 | 1.01e-01 | 5.15e-02 |
| GOBP NEGATIVE REGULATION OF INFLAMMATORY RESPONSE TO WOUNDING | 7 | 6.43e-01 | -1.01e-01 | 9.15e-01 |
| GOBP PARASYMPATHETIC NERVOUS SYSTEM DEVELOPMENT | 10 | 5.79e-01 | -1.01e-01 | 8.92e-01 |
| GOBP NERVE DEVELOPMENT | 58 | 1.82e-01 | 1.01e-01 | 6.55e-01 |
| GOBP MEGAKARYOCYTE DIFFERENTIATION | 55 | 1.94e-01 | -1.01e-01 | 6.67e-01 |
| GOBP VERY LONG CHAIN FATTY ACID METABOLIC PROCESS | 33 | 3.14e-01 | 1.01e-01 | 7.66e-01 |
| GOCC BRISC COMPLEX | 6 | 6.68e-01 | 1.01e-01 | 9.22e-01 |
| GOBP POSITIVE REGULATION OF RELEASE OF SEQUESTERED CALCIUM ION INTO CYTOSOL | 27 | 3.63e-01 | -1.01e-01 | 8.02e-01 |
| GOCC CORVET COMPLEX | 7 | 6.43e-01 | -1.01e-01 | 9.15e-01 |
| GOBP ALDITOL METABOLIC PROCESS | 17 | 4.71e-01 | -1.01e-01 | 8.54e-01 |
| GOBP CALCINEURIN MEDIATED SIGNALING | 39 | 2.75e-01 | -1.01e-01 | 7.38e-01 |
| GOBP LYMPHOCYTE HOMEOSTASIS | 73 | 1.36e-01 | 1.01e-01 | 6.02e-01 |
| GOCC VARICOSITY | 6 | 6.69e-01 | -1.01e-01 | 9.22e-01 |
| GOBP INHIBITORY SYNAPSE ASSEMBLY | 11 | 5.62e-01 | 1.01e-01 | 8.90e-01 |
| GOBP AMYLOID FIBRIL FORMATION | 36 | 2.95e-01 | 1.01e-01 | 7.52e-01 |
| GOBP ORGANELLE FISSION | 416 | 4.19e-04 | 1.01e-01 | 4.02e-02 |
| GOBP PROTEASOMAL PROTEIN CATABOLIC PROCESS | 491 | 1.31e-04 | 1.01e-01 | 1.90e-02 |
| GOCC GOLGI STACK | 127 | 4.98e-02 | 1.01e-01 | 4.27e-01 |
| GOBP POSITIVE REGULATION OF KERATINOCYTE PROLIFERATION | 8 | 6.21e-01 | -1.01e-01 | 9.09e-01 |
| GOBP POSITIVE REGULATION OF INTERLEUKIN 12 PRODUCTION | 36 | 2.96e-01 | 1.01e-01 | 7.53e-01 |
| GOBP SPLICEOSOMAL COMPLEX ASSEMBLY | 75 | 1.32e-01 | 1.01e-01 | 5.96e-01 |
| GOBP POSITIVE REGULATION OF PLASMA MEMBRANE BOUNDED CELL PROJECTION ASSEMBLY | 97 | 8.66e-02 | 1.01e-01 | 5.15e-01 |
| GOBP PURINE RIBONUCLEOSIDE SALVAGE | 7 | 6.45e-01 | 1.01e-01 | 9.15e-01 |
| GOBP CELL FATE COMMITMENT INVOLVED IN FORMATION OF PRIMARY GERM LAYER | 18 | 4.60e-01 | 1.01e-01 | 8.47e-01 |
| GOMF ERBB 3 CLASS RECEPTOR BINDING | 5 | 6.97e-01 | 1.01e-01 | 9.28e-01 |
| GOBP URETER DEVELOPMENT | 7 | 6.45e-01 | -1.01e-01 | 9.15e-01 |
| GOBP POSITIVE REGULATION OF MITOCHONDRIAL MEMBRANE POTENTIAL | 7 | 6.45e-01 | -1.01e-01 | 9.15e-01 |
| GOBP POSTSYNAPSE ASSEMBLY | 29 | 3.49e-01 | -1.01e-01 | 7.92e-01 |
| GOMF ENDOPEPTIDASE REGULATOR ACTIVITY | 108 | 7.12e-02 | 1.00e-01 | 4.84e-01 |
| GOBP VESICLE BUDDING FROM MEMBRANE | 83 | 1.14e-01 | 1.00e-01 | 5.70e-01 |
| GOMF INOSITOL TETRAKISPHOSPHATE PHOSPHATASE ACTIVITY | 7 | 6.45e-01 | -1.00e-01 | 9.15e-01 |
| GOCC MLL1 2 COMPLEX | 32 | 3.26e-01 | -1.00e-01 | 7.76e-01 |
| GOCC RIPOPTOSOME | 6 | 6.70e-01 | 1.00e-01 | 9.22e-01 |
| GOBP MESODERMAL CELL DIFFERENTIATION | 17 | 4.74e-01 | -1.00e-01 | 8.55e-01 |
| GOBP POSITIVE REGULATION OF EPITHELIAL CELL PROLIFERATION INVOLVED IN WOUND HEALING | 5 | 6.98e-01 | 1.00e-01 | 9.28e-01 |
| GOBP AMIDE CATABOLIC PROCESS | 11 | 5.65e-01 | -1.00e-01 | 8.90e-01 |
| GOMF PHOSPHOLIPASE A2 ACTIVITY | 22 | 4.15e-01 | -1.00e-01 | 8.29e-01 |
| GOBP VASCULAR ENDOTHELIAL GROWTH FACTOR PRODUCTION | 29 | 3.50e-01 | 1.00e-01 | 7.93e-01 |
| GOBP POSITIVE REGULATION OF VESICLE FUSION | 8 | 6.23e-01 | 1.00e-01 | 9.09e-01 |
| GOBP CELLULAR RESPONSE TO MACROPHAGE COLONY STIMULATING FACTOR STIMULUS | 11 | 5.65e-01 | 1.00e-01 | 8.90e-01 |
| GOBP CENTRIOLE CENTRIOLE COHESION | 15 | 5.01e-01 | 1.00e-01 | 8.65e-01 |
| GOBP REGULATION OF NEUROTRANSMITTER SECRETION | 64 | 1.66e-01 | 1.00e-01 | 6.30e-01 |
| GOMF SUPEROXIDE GENERATING NAD P H OXIDASE ACTIVITY | 6 | 6.71e-01 | -1.00e-01 | 9.22e-01 |
| GOBP ATTACHMENT OF GPI ANCHOR TO PROTEIN | 6 | 6.71e-01 | 1.00e-01 | 9.22e-01 |
| GOMF WATER TRANSMEMBRANE TRANSPORTER ACTIVITY | 8 | 6.24e-01 | -1.00e-01 | 9.09e-01 |
| GOCC MICROBODY | 128 | 5.06e-02 | 1.00e-01 | 4.29e-01 |
| GOBP REGULATION OF CD4 POSITIVE CD25 POSITIVE ALPHA BETA REGULATORY T CELL DIFFERENTIATION | 7 | 6.47e-01 | -1.00e-01 | 9.16e-01 |
| GOBP POSITIVE REGULATION OF OXIDOREDUCTASE ACTIVITY | 31 | 3.35e-01 | 1.00e-01 | 7.84e-01 |
| GOBP NEGATIVE REGULATION OF ANTIGEN RECEPTOR MEDIATED SIGNALING PATHWAY | 32 | 3.28e-01 | 1.00e-01 | 7.78e-01 |
| GOBP POSITIVE REGULATION OF INFLAMMATORY RESPONSE | 119 | 5.96e-02 | 1.00e-01 | 4.53e-01 |
| GOBP ODONTOGENESIS | 75 | 1.34e-01 | -1.00e-01 | 5.99e-01 |
| GOMF CYTOKINE RECEPTOR ACTIVITY | 78 | 1.27e-01 | 9.99e-02 | 5.92e-01 |
| GOCC SYNAPTIC MEMBRANE | 240 | 7.68e-03 | -9.99e-02 | 2.02e-01 |
| GOCC INTRACELLULAR PROTEIN CONTAINING COMPLEX | 845 | 8.22e-07 | 9.99e-02 | 5.61e-04 |
| GOMF U3 SNORNA BINDING | 10 | 5.84e-01 | -9.99e-02 | 8.93e-01 |
| GOBP NEGATIVE REGULATION OF CALCIUM ION TRANSPORT | 41 | 2.68e-01 | 9.99e-02 | 7.33e-01 |
| GOBP NATURAL KILLER CELL PROLIFERATION | 12 | 5.49e-01 | 9.99e-02 | 8.84e-01 |
| GOBP GLIAL CELL PROLIFERATION | 42 | 2.63e-01 | 9.99e-02 | 7.30e-01 |
| GOBP ANOIKIS | 29 | 3.52e-01 | -9.98e-02 | 7.94e-01 |
| GOBP REGULATION OF MITOCHONDRIAL GENE EXPRESSION | 33 | 3.21e-01 | -9.98e-02 | 7.73e-01 |
| GOBP REGULATION OF INTRACELLULAR TRANSPORT | 238 | 8.02e-03 | 9.98e-02 | 2.06e-01 |
| GOBP CARDIAC NEURAL CREST CELL DIFFERENTIATION INVOLVED IN HEART DEVELOPMENT | 9 | 6.04e-01 | -9.98e-02 | 9.03e-01 |
| GOBP POSITIVE REGULATION OF DEFENSE RESPONSE | 430 | 3.92e-04 | 9.97e-02 | 3.87e-02 |
| GOBP POSITIVE REGULATION OF CHOLESTEROL METABOLIC PROCESS | 9 | 6.04e-01 | -9.97e-02 | 9.03e-01 |
| GOBP EARLY ENDOSOME TO GOLGI TRANSPORT | 16 | 4.90e-01 | -9.97e-02 | 8.61e-01 |
| GOBP COLUMNAR CUBOIDAL EPITHELIAL CELL DIFFERENTIATION | 71 | 1.47e-01 | -9.96e-02 | 6.13e-01 |
| GOMF TRNA BINDING | 78 | 1.28e-01 | 9.96e-02 | 5.93e-01 |
| GOBP POSITIVE REGULATION OF CHROMOSOME ORGANIZATION | 106 | 7.66e-02 | 9.95e-02 | 4.93e-01 |
| GOBP LAMELLIPODIUM MORPHOGENESIS | 17 | 4.77e-01 | -9.95e-02 | 8.57e-01 |
| GOBP CYTOSOLIC RIBOSOME ASSEMBLY | 9 | 6.05e-01 | 9.95e-02 | 9.03e-01 |
| GOBP GALACTOSYLCERAMIDE BIOSYNTHETIC PROCESS | 5 | 7.00e-01 | -9.95e-02 | 9.28e-01 |
| GOCC COMPLEX OF COLLAGEN TRIMERS | 13 | 5.35e-01 | -9.94e-02 | 8.79e-01 |
| GOBP NOTCH SIGNALING PATHWAY | 128 | 5.22e-02 | -9.94e-02 | 4.33e-01 |
| GOBP VESICLE ORGANIZATION | 328 | 1.99e-03 | 9.93e-02 | 1.09e-01 |
| GOBP INNATE IMMUNE RESPONSE | 783 | 2.30e-06 | 9.93e-02 | 1.07e-03 |
| GOMF ACTIVIN BINDING | 10 | 5.87e-01 | 9.93e-02 | 8.95e-01 |
| GOBP REGULATION OF BMP SIGNALING PATHWAY | 67 | 1.60e-01 | -9.93e-02 | 6.27e-01 |
| GOBP VIRAL TRANSLATION | 19 | 4.54e-01 | 9.93e-02 | 8.43e-01 |
| GOBP REGULATION OF ACTION POTENTIAL | 40 | 2.77e-01 | 9.92e-02 | 7.39e-01 |
| GOMF CATALYTIC ACTIVITY ACTING ON A TRNA | 138 | 4.44e-02 | 9.91e-02 | 4.11e-01 |
| GOBP MRNA PROCESSING | 455 | 2.91e-04 | 9.91e-02 | 3.14e-02 |
| GOBP POSITIVE REGULATION OF TUMOR NECROSIS FACTOR SUPERFAMILY CYTOKINE PRODUCTION | 98 | 9.01e-02 | 9.91e-02 | 5.25e-01 |
| GOBP T HELPER 17 CELL LINEAGE COMMITMENT | 16 | 4.93e-01 | -9.90e-02 | 8.62e-01 |
| GOMF NUCLEOSIDE DIPHOSPHATE KINASE ACTIVITY | 14 | 5.21e-01 | 9.90e-02 | 8.74e-01 |
| GOBP REGULATION OF MICROVILLUS LENGTH | 6 | 6.75e-01 | -9.90e-02 | 9.23e-01 |
| GOBP IMMATURE T CELL PROLIFERATION | 9 | 6.07e-01 | 9.90e-02 | 9.03e-01 |
| GOBP CELLULAR RESPONSE TO PARATHYROID HORMONE STIMULUS | 9 | 6.07e-01 | -9.89e-02 | 9.03e-01 |
| GOMF ABC TYPE GLUTATHIONE S CONJUGATE TRANSPORTER ACTIVITY | 8 | 6.28e-01 | -9.89e-02 | 9.11e-01 |
| GOBP RETINA VASCULATURE DEVELOPMENT IN CAMERA TYPE EYE | 16 | 4.94e-01 | 9.88e-02 | 8.62e-01 |
| GOBP POSITIVE REGULATION OF REGULATORY T CELL DIFFERENTIATION | 22 | 4.23e-01 | -9.87e-02 | 8.30e-01 |
| GOBP NEGATIVE REGULATION OF POTASSIUM ION TRANSPORT | 19 | 4.57e-01 | 9.87e-02 | 8.45e-01 |
| GOMF STRUCTURAL MOLECULE ACTIVITY CONFERRING ELASTICITY | 11 | 5.71e-01 | -9.86e-02 | 8.91e-01 |
| GOBP AMPA GLUTAMATE RECEPTOR CLUSTERING | 7 | 6.51e-01 | 9.86e-02 | 9.18e-01 |
| GOBP POSITIVE REGULATION OF PROTEIN KINASE A SIGNALING | 6 | 6.76e-01 | 9.85e-02 | 9.24e-01 |
| GOBP POSITIVE REGULATION OF CELL CYCLE PROCESS | 212 | 1.34e-02 | 9.85e-02 | 2.50e-01 |
| GOBP NUCLEOBASE BIOSYNTHETIC PROCESS | 17 | 4.82e-01 | 9.85e-02 | 8.59e-01 |
| GOCC MEIOTIC SPINDLE | 9 | 6.09e-01 | 9.84e-02 | 9.03e-01 |
| GOBP NEUROBLAST PROLIFERATION | 50 | 2.29e-01 | 9.84e-02 | 7.01e-01 |
| GOBP TRANSFORMING GROWTH FACTOR BETA1 PRODUCTION | 8 | 6.30e-01 | -9.84e-02 | 9.11e-01 |
| GOCC KATANIN COMPLEX | 5 | 7.03e-01 | -9.83e-02 | 9.31e-01 |
| GOBP RNA CATABOLIC PROCESS | 278 | 4.81e-03 | 9.83e-02 | 1.69e-01 |
| GOBP PROTEIN IMPORT INTO PEROXISOME MATRIX SUBSTRATE RELEASE | 5 | 7.04e-01 | -9.82e-02 | 9.31e-01 |
| GOBP POSITIVE REGULATION OF MEMBRANE DEPOLARIZATION | 7 | 6.53e-01 | -9.82e-02 | 9.18e-01 |
| GOBP ALCOHOL BIOSYNTHETIC PROCESS | 108 | 7.79e-02 | 9.82e-02 | 4.96e-01 |
| GOCC SPINDLE | 395 | 8.17e-04 | 9.81e-02 | 6.53e-02 |
| GOBP SPHINGOLIPID BIOSYNTHETIC PROCESS | 91 | 1.06e-01 | 9.80e-02 | 5.59e-01 |
| GOBP PENTOSE METABOLIC PROCESS | 10 | 5.92e-01 | 9.80e-02 | 8.97e-01 |
| GOMF LYSINE N METHYLTRANSFERASE ACTIVITY | 58 | 1.97e-01 | -9.80e-02 | 6.69e-01 |
| GOBP DEFENSE RESPONSE TO GRAM POSITIVE BACTERIUM | 74 | 1.45e-01 | -9.80e-02 | 6.12e-01 |
| GOBP POST TRANSLATIONAL PROTEIN MODIFICATION | 882 | 8.20e-07 | 9.79e-02 | 5.61e-04 |
| GOBP ANTIGEN PROCESSING AND PRESENTATION OF ENDOGENOUS ANTIGEN | 26 | 3.88e-01 | -9.78e-02 | 8.17e-01 |
| GOBP CRANIOFACIAL SUTURE MORPHOGENESIS | 11 | 5.74e-01 | 9.78e-02 | 8.92e-01 |
| GOMF TRANSCRIPTION ELONGATION FACTOR ACTIVITY | 7 | 6.54e-01 | 9.78e-02 | 9.18e-01 |
| GOBP AMINE TRANSPORT | 58 | 1.98e-01 | 9.77e-02 | 6.70e-01 |
| GOBP COPULATION | 14 | 5.27e-01 | 9.77e-02 | 8.76e-01 |
| GOBP ACTIN MEDIATED CELL CONTRACTION | 77 | 1.39e-01 | 9.76e-02 | 6.04e-01 |
| GOMF ALPHA GLUCOSIDASE ACTIVITY | 6 | 6.79e-01 | -9.76e-02 | 9.24e-01 |
| GOBP MUSCLE ATROPHY | 8 | 6.33e-01 | -9.75e-02 | 9.13e-01 |
| GOBP REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY IN RESPONSE TO OSMOTIC STRESS | 6 | 6.79e-01 | -9.75e-02 | 9.24e-01 |
| GOBP TOLL LIKE RECEPTOR 2 SIGNALING PATHWAY | 16 | 5.00e-01 | 9.74e-02 | 8.64e-01 |
| GOBP SCARNA LOCALIZATION TO CAJAL BODY | 5 | 7.06e-01 | 9.74e-02 | 9.32e-01 |
| GOBP REGULATION OF T CELL EXTRAVASATION | 6 | 6.80e-01 | 9.74e-02 | 9.24e-01 |
| GOBP SYNAPTIC ASSEMBLY AT NEUROMUSCULAR JUNCTION | 5 | 7.06e-01 | -9.73e-02 | 9.32e-01 |
| GOBP PROTEIN DEGLYCOSYLATION | 15 | 5.14e-01 | 9.73e-02 | 8.71e-01 |
| GOBP INTESTINAL ABSORPTION | 30 | 3.57e-01 | -9.73e-02 | 7.98e-01 |
| GOBP LABYRINTHINE LAYER DEVELOPMENT | 32 | 3.41e-01 | 9.73e-02 | 7.88e-01 |
| GOBP NEUROTROPHIN SIGNALING PATHWAY | 28 | 3.73e-01 | 9.72e-02 | 8.09e-01 |
| GOBP CELLULAR SENESCENCE | 90 | 1.11e-01 | 9.72e-02 | 5.64e-01 |
| GOBP POSTSYNAPTIC SPECIALIZATION ORGANIZATION | 34 | 3.27e-01 | -9.72e-02 | 7.77e-01 |
| GOBP NEGATIVE REGULATION OF GLIAL CELL MIGRATION | 6 | 6.80e-01 | 9.72e-02 | 9.24e-01 |
| GOBP BONE MARROW DEVELOPMENT | 8 | 6.34e-01 | -9.72e-02 | 9.14e-01 |
| GOBP EOSINOPHIL MEDIATED IMMUNITY | 9 | 6.14e-01 | 9.72e-02 | 9.04e-01 |
| GOMF EXTRACELLULAR LIGAND GATED MONOATOMIC ION CHANNEL ACTIVITY | 30 | 3.57e-01 | -9.71e-02 | 7.98e-01 |
| GOCC MALE PRONUCLEUS | 7 | 6.56e-01 | 9.71e-02 | 9.18e-01 |
| GOBP REGULATION OF EPITHELIAL TO MESENCHYMAL TRANSITION INVOLVED IN ENDOCARDIAL CUSHION FORMATION | 6 | 6.80e-01 | 9.71e-02 | 9.24e-01 |
| GOBP CIRCADIAN SLEEP WAKE CYCLE SLEEP | 11 | 5.77e-01 | 9.70e-02 | 8.92e-01 |
| GOBP SKELETAL MUSCLE CONTRACTION | 33 | 3.35e-01 | -9.70e-02 | 7.84e-01 |
| GOBP ANDROGEN RECEPTOR SIGNALING PATHWAY | 41 | 2.83e-01 | 9.70e-02 | 7.43e-01 |
| GOBP REGULATION OF MEMBRANE LIPID METABOLIC PROCESS | 14 | 5.30e-01 | -9.69e-02 | 8.78e-01 |
| GOBP ORGAN GROWTH | 118 | 6.91e-02 | 9.69e-02 | 4.77e-01 |
| GOBP RADIAL GLIAL CELL DIFFERENTIATION | 8 | 6.35e-01 | 9.69e-02 | 9.14e-01 |
| GOMF G RICH STRAND TELOMERIC DNA BINDING | 10 | 5.96e-01 | 9.69e-02 | 9.01e-01 |
| GOBP RESPONSE TO GAMMA RADIATION | 46 | 2.56e-01 | 9.69e-02 | 7.25e-01 |
| GOBP PURINE NUCLEOSIDE BIOSYNTHETIC PROCESS | 11 | 5.78e-01 | 9.68e-02 | 8.92e-01 |
| GOCC SPERM HEAD | 7 | 6.57e-01 | -9.68e-02 | 9.19e-01 |
| GOBP REGULATION OF B CELL MEDIATED IMMUNITY | 59 | 1.98e-01 | 9.68e-02 | 6.70e-01 |
| GOBP RETROGRADE VESICLE MEDIATED TRANSPORT GOLGI TO ENDOPLASMIC RETICULUM | 50 | 2.36e-01 | 9.68e-02 | 7.07e-01 |
| GOMF ALPHA TUBULIN BINDING | 38 | 3.02e-01 | 9.68e-02 | 7.57e-01 |
| GOBP DORSAL VENTRAL NEURAL TUBE PATTERNING | 10 | 5.96e-01 | 9.68e-02 | 9.01e-01 |
| GOBP REGULATION OF NUCLEAR TRANSCRIBED MRNA CATABOLIC PROCESS NONSENSE MEDIATED DECAY | 12 | 5.62e-01 | -9.67e-02 | 8.89e-01 |
| GOBP APOPTOTIC PROCESS INVOLVED IN DEVELOPMENT | 23 | 4.22e-01 | -9.67e-02 | 8.30e-01 |
| GOBP REGULATION OF CD40 SIGNALING PATHWAY | 5 | 7.08e-01 | -9.67e-02 | 9.33e-01 |
| GOBP MEMBRANE LIPID CATABOLIC PROCESS | 42 | 2.78e-01 | 9.67e-02 | 7.40e-01 |
| GOBP REGULATION OF FATTY ACID METABOLIC PROCESS | 68 | 1.68e-01 | -9.66e-02 | 6.33e-01 |
| GOBP PROTEIN LOCALIZATION TO ORGANELLE | 872 | 1.29e-06 | 9.66e-02 | 7.51e-04 |
| GOBP PROTEOLYSIS INVOLVED IN PROTEIN CATABOLIC PROCESS | 704 | 1.27e-05 | 9.66e-02 | 3.92e-03 |
| GOBP DICARBOXYLIC ACID BIOSYNTHETIC PROCESS | 11 | 5.79e-01 | 9.66e-02 | 8.92e-01 |
| GOBP POST TRANSCRIPTIONAL REGULATION OF GENE EXPRESSION | 497 | 2.28e-04 | 9.66e-02 | 2.70e-02 |
| GOBP DORSAL VENTRAL AXIS SPECIFICATION | 10 | 5.97e-01 | 9.65e-02 | 9.02e-01 |
| GOBP MAINTENANCE OF PROTEIN LOCATION IN CELL | 59 | 2.00e-01 | 9.65e-02 | 6.71e-01 |
| GOMF GDP DISSOCIATION INHIBITOR ACTIVITY | 15 | 5.17e-01 | -9.65e-02 | 8.73e-01 |
| GOMF FOUR WAY JUNCTION HELICASE ACTIVITY | 6 | 6.82e-01 | 9.65e-02 | 9.24e-01 |
| GOBP POSITIVE REGULATION OF PROTEIN BINDING | 48 | 2.48e-01 | 9.65e-02 | 7.17e-01 |
| GOBP POSITIVE REGULATION OF MAMMARY GLAND EPITHELIAL CELL PROLIFERATION | 6 | 6.82e-01 | -9.65e-02 | 9.24e-01 |
| GOBP FOREBRAIN RADIAL GLIAL CELL DIFFERENTIATION | 5 | 7.09e-01 | 9.64e-02 | 9.33e-01 |
| GOBP REGULATION OF HUMORAL IMMUNE RESPONSE | 31 | 3.53e-01 | 9.64e-02 | 7.94e-01 |
| GOMF SIGNALING RECEPTOR INHIBITOR ACTIVITY | 14 | 5.33e-01 | 9.63e-02 | 8.79e-01 |
| GOBP VESICLE TRANSPORT ALONG MICROTUBULE | 44 | 2.69e-01 | 9.63e-02 | 7.34e-01 |
| GOBP RNA POLYMERASE II PREINITIATION COMPLEX ASSEMBLY | 53 | 2.25e-01 | 9.63e-02 | 6.98e-01 |
| GOMF ATPASE COUPLED LIPID TRANSMEMBRANE TRANSPORTER ACTIVITY | 6 | 6.83e-01 | -9.62e-02 | 9.24e-01 |
| GOBP PROTEIN O LINKED MANNOSYLATION | 19 | 4.68e-01 | -9.62e-02 | 8.53e-01 |
| GOBP ESTABLISHMENT OR MAINTENANCE OF MONOPOLAR CELL POLARITY | 21 | 4.45e-01 | -9.62e-02 | 8.41e-01 |
| GOBP MITOTIC CELL CYCLE PROCESS | 689 | 1.69e-05 | 9.62e-02 | 4.51e-03 |
| GOBP THIOESTER BIOSYNTHETIC PROCESS | 44 | 2.70e-01 | 9.62e-02 | 7.35e-01 |
| GOBP ENDOCRINE PANCREAS DEVELOPMENT | 24 | 4.15e-01 | -9.62e-02 | 8.29e-01 |
| GOBP REGULATION OF KETONE BIOSYNTHETIC PROCESS | 17 | 4.92e-01 | -9.62e-02 | 8.62e-01 |
| GOMF ORGANIC ACID TRANSMEMBRANE TRANSPORTER ACTIVITY | 121 | 6.77e-02 | -9.62e-02 | 4.73e-01 |
| GOMF GLYCEROPHOSPHOLIPID FLIPPASE ACTIVITY | 11 | 5.81e-01 | 9.61e-02 | 8.93e-01 |
| GOBP HOMOCYSTEINE METABOLIC PROCESS | 9 | 6.18e-01 | -9.61e-02 | 9.06e-01 |
| GOBP PHOTORECEPTOR CELL DIFFERENTIATION | 41 | 2.87e-01 | -9.61e-02 | 7.47e-01 |
| GOCC MITOTIC SPINDLE MICROTUBULE | 14 | 5.34e-01 | 9.61e-02 | 8.79e-01 |
| GOBP REGULATION OF ORGANELLE ASSEMBLY | 226 | 1.28e-02 | 9.61e-02 | 2.49e-01 |
| GOBP ENDOSOME ORGANIZATION | 95 | 1.06e-01 | 9.60e-02 | 5.59e-01 |
| GOMF HISTONE H3 ACETYLTRANSFERASE ACTIVITY | 15 | 5.20e-01 | -9.60e-02 | 8.74e-01 |
| GOMF LIGASE ACTIVITY FORMING CARBON SULFUR BONDS | 37 | 3.12e-01 | 9.60e-02 | 7.65e-01 |
| GOBP NERVOUS SYSTEM PROCESS INVOLVED IN REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE | 5 | 7.10e-01 | 9.59e-02 | 9.34e-01 |
| GOBP BRANCHED CHAIN AMINO ACID CATABOLIC PROCESS | 21 | 4.47e-01 | 9.59e-02 | 8.42e-01 |
| GOBP REGULATION OF CELLULAR RESPONSE TO HEAT | 16 | 5.07e-01 | 9.59e-02 | 8.68e-01 |
| GOBP REGULATION OF CELLULAR AMINO ACID METABOLIC PROCESS | 8 | 6.39e-01 | 9.59e-02 | 9.15e-01 |
| GOBP NEGATIVE REGULATION OF SINGLE STRANDED VIRAL RNA REPLICATION VIA DOUBLE STRANDED DNA INTERMEDIATE | 15 | 5.20e-01 | 9.59e-02 | 8.74e-01 |
| GOBP TYPE II INTERFERON MEDIATED SIGNALING PATHWAY | 25 | 4.07e-01 | 9.58e-02 | 8.26e-01 |
| GOBP INTERLEUKIN 12 PRODUCTION | 56 | 2.15e-01 | 9.58e-02 | 6.91e-01 |
| GOBP PYRIMIDINE NUCLEOSIDE TRIPHOSPHATE BIOSYNTHETIC PROCESS | 17 | 4.95e-01 | -9.57e-02 | 8.62e-01 |
| GOMF NEUROTRANSMITTER RECEPTOR ACTIVITY | 34 | 3.34e-01 | -9.57e-02 | 7.84e-01 |
| GOCC CUL3 RING UBIQUITIN LIGASE COMPLEX | 36 | 3.21e-01 | 9.56e-02 | 7.73e-01 |
| GOCC PRERIBOSOME SMALL SUBUNIT PRECURSOR | 14 | 5.36e-01 | -9.55e-02 | 8.79e-01 |
| GOBP PROSTATE GLANDULAR ACINUS DEVELOPMENT | 5 | 7.12e-01 | 9.55e-02 | 9.35e-01 |
| GOBP AXONEME ASSEMBLY | 66 | 1.80e-01 | -9.55e-02 | 6.53e-01 |
| GOCC CLATHRIN SCULPTED VESICLE | 8 | 6.40e-01 | 9.54e-02 | 9.15e-01 |
| GOBP MICROGLIA DIFFERENTIATION | 11 | 5.84e-01 | 9.54e-02 | 8.93e-01 |
| GOBP REGULATION OF PROTON TRANSPORT | 15 | 5.23e-01 | -9.54e-02 | 8.75e-01 |
| GOBP PROTEIN LOCALIZATION TO CYTOSKELETON | 58 | 2.09e-01 | 9.53e-02 | 6.83e-01 |
| GOBP REGULATION OF PHOSPHOLIPID BIOSYNTHETIC PROCESS | 10 | 6.02e-01 | -9.53e-02 | 9.03e-01 |
| GOBP REGULATION OF CYTOKINESIS | 78 | 1.46e-01 | 9.53e-02 | 6.13e-01 |
| GOBP REGULATION OF AMYLOID BETA CLEARANCE | 13 | 5.52e-01 | 9.52e-02 | 8.86e-01 |
| GOMF HSP70 PROTEIN BINDING | 45 | 2.69e-01 | 9.52e-02 | 7.34e-01 |
| GOBP 2 OXOGLUTARATE METABOLIC PROCESS | 14 | 5.38e-01 | -9.52e-02 | 8.79e-01 |
| GOBP NON MOTILE CILIUM ASSEMBLY | 59 | 2.06e-01 | 9.51e-02 | 6.81e-01 |
| GOBP HYDROGEN PEROXIDE CATABOLIC PROCESS | 26 | 4.01e-01 | 9.51e-02 | 8.23e-01 |
| GOMF PHOSPHATIDYLGLYCEROL BINDING | 12 | 5.68e-01 | 9.51e-02 | 8.90e-01 |
| GOBP PERICENTRIC HETEROCHROMATIN FORMATION | 5 | 7.13e-01 | -9.51e-02 | 9.35e-01 |
| GOMF KINASE REGULATOR ACTIVITY | 245 | 1.04e-02 | 9.50e-02 | 2.29e-01 |
| GOMF INSULIN LIKE GROWTH FACTOR BINDING | 14 | 5.38e-01 | -9.50e-02 | 8.79e-01 |
| GOMF BETA CATENIN BINDING | 75 | 1.55e-01 | -9.50e-02 | 6.17e-01 |
| GOBP NEUROMUSCULAR SYNAPTIC TRANSMISSION | 20 | 4.62e-01 | -9.50e-02 | 8.48e-01 |
| GOMF DIPEPTIDYL PEPTIDASE ACTIVITY | 9 | 6.22e-01 | 9.50e-02 | 9.09e-01 |
| GOCC INTERCELLULAR CANALICULUS | 5 | 7.13e-01 | 9.49e-02 | 9.35e-01 |
| GOBP DIOL METABOLIC PROCESS | 30 | 3.68e-01 | 9.49e-02 | 8.05e-01 |
| GOBP PYRIDINE CONTAINING COMPOUND CATABOLIC PROCESS | 86 | 1.28e-01 | -9.49e-02 | 5.93e-01 |
| GOBP CELL MATRIX ADHESION | 189 | 2.45e-02 | -9.49e-02 | 3.39e-01 |
| GOBP NON MEMBRANE BOUNDED ORGANELLE ASSEMBLY | 368 | 1.78e-03 | 9.49e-02 | 1.02e-01 |
| GOBP REGULATION OF SPONTANEOUS SYNAPTIC TRANSMISSION | 6 | 6.88e-01 | -9.48e-02 | 9.27e-01 |
| GOMF CARBOHYDRATE KINASE ACTIVITY | 21 | 4.52e-01 | -9.48e-02 | 8.43e-01 |
| GOBP REGULATION OF CARBOHYDRATE BIOSYNTHETIC PROCESS | 80 | 1.43e-01 | -9.48e-02 | 6.10e-01 |
| GOMF ATPASE COUPLED INORGANIC ANION TRANSMEMBRANE TRANSPORTER ACTIVITY | 9 | 6.22e-01 | -9.48e-02 | 9.09e-01 |
| GOBP NEGATIVE REGULATION OF HEMATOPOIETIC PROGENITOR CELL DIFFERENTIATION | 11 | 5.86e-01 | 9.48e-02 | 8.95e-01 |
| GOBP REGULATION OF PEPTIDYL CYSTEINE S NITROSYLATION | 9 | 6.23e-01 | 9.48e-02 | 9.09e-01 |
| GOBP NEGATIVE REGULATION OF ENDOTHELIAL CELL APOPTOTIC PROCESS | 23 | 4.32e-01 | -9.47e-02 | 8.35e-01 |
| GOBP REGULATION OF PH | 83 | 1.36e-01 | 9.47e-02 | 6.02e-01 |
| GOBP POSITIVE REGULATION OF NEURON PROJECTION REGENERATION | 9 | 6.23e-01 | -9.47e-02 | 9.09e-01 |
| GOBP MEMBRANE FUSION | 145 | 4.90e-02 | 9.47e-02 | 4.25e-01 |
| GOMF TRNA PSEUDOURIDINE SYNTHASE ACTIVITY | 8 | 6.43e-01 | 9.47e-02 | 9.15e-01 |
| GOBP MEIOTIC SPINDLE ORGANIZATION | 17 | 4.99e-01 | 9.47e-02 | 8.64e-01 |
| GOMF SULFUR COMPOUND TRANSMEMBRANE TRANSPORTER ACTIVITY | 47 | 2.62e-01 | -9.46e-02 | 7.29e-01 |
| GOBP L SERINE METABOLIC PROCESS | 11 | 5.87e-01 | -9.46e-02 | 8.95e-01 |
| GOBP NEGATIVE REGULATION OF CD4 POSITIVE ALPHA BETA T CELL DIFFERENTIATION | 20 | 4.64e-01 | -9.46e-02 | 8.50e-01 |
| GOMF AMMONIA LYASE ACTIVITY | 5 | 7.14e-01 | -9.46e-02 | 9.35e-01 |
| GOBP CELL CYCLE PROCESS | 1102 | 1.21e-07 | 9.45e-02 | 2.80e-04 |
| GOBP REGULATION OF RNA SPLICING | 167 | 3.51e-02 | 9.45e-02 | 3.88e-01 |
| GOBP VIRAL BUDDING | 24 | 4.23e-01 | 9.44e-02 | 8.30e-01 |
| GOBP REGULATION OF ERAD PATHWAY | 23 | 4.33e-01 | 9.44e-02 | 8.36e-01 |
| GOBP NEGATIVE REGULATION OF RESPONSE TO BIOTIC STIMULUS | 109 | 8.86e-02 | 9.44e-02 | 5.21e-01 |
| GOBP PLASMA CELL DIFFERENTIATION | 8 | 6.44e-01 | 9.44e-02 | 9.15e-01 |
| GOBP NEGATIVE REGULATION OF PROTEOLYSIS INVOLVED IN PROTEIN CATABOLIC PROCESS | 65 | 1.88e-01 | 9.43e-02 | 6.62e-01 |
| GOBP POSITIVE REGULATION OF SUBSTRATE ADHESION DEPENDENT CELL SPREADING | 35 | 3.34e-01 | -9.43e-02 | 7.84e-01 |
| GOBP POSITIVE REGULATION OF T HELPER 2 CELL DIFFERENTIATION | 7 | 6.66e-01 | 9.43e-02 | 9.22e-01 |
| GOBP REGULATION OF RESPONSE TO TYPE II INTERFERON | 13 | 5.56e-01 | -9.43e-02 | 8.87e-01 |
| GOBP IMMUNE SYSTEM DEVELOPMENT | 172 | 3.30e-02 | 9.42e-02 | 3.79e-01 |
| GOBP ACUTE INFLAMMATORY RESPONSE | 79 | 1.48e-01 | 9.42e-02 | 6.13e-01 |
| GOBP REGULATION OF LIGASE ACTIVITY | 9 | 6.25e-01 | 9.42e-02 | 9.09e-01 |
| GOBP FIBROBLAST ACTIVATION | 12 | 5.72e-01 | 9.42e-02 | 8.92e-01 |
| GOBP RNA SPLICING | 423 | 8.95e-04 | 9.42e-02 | 6.76e-02 |
| GOMF RNA POLYMERASE I GENERAL TRANSCRIPTION INITIATION FACTOR ACTIVITY | 6 | 6.90e-01 | -9.42e-02 | 9.27e-01 |
| GOBP PYRIMIDINE DEOXYRIBONUCLEOTIDE METABOLIC PROCESS | 21 | 4.55e-01 | -9.41e-02 | 8.44e-01 |
| GOMF SODIUM CHANNEL INHIBITOR ACTIVITY | 8 | 6.45e-01 | 9.41e-02 | 9.15e-01 |
| GOBP NEGATIVE REGULATION OF CALCIUM MEDIATED SIGNALING | 19 | 4.78e-01 | -9.41e-02 | 8.57e-01 |
| GOBP CHAPERONE MEDIATED PROTEIN FOLDING | 72 | 1.67e-01 | 9.41e-02 | 6.33e-01 |
| GOBP TRNA SURVEILLANCE | 8 | 6.45e-01 | 9.41e-02 | 9.15e-01 |
| GOBP REGULATION OF POSTSYNAPSE ORGANIZATION | 82 | 1.41e-01 | 9.40e-02 | 6.08e-01 |
| GOCC CILIARY TRANSITION FIBER | 7 | 6.67e-01 | 9.39e-02 | 9.22e-01 |
| GOMF SULFURTRANSFERASE ACTIVITY | 11 | 5.90e-01 | -9.39e-02 | 8.96e-01 |
| GOBP GMP METABOLIC PROCESS | 26 | 4.07e-01 | 9.39e-02 | 8.26e-01 |
| GOBP REGULATION OF LYMPHOCYTE MIGRATION | 60 | 2.08e-01 | 9.39e-02 | 6.82e-01 |
| GOMF TRANSMEMBRANE TRANSPORTER BINDING | 111 | 8.76e-02 | 9.39e-02 | 5.18e-01 |
| GOBP OTOLITH DEVELOPMENT | 5 | 7.16e-01 | -9.38e-02 | 9.36e-01 |
| GOBP FAT SOLUBLE VITAMIN METABOLIC PROCESS | 26 | 4.08e-01 | -9.38e-02 | 8.26e-01 |
| GOBP NEGATIVE REGULATION OF SCHWANN CELL PROLIFERATION | 7 | 6.68e-01 | 9.38e-02 | 9.22e-01 |
| GOBP PEPTIDYL PROLINE MODIFICATION | 27 | 3.99e-01 | 9.38e-02 | 8.22e-01 |
| GOBP CELLULAR RESPONSE TO INCREASED OXYGEN LEVELS | 10 | 6.08e-01 | 9.37e-02 | 9.03e-01 |
| GOBP CALCIUM ION REGULATED EXOCYTOSIS | 43 | 2.88e-01 | -9.37e-02 | 7.47e-01 |
| GOMF EXONUCLEASE ACTIVITY ACTIVE WITH EITHER RIBO OR DEOXYRIBONUCLEIC ACIDS AND PRODUCING 5 PHOSPHOMONOESTERS | 61 | 2.06e-01 | 9.37e-02 | 6.81e-01 |
| GOCC SODIUM POTASSIUM EXCHANGING ATPASE COMPLEX | 8 | 6.47e-01 | -9.36e-02 | 9.16e-01 |
| GOBP NEGATIVE REGULATION OF LEUKOCYTE APOPTOTIC PROCESS | 48 | 2.62e-01 | 9.35e-02 | 7.29e-01 |
| GOBP PROTEIN DEPHOSPHORYLATION | 180 | 3.05e-02 | 9.35e-02 | 3.66e-01 |
| GOCC GOLGI CISTERNA | 98 | 1.10e-01 | 9.35e-02 | 5.63e-01 |
| GOBP POSITIVE REGULATION OF CIRCADIAN RHYTHM | 10 | 6.09e-01 | 9.35e-02 | 9.03e-01 |
| GOMF ARGININE BINDING | 7 | 6.69e-01 | -9.34e-02 | 9.22e-01 |
| GOBP NEGATIVE REGULATION OF TRANSFORMING GROWTH FACTOR BETA PRODUCTION | 8 | 6.47e-01 | -9.34e-02 | 9.16e-01 |
| GOBP REGULATION OF LOCOMOTION INVOLVED IN LOCOMOTORY BEHAVIOR | 5 | 7.18e-01 | 9.34e-02 | 9.36e-01 |
| GOBP REGULATION OF DEFENSE RESPONSE | 679 | 3.38e-05 | 9.34e-02 | 6.28e-03 |
| GOBP POSITIVE REGULATION OF CARDIAC MUSCLE CELL PROLIFERATION | 17 | 5.05e-01 | 9.34e-02 | 8.66e-01 |
| GOBP CALCIUM DEPENDENT CELL CELL ADHESION VIA PLASMA MEMBRANE CELL ADHESION MOLECULES | 24 | 4.29e-01 | 9.33e-02 | 8.34e-01 |
| GOBP PROTEIN LOCALIZATION TO NUCLEUS | 280 | 7.20e-03 | 9.33e-02 | 1.95e-01 |
| GOMF RNA POLYMERASE III GENERAL TRANSCRIPTION INITIATION FACTOR ACTIVITY | 12 | 5.76e-01 | -9.33e-02 | 8.92e-01 |
| GOBP CORNEA DEVELOPMENT IN CAMERA TYPE EYE | 6 | 6.92e-01 | 9.33e-02 | 9.27e-01 |
| GOMF STEROL BINDING | 58 | 2.19e-01 | 9.33e-02 | 6.94e-01 |
| GOBP N TERMINAL PROTEIN AMINO ACID MODIFICATION | 24 | 4.29e-01 | 9.33e-02 | 8.34e-01 |
| GOMF CD4 RECEPTOR BINDING | 7 | 6.69e-01 | 9.32e-02 | 9.22e-01 |
| GOBP POSITIVE REGULATION OF JNK CASCADE | 82 | 1.45e-01 | -9.32e-02 | 6.12e-01 |
| GOBP CEREBRAL CORTEX CELL MIGRATION | 36 | 3.33e-01 | 9.31e-02 | 7.84e-01 |
| GOMF CYTIDINE DEAMINASE ACTIVITY | 11 | 5.93e-01 | 9.31e-02 | 8.99e-01 |
| GOBP REGULATION OF GAP JUNCTION ASSEMBLY | 6 | 6.93e-01 | 9.31e-02 | 9.27e-01 |
| GOBP TRNA 3 END PROCESSING | 7 | 6.70e-01 | 9.31e-02 | 9.22e-01 |
| GOBP NEGATIVE REGULATION OF T CELL APOPTOTIC PROCESS | 22 | 4.50e-01 | 9.30e-02 | 8.43e-01 |
| GOMF GUANYL RIBONUCLEOTIDE BINDING | 338 | 3.33e-03 | 9.29e-02 | 1.36e-01 |
| GOBP DETECTION OF VISIBLE LIGHT | 31 | 3.71e-01 | -9.29e-02 | 8.07e-01 |
| GOBP NUCLEUS LOCALIZATION | 29 | 3.86e-01 | -9.29e-02 | 8.16e-01 |
| GOBP REGULATION OF MUSCLE CELL DIFFERENTIATION | 109 | 9.40e-02 | -9.29e-02 | 5.34e-01 |
| GOBP MITOTIC NUCLEAR MEMBRANE DISASSEMBLY | 8 | 6.49e-01 | 9.28e-02 | 9.17e-01 |
| GOBP CILIUM DISASSEMBLY | 6 | 6.94e-01 | -9.28e-02 | 9.27e-01 |
| GOBP AUTOPHAGOSOME ORGANIZATION | 118 | 8.16e-02 | 9.28e-02 | 5.02e-01 |
| GOBP REGULATION OF METAPHASE PLATE CONGRESSION | 14 | 5.48e-01 | 9.28e-02 | 8.84e-01 |
| GOBP ION CHANNEL MODULATING G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY | 8 | 6.49e-01 | -9.28e-02 | 9.17e-01 |
| GOCC SCHMIDT LANTERMAN INCISURE | 9 | 6.30e-01 | -9.28e-02 | 9.11e-01 |
| GOCC AXONAL GROWTH CONE | 22 | 4.52e-01 | -9.27e-02 | 8.43e-01 |
| GOBP POSITIVE REGULATION OF EXOSOMAL SECRETION | 14 | 5.48e-01 | 9.27e-02 | 8.84e-01 |
| GOBP DNA DAMAGE RESPONSE SIGNAL TRANSDUCTION RESULTING IN TRANSCRIPTION | 16 | 5.21e-01 | -9.27e-02 | 8.74e-01 |
| GOMF ACYL COA OXIDASE ACTIVITY | 7 | 6.71e-01 | 9.26e-02 | 9.22e-01 |
| GOMF RNA 2 O METHYLTRANSFERASE ACTIVITY | 9 | 6.31e-01 | -9.26e-02 | 9.12e-01 |
| GOCC BASAL CORTEX | 5 | 7.20e-01 | -9.25e-02 | 9.37e-01 |
| GOBP CALCIUM ION IMPORT | 57 | 2.27e-01 | -9.25e-02 | 7.00e-01 |
| GOBP REGULATION OF AXONOGENESIS | 113 | 8.95e-02 | -9.25e-02 | 5.24e-01 |
| GOBP DETECTION OF TEMPERATURE STIMULUS INVOLVED IN SENSORY PERCEPTION OF PAIN | 13 | 5.64e-01 | 9.25e-02 | 8.90e-01 |
| GOBP DISACCHARIDE METABOLIC PROCESS | 6 | 6.95e-01 | -9.24e-02 | 9.27e-01 |
| GOBP REGULATION OF GLIAL CELL DIFFERENTIATION | 50 | 2.58e-01 | -9.24e-02 | 7.27e-01 |
| GOBP MAGNESIUM ION TRANSPORT | 17 | 5.09e-01 | 9.24e-02 | 8.69e-01 |
| GOBP ESTROUS CYCLE | 12 | 5.79e-01 | -9.24e-02 | 8.92e-01 |
| GOBP DENDRITIC SPINE MAINTENANCE | 17 | 5.10e-01 | 9.23e-02 | 8.69e-01 |
| GOBP REGULATION OF MICROTUBULE POLYMERIZATION | 56 | 2.32e-01 | -9.23e-02 | 7.04e-01 |
| GOBP POSITIVE REGULATION OF PROTEIN AUTOPHOSPHORYLATION | 22 | 4.54e-01 | 9.23e-02 | 8.43e-01 |
| GOBP AMINO ACID NEUROTRANSMITTER REUPTAKE | 5 | 7.21e-01 | -9.23e-02 | 9.37e-01 |
| GOMF CAMP RESPONSE ELEMENT BINDING | 10 | 6.13e-01 | 9.23e-02 | 9.04e-01 |
| GOBP REGULATION OF CHONDROCYTE DIFFERENTIATION | 29 | 3.90e-01 | -9.23e-02 | 8.18e-01 |
| GOBP PROTEIN MODIFICATION BY SMALL PROTEIN CONJUGATION | 749 | 1.75e-05 | 9.22e-02 | 4.51e-03 |
| GOBP XMP METABOLIC PROCESS | 7 | 6.73e-01 | -9.22e-02 | 9.23e-01 |
| GOBP NUCLEOBASE CONTAINING SMALL MOLECULE CATABOLIC PROCESS | 28 | 3.98e-01 | 9.22e-02 | 8.22e-01 |
| GOMF PYRUVATE DEHYDROGENASE ACETYL TRANSFERRING KINASE ACTIVITY | 5 | 7.21e-01 | 9.21e-02 | 9.37e-01 |
| GOBP MONOCYTE CHEMOTAXIS | 34 | 3.52e-01 | 9.21e-02 | 7.94e-01 |
| GOBP REGULATION OF NATURAL KILLER CELL ACTIVATION | 36 | 3.39e-01 | 9.21e-02 | 7.87e-01 |
| GOMF MRNA BINDING | 306 | 5.63e-03 | 9.20e-02 | 1.79e-01 |
| GOBP REGULATION OF MEIOTIC NUCLEAR DIVISION | 18 | 4.99e-01 | 9.19e-02 | 8.64e-01 |
| GOBP REGULATION OF LYMPHOCYTE MEDIATED IMMUNITY | 172 | 3.78e-02 | 9.18e-02 | 3.94e-01 |
| GOBP REGULATION OF NEUROINFLAMMATORY RESPONSE | 27 | 4.09e-01 | 9.18e-02 | 8.26e-01 |
| GOBP POSITIVE REGULATION OF SMALL MOLECULE METABOLIC PROCESS | 105 | 1.04e-01 | -9.18e-02 | 5.56e-01 |
| GOBP NEURON RECOGNITION | 28 | 4.01e-01 | 9.17e-02 | 8.23e-01 |
| GOBP GAMMA DELTA T CELL DIFFERENTIATION | 13 | 5.67e-01 | 9.17e-02 | 8.90e-01 |
| GOBP REGULATION OF GLOMERULAR FILTRATION | 8 | 6.54e-01 | 9.16e-02 | 9.18e-01 |
| GOBP REGULATION OF MRNA SPLICING VIA SPLICEOSOME | 96 | 1.21e-01 | 9.16e-02 | 5.84e-01 |
| GOBP HETEROCHROMATIN ORGANIZATION | 11 | 5.99e-01 | 9.16e-02 | 9.02e-01 |
| GOMF RNA METHYLTRANSFERASE ACTIVITY | 63 | 2.09e-01 | 9.15e-02 | 6.82e-01 |
| GOCC FILOPODIUM MEMBRANE | 13 | 5.68e-01 | -9.15e-02 | 8.90e-01 |
| GOBP RESPONSE TO TESTOSTERONE | 32 | 3.71e-01 | 9.15e-02 | 8.07e-01 |
| GOBP POSITIVE REGULATION OF JUN KINASE ACTIVITY | 25 | 4.29e-01 | -9.15e-02 | 8.34e-01 |
| GOBP CELL CYCLE G2 M PHASE TRANSITION | 143 | 5.90e-02 | 9.15e-02 | 4.53e-01 |
| GOMF SPECTRIN BINDING | 24 | 4.38e-01 | -9.14e-02 | 8.39e-01 |
| GOBP CELL ADHESION MOLECULE PRODUCTION | 8 | 6.54e-01 | 9.14e-02 | 9.18e-01 |
| GOBP PYRIMIDINE NUCLEOSIDE METABOLIC PROCESS | 23 | 4.48e-01 | 9.14e-02 | 8.43e-01 |
| GOBP POSTSYNAPTIC SPECIALIZATION ASSEMBLY | 21 | 4.69e-01 | -9.13e-02 | 8.53e-01 |
| GOCC MEMBRANE COAT | 92 | 1.30e-01 | 9.13e-02 | 5.94e-01 |
| GOMF ADENOSINE RECEPTOR BINDING | 7 | 6.76e-01 | 9.13e-02 | 9.24e-01 |
| GOBP REGULATION OF ATP DEPENDENT ACTIVITY | 55 | 2.41e-01 | 9.13e-02 | 7.11e-01 |
| GOBP MITOTIC DNA REPLICATION | 17 | 5.15e-01 | 9.13e-02 | 8.71e-01 |
| GOBP GLUCOCORTICOID SECRETION | 9 | 6.35e-01 | -9.13e-02 | 9.14e-01 |
| GOBP SEQUESTERING OF ACTIN MONOMERS | 9 | 6.36e-01 | -9.12e-02 | 9.14e-01 |
| GOBP REGULATION OF ORGANIC ACID TRANSPORT | 55 | 2.42e-01 | 9.12e-02 | 7.12e-01 |
| GOBP PLASMA MEMBRANE REPAIR | 26 | 4.21e-01 | 9.12e-02 | 8.30e-01 |
| GOBP SYNAPTIC VESICLE MATURATION | 22 | 4.59e-01 | 9.11e-02 | 8.47e-01 |
| GOBP NEGATIVE REGULATION OF PEPTIDASE ACTIVITY | 83 | 1.51e-01 | 9.11e-02 | 6.13e-01 |
| GOBP HOMOPHILIC CELL ADHESION VIA PLASMA MEMBRANE ADHESION MOLECULES | 83 | 1.51e-01 | -9.11e-02 | 6.13e-01 |
| GOBP INOSITOL METABOLIC PROCESS | 8 | 6.56e-01 | -9.11e-02 | 9.18e-01 |
| GOBP EYE PHOTORECEPTOR CELL DIFFERENTIATION | 30 | 3.88e-01 | -9.10e-02 | 8.17e-01 |
| GOCC VESICLE COAT | 59 | 2.27e-01 | 9.09e-02 | 7.00e-01 |
| GOBP GRANZYME MEDIATED PROGRAMMED CELL DEATH SIGNALING PATHWAY | 8 | 6.56e-01 | 9.09e-02 | 9.18e-01 |
| GOCC BLOC COMPLEX | 19 | 4.93e-01 | 9.09e-02 | 8.62e-01 |
| GOBP POSITIVE REGULATION OF CANONICAL NF KAPPAB SIGNAL TRANSDUCTION | 192 | 2.99e-02 | 9.09e-02 | 3.64e-01 |
| GOBP NEGATIVE REGULATION OF TISSUE REMODELING | 14 | 5.56e-01 | -9.08e-02 | 8.87e-01 |
| GOBP POSITIVE REGULATION OF ACTIVATED T CELL PROLIFERATION | 19 | 4.93e-01 | -9.08e-02 | 8.62e-01 |
| GOBP CELL CELL SIGNALING INVOLVED IN CARDIAC CONDUCTION | 18 | 5.05e-01 | -9.08e-02 | 8.66e-01 |
| GOBP VASCULAR ASSOCIATED SMOOTH MUSCLE CELL DEVELOPMENT | 8 | 6.57e-01 | -9.08e-02 | 9.18e-01 |
| GOCC PROTEIN COMPLEX INVOLVED IN CELL ADHESION | 50 | 2.67e-01 | -9.07e-02 | 7.33e-01 |
| GOBP MEIOSIS I CELL CYCLE PROCESS | 98 | 1.21e-01 | 9.07e-02 | 5.84e-01 |
| GOBP POSITIVE REGULATION OF TELOMERE CAPPING | 15 | 5.43e-01 | -9.07e-02 | 8.82e-01 |
| GOBP SYNAPTIC VESICLE COATING | 5 | 7.25e-01 | -9.07e-02 | 9.38e-01 |
| GOMF INORGANIC ANION TRANSMEMBRANE TRANSPORTER ACTIVITY | 101 | 1.15e-01 | -9.07e-02 | 5.73e-01 |
| GOBP REGULATION OF TRANSCRIPTION BY RNA POLYMERASE III | 30 | 3.90e-01 | 9.07e-02 | 8.18e-01 |
| GOBP POSITIVE REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY IN ABSENCE OF LIGAND | 9 | 6.38e-01 | -9.07e-02 | 9.15e-01 |
| GOBP POSITIVE REGULATION OF COA TRANSFERASE ACTIVITY | 5 | 7.26e-01 | -9.06e-02 | 9.38e-01 |
| GOBP REGULATION OF COA TRANSFERASE ACTIVITY | 5 | 7.26e-01 | -9.06e-02 | 9.38e-01 |
| GOBP POSITIVE REGULATION OF CARDIAC MUSCLE CONTRACTION | 6 | 7.01e-01 | -9.06e-02 | 9.28e-01 |
| GOMF ICOSANOID RECEPTOR ACTIVITY | 14 | 5.57e-01 | 9.06e-02 | 8.87e-01 |
| GOCC INO80 TYPE COMPLEX | 27 | 4.15e-01 | -9.06e-02 | 8.29e-01 |
| GOMF SNORNA BINDING | 32 | 3.75e-01 | -9.06e-02 | 8.09e-01 |
| GOMF DNA EXONUCLEASE ACTIVITY | 25 | 4.33e-01 | -9.05e-02 | 8.36e-01 |
| GOBP STEROL BIOSYNTHETIC PROCESS | 49 | 2.73e-01 | 9.05e-02 | 7.36e-01 |
| GOCC EXON EXON JUNCTION COMPLEX | 20 | 4.84e-01 | 9.05e-02 | 8.60e-01 |
| GOCC PROTEIN LIPID COMPLEX | 23 | 4.53e-01 | -9.04e-02 | 8.43e-01 |
| GOMF LIGASE ACTIVITY FORMING CARBON NITROGEN BONDS | 44 | 3.00e-01 | -9.04e-02 | 7.56e-01 |
| GOBP REGULATION OF TRANSCRIPTION BY RNA POLYMERASE I | 44 | 3.00e-01 | -9.03e-02 | 7.56e-01 |
| GOMF TRANSMEMBRANE EPHRIN RECEPTOR ACTIVITY | 9 | 6.39e-01 | -9.03e-02 | 9.15e-01 |
| GOBP REGULATION OF NOTCH SIGNALING PATHWAY | 73 | 1.82e-01 | -9.02e-02 | 6.55e-01 |
| GOMF CULLIN FAMILY PROTEIN BINDING | 24 | 4.44e-01 | 9.02e-02 | 8.41e-01 |
| GOMF MONOATOMIC CATION CHANNEL ACTIVITY | 214 | 2.29e-02 | -9.02e-02 | 3.29e-01 |
| GOBP PROTEASOME MEDIATED UBIQUITIN DEPENDENT PROTEIN CATABOLIC PROCESS | 374 | 2.75e-03 | 9.02e-02 | 1.25e-01 |
| GOBP SYNAPSE MATURATION | 25 | 4.35e-01 | 9.02e-02 | 8.37e-01 |
| GOMF PHOSPHOTRANSFERASE ACTIVITY PHOSPHATE GROUP AS ACCEPTOR | 32 | 3.77e-01 | 9.02e-02 | 8.10e-01 |
| GOBP MITOTIC CELL CYCLE | 811 | 1.31e-05 | 9.01e-02 | 3.93e-03 |
| GOMF TUMOR NECROSIS FACTOR RECEPTOR SUPERFAMILY BINDING | 44 | 3.01e-01 | -9.01e-02 | 7.57e-01 |
| GOBP APOPTOTIC MITOCHONDRIAL CHANGES | 95 | 1.29e-01 | -9.00e-02 | 5.94e-01 |
| GOMF CALCIUM ION TRANSMEMBRANE TRANSPORTER ACTIVITY | 104 | 1.13e-01 | -9.00e-02 | 5.68e-01 |
| GOBP ANTIGEN PROCESSING AND PRESENTATION OF PEPTIDE ANTIGEN | 62 | 2.20e-01 | 9.00e-02 | 6.94e-01 |
| GOBP DIET INDUCED THERMOGENESIS | 9 | 6.40e-01 | 9.00e-02 | 9.15e-01 |
| GOBP VESICLE TARGETING TO FROM OR WITHIN GOLGI | 33 | 3.71e-01 | 9.00e-02 | 8.08e-01 |
| GOBP RETINAL METABOLIC PROCESS | 12 | 5.90e-01 | -8.99e-02 | 8.96e-01 |
| GOBP MIDDLE EAR MORPHOGENESIS | 9 | 6.41e-01 | 8.98e-02 | 9.15e-01 |
| GOBP VENTRICULAR SYSTEM DEVELOPMENT | 28 | 4.11e-01 | 8.98e-02 | 8.26e-01 |
| GOBP PROTEIN CATABOLIC PROCESS IN THE VACUOLE | 22 | 4.66e-01 | -8.98e-02 | 8.51e-01 |
| GOMF UBIQUITIN LIGASE ACTIVATOR ACTIVITY | 9 | 6.41e-01 | 8.98e-02 | 9.15e-01 |
| GOBP MRNA TRANSPORT | 123 | 8.56e-02 | 8.98e-02 | 5.12e-01 |
| GOBP OLFACTORY LOBE DEVELOPMENT | 21 | 4.77e-01 | 8.97e-02 | 8.57e-01 |
| GOBP MYELOID PROGENITOR CELL DIFFERENTIATION | 9 | 6.41e-01 | -8.97e-02 | 9.15e-01 |
| GOCC PROTEASOME REGULATORY PARTICLE LID SUBCOMPLEX | 7 | 6.81e-01 | 8.97e-02 | 9.24e-01 |
| GOBP VERY LOW DENSITY LIPOPROTEIN PARTICLE ASSEMBLY | 8 | 6.61e-01 | 8.96e-02 | 9.21e-01 |
| GOBP REGULATION OF EXTENT OF CELL GROWTH | 77 | 1.74e-01 | -8.96e-02 | 6.42e-01 |
| GOCC PEPTIDASE COMPLEX | 108 | 1.08e-01 | 8.95e-02 | 5.61e-01 |
| GOBP REGULATION OF SODIUM ION TRANSMEMBRANE TRANSPORT | 45 | 2.99e-01 | 8.95e-02 | 7.55e-01 |
| GOBP POSITIVE REGULATION OF GAMMA DELTA T CELL DIFFERENTIATION | 7 | 6.82e-01 | 8.95e-02 | 9.24e-01 |
| GOMF POTASSIUM ION TRANSMEMBRANE TRANSPORTER ACTIVITY | 97 | 1.28e-01 | -8.94e-02 | 5.93e-01 |
| GOBP PROTEIN INSERTION INTO ER MEMBRANE BY STOP TRANSFER MEMBRANE ANCHOR SEQUENCE | 11 | 6.08e-01 | 8.94e-02 | 9.03e-01 |
| GOBP REGULATION OF PROTEIN LOCALIZATION TO NUCLEUS | 125 | 8.44e-02 | 8.94e-02 | 5.09e-01 |
| GOBP L AMINO ACID CATABOLIC PROCESS | 50 | 2.74e-01 | -8.94e-02 | 7.37e-01 |
| GOMF FERRIC IRON BINDING | 7 | 6.82e-01 | -8.94e-02 | 9.24e-01 |
| GOBP PHAGOSOME ACIDIFICATION | 7 | 6.82e-01 | -8.93e-02 | 9.24e-01 |
| GOBP CD4 POSITIVE ALPHA BETA T CELL CYTOKINE PRODUCTION | 16 | 5.36e-01 | 8.93e-02 | 8.79e-01 |
| GOMF CHEMOATTRACTANT ACTIVITY | 17 | 5.24e-01 | 8.93e-02 | 8.76e-01 |
| GOBP REGULATION OF CALCIUM IMPORT INTO THE MITOCHONDRION | 6 | 7.05e-01 | 8.93e-02 | 9.32e-01 |
| GOBP BRANCHED CHAIN AMINO ACID TRANSPORT | 11 | 6.08e-01 | -8.93e-02 | 9.03e-01 |
| GOMF HISTONE METHYLTRANSFERASE ACTIVITY | 62 | 2.24e-01 | -8.93e-02 | 6.97e-01 |
| GOBP POSITIVE REGULATION OF BINDING | 95 | 1.33e-01 | 8.93e-02 | 5.98e-01 |
| GOBP VIRAL RNA GENOME REPLICATION | 28 | 4.14e-01 | 8.93e-02 | 8.29e-01 |
| GOMF LBD DOMAIN BINDING | 5 | 7.30e-01 | -8.93e-02 | 9.40e-01 |
| GOMF MICROTUBULE BINDING | 253 | 1.45e-02 | 8.92e-02 | 2.59e-01 |
| GOBP AMIDE BIOSYNTHETIC PROCESS | 131 | 7.79e-02 | 8.92e-02 | 4.96e-01 |
| GOBP REGULATION OF ASTROCYTE DIFFERENTIATION | 18 | 5.12e-01 | -8.92e-02 | 8.70e-01 |
| GOMF DNA DNA TETHERING ACTIVITY | 7 | 6.83e-01 | 8.91e-02 | 9.24e-01 |
| GOBP SENSORY PERCEPTION OF CHEMICAL STIMULUS | 96 | 1.31e-01 | 8.91e-02 | 5.95e-01 |
| GOBP PROTEIN IMPORT INTO PEROXISOME MATRIX | 14 | 5.64e-01 | -8.91e-02 | 8.90e-01 |
| GOBP NUCLEOSIDE METABOLIC PROCESS | 52 | 2.66e-01 | 8.91e-02 | 7.33e-01 |
| GOMF MONOCARBOXYLIC ACID BINDING | 48 | 2.86e-01 | -8.91e-02 | 7.45e-01 |
| GOBP NUCLEAR TRANSCRIBED MRNA CATABOLIC PROCESS NONSENSE MEDIATED DECAY | 40 | 3.30e-01 | 8.91e-02 | 7.81e-01 |
| GOBP KERATINOCYTE MIGRATION | 14 | 5.64e-01 | -8.91e-02 | 8.90e-01 |
| GOMF NEUROTRANSMITTER TRANSMEMBRANE TRANSPORTER ACTIVITY | 12 | 5.93e-01 | -8.90e-02 | 8.99e-01 |
| GOBP REGULATION OF SECONDARY METABOLIC PROCESS | 11 | 6.09e-01 | 8.90e-02 | 9.03e-01 |
| GOBP POSITIVE REGULATION OF PLASMINOGEN ACTIVATION | 8 | 6.63e-01 | -8.90e-02 | 9.21e-01 |
| GOBP TRANSLATIONAL TERMINATION | 16 | 5.38e-01 | 8.89e-02 | 8.79e-01 |
| GOBP 2FE 2S CLUSTER ASSEMBLY | 11 | 6.10e-01 | -8.89e-02 | 9.03e-01 |
| GOBP FOREBRAIN CELL MIGRATION | 47 | 2.92e-01 | 8.88e-02 | 7.49e-01 |
| GOBP POSITIVE REGULATION OF PROTEIN LOCALIZATION TO CELL CORTEX | 6 | 7.06e-01 | -8.88e-02 | 9.32e-01 |
| GOMF TRANSPORTER REGULATOR ACTIVITY | 115 | 1.00e-01 | 8.88e-02 | 5.47e-01 |
| GOBP REGULATION OF MRNA METABOLIC PROCESS | 267 | 1.26e-02 | 8.87e-02 | 2.49e-01 |
| GOBP POSITIVE REGULATION OF BONE MINERALIZATION | 31 | 3.93e-01 | -8.87e-02 | 8.20e-01 |
| GOMF MONOATOMIC ANION SODIUM SYMPORTER ACTIVITY | 12 | 5.95e-01 | -8.87e-02 | 9.01e-01 |
| GOBP RESPONSE TO PAIN | 22 | 4.72e-01 | -8.86e-02 | 8.54e-01 |
| GOBP RESPONSE TO ANTIBIOTIC | 36 | 3.58e-01 | 8.86e-02 | 7.98e-01 |
| GOBP NEURON CELLULAR HOMEOSTASIS | 49 | 2.84e-01 | 8.86e-02 | 7.44e-01 |
| GOCC MANCHETTE | 18 | 5.16e-01 | 8.85e-02 | 8.72e-01 |
| GOBP SYNAPTIC TRANSMISSION CHOLINERGIC | 19 | 5.04e-01 | -8.84e-02 | 8.66e-01 |
| GOMF METALLOCHAPERONE ACTIVITY | 13 | 5.81e-01 | 8.84e-02 | 8.93e-01 |
| GOBP DENDRITIC SPINE MORPHOGENESIS | 49 | 2.84e-01 | 8.84e-02 | 7.45e-01 |
| GOBP MAINTENANCE OF APICAL BASAL CELL POLARITY | 9 | 6.46e-01 | 8.84e-02 | 9.16e-01 |
| GOBP ETHER BIOSYNTHETIC PROCESS | 12 | 5.96e-01 | 8.83e-02 | 9.01e-01 |
| GOBP SEQUESTERING OF CALCIUM ION | 103 | 1.22e-01 | -8.83e-02 | 5.85e-01 |
| GOBP NATURAL KILLER CELL MEDIATED IMMUNITY | 73 | 1.92e-01 | 8.83e-02 | 6.65e-01 |
| GOMF LOW DENSITY LIPOPROTEIN PARTICLE RECEPTOR BINDING | 20 | 4.95e-01 | 8.82e-02 | 8.62e-01 |
| GOBP EMBRYONIC SKELETAL JOINT DEVELOPMENT | 6 | 7.08e-01 | 8.82e-02 | 9.33e-01 |
| GOBP CHOLESTEROL STORAGE | 21 | 4.84e-01 | 8.81e-02 | 8.60e-01 |
| GOBP L LEUCINE IMPORT ACROSS PLASMA MEMBRANE | 5 | 7.33e-01 | -8.81e-02 | 9.41e-01 |
| GOCC 9PLUS0 NON MOTILE CILIUM | 91 | 1.46e-01 | 8.81e-02 | 6.13e-01 |
| GOBP PHOTORECEPTOR CELL DEVELOPMENT | 33 | 3.81e-01 | -8.81e-02 | 8.14e-01 |
| GOBP REGULATION OF CELL CYCLE PROCESS | 629 | 1.63e-04 | 8.81e-02 | 2.18e-02 |
| GOBP AMINOGLYCAN METABOLIC PROCESS | 103 | 1.22e-01 | -8.81e-02 | 5.86e-01 |
| GOBP OVULATION | 10 | 6.30e-01 | 8.81e-02 | 9.11e-01 |
| GOBP NUCLEAR PORE LOCALIZATION | 5 | 7.33e-01 | 8.80e-02 | 9.41e-01 |
| GOCC TRANSPORT VESICLE MEMBRANE | 190 | 3.64e-02 | 8.80e-02 | 3.90e-01 |
| GOBP DNA TEMPLATED DNA REPLICATION | 159 | 5.57e-02 | 8.80e-02 | 4.40e-01 |
| GOCC U12 TYPE SPLICEOSOMAL COMPLEX | 26 | 4.38e-01 | 8.79e-02 | 8.39e-01 |
| GOMF GTPASE ACTIVITY | 285 | 1.07e-02 | 8.79e-02 | 2.34e-01 |
| GOBP HOMOLOGOUS CHROMOSOME SEGREGATION | 45 | 3.08e-01 | 8.78e-02 | 7.62e-01 |
| GOMF UBIQUITIN LIKE PROTEIN LIGASE ACTIVITY | 318 | 7.15e-03 | 8.77e-02 | 1.94e-01 |
| GOBP REGULATION OF MICROVILLUS ORGANIZATION | 12 | 5.99e-01 | 8.77e-02 | 9.02e-01 |
| GOBP NEGATIVE REGULATION OF SIGNAL TRANSDUCTION IN ABSENCE OF LIGAND | 24 | 4.57e-01 | 8.77e-02 | 8.45e-01 |
| GOBP NEGATIVE REGULATION OF NEURON APOPTOTIC PROCESS | 112 | 1.09e-01 | 8.76e-02 | 5.62e-01 |
| GOBP RESPONSE TO ACID CHEMICAL | 103 | 1.25e-01 | 8.76e-02 | 5.88e-01 |
| GOBP REGULATION OF FERTILIZATION | 7 | 6.88e-01 | -8.76e-02 | 9.27e-01 |
| GOCC EXTRINSIC COMPONENT OF SYNAPTIC MEMBRANE | 12 | 5.99e-01 | 8.76e-02 | 9.03e-01 |
| GOMF STRUCTURAL CONSTITUENT OF POSTSYNAPSE | 12 | 6.00e-01 | 8.75e-02 | 9.03e-01 |
| GOBP REGULATION OF SKELETAL MUSCLE CELL DIFFERENTIATION | 12 | 6.00e-01 | 8.75e-02 | 9.03e-01 |
| GOBP REGULATION OF SODIUM ION TRANSMEMBRANE TRANSPORTER ACTIVITY | 36 | 3.64e-01 | 8.75e-02 | 8.02e-01 |
| GOBP PEPTIDYL SERINE MODIFICATION | 224 | 2.41e-02 | 8.75e-02 | 3.37e-01 |
| GOCC RNA POLYMERASE III COMPLEX | 18 | 5.21e-01 | -8.75e-02 | 8.74e-01 |
| GOBP ONE CARBON COMPOUND TRANSPORT | 16 | 5.45e-01 | 8.75e-02 | 8.83e-01 |
| GOCC U6 SNRNP | 8 | 6.69e-01 | 8.74e-02 | 9.22e-01 |
| GOBP NEGATIVE REGULATION OF PROTEIN SERINE THREONINE KINASE ACTIVITY | 73 | 1.97e-01 | 8.74e-02 | 6.69e-01 |
| GOBP NEGATIVE REGULATION OF NEURON PROJECTION REGENERATION | 14 | 5.72e-01 | 8.73e-02 | 8.91e-01 |
| GOBP REGULATION OF HAIR CYCLE | 16 | 5.46e-01 | 8.72e-02 | 8.84e-01 |
| GOBP NEGATIVE REGULATION OF CD8 POSITIVE ALPHA BETA T CELL ACTIVATION | 7 | 6.89e-01 | -8.72e-02 | 9.27e-01 |
| GOBP SUPPRESSION OF VIRAL RELEASE BY HOST | 15 | 5.59e-01 | -8.72e-02 | 8.88e-01 |
| GOBP NEGATIVE REGULATION OF MEIOTIC CELL CYCLE PHASE TRANSITION | 5 | 7.36e-01 | 8.72e-02 | 9.42e-01 |
| GOBP MITOCHONDRIAL RNA MODIFICATION | 9 | 6.51e-01 | -8.72e-02 | 9.17e-01 |
| GOBP ANTIGEN PROCESSING AND PRESENTATION OF PEPTIDE ANTIGEN VIA MHC CLASS IB | 12 | 6.01e-01 | -8.72e-02 | 9.03e-01 |
| GOMF METAL CATION MONOATOMIC CATION ANTIPORTER ACTIVITY | 31 | 4.01e-01 | 8.71e-02 | 8.23e-01 |
| GOBP REGULATION OF ANTIGEN PROCESSING AND PRESENTATION OF PEPTIDE ANTIGEN | 5 | 7.36e-01 | -8.70e-02 | 9.42e-01 |
| GOBP NEGATIVE REGULATION OF CALCIUM ION IMPORT | 8 | 6.70e-01 | 8.70e-02 | 9.22e-01 |
| GOBP PROTEIN MATURATION BY IRON SULFUR CLUSTER TRANSFER | 17 | 5.35e-01 | -8.70e-02 | 8.79e-01 |
| GOCC ZYMOGEN GRANULE | 12 | 6.02e-01 | 8.70e-02 | 9.03e-01 |
| GOMF PROTEIN FOLDING CHAPERONE | 58 | 2.52e-01 | 8.69e-02 | 7.21e-01 |
| GOCC GLYCOPROTEIN COMPLEX | 19 | 5.12e-01 | -8.69e-02 | 8.70e-01 |
| GOCC GBAF COMPLEX | 13 | 5.88e-01 | -8.69e-02 | 8.95e-01 |
| GOMF HISTONE H3K4 DEMETHYLASE ACTIVITY | 8 | 6.71e-01 | 8.68e-02 | 9.22e-01 |
| GOMF INTERLEUKIN 17 RECEPTOR ACTIVITY | 6 | 7.13e-01 | -8.68e-02 | 9.35e-01 |
| GOBP OLIGODENDROCYTE PROGENITOR PROLIFERATION | 5 | 7.37e-01 | 8.68e-02 | 9.42e-01 |
| GOBP GLANDULAR EPITHELIAL CELL DEVELOPMENT | 23 | 4.71e-01 | -8.67e-02 | 8.54e-01 |
| GOCC RADIAL SPOKE | 6 | 7.13e-01 | -8.67e-02 | 9.35e-01 |
| GOBP GLANDULAR EPITHELIAL CELL DIFFERENTIATION | 39 | 3.49e-01 | -8.67e-02 | 7.92e-01 |
| GOBP REGULATION OF SYNAPSE ASSEMBLY | 80 | 1.80e-01 | -8.66e-02 | 6.53e-01 |
| GOBP NEGATIVE REGULATION OF PROTEIN UBIQUITINATION | 70 | 2.10e-01 | 8.66e-02 | 6.83e-01 |
| GOMF ATPASE COUPLED INTRAMEMBRANE LIPID TRANSPORTER ACTIVITY | 24 | 4.63e-01 | 8.66e-02 | 8.49e-01 |
| GOBP NEGATIVE REGULATION OF NATURAL KILLER CELL ACTIVATION | 10 | 6.35e-01 | -8.66e-02 | 9.14e-01 |
| GOBP POSITIVE REGULATION OF SIGNALING RECEPTOR ACTIVITY | 21 | 4.92e-01 | 8.66e-02 | 8.62e-01 |
| GOBP PROTEIN TRANSMEMBRANE IMPORT INTO INTRACELLULAR ORGANELLE | 37 | 3.62e-01 | -8.66e-02 | 8.02e-01 |
| GOBP POSITIVE REGULATION OF RESPONSE TO EXTERNAL STIMULUS | 528 | 6.70e-04 | 8.65e-02 | 5.61e-02 |
| GOBP POSITIVE REGULATION OF SMOOTH MUSCLE CELL DIFFERENTIATION | 14 | 5.75e-01 | -8.65e-02 | 8.92e-01 |
| GOBP FEMALE GAMETE GENERATION | 108 | 1.21e-01 | 8.64e-02 | 5.84e-01 |
| GOMF INTRACELLULARLY CALCIUM GATED CHLORIDE CHANNEL ACTIVITY | 12 | 6.04e-01 | -8.64e-02 | 9.03e-01 |
| GOCC PHOTORECEPTOR OUTER SEGMENT MEMBRANE | 12 | 6.04e-01 | 8.64e-02 | 9.03e-01 |
| GOBP PURINE RIBONUCLEOTIDE SALVAGE | 7 | 6.92e-01 | -8.63e-02 | 9.27e-01 |
| GOBP ADIPOSE TISSUE DEVELOPMENT | 55 | 2.68e-01 | 8.63e-02 | 7.33e-01 |
| GOBP REGULATION OF POST TRANSLATIONAL PROTEIN MODIFICATION | 227 | 2.51e-02 | 8.63e-02 | 3.43e-01 |
| GOCC NADH DEHYDROGENASE COMPLEX | 50 | 2.91e-01 | -8.63e-02 | 7.48e-01 |
| GOBP NEGATIVE REGULATION OF UBIQUITIN DEPENDENT PROTEIN CATABOLIC PROCESS | 49 | 2.96e-01 | 8.62e-02 | 7.53e-01 |
| GOBP REGULATION OF GROWTH RATE | 5 | 7.39e-01 | -8.62e-02 | 9.42e-01 |
| GOCC SPECTRIN ASSOCIATED CYTOSKELETON | 8 | 6.73e-01 | -8.62e-02 | 9.23e-01 |
| GOBP ENDOSOMAL LUMEN ACIDIFICATION | 14 | 5.77e-01 | -8.61e-02 | 8.92e-01 |
| GOCC POSTSYNAPTIC MEMBRANE | 160 | 6.02e-02 | -8.61e-02 | 4.55e-01 |
| GOBP NEGATIVE REGULATION OF RECEPTOR MEDIATED ENDOCYTOSIS | 24 | 4.65e-01 | -8.61e-02 | 8.51e-01 |
| GOBP MODIFIED AMINO ACID TRANSPORT | 32 | 3.99e-01 | -8.61e-02 | 8.22e-01 |
| GOBP RENAL ALBUMIN ABSORPTION | 5 | 7.39e-01 | -8.60e-02 | 9.42e-01 |
| GOBP CLATHRIN COAT ASSEMBLY | 17 | 5.39e-01 | 8.60e-02 | 8.80e-01 |
| GOBP MITOTIC CYTOKINETIC PROCESS | 31 | 4.07e-01 | 8.60e-02 | 8.26e-01 |
| GOCC EKC KEOPS COMPLEX | 5 | 7.39e-01 | -8.60e-02 | 9.42e-01 |
| GOMF NUCLEOSIDE TRANSMEMBRANE TRANSPORTER ACTIVITY | 8 | 6.74e-01 | 8.59e-02 | 9.23e-01 |
| GOBP POSITIVE REGULATION OF PATTERN RECOGNITION RECEPTOR SIGNALING PATHWAY | 64 | 2.34e-01 | 8.59e-02 | 7.05e-01 |
| GOBP LOCOMOTORY EXPLORATION BEHAVIOR | 12 | 6.06e-01 | 8.59e-02 | 9.03e-01 |
| GOBP DETOXIFICATION | 117 | 1.09e-01 | 8.59e-02 | 5.62e-01 |
| GOBP REGULATION OF DNA DAMAGE RESPONSE SIGNAL TRANSDUCTION BY P53 CLASS MEDIATOR RESULTING IN TRANSCRIPTION OF P21 CLASS MEDIATOR | 6 | 7.16e-01 | -8.59e-02 | 9.36e-01 |
| GOBP SPERM EGG RECOGNITION | 27 | 4.40e-01 | -8.59e-02 | 8.40e-01 |
| GOBP POSITIVE REGULATION OF HEMOGLOBIN BIOSYNTHETIC PROCESS | 5 | 7.40e-01 | -8.58e-02 | 9.42e-01 |
| GOBP NEGATIVE REGULATION OF CATION CHANNEL ACTIVITY | 22 | 4.86e-01 | 8.58e-02 | 8.60e-01 |
| GOBP PROTEIN LOCALIZATION TO GOLGI APPARATUS | 29 | 4.24e-01 | 8.58e-02 | 8.31e-01 |
| GOBP PROTEIN LOCALIZATION TO SYNAPSE | 59 | 2.54e-01 | -8.58e-02 | 7.23e-01 |
| GOBP DITERPENOID METABOLIC PROCESS | 48 | 3.04e-01 | -8.57e-02 | 7.60e-01 |
| GOBP ASTROCYTE DEVELOPMENT | 32 | 4.02e-01 | -8.57e-02 | 8.23e-01 |
| GOMF MYOSIN II BINDING | 11 | 6.23e-01 | -8.57e-02 | 9.09e-01 |
| GOMF GAP JUNCTION CHANNEL ACTIVITY | 6 | 7.16e-01 | 8.56e-02 | 9.36e-01 |
| GOBP ENDOTHELIAL CELL CHEMOTAXIS | 19 | 5.18e-01 | -8.56e-02 | 8.73e-01 |
| GOBP CENTRAL NERVOUS SYSTEM MYELIN FORMATION | 6 | 7.17e-01 | -8.56e-02 | 9.36e-01 |
| GOBP PROTEIN UNFOLDING | 5 | 7.40e-01 | -8.56e-02 | 9.42e-01 |
| GOBP MITOTIC NUCLEAR DIVISION | 258 | 1.80e-02 | 8.56e-02 | 2.91e-01 |
| GOMF RECEPTOR TYROSINE KINASE BINDING | 68 | 2.22e-01 | -8.56e-02 | 6.97e-01 |
| GOBP NEPHRON EPITHELIUM DEVELOPMENT | 75 | 2.01e-01 | -8.55e-02 | 6.72e-01 |
| GOMF DNA DNA ANNEALING ACTIVITY | 7 | 6.95e-01 | -8.54e-02 | 9.27e-01 |
| GOBP METANEPHROS MORPHOGENESIS | 16 | 5.54e-01 | -8.54e-02 | 8.86e-01 |
| GOBP NEGATIVE REGULATION OF TRANSMEMBRANE TRANSPORT | 92 | 1.57e-01 | 8.54e-02 | 6.21e-01 |
| GOBP POSITIVE REGULATION OF ERBB SIGNALING PATHWAY | 26 | 4.51e-01 | -8.54e-02 | 8.43e-01 |
| GOCC SECRETORY GRANULE MEMBRANE | 281 | 1.38e-02 | 8.54e-02 | 2.53e-01 |
| GOMF DYNEIN LIGHT CHAIN BINDING | 7 | 6.96e-01 | 8.54e-02 | 9.27e-01 |
| GOBP POSITIVE REGULATION OF CYCLIN DEPENDENT PROTEIN KINASE ACTIVITY | 11 | 6.24e-01 | 8.53e-02 | 9.09e-01 |
| GOMF GTPASE ACTIVATOR ACTIVITY | 253 | 1.96e-02 | -8.53e-02 | 3.06e-01 |
| GOBP REGULATION OF PROTEIN LOCALIZATION TO CILIUM | 10 | 6.41e-01 | 8.53e-02 | 9.15e-01 |
| GOBP G PROTEIN COUPLED ACETYLCHOLINE RECEPTOR SIGNALING PATHWAY | 16 | 5.55e-01 | 8.52e-02 | 8.87e-01 |
| GOBP POSITIVE REGULATION OF TRANSLATION IN RESPONSE TO ENDOPLASMIC RETICULUM STRESS | 5 | 7.42e-01 | 8.52e-02 | 9.42e-01 |
| GOBP LONG CHAIN FATTY ACYL COA BIOSYNTHETIC PROCESS | 17 | 5.43e-01 | 8.52e-02 | 8.82e-01 |
| GOBP REGULATION OF CELL KILLING | 97 | 1.48e-01 | 8.51e-02 | 6.13e-01 |
| GOBP FORMATION OF CYTOPLASMIC TRANSLATION INITIATION COMPLEX | 15 | 5.68e-01 | 8.51e-02 | 8.90e-01 |
| GOBP PEPTIDE BIOSYNTHETIC PROCESS | 22 | 4.90e-01 | 8.51e-02 | 8.61e-01 |
| GOCC CILIARY TRANSITION ZONE | 67 | 2.29e-01 | 8.51e-02 | 7.01e-01 |
| GOBP REGULATION OF AMINE METABOLIC PROCESS | 21 | 5.00e-01 | -8.51e-02 | 8.64e-01 |
| GOBP INTRACELLULAR SODIUM ION HOMEOSTASIS | 14 | 5.82e-01 | 8.50e-02 | 8.93e-01 |
| GOBP MATERNAL PROCESS INVOLVED IN FEMALE PREGNANCY | 45 | 3.24e-01 | -8.50e-02 | 7.75e-01 |
| GOBP REGULATION OF ENDOCRINE PROCESS | 24 | 4.71e-01 | 8.50e-02 | 8.54e-01 |
| GOBP AXO DENDRITIC PROTEIN TRANSPORT | 9 | 6.59e-01 | -8.50e-02 | 9.19e-01 |
| GOMF POLYOL TRANSMEMBRANE TRANSPORTER ACTIVITY | 9 | 6.59e-01 | 8.50e-02 | 9.19e-01 |
| GOCC CYTOPLASMIC SIDE OF LYSOSOMAL MEMBRANE | 13 | 5.96e-01 | 8.50e-02 | 9.01e-01 |
| GOBP RESPONSE TO SYMBIONT | 5 | 7.42e-01 | 8.50e-02 | 9.42e-01 |
| GOMF OXIDOREDUCTION DRIVEN ACTIVE TRANSMEMBRANE TRANSPORTER ACTIVITY | 66 | 2.33e-01 | -8.49e-02 | 7.05e-01 |
| GOBP PLATELET DERIVED GROWTH FACTOR RECEPTOR BETA SIGNALING PATHWAY | 12 | 6.10e-01 | -8.49e-02 | 9.03e-01 |
| GOBP CELLULAR RESPONSE TO TYPE II INTERFERON | 84 | 1.79e-01 | 8.49e-02 | 6.50e-01 |
| GOBP NEGATIVE REGULATION OF VIRAL TRANSCRIPTION | 14 | 5.83e-01 | -8.48e-02 | 8.93e-01 |
| GOCC ATAC COMPLEX | 14 | 5.83e-01 | 8.48e-02 | 8.93e-01 |
| GOBP NEGATIVE REGULATION OF EPITHELIAL CELL PROLIFERATION INVOLVED IN PROSTATE GLAND DEVELOPMENT | 6 | 7.19e-01 | 8.48e-02 | 9.36e-01 |
| GOBP NEGATIVE REGULATION OF NEUROBLAST PROLIFERATION | 8 | 6.78e-01 | 8.47e-02 | 9.24e-01 |
| GOBP REGULATION OF PROTEIN BINDING | 110 | 1.25e-01 | -8.47e-02 | 5.88e-01 |
| GOBP CELLULAR RESPONSE TO LIPOPROTEIN PARTICLE STIMULUS | 31 | 4.15e-01 | 8.46e-02 | 8.29e-01 |
| GOBP REGULATION OF MITOTIC CYTOKINESIS | 15 | 5.70e-01 | -8.46e-02 | 8.90e-01 |
| GOBP NEGATIVE REGULATION OF PERK MEDIATED UNFOLDED PROTEIN RESPONSE | 7 | 6.98e-01 | -8.46e-02 | 9.28e-01 |
| GOBP ERROR FREE TRANSLESION SYNTHESIS | 5 | 7.43e-01 | -8.45e-02 | 9.42e-01 |
| GOBP NEGATIVE REGULATION OF CD4 POSITIVE ALPHA BETA T CELL ACTIVATION | 32 | 4.08e-01 | 8.45e-02 | 8.26e-01 |
| GOBP REGULATION OF POSTSYNAPTIC SPECIALIZATION ASSEMBLY | 10 | 6.44e-01 | -8.45e-02 | 9.15e-01 |
| GOMF IRON ION TRANSMEMBRANE TRANSPORTER ACTIVITY | 10 | 6.44e-01 | -8.45e-02 | 9.15e-01 |
| GOBP HOMEOSTASIS OF NUMBER OF CELLS | 289 | 1.35e-02 | 8.44e-02 | 2.50e-01 |
| GOBP NEGATIVE REGULATION OF RELAXATION OF MUSCLE | 6 | 7.20e-01 | 8.44e-02 | 9.37e-01 |
| GOBP NEGATIVE REGULATION OF GLYCOGEN METABOLIC PROCESS | 6 | 7.21e-01 | -8.43e-02 | 9.37e-01 |
| GOCC CLATHRIN COATED PIT | 69 | 2.26e-01 | -8.42e-02 | 7.00e-01 |
| GOBP MODULATION BY HOST OF SYMBIONT PROCESS | 77 | 2.01e-01 | 8.42e-02 | 6.73e-01 |
| GOBP REGULATION OF CELLULAR RESPONSE TO OXIDATIVE STRESS | 22 | 4.94e-01 | 8.42e-02 | 8.62e-01 |
| GOMF NUCLEAR RECEPTOR BINDING | 123 | 1.07e-01 | 8.41e-02 | 5.60e-01 |
| GOBP CELLULAR RESPONSE TO STEROL DEPLETION | 14 | 5.86e-01 | 8.41e-02 | 8.94e-01 |
| GOBP T HELPER 2 CELL DIFFERENTIATION | 18 | 5.37e-01 | -8.41e-02 | 8.79e-01 |
| GOBP POSITIVE REGULATION OF NUCLEAR CELL CYCLE DNA REPLICATION | 7 | 7.00e-01 | -8.41e-02 | 9.28e-01 |
| GOMF PROCOLLAGEN PROLINE DIOXYGENASE ACTIVITY | 7 | 7.00e-01 | -8.41e-02 | 9.28e-01 |
| GOBP PROTEIN LOCALIZATION TO AXON | 8 | 6.81e-01 | -8.41e-02 | 9.24e-01 |
| GOMF ADENOSINE 3 5 BISPHOSPHATE TRANSMEMBRANE TRANSPORTER ACTIVITY | 5 | 7.45e-01 | -8.40e-02 | 9.42e-01 |
| GOBP REGULATION OF NEUROTRANSMITTER TRANSPORT | 75 | 2.08e-01 | 8.40e-02 | 6.82e-01 |
| GOBP DENTATE GYRUS DEVELOPMENT | 16 | 5.61e-01 | -8.40e-02 | 8.88e-01 |
| GOCC BETA CATENIN DESTRUCTION COMPLEX | 12 | 6.15e-01 | -8.40e-02 | 9.05e-01 |
| GOCC RNA POLYMERASE COMPLEX | 100 | 1.47e-01 | 8.39e-02 | 6.13e-01 |
| GOMF INTRAMEMBRANE LIPID TRANSPORTER ACTIVITY | 35 | 3.90e-01 | 8.39e-02 | 8.18e-01 |
| GOBP EPIBOLY | 35 | 3.90e-01 | -8.39e-02 | 8.18e-01 |
| GOBP CRISTAE FORMATION | 19 | 5.27e-01 | -8.38e-02 | 8.76e-01 |
| GOBP VIRION ASSEMBLY | 33 | 4.05e-01 | 8.38e-02 | 8.25e-01 |
| GOBP FATTY ACID BETA OXIDATION | 70 | 2.26e-01 | -8.38e-02 | 6.98e-01 |
| GOBP RESPONSE TO MUSCLE STRETCH | 21 | 5.07e-01 | -8.37e-02 | 8.68e-01 |
| GOBP NEGATIVE REGULATION OF RESPONSE TO OXIDATIVE STRESS | 9 | 6.64e-01 | 8.37e-02 | 9.22e-01 |
| GOBP CARBOHYDRATE BIOSYNTHETIC PROCESS | 166 | 6.29e-02 | -8.37e-02 | 4.63e-01 |
| GOCC NUCLEAR ENVELOPE | 453 | 2.28e-03 | 8.37e-02 | 1.17e-01 |
| GOBP NEGATIVE REGULATION OF GLIAL CELL APOPTOTIC PROCESS | 8 | 6.82e-01 | 8.37e-02 | 9.24e-01 |
| GOBP LUNG MORPHOGENESIS | 35 | 3.93e-01 | -8.34e-02 | 8.20e-01 |
| GOBP INCLUSION BODY ASSEMBLY | 20 | 5.19e-01 | -8.34e-02 | 8.74e-01 |
| GOMF ATPASE BINDING | 69 | 2.31e-01 | 8.34e-02 | 7.04e-01 |
| GOBP REGULATION OF AXON GUIDANCE | 6 | 7.24e-01 | 8.33e-02 | 9.38e-01 |
| GOBP REGULATION OF AUTOPHAGOSOME MATURATION | 17 | 5.52e-01 | -8.33e-02 | 8.86e-01 |
| GOBP CONSTITUTIVE HETEROCHROMATIN FORMATION | 12 | 6.17e-01 | 8.33e-02 | 9.06e-01 |
| GOBP CELL MIGRATION IN HINDBRAIN | 13 | 6.03e-01 | -8.33e-02 | 9.03e-01 |
| GOMF GENERAL TRANSCRIPTION INITIATION FACTOR BINDING | 51 | 3.04e-01 | 8.33e-02 | 7.58e-01 |
| GOBP KERATINOCYTE DIFFERENTIATION | 88 | 1.77e-01 | 8.33e-02 | 6.48e-01 |
| GOBP SEGMENT SPECIFICATION | 8 | 6.84e-01 | -8.32e-02 | 9.25e-01 |
| GOBP POSITIVE REGULATION OF ENDOTHELIAL CELL MIGRATION | 88 | 1.77e-01 | -8.32e-02 | 6.48e-01 |
| GOBP RETROGRADE TRANS SYNAPTIC SIGNALING BY LIPID | 5 | 7.47e-01 | -8.32e-02 | 9.43e-01 |
| GOBP SALIVA SECRETION | 6 | 7.24e-01 | -8.31e-02 | 9.38e-01 |
| GOBP POSITIVE REGULATION OF RESPONSE TO CYTOKINE STIMULUS | 60 | 2.66e-01 | 8.31e-02 | 7.33e-01 |
| GOBP NEGATIVE REGULATION OF GTPASE ACTIVITY | 19 | 5.31e-01 | -8.31e-02 | 8.78e-01 |
| GOMF ENZYME SUBSTRATE ADAPTOR ACTIVITY | 68 | 2.36e-01 | 8.31e-02 | 7.07e-01 |
| GOMF NON MEMBRANE SPANNING PROTEIN TYROSINE KINASE ACTIVITY | 43 | 3.46e-01 | 8.30e-02 | 7.90e-01 |
| GOCC EUCHROMATIN | 50 | 3.10e-01 | 8.30e-02 | 7.64e-01 |
| GOBP CEREBELLAR GRANULAR LAYER DEVELOPMENT | 9 | 6.66e-01 | -8.30e-02 | 9.22e-01 |
| GOBP REGULATION OF SENSORY PERCEPTION | 12 | 6.19e-01 | 8.30e-02 | 9.07e-01 |
| GOCC CORTICAL ACTIN CYTOSKELETON | 67 | 2.41e-01 | -8.29e-02 | 7.11e-01 |
| GOBP ALPHA LINOLENIC ACID METABOLIC PROCESS | 9 | 6.67e-01 | -8.28e-02 | 9.22e-01 |
| GOBP CIRCADIAN SLEEP WAKE CYCLE | 13 | 6.05e-01 | 8.28e-02 | 9.03e-01 |
| GOBP SUBSTRATE ADHESION DEPENDENT CELL SPREADING | 85 | 1.88e-01 | -8.27e-02 | 6.62e-01 |
| GOBP REGULATION OF MITOTIC CELL CYCLE PHASE TRANSITION | 309 | 1.25e-02 | 8.27e-02 | 2.49e-01 |
| GOMF PROTEIN TYROSINE PHOSPHATASE ACTIVITY | 79 | 2.04e-01 | 8.26e-02 | 6.79e-01 |
| GOBP SKELETAL MUSCLE ADAPTATION | 10 | 6.51e-01 | -8.25e-02 | 9.18e-01 |
| GOCC COLLAGEN TRIMER | 45 | 3.38e-01 | -8.25e-02 | 7.87e-01 |
| GOBP MODIFICATION DEPENDENT MACROMOLECULE CATABOLIC PROCESS | 580 | 6.91e-04 | 8.25e-02 | 5.74e-02 |
| GOBP POSITIVE REGULATION OF LAMELLIPODIUM ASSEMBLY | 25 | 4.75e-01 | 8.25e-02 | 8.56e-01 |
| GOBP MITOCHONDRIAL MEMBRANE ORGANIZATION | 110 | 1.35e-01 | -8.24e-02 | 6.00e-01 |
| GOCC ALPHA BETA T CELL RECEPTOR COMPLEX | 10 | 6.52e-01 | -8.24e-02 | 9.18e-01 |
| GOBP POSITIVE REGULATION OF INTEGRIN ACTIVATION | 6 | 7.27e-01 | 8.24e-02 | 9.39e-01 |
| GOBP NUCLEAR TRANSPORT | 309 | 1.28e-02 | 8.23e-02 | 2.49e-01 |
| GOBP GLUCOSAMINE CONTAINING COMPOUND METABOLIC PROCESS | 20 | 5.24e-01 | 8.23e-02 | 8.76e-01 |
| GOMF CHEMOKINE ACTIVITY | 21 | 5.14e-01 | -8.23e-02 | 8.71e-01 |
| GOBP MITOCHONDRIAL RNA PROCESSING | 22 | 5.04e-01 | 8.23e-02 | 8.66e-01 |
| GOMF MANNOSE BINDING | 19 | 5.35e-01 | 8.23e-02 | 8.79e-01 |
| GOBP NEGATIVE REGULATION OF STRIATED MUSCLE CONTRACTION | 6 | 7.27e-01 | -8.22e-02 | 9.39e-01 |
| GOMF ALKALI METAL ION BINDING | 12 | 6.22e-01 | -8.22e-02 | 9.09e-01 |
| GOBP POSITIVE REGULATION OF MONOCYTE CHEMOTACTIC PROTEIN 1 PRODUCTION | 12 | 6.22e-01 | 8.22e-02 | 9.09e-01 |
| GOMF HMG BOX DOMAIN BINDING | 8 | 6.87e-01 | -8.22e-02 | 9.27e-01 |
| GOBP VACUOLE FUSION | 11 | 6.37e-01 | 8.22e-02 | 9.14e-01 |
| GOBP PROTEIN HETEROTETRAMERIZATION | 13 | 6.08e-01 | 8.21e-02 | 9.03e-01 |
| GOBP NEGATIVE REGULATION OF SMALL MOLECULE METABOLIC PROCESS | 80 | 2.04e-01 | -8.21e-02 | 6.79e-01 |
| GOBP REGULATION OF CELL CYCLE G2 M PHASE TRANSITION | 109 | 1.39e-01 | 8.21e-02 | 6.04e-01 |
| GOBP REGULATION OF ANIMAL ORGAN FORMATION | 10 | 6.53e-01 | 8.21e-02 | 9.18e-01 |
| GOBP VACUOLE ORGANIZATION | 218 | 3.67e-02 | 8.21e-02 | 3.91e-01 |
| GOBP NEGATIVE REGULATION OF CHONDROCYTE DIFFERENTIATION | 9 | 6.70e-01 | -8.21e-02 | 9.22e-01 |
| GOBP NEGATIVE REGULATION OF RHO PROTEIN SIGNAL TRANSDUCTION | 18 | 5.47e-01 | 8.20e-02 | 8.84e-01 |
| GOCC ELONGATOR HOLOENZYME COMPLEX | 6 | 7.28e-01 | 8.20e-02 | 9.39e-01 |
| GOCC TRICARBOXYLIC ACID CYCLE HETEROMERIC ENZYME COMPLEX | 17 | 5.58e-01 | 8.20e-02 | 8.88e-01 |
| GOBP RNA EXPORT FROM NUCLEUS | 87 | 1.86e-01 | 8.19e-02 | 6.61e-01 |
| GOBP THIAMINE DIPHOSPHATE METABOLIC PROCESS | 5 | 7.51e-01 | 8.19e-02 | 9.45e-01 |
| GOBP RESPONSE TO STEROL DEPLETION | 16 | 5.71e-01 | 8.19e-02 | 8.90e-01 |
| GOBP CELLULAR COMPONENT ASSEMBLY INVOLVED IN MORPHOGENESIS | 90 | 1.79e-01 | 8.19e-02 | 6.52e-01 |
| GOCC PARANODAL JUNCTION | 8 | 6.88e-01 | -8.19e-02 | 9.27e-01 |
| GOBP REGULATION OF LEUKOCYTE CHEMOTAXIS | 97 | 1.64e-01 | 8.19e-02 | 6.30e-01 |
| GOBP CELL PROLIFERATION INVOLVED IN HEART MORPHOGENESIS | 11 | 6.38e-01 | 8.18e-02 | 9.15e-01 |
| GOBP REGULATION OF MICROTUBULE NUCLEATION | 19 | 5.37e-01 | -8.18e-02 | 8.79e-01 |
| GOBP STRIATUM DEVELOPMENT | 18 | 5.48e-01 | 8.18e-02 | 8.84e-01 |
| GOBP SUBPALLIUM DEVELOPMENT | 18 | 5.48e-01 | 8.18e-02 | 8.84e-01 |
| GOBP PUTRESCINE METABOLIC PROCESS | 8 | 6.89e-01 | 8.18e-02 | 9.27e-01 |
| GOBP EMBRYONIC BRAIN DEVELOPMENT | 15 | 5.84e-01 | 8.17e-02 | 8.93e-01 |
| GOMF HISTONE H3 METHYLTRANSFERASE ACTIVITY | 39 | 3.77e-01 | -8.17e-02 | 8.10e-01 |
| GOBP NUCLEAR EXPORT | 161 | 7.36e-02 | 8.17e-02 | 4.88e-01 |
| GOMF PEPTIDE ANTIGEN BINDING | 45 | 3.43e-01 | -8.17e-02 | 7.89e-01 |
| GOBP DEFINITIVE HEMOPOIESIS | 19 | 5.38e-01 | -8.17e-02 | 8.79e-01 |
| GOMF HISTONE H4K5 ACETYLTRANSFERASE ACTIVITY | 11 | 6.39e-01 | -8.16e-02 | 9.15e-01 |
| GOBP ENDOSOMAL TRANSPORT | 271 | 2.08e-02 | 8.16e-02 | 3.14e-01 |
| GOBP CELL SUBSTRATE JUNCTION DISASSEMBLY | 8 | 6.89e-01 | 8.16e-02 | 9.27e-01 |
| GOMF T CELL RECEPTOR BINDING | 11 | 6.39e-01 | -8.16e-02 | 9.15e-01 |
| GOBP SENSORY PERCEPTION OF PAIN | 50 | 3.19e-01 | 8.15e-02 | 7.70e-01 |
| GOBP NEGATIVE REGULATION OF CELL CYCLE | 336 | 1.03e-02 | 8.15e-02 | 2.28e-01 |
| GOBP NEGATIVE REGULATION OF FIBROBLAST GROWTH FACTOR RECEPTOR SIGNALING PATHWAY | 13 | 6.11e-01 | -8.14e-02 | 9.04e-01 |
| GOBP PHOSPHATIDIC ACID METABOLIC PROCESS | 30 | 4.40e-01 | -8.14e-02 | 8.40e-01 |
| GOBP POSITIVE REGULATION OF LEUKOCYTE MEDIATED IMMUNITY | 136 | 1.01e-01 | 8.14e-02 | 5.49e-01 |
| GOMF KINASE INHIBITOR ACTIVITY | 73 | 2.29e-01 | 8.14e-02 | 7.02e-01 |
| GOBP MHC CLASS I BIOSYNTHETIC PROCESS | 6 | 7.30e-01 | 8.13e-02 | 9.40e-01 |
| GOBP UTERINE SMOOTH MUSCLE CONTRACTION | 6 | 7.30e-01 | -8.13e-02 | 9.40e-01 |
| GOBP SERTOLI CELL DIFFERENTIATION | 15 | 5.86e-01 | 8.13e-02 | 8.94e-01 |
| GOBP MACROPHAGE DIFFERENTIATION | 51 | 3.15e-01 | 8.13e-02 | 7.67e-01 |
| GOCC MSL COMPLEX | 5 | 7.53e-01 | 8.12e-02 | 9.45e-01 |
| GOBP SYNAPTIC TRANSMISSION GABAERGIC | 36 | 3.99e-01 | 8.12e-02 | 8.22e-01 |
| GOBP POSITIVE REGULATION OF STORE OPERATED CALCIUM CHANNEL ACTIVITY | 5 | 7.53e-01 | 8.12e-02 | 9.45e-01 |
| GOBP PINOCYTOSIS | 20 | 5.30e-01 | -8.12e-02 | 8.78e-01 |
| GOBP POSITIVE REGULATION OF CELL CYCLE PHASE TRANSITION | 98 | 1.65e-01 | 8.12e-02 | 6.30e-01 |
| GOCC PHOTORECEPTOR CONNECTING CILIUM | 35 | 4.06e-01 | 8.11e-02 | 8.26e-01 |
| GOBP CHONDROITIN SULFATE PROTEOGLYCAN METABOLIC PROCESS | 27 | 4.66e-01 | -8.11e-02 | 8.51e-01 |
| GOBP ALDITOL CATABOLIC PROCESS | 6 | 7.31e-01 | 8.11e-02 | 9.40e-01 |
| GOBP POSITIVE REGULATION OF NATURAL KILLER CELL MEDIATED IMMUNE RESPONSE TO TUMOR CELL | 6 | 7.31e-01 | -8.11e-02 | 9.40e-01 |
| GOBP PTERIDINE CONTAINING COMPOUND METABOLIC PROCESS | 32 | 4.27e-01 | 8.11e-02 | 8.34e-01 |
| GOBP REGULATION OF DNA STRAND ELONGATION | 17 | 5.63e-01 | -8.10e-02 | 8.90e-01 |
| GOBP LIPID OXIDATION | 98 | 1.66e-01 | -8.10e-02 | 6.30e-01 |
| GOBP ESTABLISHMENT OF PROTEIN LOCALIZATION TO PEROXISOME | 19 | 5.41e-01 | 8.10e-02 | 8.81e-01 |
| GOBP MEIOTIC CHROMOSOME CONDENSATION | 6 | 7.31e-01 | 8.09e-02 | 9.41e-01 |
| GOBP VASCULAR WOUND HEALING | 15 | 5.87e-01 | 8.09e-02 | 8.95e-01 |
| GOBP DOPAMINE SECRETION | 18 | 5.52e-01 | 8.09e-02 | 8.86e-01 |
| GOBP NUCLEOLUS ORGANIZATION | 18 | 5.53e-01 | -8.08e-02 | 8.86e-01 |
| GOBP REGULATION OF CELL CYCLE | 940 | 2.75e-05 | 8.08e-02 | 5.43e-03 |
| GOBP INTRACELLULAR TRANSPORT | 1246 | 1.66e-06 | 8.07e-02 | 8.50e-04 |
| GOMF CORE PROMOTER SEQUENCE SPECIFIC DNA BINDING | 39 | 3.83e-01 | 8.07e-02 | 8.15e-01 |
| GOBP OUTFLOW TRACT MORPHOGENESIS | 47 | 3.39e-01 | 8.07e-02 | 7.87e-01 |
| GOCC GOLGI CIS CISTERNA | 19 | 5.43e-01 | -8.07e-02 | 8.82e-01 |
| GOBP INDOLALKYLAMINE METABOLIC PROCESS | 11 | 6.43e-01 | 8.07e-02 | 9.15e-01 |
| GOBP CORTICOSTEROID HORMONE SECRETION | 12 | 6.29e-01 | -8.07e-02 | 9.11e-01 |
| GOBP PEPTIDYL LYSINE METHYLATION | 23 | 5.03e-01 | -8.06e-02 | 8.66e-01 |
| GOBP POSITIVE REGULATION OF CELL CYCLE CHECKPOINT | 18 | 5.54e-01 | 8.06e-02 | 8.86e-01 |
| GOBP CARBOHYDRATE DERIVATIVE TRANSPORT | 81 | 2.10e-01 | -8.06e-02 | 6.83e-01 |
| GOCC CORNIFIED ENVELOPE | 23 | 5.04e-01 | 8.06e-02 | 8.66e-01 |
| GOCC TRANSFERASE COMPLEX TRANSFERRING PHOSPHORUS CONTAINING GROUPS | 274 | 2.18e-02 | 8.05e-02 | 3.22e-01 |
| GOBP RESPONSE TO GONADOTROPIN | 18 | 5.54e-01 | -8.05e-02 | 8.87e-01 |
| GOBP INTRINSIC APOPTOTIC SIGNALING PATHWAY IN RESPONSE TO DNA DAMAGE BY P53 CLASS MEDIATOR | 43 | 3.61e-01 | 8.04e-02 | 8.01e-01 |
| GOBP REGULATION OF LEUKOCYTE MEDIATED IMMUNITY | 225 | 3.77e-02 | 8.04e-02 | 3.94e-01 |
| GOBP CELL CYCLE | 1404 | 4.58e-07 | 8.04e-02 | 4.62e-04 |
| GOMF LIM DOMAIN BINDING | 5 | 7.56e-01 | -8.04e-02 | 9.46e-01 |
| GOMF CATALYTIC ACTIVITY ACTING ON RNA | 380 | 7.15e-03 | 8.04e-02 | 1.94e-01 |
| GOBP DEFENSE RESPONSE TO OTHER ORGANISM | 968 | 2.32e-05 | 8.04e-02 | 5.12e-03 |
| GOBP CELL CELL ADHESION MEDIATED BY CADHERIN | 32 | 4.31e-01 | -8.04e-02 | 8.35e-01 |
| GOBP REGULATION OF DOPAMINE SECRETION | 13 | 6.16e-01 | -8.03e-02 | 9.06e-01 |
| GOBP BILE ACID METABOLIC PROCESS | 35 | 4.11e-01 | 8.03e-02 | 8.26e-01 |
| GOBP POSITIVE REGULATION OF MEMBRANE POTENTIAL | 10 | 6.60e-01 | -8.03e-02 | 9.20e-01 |
| GOBP TRANSCRIPTION BY RNA POLYMERASE I | 70 | 2.45e-01 | -8.03e-02 | 7.15e-01 |
| GOBP PHAGOCYTOSIS ENGULFMENT | 45 | 3.52e-01 | 8.03e-02 | 7.94e-01 |
| GOMF NUCLEOSIDE KINASE ACTIVITY | 9 | 6.77e-01 | -8.03e-02 | 9.24e-01 |
| GOBP REGULATION OF LONG TERM SYNAPTIC POTENTIATION | 34 | 4.18e-01 | 8.02e-02 | 8.30e-01 |
| GOMF SPLICING FACTOR BINDING | 6 | 7.34e-01 | 8.02e-02 | 9.41e-01 |
| GOCC DEUTEROSOME | 5 | 7.56e-01 | 8.02e-02 | 9.46e-01 |
| GOBP ORGANELLE LOCALIZATION | 536 | 1.50e-03 | 8.02e-02 | 9.19e-02 |
| GOBP POSITIVE REGULATION OF PHAGOCYTOSIS | 58 | 2.91e-01 | 8.01e-02 | 7.48e-01 |
| GOBP DNA DAMAGE RESPONSE SIGNAL TRANSDUCTION BY P53 CLASS MEDIATOR | 67 | 2.57e-01 | 8.01e-02 | 7.27e-01 |
| GOBP PYRAMIDAL NEURON DIFFERENTIATION | 12 | 6.31e-01 | 8.01e-02 | 9.12e-01 |
| GOBP MANNOSYLATION | 26 | 4.80e-01 | 8.01e-02 | 8.59e-01 |
| GOBP NEURON CELL CELL ADHESION | 8 | 6.95e-01 | 8.00e-02 | 9.27e-01 |
| GOBP INNER EAR MORPHOGENESIS | 59 | 2.88e-01 | -8.00e-02 | 7.47e-01 |
| GOBP HOMOTYPIC CELL CELL ADHESION | 81 | 2.13e-01 | -8.00e-02 | 6.88e-01 |
| GOBP MEMBRANE DEPOLARIZATION DURING ACTION POTENTIAL | 19 | 5.46e-01 | 8.00e-02 | 8.84e-01 |
| GOBP GLIOGENESIS | 258 | 2.71e-02 | -7.99e-02 | 3.53e-01 |
| GOBP STORE OPERATED CALCIUM ENTRY | 19 | 5.47e-01 | -7.98e-02 | 8.84e-01 |
| GOBP REGULATORY T CELL DIFFERENTIATION | 36 | 4.07e-01 | -7.98e-02 | 8.26e-01 |
| GOBP NEURON REMODELING | 10 | 6.62e-01 | -7.98e-02 | 9.21e-01 |
| GOBP PUTRESCINE BIOSYNTHETIC PROCESS | 5 | 7.58e-01 | -7.97e-02 | 9.46e-01 |
| GOCC OXIDOREDUCTASE COMPLEX | 114 | 1.42e-01 | -7.97e-02 | 6.09e-01 |
| GOBP MITOTIC CHROMOSOME CONDENSATION | 19 | 5.48e-01 | -7.97e-02 | 8.84e-01 |
| GOBP CEREBRAL CORTEX NEURON DIFFERENTIATION | 14 | 6.06e-01 | 7.97e-02 | 9.03e-01 |
| GOBP KERATINIZATION | 18 | 5.58e-01 | -7.97e-02 | 8.88e-01 |
| GOMF DYNEIN HEAVY CHAIN BINDING | 13 | 6.19e-01 | 7.96e-02 | 9.07e-01 |
| GOBP MEMBRANE INVAGINATION | 61 | 2.82e-01 | 7.96e-02 | 7.43e-01 |
| GOMF ACETYLGLUCOSAMINYLTRANSFERASE ACTIVITY | 37 | 4.02e-01 | -7.96e-02 | 8.23e-01 |
| GOBP NEGATIVE REGULATION OF CYTOPLASMIC PATTERN RECOGNITION RECEPTOR SIGNALING PATHWAY | 48 | 3.40e-01 | 7.96e-02 | 7.88e-01 |
| GOCC CYTOPLASMIC MICROTUBULE | 76 | 2.30e-01 | 7.96e-02 | 7.03e-01 |
| GOCC BCL 2 FAMILY PROTEIN COMPLEX | 10 | 6.63e-01 | -7.96e-02 | 9.21e-01 |
| GOCC PRESPLICEOSOME | 17 | 5.70e-01 | -7.95e-02 | 8.90e-01 |
| GOBP NUCLEAR ENVELOPE ORGANIZATION | 56 | 3.03e-01 | 7.95e-02 | 7.58e-01 |
| GOBP DEPHOSPHORYLATION | 245 | 3.21e-02 | 7.95e-02 | 3.76e-01 |
| GOBP POSITIVE REGULATION OF SPINDLE ASSEMBLY | 7 | 7.16e-01 | 7.95e-02 | 9.36e-01 |
| GOBP NEGATIVE REGULATION OF CELL SUBSTRATE ADHESION | 48 | 3.41e-01 | -7.95e-02 | 7.88e-01 |
| GOBP RESPONSE TO CHEMOKINE | 66 | 2.64e-01 | 7.95e-02 | 7.31e-01 |
| GOMF DNA HELICASE ACTIVITY | 59 | 2.91e-01 | 7.95e-02 | 7.48e-01 |
| GOBP FATTY ACYL COA BIOSYNTHETIC PROCESS | 25 | 4.92e-01 | 7.95e-02 | 8.62e-01 |
| GOMF VOLTAGE GATED POTASSIUM CHANNEL ACTIVITY | 55 | 3.08e-01 | -7.95e-02 | 7.62e-01 |
| GOCC AMPHISOME | 13 | 6.20e-01 | 7.95e-02 | 9.08e-01 |
| GOBP REGULATION OF NATURAL KILLER CELL MEDIATED IMMUNITY | 47 | 3.46e-01 | 7.94e-02 | 7.90e-01 |
| GOCC INNER KINETOCHORE | 19 | 5.49e-01 | 7.94e-02 | 8.84e-01 |
| GOBP REGULATION OF DIGESTIVE SYSTEM PROCESS | 24 | 5.01e-01 | 7.94e-02 | 8.64e-01 |
| GOBP BIOLOGICAL PROCESS INVOLVED IN INTERSPECIES INTERACTION BETWEEN ORGANISMS | 1371 | 8.45e-07 | 7.94e-02 | 5.61e-04 |
| GOMF EXONUCLEASE ACTIVITY | 87 | 2.01e-01 | 7.93e-02 | 6.72e-01 |
| GOBP REGULATION OF DNA TEMPLATED DNA REPLICATION INITIATION | 14 | 6.07e-01 | -7.93e-02 | 9.03e-01 |
| GOMF PYRIMIDINE NUCLEOSIDE TRANSMEMBRANE TRANSPORTER ACTIVITY | 6 | 7.37e-01 | 7.93e-02 | 9.42e-01 |
| GOMF MOLECULAR CONDENSATE SCAFFOLD ACTIVITY | 35 | 4.17e-01 | 7.92e-02 | 8.30e-01 |
| GOCC NUCLEAR BODY | 781 | 1.68e-04 | 7.92e-02 | 2.18e-02 |
| GOBP PROTEIN MATURATION BY 4FE 4S CLUSTER TRANSFER | 8 | 6.98e-01 | 7.92e-02 | 9.28e-01 |
| GOMF ATP DEPENDENT PROTEIN DISAGGREGASE ACTIVITY | 6 | 7.37e-01 | -7.92e-02 | 9.42e-01 |
| GOMF C X C CHEMOKINE RECEPTOR ACTIVITY | 8 | 6.98e-01 | 7.91e-02 | 9.28e-01 |
| GOMF STEROID DEHYDROGENASE ACTIVITY ACTING ON THE CH OH GROUP OF DONORS NAD OR NADP AS ACCEPTOR | 23 | 5.11e-01 | -7.91e-02 | 8.70e-01 |
| GOBP POST TRANSLATIONAL PROTEIN TARGETING TO ENDOPLASMIC RETICULUM MEMBRANE | 14 | 6.08e-01 | 7.91e-02 | 9.03e-01 |
| GOBP CMP METABOLIC PROCESS | 7 | 7.17e-01 | -7.91e-02 | 9.36e-01 |
| GOMF OXIDOREDUCTASE ACTIVITY ACTING ON A SULFUR GROUP OF DONORS DISULFIDE AS ACCEPTOR | 9 | 6.81e-01 | -7.91e-02 | 9.24e-01 |
| GOCC BLOC 1 COMPLEX | 14 | 6.09e-01 | 7.90e-02 | 9.03e-01 |
| GOBP CELLULAR RESPONSE TO VITAMIN | 21 | 5.31e-01 | -7.89e-02 | 8.78e-01 |
| GOMF ESTROGEN RESPONSE ELEMENT BINDING | 8 | 6.99e-01 | 7.89e-02 | 9.28e-01 |
| GOMF CHEMOKINE RECEPTOR BINDING | 30 | 4.55e-01 | 7.89e-02 | 8.44e-01 |
| GOCC CELL CELL JUNCTION | 385 | 7.91e-03 | -7.89e-02 | 2.04e-01 |
| GOCC NODE OF RANVIER | 10 | 6.66e-01 | -7.88e-02 | 9.22e-01 |
| GOBP POSITIVE REGULATION OF CELL KILLING | 65 | 2.72e-01 | 7.88e-02 | 7.36e-01 |
| GOBP RESOLUTION OF DNA RECOMBINATION INTERMEDIATES | 6 | 7.38e-01 | 7.88e-02 | 9.42e-01 |
| GOBP KIDNEY MESENCHYME DEVELOPMENT | 7 | 7.18e-01 | 7.88e-02 | 9.36e-01 |
| GOBP POSITIVE REGULATION OF CHROMATIN BINDING | 8 | 7.00e-01 | 7.88e-02 | 9.28e-01 |
| GOBP OVULATION CYCLE PROCESS | 33 | 4.34e-01 | 7.88e-02 | 8.36e-01 |
| GOBP RESPONSE TO COPPER ION | 23 | 5.13e-01 | -7.88e-02 | 8.71e-01 |
| GOBP N TERMINAL PROTEIN AMINO ACID ACETYLATION | 14 | 6.10e-01 | 7.88e-02 | 9.03e-01 |
| GOMF DIACYLGLYCEROL DEPENDENT SERINE THREONINE KINASE ACTIVITY | 14 | 6.10e-01 | 7.88e-02 | 9.03e-01 |
| GOBP VENTRICULAR CARDIAC MUSCLE CELL MEMBRANE REPOLARIZATION | 19 | 5.53e-01 | 7.87e-02 | 8.86e-01 |
| GOBP VAGINA DEVELOPMENT | 7 | 7.18e-01 | 7.87e-02 | 9.36e-01 |
| GOBP REGULATION OF UNSATURATED FATTY ACID BIOSYNTHETIC PROCESS | 9 | 6.83e-01 | 7.86e-02 | 9.24e-01 |
| GOBP NEURAL PRECURSOR CELL PROLIFERATION | 114 | 1.47e-01 | 7.86e-02 | 6.13e-01 |
| GOBP ESTABLISHMENT OF PROTEIN LOCALIZATION TO ORGANELLE | 420 | 5.72e-03 | 7.86e-02 | 1.80e-01 |
| GOBP POSITIVE REGULATION OF CARDIAC EPITHELIAL TO MESENCHYMAL TRANSITION | 8 | 7.00e-01 | 7.86e-02 | 9.28e-01 |
| GOCC ENDOLYSOSOME | 29 | 4.64e-01 | -7.86e-02 | 8.50e-01 |
| GOCC COP9 SIGNALOSOME | 36 | 4.15e-01 | -7.86e-02 | 8.29e-01 |
| GOBP POSITIVE REGULATION OF CELL ADHESION MEDIATED BY INTEGRIN | 16 | 5.86e-01 | -7.86e-02 | 8.95e-01 |
| GOBP GASTRULATION WITH MOUTH FORMING SECOND | 21 | 5.33e-01 | -7.85e-02 | 8.79e-01 |
| GOBP TYPE B PANCREATIC CELL APOPTOTIC PROCESS | 7 | 7.19e-01 | 7.85e-02 | 9.36e-01 |
| GOBP SYNAPTIC VESICLE LOCALIZATION | 49 | 3.42e-01 | 7.85e-02 | 7.89e-01 |
| GOBP OOGENESIS | 70 | 2.56e-01 | 7.84e-02 | 7.26e-01 |
| GOBP PHOSPHATIDYLCHOLINE METABOLIC PROCESS | 59 | 2.97e-01 | -7.84e-02 | 7.53e-01 |
| GOBP SEX DETERMINATION | 10 | 6.68e-01 | -7.84e-02 | 9.22e-01 |
| GOMF PHOSPHORUS OXYGEN LYASE ACTIVITY | 17 | 5.76e-01 | -7.84e-02 | 8.92e-01 |
| GOBP DORSAL VENTRAL PATTERN FORMATION | 47 | 3.52e-01 | -7.84e-02 | 7.94e-01 |
| GOBP POSITIVE REGULATION OF MITOCHONDRIAL FUSION | 5 | 7.61e-01 | 7.84e-02 | 9.48e-01 |
| GOMF HISTONE H3K27ME2 H3K27ME3 DEMETHYLASE ACTIVITY | 5 | 7.62e-01 | 7.84e-02 | 9.48e-01 |
| GOCC GOLGI APPARATUS SUBCOMPARTMENT | 338 | 1.33e-02 | 7.83e-02 | 2.50e-01 |
| GOMF 3 5 CYCLIC AMP PHOSPHODIESTERASE ACTIVITY | 18 | 5.65e-01 | 7.83e-02 | 8.90e-01 |
| GOBP PLATELET ACTIVATION | 116 | 1.45e-01 | -7.83e-02 | 6.13e-01 |
| GOBP GAMETE GENERATION | 533 | 2.01e-03 | 7.82e-02 | 1.10e-01 |
| GOMF OXIDOREDUCTASE ACTIVITY ACTING ON PEROXIDE AS ACCEPTOR | 49 | 3.44e-01 | 7.82e-02 | 7.89e-01 |
| GOMF TUBULIN BINDING | 342 | 1.30e-02 | 7.82e-02 | 2.49e-01 |
| GOBP REGULATION OF SMALL MOLECULE METABOLIC PROCESS | 252 | 3.26e-02 | -7.82e-02 | 3.77e-01 |
| GOBP DOUBLE STRAND BREAK REPAIR VIA BREAK INDUCED REPLICATION | 12 | 6.39e-01 | -7.82e-02 | 9.15e-01 |
| GOBP RESPONSE TO SODIUM PHOSPHATE | 9 | 6.85e-01 | -7.82e-02 | 9.25e-01 |
| GOCC MALE GERM CELL NUCLEUS | 43 | 3.75e-01 | 7.81e-02 | 8.09e-01 |
| GOBP POSITIVE REGULATION OF DNA BIOSYNTHETIC PROCESS | 63 | 2.83e-01 | 7.81e-02 | 7.44e-01 |
| GOCC POSTSYNAPTIC SPECIALIZATION | 260 | 3.01e-02 | -7.81e-02 | 3.64e-01 |
| GOBP DENDRITE MORPHOGENESIS | 112 | 1.54e-01 | 7.81e-02 | 6.16e-01 |
| GOBP QUINONE METABOLIC PROCESS | 22 | 5.26e-01 | -7.81e-02 | 8.76e-01 |
| GOBP CELL CYCLE DNA REPLICATION INITIATION | 5 | 7.63e-01 | 7.80e-02 | 9.48e-01 |
| GOBP POSITIVE REGULATION OF LIPOPOLYSACCHARIDE MEDIATED SIGNALING PATHWAY | 10 | 6.69e-01 | -7.80e-02 | 9.22e-01 |
| GOBP REGULATION OF EPIDERMIS DEVELOPMENT | 45 | 3.65e-01 | -7.80e-02 | 8.04e-01 |
| GOMF HISTONE BINDING | 226 | 4.34e-02 | 7.80e-02 | 4.09e-01 |
| GOBP REGULATION OF CALCIDIOL 1 MONOOXYGENASE ACTIVITY | 7 | 7.21e-01 | 7.80e-02 | 9.37e-01 |
| GOMF PHOSPHOLIPID SCRAMBLASE ACTIVITY | 11 | 6.55e-01 | 7.79e-02 | 9.18e-01 |
| GOBP CYTOSOLIC TRANSPORT | 133 | 1.21e-01 | 7.79e-02 | 5.84e-01 |
| GOBP ICOSANOID SECRETION | 25 | 5.01e-01 | 7.78e-02 | 8.64e-01 |
| GOBP SMALL NUCLEOLAR RIBONUCLEOPROTEIN COMPLEX ASSEMBLY | 10 | 6.70e-01 | -7.78e-02 | 9.22e-01 |
| GOBP POSITIVE REGULATION OF PROTEIN LOCALIZATION TO NUCLEUS | 82 | 2.23e-01 | 7.78e-02 | 6.97e-01 |
| GOBP RESPONSE TO FOLLICLE STIMULATING HORMONE | 11 | 6.55e-01 | -7.78e-02 | 9.18e-01 |
| GOBP NUCLEAR MEMBRANE ORGANIZATION | 46 | 3.62e-01 | 7.78e-02 | 8.01e-01 |
| GOBP PYRIMIDINE DEOXYRIBONUCLEOSIDE MONOPHOSPHATE METABOLIC PROCESS | 9 | 6.86e-01 | -7.77e-02 | 9.26e-01 |
| GOBP EYE PHOTORECEPTOR CELL DEVELOPMENT | 21 | 5.38e-01 | -7.77e-02 | 8.79e-01 |
| GOBP EXTRINSIC APOPTOTIC SIGNALING PATHWAY VIA DEATH DOMAIN RECEPTORS | 71 | 2.58e-01 | -7.76e-02 | 7.27e-01 |
| GOBP REGULATION OF HEXOKINASE ACTIVITY | 5 | 7.64e-01 | -7.76e-02 | 9.49e-01 |
| GOBP CELLULAR RESPONSE TO ETHANOL | 11 | 6.56e-01 | 7.76e-02 | 9.18e-01 |
| GOBP GALACTOLIPID METABOLIC PROCESS | 6 | 7.42e-01 | 7.75e-02 | 9.42e-01 |
| GOBP RECEPTOR INTERNALIZATION | 101 | 1.78e-01 | 7.75e-02 | 6.50e-01 |
| GOCC TRANSCRIPTION FACTOR TFIIH HOLO COMPLEX | 12 | 6.42e-01 | 7.75e-02 | 9.15e-01 |
| GOBP CILIUM MOVEMENT | 127 | 1.32e-01 | -7.74e-02 | 5.96e-01 |
| GOMF ORGANIC CATION TRANSMEMBRANE TRANSPORTER ACTIVITY | 52 | 3.35e-01 | 7.73e-02 | 7.84e-01 |
| GOMF OXIDOREDUCTASE ACTIVITY ACTING ON NAD P H QUINONE OR SIMILAR COMPOUND AS ACCEPTOR | 56 | 3.17e-01 | -7.73e-02 | 7.68e-01 |
| GOBP REGULATION OF OLIGODENDROCYTE DIFFERENTIATION | 28 | 4.79e-01 | -7.73e-02 | 8.58e-01 |
| GOMF DNA POLYMERASE ACTIVITY | 28 | 4.79e-01 | 7.73e-02 | 8.58e-01 |
| GOBP HIPPO SIGNALING | 46 | 3.65e-01 | 7.72e-02 | 8.03e-01 |
| GOMF TYPE I TRANSFORMING GROWTH FACTOR BETA RECEPTOR BINDING | 10 | 6.72e-01 | 7.72e-02 | 9.23e-01 |
| GOBP CELLULAR RESPONSE TO CAFFEINE | 9 | 6.88e-01 | -7.72e-02 | 9.27e-01 |
| GOBP EMBRYONIC HEMOPOIESIS | 21 | 5.40e-01 | 7.72e-02 | 8.80e-01 |
| GOBP DETECTION OF CHEMICAL STIMULUS INVOLVED IN SENSORY PERCEPTION OF TASTE | 16 | 5.93e-01 | 7.72e-02 | 8.99e-01 |
| GOBP PLASMA MEMBRANE RAFT ORGANIZATION | 8 | 7.06e-01 | -7.71e-02 | 9.32e-01 |
| GOBP ONE CARBON METABOLIC PROCESS | 33 | 4.43e-01 | -7.71e-02 | 8.41e-01 |
| GOBP REGULATION OF CELLULAR KETONE METABOLIC PROCESS | 101 | 1.81e-01 | -7.71e-02 | 6.54e-01 |
| GOBP ADENYLATE CYCLASE INHIBITING G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY | 50 | 3.46e-01 | -7.71e-02 | 7.90e-01 |
| GOBP IMMUNE RESPONSE REGULATING SIGNALING PATHWAY | 509 | 2.96e-03 | 7.70e-02 | 1.29e-01 |
| GOBP METANEPHRIC RENAL VESICLE MORPHOGENESIS | 7 | 7.24e-01 | 7.70e-02 | 9.38e-01 |
| GOBP CELLULAR RESPONSE TO ALDEHYDE | 13 | 6.31e-01 | -7.69e-02 | 9.12e-01 |
| GOBP DETECTION OF TEMPERATURE STIMULUS | 15 | 6.06e-01 | 7.69e-02 | 9.03e-01 |
| GOBP ADENYLATE CYCLASE ACTIVATING ADRENERGIC RECEPTOR SIGNALING PATHWAY | 11 | 6.59e-01 | 7.69e-02 | 9.19e-01 |
| GOBP VESICLE CYTOSKELETAL TRAFFICKING | 57 | 3.15e-01 | 7.69e-02 | 7.67e-01 |
| GOBP SMOOTHENED SIGNALING PATHWAY | 119 | 1.47e-01 | 7.69e-02 | 6.13e-01 |
| GOBP NEGATIVE REGULATION OF STRESS ACTIVATED PROTEIN KINASE SIGNALING CASCADE | 8 | 7.07e-01 | -7.68e-02 | 9.32e-01 |
| GOBP REGULATION OF HEMATOPOIETIC PROGENITOR CELL DIFFERENTIATION | 35 | 4.32e-01 | 7.67e-02 | 8.36e-01 |
| GOBP NEGATIVE REGULATION OF CELLULAR RESPONSE TO INSULIN STIMULUS | 37 | 4.19e-01 | -7.67e-02 | 8.30e-01 |
| GOMF MAP KINASE KINASE KINASE ACTIVITY | 24 | 5.15e-01 | 7.67e-02 | 8.71e-01 |
| GOMF NUCLEOBASE CONTAINING COMPOUND KINASE ACTIVITY | 39 | 4.07e-01 | 7.67e-02 | 8.26e-01 |
| GOBP CYCLIC NUCLEOTIDE TRANSPORT | 10 | 6.75e-01 | 7.67e-02 | 9.23e-01 |
| GOCC PROTON TRANSPORTING ATP SYNTHASE COMPLEX | 21 | 5.43e-01 | -7.67e-02 | 8.82e-01 |
| GOMF ATP HYDROLYSIS ACTIVITY | 374 | 1.09e-02 | 7.67e-02 | 2.37e-01 |
| GOBP REGULATION OF CELL CYCLE G1 S PHASE TRANSITION | 163 | 9.13e-02 | 7.67e-02 | 5.27e-01 |
| GOBP POSITIVE REGULATION OF SYNAPTIC VESICLE RECYCLING | 7 | 7.26e-01 | 7.66e-02 | 9.38e-01 |
| GOBP PYRUVATE FAMILY AMINO ACID METABOLIC PROCESS | 9 | 6.91e-01 | -7.66e-02 | 9.27e-01 |
| GOMF AMIDE TRANSMEMBRANE TRANSPORTER ACTIVITY | 29 | 4.76e-01 | -7.65e-02 | 8.57e-01 |
| GOBP REGULATION OF MULTICELLULAR ORGANISM GROWTH | 48 | 3.59e-01 | 7.65e-02 | 7.99e-01 |
| GOMF ACYLTRANSFERASE ACTIVITY | 627 | 1.08e-03 | 7.65e-02 | 7.42e-02 |
| GOBP POSITIVE REGULATION OF INTERLEUKIN 8 PRODUCTION | 50 | 3.50e-01 | -7.64e-02 | 7.93e-01 |
| GOMF PRIMARY ACTIVE TRANSMEMBRANE TRANSPORTER ACTIVITY | 142 | 1.16e-01 | -7.64e-02 | 5.74e-01 |
| GOBP INORGANIC ANION TRANSMEMBRANE TRANSPORT | 80 | 2.37e-01 | -7.64e-02 | 7.08e-01 |
| GOBP MOTOR BEHAVIOR | 18 | 5.75e-01 | 7.64e-02 | 8.92e-01 |
| GOCC PHAGOPHORE ASSEMBLY SITE | 35 | 4.34e-01 | 7.63e-02 | 8.36e-01 |
| GOBP NEGATIVE REGULATION OF SMALL GTPASE MEDIATED SIGNAL TRANSDUCTION | 48 | 3.60e-01 | 7.63e-02 | 8.00e-01 |
| GOCC EARLY ENDOSOME | 386 | 1.02e-02 | 7.62e-02 | 2.27e-01 |
| GOBP XENOBIOTIC TRANSMEMBRANE TRANSPORT | 15 | 6.09e-01 | 7.62e-02 | 9.03e-01 |
| GOCC CATALYTIC COMPLEX | 1589 | 4.17e-07 | 7.62e-02 | 4.62e-04 |
| GOMF THIOLESTER HYDROLASE ACTIVITY | 38 | 4.17e-01 | 7.61e-02 | 8.30e-01 |
| GOBP CELL SUBSTRATE ADHESION | 287 | 2.65e-02 | -7.61e-02 | 3.52e-01 |
| GOBP AMINO ACID BETAINE METABOLIC PROCESS | 13 | 6.35e-01 | 7.61e-02 | 9.14e-01 |
| GOBP NEGATIVE REGULATION OF REGULATED SECRETORY PATHWAY | 20 | 5.56e-01 | 7.61e-02 | 8.87e-01 |
| GOBP TERPENOID METABOLIC PROCESS | 56 | 3.24e-01 | -7.61e-02 | 7.75e-01 |
| GOBP POSTSYNAPTIC DENSITY ASSEMBLY | 16 | 5.98e-01 | -7.61e-02 | 9.02e-01 |
| GOBP ESTABLISHMENT OF SPINDLE ORIENTATION | 35 | 4.36e-01 | 7.61e-02 | 8.37e-01 |
| GOBP POSITIVE REGULATION OF LYMPHOCYTE MIGRATION | 36 | 4.30e-01 | 7.60e-02 | 8.35e-01 |
| GOMF RNA POLYMERASE II C TERMINAL DOMAIN BINDING | 10 | 6.77e-01 | 7.60e-02 | 9.24e-01 |
| GOBP NEGATIVE REGULATION OF EPITHELIAL CELL PROLIFERATION | 98 | 1.94e-01 | 7.60e-02 | 6.67e-01 |
| GOBP NEGATIVE REGULATION OF MACROPHAGE DIFFERENTIATION | 5 | 7.69e-01 | 7.59e-02 | 9.51e-01 |
| GOCC PLATELET ALPHA GRANULE LUMEN | 52 | 3.44e-01 | -7.59e-02 | 7.89e-01 |
| GOBP MACROMOLECULE DEACYLATION | 56 | 3.26e-01 | -7.59e-02 | 7.77e-01 |
| GOMF NF KAPPAB BINDING | 29 | 4.79e-01 | -7.59e-02 | 8.58e-01 |
| GOBP NEGATIVE ADAPTATION OF SIGNALING PATHWAY | 11 | 6.63e-01 | -7.59e-02 | 9.21e-01 |
| GOBP POSITIVE REGULATION OF T CELL MEDIATED IMMUNITY | 59 | 3.14e-01 | 7.58e-02 | 7.66e-01 |
| GOMF HYDROLASE ACTIVITY HYDROLYZING O GLYCOSYL COMPOUNDS | 70 | 2.73e-01 | -7.58e-02 | 7.36e-01 |
| GOBP CELL CELL JUNCTION ORGANIZATION | 159 | 9.90e-02 | -7.58e-02 | 5.46e-01 |
| GOCC CATION CHANNEL COMPLEX | 134 | 1.30e-01 | -7.58e-02 | 5.94e-01 |
| GOBP NEGATIVE REGULATION OF CELL JUNCTION ASSEMBLY | 24 | 5.20e-01 | -7.58e-02 | 8.74e-01 |
| GOBP POSITIVE REGULATION OF RAS PROTEIN SIGNAL TRANSDUCTION | 12 | 6.49e-01 | 7.58e-02 | 9.17e-01 |
| GOBP B CELL RECEPTOR SIGNALING PATHWAY | 72 | 2.67e-01 | 7.57e-02 | 7.33e-01 |
| GOBP SPLICEOSOMAL SNRNP ASSEMBLY | 40 | 4.08e-01 | -7.57e-02 | 8.26e-01 |
| GOMF CALMODULIN BINDING | 152 | 1.08e-01 | -7.56e-02 | 5.61e-01 |
| GOMF GROWTH FACTOR BINDING | 104 | 1.83e-01 | -7.56e-02 | 6.55e-01 |
| GOBP CORONARY VASCULATURE MORPHOGENESIS | 14 | 6.25e-01 | 7.55e-02 | 9.09e-01 |
| GOBP ORGANELLE TRANSPORT ALONG MICROTUBULE | 84 | 2.31e-01 | 7.55e-02 | 7.04e-01 |
| GOBP OLIGODENDROCYTE DEVELOPMENT | 34 | 4.46e-01 | -7.55e-02 | 8.42e-01 |
| GOBP SYNAPTIC TRANSMISSION GLUTAMATERGIC | 67 | 2.85e-01 | 7.55e-02 | 7.45e-01 |
| GOMF OXIDOREDUCTASE ACTIVITY ACTING ON PAIRED DONORS WITH INCORPORATION OR REDUCTION OF MOLECULAR OXYGEN NAD P H AS ONE DONOR AND INCORPORATION OF ONE ATOM OF OXYGEN | 22 | 5.40e-01 | -7.55e-02 | 8.80e-01 |
| GOBP GANGLIOSIDE METABOLIC PROCESS | 21 | 5.49e-01 | -7.55e-02 | 8.84e-01 |
| GOCC CHROMOSOME PASSENGER COMPLEX | 6 | 7.49e-01 | -7.54e-02 | 9.44e-01 |
| GOMF PHOSPHATE ION BINDING | 10 | 6.80e-01 | 7.54e-02 | 9.24e-01 |
| GOBP CARDIAC CONDUCTION | 65 | 2.93e-01 | 7.54e-02 | 7.50e-01 |
| GOBP REGULATION OF RESPONSE TO OXIDATIVE STRESS | 32 | 4.61e-01 | 7.53e-02 | 8.48e-01 |
| GOBP PYRIMIDINE NUCLEOBASE BIOSYNTHETIC PROCESS | 7 | 7.30e-01 | -7.53e-02 | 9.40e-01 |
| GOBP POSITIVE REGULATION OF CHEMOKINE C X C MOTIF LIGAND 2 PRODUCTION | 10 | 6.80e-01 | -7.53e-02 | 9.24e-01 |
| GOBP ESTABLISHMENT OF LOCALIZATION IN CELL | 1707 | 2.38e-07 | 7.53e-02 | 3.69e-04 |
| GOBP WNT SIGNALING PATHWAY PLANAR CELL POLARITY PATHWAY | 38 | 4.22e-01 | -7.52e-02 | 8.30e-01 |
| GOMF CALCIUM DEPENDENT PROTEIN KINASE ACTIVITY | 8 | 7.12e-01 | -7.52e-02 | 9.35e-01 |
| GOCC NUCLEAR OUTER MEMBRANE ENDOPLASMIC RETICULUM MEMBRANE NETWORK | 1025 | 4.68e-05 | 7.52e-02 | 8.33e-03 |
| GOBP POSITIVE REGULATION OF AXON EXTENSION | 30 | 4.76e-01 | -7.52e-02 | 8.57e-01 |
| GOBP NEGATIVE REGULATION OF RYANODINE SENSITIVE CALCIUM RELEASE CHANNEL ACTIVITY | 8 | 7.13e-01 | 7.52e-02 | 9.35e-01 |
| GOMF RS DOMAIN BINDING | 5 | 7.71e-01 | 7.51e-02 | 9.52e-01 |
| GOMF DNA BINDING TRANSCRIPTION FACTOR ACTIVITY | 1025 | 4.84e-05 | 7.51e-02 | 8.33e-03 |
| GOCC I BAND | 102 | 1.90e-01 | 7.51e-02 | 6.62e-01 |
| GOBP CELLULAR RESPONSE TO STARVATION | 151 | 1.11e-01 | 7.51e-02 | 5.65e-01 |
| GOBP CERAMIDE BIOSYNTHETIC PROCESS | 56 | 3.31e-01 | 7.51e-02 | 7.82e-01 |
| GOMF OXIDOREDUCTASE ACTIVITY ACTING ON THE ALDEHYDE OR OXO GROUP OF DONORS | 36 | 4.36e-01 | 7.50e-02 | 8.37e-01 |
| GOBP REGULATION OF LIPOPROTEIN PARTICLE CLEARANCE | 14 | 6.27e-01 | -7.50e-02 | 9.11e-01 |
| GOBP ESTABLISHMENT OF PIGMENT GRANULE LOCALIZATION | 19 | 5.72e-01 | 7.50e-02 | 8.91e-01 |
| GOBP CYCLIC GMP AMP TRANSMEMBRANE IMPORT ACROSS PLASMA MEMBRANE | 7 | 7.31e-01 | 7.49e-02 | 9.41e-01 |
| GOMF ANTIGEN BINDING | 149 | 1.15e-01 | -7.49e-02 | 5.72e-01 |
| GOBP MITOCHONDRIAL FRAGMENTATION INVOLVED IN APOPTOTIC PROCESS | 9 | 6.97e-01 | -7.48e-02 | 9.28e-01 |
| GOMF LIPID TRANSFER ACTIVITY | 45 | 3.86e-01 | -7.48e-02 | 8.15e-01 |
| GOMF PROTEIN SERINE THREONINE KINASE INHIBITOR ACTIVITY | 36 | 4.38e-01 | -7.48e-02 | 8.39e-01 |
| GOMF PHOSPHATIDYLINOSITOL 4 5 BISPHOSPHATE PHOSPHATASE ACTIVITY | 11 | 6.68e-01 | -7.47e-02 | 9.22e-01 |
| GOBP INTRACELLULAR PROTEIN TRANSPORT | 622 | 1.47e-03 | 7.47e-02 | 9.09e-02 |
| GOBP PROTEIN CATABOLIC PROCESS | 901 | 1.44e-04 | 7.47e-02 | 2.03e-02 |
| GOMF NUCLEOSIDE TRIPHOSPHATASE REGULATOR ACTIVITY | 452 | 6.51e-03 | -7.47e-02 | 1.89e-01 |
| GOBP NEGATIVE REGULATION OF NUCLEOTIDE CATABOLIC PROCESS | 18 | 5.83e-01 | -7.47e-02 | 8.93e-01 |
| GOMF SH3 DOMAIN BINDING | 110 | 1.76e-01 | -7.47e-02 | 6.46e-01 |
| GOBP REGULATION OF LYSOSOME ORGANIZATION | 12 | 6.54e-01 | -7.46e-02 | 9.18e-01 |
| GOBP POSITIVE REGULATION OF CYTOKINE PRODUCTION | 418 | 8.89e-03 | 7.46e-02 | 2.18e-01 |
| GOMF TASTE RECEPTOR ACTIVITY | 9 | 6.98e-01 | 7.46e-02 | 9.28e-01 |
| GOBP NON PROTEINOGENIC AMINO ACID BIOSYNTHETIC PROCESS | 13 | 6.42e-01 | 7.46e-02 | 9.15e-01 |
| GOMF CARBOHYDRATE PROTON SYMPORTER ACTIVITY | 6 | 7.52e-01 | -7.46e-02 | 9.45e-01 |
| GOCC NUCLEAR SPECK | 388 | 1.17e-02 | 7.45e-02 | 2.43e-01 |
| GOBP PLASMA MEMBRANE TUBULATION | 18 | 5.84e-01 | 7.45e-02 | 8.93e-01 |
| GOBP RESPONSE TO NICOTINE | 30 | 4.80e-01 | 7.45e-02 | 8.59e-01 |
| GOBP APICAL JUNCTION ASSEMBLY | 55 | 3.40e-01 | -7.44e-02 | 7.88e-01 |
| GOCC INNER MITOCHONDRIAL MEMBRANE PROTEIN COMPLEX | 153 | 1.12e-01 | -7.44e-02 | 5.67e-01 |
| GOBP NEGATIVE REGULATION OF ACTIVIN RECEPTOR SIGNALING PATHWAY | 12 | 6.55e-01 | -7.44e-02 | 9.18e-01 |
| GOMF INTERMEDIATE FILAMENT BINDING | 7 | 7.33e-01 | 7.44e-02 | 9.41e-01 |
| GOBP AUTOPHAGY OF MITOCHONDRION | 100 | 1.99e-01 | -7.44e-02 | 6.71e-01 |
| GOMF DNA METHYLTRANSFERASE ACTIVITY | 6 | 7.52e-01 | -7.44e-02 | 9.45e-01 |
| GOBP LUNG ALVEOLUS DEVELOPMENT | 34 | 4.53e-01 | 7.44e-02 | 8.43e-01 |
| GOMF GLYCOSYLTRANSFERASE ACTIVITY | 217 | 5.92e-02 | 7.43e-02 | 4.53e-01 |
| GOBP PEPTIDYL PROLINE HYDROXYLATION TO 4 HYDROXY L PROLINE | 7 | 7.33e-01 | -7.43e-02 | 9.41e-01 |
| GOMF PEPTIDYL PROLINE 4 DIOXYGENASE ACTIVITY | 7 | 7.33e-01 | -7.43e-02 | 9.41e-01 |
| GOBP REGULATION OF NEUROTROPHIN TRK RECEPTOR SIGNALING PATHWAY | 8 | 7.16e-01 | 7.43e-02 | 9.36e-01 |
| GOMF SPHINGOMYELIN PHOSPHODIESTERASE ACTIVITY | 6 | 7.53e-01 | -7.43e-02 | 9.45e-01 |
| GOBP SYNAPTIC VESICLE PRIMING | 15 | 6.18e-01 | -7.43e-02 | 9.07e-01 |
| GOBP CEREBELLAR GRANULAR LAYER MORPHOGENESIS | 6 | 7.53e-01 | 7.43e-02 | 9.45e-01 |
| GOBP PHENOL CONTAINING COMPOUND BIOSYNTHETIC PROCESS | 30 | 4.82e-01 | 7.42e-02 | 8.59e-01 |
| GOBP UTERUS DEVELOPMENT | 16 | 6.07e-01 | 7.42e-02 | 9.03e-01 |
| GOBP PHAGOSOME LYSOSOME FUSION | 12 | 6.56e-01 | 7.42e-02 | 9.18e-01 |
| GOBP NEUROENDOCRINE CELL DIFFERENTIATION | 8 | 7.16e-01 | 7.42e-02 | 9.36e-01 |
| GOBP REGULATION OF RESPONSE TO EXTERNAL STIMULUS | 878 | 1.95e-04 | 7.41e-02 | 2.41e-02 |
| GOBP REGULATION OF CARDIAC MUSCLE CONTRACTION BY CALCIUM ION SIGNALING | 20 | 5.66e-01 | 7.41e-02 | 8.90e-01 |
| GOBP GLUTATHIONE CATABOLIC PROCESS | 5 | 7.74e-01 | 7.41e-02 | 9.54e-01 |
| GOMF MRNA 3 UTR BINDING | 89 | 2.27e-01 | 7.41e-02 | 7.00e-01 |
| GOBP RESPONSE TO CAFFEINE | 13 | 6.44e-01 | 7.40e-02 | 9.15e-01 |
| GOBP RENAL SYSTEM PROCESS | 83 | 2.44e-01 | -7.40e-02 | 7.13e-01 |
| GOBP CILIUM OR FLAGELLUM DEPENDENT CELL MOTILITY | 102 | 1.97e-01 | -7.40e-02 | 6.69e-01 |
| GOMF SNAP RECEPTOR ACTIVITY | 35 | 4.49e-01 | 7.39e-02 | 8.43e-01 |
| GOBP REGULATION OF CHEMOKINE MEDIATED SIGNALING PATHWAY | 8 | 7.17e-01 | 7.39e-02 | 9.36e-01 |
| GOBP POSITIVE REGULATION OF MITOCHONDRIAL FISSION | 19 | 5.77e-01 | 7.39e-02 | 8.92e-01 |
| GOBP CELLULAR RESPONSE TO TOXIC SUBSTANCE | 110 | 1.81e-01 | 7.39e-02 | 6.54e-01 |
| GOMF UDP GALACTOSE BETA N ACETYLGLUCOSAMINE BETA 1 3 GALACTOSYLTRANSFERASE ACTIVITY | 9 | 7.01e-01 | -7.39e-02 | 9.29e-01 |
| GOBP MALE GAMETE GENERATION | 414 | 9.92e-03 | 7.39e-02 | 2.25e-01 |
| GOMF DIOXYGENASE ACTIVITY | 81 | 2.50e-01 | -7.39e-02 | 7.18e-01 |
| GOBP POSITIVE REGULATION OF BEHAVIOR | 14 | 6.32e-01 | -7.39e-02 | 9.12e-01 |
| GOBP DICARBOXYLIC ACID METABOLIC PROCESS | 78 | 2.60e-01 | 7.38e-02 | 7.28e-01 |
| GOBP RECEPTOR LOCALIZATION TO SYNAPSE | 47 | 3.81e-01 | -7.38e-02 | 8.14e-01 |
| GOBP SYNAPTIC VESICLE RECYCLING | 70 | 2.86e-01 | -7.38e-02 | 7.45e-01 |
| GOBP TONIC SMOOTH MUSCLE CONTRACTION | 5 | 7.75e-01 | -7.38e-02 | 9.54e-01 |
| GOBP NEGATIVE REGULATION OF TELOMERASE ACTIVITY | 8 | 7.18e-01 | -7.38e-02 | 9.36e-01 |
| GOBP PROTEIN HOMOTETRAMERIZATION | 51 | 3.62e-01 | -7.38e-02 | 8.01e-01 |
| GOBP INTRACELLULAR GLUCOSE HOMEOSTASIS | 121 | 1.61e-01 | -7.38e-02 | 6.28e-01 |
| GOBP MYELOID LEUKOCYTE CYTOKINE PRODUCTION | 45 | 3.92e-01 | 7.37e-02 | 8.19e-01 |
| GOBP CELLULAR RESPONSE TO IRON ION | 7 | 7.36e-01 | -7.37e-02 | 9.42e-01 |
| GOBP NEGATIVE REGULATION OF DOUBLE STRAND BREAK REPAIR VIA HOMOLOGOUS RECOMBINATION | 26 | 5.15e-01 | -7.37e-02 | 8.71e-01 |
| GOBP CAP DEPENDENT TRANSLATIONAL INITIATION | 7 | 7.36e-01 | -7.37e-02 | 9.42e-01 |
| GOBP G PROTEIN COUPLED SEROTONIN RECEPTOR SIGNALING PATHWAY | 8 | 7.18e-01 | -7.37e-02 | 9.36e-01 |
| GOCC MITOTIC SPINDLE | 169 | 9.86e-02 | 7.37e-02 | 5.45e-01 |
| GOMF LIPID KINASE ACTIVITY | 39 | 4.26e-01 | 7.36e-02 | 8.33e-01 |
| GOMF SODIUM PHOSPHATE SYMPORTER ACTIVITY | 6 | 7.55e-01 | -7.36e-02 | 9.45e-01 |
| GOBP LONG TERM MEMORY | 27 | 5.08e-01 | -7.36e-02 | 8.69e-01 |
| GOBP NEGATIVE REGULATION OF HYDROLASE ACTIVITY | 140 | 1.33e-01 | 7.36e-02 | 5.98e-01 |
| GOBP BIOLOGICAL PROCESS INVOLVED IN INTERACTION WITH HOST | 167 | 1.01e-01 | 7.35e-02 | 5.49e-01 |
| GOBP FEAR RESPONSE | 31 | 4.79e-01 | 7.35e-02 | 8.58e-01 |
| GOBP IMMATURE B CELL DIFFERENTIATION | 11 | 6.73e-01 | 7.35e-02 | 9.23e-01 |
| GOBP REGULATION OF RECEPTOR MEDIATED ENDOCYTOSIS | 88 | 2.33e-01 | 7.35e-02 | 7.05e-01 |
| GOBP REGULATION OF PROTEIN AUTOPHOSPHORYLATION | 33 | 4.65e-01 | 7.35e-02 | 8.51e-01 |
| GOBP SULFUR AMINO ACID TRANSPORT | 10 | 6.87e-01 | -7.35e-02 | 9.27e-01 |
| GOBP NEUROTRANSMITTER RECEPTOR INTERNALIZATION | 26 | 5.17e-01 | 7.35e-02 | 8.72e-01 |
| GOBP POSITIVE REGULATION OF ERAD PATHWAY | 16 | 6.11e-01 | 7.34e-02 | 9.04e-01 |
| GOMF HYDROLASE ACTIVITY ACTING ON CARBON NITROGEN BUT NOT PEPTIDE BONDS IN LINEAR AMIDES | 69 | 2.92e-01 | -7.34e-02 | 7.49e-01 |
| GOMF SERINE TYPE EXOPEPTIDASE ACTIVITY | 11 | 6.73e-01 | 7.34e-02 | 9.23e-01 |
| GOBP GLAND MORPHOGENESIS | 84 | 2.45e-01 | 7.34e-02 | 7.15e-01 |
| GOBP REGULATION OF SPINDLE ORGANIZATION | 45 | 3.95e-01 | 7.33e-02 | 8.20e-01 |
| GOBP EMBRYONIC FORELIMB MORPHOGENESIS | 15 | 6.23e-01 | -7.33e-02 | 9.09e-01 |
| GOBP REGULATION OF SPROUTING ANGIOGENESIS | 33 | 4.66e-01 | -7.33e-02 | 8.51e-01 |
| GOBP CELLULAR RESPONSE TO PROSTAGLANDIN E STIMULUS | 14 | 6.35e-01 | -7.33e-02 | 9.14e-01 |
| GOBP SMALL MOLECULE CATABOLIC PROCESS | 310 | 2.65e-02 | -7.33e-02 | 3.52e-01 |
| GOBP BLOOD VESSEL REMODELING | 32 | 4.73e-01 | -7.33e-02 | 8.55e-01 |
| GOBP REGULATION OF MITOTIC CELL CYCLE | 448 | 7.87e-03 | 7.33e-02 | 2.04e-01 |
| GOMF POLYAMINE TRANSMEMBRANE TRANSPORTER ACTIVITY | 7 | 7.37e-01 | -7.33e-02 | 9.42e-01 |
| GOBP NEGATIVE REGULATION OF CELLULAR RESPONSE TO HYPOXIA | 8 | 7.20e-01 | 7.32e-02 | 9.37e-01 |
| GOBP ESTABLISHMENT OF PROTEIN LOCALIZATION TO CHROMOSOME | 27 | 5.10e-01 | 7.32e-02 | 8.70e-01 |
| GOBP DNA REPLICATION | 266 | 4.00e-02 | 7.32e-02 | 3.99e-01 |
| GOMF BETA GALACTOSIDE CMP ALPHA 2 3 SIALYLTRANSFERASE ACTIVITY | 6 | 7.57e-01 | 7.30e-02 | 9.46e-01 |
| GOBP SIRNA MEDIATED RETROTRANSPOSON SILENCING BY HETEROCHROMATIN FORMATION | 5 | 7.78e-01 | 7.29e-02 | 9.54e-01 |
| GOBP SEROTONIN SECRETION | 7 | 7.38e-01 | -7.29e-02 | 9.42e-01 |
| GOMF ASPARTIC TYPE PEPTIDASE ACTIVITY | 21 | 5.63e-01 | 7.29e-02 | 8.90e-01 |
| GOBP REGULATION OF PHOSPHOLIPID METABOLIC PROCESS | 24 | 5.37e-01 | -7.28e-02 | 8.79e-01 |
| GOBP MYELOID CELL HOMEOSTASIS | 163 | 1.09e-01 | 7.28e-02 | 5.62e-01 |
| GOBP PEPTIDE CROSS LINKING | 16 | 6.15e-01 | -7.26e-02 | 9.05e-01 |
| GOBP RESPONSE TO PROTOZOAN | 27 | 5.14e-01 | -7.26e-02 | 8.71e-01 |
| GOBP VESICLE MEDIATED TRANSPORT TO THE PLASMA MEMBRANE | 139 | 1.40e-01 | 7.26e-02 | 6.06e-01 |
| GOBP REGULATION OF MUCUS SECRETION | 8 | 7.22e-01 | -7.26e-02 | 9.38e-01 |
| GOBP GOLGI TO LYSOSOME TRANSPORT | 11 | 6.77e-01 | -7.25e-02 | 9.24e-01 |
| GOBP REGULATION OF PHAGOCYTOSIS | 83 | 2.54e-01 | 7.25e-02 | 7.22e-01 |
| GOCC NON MOTILE CILIUM | 119 | 1.73e-01 | 7.24e-02 | 6.40e-01 |
| GOBP POSITIVE REGULATION OF EXOCYTOSIS | 62 | 3.24e-01 | 7.24e-02 | 7.75e-01 |
| GOBP RESPONSE TO OSMOTIC STRESS | 74 | 2.82e-01 | -7.23e-02 | 7.43e-01 |
| GOBP ENDOPLASMIC RETICULUM CALCIUM ION HOMEOSTASIS | 25 | 5.31e-01 | 7.23e-02 | 8.79e-01 |
| GOCC ACTIN CYTOSKELETON | 421 | 1.10e-02 | -7.23e-02 | 2.38e-01 |
| GOBP MANGANESE ION TRANSPORT | 10 | 6.92e-01 | 7.23e-02 | 9.27e-01 |
| GOBP SULFUR COMPOUND BIOSYNTHETIC PROCESS | 139 | 1.41e-01 | 7.23e-02 | 6.08e-01 |
| GOBP MONOCARBOXYLIC ACID CATABOLIC PROCESS | 111 | 1.88e-01 | -7.23e-02 | 6.62e-01 |
| GOMF PHOSPHATIDYLCHOLINE FLOPPASE ACTIVITY | 8 | 7.23e-01 | 7.23e-02 | 9.38e-01 |
| GOBP TELOMERE MAINTENANCE VIA TELOMERE LENGTHENING | 78 | 2.70e-01 | 7.23e-02 | 7.35e-01 |
| GOBP NEGATIVE REGULATION OF PEPTIDYL THREONINE PHOSPHORYLATION | 16 | 6.17e-01 | -7.22e-02 | 9.06e-01 |
| GOBP POSITIVE REGULATION OF CALCINEURIN MEDIATED SIGNALING | 16 | 6.17e-01 | 7.22e-02 | 9.06e-01 |
| GOBP REGULATION OF SYNAPTIC VESICLE RECYCLING | 24 | 5.40e-01 | 7.22e-02 | 8.80e-01 |
| GOCC PHAGOCYTIC VESICLE MEMBRANE | 76 | 2.77e-01 | 7.22e-02 | 7.39e-01 |
| GOCC SYNAPTIC VESICLE MEMBRANE | 96 | 2.22e-01 | 7.21e-02 | 6.97e-01 |
| GOBP AXON ENSHEATHMENT IN CENTRAL NERVOUS SYSTEM | 16 | 6.17e-01 | 7.21e-02 | 9.06e-01 |
| GOMF PHOSPHATIDYLINOSITOL 3 KINASE ACTIVATOR ACTIVITY | 5 | 7.80e-01 | 7.21e-02 | 9.55e-01 |
| GOCC CULLIN RING UBIQUITIN LIGASE COMPLEX | 167 | 1.08e-01 | 7.21e-02 | 5.61e-01 |
| GOBP REGULATION OF SKELETAL MUSCLE TISSUE DEVELOPMENT | 16 | 6.18e-01 | -7.21e-02 | 9.06e-01 |
| GOBP ISOTYPE SWITCHING TO IGA ISOTYPES | 7 | 7.41e-01 | -7.20e-02 | 9.42e-01 |
| GOBP MACROMOLECULE CATABOLIC PROCESS | 1247 | 1.91e-05 | 7.20e-02 | 4.67e-03 |
| GOBP MAMMARY GLAND EPITHELIAL CELL PROLIFERATION | 23 | 5.50e-01 | -7.20e-02 | 8.84e-01 |
| GOCC EMC COMPLEX | 10 | 6.93e-01 | 7.20e-02 | 9.27e-01 |
| GOBP RESPONSE TO AUDITORY STIMULUS | 19 | 5.87e-01 | 7.20e-02 | 8.95e-01 |
| GOBP MAST CELL CHEMOTAXIS | 8 | 7.25e-01 | -7.19e-02 | 9.38e-01 |
| GOBP REGULATION OF LYSOSOME SIZE | 8 | 7.25e-01 | -7.19e-02 | 9.38e-01 |
| GOCC BORC COMPLEX | 8 | 7.25e-01 | -7.19e-02 | 9.38e-01 |
| GOBP CELLULAR RESPONSE TO HEAT | 56 | 3.52e-01 | 7.19e-02 | 7.94e-01 |
| GOBP NEGATIVE REGULATION OF MULTICELLULAR ORGANISM GROWTH | 10 | 6.94e-01 | -7.19e-02 | 9.27e-01 |
| GOCC SWI SNF COMPLEX | 29 | 5.03e-01 | -7.19e-02 | 8.66e-01 |
| GOCC CONDENSED NUCLEAR CHROMOSOME | 66 | 3.12e-01 | 7.19e-02 | 7.65e-01 |
| GOBP RESPONSE TO EPINEPHRINE | 11 | 6.80e-01 | -7.19e-02 | 9.24e-01 |
| GOBP CHAPERONE COFACTOR DEPENDENT PROTEIN REFOLDING | 32 | 4.82e-01 | 7.19e-02 | 8.59e-01 |
| GOBP MEMORY | 90 | 2.39e-01 | 7.18e-02 | 7.08e-01 |
| GOBP CELLULAR RESPONSE TO ZINC ION | 12 | 6.67e-01 | 7.18e-02 | 9.22e-01 |
| GOBP GLUTAMATERGIC NEURON DIFFERENTIATION | 10 | 6.94e-01 | 7.18e-02 | 9.27e-01 |
| GOBP REGULATION OF MYOBLAST FUSION | 17 | 6.08e-01 | 7.18e-02 | 9.03e-01 |
| GOBP REGULATION OF CELL JUNCTION ASSEMBLY | 157 | 1.21e-01 | -7.18e-02 | 5.84e-01 |
| GOBP NEURAL TUBE FORMATION | 86 | 2.50e-01 | -7.18e-02 | 7.18e-01 |
| GOMF DNA DEMETHYLASE ACTIVITY | 5 | 7.81e-01 | 7.18e-02 | 9.56e-01 |
| GOBP REGULATION OF ISOTYPE SWITCHING | 37 | 4.50e-01 | 7.18e-02 | 8.43e-01 |
| GOBP ACTIVATION OF IMMUNE RESPONSE | 512 | 5.51e-03 | 7.17e-02 | 1.79e-01 |
| GOBP NEGATIVE REGULATION OF HYDROGEN PEROXIDE MEDIATED PROGRAMMED CELL DEATH | 6 | 7.61e-01 | -7.17e-02 | 9.48e-01 |
| GOCC GOLGI MEMBRANE | 600 | 2.72e-03 | 7.17e-02 | 1.24e-01 |
| GOBP PERICARDIUM DEVELOPMENT | 8 | 7.26e-01 | 7.17e-02 | 9.38e-01 |
| GOCC CENTROSOME | 680 | 1.45e-03 | 7.17e-02 | 9.04e-02 |
| GOBP VASCULAR TRANSPORT | 66 | 3.14e-01 | 7.16e-02 | 7.66e-01 |
| GOBP SIGNALING RECEPTOR LIGAND PRECURSOR PROCESSING | 29 | 5.05e-01 | 7.16e-02 | 8.66e-01 |
| GOBP PEPTIDYL ARGININE METHYLATION TO ASYMMETRICAL DIMETHYL ARGININE | 7 | 7.43e-01 | -7.16e-02 | 9.42e-01 |
| GOMF TRANSFORMING GROWTH FACTOR BETA RECEPTOR BINDING | 22 | 5.61e-01 | 7.16e-02 | 8.88e-01 |
| GOMF SINGLE STRANDED DNA EXODEOXYRIBONUCLEASE ACTIVITY | 9 | 7.10e-01 | -7.16e-02 | 9.34e-01 |
| GOBP VASOCONSTRICTION | 49 | 3.86e-01 | 7.16e-02 | 8.16e-01 |
| GOMF MANNOSIDASE ACTIVITY | 15 | 6.31e-01 | 7.16e-02 | 9.12e-01 |
| GOBP NEGATIVE REGULATION OF TRANSPORT | 320 | 2.78e-02 | 7.15e-02 | 3.58e-01 |
| GOMF PEPTIDASE ACTIVATOR ACTIVITY INVOLVED IN APOPTOTIC PROCESS | 24 | 5.44e-01 | 7.15e-02 | 8.83e-01 |
| GOBP FIBROBLAST GROWTH FACTOR RECEPTOR SIGNALING PATHWAY | 53 | 3.68e-01 | 7.15e-02 | 8.05e-01 |
| GOBP ORGANELLE MEMBRANE FUSION | 107 | 2.01e-01 | 7.15e-02 | 6.73e-01 |
| GOBP RETROTRANSPOSON SILENCING BY HETEROCHROMATIN FORMATION | 7 | 7.43e-01 | -7.15e-02 | 9.42e-01 |
| GOBP NEGATIVE REGULATION OF POST TRANSCRIPTIONAL GENE SILENCING | 12 | 6.68e-01 | 7.14e-02 | 9.22e-01 |
| GOBP POSITIVE REGULATION OF T CELL PROLIFERATION | 84 | 2.58e-01 | -7.14e-02 | 7.27e-01 |
| GOCC MITOCHONDRIAL SMALL RIBOSOMAL SUBUNIT | 32 | 4.85e-01 | 7.14e-02 | 8.60e-01 |
| GOBP AXON EXTENSION | 84 | 2.58e-01 | -7.13e-02 | 7.27e-01 |
| GOBP REGULATION OF ENDOTHELIAL CELL DIFFERENTIATION | 32 | 4.85e-01 | -7.13e-02 | 8.60e-01 |
| GOBP OSTEOBLAST DIFFERENTIATION | 164 | 1.15e-01 | 7.13e-02 | 5.73e-01 |
| GOBP CELL REDOX HOMEOSTASIS | 39 | 4.41e-01 | 7.13e-02 | 8.40e-01 |
| GOMF MANGANESE ION BINDING | 61 | 3.36e-01 | 7.13e-02 | 7.85e-01 |
| GOBP SPROUTING ANGIOGENESIS | 98 | 2.23e-01 | -7.12e-02 | 6.97e-01 |
| GOBP NEGATIVE REGULATION OF CARDIAC MUSCLE CONTRACTION | 5 | 7.83e-01 | 7.12e-02 | 9.56e-01 |
| GOBP PROTEIN NITROSYLATION | 13 | 6.57e-01 | 7.11e-02 | 9.19e-01 |
| GOMF NUCLEAR RECEPTOR COACTIVATOR ACTIVITY | 54 | 3.66e-01 | 7.11e-02 | 8.04e-01 |
| GOBP NEGATIVE REGULATION OF PROGRAMMED CELL DEATH | 696 | 1.41e-03 | 7.11e-02 | 8.82e-02 |
| GOBP POSITIVE REGULATION OF CATION CHANNEL ACTIVITY | 34 | 4.74e-01 | 7.10e-02 | 8.55e-01 |
| GOBP NEGATIVE REGULATION OF TELOMERE CAPPING | 8 | 7.28e-01 | 7.10e-02 | 9.39e-01 |
| GOBP IMMUNE RESPONSE REGULATING CELL SURFACE RECEPTOR SIGNALING PATHWAY | 328 | 2.72e-02 | 7.10e-02 | 3.54e-01 |
| GOMF GABA A RECEPTOR ACTIVITY | 5 | 7.84e-01 | 7.09e-02 | 9.57e-01 |
| GOBP VASCULAR ASSOCIATED SMOOTH MUSCLE CELL APOPTOTIC PROCESS | 9 | 7.13e-01 | 7.09e-02 | 9.35e-01 |
| GOMF ATP DEPENDENT ACTIVITY | 511 | 6.09e-03 | 7.09e-02 | 1.83e-01 |
| GOCC CENTRIOLE | 151 | 1.33e-01 | 7.09e-02 | 5.98e-01 |
| GOCC U4 SNRNP | 10 | 6.98e-01 | -7.08e-02 | 9.28e-01 |
| GOMF SIGNALING ADAPTOR ACTIVITY | 113 | 1.93e-01 | -7.08e-02 | 6.67e-01 |
| GOBP NEGATIVE REGULATION OF RESPONSE TO ENDOPLASMIC RETICULUM STRESS | 41 | 4.33e-01 | 7.07e-02 | 8.36e-01 |
| GOBP REGULATION OF NEURONAL SYNAPTIC PLASTICITY | 42 | 4.28e-01 | -7.07e-02 | 8.34e-01 |
| GOMF INOSITOL PHOSPHATE PHOSPHATASE ACTIVITY | 18 | 6.03e-01 | 7.07e-02 | 9.03e-01 |
| GOBP VITAMIN D METABOLIC PROCESS | 13 | 6.59e-01 | -7.07e-02 | 9.19e-01 |
| GOBP N ACETYLGLUCOSAMINE METABOLIC PROCESS | 14 | 6.47e-01 | 7.07e-02 | 9.16e-01 |
| GOBP REGULATION OF PATTERN RECOGNITION RECEPTOR SIGNALING PATHWAY | 154 | 1.30e-01 | 7.07e-02 | 5.94e-01 |
| GOBP MEMBRANE LIPID BIOSYNTHETIC PROCESS | 126 | 1.71e-01 | 7.07e-02 | 6.38e-01 |
| GOBP MAINTENANCE OF POSTSYNAPTIC SPECIALIZATION STRUCTURE | 8 | 7.29e-01 | -7.07e-02 | 9.40e-01 |
| GOBP CELL DIFFERENTIATION INVOLVED IN KIDNEY DEVELOPMENT | 38 | 4.51e-01 | -7.06e-02 | 8.43e-01 |
| GOBP DIGESTIVE TRACT MORPHOGENESIS | 23 | 5.58e-01 | 7.06e-02 | 8.88e-01 |
| GOBP POSITIVE REGULATION OF PHOSPHOLIPID METABOLIC PROCESS | 6 | 7.65e-01 | 7.06e-02 | 9.49e-01 |
| GOMF NUCLEAR ESTROGEN RECEPTOR BINDING | 35 | 4.70e-01 | 7.05e-02 | 8.54e-01 |
| GOCC MITOCHONDRIAL INTERMEMBRANE SPACE PROTEIN TRANSPORTER COMPLEX | 6 | 7.65e-01 | 7.05e-02 | 9.49e-01 |
| GOBP RESPONSE TO TOXIC SUBSTANCE | 194 | 9.03e-02 | 7.05e-02 | 5.25e-01 |
| GOBP REGULATION OF KILLING OF CELLS OF ANOTHER ORGANISM | 7 | 7.47e-01 | -7.05e-02 | 9.43e-01 |
| GOBP TRIF DEPENDENT TOLL LIKE RECEPTOR SIGNALING PATHWAY | 11 | 6.86e-01 | 7.05e-02 | 9.25e-01 |
| GOBP NEGATIVE REGULATION OF AUTOPHAGY | 82 | 2.71e-01 | -7.04e-02 | 7.35e-01 |
| GOBP AMINO ACID SALVAGE | 5 | 7.85e-01 | 7.04e-02 | 9.57e-01 |
| GOBP L METHIONINE SALVAGE FROM METHYLTHIOADENOSINE | 5 | 7.85e-01 | 7.04e-02 | 9.57e-01 |
| GOBP HEMATOPOIETIC PROGENITOR CELL DIFFERENTIATION | 114 | 1.94e-01 | 7.04e-02 | 6.68e-01 |
| GOBP CYTOPLASMIC TRANSLATIONAL INITIATION | 42 | 4.30e-01 | 7.03e-02 | 8.35e-01 |
| GOBP ARTERY DEVELOPMENT | 68 | 3.16e-01 | -7.03e-02 | 7.67e-01 |
| GOCC MAIN AXON | 48 | 4.00e-01 | -7.03e-02 | 8.22e-01 |
| GOCC ACTIN FILAMENT BUNDLE | 74 | 2.96e-01 | -7.03e-02 | 7.53e-01 |
| GOBP REGULATION OF KERATINOCYTE PROLIFERATION | 31 | 4.98e-01 | 7.03e-02 | 8.63e-01 |
| GOMF CHLORIDE CHANNEL ACTIVITY | 42 | 4.31e-01 | -7.02e-02 | 8.35e-01 |
| GOBP REGULATION OF PROTEIN TRANSPORT | 347 | 2.46e-02 | 7.02e-02 | 3.39e-01 |
| GOBP REGULATION OF GLUCONEOGENESIS | 44 | 4.20e-01 | -7.02e-02 | 8.30e-01 |
| GOBP PROTEIN TRANSPORT | 1231 | 3.45e-05 | 7.02e-02 | 6.29e-03 |
| GOBP CELL PROLIFERATION INVOLVED IN METANEPHROS DEVELOPMENT | 5 | 7.86e-01 | -7.02e-02 | 9.57e-01 |
| GOBP REGULATION OF TYPE I INTERFERON MEDIATED SIGNALING PATHWAY | 41 | 4.37e-01 | 7.01e-02 | 8.38e-01 |
| GOBP L AMINO ACID TRANSPORT | 70 | 3.10e-01 | 7.01e-02 | 7.64e-01 |
| GOBP RAB PROTEIN SIGNAL TRANSDUCTION | 22 | 5.69e-01 | 7.01e-02 | 8.90e-01 |
| GOMF RIBONUCLEASE P ACTIVITY | 12 | 6.74e-01 | 7.01e-02 | 9.23e-01 |
| GOBP POSITIVE REGULATION OF DNA REPLICATION | 39 | 4.49e-01 | 7.00e-02 | 8.43e-01 |
| GOBP AXIS ELONGATION | 16 | 6.28e-01 | -7.00e-02 | 9.11e-01 |
| GOBP NEGATIVE REGULATION OF MRNA METABOLIC PROCESS | 79 | 2.82e-01 | 7.00e-02 | 7.43e-01 |
| GOBP POSITIVE REGULATION OF CALCIUM ION TRANSPORT | 83 | 2.70e-01 | -7.00e-02 | 7.35e-01 |
| GOBP FIBROBLAST PROLIFERATION | 91 | 2.49e-01 | -7.00e-02 | 7.17e-01 |
| GOBP OLIGOSACCHARIDE METABOLIC PROCESS | 46 | 4.12e-01 | -7.00e-02 | 8.27e-01 |
| GOBP CLATHRIN DEPENDENT ENDOCYTOSIS | 46 | 4.12e-01 | 6.99e-02 | 8.27e-01 |
| GOBP MAMMARY GLAND DUCT MORPHOGENESIS | 24 | 5.53e-01 | 6.99e-02 | 8.86e-01 |
| GOBP FEMALE SEX DIFFERENTIATION | 78 | 2.86e-01 | 6.99e-02 | 7.45e-01 |
| GOBP REGULATION OF REGULATORY NCRNA PROCESSING | 13 | 6.63e-01 | -6.99e-02 | 9.21e-01 |
| GOMF PHOSPHATIDYLCHOLINE TRANSPORTER ACTIVITY | 16 | 6.28e-01 | -6.99e-02 | 9.11e-01 |
| GOCC ORGANELLE SUBCOMPARTMENT | 1286 | 2.60e-05 | 6.99e-02 | 5.36e-03 |
| GOBP POSITIVE REGULATION OF AGGREPHAGY | 5 | 7.87e-01 | -6.98e-02 | 9.57e-01 |
| GOBP REGULATION OF WOUND HEALING | 96 | 2.37e-01 | -6.98e-02 | 7.08e-01 |
| GOBP MICROTUBULE ANCHORING AT MICROTUBULE ORGANIZING CENTER | 13 | 6.63e-01 | 6.98e-02 | 9.21e-01 |
| GOBP REGULATION OF SIGNALING RECEPTOR ACTIVITY | 73 | 3.03e-01 | 6.98e-02 | 7.58e-01 |
| GOBP TELOMERE MAINTENANCE | 154 | 1.36e-01 | 6.97e-02 | 6.01e-01 |
| GOBP POSITIVE REGULATION OF CALCIUM ION TRANSPORT INTO CYTOSOL | 6 | 7.68e-01 | -6.97e-02 | 9.50e-01 |
| GOBP PYRIMIDINE CONTAINING COMPOUND METABOLIC PROCESS | 82 | 2.76e-01 | 6.97e-02 | 7.38e-01 |
| GOBP REGULATION OF PEPTIDYL SERINE PHOSPHORYLATION | 78 | 2.88e-01 | 6.97e-02 | 7.47e-01 |
| GOBP REGULATION OF TOLL LIKE RECEPTOR 4 SIGNALING PATHWAY | 26 | 5.39e-01 | 6.97e-02 | 8.79e-01 |
| GOBP POSITIVE REGULATION OF VASCULOGENESIS | 9 | 7.18e-01 | -6.96e-02 | 9.36e-01 |
| GOMF HORMONE BINDING | 54 | 3.77e-01 | -6.96e-02 | 8.10e-01 |
| GOBP POSITIVE REGULATION OF LIPASE ACTIVITY | 33 | 4.89e-01 | -6.96e-02 | 8.61e-01 |
| GOCC DYNEIN COMPLEX | 45 | 4.19e-01 | 6.96e-02 | 8.30e-01 |
| GOBP PLATELET DERIVED GROWTH FACTOR RECEPTOR SIGNALING PATHWAY | 47 | 4.09e-01 | 6.96e-02 | 8.26e-01 |
| GOBP RETINOL METABOLIC PROCESS | 28 | 5.24e-01 | -6.95e-02 | 8.76e-01 |
| GOBP PROTOPORPHYRINOGEN IX METABOLIC PROCESS | 11 | 6.90e-01 | -6.95e-02 | 9.27e-01 |
| GOBP METALLO SULFUR CLUSTER ASSEMBLY | 28 | 5.25e-01 | -6.95e-02 | 8.76e-01 |
| GOCC EXTRINSIC COMPONENT OF CYTOPLASMIC SIDE OF PLASMA MEMBRANE | 43 | 4.31e-01 | -6.94e-02 | 8.35e-01 |
| GOBP RESPONSE TO IRON ION | 23 | 5.64e-01 | 6.94e-02 | 8.90e-01 |
| GOBP NEURON MATURATION | 36 | 4.71e-01 | 6.94e-02 | 8.54e-01 |
| GOMF METALLOEXOPEPTIDASE ACTIVITY | 48 | 4.07e-01 | 6.92e-02 | 8.26e-01 |
| GOBP TRNA MODIFICATION | 92 | 2.52e-01 | 6.92e-02 | 7.20e-01 |
| GOBP REGULATION OF MEIOTIC CELL CYCLE | 46 | 4.17e-01 | 6.91e-02 | 8.30e-01 |
| GOBP MEMBRANE PROTEIN PROTEOLYSIS | 58 | 3.63e-01 | 6.91e-02 | 8.02e-01 |
| GOBP PURINE NUCLEOSIDE MONOPHOSPHATE METABOLIC PROCESS | 41 | 4.44e-01 | 6.91e-02 | 8.41e-01 |
| GOBP G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY COUPLED TO CYCLIC NUCLEOTIDE SECOND MESSENGER | 23 | 5.66e-01 | 6.91e-02 | 8.90e-01 |
| GOCC MICROVILLUS | 72 | 3.11e-01 | -6.91e-02 | 7.64e-01 |
| GOMF FIBRONECTIN BINDING | 22 | 5.75e-01 | 6.91e-02 | 8.92e-01 |
| GOBP CELL CELL JUNCTION ASSEMBLY | 107 | 2.17e-01 | -6.91e-02 | 6.92e-01 |
| GOCC SPINDLE MIDZONE | 34 | 4.86e-01 | 6.90e-02 | 8.60e-01 |
| GOMF OXIDOREDUCTASE ACTIVITY ACTING ON CH OH GROUP OF DONORS | 105 | 2.22e-01 | -6.90e-02 | 6.97e-01 |
| GOCC PERINUCLEOLAR COMPARTMENT | 5 | 7.89e-01 | -6.90e-02 | 9.58e-01 |
| GOMF BIOTIN BINDING | 5 | 7.89e-01 | -6.90e-02 | 9.58e-01 |
| GOBP NEGATIVE REGULATION OF SECRETION | 125 | 1.83e-01 | 6.89e-02 | 6.55e-01 |
| GOCC CLATHRIN COAT | 46 | 4.19e-01 | 6.89e-02 | 8.30e-01 |
| GOBP POSITIVE REGULATION OF COLD INDUCED THERMOGENESIS | 78 | 2.93e-01 | -6.89e-02 | 7.50e-01 |
| GOBP GLYCOPROTEIN CATABOLIC PROCESS | 29 | 5.21e-01 | 6.89e-02 | 8.74e-01 |
| GOBP RETROGRADE TRANSPORT ENDOSOME TO GOLGI | 99 | 2.36e-01 | 6.89e-02 | 7.07e-01 |
| GOBP REGULATION OF FATTY ACID BIOSYNTHETIC PROCESS | 34 | 4.87e-01 | 6.89e-02 | 8.60e-01 |
| GOCC RIBONUCLEASE P COMPLEX | 14 | 6.56e-01 | 6.88e-02 | 9.18e-01 |
| GOMF PASSIVE TRANSMEMBRANE TRANSPORTER ACTIVITY | 304 | 3.90e-02 | -6.88e-02 | 3.98e-01 |
| GOMF HYDROLASE ACTIVITY ACTING ON ACID ANHYDRIDES | 713 | 1.75e-03 | 6.88e-02 | 1.02e-01 |
| GOBP INTESTINE SMOOTH MUSCLE CONTRACTION | 5 | 7.90e-01 | 6.88e-02 | 9.59e-01 |
| GOBP REGULATION OF CD4 POSITIVE ALPHA BETA T CELL DIFFERENTIATION | 53 | 3.86e-01 | -6.88e-02 | 8.16e-01 |
| GOBP CELLULAR KETONE METABOLIC PROCESS | 164 | 1.29e-01 | -6.88e-02 | 5.94e-01 |
| GOMF CHROMATIN INSULATOR SEQUENCE BINDING | 5 | 7.90e-01 | -6.87e-02 | 9.59e-01 |
| GOBP FEVER GENERATION | 9 | 7.21e-01 | 6.87e-02 | 9.37e-01 |
| GOBP CARBON CATABOLITE REGULATION OF TRANSCRIPTION | 7 | 7.53e-01 | -6.87e-02 | 9.45e-01 |
| GOBP APICAL PROTEIN LOCALIZATION | 12 | 6.80e-01 | -6.87e-02 | 9.24e-01 |
| GOBP ADENOSINE TRANSPORT | 5 | 7.90e-01 | 6.87e-02 | 9.59e-01 |
| GOBP LYMPH VESSEL DEVELOPMENT | 18 | 6.14e-01 | 6.87e-02 | 9.04e-01 |
| GOBP MYELOID CELL ACTIVATION INVOLVED IN IMMUNE RESPONSE | 86 | 2.71e-01 | 6.87e-02 | 7.35e-01 |
| GOMF OLIGOPEPTIDE BINDING | 10 | 7.07e-01 | -6.86e-02 | 9.32e-01 |
| GOMF ADRENERGIC RECEPTOR BINDING | 12 | 6.81e-01 | 6.86e-02 | 9.24e-01 |
| GOBP POSITIVE REGULATION OF CYTOSOLIC CALCIUM ION CONCENTRATION | 119 | 1.96e-01 | 6.86e-02 | 6.68e-01 |
| GOBP OSTEOCLAST DIFFERENTIATION | 84 | 2.77e-01 | 6.86e-02 | 7.39e-01 |
| GOMF ATPASE COUPLED TRANSMEMBRANE TRANSPORTER ACTIVITY | 76 | 3.01e-01 | -6.86e-02 | 7.57e-01 |
| GOCC INTERCELLULAR BRIDGE | 79 | 2.92e-01 | -6.86e-02 | 7.49e-01 |
| GOBP NEGATIVE REGULATION OF LEUKOCYTE PROLIFERATION | 82 | 2.83e-01 | 6.85e-02 | 7.44e-01 |
| GOBP EPHRIN RECEPTOR SIGNALING PATHWAY | 40 | 4.53e-01 | 6.85e-02 | 8.43e-01 |
| GOBP HEAD MORPHOGENESIS | 28 | 5.30e-01 | 6.85e-02 | 8.78e-01 |
| GOBP NEGATIVE REGULATION OF WOUND HEALING | 54 | 3.84e-01 | -6.84e-02 | 8.15e-01 |
| GOBP NEGATIVE REGULATION OF LEUKOCYTE MIGRATION | 44 | 4.33e-01 | 6.84e-02 | 8.36e-01 |
| GOMF HISTONE H4K16 ACETYLTRANSFERASE ACTIVITY | 8 | 7.38e-01 | 6.84e-02 | 9.42e-01 |
| GOCC NUCLEAR MEMBRANE | 285 | 4.71e-02 | 6.84e-02 | 4.22e-01 |
| GOBP RETINAL ROD CELL DIFFERENTIATION | 10 | 7.08e-01 | 6.83e-02 | 9.33e-01 |
| GOBP FLUID TRANSPORT | 21 | 5.88e-01 | -6.83e-02 | 8.95e-01 |
| GOMF DEATH DOMAIN BINDING | 10 | 7.08e-01 | -6.83e-02 | 9.33e-01 |
| GOBP RESPONSE TO GLUCAGON | 11 | 6.95e-01 | -6.83e-02 | 9.27e-01 |
| GOMF MRNA 3 UTR AU RICH REGION BINDING | 25 | 5.55e-01 | -6.82e-02 | 8.87e-01 |
| GOBP POSITIVE REGULATION OF PROTEOGLYCAN BIOSYNTHETIC PROCESS | 5 | 7.92e-01 | 6.82e-02 | 9.59e-01 |
| GOBP REGULATION OF MYOBLAST DIFFERENTIATION | 53 | 3.90e-01 | -6.82e-02 | 8.18e-01 |
| GOBP FOREBRAIN DEVELOPMENT | 284 | 4.80e-02 | 6.82e-02 | 4.25e-01 |
| GOBP LEUKOCYTE AGGREGATION | 11 | 6.96e-01 | 6.81e-02 | 9.27e-01 |
| GOBP PHOSPHATIDYLGLYCEROL ACYL CHAIN REMODELING | 8 | 7.39e-01 | 6.81e-02 | 9.42e-01 |
| GOBP CELLULAR RESPONSE TO AMYLOID BETA | 32 | 5.05e-01 | 6.81e-02 | 8.66e-01 |
| GOBP REGULATION OF MITOCHONDRIAL TRANSLATION | 25 | 5.56e-01 | -6.80e-02 | 8.87e-01 |
| GOCC PLATELET DENSE GRANULE LUMEN | 9 | 7.24e-01 | 6.80e-02 | 9.38e-01 |
| GOBP RNA PROCESSING | 916 | 4.87e-04 | 6.80e-02 | 4.48e-02 |
| GOCC BLOOD MICROPARTICLE | 105 | 2.29e-01 | -6.80e-02 | 7.01e-01 |
| GOBP TRNA PROCESSING | 135 | 1.73e-01 | 6.79e-02 | 6.40e-01 |
| GOBP FIBROBLAST MIGRATION | 50 | 4.06e-01 | -6.79e-02 | 8.26e-01 |
| GOBP UV DAMAGE EXCISION REPAIR | 13 | 6.72e-01 | -6.79e-02 | 9.22e-01 |
| GOMF SHORT CHAIN FATTY ACYL COA DEHYDROGENASE ACTIVITY | 5 | 7.93e-01 | -6.78e-02 | 9.59e-01 |
| GOBP REGULATION OF KINASE ACTIVITY | 423 | 1.68e-02 | 6.78e-02 | 2.83e-01 |
| GOBP WOUND HEALING SPREADING OF EPIDERMAL CELLS | 21 | 5.91e-01 | -6.78e-02 | 8.97e-01 |
| GOCC EXCITATORY SYNAPSE | 34 | 4.95e-01 | -6.77e-02 | 8.62e-01 |
| GOCC INCLUSION BODY | 64 | 3.49e-01 | 6.77e-02 | 7.92e-01 |
| GOBP VASCULAR ENDOTHELIAL CELL PROLIFERATION | 21 | 5.91e-01 | 6.77e-02 | 8.97e-01 |
| GOBP RETINAL BIPOLAR NEURON DIFFERENTIATION | 5 | 7.93e-01 | -6.76e-02 | 9.59e-01 |
| GOBP RESPONSE TO AMINE | 35 | 4.89e-01 | 6.76e-02 | 8.61e-01 |
| GOBP MACROAUTOPHAGY | 344 | 3.13e-02 | 6.76e-02 | 3.72e-01 |
| GOBP NEGATIVE REGULATION OF PEPTIDE SECRETION | 36 | 4.83e-01 | 6.76e-02 | 8.60e-01 |
| GOBP NEURON PROJECTION ORGANIZATION | 79 | 2.99e-01 | 6.76e-02 | 7.55e-01 |
| GOBP ARACHIDONIC ACID SECRETION | 15 | 6.51e-01 | -6.76e-02 | 9.17e-01 |
| GOBP OVULATION CYCLE | 48 | 4.18e-01 | 6.75e-02 | 8.30e-01 |
| GOCC TRANS GOLGI NETWORK | 236 | 7.40e-02 | 6.75e-02 | 4.89e-01 |
| GOBP REGULATION OF INTRACELLULAR LIPID TRANSPORT | 8 | 7.41e-01 | 6.75e-02 | 9.42e-01 |
| GOBP IMPORT INTO NUCLEUS | 153 | 1.50e-01 | 6.75e-02 | 6.13e-01 |
| GOBP FAT CELL PROLIFERATION | 10 | 7.12e-01 | -6.75e-02 | 9.35e-01 |
| GOBP MITOCHONDRIAL CALCIUM ION TRANSMEMBRANE TRANSPORT | 22 | 5.84e-01 | 6.74e-02 | 8.93e-01 |
| GOBP ARGININE CATABOLIC PROCESS | 7 | 7.57e-01 | 6.74e-02 | 9.46e-01 |
| GOBP PARKIN MEDIATED STIMULATION OF MITOPHAGY IN RESPONSE TO MITOCHONDRIAL DEPOLARIZATION | 6 | 7.75e-01 | -6.74e-02 | 9.54e-01 |
| GOMF NEUROTROPHIN TRK RECEPTOR BINDING | 6 | 7.75e-01 | -6.74e-02 | 9.54e-01 |
| GOBP MULTICELLULAR ORGANISMAL REPRODUCTIVE PROCESS | 627 | 4.02e-03 | 6.73e-02 | 1.51e-01 |
| GOMF MYOSIN HEAVY CHAIN BINDING | 11 | 6.99e-01 | 6.73e-02 | 9.28e-01 |
| GOBP POSITIVE REGULATION OF SYNAPTIC TRANSMISSION GLUTAMATERGIC | 22 | 5.85e-01 | -6.72e-02 | 8.94e-01 |
| GOMF OXIDOREDUCTASE ACTIVITY ACTING ON A SULFUR GROUP OF DONORS OXYGEN AS ACCEPTOR | 11 | 6.99e-01 | 6.72e-02 | 9.28e-01 |
| GOMF SODIUM CHANNEL REGULATOR ACTIVITY | 34 | 4.98e-01 | 6.72e-02 | 8.62e-01 |
| GOBP DEVELOPMENTAL INDUCTION | 17 | 6.31e-01 | -6.72e-02 | 9.12e-01 |
| GOCC IMMUNOGLOBULIN COMPLEX | 106 | 2.32e-01 | -6.71e-02 | 7.05e-01 |
| GOMF PHOSPHOLIPASE C ACTIVITY | 23 | 5.77e-01 | -6.71e-02 | 8.92e-01 |
| GOCC POSTSYNAPSE | 483 | 1.16e-02 | -6.71e-02 | 2.43e-01 |
| GOBP NEGATIVE REGULATION OF INTERLEUKIN 1 BETA PRODUCTION | 23 | 5.78e-01 | -6.70e-02 | 8.92e-01 |
| GOCC ALPHA KETOACID DEHYDROGENASE COMPLEX | 15 | 6.53e-01 | -6.70e-02 | 9.18e-01 |
| GOBP SEQUESTERING OF METAL ION | 8 | 7.43e-01 | -6.70e-02 | 9.42e-01 |
| GOBP REGULATION OF CELL DIVISION | 144 | 1.66e-01 | 6.69e-02 | 6.30e-01 |
| GOBP RIBOSOME ASSEMBLY | 58 | 3.78e-01 | -6.69e-02 | 8.11e-01 |
| GOBP POSITIVE REGULATION OF KINASE ACTIVITY | 235 | 7.73e-02 | 6.69e-02 | 4.95e-01 |
| GOBP EPITHELIAL CELL MATURATION | 18 | 6.23e-01 | 6.69e-02 | 9.09e-01 |
| GOBP CERAMIDE TRANSPORT | 15 | 6.54e-01 | 6.69e-02 | 9.18e-01 |
| GOMF CYTOKINE BINDING | 120 | 2.06e-01 | 6.69e-02 | 6.81e-01 |
| GOBP POSITIVE REGULATION OF ANIMAL ORGAN MORPHOGENESIS | 18 | 6.24e-01 | -6.68e-02 | 9.09e-01 |
| GOBP POSITIVE REGULATION OF CELLULAR RESPONSE TO INSULIN STIMULUS | 21 | 5.96e-01 | 6.68e-02 | 9.01e-01 |
| GOBP AMP METABOLIC PROCESS | 21 | 5.96e-01 | 6.68e-02 | 9.01e-01 |
| GOBP MEMBRANE PROTEIN ECTODOMAIN PROTEOLYSIS | 46 | 4.33e-01 | 6.68e-02 | 8.36e-01 |
| GOBP REGULATION OF ADIPOSE TISSUE DEVELOPMENT | 13 | 6.77e-01 | 6.67e-02 | 9.24e-01 |
| GOBP REGULATION OF PROTEIN POLYMERIZATION | 180 | 1.23e-01 | -6.66e-02 | 5.86e-01 |
| GOMF LYSOPHOSPHATIDIC ACID BINDING | 5 | 7.96e-01 | 6.66e-02 | 9.59e-01 |
| GOCC VESICLE TETHERING COMPLEX | 65 | 3.53e-01 | 6.66e-02 | 7.94e-01 |
| GOMF UBIQUITIN LIKE PROTEIN READER ACTIVITY | 20 | 6.06e-01 | -6.66e-02 | 9.03e-01 |
| GOCC ENDOSOME LUMEN | 30 | 5.28e-01 | 6.66e-02 | 8.76e-01 |
| GOBP REGULATION OF POTASSIUM ION EXPORT ACROSS PLASMA MEMBRANE | 7 | 7.60e-01 | -6.66e-02 | 9.48e-01 |
| GOBP MORPHOGENESIS OF EMBRYONIC EPITHELIUM | 107 | 2.34e-01 | -6.66e-02 | 7.05e-01 |
| GOBP NEGATIVE REGULATION OF VASCULATURE DEVELOPMENT | 79 | 3.07e-01 | -6.65e-02 | 7.62e-01 |
| GOCC T TUBULE | 38 | 4.78e-01 | 6.65e-02 | 8.58e-01 |
| GOBP REGULATION OF EXTRACELLULAR MATRIX CONSTITUENT SECRETION | 7 | 7.61e-01 | 6.64e-02 | 9.48e-01 |
| GOBP INTERMEDIATE FILAMENT BASED PROCESS | 44 | 4.46e-01 | 6.64e-02 | 8.42e-01 |
| GOMF MECHANOSENSITIVE MONOATOMIC ION CHANNEL ACTIVITY | 13 | 6.79e-01 | -6.64e-02 | 9.24e-01 |
| GOBP POSITIVE REGULATION OF OSTEOCLAST DIFFERENTIATION | 19 | 6.17e-01 | 6.64e-02 | 9.06e-01 |
| GOBP LEUKOCYTE MEDIATED CYTOTOXICITY | 128 | 1.95e-01 | 6.63e-02 | 6.68e-01 |
| GOBP REGULATION OF CARDIAC MUSCLE CELL MEMBRANE REPOLARIZATION | 20 | 6.08e-01 | -6.63e-02 | 9.03e-01 |
| GOCC CONTRACTILE MUSCLE FIBER | 175 | 1.30e-01 | 6.63e-02 | 5.94e-01 |
| GOMF PROTEIN CARRIER CHAPERONE | 34 | 5.04e-01 | 6.63e-02 | 8.66e-01 |
| GOBP REGULATION OF UBIQUITIN PROTEIN TRANSFERASE ACTIVITY | 35 | 4.98e-01 | 6.62e-02 | 8.62e-01 |
| GOBP NEGATIVE REGULATION OF PROTEIN MODIFICATION PROCESS | 346 | 3.44e-02 | 6.62e-02 | 3.85e-01 |
| GOBP HEAT GENERATION | 14 | 6.68e-01 | 6.62e-02 | 9.22e-01 |
| GOMF PROLINE RICH REGION BINDING | 15 | 6.57e-01 | 6.62e-02 | 9.19e-01 |
| GOBP REGULATION OF PRODUCTION OF MOLECULAR MEDIATOR OF IMMUNE RESPONSE | 163 | 1.45e-01 | 6.62e-02 | 6.12e-01 |
| GOCC MITOCHONDRIAL PROTON TRANSPORTING ATP SYNTHASE COMPLEX COUPLING FACTOR F O | 10 | 7.17e-01 | -6.62e-02 | 9.36e-01 |
| GOBP NEGATIVE REGULATION OF KINASE ACTIVITY | 148 | 1.65e-01 | 6.62e-02 | 6.30e-01 |
| GOBP PULMONARY VALVE DEVELOPMENT | 14 | 6.68e-01 | 6.62e-02 | 9.22e-01 |
| GOMF RECEPTOR ANTAGONIST ACTIVITY | 8 | 7.46e-01 | -6.62e-02 | 9.43e-01 |
| GOMF NOTCH BINDING | 19 | 6.18e-01 | -6.61e-02 | 9.06e-01 |
| GOBP PIGMENT BIOSYNTHETIC PROCESS | 45 | 4.43e-01 | -6.61e-02 | 8.41e-01 |
| GOBP ECTOPIC GERM CELL PROGRAMMED CELL DEATH | 11 | 7.04e-01 | 6.61e-02 | 9.31e-01 |
| GOBP EPITHELIAL CELL APOPTOTIC PROCESS | 105 | 2.42e-01 | 6.61e-02 | 7.12e-01 |
| GOMF DEAD H BOX RNA HELICASE BINDING | 7 | 7.62e-01 | 6.61e-02 | 9.48e-01 |
| GOBP POSITIVE REGULATION OF PROTEIN DEUBIQUITINATION | 5 | 7.98e-01 | -6.61e-02 | 9.59e-01 |
| GOBP SPINDLE MIDZONE ASSEMBLY | 13 | 6.80e-01 | 6.60e-02 | 9.24e-01 |
| GOMF CYTOSKELETAL MOTOR ACTIVITY | 91 | 2.76e-01 | -6.60e-02 | 7.39e-01 |
| GOBP SEXUAL REPRODUCTION | 730 | 2.40e-03 | 6.60e-02 | 1.19e-01 |
| GOCC AUTOLYSOSOME | 14 | 6.69e-01 | 6.60e-02 | 9.22e-01 |
| GOBP DETECTION OF STIMULUS | 202 | 1.06e-01 | 6.59e-02 | 5.59e-01 |
| GOCC RESPIRATORY CHAIN COMPLEX IV | 20 | 6.10e-01 | 6.59e-02 | 9.03e-01 |
| GOCC COATED VESICLE | 279 | 5.81e-02 | 6.59e-02 | 4.49e-01 |
| GOBP POSITIVE REGULATION OF ISOTYPE SWITCHING | 28 | 5.46e-01 | 6.59e-02 | 8.84e-01 |
| GOBP NEGATIVE REGULATION OF CENTROSOME DUPLICATION | 12 | 6.93e-01 | -6.59e-02 | 9.27e-01 |
| GOBP REGULATION OF CALCINEURIN MEDIATED SIGNALING | 33 | 5.12e-01 | -6.59e-02 | 8.70e-01 |
| GOBP ENDOTHELIAL CELL MIGRATION | 174 | 1.34e-01 | -6.59e-02 | 5.99e-01 |
| GOBP PYRIMIDINE NUCLEOSIDE DIPHOSPHATE BIOSYNTHETIC PROCESS | 6 | 7.80e-01 | -6.58e-02 | 9.55e-01 |
| GOBP RNA MODIFICATION | 163 | 1.47e-01 | 6.58e-02 | 6.13e-01 |
| GOMF LAMIN BINDING | 14 | 6.70e-01 | 6.58e-02 | 9.22e-01 |
| GOBP MYOTUBE CELL DEVELOPMENT | 30 | 5.33e-01 | -6.58e-02 | 8.79e-01 |
| GOCC OUTER DYNEIN ARM | 7 | 7.63e-01 | 6.57e-02 | 9.49e-01 |
| GOBP HETEROCHROMATIN FORMATION | 110 | 2.34e-01 | 6.57e-02 | 7.05e-01 |
| GOBP POSITIVE REGULATION OF INSULIN SECRETION | 64 | 3.63e-01 | -6.57e-02 | 8.02e-01 |
| GOMF MRNA METHYLTRANSFERASE ACTIVITY | 12 | 6.94e-01 | 6.57e-02 | 9.27e-01 |
| GOBP REGULATION OF TRANSFERASE ACTIVITY | 520 | 1.04e-02 | 6.56e-02 | 2.29e-01 |
| GOCC AUTOPHAGOSOME | 107 | 2.41e-01 | 6.56e-02 | 7.11e-01 |
| GOMF ALDEHYDE DEHYDROGENASE NAD P PLUS ACTIVITY | 12 | 6.94e-01 | -6.56e-02 | 9.27e-01 |
| GOBP STEROID BIOSYNTHETIC PROCESS | 129 | 1.98e-01 | 6.56e-02 | 6.70e-01 |
| GOMF MOLECULAR FUNCTION INHIBITOR ACTIVITY | 367 | 3.10e-02 | 6.56e-02 | 3.70e-01 |
| GOCC CLATHRIN SCULPTED MONOAMINE TRANSPORT VESICLE | 5 | 8.00e-01 | 6.56e-02 | 9.60e-01 |
| GOBP LYMPHOCYTE AGGREGATION | 5 | 8.00e-01 | -6.55e-02 | 9.60e-01 |
| GOBP RESPONSE TO CORTICOSTEROID | 110 | 2.35e-01 | -6.55e-02 | 7.07e-01 |
| GOMF LIPOPOLYSACCHARIDE IMMUNE RECEPTOR ACTIVITY | 6 | 7.81e-01 | 6.55e-02 | 9.56e-01 |
| GOBP POSITIVE REGULATION OF MHC CLASS I BIOSYNTHETIC PROCESS | 5 | 8.00e-01 | -6.55e-02 | 9.60e-01 |
| GOBP CARDIAC MUSCLE CELL ACTION POTENTIAL INVOLVED IN CONTRACTION | 42 | 4.63e-01 | 6.54e-02 | 8.49e-01 |
| GOBP MAINTENANCE OF CELL NUMBER | 151 | 1.65e-01 | 6.54e-02 | 6.30e-01 |
| GOCC PHAGOCYTIC CUP | 27 | 5.57e-01 | -6.54e-02 | 8.87e-01 |
| GOBP INOSITOL TRISPHOSPHATE METABOLIC PROCESS | 9 | 7.34e-01 | -6.54e-02 | 9.41e-01 |
| GOBP PREASSEMBLY OF GPI ANCHOR IN ER MEMBRANE | 8 | 7.49e-01 | -6.53e-02 | 9.44e-01 |
| GOBP CGMP MEDIATED SIGNALING | 19 | 6.22e-01 | -6.53e-02 | 9.09e-01 |
| GOCC RAGULATOR COMPLEX | 6 | 7.82e-01 | 6.53e-02 | 9.56e-01 |
| GOBP REGULATION OF POSTSYNAPTIC DENSITY ORGANIZATION | 11 | 7.08e-01 | -6.53e-02 | 9.33e-01 |
| GOBP POSITIVE REGULATION OF PROTEIN LOCALIZATION TO PLASMA MEMBRANE | 50 | 4.25e-01 | -6.52e-02 | 8.32e-01 |
| GOBP REGULATION OF RESPONSE TO WOUNDING | 131 | 1.98e-01 | -6.52e-02 | 6.70e-01 |
| GOBP AUTONOMIC NERVOUS SYSTEM DEVELOPMENT | 24 | 5.81e-01 | -6.51e-02 | 8.93e-01 |
| GOBP REGULATION OF RELEASE OF SEQUESTERED CALCIUM ION INTO CYTOSOL | 58 | 3.91e-01 | -6.51e-02 | 8.18e-01 |
| GOCC PROTEIN FOLDING CHAPERONE COMPLEX | 38 | 4.88e-01 | 6.51e-02 | 8.60e-01 |
| GOBP POSITIVE REGULATION OF NF KAPPAB TRANSCRIPTION FACTOR ACTIVITY | 117 | 2.24e-01 | 6.50e-02 | 6.98e-01 |
| GOBP REGULATION OF HEMOGLOBIN BIOSYNTHETIC PROCESS | 7 | 7.66e-01 | 6.50e-02 | 9.49e-01 |
| GOBP REGULATION OF PROTEIN TYROSINE KINASE ACTIVITY | 40 | 4.77e-01 | 6.50e-02 | 8.57e-01 |
| GOBP APOPTOTIC CELL CLEARANCE | 41 | 4.72e-01 | -6.49e-02 | 8.54e-01 |
| GOBP REGULATION OF LYSOSOMAL LUMEN PH | 30 | 5.39e-01 | 6.49e-02 | 8.79e-01 |
| GOBP PANTOTHENATE METABOLIC PROCESS | 7 | 7.66e-01 | 6.49e-02 | 9.49e-01 |
| GOBP CELL JUNCTION ASSEMBLY | 315 | 4.79e-02 | -6.48e-02 | 4.24e-01 |
| GOCC CENTRIOLAR SUBDISTAL APPENDAGE | 9 | 7.36e-01 | -6.48e-02 | 9.42e-01 |
| GOBP RADIAL GLIA GUIDED PYRAMIDAL NEURON MIGRATION | 5 | 8.02e-01 | 6.48e-02 | 9.60e-01 |
| GOMF TRANSMEMBRANE RECEPTOR PROTEIN PHOSPHATASE ACTIVITY | 12 | 6.98e-01 | -6.48e-02 | 9.28e-01 |
| GOBP EPIDERMIS MORPHOGENESIS | 20 | 6.16e-01 | 6.48e-02 | 9.06e-01 |
| GOBP POSITIVE REGULATION OF TRANSFORMING GROWTH FACTOR BETA PRODUCTION | 14 | 6.75e-01 | 6.47e-02 | 9.23e-01 |
| GOBP CELLULAR RESPONSE TO STRESS | 1630 | 1.37e-05 | 6.47e-02 | 3.96e-03 |
| GOBP NEGATIVE REGULATION OF PROTEIN TYROSINE KINASE ACTIVITY | 18 | 6.35e-01 | 6.47e-02 | 9.14e-01 |
| GOBP REGULATION OF PROTEIN TARGETING TO MEMBRANE | 30 | 5.40e-01 | -6.47e-02 | 8.80e-01 |
| GOBP GLYCOPROTEIN BIOSYNTHETIC PROCESS | 269 | 6.79e-02 | 6.47e-02 | 4.73e-01 |
| GOBP NEGATIVE REGULATION OF THYMOCYTE APOPTOTIC PROCESS | 8 | 7.52e-01 | 6.46e-02 | 9.45e-01 |
| GOBP XENOPHAGY | 14 | 6.75e-01 | -6.46e-02 | 9.24e-01 |
| GOBP HEMATOPOIETIC STEM CELL DIFFERENTIATION | 32 | 5.27e-01 | -6.46e-02 | 8.76e-01 |
| GOCC MONOATOMIC ION CHANNEL COMPLEX | 211 | 1.06e-01 | -6.46e-02 | 5.59e-01 |
| GOBP POSITIVE REGULATION OF ENDOTHELIAL CELL APOPTOTIC PROCESS | 16 | 6.55e-01 | -6.46e-02 | 9.18e-01 |
| GOBP CARNITINE METABOLIC PROCESS | 11 | 7.11e-01 | 6.46e-02 | 9.34e-01 |
| GOBP AMEBOIDAL TYPE CELL MIGRATION | 331 | 4.36e-02 | -6.45e-02 | 4.11e-01 |
| GOMF LIPID TRANSPORTER ACTIVITY | 116 | 2.30e-01 | -6.45e-02 | 7.03e-01 |
| GOMF DNA TRANSLOCASE ACTIVITY | 5 | 8.03e-01 | -6.45e-02 | 9.61e-01 |
| GOBP NUCLEOSIDE MONOPHOSPHATE BIOSYNTHETIC PROCESS | 38 | 4.92e-01 | -6.45e-02 | 8.62e-01 |
| GOBP REGULATION OF MEMBRANE PROTEIN ECTODOMAIN PROTEOLYSIS | 24 | 5.85e-01 | 6.45e-02 | 8.93e-01 |
| GOBP INTRACELLULAR PH REDUCTION | 51 | 4.26e-01 | 6.44e-02 | 8.33e-01 |
| GOBP NUCLEOTIDE EXCISION REPAIR | 80 | 3.19e-01 | 6.44e-02 | 7.70e-01 |
| GOBP ORGANISM EMERGENCE FROM PROTECTIVE STRUCTURE | 21 | 6.09e-01 | -6.44e-02 | 9.03e-01 |
| GOBP REGULATION OF TELOMERE MAINTENANCE | 104 | 2.57e-01 | 6.44e-02 | 7.26e-01 |
| GOBP MATURATION OF 5 8S RRNA | 35 | 5.10e-01 | -6.44e-02 | 8.70e-01 |
| GOBP TRANSLATION | 618 | 6.33e-03 | 6.43e-02 | 1.87e-01 |
| GOMF POSTSYNAPTIC NEUROTRANSMITTER RECEPTOR ACTIVITY | 28 | 5.56e-01 | -6.43e-02 | 8.87e-01 |
| GOBP NEUROTROPHIN TRK RECEPTOR SIGNALING PATHWAY | 21 | 6.10e-01 | 6.43e-02 | 9.03e-01 |
| GOBP INTRINSIC APOPTOTIC SIGNALING PATHWAY IN RESPONSE TO OXIDATIVE STRESS | 52 | 4.22e-01 | 6.43e-02 | 8.30e-01 |
| GOCC SCAR COMPLEX | 12 | 7.00e-01 | 6.43e-02 | 9.28e-01 |
| GOMF NADH DEHYDROGENASE ACTIVITY | 11 | 7.12e-01 | -6.43e-02 | 9.35e-01 |
| GOBP CELLULAR PROCESS INVOLVED IN REPRODUCTION IN MULTICELLULAR ORGANISM | 253 | 7.85e-02 | 6.42e-02 | 4.97e-01 |
| GOBP NEURAL TUBE DEVELOPMENT | 127 | 2.11e-01 | -6.42e-02 | 6.84e-01 |
| GOBP REGULATION OF DENDRITIC CELL DIFFERENTIATION | 13 | 6.89e-01 | -6.42e-02 | 9.27e-01 |
| GOBP PEPTIDYL LYSINE ACETYLATION | 20 | 6.20e-01 | -6.41e-02 | 9.08e-01 |
| GOBP PROTEIN INSERTION INTO MEMBRANE | 41 | 4.78e-01 | -6.41e-02 | 8.57e-01 |
| GOBP ATF6 MEDIATED UNFOLDED PROTEIN RESPONSE | 9 | 7.39e-01 | 6.41e-02 | 9.42e-01 |
| GOBP MIRNA METABOLIC PROCESS | 91 | 2.91e-01 | 6.41e-02 | 7.48e-01 |
| GOBP POSITIVE REGULATION OF NATURAL KILLER CELL PROLIFERATION | 8 | 7.54e-01 | 6.41e-02 | 9.45e-01 |
| GOBP INTRINSIC APOPTOTIC SIGNALING PATHWAY IN RESPONSE TO HYPOXIA | 9 | 7.39e-01 | -6.40e-02 | 9.42e-01 |
| GOBP RESPONSE TO UV A | 7 | 7.69e-01 | 6.40e-02 | 9.51e-01 |
| GOBP INFLAMMASOME MEDIATED SIGNALING PATHWAY | 38 | 4.95e-01 | 6.40e-02 | 8.62e-01 |
| GOBP DESMOSOME ORGANIZATION | 8 | 7.54e-01 | 6.40e-02 | 9.45e-01 |
| GOBP MIDBRAIN DOPAMINERGIC NEURON DIFFERENTIATION | 8 | 7.54e-01 | 6.40e-02 | 9.45e-01 |
| GOBP CELLULAR RESPONSE TO GLUCOSE STARVATION | 43 | 4.68e-01 | 6.40e-02 | 8.53e-01 |
| GOMF PHOSPHOPROTEIN PHOSPHATASE ACTIVITY | 147 | 1.81e-01 | 6.39e-02 | 6.54e-01 |
| GOBP FEMALE MEIOSIS CHROMOSOME SEGREGATION | 5 | 8.05e-01 | -6.39e-02 | 9.61e-01 |
| GOBP NEGATIVE REGULATION OF ENDOTHELIAL CELL PROLIFERATION | 28 | 5.59e-01 | -6.38e-02 | 8.88e-01 |
| GOBP PRODUCTION OF MOLECULAR MEDIATOR INVOLVED IN INFLAMMATORY RESPONSE | 73 | 3.46e-01 | -6.38e-02 | 7.90e-01 |
| GOBP NEGATIVE REGULATION OF GENE EXPRESSION | 949 | 8.75e-04 | 6.38e-02 | 6.67e-02 |
| GOBP CELLULAR RESPONSE TO GLUCOCORTICOID STIMULUS | 39 | 4.91e-01 | 6.38e-02 | 8.62e-01 |
| GOMF ACTIN BINDING | 359 | 3.80e-02 | -6.37e-02 | 3.96e-01 |
| GOMF PROFILIN BINDING | 9 | 7.41e-01 | -6.37e-02 | 9.42e-01 |
| GOMF HISTONE H4 ACETYLTRANSFERASE ACTIVITY | 21 | 6.13e-01 | -6.37e-02 | 9.04e-01 |
| GOBP NITROGEN COMPOUND TRANSPORT | 1592 | 2.30e-05 | 6.37e-02 | 5.12e-03 |
| GOBP VESICLE TARGETING ROUGH ER TO CIS GOLGI | 26 | 5.74e-01 | 6.37e-02 | 8.92e-01 |
| GOMF INWARD RECTIFIER POTASSIUM CHANNEL ACTIVITY | 11 | 7.15e-01 | 6.36e-02 | 9.36e-01 |
| GOMF CYCLIN DEPENDENT PROTEIN SERINE THREONINE KINASE INHIBITOR ACTIVITY | 12 | 7.03e-01 | 6.36e-02 | 9.30e-01 |
| GOBP REGULATION OF CELL GROWTH | 320 | 5.06e-02 | -6.36e-02 | 4.29e-01 |
| GOCC ENZYME ACTIVATOR COMPLEX | 13 | 6.92e-01 | 6.35e-02 | 9.27e-01 |
| GOBP SYNAPTIC TRANSMISSION DOPAMINERGIC | 17 | 6.50e-01 | -6.35e-02 | 9.17e-01 |
| GOBP ETHER METABOLIC PROCESS | 24 | 5.90e-01 | -6.35e-02 | 8.97e-01 |
| GOBP SPHINGOLIPID METABOLIC PROCESS | 138 | 1.99e-01 | 6.34e-02 | 6.70e-01 |
| GOBP NEGATIVE REGULATION OF IMMUNE SYSTEM PROCESS | 431 | 2.41e-02 | 6.34e-02 | 3.37e-01 |
| GOBP NEUTRAL AMINO ACID TRANSPORT | 40 | 4.88e-01 | 6.34e-02 | 8.60e-01 |
| GOBP POSITIVE T CELL SELECTION | 40 | 4.88e-01 | -6.34e-02 | 8.60e-01 |
| GOCC FEMALE PRONUCLEUS | 9 | 7.42e-01 | -6.34e-02 | 9.42e-01 |
| GOBP MUCUS SECRETION | 13 | 6.92e-01 | -6.33e-02 | 9.27e-01 |
| GOCC LAMELLIPODIUM | 179 | 1.44e-01 | -6.33e-02 | 6.12e-01 |
| GOBP REGULATION OF NEUROBLAST PROLIFERATION | 29 | 5.55e-01 | 6.33e-02 | 8.87e-01 |
| GOBP TRNA 5 END PROCESSING | 16 | 6.61e-01 | 6.33e-02 | 9.21e-01 |
| GOBP REGULATION OF CELL SIZE | 149 | 1.82e-01 | -6.33e-02 | 6.55e-01 |
| GOBP REGULATION OF CALCIUM ION IMPORT | 31 | 5.42e-01 | -6.33e-02 | 8.81e-01 |
| GOBP POSITIVE REGULATION OF ARP2 3 COMPLEX MEDIATED ACTIN NUCLEATION | 8 | 7.57e-01 | 6.32e-02 | 9.46e-01 |
| GOCC PODOSOME | 32 | 5.36e-01 | -6.32e-02 | 8.79e-01 |
| GOBP GLYCOLIPID BIOSYNTHETIC PROCESS | 64 | 3.82e-01 | 6.32e-02 | 8.14e-01 |
| GOBP DNA REPAIR | 573 | 9.71e-03 | 6.32e-02 | 2.23e-01 |
| GOCC ER MEMBRANE INSERTION COMPLEX | 14 | 6.82e-01 | -6.32e-02 | 9.24e-01 |
| GOBP ACTIVIN RECEPTOR SIGNALING PATHWAY | 34 | 5.24e-01 | -6.32e-02 | 8.76e-01 |
| GOBP REGULATION OF RESPONSE TO STRESS | 1184 | 2.54e-04 | 6.32e-02 | 2.85e-02 |
| GOBP NUCLEIC ACID CATABOLIC PROCESS | 660 | 5.69e-03 | 6.31e-02 | 1.80e-01 |
| GOBP HUMORAL IMMUNE RESPONSE MEDIATED BY CIRCULATING IMMUNOGLOBULIN | 47 | 4.54e-01 | -6.31e-02 | 8.43e-01 |
| GOBP REGULATION OF ENDODERMAL CELL DIFFERENTIATION | 5 | 8.07e-01 | 6.30e-02 | 9.61e-01 |
| GOBP GLYCOSYLATION | 211 | 1.15e-01 | 6.30e-02 | 5.72e-01 |
| GOMF INSULIN LIKE GROWTH FACTOR I BINDING | 10 | 7.30e-01 | -6.30e-02 | 9.40e-01 |
| GOBP REGULATION OF SMAD PROTEIN SIGNAL TRANSDUCTION | 49 | 4.46e-01 | -6.30e-02 | 8.41e-01 |
| GOBP PHYSIOLOGICAL CARDIAC MUSCLE HYPERTROPHY | 17 | 6.53e-01 | 6.30e-02 | 9.18e-01 |
| GOMF CARBON SULFUR LYASE ACTIVITY | 13 | 6.94e-01 | -6.29e-02 | 9.27e-01 |
| GOBP ADRENERGIC RECEPTOR SIGNALING PATHWAY | 18 | 6.44e-01 | 6.29e-02 | 9.15e-01 |
| GOBP RESPONSE TO PROSTAGLANDIN E | 19 | 6.35e-01 | -6.29e-02 | 9.14e-01 |
| GOMF NEUROPEPTIDE RECEPTOR ACTIVITY | 16 | 6.63e-01 | -6.29e-02 | 9.21e-01 |
| GOMF SULFURIC ESTER HYDROLASE ACTIVITY | 13 | 6.95e-01 | -6.28e-02 | 9.27e-01 |
| GOBP PROTEIN LOCALIZATION TO CELL JUNCTION | 87 | 3.12e-01 | -6.27e-02 | 7.65e-01 |
| GOMF TRANSCRIPTION COREPRESSOR ACTIVITY | 176 | 1.51e-01 | -6.27e-02 | 6.13e-01 |
| GOBP NEGATIVE REGULATION OF G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY | 45 | 4.67e-01 | 6.27e-02 | 8.52e-01 |
| GOCC GEMINI OF COILED BODIES | 12 | 7.07e-01 | -6.26e-02 | 9.32e-01 |
| GOBP CELLULAR RESPONSE TO CARBOHYDRATE STIMULUS | 117 | 2.42e-01 | -6.26e-02 | 7.12e-01 |
| GOMF CATALYTIC ACTIVITY ACTING ON A RRNA | 21 | 6.20e-01 | -6.26e-02 | 9.08e-01 |
| GOBP INTRACELLULAR RECEPTOR SIGNALING PATHWAY | 315 | 5.63e-02 | 6.25e-02 | 4.43e-01 |
| GOBP CARBOHYDRATE METABOLIC PROCESS | 463 | 2.13e-02 | -6.25e-02 | 3.19e-01 |
| GOBP EPITHELIAL TUBE FORMATION | 104 | 2.71e-01 | -6.24e-02 | 7.35e-01 |
| GOMF ORGANIC HYDROXY COMPOUND TRANSMEMBRANE TRANSPORTER ACTIVITY | 30 | 5.54e-01 | -6.24e-02 | 8.86e-01 |
| GOBP CEREBRAL CORTEX DEVELOPMENT | 99 | 2.83e-01 | 6.24e-02 | 7.44e-01 |
| GOBP CELLULAR RESPONSE TO L GLUTAMATE | 5 | 8.09e-01 | -6.24e-02 | 9.61e-01 |
| GOBP RESPONSE TO AMYLOID BETA | 35 | 5.23e-01 | 6.24e-02 | 8.75e-01 |
| GOBP REGULATION OF MACROAUTOPHAGY | 172 | 1.58e-01 | 6.24e-02 | 6.24e-01 |
| GOBP REGULATION OF TRANSMEMBRANE RECEPTOR PROTEIN SERINE THREONINE KINASE SIGNALING PATHWAY | 199 | 1.29e-01 | -6.24e-02 | 5.94e-01 |
| GOBP REGULATION OF TUBE SIZE | 96 | 2.91e-01 | 6.24e-02 | 7.48e-01 |
| GOBP RESPONSE TO CYTOKINE | 739 | 3.91e-03 | 6.24e-02 | 1.50e-01 |
| GOBP NEGATIVE REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY VIA DEATH DOMAIN RECEPTORS | 22 | 6.13e-01 | -6.24e-02 | 9.04e-01 |
| GOCC RNA POLYMERASE II TRANSCRIPTION REPRESSOR COMPLEX | 13 | 6.97e-01 | 6.23e-02 | 9.28e-01 |
| GOBP INOSITOL PHOSPHATE BIOSYNTHETIC PROCESS | 19 | 6.38e-01 | 6.23e-02 | 9.15e-01 |
| GOBP DE NOVO AMP BIOSYNTHETIC PROCESS | 8 | 7.60e-01 | 6.23e-02 | 9.48e-01 |
| GOBP REGULATION OF ADAPTIVE IMMUNE RESPONSE | 194 | 1.34e-01 | 6.23e-02 | 5.99e-01 |
| GOCC GOLGI CISTERNA MEMBRANE | 75 | 3.51e-01 | 6.23e-02 | 7.93e-01 |
| GOBP NEGATIVE REGULATION OF FIBROBLAST MIGRATION | 8 | 7.60e-01 | 6.23e-02 | 9.48e-01 |
| GOBP POSITIVE REGULATION OF EPITHELIAL CELL MIGRATION | 127 | 2.25e-01 | -6.23e-02 | 6.98e-01 |
| GOBP S ADENOSYLMETHIONINE METABOLIC PROCESS | 13 | 6.98e-01 | -6.23e-02 | 9.28e-01 |
| GOBP ATP METABOLIC PROCESS | 195 | 1.34e-01 | -6.22e-02 | 5.99e-01 |
| GOBP NEGATIVE REGULATION OF CHOLESTEROL METABOLIC PROCESS | 5 | 8.10e-01 | 6.22e-02 | 9.61e-01 |
| GOBP MEDIUM CHAIN FATTY ACID BIOSYNTHETIC PROCESS | 6 | 7.92e-01 | 6.22e-02 | 9.59e-01 |
| GOBP POSITIVE REGULATION OF CELL MORPHOGENESIS | 32 | 5.43e-01 | 6.21e-02 | 8.82e-01 |
| GOBP REGULATION OF FIBROBLAST GROWTH FACTOR RECEPTOR SIGNALING PATHWAY | 23 | 6.06e-01 | -6.21e-02 | 9.03e-01 |
| GOBP VITAMIN BIOSYNTHETIC PROCESS | 21 | 6.22e-01 | -6.21e-02 | 9.09e-01 |
| GOMF UBIQUITIN LIKE PROTEIN BINDING | 121 | 2.38e-01 | 6.21e-02 | 7.08e-01 |
| GOMF PDZ DOMAIN BINDING | 67 | 3.80e-01 | 6.20e-02 | 8.13e-01 |
| GOBP POSITIVE REGULATION OF CELL ADHESION | 392 | 3.52e-02 | -6.20e-02 | 3.88e-01 |
| GOCC ACTOMYOSIN | 75 | 3.54e-01 | -6.19e-02 | 7.95e-01 |
| GOBP TELOMERE ORGANIZATION | 168 | 1.66e-01 | 6.19e-02 | 6.31e-01 |
| GOBP REGULATION OF CARDIAC MUSCLE CONTRACTION | 53 | 4.36e-01 | 6.19e-02 | 8.37e-01 |
| GOBP PROTEIN IMPORT INTO PEROXISOME MATRIX RECEPTOR RECYCLING | 7 | 7.77e-01 | 6.18e-02 | 9.54e-01 |
| GOBP CYTOPLASMIC MICROTUBULE ORGANIZATION | 57 | 4.20e-01 | -6.18e-02 | 8.30e-01 |
| GOCC CIS GOLGI NETWORK MEMBRANE | 8 | 7.62e-01 | 6.18e-02 | 9.48e-01 |
| GOBP COMPLEMENT RECEPTOR MEDIATED SIGNALING PATHWAY | 12 | 7.11e-01 | 6.18e-02 | 9.34e-01 |
| GOBP POSITIVE REGULATION OF ALCOHOL BIOSYNTHETIC PROCESS | 16 | 6.69e-01 | -6.17e-02 | 9.22e-01 |
| GOBP POSITIVE REGULATION OF TELOMERASE ACTIVITY | 27 | 5.79e-01 | 6.17e-02 | 8.92e-01 |
| GOBP CELLULAR DETOXIFICATION OF ALDEHYDE | 7 | 7.78e-01 | 6.17e-02 | 9.54e-01 |
| GOBP DOUBLE STRAND BREAK REPAIR | 293 | 6.95e-02 | 6.16e-02 | 4.79e-01 |
| GOBP CELL COMMUNICATION BY ELECTRICAL COUPLING | 21 | 6.25e-01 | 6.16e-02 | 9.09e-01 |
| GOCC RIBONUCLEOPROTEIN COMPLEX | 684 | 6.02e-03 | 6.16e-02 | 1.82e-01 |
| GOBP POSITIVE REGULATION OF GAMMA DELTA T CELL ACTIVATION | 9 | 7.49e-01 | 6.16e-02 | 9.44e-01 |
| GOBP MATURE B CELL DIFFERENTIATION | 31 | 5.53e-01 | 6.16e-02 | 8.86e-01 |
| GOBP POSITIVE REGULATION OF INTERLEUKIN 2 PRODUCTION | 32 | 5.47e-01 | 6.16e-02 | 8.84e-01 |
| GOBP POSITIVE REGULATION OF CELL JUNCTION ASSEMBLY | 67 | 3.84e-01 | -6.15e-02 | 8.15e-01 |
| GOBP FATTY ACID CATABOLIC PROCESS | 96 | 2.98e-01 | -6.15e-02 | 7.54e-01 |
| GOMF CATALYTIC ACTIVITY ACTING ON A NUCLEIC ACID | 586 | 1.10e-02 | 6.15e-02 | 2.38e-01 |
| GOMF THIAMINE PYROPHOSPHATE BINDING | 6 | 7.94e-01 | -6.15e-02 | 9.59e-01 |
| GOBP GAMMA AMINOBUTYRIC ACID SECRETION | 10 | 7.37e-01 | 6.14e-02 | 9.42e-01 |
| GOBP RESPIRATORY SYSTEM DEVELOPMENT | 157 | 1.84e-01 | -6.14e-02 | 6.57e-01 |
| GOBP NUCLEAR MIGRATION | 24 | 6.03e-01 | -6.14e-02 | 9.03e-01 |
| GOBP TRANSMISSION OF NERVE IMPULSE | 40 | 5.02e-01 | -6.14e-02 | 8.65e-01 |
| GOCC SAGA TYPE COMPLEX | 37 | 5.18e-01 | 6.14e-02 | 8.73e-01 |
| GOCC MITOCHONDRIAL LARGE RIBOSOMAL SUBUNIT | 56 | 4.27e-01 | -6.13e-02 | 8.34e-01 |
| GOBP CELL MIGRATION INVOLVED IN HEART DEVELOPMENT | 9 | 7.50e-01 | -6.13e-02 | 9.45e-01 |
| GOBP GLYCOSYL COMPOUND CATABOLIC PROCESS | 31 | 5.55e-01 | 6.13e-02 | 8.87e-01 |
| GOMF NUCLEOSOME BINDING | 75 | 3.59e-01 | -6.13e-02 | 7.99e-01 |
| GOMF HYDROLASE ACTIVITY ACTING ON CARBON NITROGEN BUT NOT PEPTIDE BONDS IN CYCLIC AMIDINES | 31 | 5.55e-01 | 6.13e-02 | 8.87e-01 |
| GOBP C21 STEROID HORMONE METABOLIC PROCESS | 23 | 6.11e-01 | -6.12e-02 | 9.04e-01 |
| GOBP LIPOPOLYSACCHARIDE MEDIATED SIGNALING PATHWAY | 50 | 4.54e-01 | 6.12e-02 | 8.43e-01 |
| GOBP PROTEIN ACETYLATION | 50 | 4.54e-01 | 6.12e-02 | 8.43e-01 |
| GOBP CD4 POSITIVE CD25 POSITIVE ALPHA BETA REGULATORY T CELL DIFFERENTIATION | 10 | 7.38e-01 | -6.12e-02 | 9.42e-01 |
| GOMF GUANYL NUCLEOTIDE EXCHANGE FACTOR ACTIVITY | 210 | 1.26e-01 | -6.12e-02 | 5.91e-01 |
| GOMF VITAMIN BINDING | 111 | 2.66e-01 | -6.12e-02 | 7.33e-01 |
| GOBP POSITIVE REGULATION OF CELL CELL ADHESION | 272 | 8.27e-02 | -6.11e-02 | 5.05e-01 |
| GOBP NEGATIVE REGULATION OF LYMPHOCYTE DIFFERENTIATION | 44 | 4.83e-01 | -6.11e-02 | 8.60e-01 |
| GOBP EXTRACELLULAR VESICLE BIOGENESIS | 24 | 6.04e-01 | 6.11e-02 | 9.03e-01 |
| GOBP NEURON PROJECTION GUIDANCE | 142 | 2.09e-01 | -6.11e-02 | 6.82e-01 |
| GOMF PHOSPHOLIPASE A1 ACTIVITY | 14 | 6.92e-01 | -6.11e-02 | 9.27e-01 |
| GOBP RESPONSE TO ACTIVITY | 59 | 4.17e-01 | -6.11e-02 | 8.30e-01 |
| GOBP REGULATION OF HEART RATE | 66 | 3.91e-01 | 6.11e-02 | 8.18e-01 |
| GOBP REGULATION OF RYANODINE SENSITIVE CALCIUM RELEASE CHANNEL ACTIVITY | 18 | 6.54e-01 | 6.10e-02 | 9.18e-01 |
| GOMF CARBON CARBON LYASE ACTIVITY | 44 | 4.84e-01 | -6.10e-02 | 8.60e-01 |
| GOBP CEREBRAL CORTEX RADIALLY ORIENTED CELL MIGRATION | 28 | 5.76e-01 | 6.10e-02 | 8.92e-01 |
| GOMF CYSTEINE TYPE ENDOPEPTIDASE ACTIVATOR ACTIVITY | 5 | 8.13e-01 | 6.10e-02 | 9.62e-01 |
| GOBP PROTEIN TARGETING TO MITOCHONDRION | 101 | 2.90e-01 | -6.10e-02 | 7.47e-01 |
| GOBP CELL DIFFERENTIATION INVOLVED IN EMBRYONIC PLACENTA DEVELOPMENT | 15 | 6.83e-01 | -6.09e-02 | 9.24e-01 |
| GOMF MYOSIN BINDING | 54 | 4.39e-01 | 6.09e-02 | 8.39e-01 |
| GOBP REGULATION OF INTRACELLULAR STEROID HORMONE RECEPTOR SIGNALING PATHWAY | 58 | 4.22e-01 | 6.09e-02 | 8.30e-01 |
| GOBP PROTEIN TARGETING | 299 | 7.00e-02 | 6.09e-02 | 4.81e-01 |
| GOMF RNA ENDONUCLEASE ACTIVITY | 67 | 3.88e-01 | -6.09e-02 | 8.17e-01 |
| GOBP RESPONSE TO TEMPERATURE STIMULUS | 131 | 2.29e-01 | 6.09e-02 | 7.01e-01 |
| GOBP NUCLEOSIDE BISPHOSPHATE BIOSYNTHETIC PROCESS | 54 | 4.39e-01 | 6.09e-02 | 8.39e-01 |
| GOBP POSITIVE REGULATION OF MACROAUTOPHAGY | 81 | 3.44e-01 | 6.09e-02 | 7.89e-01 |
| GOMF NEUROTRANSMITTER RECEPTOR ACTIVITY INVOLVED IN REGULATION OF POSTSYNAPTIC MEMBRANE POTENTIAL | 23 | 6.13e-01 | -6.09e-02 | 9.04e-01 |
| GOBP DETECTION OF LIGHT STIMULUS | 41 | 5.00e-01 | -6.08e-02 | 8.64e-01 |
| GOBP REGULATION OF ENTRY OF BACTERIUM INTO HOST CELL | 5 | 8.14e-01 | 6.08e-02 | 9.62e-01 |
| GOBP NEGATIVE REGULATION OF VIRAL ENTRY INTO HOST CELL | 17 | 6.64e-01 | 6.08e-02 | 9.22e-01 |
| GOMF SEQUENCE SPECIFIC DNA BINDING | 1232 | 3.33e-04 | 6.08e-02 | 3.47e-02 |
| GOBP VIRAL TRANSCRIPTION | 48 | 4.66e-01 | 6.08e-02 | 8.51e-01 |
| GOBP REGULATION OF DNA CATABOLIC PROCESS | 9 | 7.52e-01 | -6.08e-02 | 9.45e-01 |
| GOBP PROTEIN DEPOLYMERIZATION | 101 | 2.91e-01 | 6.08e-02 | 7.48e-01 |
| GOMF GLUCOSE SODIUM SYMPORTER ACTIVITY | 5 | 8.14e-01 | 6.07e-02 | 9.62e-01 |
| GOBP SULFUR COMPOUND TRANSPORT | 47 | 4.72e-01 | -6.07e-02 | 8.54e-01 |
| GOBP INOSITOL PHOSPHATE METABOLIC PROCESS | 32 | 5.52e-01 | 6.07e-02 | 8.86e-01 |
| GOBP REGULATION OF TELOMERE MAINTENANCE VIA TELOMERE LENGTHENING | 61 | 4.12e-01 | 6.07e-02 | 8.28e-01 |
| GOBP POSITIVE REGULATION OF INTRACELLULAR PROTEIN TRANSPORT | 87 | 3.28e-01 | 6.07e-02 | 7.79e-01 |
| GOBP CYTIDINE METABOLIC PROCESS | 12 | 7.16e-01 | 6.07e-02 | 9.36e-01 |
| GOBP UDP N ACETYLGLUCOSAMINE METABOLIC PROCESS | 14 | 6.94e-01 | -6.06e-02 | 9.27e-01 |
| GOMF LIPOPOLYSACCHARIDE BINDING | 28 | 5.79e-01 | -6.06e-02 | 8.92e-01 |
| GOBP POSITIVE REGULATION OF DNA TEMPLATED TRANSCRIPTION INITIATION | 65 | 3.98e-01 | 6.06e-02 | 8.22e-01 |
| GOBP REGULATION OF INOSITOL PHOSPHATE BIOSYNTHETIC PROCESS | 10 | 7.40e-01 | 6.06e-02 | 9.42e-01 |
| GOBP ACTIVATION OF CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY INVOLVED IN APOPTOTIC PROCESS | 66 | 3.95e-01 | -6.06e-02 | 8.20e-01 |
| GOMF 5S RRNA BINDING | 9 | 7.53e-01 | 6.05e-02 | 9.45e-01 |
| GOMF TRANSMEMBRANE RECEPTOR PROTEIN SERINE THREONINE KINASE ACTIVITY | 15 | 6.85e-01 | 6.05e-02 | 9.25e-01 |
| GOBP SPONTANEOUS SYNAPTIC TRANSMISSION | 13 | 7.06e-01 | -6.05e-02 | 9.32e-01 |
| GOCC ENDOPLASMIC RETICULUM GOLGI INTERMEDIATE COMPARTMENT | 124 | 2.45e-01 | 6.05e-02 | 7.14e-01 |
| GOBP SYMBIONT ENTRY INTO HOST | 133 | 2.28e-01 | 6.05e-02 | 7.01e-01 |
| GOBP NEGATIVE REGULATION OF PROTEIN CATABOLIC PROCESS | 101 | 2.94e-01 | 6.05e-02 | 7.50e-01 |
| GOBP MITOCHONDRIAL ELECTRON TRANSPORT CYTOCHROME C TO OXYGEN | 18 | 6.57e-01 | 6.05e-02 | 9.19e-01 |
| GOMF P53 BINDING | 59 | 4.22e-01 | -6.04e-02 | 8.30e-01 |
| GOBP NEGATIVE REGULATION OF INCLUSION BODY ASSEMBLY | 10 | 7.41e-01 | -6.04e-02 | 9.42e-01 |
| GOMF MISFOLDED PROTEIN BINDING | 15 | 6.85e-01 | 6.04e-02 | 9.25e-01 |
| GOBP REGULATION OF NEURON APOPTOTIC PROCESS | 175 | 1.68e-01 | 6.04e-02 | 6.34e-01 |
| GOBP TAURINE METABOLIC PROCESS | 6 | 7.98e-01 | -6.04e-02 | 9.59e-01 |
| GOBP NEGATIVE REGULATION OF CATALYTIC ACTIVITY | 337 | 5.71e-02 | 6.03e-02 | 4.45e-01 |
| GOBP POSITIVE REGULATION OF HEMATOPOIETIC STEM CELL PROLIFERATION | 6 | 7.98e-01 | -6.03e-02 | 9.59e-01 |
| GOBP POSITIVE REGULATION OF T CELL MIGRATION | 30 | 5.68e-01 | 6.03e-02 | 8.90e-01 |
| GOCC TRANS GOLGI NETWORK TRANSPORT VESICLE MEMBRANE | 18 | 6.58e-01 | 6.03e-02 | 9.19e-01 |
| GOBP DNA DAMAGE RESPONSE | 844 | 2.96e-03 | 6.03e-02 | 1.29e-01 |
| GOBP NEGATIVE REGULATION OF CHOLESTEROL STORAGE | 9 | 7.54e-01 | 6.02e-02 | 9.45e-01 |
| GOBP POSITIVE REGULATION OF VASOCONSTRICTION | 19 | 6.49e-01 | -6.02e-02 | 9.17e-01 |
| GOBP POSITIVE REGULATION OF PROTEASOMAL UBIQUITIN DEPENDENT PROTEIN CATABOLIC PROCESS | 73 | 3.74e-01 | -6.02e-02 | 8.09e-01 |
| GOBP RENAL FILTRATION | 25 | 6.02e-01 | -6.02e-02 | 9.03e-01 |
| GOBP NEGATIVE REGULATION OF HIPPO SIGNALING | 21 | 6.34e-01 | -6.01e-02 | 9.13e-01 |
| GOBP POSITIVE REGULATION OF CALCIUM ION IMPORT | 19 | 6.50e-01 | -6.01e-02 | 9.17e-01 |
| GOBP DNA REPLICATION DEPENDENT CHROMATIN ASSEMBLY | 6 | 7.99e-01 | -6.01e-02 | 9.60e-01 |
| GOBP POSITIVE REGULATION OF IMMUNE RESPONSE | 673 | 7.91e-03 | 6.01e-02 | 2.04e-01 |
| GOBP SECRETION BY TISSUE | 30 | 5.69e-01 | -6.00e-02 | 8.90e-01 |
| GOBP MITOTIC G1 S TRANSITION CHECKPOINT SIGNALING | 28 | 5.83e-01 | 6.00e-02 | 8.93e-01 |
| GOBP PYRAMIDAL NEURON DEVELOPMENT | 10 | 7.43e-01 | 6.00e-02 | 9.42e-01 |
| GOBP NEGATIVE REGULATION OF ENDOTHELIAL CELL DIFFERENTIATION | 7 | 7.83e-01 | -6.00e-02 | 9.57e-01 |
| GOCC AZUROPHIL GRANULE LUMEN | 86 | 3.36e-01 | -6.00e-02 | 7.86e-01 |
| GOBP INTERLEUKIN 4 PRODUCTION | 31 | 5.63e-01 | -6.00e-02 | 8.90e-01 |
| GOBP POSITIVE REGULATION OF NEURON DIFFERENTIATION | 48 | 4.72e-01 | -6.00e-02 | 8.55e-01 |
| GOCC FICOLIN 1 RICH GRANULE LUMEN | 122 | 2.53e-01 | 5.99e-02 | 7.22e-01 |
| GOBP MULTICELLULAR ORGANISMAL MOVEMENT | 44 | 4.92e-01 | -5.99e-02 | 8.62e-01 |
| GOBP NEGATIVE REGULATION OF PHOSPHORYLATION | 250 | 1.03e-01 | 5.99e-02 | 5.54e-01 |
| GOBP VACUOLAR ACIDIFICATION | 33 | 5.52e-01 | 5.99e-02 | 8.86e-01 |
| GOBP T CELL LINEAGE COMMITMENT | 30 | 5.70e-01 | -5.99e-02 | 8.90e-01 |
| GOBP POSITIVE REGULATION OF UBIQUITIN PROTEIN LIGASE ACTIVITY | 9 | 7.56e-01 | -5.99e-02 | 9.46e-01 |
| GOMF PROTEIN PHOSPHATASE BINDING | 130 | 2.39e-01 | 5.98e-02 | 7.08e-01 |
| GOBP REGULATION OF CARBOHYDRATE METABOLIC PROCESS | 150 | 2.06e-01 | -5.98e-02 | 6.81e-01 |
| GOBP REGULATION OF SYNAPTIC PLASTICITY | 145 | 2.14e-01 | -5.98e-02 | 6.89e-01 |
| GOBP POSITIVE REGULATION OF CELL DIVISION | 68 | 3.94e-01 | 5.97e-02 | 8.20e-01 |
| GOBP G0 TO G1 TRANSITION | 35 | 5.41e-01 | -5.97e-02 | 8.81e-01 |
| GOBP EXOCYTOSIS | 284 | 8.34e-02 | 5.97e-02 | 5.05e-01 |
| GOBP NEGATIVE REGULATION OF ALPHA BETA T CELL ACTIVATION | 40 | 5.14e-01 | 5.97e-02 | 8.71e-01 |
| GOBP NEGATIVE REGULATION OF MRNA PROCESSING | 21 | 6.36e-01 | -5.97e-02 | 9.14e-01 |
| GOMF CARBON NITROGEN LYASE ACTIVITY | 12 | 7.20e-01 | 5.97e-02 | 9.37e-01 |
| GOBP INTEGRIN ACTIVATION | 17 | 6.70e-01 | -5.97e-02 | 9.22e-01 |
| GOBP MITOCHONDRIAL PROTEIN PROCESSING | 13 | 7.10e-01 | -5.97e-02 | 9.33e-01 |
| GOBP REGULATION OF VENTRICULAR CARDIAC MUSCLE CELL ACTION POTENTIAL | 10 | 7.44e-01 | -5.97e-02 | 9.42e-01 |
| GOBP DETECTION OF CALCIUM ION | 11 | 7.32e-01 | 5.97e-02 | 9.41e-01 |
| GOBP DEFENSE RESPONSE | 1410 | 1.77e-04 | 5.97e-02 | 2.26e-02 |
| GOBP BROWN FAT CELL DIFFERENTIATION | 38 | 5.25e-01 | 5.96e-02 | 8.76e-01 |
| GOBP REGULATION OF LIPID BIOSYNTHETIC PROCESS | 131 | 2.39e-01 | -5.96e-02 | 7.08e-01 |
| GOCC BASAL PART OF CELL | 226 | 1.23e-01 | -5.95e-02 | 5.86e-01 |
| GOBP REGULATION OF MITOTIC NUCLEAR DIVISION | 104 | 2.95e-01 | 5.95e-02 | 7.51e-01 |
| GOBP POSITIVE REGULATION OF LYMPHOCYTE APOPTOTIC PROCESS | 15 | 6.90e-01 | 5.95e-02 | 9.27e-01 |
| GOBP POSITIVE REGULATION OF TRANSLATIONAL INITIATION | 22 | 6.29e-01 | 5.94e-02 | 9.11e-01 |
| GOBP REGULATION OF HEPATOCYTE PROLIFERATION | 12 | 7.22e-01 | 5.94e-02 | 9.37e-01 |
| GOMF MANGANESE ION TRANSMEMBRANE TRANSPORTER ACTIVITY | 8 | 7.71e-01 | -5.94e-02 | 9.52e-01 |
| GOBP CDC42 PROTEIN SIGNAL TRANSDUCTION | 12 | 7.22e-01 | 5.94e-02 | 9.38e-01 |
| GOBP GLYCOSYLCERAMIDE CATABOLIC PROCESS | 5 | 8.18e-01 | 5.94e-02 | 9.63e-01 |
| GOBP REGULATION OF PANCREATIC JUICE SECRETION | 6 | 8.01e-01 | 5.93e-02 | 9.60e-01 |
| GOBP POSITIVE REGULATION OF MAP KINASE ACTIVITY | 65 | 4.08e-01 | -5.93e-02 | 8.26e-01 |
| GOBP VESICLE LOCALIZATION | 196 | 1.52e-01 | 5.93e-02 | 6.16e-01 |
| GOBP POSITIVE REGULATION OF SMAD PROTEIN SIGNAL TRANSDUCTION | 30 | 5.74e-01 | -5.93e-02 | 8.92e-01 |
| GOBP POSITIVE REGULATION OF ADAPTIVE IMMUNE RESPONSE | 119 | 2.64e-01 | 5.93e-02 | 7.31e-01 |
| GOMF NUCLEOSIDE TRIPHOSPHATE DIPHOSPHATASE ACTIVITY | 10 | 7.46e-01 | 5.92e-02 | 9.43e-01 |
| GOMF METALLOENDOPEPTIDASE ACTIVITY | 70 | 3.92e-01 | -5.92e-02 | 8.19e-01 |
| GOBP CELLULAR RESPONSE TO PEPTIDE HORMONE STIMULUS | 245 | 1.11e-01 | 5.92e-02 | 5.64e-01 |
| GOMF CHOLESTEROL BINDING | 44 | 4.97e-01 | 5.91e-02 | 8.62e-01 |
| GOBP NUCLEOSIDE DIPHOSPHATE CATABOLIC PROCESS | 88 | 3.38e-01 | -5.91e-02 | 7.87e-01 |
| GOBP POSITIVE REGULATION OF ORGAN GROWTH | 30 | 5.76e-01 | -5.90e-02 | 8.92e-01 |
| GOMF STRUCTURAL MOLECULE ACTIVITY | 529 | 2.03e-02 | -5.90e-02 | 3.11e-01 |
| GOBP MICROTUBULE POLYMERIZATION | 89 | 3.36e-01 | -5.90e-02 | 7.86e-01 |
| GOBP LEUKOCYTE ADHESION TO ARTERIAL ENDOTHELIAL CELL | 5 | 8.20e-01 | -5.89e-02 | 9.63e-01 |
| GOBP CYTIDINE TO URIDINE EDITING | 11 | 7.35e-01 | 5.89e-02 | 9.42e-01 |
| GOBP PROTEIN HEXAMERIZATION | 9 | 7.60e-01 | 5.89e-02 | 9.48e-01 |
| GOBP REGULATION OF T CELL RECEPTOR SIGNALING PATHWAY | 48 | 4.81e-01 | 5.88e-02 | 8.59e-01 |
| GOBP REGULATION OF VASOCONSTRICTION | 38 | 5.31e-01 | 5.88e-02 | 8.78e-01 |
| GOMF MICROTUBULE SEVERING ATPASE ACTIVITY | 6 | 8.03e-01 | 5.88e-02 | 9.61e-01 |
| GOBP SRP DEPENDENT COTRANSLATIONAL PROTEIN TARGETING TO MEMBRANE TRANSLOCATION | 7 | 7.88e-01 | 5.87e-02 | 9.58e-01 |
| GOCC SPINDLE POLE CENTROSOME | 13 | 7.14e-01 | -5.87e-02 | 9.35e-01 |
| GOBP REGULATION OF MITOCHONDRIAL DEPOLARIZATION | 14 | 7.04e-01 | 5.86e-02 | 9.31e-01 |
| GOBP TIGHT JUNCTION ORGANIZATION | 58 | 4.40e-01 | -5.86e-02 | 8.40e-01 |
| GOBP VESICLE DOCKING INVOLVED IN EXOCYTOSIS | 30 | 5.79e-01 | 5.86e-02 | 8.92e-01 |
| GOBP MYELOID LEUKOCYTE ACTIVATION | 205 | 1.49e-01 | 5.85e-02 | 6.13e-01 |
| GOBP THYMUS DEVELOPMENT | 38 | 5.33e-01 | -5.85e-02 | 8.79e-01 |
| GOBP REGULATION OF BILE ACID METABOLIC PROCESS | 8 | 7.75e-01 | 5.85e-02 | 9.54e-01 |
| GOMF CELL CELL ADHESION MEDIATOR ACTIVITY | 33 | 5.61e-01 | -5.85e-02 | 8.88e-01 |
| GOBP REGULATION OF ENDOTHELIAL CELL MIGRATION | 132 | 2.46e-01 | -5.85e-02 | 7.16e-01 |
| GOBP TUMOR NECROSIS FACTOR SUPERFAMILY CYTOKINE PRODUCTION | 155 | 2.09e-01 | 5.85e-02 | 6.83e-01 |
| GOBP PROTEIN LOCALIZATION TO NUCLEOLUS | 17 | 6.77e-01 | 5.84e-02 | 9.24e-01 |
| GOBP GLUTAMATE CATABOLIC PROCESS | 5 | 8.21e-01 | -5.84e-02 | 9.64e-01 |
| GOBP POSITIVE REGULATION OF SMOOTH MUSCLE CELL MIGRATION | 32 | 5.68e-01 | 5.84e-02 | 8.90e-01 |
| GOBP NEGATIVE REGULATION OF TRANSFERASE ACTIVITY | 177 | 1.81e-01 | 5.83e-02 | 6.54e-01 |
| GOBP REGULATION OF CELLULAR RESPONSE TO STRESS | 472 | 3.00e-02 | 5.83e-02 | 3.64e-01 |
| GOBP ORGANELLE FUSION | 146 | 2.24e-01 | 5.83e-02 | 6.97e-01 |
| GOBP NEGATIVE REGULATION OF CHEMOKINE C C MOTIF LIGAND 5 PRODUCTION | 5 | 8.21e-01 | 5.83e-02 | 9.64e-01 |
| GOBP GLYCOSYL COMPOUND BIOSYNTHETIC PROCESS | 24 | 6.21e-01 | 5.83e-02 | 9.09e-01 |
| GOMF PROTEIN TYROSINE KINASE BINDING | 96 | 3.24e-01 | -5.83e-02 | 7.75e-01 |
| GOBP INTERSTRAND CROSS LINK REPAIR | 40 | 5.24e-01 | 5.82e-02 | 8.76e-01 |
| GOMF FIBROBLAST GROWTH FACTOR RECEPTOR BINDING | 11 | 7.38e-01 | -5.82e-02 | 9.42e-01 |
| GOCC HISTONE METHYLTRANSFERASE COMPLEX | 67 | 4.10e-01 | -5.82e-02 | 8.26e-01 |
| GOBP RECEPTOR MEDIATED ENDOCYTOSIS | 211 | 1.45e-01 | 5.82e-02 | 6.12e-01 |
| GOMF OXIDOREDUCTASE ACTIVITY ACTING ON NAD P H | 80 | 3.68e-01 | -5.82e-02 | 8.05e-01 |
| GOBP GLYOXYLATE METABOLIC PROCESS | 5 | 8.22e-01 | 5.82e-02 | 9.64e-01 |
| GOBP ORGANELLE ASSEMBLY | 887 | 3.30e-03 | 5.82e-02 | 1.35e-01 |
| GOBP LEUKOCYTE ACTIVATION INVOLVED IN INFLAMMATORY RESPONSE | 41 | 5.20e-01 | -5.81e-02 | 8.74e-01 |
| GOBP REGULATION OF EXOSOMAL SECRETION | 18 | 6.70e-01 | 5.81e-02 | 9.22e-01 |
| GOBP REGULATION OF T CELL MIGRATION | 42 | 5.15e-01 | 5.81e-02 | 8.71e-01 |
| GOCC ENDOSOME MEMBRANE | 515 | 2.41e-02 | 5.81e-02 | 3.37e-01 |
| GOBP MULTICELLULAR ORGANISM GROWTH | 119 | 2.74e-01 | 5.80e-02 | 7.37e-01 |
| GOMF OXIDOREDUCTASE ACTIVITY ACTING ON A HEME GROUP OF DONORS | 14 | 7.07e-01 | 5.80e-02 | 9.32e-01 |
| GOCC ENDOLYSOSOME MEMBRANE | 20 | 6.53e-01 | -5.80e-02 | 9.18e-01 |
| GOBP VASCULAR ASSOCIATED SMOOTH MUSCLE CELL MIGRATION | 22 | 6.38e-01 | 5.80e-02 | 9.15e-01 |
| GOBP MORPHOGENESIS OF AN EPITHELIAL BUD | 6 | 8.06e-01 | 5.80e-02 | 9.61e-01 |
| GOMF DELAYED RECTIFIER POTASSIUM CHANNEL ACTIVITY | 18 | 6.70e-01 | -5.80e-02 | 9.22e-01 |
| GOMF G PROTEIN COUPLED GLUTAMATE RECEPTOR BINDING | 8 | 7.77e-01 | 5.79e-02 | 9.54e-01 |
| GOBP MAINTENANCE OF PROTEIN LOCALIZATION IN ORGANELLE | 39 | 5.32e-01 | 5.78e-02 | 8.79e-01 |
| GOBP CELL ADHESION | 1115 | 1.13e-03 | -5.78e-02 | 7.42e-02 |
| GOBP NEGATIVE REGULATION OF TOR SIGNALING | 65 | 4.20e-01 | 5.78e-02 | 8.30e-01 |
| GOBP REGULATION OF RESPIRATORY GASEOUS EXCHANGE BY NERVOUS SYSTEM PROCESS | 8 | 7.77e-01 | -5.78e-02 | 9.54e-01 |
| GOBP NEURON INTRINSIC APOPTOTIC SIGNALING PATHWAY IN RESPONSE TO OXIDATIVE STRESS | 18 | 6.71e-01 | -5.78e-02 | 9.22e-01 |
| GOBP REGULATION OF NEUTROPHIL EXTRAVASATION | 7 | 7.91e-01 | 5.77e-02 | 9.59e-01 |
| GOBP DNA METABOLIC PROCESS | 910 | 3.18e-03 | 5.77e-02 | 1.32e-01 |
| GOBP CYTOPLASMIC SEQUESTERING OF NF KAPPAB | 6 | 8.07e-01 | 5.77e-02 | 9.61e-01 |
| GOMF SH2 DOMAIN BINDING | 42 | 5.18e-01 | -5.76e-02 | 8.73e-01 |
| GOBP MITOCHONDRIAL DNA METABOLIC PROCESS | 21 | 6.47e-01 | -5.76e-02 | 9.16e-01 |
| GOBP NEGATIVE REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY | 73 | 3.95e-01 | 5.76e-02 | 8.20e-01 |
| GOBP SPERMATID DIFFERENTIATION | 140 | 2.39e-01 | 5.76e-02 | 7.08e-01 |
| GOBP REGULATION OF AMYLOID PRECURSOR PROTEIN CATABOLIC PROCESS | 39 | 5.34e-01 | -5.76e-02 | 8.79e-01 |
| GOBP LENS FIBER CELL DEVELOPMENT | 10 | 7.52e-01 | -5.76e-02 | 9.45e-01 |
| GOCC CYTOSOLIC RIBOSOME | 113 | 2.90e-01 | 5.76e-02 | 7.47e-01 |
| GOBP NEGATIVE REGULATION OF CERAMIDE BIOSYNTHETIC PROCESS | 5 | 8.24e-01 | -5.75e-02 | 9.64e-01 |
| GOCC MRNA CLEAVAGE AND POLYADENYLATION SPECIFICITY FACTOR COMPLEX | 17 | 6.81e-01 | 5.75e-02 | 9.24e-01 |
| GOBP NUCLEOBASE CONTAINING SMALL MOLECULE INTERCONVERSION | 8 | 7.78e-01 | 5.75e-02 | 9.54e-01 |
| GOBP MUSCLE CELL CELLULAR HOMEOSTASIS | 20 | 6.56e-01 | -5.75e-02 | 9.18e-01 |
| GOCC STEREOCILIUM BUNDLE | 50 | 4.82e-01 | -5.75e-02 | 8.59e-01 |
| GOBP ORGANIC HYDROXY COMPOUND BIOSYNTHETIC PROCESS | 182 | 1.81e-01 | 5.75e-02 | 6.54e-01 |
| GOBP PRODUCTION OF MOLECULAR MEDIATOR OF IMMUNE RESPONSE | 251 | 1.17e-01 | 5.75e-02 | 5.76e-01 |
| GOBP RESPONSE TO AMPHETAMINE | 24 | 6.26e-01 | 5.75e-02 | 9.10e-01 |
| GOBP BRANCHING MORPHOGENESIS OF AN EPITHELIAL TUBE | 95 | 3.33e-01 | -5.75e-02 | 7.84e-01 |
| GOBP TRNA DECAY | 16 | 6.91e-01 | 5.75e-02 | 9.27e-01 |
| GOBP POSITIVE REGULATION OF FOCAL ADHESION ASSEMBLY | 18 | 6.73e-01 | 5.74e-02 | 9.23e-01 |
| GOBP CENTROSOME SEPARATION | 15 | 7.00e-01 | 5.74e-02 | 9.28e-01 |
| GOBP MAMMARY GLAND EPITHELIAL CELL DIFFERENTIATION | 13 | 7.20e-01 | 5.74e-02 | 9.37e-01 |
| GOBP RESPONSE TO ALDOSTERONE | 16 | 6.91e-01 | 5.74e-02 | 9.27e-01 |
| GOBP REGULATION OF MEIOTIC CELL CYCLE PHASE TRANSITION | 8 | 7.79e-01 | -5.74e-02 | 9.54e-01 |
| GOBP NEPHRON DEVELOPMENT | 105 | 3.10e-01 | -5.74e-02 | 7.64e-01 |
| GOMF BENZODIAZEPINE RECEPTOR BINDING | 5 | 8.24e-01 | 5.73e-02 | 9.64e-01 |
| GOBP BONE RESORPTION | 49 | 4.88e-01 | -5.73e-02 | 8.60e-01 |
| GOBP POSITIVE REGULATION OF PROTEIN DEPHOSPHORYLATION | 39 | 5.36e-01 | -5.73e-02 | 8.79e-01 |
| GOBP ENDOTHELIAL CELL DEVELOPMENT | 59 | 4.46e-01 | 5.73e-02 | 8.42e-01 |
| GOBP ACYL COA METABOLIC PROCESS | 84 | 3.64e-01 | 5.73e-02 | 8.02e-01 |
| GOBP TRANSITION BETWEEN FAST AND SLOW FIBER | 5 | 8.25e-01 | -5.72e-02 | 9.64e-01 |
| GOBP POSITIVE REGULATION OF CHOLESTEROL STORAGE | 6 | 8.08e-01 | -5.72e-02 | 9.61e-01 |
| GOBP NEGATIVE REGULATION OF ANDROGEN RECEPTOR SIGNALING PATHWAY | 10 | 7.54e-01 | 5.72e-02 | 9.45e-01 |
| GOBP OOCYTE DIFFERENTIATION | 43 | 5.17e-01 | 5.71e-02 | 8.72e-01 |
| GOBP ANTIGEN PROCESSING AND PRESENTATION OF PEPTIDE OR POLYSACCHARIDE ANTIGEN VIA MHC CLASS II | 33 | 5.70e-01 | 5.71e-02 | 8.90e-01 |
| GOBP PROTON MOTIVE FORCE DRIVEN ATP SYNTHESIS | 74 | 3.96e-01 | -5.71e-02 | 8.20e-01 |
| GOBP REGULATION OF INSULIN SECRETION | 124 | 2.72e-01 | -5.71e-02 | 7.36e-01 |
| GOCC NPBAF COMPLEX | 14 | 7.11e-01 | -5.71e-02 | 9.35e-01 |
| GOBP NEGATIVE REGULATION OF BINDING | 90 | 3.49e-01 | -5.71e-02 | 7.92e-01 |
| GOBP TOLL SIGNALING PATHWAY | 11 | 7.43e-01 | -5.71e-02 | 9.42e-01 |
| GOBP REGULATION OF CENTROMERIC SISTER CHROMATID COHESION | 5 | 8.25e-01 | 5.71e-02 | 9.64e-01 |
| GOMF UBIQUITIN PROTEIN TRANSFERASE REGULATOR ACTIVITY | 30 | 5.89e-01 | 5.70e-02 | 8.96e-01 |
| GOBP REGULATION OF RESPONSE TO CYTOKINE STIMULUS | 153 | 2.23e-01 | 5.70e-02 | 6.97e-01 |
| GOCC NEURON TO NEURON SYNAPSE | 273 | 1.05e-01 | -5.70e-02 | 5.57e-01 |
| GOBP NEGATIVE REGULATION OF PROTEIN METABOLIC PROCESS | 671 | 1.18e-02 | 5.70e-02 | 2.43e-01 |
| GOBP RIBONUCLEOSIDE MONOPHOSPHATE BIOSYNTHETIC PROCESS | 32 | 5.77e-01 | -5.70e-02 | 8.92e-01 |
| GOBP SECONDARY HEART FIELD SPECIFICATION | 7 | 7.94e-01 | 5.70e-02 | 9.59e-01 |
| GOBP RAC PROTEIN SIGNAL TRANSDUCTION | 45 | 5.08e-01 | 5.70e-02 | 8.69e-01 |
| GOBP NUCLEOSIDE TRIPHOSPHATE BIOSYNTHETIC PROCESS | 115 | 2.92e-01 | -5.69e-02 | 7.49e-01 |
| GOBP PENTOSE PHOSPHATE SHUNT NON OXIDATIVE BRANCH | 5 | 8.26e-01 | -5.69e-02 | 9.64e-01 |
| GOBP REGULATION OF VITAMIN METABOLIC PROCESS | 11 | 7.44e-01 | -5.69e-02 | 9.42e-01 |
| GOBP REGULATION OF INTEGRIN ACTIVATION | 11 | 7.44e-01 | 5.69e-02 | 9.42e-01 |
| GOBP POSITIVE REGULATION OF CD8 POSITIVE ALPHA BETA T CELL ACTIVATION | 8 | 7.81e-01 | 5.68e-02 | 9.56e-01 |
| GOBP T CELL EXTRAVASATION | 12 | 7.33e-01 | -5.68e-02 | 9.41e-01 |
| GOBP GALACTOSE METABOLIC PROCESS | 9 | 7.68e-01 | -5.68e-02 | 9.50e-01 |
| GOBP VESICLE DOCKING | 50 | 4.88e-01 | 5.67e-02 | 8.60e-01 |
| GOBP RHOMBOMERE DEVELOPMENT | 5 | 8.26e-01 | -5.67e-02 | 9.64e-01 |
| GOMF NITRIC OXIDE SYNTHASE REGULATOR ACTIVITY | 7 | 7.95e-01 | 5.67e-02 | 9.59e-01 |
| GOBP REGULATION OF T CELL MEDIATED CYTOTOXICITY | 42 | 5.25e-01 | 5.67e-02 | 8.76e-01 |
| GOBP REGULATION OF TRANSMISSION OF NERVE IMPULSE | 8 | 7.81e-01 | -5.67e-02 | 9.56e-01 |
| GOBP POSITIVE REGULATION OF SEQUESTERING OF TRIGLYCERIDE | 7 | 7.95e-01 | 5.67e-02 | 9.59e-01 |
| GOBP POSITIVE REGULATION OF SECRETION | 227 | 1.42e-01 | 5.66e-02 | 6.09e-01 |
| GOBP ESTABLISHMENT OF PROTEIN LOCALIZATION | 1491 | 2.62e-04 | 5.66e-02 | 2.89e-02 |
| GOBP NEGATIVE REGULATION OF GROWTH | 176 | 1.96e-01 | -5.66e-02 | 6.68e-01 |
| GOBP NADP METABOLIC PROCESS | 40 | 5.36e-01 | -5.65e-02 | 8.79e-01 |
| GOBP EXPORT ACROSS PLASMA MEMBRANE | 54 | 4.73e-01 | 5.65e-02 | 8.55e-01 |
| GOBP POSITIVE REGULATION OF TRANSFERASE ACTIVITY | 298 | 9.34e-02 | 5.65e-02 | 5.33e-01 |
| GOBP RESPONSE TO CELL CYCLE CHECKPOINT SIGNALING | 9 | 7.69e-01 | 5.65e-02 | 9.51e-01 |
| GOBP RESPONSE TO VITAMIN E | 7 | 7.96e-01 | -5.64e-02 | 9.59e-01 |
| GOBP NAIL DEVELOPMENT | 5 | 8.27e-01 | 5.64e-02 | 9.64e-01 |
| GOMF CIS REGULATORY REGION SEQUENCE SPECIFIC DNA BINDING | 871 | 4.73e-03 | 5.64e-02 | 1.68e-01 |
| GOBP PROTEIN K48 LINKED DEUBIQUITINATION | 25 | 6.25e-01 | 5.64e-02 | 9.10e-01 |
| GOBP SOMATIC STEM CELL POPULATION MAINTENANCE | 51 | 4.86e-01 | 5.64e-02 | 8.60e-01 |
| GOBP EPITHELIAL CELL DIFFERENTIATION INVOLVED IN KIDNEY DEVELOPMENT | 33 | 5.75e-01 | -5.64e-02 | 8.92e-01 |
| GOMF PROTON CHANNEL ACTIVITY | 21 | 6.55e-01 | -5.64e-02 | 9.18e-01 |
| GOMF ACID THIOL LIGASE ACTIVITY | 27 | 6.12e-01 | 5.64e-02 | 9.04e-01 |
| GOBP PURINE DEOXYRIBONUCLEOSIDE MONOPHOSPHATE CATABOLIC PROCESS | 5 | 8.27e-01 | -5.63e-02 | 9.64e-01 |
| GOBP VOLUNTARY MUSCULOSKELETAL MOVEMENT | 7 | 7.96e-01 | 5.63e-02 | 9.59e-01 |
| GOBP PHOSPHATIDYLINOSITOL MEDIATED SIGNALING | 22 | 6.47e-01 | -5.63e-02 | 9.16e-01 |
| GOBP LYMPHOCYTE ACTIVATION INVOLVED IN IMMUNE RESPONSE | 184 | 1.88e-01 | 5.63e-02 | 6.62e-01 |
| GOCC TRANSPORTER COMPLEX | 328 | 7.99e-02 | -5.63e-02 | 4.98e-01 |
| GOBP REGULATION OF IMMUNOGLOBULIN PRODUCTION | 68 | 4.22e-01 | 5.63e-02 | 8.30e-01 |
| GOBP NEGATIVE REGULATION OF PROTEOLYSIS | 169 | 2.07e-01 | 5.62e-02 | 6.82e-01 |
| GOBP POTASSIUM ION TRANSPORT | 152 | 2.32e-01 | -5.62e-02 | 7.04e-01 |
| GOMF CERAMIDE BINDING | 18 | 6.80e-01 | -5.62e-02 | 9.24e-01 |
| GOBP REGULATION OF NEURON PROJECTION REGENERATION | 27 | 6.13e-01 | -5.62e-02 | 9.04e-01 |
| GOMF LIPOPROTEIN PARTICLE RECEPTOR BINDING | 23 | 6.41e-01 | 5.62e-02 | 9.15e-01 |
| GOBP GLUTAMATE METABOLIC PROCESS | 25 | 6.27e-01 | 5.62e-02 | 9.11e-01 |
| GOBP RIBONUCLEOSIDE CATABOLIC PROCESS | 18 | 6.80e-01 | 5.62e-02 | 9.24e-01 |
| GOMF MONOSACCHARIDE BINDING | 66 | 4.30e-01 | -5.61e-02 | 8.35e-01 |
| GOBP REGULATION OF PROTEIN DEPHOSPHORYLATION | 67 | 4.27e-01 | 5.61e-02 | 8.33e-01 |
| GOBP CYTOLYSIS | 5 | 8.28e-01 | -5.61e-02 | 9.64e-01 |
| GOBP PROTEIN DNA COMPLEX ASSEMBLY | 178 | 1.97e-01 | 5.61e-02 | 6.69e-01 |
| GOBP CGMP METABOLIC PROCESS | 10 | 7.59e-01 | 5.61e-02 | 9.47e-01 |
| GOBP CELLULAR RESPONSE TO INSULIN STIMULUS | 178 | 1.97e-01 | 5.61e-02 | 6.69e-01 |
| GOBP CALCIUM ION HOMEOSTASIS | 231 | 1.43e-01 | -5.60e-02 | 6.10e-01 |
| GOBP CYTOKINE MEDIATED SIGNALING PATHWAY | 394 | 5.67e-02 | 5.60e-02 | 4.44e-01 |
| GOMF MHC CLASS II PROTEIN COMPLEX BINDING | 25 | 6.28e-01 | -5.59e-02 | 9.11e-01 |
| GOBP MYELOID LEUKOCYTE DIFFERENTIATION | 188 | 1.86e-01 | 5.59e-02 | 6.60e-01 |
| GOBP SMOOTH MUSCLE CELL DIFFERENTIATION | 45 | 5.16e-01 | -5.59e-02 | 8.72e-01 |
| GOBP POSITIVE REGULATION OF TORC1 SIGNALING | 54 | 4.77e-01 | -5.59e-02 | 8.57e-01 |
| GOCC STEREOCILIA COUPLING LINK | 5 | 8.29e-01 | -5.59e-02 | 9.64e-01 |
| GOBP CRANIAL NERVE STRUCTURAL ORGANIZATION | 7 | 7.98e-01 | -5.59e-02 | 9.59e-01 |
| GOBP PHAGOLYSOSOME ASSEMBLY | 16 | 6.99e-01 | 5.59e-02 | 9.28e-01 |
| GOMF GLYCEROL CHANNEL ACTIVITY | 5 | 8.29e-01 | 5.59e-02 | 9.64e-01 |
| GOBP CIRCADIAN SLEEP WAKE CYCLE NON REM SLEEP | 5 | 8.29e-01 | -5.59e-02 | 9.64e-01 |
| GOBP INTERLEUKIN 1 ALPHA PRODUCTION | 6 | 8.13e-01 | 5.58e-02 | 9.62e-01 |
| GOCC MLL3 4 COMPLEX | 12 | 7.38e-01 | 5.58e-02 | 9.42e-01 |
| GOBP TRNA THREONYLCARBAMOYLADENOSINE METABOLIC PROCESS | 16 | 7.00e-01 | -5.57e-02 | 9.28e-01 |
| GOBP REGULATION OF ESTABLISHMENT OF PROTEIN LOCALIZATION | 437 | 4.61e-02 | 5.57e-02 | 4.17e-01 |
| GOBP HRI MEDIATED SIGNALING | 6 | 8.14e-01 | -5.56e-02 | 9.62e-01 |
| GOBP NUCLEAR MEMBRANE REASSEMBLY | 25 | 6.30e-01 | 5.56e-02 | 9.12e-01 |
| GOCC EXORIBONUCLEASE COMPLEX | 25 | 6.30e-01 | -5.56e-02 | 9.12e-01 |
| GOBP GLUTAMATE SECRETION | 20 | 6.67e-01 | 5.56e-02 | 9.22e-01 |
| GOBP TISSUE MIGRATION | 248 | 1.32e-01 | -5.55e-02 | 5.97e-01 |
| GOBP REGULATION OF PROTEIN SERINE THREONINE KINASE ACTIVITY | 216 | 1.60e-01 | 5.55e-02 | 6.27e-01 |
| GOBP REGULATION OF PLASMA MEMBRANE ORGANIZATION | 17 | 6.92e-01 | 5.55e-02 | 9.27e-01 |
| GOBP LEUKOTRIENE BIOSYNTHETIC PROCESS | 13 | 7.29e-01 | -5.55e-02 | 9.40e-01 |
| GOBP PROGRAMMED NECROTIC CELL DEATH | 50 | 4.97e-01 | -5.55e-02 | 8.62e-01 |
| GOCC CATION TRANSPORTING ATPASE COMPLEX | 11 | 7.50e-01 | 5.55e-02 | 9.45e-01 |
| GOBP ANIMAL ORGAN FORMATION | 35 | 5.70e-01 | 5.54e-02 | 8.90e-01 |
| GOBP POSITIVE REGULATION OF TRANSMEMBRANE TRANSPORT | 153 | 2.37e-01 | 5.54e-02 | 7.08e-01 |
| GOCC GPI ANCHOR TRANSAMIDASE COMPLEX | 5 | 8.30e-01 | 5.54e-02 | 9.64e-01 |
| GOBP NUCLEAR MRNA SURVEILLANCE | 11 | 7.51e-01 | -5.53e-02 | 9.45e-01 |
| GOBP STEROID HORMONE MEDIATED SIGNALING PATHWAY | 113 | 3.10e-01 | 5.53e-02 | 7.64e-01 |
| GOBP REGULATION OF HOMOTYPIC CELL CELL ADHESION | 29 | 6.06e-01 | -5.53e-02 | 9.03e-01 |
| GOBP LENS MORPHOGENESIS IN CAMERA TYPE EYE | 14 | 7.20e-01 | -5.52e-02 | 9.37e-01 |
| GOCC PROTEASOME CORE COMPLEX | 18 | 6.85e-01 | 5.52e-02 | 9.25e-01 |
| GOMF OXIDOREDUCTASE ACTIVITY ACTING ON PAIRED DONORS WITH INCORPORATION OR REDUCTION OF MOLECULAR OXYGEN REDUCED FLAVIN OR FLAVOPROTEIN AS ONE DONOR AND INCORPORATION OF ONE ATOM OF OXYGEN | 20 | 6.69e-01 | -5.52e-02 | 9.22e-01 |
| GOBP INTESTINAL CHOLESTEROL ABSORPTION | 10 | 7.62e-01 | 5.52e-02 | 9.48e-01 |
| GOBP RESPONSE TO CYCLOHEXIMIDE | 5 | 8.31e-01 | -5.52e-02 | 9.64e-01 |
| GOBP CARBOHYDRATE CATABOLIC PROCESS | 142 | 2.56e-01 | -5.52e-02 | 7.26e-01 |
| GOBP ACROSOME REACTION | 21 | 6.62e-01 | -5.52e-02 | 9.21e-01 |
| GOBP G PROTEIN COUPLED PURINERGIC RECEPTOR SIGNALING PATHWAY | 11 | 7.51e-01 | 5.51e-02 | 9.45e-01 |
| GOBP ENDOMEMBRANE SYSTEM ORGANIZATION | 524 | 3.08e-02 | 5.51e-02 | 3.69e-01 |
| GOBP POSITIVE REGULATION OF DENDRITE DEVELOPMENT | 10 | 7.63e-01 | -5.51e-02 | 9.48e-01 |
| GOBP PRIMITIVE ERYTHROCYTE DIFFERENTIATION | 5 | 8.31e-01 | 5.51e-02 | 9.64e-01 |
| GOBP NEGATIVE REGULATION OF BLOOD CIRCULATION | 17 | 6.94e-01 | -5.51e-02 | 9.27e-01 |
| GOBP UREA TRANSPORT | 8 | 7.87e-01 | 5.51e-02 | 9.57e-01 |
| GOMF PROTEIN SERINE THREONINE PHOSPHATASE INHIBITOR ACTIVITY | 10 | 7.63e-01 | 5.50e-02 | 9.49e-01 |
| GOMF MONOAMINE TRANSMEMBRANE TRANSPORTER ACTIVITY | 7 | 8.01e-01 | 5.50e-02 | 9.60e-01 |
| GOBP CERAMIDE 1 PHOSPHATE TRANSPORT | 6 | 8.16e-01 | 5.50e-02 | 9.62e-01 |
| GOMF CERAMIDE 1 PHOSPHATE TRANSFER ACTIVITY | 6 | 8.16e-01 | 5.50e-02 | 9.62e-01 |
| GOBP POSITIVE REGULATION OF NEURON MIGRATION | 17 | 6.95e-01 | -5.50e-02 | 9.27e-01 |
| GOBP CELL FATE DETERMINATION | 22 | 6.55e-01 | -5.50e-02 | 9.18e-01 |
| GOMF D LOOP DNA BINDING | 5 | 8.31e-01 | 5.50e-02 | 9.64e-01 |
| GOMF LYASE ACTIVITY | 169 | 2.18e-01 | -5.49e-02 | 6.93e-01 |
| GOCC OUTER MITOCHONDRIAL MEMBRANE PROTEIN COMPLEX | 22 | 6.56e-01 | 5.49e-02 | 9.18e-01 |
| GOBP GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR PRODUCTION | 10 | 7.64e-01 | -5.48e-02 | 9.49e-01 |
| GOMF THIOL OXIDASE ACTIVITY | 6 | 8.16e-01 | -5.48e-02 | 9.63e-01 |
| GOMF PHOSPHATIDYLINOSITOL 4 5 BISPHOSPHATE BINDING | 68 | 4.35e-01 | -5.48e-02 | 8.36e-01 |
| GOMF EXTRACELLULARLY ATP GATED MONOATOMIC CATION CHANNEL ACTIVITY | 5 | 8.32e-01 | 5.47e-02 | 9.64e-01 |
| GOBP ORGANIC ACID TRANSMEMBRANE TRANSPORT | 115 | 3.11e-01 | -5.47e-02 | 7.65e-01 |
| GOBP REGULATION OF DELAYED RECTIFIER POTASSIUM CHANNEL ACTIVITY | 14 | 7.23e-01 | 5.47e-02 | 9.38e-01 |
| GOBP REGULATION OF IMMUNE RESPONSE | 837 | 7.25e-03 | 5.47e-02 | 1.95e-01 |
| GOBP TRANSEPITHELIAL TRANSPORT | 21 | 6.65e-01 | 5.47e-02 | 9.22e-01 |
| GOBP ICOSANOID CATABOLIC PROCESS | 7 | 8.02e-01 | -5.46e-02 | 9.61e-01 |
| GOBP NEURAL CREST FORMATION | 10 | 7.65e-01 | -5.46e-02 | 9.49e-01 |
| GOMF TRANSMEMBRANE RECEPTOR PROTEIN KINASE ACTIVITY | 55 | 4.84e-01 | 5.46e-02 | 8.60e-01 |
| GOBP POSITIVE REGULATION OF MACROPHAGE DIFFERENTIATION | 12 | 7.43e-01 | -5.46e-02 | 9.42e-01 |
| GOMF ORGANIC ACID BINDING | 138 | 2.69e-01 | -5.46e-02 | 7.33e-01 |
| GOMF PEPTIDASE REGULATOR ACTIVITY | 150 | 2.49e-01 | 5.45e-02 | 7.18e-01 |
| GOMF PHOSPHATIDYLINOSITOL 5 PHOSPHATE BINDING | 18 | 6.89e-01 | 5.45e-02 | 9.27e-01 |
| GOBP ESTABLISHMENT OF ENDOTHELIAL INTESTINAL BARRIER | 14 | 7.24e-01 | 5.44e-02 | 9.38e-01 |
| GOBP SENSORY ORGAN MORPHOGENESIS | 166 | 2.27e-01 | -5.44e-02 | 7.00e-01 |
| GOBP REGULATION OF NERVOUS SYSTEM PROCESS | 83 | 3.92e-01 | -5.44e-02 | 8.19e-01 |
| GOBP REGULATION OF PROTEASOMAL PROTEIN CATABOLIC PROCESS | 175 | 2.15e-01 | 5.44e-02 | 6.91e-01 |
| GOBP LEUKOCYTE TETHERING OR ROLLING | 26 | 6.31e-01 | 5.43e-02 | 9.12e-01 |
| GOBP PROTEIN LOCALIZATION TO CELL CELL JUNCTION | 21 | 6.67e-01 | -5.43e-02 | 9.22e-01 |
| GOBP ARGININE METABOLIC PROCESS | 13 | 7.35e-01 | -5.43e-02 | 9.42e-01 |
| GOBP INTRACILIARY TRANSPORT | 43 | 5.38e-01 | 5.43e-02 | 8.79e-01 |
| GOMF PHOSPHATIDYLINOSITOL 3 5 BISPHOSPHATE BINDING | 24 | 6.45e-01 | 5.43e-02 | 9.15e-01 |
| GOBP REGULATION OF EXOCYTOSIS | 140 | 2.68e-01 | 5.43e-02 | 7.33e-01 |
| GOBP POSITIVE REGULATION OF OSTEOBLAST DIFFERENTIATION | 45 | 5.29e-01 | 5.42e-02 | 8.77e-01 |
| GOBP PYRIMIDINE NUCLEOTIDE CATABOLIC PROCESS | 19 | 6.82e-01 | -5.42e-02 | 9.24e-01 |
| GOCC CELL BODY MEMBRANE | 18 | 6.90e-01 | 5.42e-02 | 9.27e-01 |
| GOBP POSITIVE REGULATION OF MITOTIC CELL CYCLE | 112 | 3.22e-01 | 5.42e-02 | 7.73e-01 |
| GOBP VERY LONG CHAIN FATTY ACID BIOSYNTHETIC PROCESS | 12 | 7.45e-01 | 5.42e-02 | 9.43e-01 |
| GOCC MHC PROTEIN COMPLEX | 23 | 6.53e-01 | -5.42e-02 | 9.18e-01 |
| GOBP NEGATIVE REGULATION OF CELL GROWTH | 139 | 2.70e-01 | -5.42e-02 | 7.35e-01 |
| GOBP REGULATION OF GLIOGENESIS | 76 | 4.15e-01 | -5.41e-02 | 8.29e-01 |
| GOBP GLYCOSYL COMPOUND METABOLIC PROCESS | 73 | 4.24e-01 | 5.41e-02 | 8.31e-01 |
| GOBP RESPONSE TO TUMOR CELL | 40 | 5.54e-01 | -5.40e-02 | 8.87e-01 |
| GOBP LUTEINIZATION | 10 | 7.68e-01 | 5.40e-02 | 9.50e-01 |
| GOBP NEGATIVE REGULATION OF IMMUNE RESPONSE | 172 | 2.22e-01 | 5.40e-02 | 6.97e-01 |
| GOBP POSITIVE REGULATION OF MYELOID LEUKOCYTE CYTOKINE PRODUCTION INVOLVED IN IMMUNE RESPONSE | 32 | 5.97e-01 | 5.40e-02 | 9.02e-01 |
| GOBP GRANULOCYTE CHEMOTAXIS | 89 | 3.79e-01 | 5.40e-02 | 8.12e-01 |
| GOBP GAMMA AMINOBUTYRIC ACID SIGNALING PATHWAY | 12 | 7.46e-01 | 5.39e-02 | 9.43e-01 |
| GOMF CARBOXYLIC ESTER HYDROLASE ACTIVITY | 113 | 3.22e-01 | -5.39e-02 | 7.74e-01 |
| GOBP POSITIVE REGULATION OF IMMUNE EFFECTOR PROCESS | 222 | 1.67e-01 | 5.39e-02 | 6.31e-01 |
| GOMF PHOSPHATIDYLINOSITOL BISPHOSPHATE BINDING | 87 | 3.85e-01 | -5.39e-02 | 8.15e-01 |
| GOBP GOLGI LUMEN ACIDIFICATION | 13 | 7.37e-01 | 5.39e-02 | 9.42e-01 |
| GOMF 5 3 DNA HELICASE ACTIVITY | 9 | 7.80e-01 | 5.39e-02 | 9.55e-01 |
| GOBP REGULATION OF HAIR FOLLICLE DEVELOPMENT | 10 | 7.68e-01 | -5.38e-02 | 9.51e-01 |
| GOCC COATED VESICLE MEMBRANE | 176 | 2.18e-01 | 5.38e-02 | 6.93e-01 |
| GOBP REGULATION OF CALCIUM ION TRANSMEMBRANE TRANSPORTER ACTIVITY | 47 | 5.24e-01 | -5.37e-02 | 8.76e-01 |
| GOBP NEGATIVE REGULATION OF STEM CELL DIFFERENTIATION | 21 | 6.70e-01 | 5.37e-02 | 9.22e-01 |
| GOBP STEM CELL DEVELOPMENT | 54 | 4.95e-01 | -5.37e-02 | 8.62e-01 |
| GOBP KETONE BODY METABOLIC PROCESS | 7 | 8.06e-01 | -5.37e-02 | 9.61e-01 |
| GOBP HINDBRAIN RADIAL GLIA GUIDED CELL MIGRATION | 8 | 7.93e-01 | -5.37e-02 | 9.59e-01 |
| GOBP PROTEOGLYCAN METABOLIC PROCESS | 65 | 4.54e-01 | -5.37e-02 | 8.43e-01 |
| GOBP REGULATION OF POLYAMINE TRANSMEMBRANE TRANSPORT | 5 | 8.35e-01 | 5.37e-02 | 9.65e-01 |
| GOMF ORNITHINE DECARBOXYLASE REGULATOR ACTIVITY | 5 | 8.35e-01 | 5.37e-02 | 9.65e-01 |
| GOBP GAMMA DELTA T CELL ACTIVATION | 25 | 6.42e-01 | 5.37e-02 | 9.15e-01 |
| GOMF U1 SNRNA BINDING | 8 | 7.93e-01 | -5.36e-02 | 9.59e-01 |
| GOBP NEGATIVE REGULATION OF RECEPTOR RECYCLING | 5 | 8.36e-01 | -5.36e-02 | 9.65e-01 |
| GOMF FATTY ACID DERIVATIVE BINDING | 17 | 7.02e-01 | -5.36e-02 | 9.30e-01 |
| GOBP REGULATION OF PROGRAMMED NECROTIC CELL DEATH | 30 | 6.12e-01 | -5.36e-02 | 9.04e-01 |
| GOBP CALCIUM ION TRANSMEMBRANE TRANSPORT | 246 | 1.48e-01 | -5.36e-02 | 6.13e-01 |
| GOCC SYMMETRIC SYNAPSE | 7 | 8.06e-01 | 5.35e-02 | 9.61e-01 |
| GOMF L ASPARTATE TRANSMEMBRANE TRANSPORTER ACTIVITY | 7 | 8.06e-01 | 5.35e-02 | 9.61e-01 |
| GOBP REGULATION OF SIGNAL TRANSDUCTION BY P53 CLASS MEDIATOR | 99 | 3.57e-01 | 5.35e-02 | 7.98e-01 |
| GOBP PHOSPHATIDYLGLYCEROL METABOLIC PROCESS | 28 | 6.24e-01 | -5.35e-02 | 9.09e-01 |
| GOBP REGULATION OF ENDODEOXYRIBONUCLEASE ACTIVITY | 8 | 7.93e-01 | -5.35e-02 | 9.59e-01 |
| GOMF DIPEPTIDASE ACTIVITY | 13 | 7.38e-01 | 5.35e-02 | 9.42e-01 |
| GOBP SNO S RNA PROCESSING | 12 | 7.48e-01 | -5.35e-02 | 9.44e-01 |
| GOBP MORPHOGENESIS OF AN ENDOTHELIUM | 13 | 7.39e-01 | 5.34e-02 | 9.42e-01 |
| GOBP DNA DAMAGE RESPONSE SIGNAL TRANSDUCTION BY P53 CLASS MEDIATOR RESULTING IN CELL CYCLE ARREST | 17 | 7.03e-01 | -5.34e-02 | 9.30e-01 |
| GOBP FC GAMMA RECEPTOR SIGNALING PATHWAY | 33 | 5.95e-01 | 5.34e-02 | 9.01e-01 |
| GOBP EPIDERMAL GROWTH FACTOR RECEPTOR SIGNALING PATHWAY | 89 | 3.84e-01 | 5.34e-02 | 8.15e-01 |
| GOBP REGULATION OF APOPTOTIC CELL CLEARANCE | 8 | 7.94e-01 | -5.33e-02 | 9.59e-01 |
| GOCC MEMBRANE MICRODOMAIN | 238 | 1.57e-01 | 5.33e-02 | 6.21e-01 |
| GOBP NEGATIVE REGULATION OF MUSCLE CELL DIFFERENTIATION | 50 | 5.14e-01 | -5.33e-02 | 8.71e-01 |
| GOBP RESPONSE TO FATTY ACID | 42 | 5.50e-01 | 5.33e-02 | 8.84e-01 |
| GOBP KIDNEY EPITHELIUM DEVELOPMENT | 94 | 3.73e-01 | -5.32e-02 | 8.09e-01 |
| GOBP ENDOTHELIAL CELL APOPTOTIC PROCESS | 45 | 5.37e-01 | -5.32e-02 | 8.79e-01 |
| GOBP CELLULAR HYPEROSMOTIC RESPONSE | 18 | 6.96e-01 | -5.31e-02 | 9.28e-01 |
| GOMF FOLIC ACID BINDING | 12 | 7.50e-01 | -5.30e-02 | 9.45e-01 |
| GOBP POSITIVE REGULATION OF DNA TEMPLATED TRANSCRIPTION ELONGATION | 58 | 4.85e-01 | 5.30e-02 | 8.60e-01 |
| GOBP NEGATIVE REGULATION OF TRANSCRIPTION BY RNA POLYMERASE I | 11 | 7.61e-01 | -5.30e-02 | 9.48e-01 |
| GOBP SPERM MOTILITY | 80 | 4.12e-01 | -5.30e-02 | 8.28e-01 |
| GOBP ATP BIOSYNTHETIC PROCESS | 92 | 3.80e-01 | -5.30e-02 | 8.13e-01 |
| GOMF STORE OPERATED CALCIUM CHANNEL ACTIVITY | 7 | 8.08e-01 | -5.30e-02 | 9.61e-01 |
| GOBP PROTEIN LOCALIZATION TO MITOCHONDRION | 122 | 3.13e-01 | -5.29e-02 | 7.65e-01 |
| GOBP CARDIAC MUSCLE CONTRACTION | 100 | 3.60e-01 | 5.29e-02 | 8.00e-01 |
| GOBP ACTOMYOSIN CONTRACTILE RING ORGANIZATION | 10 | 7.72e-01 | -5.29e-02 | 9.52e-01 |
| GOBP BIOGENIC AMINE METABOLIC PROCESS | 71 | 4.41e-01 | -5.29e-02 | 8.40e-01 |
| GOBP LIPID DROPLET FORMATION | 12 | 7.51e-01 | -5.29e-02 | 9.45e-01 |
| GOBP RESPONSE TO RETINOIC ACID | 68 | 4.51e-01 | -5.29e-02 | 8.43e-01 |
| GOBP NEGATIVE REGULATION OF NEURON PROJECTION DEVELOPMENT | 103 | 3.54e-01 | 5.29e-02 | 7.95e-01 |
| GOCC NEURONAL DENSE CORE VESICLE | 11 | 7.61e-01 | 5.29e-02 | 9.48e-01 |
| GOBP EAR MORPHOGENESIS | 70 | 4.44e-01 | -5.29e-02 | 8.41e-01 |
| GOBP SKELETAL MYOFIBRIL ASSEMBLY | 6 | 8.23e-01 | -5.29e-02 | 9.64e-01 |
| GOBP NEGATIVE REGULATION OF PROTEIN CONTAINING COMPLEX ASSEMBLY | 125 | 3.07e-01 | -5.29e-02 | 7.62e-01 |
| GOBP REGULATION OF CATION CHANNEL ACTIVITY | 70 | 4.45e-01 | 5.28e-02 | 8.41e-01 |
| GOBP CHOLESTEROL IMPORT | 7 | 8.09e-01 | 5.28e-02 | 9.61e-01 |
| GOBP CHEMOKINE PRODUCTION | 78 | 4.20e-01 | 5.28e-02 | 8.30e-01 |
| GOBP RHO PROTEIN SIGNAL TRANSDUCTION | 120 | 3.18e-01 | -5.28e-02 | 7.69e-01 |
| GOMF BRANCHED CHAIN AMINO ACID TRANSMEMBRANE TRANSPORTER ACTIVITY | 8 | 7.96e-01 | 5.28e-02 | 9.59e-01 |
| GOMF SNRNP BINDING | 9 | 7.84e-01 | 5.28e-02 | 9.57e-01 |
| GOMF SODIUM ION TRANSMEMBRANE TRANSPORTER ACTIVITY | 105 | 3.51e-01 | -5.27e-02 | 7.93e-01 |
| GOBP GAMMA AMINOBUTYRIC ACID TRANSPORT | 14 | 7.33e-01 | -5.27e-02 | 9.41e-01 |
| GOBP PROTEIN TARGETING TO MEMBRANE | 108 | 3.44e-01 | 5.27e-02 | 7.89e-01 |
| GOCC COSTAMERE | 15 | 7.24e-01 | 5.27e-02 | 9.38e-01 |
| GOBP INTRINSIC APOPTOTIC SIGNALING PATHWAY IN RESPONSE TO HYDROGEN PEROXIDE | 7 | 8.09e-01 | -5.26e-02 | 9.61e-01 |
| GOBP PROTEIN DNA COMPLEX DISASSEMBLY | 20 | 6.84e-01 | -5.26e-02 | 9.25e-01 |
| GOMF PROTEIN ARGININE N METHYLTRANSFERASE ACTIVITY | 11 | 7.62e-01 | 5.26e-02 | 9.48e-01 |
| GOBP POSITIVE REGULATION OF NECROPTOTIC PROCESS | 6 | 8.23e-01 | 5.26e-02 | 9.64e-01 |
| GOBP NEGATIVE REGULATION OF CELL CYCLE G1 S PHASE TRANSITION | 67 | 4.56e-01 | 5.26e-02 | 8.44e-01 |
| GOCC DNA REPLICATION PREINITIATION COMPLEX | 12 | 7.53e-01 | 5.25e-02 | 9.45e-01 |
| GOMF CYCLASE REGULATOR ACTIVITY | 9 | 7.85e-01 | 5.24e-02 | 9.57e-01 |
| GOBP STEROID HORMONE SECRETION | 19 | 6.92e-01 | 5.24e-02 | 9.27e-01 |
| GOBP INORGANIC ANION TRANSPORT | 111 | 3.40e-01 | -5.24e-02 | 7.88e-01 |
| GOBP NEUTROPHIL EXTRAVASATION | 13 | 7.43e-01 | 5.24e-02 | 9.42e-01 |
| GOBP ARP2 3 COMPLEX MEDIATED ACTIN NUCLEATION | 42 | 5.57e-01 | 5.24e-02 | 8.87e-01 |
| GOMF FMN BINDING | 12 | 7.53e-01 | -5.24e-02 | 9.45e-01 |
| GOBP ORGANELLE INHERITANCE | 15 | 7.25e-01 | -5.24e-02 | 9.38e-01 |
| GOBP EMBRYONIC ORGAN MORPHOGENESIS | 169 | 2.40e-01 | -5.24e-02 | 7.10e-01 |
| GOBP MEMBRANE LIPID METABOLIC PROCESS | 180 | 2.26e-01 | 5.24e-02 | 6.98e-01 |
| GOBP CUT METABOLIC PROCESS | 5 | 8.39e-01 | 5.24e-02 | 9.66e-01 |
| GOBP LEUKOCYTE DEGRANULATION | 70 | 4.49e-01 | 5.23e-02 | 8.43e-01 |
| GOBP MAINTENANCE OF PROTEIN LOCATION IN NUCLEUS | 22 | 6.71e-01 | 5.23e-02 | 9.22e-01 |
| GOBP REGULATION OF AGGREPHAGY | 7 | 8.11e-01 | -5.23e-02 | 9.62e-01 |
| GOBP PROTEOLYSIS | 1312 | 1.48e-03 | 5.23e-02 | 9.09e-02 |
| GOBP GLUTATHIONE METABOLIC PROCESS | 38 | 5.77e-01 | 5.23e-02 | 8.92e-01 |
| GOMF TRANSMEMBRANE RECEPTOR PROTEIN TYROSINE KINASE ACTIVITY | 40 | 5.67e-01 | 5.23e-02 | 8.90e-01 |
| GOCC EXTERNAL SIDE OF PLASMA MEMBRANE | 318 | 1.09e-01 | 5.23e-02 | 5.62e-01 |
| GOMF CLATHRIN BINDING | 42 | 5.58e-01 | 5.23e-02 | 8.88e-01 |
| GOBP REGULATION OF DNA TEMPLATED TRANSCRIPTION INITIATION | 76 | 4.31e-01 | 5.23e-02 | 8.35e-01 |
| GOBP TRANSCRIPTION PREINITIATION COMPLEX ASSEMBLY | 65 | 4.66e-01 | 5.23e-02 | 8.52e-01 |
| GOBP REGULATION OF OSTEOCLAST DIFFERENTIATION | 53 | 5.11e-01 | 5.22e-02 | 8.70e-01 |
| GOBP SOMITOGENESIS | 38 | 5.78e-01 | 5.22e-02 | 8.92e-01 |
| GOBP SMOOTH MUSCLE CONTRACTION | 67 | 4.60e-01 | 5.22e-02 | 8.47e-01 |
| GOBP PEPTIDYL LYSINE MODIFICATION | 138 | 2.90e-01 | -5.22e-02 | 7.47e-01 |
| GOCC LYSOSOMAL LUMEN | 73 | 4.41e-01 | -5.21e-02 | 8.41e-01 |
| GOBP NEGATIVE REGULATION OF CELL PROJECTION ORGANIZATION | 147 | 2.76e-01 | 5.21e-02 | 7.38e-01 |
| GOCC CONTRACTILE RING | 11 | 7.65e-01 | -5.21e-02 | 9.49e-01 |
| GOBP INTRACELLULAR PROTEIN TRANSMEMBRANE TRANSPORT | 28 | 6.34e-01 | 5.20e-02 | 9.13e-01 |
| GOBP REGULATION OF PINOCYTOSIS | 11 | 7.65e-01 | -5.20e-02 | 9.49e-01 |
| GOBP CELL ACTIVATION INVOLVED IN IMMUNE RESPONSE | 264 | 1.46e-01 | 5.20e-02 | 6.13e-01 |
| GOMF INTRAMOLECULAR TRANSFERASE ACTIVITY | 25 | 6.53e-01 | 5.20e-02 | 9.18e-01 |
| GOBP CELL JUNCTION DISASSEMBLY | 22 | 6.73e-01 | 5.19e-02 | 9.23e-01 |
| GOBP RESPONSE TO ACIDIC PH | 17 | 7.11e-01 | -5.19e-02 | 9.34e-01 |
| GOBP LUNG ASSOCIATED MESENCHYME DEVELOPMENT | 7 | 8.12e-01 | -5.19e-02 | 9.62e-01 |
| GOBP REGULATION OF LAMELLIPODIUM ASSEMBLY | 34 | 6.01e-01 | 5.19e-02 | 9.03e-01 |
| GOBP REGULATION OF AUTOPHAGY | 333 | 1.04e-01 | 5.19e-02 | 5.55e-01 |
| GOMF TRANSCRIPTION REGULATOR ACTIVITY | 1479 | 8.65e-04 | 5.18e-02 | 6.64e-02 |
| GOBP POSITIVE REGULATION OF EPITHELIAL CELL PROLIFERATION | 138 | 2.93e-01 | -5.18e-02 | 7.50e-01 |
| GOBP INTRINSIC APOPTOTIC SIGNALING PATHWAY | 279 | 1.36e-01 | 5.18e-02 | 6.02e-01 |
| GOMF IMMUNOGLOBULIN RECEPTOR BINDING | 19 | 6.96e-01 | -5.18e-02 | 9.28e-01 |
| GOBP REGULATION OF MUSCLE TISSUE DEVELOPMENT | 29 | 6.29e-01 | 5.18e-02 | 9.11e-01 |
| GOMF PHOSPHOPROTEIN BINDING | 87 | 4.04e-01 | 5.18e-02 | 8.25e-01 |
| GOBP NUCLEOSIDE DIPHOSPHATE BIOSYNTHETIC PROCESS | 12 | 7.56e-01 | 5.18e-02 | 9.46e-01 |
| GOBP COGNITION | 229 | 1.77e-01 | 5.18e-02 | 6.48e-01 |
| GOMF TRANSPORTER ACTIVITY | 871 | 9.63e-03 | -5.17e-02 | 2.22e-01 |
| GOBP MEMBRANE DISASSEMBLY | 13 | 7.47e-01 | 5.17e-02 | 9.43e-01 |
| GOBP REGULATION OF PROTEIN AUTOUBIQUITINATION | 6 | 8.26e-01 | 5.17e-02 | 9.64e-01 |
| GOMF UBIQUITIN PROTEIN TRANSFERASE INHIBITOR ACTIVITY | 12 | 7.57e-01 | -5.17e-02 | 9.46e-01 |
| GOBP CDP CHOLINE PATHWAY | 7 | 8.13e-01 | -5.16e-02 | 9.62e-01 |
| GOBP EMBRYONIC SKELETAL SYSTEM MORPHOGENESIS | 43 | 5.58e-01 | -5.16e-02 | 8.88e-01 |
| GOBP PROTEIN TRANSMEMBRANE TRANSPORT | 68 | 4.62e-01 | 5.16e-02 | 8.48e-01 |
| GOBP PATTERN SPECIFICATION PROCESS | 265 | 1.49e-01 | -5.16e-02 | 6.13e-01 |
| GOCC SM LIKE PROTEIN FAMILY COMPLEX | 88 | 4.04e-01 | 5.15e-02 | 8.25e-01 |
| GOCC BASOLATERAL PLASMA MEMBRANE | 188 | 2.24e-01 | -5.14e-02 | 6.97e-01 |
| GOBP ACTIVATION OF PROTEIN KINASE ACTIVITY | 59 | 4.95e-01 | 5.14e-02 | 8.62e-01 |
| GOBP DOUBLE STRAND BREAK REPAIR VIA SYNTHESIS DEPENDENT STRAND ANNEALING | 7 | 8.14e-01 | 5.14e-02 | 9.62e-01 |
| GOBP SMAD PROTEIN SIGNAL TRANSDUCTION | 66 | 4.71e-01 | -5.13e-02 | 8.54e-01 |
| GOMF STRUCTURAL CONSTITUENT OF SYNAPSE | 14 | 7.39e-01 | 5.13e-02 | 9.42e-01 |
| GOMF DEATH RECEPTOR BINDING | 17 | 7.14e-01 | -5.13e-02 | 9.35e-01 |
| GOBP REGULATION OF VASCULAR WOUND HEALING | 8 | 8.02e-01 | -5.13e-02 | 9.60e-01 |
| GOBP SMOOTH MUSCLE CELL APOPTOTIC PROCESS | 25 | 6.57e-01 | 5.13e-02 | 9.19e-01 |
| GOBP NEGATIVE REGULATION OF ADAPTIVE IMMUNE RESPONSE | 59 | 4.96e-01 | 5.12e-02 | 8.62e-01 |
| GOBP POSITIVE REGULATION OF MITOPHAGY | 15 | 7.31e-01 | -5.12e-02 | 9.41e-01 |
| GOBP MICROAUTOPHAGY | 22 | 6.78e-01 | 5.12e-02 | 9.24e-01 |
| GOBP FORELIMB MORPHOGENESIS | 19 | 6.99e-01 | 5.12e-02 | 9.28e-01 |
| GOBP SENSORY PERCEPTION OF TASTE | 27 | 6.46e-01 | -5.11e-02 | 9.15e-01 |
| GOBP EYE MORPHOGENESIS | 100 | 3.77e-01 | -5.11e-02 | 8.10e-01 |
| GOCC NUCLEOLUS | 972 | 7.06e-03 | 5.11e-02 | 1.94e-01 |
| GOBP PURINE NUCLEOTIDE SALVAGE | 10 | 7.80e-01 | -5.11e-02 | 9.55e-01 |
| GOMF LIPOPEPTIDE BINDING | 9 | 7.91e-01 | -5.10e-02 | 9.59e-01 |
| GOMF ACETYLTRANSFERASE ACTIVITY | 85 | 4.16e-01 | 5.10e-02 | 8.30e-01 |
| GOBP DNA RECOMBINATION | 307 | 1.24e-01 | 5.10e-02 | 5.88e-01 |
| GOBP POSITIVE REGULATION OF ATP BIOSYNTHETIC PROCESS | 7 | 8.15e-01 | 5.10e-02 | 9.62e-01 |
| GOBP REGULATION OF CD8 POSITIVE ALPHA BETA T CELL DIFFERENTIATION | 8 | 8.03e-01 | 5.10e-02 | 9.61e-01 |
| GOBP THALAMUS DEVELOPMENT | 9 | 7.91e-01 | -5.10e-02 | 9.59e-01 |
| GOBP APOPTOTIC DNA FRAGMENTATION | 15 | 7.33e-01 | 5.09e-02 | 9.41e-01 |
| GOBP POSITIVE REGULATION OF STEROID METABOLIC PROCESS | 18 | 7.08e-01 | -5.09e-02 | 9.33e-01 |
| GOBP GLIAL CELL MIGRATION | 51 | 5.29e-01 | -5.09e-02 | 8.78e-01 |
| GOBP HYPEROSMOTIC RESPONSE | 24 | 6.66e-01 | -5.09e-02 | 9.22e-01 |
| GOMF HEXOKINASE ACTIVITY | 5 | 8.44e-01 | -5.09e-02 | 9.68e-01 |
| GOBP ATRIAL CARDIAC MUSCLE TISSUE DEVELOPMENT | 5 | 8.44e-01 | -5.08e-02 | 9.68e-01 |
| GOCC ENDOPLASMIC RETICULUM GOLGI INTERMEDIATE COMPARTMENT MEMBRANE | 74 | 4.51e-01 | 5.07e-02 | 8.43e-01 |
| GOBP PEPTIDE TRANSPORT | 185 | 2.34e-01 | -5.07e-02 | 7.05e-01 |
| GOCC CUL5 RING UBIQUITIN LIGASE COMPLEX | 10 | 7.81e-01 | 5.07e-02 | 9.56e-01 |
| GOBP NEGATIVE REGULATION OF CGAS STING SIGNALING PATHWAY | 12 | 7.61e-01 | -5.07e-02 | 9.48e-01 |
| GOMF G PROTEIN COUPLED RECEPTOR BINDING | 171 | 2.53e-01 | -5.07e-02 | 7.22e-01 |
| GOBP CELLULAR RESPONSE TO ORGANIC SUBSTANCE | 1514 | 1.01e-03 | 5.06e-02 | 7.18e-02 |
| GOBP PROSTANOID BIOSYNTHETIC PROCESS | 22 | 6.81e-01 | 5.06e-02 | 9.24e-01 |
| GOBP NEGATIVE REGULATION OF SMOOTH MUSCLE CELL MIGRATION | 16 | 7.26e-01 | -5.06e-02 | 9.39e-01 |
| GOBP SYNCYTIUM FORMATION | 52 | 5.28e-01 | -5.06e-02 | 8.76e-01 |
| GOMF PHOSPHATIDYLETHANOLAMINE BINDING | 13 | 7.52e-01 | 5.06e-02 | 9.45e-01 |
| GOBP REGULATION OF MACROPHAGE ACTIVATION | 47 | 5.49e-01 | 5.06e-02 | 8.84e-01 |
| GOBP CELLULAR RESPONSE TO PROGESTERONE STIMULUS | 5 | 8.45e-01 | 5.05e-02 | 9.68e-01 |
| GOBP NEGATIVE REGULATION OF LIPID BIOSYNTHETIC PROCESS | 43 | 5.67e-01 | 5.05e-02 | 8.90e-01 |
| GOMF LIPOPROTEIN LIPASE ACTIVITY | 6 | 8.31e-01 | -5.04e-02 | 9.64e-01 |
| GOBP REGULATION OF CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY | 162 | 2.68e-01 | 5.04e-02 | 7.33e-01 |
| GOBP PROSTATE GLAND MORPHOGENESIS | 12 | 7.62e-01 | 5.04e-02 | 9.48e-01 |
| GOCC GOLGI TRANSPORT COMPLEX | 10 | 7.83e-01 | -5.04e-02 | 9.56e-01 |
| GOBP CRANIAL SKELETAL SYSTEM DEVELOPMENT | 45 | 5.59e-01 | 5.03e-02 | 8.88e-01 |
| GOMF PROTEIN HOMODIMERIZATION ACTIVITY | 580 | 3.84e-02 | 5.03e-02 | 3.98e-01 |
| GOBP PROSTAGLANDIN TRANSPORT | 15 | 7.36e-01 | 5.03e-02 | 9.42e-01 |
| GOBP COLLAGEN ACTIVATED SIGNALING PATHWAY | 12 | 7.63e-01 | 5.03e-02 | 9.49e-01 |
| GOBP BLASTOCYST DEVELOPMENT | 97 | 3.93e-01 | 5.02e-02 | 8.20e-01 |
| GOBP NEGATIVE REGULATION OF BEHAVIOR | 8 | 8.06e-01 | 5.02e-02 | 9.61e-01 |
| GOBP MONOAMINE TRANSPORT | 50 | 5.40e-01 | -5.02e-02 | 8.80e-01 |
| GOCC FICOLIN 1 RICH GRANULE | 179 | 2.47e-01 | 5.01e-02 | 7.16e-01 |
| GOBP REGULATION OF HEART RATE BY CARDIAC CONDUCTION | 29 | 6.40e-01 | 5.01e-02 | 9.15e-01 |
| GOCC AZUROPHIL GRANULE MEMBRANE | 58 | 5.10e-01 | 5.01e-02 | 8.69e-01 |
| GOBP HEART GROWTH | 61 | 4.99e-01 | 5.01e-02 | 8.64e-01 |
| GOBP REGULATION OF CATABOLIC PROCESS | 904 | 1.08e-02 | 5.00e-02 | 2.34e-01 |
| GOBP T CELL SELECTION | 52 | 5.33e-01 | -5.00e-02 | 8.79e-01 |
| GOBP VITAMIN D BIOSYNTHETIC PROCESS | 8 | 8.06e-01 | 5.00e-02 | 9.61e-01 |
| GOCC CYTOPLASMIC SIDE OF ENDOPLASMIC RETICULUM MEMBRANE | 19 | 7.06e-01 | 5.00e-02 | 9.32e-01 |
| GOMF MAGNESIUM ION TRANSMEMBRANE TRANSPORTER ACTIVITY | 16 | 7.29e-01 | 5.00e-02 | 9.40e-01 |
| GOBP NEGATIVE REGULATION OF EPITHELIAL CELL MIGRATION | 53 | 5.29e-01 | -5.00e-02 | 8.78e-01 |
| GOBP REGULATION OF MRNA PROCESSING | 118 | 3.49e-01 | 4.99e-02 | 7.92e-01 |
| GOMF FERROUS IRON TRANSMEMBRANE TRANSPORTER ACTIVITY | 6 | 8.33e-01 | 4.99e-02 | 9.64e-01 |
| GOBP CAMERA TYPE EYE MORPHOGENESIS | 82 | 4.35e-01 | -4.98e-02 | 8.37e-01 |
| GOBP PROTEIN QUALITY CONTROL FOR MISFOLDED OR INCOMPLETELY SYNTHESIZED PROTEINS | 25 | 6.66e-01 | 4.98e-02 | 9.22e-01 |
| GOCC COMMITMENT COMPLEX | 5 | 8.47e-01 | 4.98e-02 | 9.68e-01 |
| GOMF PHOSPHORIC ESTER HYDROLASE ACTIVITY | 305 | 1.35e-01 | 4.98e-02 | 5.99e-01 |
| GOBP REGULATION OF T CELL MEDIATED IMMUNITY | 90 | 4.14e-01 | 4.98e-02 | 8.29e-01 |
| GOBP SKELETAL MUSCLE SATELLITE CELL ACTIVATION | 6 | 8.33e-01 | -4.98e-02 | 9.64e-01 |
| GOCC VACUOLAR LUMEN | 148 | 2.96e-01 | -4.97e-02 | 7.53e-01 |
| GOMF MAGNESIUM ION BINDING | 210 | 2.14e-01 | 4.97e-02 | 6.90e-01 |
| GOBP ANTIGEN PROCESSING AND PRESENTATION OF EXOGENOUS PEPTIDE ANTIGEN | 38 | 5.96e-01 | 4.97e-02 | 9.01e-01 |
| GOBP IMMUNOGLOBULIN PRODUCTION | 152 | 2.90e-01 | 4.97e-02 | 7.47e-01 |
| GOBP POSITIVE REGULATION BY HOST OF VIRAL TRANSCRIPTION | 17 | 7.23e-01 | 4.97e-02 | 9.38e-01 |
| GOBP REGULATION OF ERBB SIGNALING PATHWAY | 61 | 5.02e-01 | 4.96e-02 | 8.66e-01 |
| GOBP POSITIVE REGULATION OF MITOTIC SISTER CHROMATID SEPARATION | 18 | 7.15e-01 | 4.96e-02 | 9.36e-01 |
| GOBP PROTEIN RETENTION IN ER LUMEN | 7 | 8.20e-01 | 4.96e-02 | 9.63e-01 |
| GOCC CTF18 RFC LIKE COMPLEX | 8 | 8.08e-01 | -4.96e-02 | 9.61e-01 |
| GOBP POSITIVE REGULATION OF TRANSLATION | 119 | 3.50e-01 | 4.96e-02 | 7.93e-01 |
| GOBP VENTRICULAR SEPTUM DEVELOPMENT | 52 | 5.37e-01 | 4.95e-02 | 8.79e-01 |
| GOBP UREA TRANSMEMBRANE TRANSPORT | 6 | 8.34e-01 | 4.95e-02 | 9.64e-01 |
| GOMF UREA TRANSMEMBRANE TRANSPORTER ACTIVITY | 6 | 8.34e-01 | 4.95e-02 | 9.64e-01 |
| GOBP DNA STRAND ELONGATION INVOLVED IN DNA REPLICATION | 15 | 7.40e-01 | -4.95e-02 | 9.42e-01 |
| GOBP ATRIAL SEPTUM MORPHOGENESIS | 8 | 8.09e-01 | -4.94e-02 | 9.61e-01 |
| GOCC DISTAL AXON | 195 | 2.34e-01 | -4.94e-02 | 7.05e-01 |
| GOBP SARCOMERE ORGANIZATION | 29 | 6.45e-01 | -4.94e-02 | 9.15e-01 |
| GOBP MATURATION OF SSU RRNA | 52 | 5.38e-01 | -4.94e-02 | 8.79e-01 |
| GOMF LIPID BINDING | 663 | 3.01e-02 | -4.94e-02 | 3.64e-01 |
| GOCC GERM CELL NUCLEUS | 52 | 5.38e-01 | 4.94e-02 | 8.79e-01 |
| GOBP AXIAL MESODERM DEVELOPMENT | 7 | 8.21e-01 | -4.93e-02 | 9.64e-01 |
| GOMF HEAT SHOCK PROTEIN BINDING | 117 | 3.57e-01 | 4.93e-02 | 7.98e-01 |
| GOBP CALCIUM ION IMPORT ACROSS PLASMA MEMBRANE | 30 | 6.40e-01 | -4.93e-02 | 9.15e-01 |
| GOBP TRANSCYTOSIS | 18 | 7.17e-01 | -4.93e-02 | 9.36e-01 |
| GOBP SODIUM ION IMPORT ACROSS PLASMA MEMBRANE | 16 | 7.33e-01 | -4.93e-02 | 9.41e-01 |
| GOBP PROTEIN SUMOYLATION | 62 | 5.03e-01 | 4.92e-02 | 8.66e-01 |
| GOBP RESPONSE TO INTERLEUKIN 17 | 15 | 7.42e-01 | 4.92e-02 | 9.42e-01 |
| GOMF COA LIGASE ACTIVITY | 23 | 6.83e-01 | -4.91e-02 | 9.24e-01 |
| GOBP RECEPTOR CATABOLIC PROCESS | 27 | 6.59e-01 | -4.91e-02 | 9.19e-01 |
| GOBP TEMPERATURE HOMEOSTASIS | 145 | 3.07e-01 | -4.91e-02 | 7.62e-01 |
| GOBP REGULATION OF PROTEIN MODIFICATION PROCESS | 995 | 8.83e-03 | 4.91e-02 | 2.17e-01 |
| GOMF PHOSPHATASE ACTIVITY | 230 | 2.00e-01 | 4.91e-02 | 6.71e-01 |
| GOBP ORGANIC ANION TRANSPORT | 311 | 1.37e-01 | -4.91e-02 | 6.03e-01 |
| GOBP PHOSPHATIDYLCHOLINE CATABOLIC PROCESS | 12 | 7.69e-01 | 4.90e-02 | 9.51e-01 |
| GOCC MULTIVESICULAR BODY MEMBRANE | 26 | 6.65e-01 | -4.90e-02 | 9.22e-01 |
| GOBP POSITIVE REGULATION OF PROTEIN SUMOYLATION | 11 | 7.78e-01 | -4.90e-02 | 9.54e-01 |
| GOBP REGULATION OF NUCLEAR DIVISION | 117 | 3.60e-01 | 4.90e-02 | 8.00e-01 |
| GOCC FEMALE GERM CELL NUCLEUS | 10 | 7.89e-01 | 4.90e-02 | 9.58e-01 |
| GOBP NEGATIVE REGULATION OF RESPONSE TO TUMOR CELL | 8 | 8.11e-01 | -4.90e-02 | 9.62e-01 |
| GOBP POSITIVE REGULATION OF TRANSPORTER ACTIVITY | 69 | 4.82e-01 | 4.89e-02 | 8.59e-01 |
| GOBP RESPONSE TO NITROGEN COMPOUND | 842 | 1.59e-02 | 4.89e-02 | 2.74e-01 |
| GOBP REGULATION OF MEMBRANE POTENTIAL | 302 | 1.44e-01 | -4.89e-02 | 6.12e-01 |
| GOBP RESPIRATORY GASEOUS EXCHANGE BY RESPIRATORY SYSTEM | 61 | 5.09e-01 | 4.89e-02 | 8.69e-01 |
| GOBP POSITIVE REGULATION OF PHOSPHOLIPASE ACTIVITY | 28 | 6.54e-01 | -4.89e-02 | 9.18e-01 |
| GOBP PROTEIN HETEROOLIGOMERIZATION | 23 | 6.85e-01 | 4.89e-02 | 9.25e-01 |
| GOBP MYELOID CELL DEVELOPMENT | 82 | 4.45e-01 | -4.88e-02 | 8.41e-01 |
| GOMF HYDROXYMETHYL FORMYL AND RELATED TRANSFERASE ACTIVITY | 8 | 8.11e-01 | -4.88e-02 | 9.62e-01 |
| GOMF ALCOHOL BINDING | 66 | 4.93e-01 | 4.88e-02 | 8.62e-01 |
| GOBP POSITIVE REGULATION OF RECEPTOR INTERNALIZATION | 20 | 7.06e-01 | -4.88e-02 | 9.32e-01 |
| GOBP NUCLEOTIDE TRANSMEMBRANE TRANSPORT | 25 | 6.73e-01 | 4.88e-02 | 9.23e-01 |
| GOBP HYPEROSMOTIC SALINITY RESPONSE | 9 | 8.00e-01 | -4.88e-02 | 9.60e-01 |
| GOBP NITRIC OXIDE MEDIATED SIGNAL TRANSDUCTION | 15 | 7.44e-01 | 4.88e-02 | 9.42e-01 |
| GOMF PEPTIDE RECEPTOR ACTIVITY | 61 | 5.10e-01 | -4.87e-02 | 8.70e-01 |
| GOBP DNA BIOSYNTHETIC PROCESS | 174 | 2.68e-01 | 4.87e-02 | 7.33e-01 |
| GOBP HYDROGEN PEROXIDE METABOLIC PROCESS | 44 | 5.76e-01 | 4.87e-02 | 8.92e-01 |
| GOBP REGULATION OF PODOSOME ASSEMBLY | 12 | 7.70e-01 | -4.87e-02 | 9.51e-01 |
| GOBP DEOXYRIBONUCLEOSIDE DIPHOSPHATE METABOLIC PROCESS | 5 | 8.50e-01 | 4.87e-02 | 9.69e-01 |
| GOBP REGULATION OF TISSUE REMODELING | 52 | 5.44e-01 | -4.87e-02 | 8.82e-01 |
| GOBP POSITIVE REGULATION OF REACTIVE OXYGEN SPECIES METABOLIC PROCESS | 57 | 5.25e-01 | -4.87e-02 | 8.76e-01 |
| GOBP RHYTHMIC PROCESS | 226 | 2.08e-01 | 4.86e-02 | 6.82e-01 |
| GOMF TRAIL BINDING | 5 | 8.51e-01 | 4.86e-02 | 9.69e-01 |
| GOMF MHC PROTEIN COMPLEX BINDING | 35 | 6.19e-01 | 4.86e-02 | 9.07e-01 |
| GOBP REGULATION OF ADIPONECTIN SECRETION | 7 | 8.24e-01 | -4.86e-02 | 9.64e-01 |
| GOBP INTERLEUKIN 2 PRODUCTION | 60 | 5.15e-01 | -4.86e-02 | 8.71e-01 |
| GOMF MITOGEN ACTIVATED PROTEIN KINASE BINDING | 29 | 6.51e-01 | -4.85e-02 | 9.17e-01 |
| GOBP CATECHOL CONTAINING COMPOUND METABOLIC PROCESS | 34 | 6.24e-01 | -4.85e-02 | 9.09e-01 |
| GOBP GLYCOSIDE CATABOLIC PROCESS | 7 | 8.24e-01 | -4.85e-02 | 9.64e-01 |
| GOBP CELL DIFFERENTIATION INVOLVED IN METANEPHROS DEVELOPMENT | 10 | 7.91e-01 | -4.85e-02 | 9.59e-01 |
| GOMF WIDE PORE CHANNEL ACTIVITY | 17 | 7.30e-01 | 4.84e-02 | 9.40e-01 |
| GOBP NEGATIVE REGULATION OF LYMPHOCYTE ACTIVATION | 139 | 3.25e-01 | 4.84e-02 | 7.76e-01 |
| GOMF TPR DOMAIN BINDING | 7 | 8.25e-01 | 4.83e-02 | 9.64e-01 |
| GOBP REGULATION OF PROTEIN DEPOLYMERIZATION | 75 | 4.69e-01 | 4.83e-02 | 8.54e-01 |
| GOBP STRESS FIBER ASSEMBLY | 95 | 4.16e-01 | -4.83e-02 | 8.30e-01 |
| GOBP MICROTUBULE BASED TRANSPORT | 191 | 2.50e-01 | 4.83e-02 | 7.18e-01 |
| GOBP CIRCADIAN REGULATION OF GENE EXPRESSION | 60 | 5.18e-01 | -4.83e-02 | 8.73e-01 |
| GOBP REGULATION OF ENDOSOME TO PLASMA MEMBRANE PROTEIN TRANSPORT | 5 | 8.52e-01 | 4.83e-02 | 9.69e-01 |
| GOBP NEGATIVE REGULATION OF CELLULAR RESPIRATION | 8 | 8.13e-01 | -4.82e-02 | 9.62e-01 |
| GOCC INTERMEDIATE FILAMENT CYTOSKELETON | 91 | 4.27e-01 | -4.82e-02 | 8.33e-01 |
| GOBP RRNA METHYLATION | 24 | 6.83e-01 | -4.82e-02 | 9.24e-01 |
| GOBP FATTY ACID TRANSPORT | 76 | 4.68e-01 | -4.82e-02 | 8.53e-01 |
| GOBP LIPID DROPLET ORGANIZATION | 30 | 6.48e-01 | 4.81e-02 | 9.16e-01 |
| GOBP INDOLE CONTAINING COMPOUND METABOLIC PROCESS | 18 | 7.24e-01 | -4.81e-02 | 9.38e-01 |
| GOMF ACETYLATION DEPENDENT PROTEIN BINDING | 24 | 6.83e-01 | -4.81e-02 | 9.24e-01 |
| GOBP REGULATION OF PROGRAMMED CELL DEATH | 1197 | 5.15e-03 | 4.81e-02 | 1.75e-01 |
| GOBP POSITIVE REGULATION OF EPITHELIAL TO MESENCHYMAL TRANSITION | 44 | 5.81e-01 | -4.80e-02 | 8.93e-01 |
| GOMF ENZYME INHIBITOR ACTIVITY | 277 | 1.69e-01 | 4.80e-02 | 6.35e-01 |
| GOCC ACETYLTRANSFERASE COMPLEX | 94 | 4.21e-01 | 4.80e-02 | 8.30e-01 |
| GOBP POSITIVE REGULATION OF PROTEIN MATURATION | 22 | 6.97e-01 | -4.80e-02 | 9.28e-01 |
| GOCC PERINUCLEAR REGION OF CYTOPLASM | 617 | 4.20e-02 | 4.80e-02 | 4.05e-01 |
| GOBP NEGATIVE REGULATION OF PROTEIN LOCALIZATION TO MICROTUBULE | 5 | 8.53e-01 | -4.79e-02 | 9.69e-01 |
| GOBP NEGATIVE REGULATION OF PLASMA MEMBRANE BOUNDED CELL PROJECTION ASSEMBLY | 34 | 6.29e-01 | 4.79e-02 | 9.11e-01 |
| GOMF 3 5 EXONUCLEASE ACTIVITY | 58 | 5.28e-01 | 4.79e-02 | 8.76e-01 |
| GOMF SOLUTE SODIUM SYMPORTER ACTIVITY | 46 | 5.74e-01 | 4.79e-02 | 8.92e-01 |
| GOCC APICAL PART OF CELL | 314 | 1.44e-01 | 4.79e-02 | 6.12e-01 |
| GOBP ENDOPLASMIC RETICULUM LOCALIZATION | 7 | 8.26e-01 | 4.79e-02 | 9.64e-01 |
| GOBP CELLULAR RESPONSE TO LIGHT STIMULUS | 100 | 4.08e-01 | -4.79e-02 | 8.26e-01 |
| GOBP RESPONSE TO ARSENIC CONTAINING SUBSTANCE | 28 | 6.61e-01 | -4.79e-02 | 9.21e-01 |
| GOCC CORTICAL CYTOSKELETON | 92 | 4.28e-01 | -4.79e-02 | 8.34e-01 |
| GOBP RESPONSE TO PEPTIDE HORMONE | 337 | 1.31e-01 | 4.78e-02 | 5.95e-01 |
| GOMF INORGANIC MOLECULAR ENTITY TRANSMEMBRANE TRANSPORTER ACTIVITY | 507 | 6.54e-02 | -4.78e-02 | 4.67e-01 |
| GOBP REGULATION OF CELLULAR EXTRAVASATION | 33 | 6.35e-01 | -4.78e-02 | 9.14e-01 |
| GOBP PLASMA MEMBRANE ORGANIZATION | 125 | 3.56e-01 | -4.78e-02 | 7.97e-01 |
| GOBP MITOCHONDRIAL RNA METABOLIC PROCESS | 56 | 5.36e-01 | 4.78e-02 | 8.79e-01 |
| GOBP REGULATION OF LYMPHOID PROGENITOR CELL DIFFERENTIATION | 11 | 7.84e-01 | 4.78e-02 | 9.57e-01 |
| GOCC NUCLEAR PROTEIN CONTAINING COMPLEX | 1190 | 5.56e-03 | 4.78e-02 | 1.79e-01 |
| GOBP INSULIN SECRETION | 146 | 3.19e-01 | -4.78e-02 | 7.70e-01 |
| GOBP RESPONSE TO ORGANOPHOSPHORUS | 96 | 4.19e-01 | -4.77e-02 | 8.30e-01 |
| GOBP CHEMOSENSORY BEHAVIOR | 13 | 7.66e-01 | -4.77e-02 | 9.49e-01 |
| GOBP DEVELOPMENT OF PRIMARY FEMALE SEXUAL CHARACTERISTICS | 71 | 4.87e-01 | 4.77e-02 | 8.60e-01 |
| GOBP RESPONSE TO PLATELET DERIVED GROWTH FACTOR | 21 | 7.05e-01 | 4.77e-02 | 9.32e-01 |
| GOBP LEUKOTRIENE METABOLIC PROCESS | 23 | 6.92e-01 | -4.77e-02 | 9.27e-01 |
| GOBP CYTOKINE PRODUCTION INVOLVED IN IMMUNE RESPONSE | 109 | 3.90e-01 | 4.77e-02 | 8.18e-01 |
| GOMF KINESIN BINDING | 39 | 6.07e-01 | -4.76e-02 | 9.03e-01 |
| GOBP REGULATION OF CELLULAR CATABOLIC PROCESS | 403 | 1.01e-01 | 4.76e-02 | 5.49e-01 |
| GOBP NEGATIVE REGULATION OF TOLL LIKE RECEPTOR 4 SIGNALING PATHWAY | 10 | 7.94e-01 | 4.76e-02 | 9.59e-01 |
| GOBP FACE MORPHOGENESIS | 23 | 6.93e-01 | 4.76e-02 | 9.27e-01 |
| GOMF METALLOCARBOXYPEPTIDASE ACTIVITY | 16 | 7.42e-01 | 4.76e-02 | 9.42e-01 |
| GOBP REGULATION OF PEPTIDE TRANSPORT | 142 | 3.28e-01 | -4.76e-02 | 7.78e-01 |
| GOBP PIRNA PROCESSING | 12 | 7.75e-01 | 4.76e-02 | 9.54e-01 |
| GOBP SKIN MORPHOGENESIS | 8 | 8.16e-01 | -4.75e-02 | 9.63e-01 |
| GOBP POSITIVE REGULATION OF PRODUCTION OF MOLECULAR MEDIATOR OF IMMUNE RESPONSE | 118 | 3.72e-01 | 4.75e-02 | 8.08e-01 |
| GOBP REGULATION OF PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR SIGNALING PATHWAY | 9 | 8.05e-01 | -4.75e-02 | 9.61e-01 |
| GOBP UBIQUITIN DEPENDENT PROTEIN CATABOLIC PROCESS VIA THE MULTIVESICULAR BODY SORTING PATHWAY | 35 | 6.27e-01 | 4.75e-02 | 9.11e-01 |
| GOMF PROTEASE BINDING | 113 | 3.84e-01 | 4.74e-02 | 8.15e-01 |
| GOBP POSITIVE REGULATION OF TELOMERE MAINTENANCE | 69 | 4.96e-01 | 4.74e-02 | 8.62e-01 |
| GOBP BRADYKININ CATABOLIC PROCESS | 6 | 8.41e-01 | 4.74e-02 | 9.67e-01 |
| GOMF OXIDOREDUCTASE ACTIVITY ACTING ON THE ALDEHYDE OR OXO GROUP OF DONORS DISULFIDE AS ACCEPTOR | 7 | 8.28e-01 | 4.74e-02 | 9.64e-01 |
| GOBP BLASTOCYST FORMATION | 36 | 6.23e-01 | -4.73e-02 | 9.09e-01 |
| GOBP MUCOPOLYSACCHARIDE METABOLIC PROCESS | 77 | 4.74e-01 | -4.72e-02 | 8.55e-01 |
| GOBP ORGANIC ACID CATABOLIC PROCESS | 206 | 2.43e-01 | -4.72e-02 | 7.13e-01 |
| GOMF CADHERIN BINDING | 295 | 1.63e-01 | 4.72e-02 | 6.30e-01 |
| GOBP POSITIVE REGULATION OF CELL SUBSTRATE ADHESION | 95 | 4.26e-01 | -4.72e-02 | 8.33e-01 |
| GOBP C TERMINAL PROTEIN LIPIDATION | 9 | 8.06e-01 | 4.72e-02 | 9.61e-01 |
| GOBP INFLAMMATORY RESPONSE TO ANTIGENIC STIMULUS | 66 | 5.07e-01 | 4.72e-02 | 8.68e-01 |
| GOBP MAST CELL MIGRATION | 10 | 7.96e-01 | 4.72e-02 | 9.59e-01 |
| GOCC SEC61 TRANSLOCON COMPLEX | 5 | 8.55e-01 | -4.72e-02 | 9.71e-01 |
| GOBP POSITIVE REGULATION OF VIRAL LIFE CYCLE | 23 | 6.95e-01 | -4.71e-02 | 9.27e-01 |
| GOBP NEGATIVE REGULATION OF PHOSPHORUS METABOLIC PROCESS | 305 | 1.58e-01 | 4.71e-02 | 6.23e-01 |
| GOBP POSITIVE REGULATION OF GENE EXPRESSION | 943 | 1.44e-02 | 4.70e-02 | 2.58e-01 |
| GOBP POSITIVE REGULATION OF PROTEIN KINASE ACTIVITY | 204 | 2.47e-01 | 4.70e-02 | 7.16e-01 |
| GOBP POSITIVE REGULATION OF CHEMOKINE PRODUCTION | 59 | 5.32e-01 | 4.70e-02 | 8.79e-01 |
| GOBP POSITIVE REGULATION OF HUMORAL IMMUNE RESPONSE | 12 | 7.78e-01 | 4.70e-02 | 9.54e-01 |
| GOBP EXECUTION PHASE OF APOPTOSIS | 66 | 5.09e-01 | -4.70e-02 | 8.69e-01 |
| GOCC POLYMERIC CYTOSKELETAL FIBER | 532 | 6.37e-02 | -4.70e-02 | 4.64e-01 |
| GOBP NEGATIVE REGULATION OF MYELOID LEUKOCYTE DIFFERENTIATION | 40 | 6.07e-01 | 4.70e-02 | 9.03e-01 |
| GOBP POSITIVE REGULATION OF CARBOHYDRATE METABOLIC PROCESS | 59 | 5.33e-01 | -4.70e-02 | 8.79e-01 |
| GOBP RESPONSE TO ALCOHOL | 192 | 2.62e-01 | -4.70e-02 | 7.29e-01 |
| GOBP URONIC ACID METABOLIC PROCESS | 9 | 8.07e-01 | -4.69e-02 | 9.61e-01 |
| GOBP GLOMERULAR BASEMENT MEMBRANE DEVELOPMENT | 9 | 8.08e-01 | -4.69e-02 | 9.61e-01 |
| GOBP POSITIVE REGULATION OF NATURAL KILLER CELL ACTIVATION | 19 | 7.24e-01 | 4.69e-02 | 9.38e-01 |
| GOBP REGULATION OF T CELL APOPTOTIC PROCESS | 36 | 6.27e-01 | 4.69e-02 | 9.11e-01 |
| GOBP ADULT LOCOMOTORY BEHAVIOR | 52 | 5.59e-01 | -4.69e-02 | 8.88e-01 |
| GOMF MEMBRANE INSERTASE ACTIVITY | 17 | 7.38e-01 | 4.69e-02 | 9.42e-01 |
| GOBP DEVELOPMENTAL PROCESS INVOLVED IN REPRODUCTION | 656 | 4.10e-02 | 4.68e-02 | 4.02e-01 |
| GOBP MICROTUBULE NUCLEATION | 45 | 5.87e-01 | -4.68e-02 | 8.95e-01 |
| GOBP DENDRITIC CELL ANTIGEN PROCESSING AND PRESENTATION | 13 | 7.70e-01 | 4.67e-02 | 9.51e-01 |
| GOBP REGULATION OF CALCIUM ION TRANSPORT INTO CYTOSOL | 10 | 7.98e-01 | -4.67e-02 | 9.59e-01 |
| GOBP REGULATION OF MUSCLE ADAPTATION | 63 | 5.22e-01 | 4.67e-02 | 8.75e-01 |
| GOBP NEGATIVE REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE | 16 | 7.47e-01 | -4.67e-02 | 9.43e-01 |
| GOCC REPLICATION FORK | 74 | 4.88e-01 | 4.66e-02 | 8.60e-01 |
| GOBP BRANCHING INVOLVED IN SALIVARY GLAND MORPHOGENESIS | 17 | 7.39e-01 | 4.66e-02 | 9.42e-01 |
| GOBP REGULATION OF NEUROTRANSMITTER RECEPTOR LOCALIZATION TO POSTSYNAPTIC SPECIALIZATION MEMBRANE | 9 | 8.09e-01 | -4.66e-02 | 9.61e-01 |
| GOBP NEGATIVE REGULATION OF ENDOPLASMIC RETICULUM UNFOLDED PROTEIN RESPONSE | 14 | 7.63e-01 | 4.66e-02 | 9.48e-01 |
| GOBP NEGATIVE REGULATION OF INTRACELLULAR STEROID HORMONE RECEPTOR SIGNALING PATHWAY | 28 | 6.70e-01 | 4.66e-02 | 9.22e-01 |
| GOMF CATALYTIC ACTIVITY ACTING ON DNA | 234 | 2.20e-01 | 4.65e-02 | 6.94e-01 |
| GOBP CELL ADHESION MEDIATED BY INTEGRIN | 74 | 4.89e-01 | 4.65e-02 | 8.61e-01 |
| GOBP STEM CELL PROLIFERATION | 73 | 4.92e-01 | -4.65e-02 | 8.62e-01 |
| GOBP ESTABLISHMENT OF ENDOTHELIAL BARRIER | 49 | 5.74e-01 | 4.65e-02 | 8.92e-01 |
| GOBP REGULATION OF DOUBLE STRAND BREAK REPAIR VIA HOMOLOGOUS RECOMBINATION | 79 | 4.75e-01 | -4.65e-02 | 8.56e-01 |
| GOBP POSTSYNAPTIC NEUROTRANSMITTER RECEPTOR INTERNALIZATION | 24 | 6.94e-01 | 4.65e-02 | 9.27e-01 |
| GOBP VENTRICULAR SEPTUM MORPHOGENESIS | 30 | 6.60e-01 | 4.65e-02 | 9.20e-01 |
| GOCC HETEROCHROMATIN | 74 | 4.90e-01 | -4.65e-02 | 8.61e-01 |
| GOBP CHONDROCYTE DIFFERENTIATION | 76 | 4.84e-01 | 4.64e-02 | 8.60e-01 |
| GOBP NEGATIVE REGULATION OF RAS PROTEIN SIGNAL TRANSDUCTION | 22 | 7.06e-01 | 4.64e-02 | 9.32e-01 |
| GOBP RESPONSE TO POTASSIUM ION | 14 | 7.64e-01 | -4.64e-02 | 9.49e-01 |
| GOBP POSITIVE REGULATION OF DNA REPAIR | 122 | 3.77e-01 | 4.64e-02 | 8.10e-01 |
| GOMF AMINO ACID MONOATOMIC CATION SYMPORTER ACTIVITY | 15 | 7.56e-01 | 4.63e-02 | 9.46e-01 |
| GOMF PALMITOYLTRANSFERASE ACTIVITY | 35 | 6.35e-01 | -4.63e-02 | 9.14e-01 |
| GOBP REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE BY CIRCULATORY RENIN ANGIOTENSIN | 13 | 7.73e-01 | -4.63e-02 | 9.53e-01 |
| GOBP MYOBLAST DIFFERENTIATION | 81 | 4.71e-01 | -4.63e-02 | 8.54e-01 |
| GOBP VASODILATION | 37 | 6.26e-01 | 4.62e-02 | 9.11e-01 |
| GOCC PHOSPHATIDYLINOSITOL 3 KINASE COMPLEX CLASS I | 9 | 8.10e-01 | 4.62e-02 | 9.61e-01 |
| GOBP RESPONSE TO INACTIVITY | 10 | 8.00e-01 | 4.62e-02 | 9.60e-01 |
| GOBP NEGATIVE REGULATION OF SMOOTHENED SIGNALING PATHWAY | 30 | 6.62e-01 | -4.62e-02 | 9.21e-01 |
| GOMF CARBOXYPEPTIDASE ACTIVITY | 31 | 6.57e-01 | 4.61e-02 | 9.18e-01 |
| GOBP POSITIVE REGULATION OF AMYLOID FIBRIL FORMATION | 5 | 8.58e-01 | 4.61e-02 | 9.72e-01 |
| GOBP ENDODERM DEVELOPMENT | 63 | 5.27e-01 | -4.61e-02 | 8.76e-01 |
| GOBP REGULATION OF DOUBLE STRAND BREAK REPAIR VIA NONHOMOLOGOUS END JOINING | 28 | 6.73e-01 | 4.61e-02 | 9.23e-01 |
| GOBP REGULATION OF MICROTUBULE DEPOLYMERIZATION | 25 | 6.90e-01 | 4.61e-02 | 9.27e-01 |
| GOMF SPHINGOLIPID BINDING | 26 | 6.84e-01 | 4.61e-02 | 9.25e-01 |
| GOBP TRIGLYCERIDE METABOLIC PROCESS | 76 | 4.88e-01 | 4.60e-02 | 8.60e-01 |
| GOMF CHLORIDE ION BINDING | 6 | 8.45e-01 | -4.60e-02 | 9.68e-01 |
| GOCC MICROTUBULE ORGANIZING CENTER | 796 | 2.73e-02 | 4.60e-02 | 3.55e-01 |
| GOBP GLUCOCORTICOID METABOLIC PROCESS | 13 | 7.74e-01 | -4.60e-02 | 9.54e-01 |
| GOBP REPRODUCTIVE SYSTEM DEVELOPMENT | 209 | 2.52e-01 | 4.60e-02 | 7.20e-01 |
| GOBP REGULATORY NCRNA MEDIATED HETEROCHROMATIN FORMATION | 11 | 7.92e-01 | 4.60e-02 | 9.59e-01 |
| GOBP POSITIVE REGULATION OF GLYCOPROTEIN METABOLIC PROCESS | 20 | 7.22e-01 | 4.59e-02 | 9.38e-01 |
| GOBP REGULATION OF ATP METABOLIC PROCESS | 61 | 5.35e-01 | -4.59e-02 | 8.79e-01 |
| GOBP SYNAPTIC VESICLE UNCOATING | 5 | 8.59e-01 | -4.59e-02 | 9.72e-01 |
| GOBP NEGATIVE REGULATION OF MONONUCLEAR CELL MIGRATION | 29 | 6.69e-01 | 4.59e-02 | 9.22e-01 |
| GOBP BENZENE CONTAINING COMPOUND METABOLIC PROCESS | 21 | 7.16e-01 | -4.59e-02 | 9.36e-01 |
| GOBP REGULATION OF CELL PROJECTION ASSEMBLY | 202 | 2.62e-01 | 4.58e-02 | 7.29e-01 |
| GOMF FLAVIN ADENINE DINUCLEOTIDE BINDING | 79 | 4.81e-01 | -4.58e-02 | 8.59e-01 |
| GOMF MHC CLASS I PROTEIN BINDING | 20 | 7.23e-01 | 4.58e-02 | 9.38e-01 |
| GOBP PROCESS UTILIZING AUTOPHAGIC MECHANISM | 552 | 6.57e-02 | 4.58e-02 | 4.68e-01 |
| GOBP RESPONSE TO CARBOHYDRATE | 175 | 2.96e-01 | -4.58e-02 | 7.53e-01 |
| GOBP CELL MIGRATION INVOLVED IN SPROUTING ANGIOGENESIS | 41 | 6.12e-01 | -4.58e-02 | 9.04e-01 |
| GOCC POSTSYNAPTIC ENDOSOME | 12 | 7.84e-01 | 4.58e-02 | 9.57e-01 |
| GOBP TELOMERE MAINTENANCE VIA RECOMBINATION | 14 | 7.67e-01 | 4.58e-02 | 9.50e-01 |
| GOBP TYPE I PNEUMOCYTE DIFFERENTIATION | 6 | 8.46e-01 | -4.57e-02 | 9.68e-01 |
| GOBP INTESTINAL EPITHELIAL CELL DIFFERENTIATION | 15 | 7.59e-01 | 4.57e-02 | 9.47e-01 |
| GOBP ORGANONITROGEN COMPOUND BIOSYNTHETIC PROCESS | 1511 | 3.01e-03 | 4.57e-02 | 1.29e-01 |
| GOBP PROSTHETIC GROUP METABOLIC PROCESS | 6 | 8.46e-01 | -4.57e-02 | 9.68e-01 |
| GOBP REGULATION OF MAST CELL CHEMOTAXIS | 6 | 8.46e-01 | -4.57e-02 | 9.68e-01 |
| GOMF OXIDOREDUCTASE ACTIVITY ACTING ON THE CH NH GROUP OF DONORS NAD OR NADP AS ACCEPTOR | 16 | 7.52e-01 | 4.57e-02 | 9.45e-01 |
| GOMF CERAMIDE 1 PHOSPHATE BINDING | 7 | 8.34e-01 | 4.57e-02 | 9.65e-01 |
| GOBP POSITIVE REGULATION OF MYELOID CELL DIFFERENTIATION | 82 | 4.74e-01 | 4.57e-02 | 8.56e-01 |
| GOBP NAD METABOLIC PROCESS | 57 | 5.51e-01 | -4.57e-02 | 8.85e-01 |
| GOBP REGULATION OF CELLULAR RESPONSE TO HYPOXIA | 14 | 7.67e-01 | -4.57e-02 | 9.50e-01 |
| GOCC SAGA COMPLEX | 23 | 7.05e-01 | -4.57e-02 | 9.31e-01 |
| GOCC VESICLE MEMBRANE | 1070 | 1.17e-02 | 4.57e-02 | 2.43e-01 |
| GOBP RESPONSE TO BMP | 104 | 4.21e-01 | -4.57e-02 | 8.30e-01 |
| GOBP POSITIVE REGULATION OF T HELPER 17 TYPE IMMUNE RESPONSE | 17 | 7.45e-01 | -4.56e-02 | 9.42e-01 |
| GOMF OLIGOPEPTIDE TRANSMEMBRANE TRANSPORTER ACTIVITY | 11 | 7.93e-01 | 4.56e-02 | 9.59e-01 |
| GOBP REGULATION OF ANDROGEN RECEPTOR SIGNALING PATHWAY | 23 | 7.05e-01 | -4.56e-02 | 9.32e-01 |
| GOCC GLUTAMATERGIC SYNAPSE | 315 | 1.64e-01 | -4.56e-02 | 6.30e-01 |
| GOBP RECEPTOR METABOLIC PROCESS | 66 | 5.22e-01 | 4.56e-02 | 8.75e-01 |
| GOMF HISTONE METHYLTRANSFERASE BINDING | 13 | 7.76e-01 | 4.56e-02 | 9.54e-01 |
| GOBP PLASMA MEMBRANE TO ENDOSOME TRANSPORT | 8 | 8.23e-01 | 4.56e-02 | 9.64e-01 |
| GOBP DETERMINATION OF ADULT LIFESPAN | 27 | 6.82e-01 | -4.55e-02 | 9.24e-01 |
| GOBP NEGATIVE REGULATION OF GENE EXPRESSION EPIGENETIC | 140 | 3.53e-01 | 4.55e-02 | 7.94e-01 |
| GOBP POSITIVE REGULATION OF PROTEIN IMPORT INTO NUCLEUS | 35 | 6.42e-01 | 4.55e-02 | 9.15e-01 |
| GOBP AMIDE TRANSPORT | 231 | 2.34e-01 | -4.54e-02 | 7.05e-01 |
| GOMF PROTEIN DIMERIZATION ACTIVITY | 827 | 2.66e-02 | 4.54e-02 | 3.52e-01 |
| GOBP NEUROTRANSMITTER SECRETION | 110 | 4.11e-01 | 4.54e-02 | 8.26e-01 |
| GOBP NEGATIVE REGULATION OF NATURAL KILLER CELL MEDIATED IMMUNITY | 19 | 7.32e-01 | -4.54e-02 | 9.41e-01 |
| GOBP MEMBRANE RAFT ASSEMBLY | 9 | 8.14e-01 | 4.54e-02 | 9.62e-01 |
| GOMF 4 IRON 4 SULFUR CLUSTER BINDING | 45 | 5.99e-01 | -4.53e-02 | 9.02e-01 |
| GOBP ACTIN FILAMENT BASED PROCESS | 652 | 4.83e-02 | -4.53e-02 | 4.25e-01 |
| GOBP LACTATE TRANSMEMBRANE TRANSPORT | 6 | 8.48e-01 | 4.53e-02 | 9.68e-01 |
| GOBP CHEMOKINE C C MOTIF LIGAND 5 PRODUCTION | 9 | 8.14e-01 | 4.53e-02 | 9.62e-01 |
| GOBP REGULATION OF FEEDING BEHAVIOR | 18 | 7.40e-01 | -4.52e-02 | 9.42e-01 |
| GOMF DEMETHYLASE ACTIVITY | 36 | 6.39e-01 | 4.52e-02 | 9.15e-01 |
| GOBP HEPARIN METABOLIC PROCESS | 14 | 7.70e-01 | 4.52e-02 | 9.51e-01 |
| GOMF NADH DEHYDROGENASE UBIQUINONE ACTIVITY | 41 | 6.16e-01 | -4.52e-02 | 9.06e-01 |
| GOBP LEUKOCYTE CHEMOTAXIS | 180 | 2.96e-01 | 4.52e-02 | 7.53e-01 |
| GOBP POSITIVE REGULATION OF CYTOKINE PRODUCTION INVOLVED IN IMMUNE RESPONSE | 76 | 4.96e-01 | 4.52e-02 | 8.62e-01 |
| GOBP NEGATIVE REGULATION OF DEVELOPMENTAL GROWTH | 73 | 5.04e-01 | -4.52e-02 | 8.66e-01 |
| GOBP REGULATION OF CELLULAR LOCALIZATION | 808 | 2.91e-02 | 4.52e-02 | 3.60e-01 |
| GOBP POSITIVE REGULATION OF FAT CELL DIFFERENTIATION | 45 | 6.00e-01 | -4.51e-02 | 9.03e-01 |
| GOMF MUSCLE ALPHA ACTININ BINDING | 11 | 7.96e-01 | -4.51e-02 | 9.59e-01 |
| GOBP PURINE NUCLEOSIDE MONOPHOSPHATE CATABOLIC PROCESS | 10 | 8.05e-01 | 4.51e-02 | 9.61e-01 |
| GOBP POSITIVE REGULATION OF CILIUM ASSEMBLY | 27 | 6.85e-01 | -4.51e-02 | 9.25e-01 |
| GOMF AMINO ACID TRANSMEMBRANE TRANSPORTER ACTIVITY | 63 | 5.36e-01 | -4.51e-02 | 8.79e-01 |
| GOBP CELL SURFACE RECEPTOR PROTEIN SERINE THREONINE KINASE SIGNALING PATHWAY | 270 | 2.02e-01 | -4.51e-02 | 6.76e-01 |
| GOBP POSITIVE REGULATION OF IMMUNE SYSTEM PROCESS | 939 | 1.93e-02 | 4.51e-02 | 3.05e-01 |
| GOBP TRIGLYCERIDE BIOSYNTHETIC PROCESS | 35 | 6.45e-01 | 4.51e-02 | 9.15e-01 |
| GOBP MICROTUBULE CYTOSKELETON ORGANIZATION | 558 | 6.91e-02 | 4.50e-02 | 4.77e-01 |
| GOBP RETINA LAYER FORMATION | 12 | 7.87e-01 | 4.50e-02 | 9.57e-01 |
| GOMF RISC COMPLEX BINDING | 5 | 8.62e-01 | 4.50e-02 | 9.73e-01 |
| GOBP NUCLEOBASE CONTAINING SMALL MOLECULE BIOSYNTHETIC PROCESS | 18 | 7.41e-01 | -4.50e-02 | 9.42e-01 |
| GOBP VESICLE MEDIATED TRANSPORT | 1325 | 6.01e-03 | 4.50e-02 | 1.82e-01 |
| GOBP REGULATION OF PROTEIN MATURATION | 56 | 5.61e-01 | -4.49e-02 | 8.88e-01 |
| GOBP POSITIVE REGULATION OF AMYLOID BETA CLEARANCE | 6 | 8.49e-01 | -4.48e-02 | 9.68e-01 |
| GOBP POSITIVE REGULATION OF BLOOD CIRCULATION | 24 | 7.04e-01 | 4.48e-02 | 9.31e-01 |
| GOBP CELLULAR RESPONSE TO CHOLESTEROL | 15 | 7.64e-01 | 4.48e-02 | 9.49e-01 |
| GOBP CARDIAC CONDUCTION SYSTEM DEVELOPMENT | 16 | 7.56e-01 | 4.48e-02 | 9.46e-01 |
| GOBP SENSORY PERCEPTION OF MECHANICAL STIMULUS | 120 | 3.97e-01 | -4.48e-02 | 8.21e-01 |
| GOBP REGULATION OF COLLATERAL SPROUTING | 16 | 7.57e-01 | 4.48e-02 | 9.46e-01 |
| GOBP COBALAMIN METABOLIC PROCESS | 9 | 8.16e-01 | 4.48e-02 | 9.63e-01 |
| GOBP REGULATION OF MITOTIC CENTROSOME SEPARATION | 8 | 8.27e-01 | 4.47e-02 | 9.64e-01 |
| GOBP POSITIVE REGULATION OF ENDOCYTOSIS | 125 | 3.88e-01 | 4.47e-02 | 8.17e-01 |
| GOCC MCM COMPLEX | 11 | 7.97e-01 | -4.47e-02 | 9.59e-01 |
| GOMF ZINC ION BINDING | 672 | 4.83e-02 | 4.47e-02 | 4.25e-01 |
| GOCC ANCHORING JUNCTION | 734 | 3.96e-02 | -4.46e-02 | 3.98e-01 |
| GOMF PHOSPHOTRANSFERASE ACTIVITY FOR OTHER SUBSTITUTED PHOSPHATE GROUPS | 22 | 7.17e-01 | 4.46e-02 | 9.36e-01 |
| GOCC VESICLE LUMEN | 292 | 1.90e-01 | -4.46e-02 | 6.62e-01 |
| GOBP REGULATION OF GLUCOSE IMPORT | 45 | 6.05e-01 | 4.46e-02 | 9.03e-01 |
| GOBP REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY IN RESPONSE TO DNA DAMAGE | 35 | 6.48e-01 | -4.46e-02 | 9.16e-01 |
| GOBP POSITIVE REGULATION OF CHROMOSOME SEPARATION | 28 | 6.83e-01 | 4.46e-02 | 9.24e-01 |
| GOBP REGULATION OF INFLAMMATORY RESPONSE | 310 | 1.77e-01 | 4.46e-02 | 6.48e-01 |
| GOBP REGULATION OF TELOMERASE ACTIVITY | 40 | 6.26e-01 | 4.46e-02 | 9.10e-01 |
| GOBP INTRACILIARY RETROGRADE TRANSPORT | 14 | 7.73e-01 | 4.46e-02 | 9.53e-01 |
| GOCC NUCLEOID | 45 | 6.05e-01 | 4.45e-02 | 9.03e-01 |
| GOBP RENAL SYSTEM PROCESS INVOLVED IN REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE | 17 | 7.51e-01 | 4.45e-02 | 9.45e-01 |
| GOBP ESTABLISHMENT OF PROTEIN LOCALIZATION TO CHROMATIN | 8 | 8.28e-01 | -4.45e-02 | 9.64e-01 |
| GOCC RESPIRASOME | 95 | 4.54e-01 | -4.44e-02 | 8.43e-01 |
| GOBP NEGATIVE REGULATION OF RESPONSE TO WOUNDING | 74 | 5.09e-01 | -4.44e-02 | 8.69e-01 |
| GOMF VITAMIN B6 BINDING | 45 | 6.06e-01 | -4.44e-02 | 9.03e-01 |
| GOBP ERBB SIGNALING PATHWAY | 106 | 4.30e-01 | 4.44e-02 | 8.35e-01 |
| GOBP REGULATION OF WOUND HEALING SPREADING OF EPIDERMAL CELLS | 8 | 8.28e-01 | 4.44e-02 | 9.64e-01 |
| GOBP LATE ENDOSOME TO GOLGI TRANSPORT | 5 | 8.64e-01 | 4.44e-02 | 9.74e-01 |
| GOBP MAINTENANCE OF GASTROINTESTINAL EPITHELIUM | 13 | 7.82e-01 | -4.43e-02 | 9.56e-01 |
| GOCC EXOCYTIC VESICLE | 176 | 3.11e-01 | 4.43e-02 | 7.64e-01 |
| GOBP BLOOD VESSEL ENDOTHELIAL CELL MIGRATION | 98 | 4.49e-01 | -4.43e-02 | 8.43e-01 |
| GOBP POSITIVE REGULATION OF SIGNAL TRANSDUCTION BY P53 CLASS MEDIATOR | 28 | 6.85e-01 | 4.43e-02 | 9.25e-01 |
| GOBP POSITIVE REGULATION OF PROTEIN KINASE C SIGNALING | 7 | 8.39e-01 | 4.43e-02 | 9.66e-01 |
| GOBP CARDIAC EPITHELIAL TO MESENCHYMAL TRANSITION | 23 | 7.13e-01 | 4.43e-02 | 9.35e-01 |
| GOBP NEURON APOPTOTIC PROCESS | 216 | 2.62e-01 | 4.43e-02 | 7.29e-01 |
| GOBP NEGATIVE REGULATION OF DEFENSE RESPONSE | 215 | 2.64e-01 | 4.42e-02 | 7.31e-01 |
| GOBP INTERLEUKIN 1 PRODUCTION | 95 | 4.57e-01 | 4.42e-02 | 8.45e-01 |
| GOBP REGULATION OF SUPRAMOLECULAR FIBER ORGANIZATION | 333 | 1.66e-01 | -4.42e-02 | 6.30e-01 |
| GOBP REGULATION OF CELL MIGRATION INVOLVED IN SPROUTING ANGIOGENESIS | 29 | 6.81e-01 | -4.42e-02 | 9.24e-01 |
| GOBP POSITIVE REGULATION OF CALCIUM ION TRANSMEMBRANE TRANSPORT | 56 | 5.68e-01 | -4.42e-02 | 8.90e-01 |
| GOBP POSITIVE REGULATION OF CELL SUBSTRATE JUNCTION ORGANIZATION | 23 | 7.14e-01 | 4.41e-02 | 9.35e-01 |
| GOMF UBIQUITIN LIGASE INHIBITOR ACTIVITY | 9 | 8.19e-01 | -4.41e-02 | 9.63e-01 |
| GOBP PROTEIN RNA COMPLEX ORGANIZATION | 199 | 2.84e-01 | 4.41e-02 | 7.44e-01 |
| GOCC IMMUNOGLOBULIN COMPLEX CIRCULATING | 11 | 8.00e-01 | 4.40e-02 | 9.60e-01 |
| GOBP REGULATION OF MYELOID LEUKOCYTE MEDIATED IMMUNITY | 51 | 5.86e-01 | 4.40e-02 | 8.95e-01 |
| GOBP VESICLE TRANSPORT ALONG ACTIN FILAMENT | 8 | 8.29e-01 | 4.40e-02 | 9.64e-01 |
| GOCC CELL CORTEX | 266 | 2.17e-01 | -4.40e-02 | 6.92e-01 |
| GOCC BLEB | 9 | 8.19e-01 | -4.40e-02 | 9.63e-01 |
| GOBP CENTRAL NERVOUS SYSTEM NEURON DIFFERENTIATION | 107 | 4.32e-01 | 4.40e-02 | 8.36e-01 |
| GOBP B CELL DIFFERENTIATION | 124 | 3.98e-01 | 4.40e-02 | 8.22e-01 |
| GOBP POLYAMINE TRANSPORT | 13 | 7.84e-01 | 4.40e-02 | 9.57e-01 |
| GOBP THYMIC T CELL SELECTION | 21 | 7.27e-01 | -4.39e-02 | 9.39e-01 |
| GOBP ORGANONITROGEN COMPOUND CATABOLIC PROCESS | 1268 | 8.63e-03 | 4.39e-02 | 2.15e-01 |
| GOBP NEGATIVE REGULATION OF MACROPHAGE MIGRATION | 12 | 7.92e-01 | 4.39e-02 | 9.59e-01 |
| GOBP REGULATION OF CELL SUBSTRATE JUNCTION ORGANIZATION | 57 | 5.67e-01 | -4.39e-02 | 8.90e-01 |
| GOMF SMAD BINDING | 65 | 5.41e-01 | 4.39e-02 | 8.81e-01 |
| GOBP REPRODUCTIVE PROCESS | 1012 | 1.83e-02 | 4.39e-02 | 2.94e-01 |
| GOBP TETRAHYDROFOLATE INTERCONVERSION | 9 | 8.20e-01 | 4.39e-02 | 9.63e-01 |
| GOMF DYNEIN INTERMEDIATE CHAIN BINDING | 33 | 6.63e-01 | 4.38e-02 | 9.21e-01 |
| GOCC SPECIFIC GRANULE | 156 | 3.45e-01 | -4.38e-02 | 7.89e-01 |
| GOBP PURINE NUCLEOSIDE MONOPHOSPHATE BIOSYNTHETIC PROCESS | 20 | 7.34e-01 | 4.38e-02 | 9.42e-01 |
| GOBP NEGATIVE REGULATION OF OSTEOBLAST PROLIFERATION | 9 | 8.20e-01 | -4.38e-02 | 9.63e-01 |
| GOBP RESPONSE TO NERVE GROWTH FACTOR | 37 | 6.45e-01 | 4.38e-02 | 9.15e-01 |
| GOCC EPSILON DNA POLYMERASE COMPLEX | 5 | 8.65e-01 | -4.38e-02 | 9.74e-01 |
| GOBP LONG CHAIN FATTY ACYL COA METABOLIC PROCESS | 23 | 7.16e-01 | 4.38e-02 | 9.36e-01 |
| GOMF PHOSPHATASE BINDING | 170 | 3.25e-01 | 4.37e-02 | 7.76e-01 |
| GOBP CARBOHYDRATE HOMEOSTASIS | 191 | 2.98e-01 | -4.37e-02 | 7.53e-01 |
| GOBP CELL CELL ADHESION | 707 | 4.78e-02 | -4.37e-02 | 4.24e-01 |
| GOMF STEROID BINDING | 80 | 5.00e-01 | 4.37e-02 | 8.64e-01 |
| GOBP CELL JUNCTION ORGANIZATION | 546 | 8.13e-02 | -4.36e-02 | 5.02e-01 |
| GOBP KERATINOCYTE PROLIFERATION | 37 | 6.46e-01 | 4.36e-02 | 9.15e-01 |
| GOBP REGULATION OF MITOTIC RECOMBINATION | 6 | 8.53e-01 | 4.36e-02 | 9.70e-01 |
| GOBP CHITIN METABOLIC PROCESS | 5 | 8.66e-01 | -4.36e-02 | 9.74e-01 |
| GOMF CHITINASE ACTIVITY | 5 | 8.66e-01 | -4.36e-02 | 9.74e-01 |
| GOMF URIDYLYLTRANSFERASE ACTIVITY | 7 | 8.42e-01 | -4.36e-02 | 9.67e-01 |
| GOBP ICOSANOID BIOSYNTHETIC PROCESS | 39 | 6.37e-01 | 4.36e-02 | 9.15e-01 |
| GOCC MICROTUBULE END | 31 | 6.74e-01 | -4.36e-02 | 9.23e-01 |
| GOCC RIBOSOME | 224 | 2.61e-01 | 4.36e-02 | 7.29e-01 |
| GOBP POSITIVE REGULATION OF INTERLEUKIN 4 PRODUCTION | 25 | 7.06e-01 | -4.36e-02 | 9.32e-01 |
| GOBP NEUTROPHIL CHEMOTAXIS | 69 | 5.32e-01 | 4.36e-02 | 8.79e-01 |
| GOBP HEART FORMATION | 19 | 7.42e-01 | 4.35e-02 | 9.42e-01 |
| GOBP B CELL ACTIVATION | 239 | 2.47e-01 | 4.35e-02 | 7.16e-01 |
| GOBP NEUROMUSCULAR PROCESS | 111 | 4.29e-01 | -4.35e-02 | 8.34e-01 |
| GOBP RESPONSE TO PH | 26 | 7.01e-01 | -4.35e-02 | 9.29e-01 |
| GOBP FOREBRAIN NEURON DEVELOPMENT | 16 | 7.64e-01 | 4.34e-02 | 9.49e-01 |
| GOBP TUBE FORMATION | 116 | 4.19e-01 | -4.34e-02 | 8.30e-01 |
| GOBP REGULATION OF LIPOPROTEIN LIPASE ACTIVITY | 5 | 8.67e-01 | -4.34e-02 | 9.74e-01 |
| GOBP ENDOTHELIUM DEVELOPMENT | 108 | 4.36e-01 | 4.34e-02 | 8.37e-01 |
| GOBP POSITIVE REGULATION OF CHEMOTAXIS | 103 | 4.47e-01 | 4.34e-02 | 8.42e-01 |
| GOBP POSITIVE REGULATION OF CATABOLIC PROCESS | 478 | 1.04e-01 | 4.34e-02 | 5.56e-01 |
| GOBP ERYTHROCYTE HOMEOSTASIS | 133 | 3.88e-01 | 4.34e-02 | 8.17e-01 |
| GOBP VENOUS BLOOD VESSEL DEVELOPMENT | 10 | 8.12e-01 | -4.33e-02 | 9.62e-01 |
| GOBP CHRONIC INFLAMMATORY RESPONSE | 15 | 7.71e-01 | -4.33e-02 | 9.52e-01 |
| GOBP CYTOPLASMIC TRANSLATION | 157 | 3.49e-01 | 4.33e-02 | 7.92e-01 |
| GOBP PHOSPHATIDYLINOSITOL 3 KINASE PROTEIN KINASE B SIGNAL TRANSDUCTION | 230 | 2.58e-01 | -4.33e-02 | 7.27e-01 |
| GOMF SULFUR AMINO ACID TRANSMEMBRANE TRANSPORTER ACTIVITY | 10 | 8.13e-01 | -4.33e-02 | 9.62e-01 |
| GOBP VENTRICULAR CARDIAC MUSCLE TISSUE DEVELOPMENT | 37 | 6.48e-01 | -4.33e-02 | 9.17e-01 |
| GOBP REGULATION OF CATALYTIC ACTIVITY | 1109 | 1.50e-02 | 4.33e-02 | 2.64e-01 |
| GOBP NEGATIVE REGULATION OF VASCULAR PERMEABILITY | 12 | 7.95e-01 | -4.33e-02 | 9.59e-01 |
| GOBP BONE MATURATION | 19 | 7.44e-01 | -4.33e-02 | 9.42e-01 |
| GOBP MICROTUBULE BASED PROCESS | 782 | 3.97e-02 | 4.33e-02 | 3.98e-01 |
| GOBP BEHAVIOR | 436 | 1.22e-01 | 4.33e-02 | 5.85e-01 |
| GOBP REGULATION OF SYNCYTIUM FORMATION BY PLASMA MEMBRANE FUSION | 21 | 7.32e-01 | -4.33e-02 | 9.41e-01 |
| GOBP REGULATION OF EMBRYONIC DEVELOPMENT | 78 | 5.09e-01 | -4.32e-02 | 8.69e-01 |
| GOCC FANCONI ANAEMIA NUCLEAR COMPLEX | 13 | 7.87e-01 | 4.32e-02 | 9.57e-01 |
| GOBP REGULATION OF MICROTUBULE POLYMERIZATION OR DEPOLYMERIZATION | 84 | 4.94e-01 | -4.32e-02 | 8.62e-01 |
| GOBP RESPONSE TO ETHER | 13 | 7.88e-01 | -4.32e-02 | 9.57e-01 |
| GOBP REGULATION OF RNA POLYMERASE II REGULATORY REGION SEQUENCE SPECIFIC DNA BINDING | 5 | 8.67e-01 | 4.32e-02 | 9.74e-01 |
| GOCC AXOLEMMA | 11 | 8.04e-01 | 4.32e-02 | 9.61e-01 |
| GOBP INTRACELLULAR ESTROGEN RECEPTOR SIGNALING PATHWAY | 47 | 6.09e-01 | 4.31e-02 | 9.03e-01 |
| GOMF SIGNALING RECEPTOR BINDING | 1011 | 2.05e-02 | -4.31e-02 | 3.12e-01 |
| GOBP SENSORY SYSTEM DEVELOPMENT | 253 | 2.38e-01 | -4.31e-02 | 7.08e-01 |
| GOBP REGULATION OF CELL SUBSTRATE ADHESION | 173 | 3.28e-01 | -4.31e-02 | 7.79e-01 |
| GOCC ALPHA DNA POLYMERASE PRIMASE COMPLEX | 5 | 8.67e-01 | -4.31e-02 | 9.74e-01 |
| GOBP REGULATION OF REACTIVE OXYGEN SPECIES METABOLIC PROCESS | 120 | 4.15e-01 | 4.31e-02 | 8.29e-01 |
| GOBP TUBULIN DEACETYLATION | 22 | 7.27e-01 | -4.31e-02 | 9.39e-01 |
| GOBP HORMONE BIOSYNTHETIC PROCESS | 45 | 6.18e-01 | -4.30e-02 | 9.06e-01 |
| GOBP REGULATION OF DNA METABOLIC PROCESS | 462 | 1.13e-01 | 4.30e-02 | 5.69e-01 |
| GOBP REGULATION OF SMOOTHENED SIGNALING PATHWAY | 70 | 5.34e-01 | 4.30e-02 | 8.79e-01 |
| GOBP NEGATIVE REGULATION OF TRANSLATIONAL ELONGATION | 5 | 8.68e-01 | 4.30e-02 | 9.74e-01 |
| GOBP REGULATION OF ARP2 3 COMPLEX MEDIATED ACTIN NUCLEATION | 29 | 6.89e-01 | -4.30e-02 | 9.27e-01 |
| GOCC PCG PROTEIN COMPLEX | 45 | 6.18e-01 | -4.29e-02 | 9.07e-01 |
| GOMF PHOSPHORIC DIESTER HYDROLASE ACTIVITY | 74 | 5.23e-01 | 4.29e-02 | 8.75e-01 |
| GOBP HINDLIMB MORPHOGENESIS | 14 | 7.81e-01 | -4.29e-02 | 9.56e-01 |
| GOMF SNARE BINDING | 87 | 4.89e-01 | 4.29e-02 | 8.61e-01 |
| GOBP REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE | 63 | 5.57e-01 | -4.28e-02 | 8.87e-01 |
| GOMF PROTEIN PHOSPHORYLATED AMINO ACID BINDING | 57 | 5.77e-01 | 4.28e-02 | 8.92e-01 |
| GOCC SEX CHROMATIN | 6 | 8.56e-01 | -4.28e-02 | 9.71e-01 |
| GOBP RESPONSE TO PARATHYROID HORMONE | 10 | 8.15e-01 | -4.27e-02 | 9.62e-01 |
| GOCC HISTONE DEACETYLASE COMPLEX | 79 | 5.12e-01 | -4.27e-02 | 8.70e-01 |
| GOBP TRANSPOSITION | 26 | 7.06e-01 | 4.27e-02 | 9.32e-01 |
| GOBP POSITIVE REGULATION OF RNA SPLICING | 41 | 6.36e-01 | 4.27e-02 | 9.14e-01 |
| GOMF VIRION BINDING | 7 | 8.45e-01 | -4.27e-02 | 9.68e-01 |
| GOBP NEGATIVE REGULATION OF TYPE I INTERFERON PRODUCTION | 42 | 6.32e-01 | 4.27e-02 | 9.12e-01 |
| GOBP NEGATIVE REGULATION OF PHOSPHOLIPASE ACTIVITY | 6 | 8.56e-01 | 4.26e-02 | 9.71e-01 |
| GOBP CORTISOL BIOSYNTHETIC PROCESS | 6 | 8.57e-01 | 4.26e-02 | 9.71e-01 |
| GOBP CORTISOL METABOLIC PROCESS | 6 | 8.57e-01 | 4.26e-02 | 9.71e-01 |
| GOBP REGULATION OF RECEPTOR CATABOLIC PROCESS | 11 | 8.07e-01 | -4.26e-02 | 9.61e-01 |
| GOCC MICROTUBULE CYTOSKELETON | 1234 | 1.19e-02 | 4.26e-02 | 2.43e-01 |
| GOCC MHC CLASS II PROTEIN COMPLEX | 15 | 7.75e-01 | -4.26e-02 | 9.54e-01 |
| GOBP REGULATION OF HIPPO SIGNALING | 33 | 6.72e-01 | 4.26e-02 | 9.23e-01 |
| GOCC MITOCHONDRIAL PROTEIN CONTAINING COMPLEX | 276 | 2.24e-01 | -4.25e-02 | 6.97e-01 |
| GOBP GERMINAL CENTER FORMATION | 13 | 7.91e-01 | 4.25e-02 | 9.59e-01 |
| GOMF ENDONUCLEASE ACTIVITY | 118 | 4.25e-01 | -4.25e-02 | 8.32e-01 |
| GOBP NEGATIVE REGULATION OF RECEPTOR SIGNALING PATHWAY VIA STAT | 18 | 7.55e-01 | 4.25e-02 | 9.45e-01 |
| GOBP TELOMERE MAINTENANCE VIA SEMI CONSERVATIVE REPLICATION | 9 | 8.25e-01 | 4.25e-02 | 9.64e-01 |
| GOBP POSITIVE REGULATION OF AMYLOID BETA FORMATION | 18 | 7.55e-01 | 4.24e-02 | 9.46e-01 |
| GOBP REGULATION OF NUCLEOTIDE BINDING OLIGOMERIZATION DOMAIN CONTAINING 2 SIGNALING PATHWAY | 9 | 8.26e-01 | 4.24e-02 | 9.64e-01 |
| GOBP CEREBELLAR CORTEX MORPHOGENESIS | 28 | 6.98e-01 | 4.24e-02 | 9.28e-01 |
| GOMF CLATHRIN HEAVY CHAIN BINDING | 10 | 8.16e-01 | 4.24e-02 | 9.63e-01 |
| GOCC SMOOTH ENDOPLASMIC RETICULUM MEMBRANE | 5 | 8.70e-01 | 4.24e-02 | 9.75e-01 |
| GOBP POLYOL TRANSMEMBRANE TRANSPORT | 9 | 8.26e-01 | -4.24e-02 | 9.64e-01 |
| GOBP INSULIN RECEPTOR SIGNALING PATHWAY | 108 | 4.47e-01 | 4.24e-02 | 8.42e-01 |
| GOBP CYTOSKELETON DEPENDENT INTRACELLULAR TRANSPORT | 187 | 3.18e-01 | 4.23e-02 | 7.69e-01 |
| GOBP CORTICAL ACTIN CYTOSKELETON ORGANIZATION | 41 | 6.39e-01 | -4.23e-02 | 9.15e-01 |
| GOBP NON PROTEINOGENIC AMINO ACID CATABOLIC PROCESS | 14 | 7.84e-01 | 4.23e-02 | 9.57e-01 |
| GOBP RESPONSE TO FUNGUS | 48 | 6.13e-01 | -4.22e-02 | 9.04e-01 |
| GOBP AMINE METABOLIC PROCESS | 82 | 5.09e-01 | -4.22e-02 | 8.69e-01 |
| GOBP PANCREAS DEVELOPMENT | 43 | 6.33e-01 | 4.21e-02 | 9.13e-01 |
| GOCC PLASMA MEMBRANE SIGNALING RECEPTOR COMPLEX | 241 | 2.60e-01 | -4.21e-02 | 7.28e-01 |
| GOBP ENSHEATHMENT OF NEURONS | 132 | 4.03e-01 | -4.21e-02 | 8.24e-01 |
| GOBP REGULATION OF CELLULAR RESPONSE TO GROWTH FACTOR STIMULUS | 226 | 2.76e-01 | -4.20e-02 | 7.39e-01 |
| GOMF CIS TRANS ISOMERASE ACTIVITY | 36 | 6.63e-01 | 4.20e-02 | 9.21e-01 |
| GOBP REGULATION OF DNA DIRECTED DNA POLYMERASE ACTIVITY | 9 | 8.27e-01 | -4.20e-02 | 9.64e-01 |
| GOBP PYRIMIDINE NUCLEOTIDE BIOSYNTHETIC PROCESS | 29 | 6.96e-01 | -4.20e-02 | 9.27e-01 |
| GOBP RETINAL GANGLION CELL AXON GUIDANCE | 15 | 7.78e-01 | 4.20e-02 | 9.54e-01 |
| GOBP MEDIUM CHAIN FATTY ACID METABOLIC PROCESS | 11 | 8.10e-01 | 4.20e-02 | 9.61e-01 |
| GOMF PROTEIN TYROSINE KINASE ACTIVITY | 115 | 4.37e-01 | 4.20e-02 | 8.38e-01 |
| GOCC MULTIMERIC RIBONUCLEASE P COMPLEX | 10 | 8.18e-01 | -4.19e-02 | 9.63e-01 |
| GOMF RIBONUCLEASE P RNA BINDING | 10 | 8.18e-01 | -4.19e-02 | 9.63e-01 |
| GOBP CELL COMMUNICATION BY ELECTRICAL COUPLING INVOLVED IN CARDIAC CONDUCTION | 17 | 7.65e-01 | 4.19e-02 | 9.49e-01 |
| GOBP HAIR FOLLICLE MATURATION | 9 | 8.28e-01 | -4.19e-02 | 9.64e-01 |
| GOBP APOPTOTIC PROCESS | 1547 | 6.04e-03 | 4.19e-02 | 1.82e-01 |
| GOBP CELLULAR RESPONSE TO STEROID HORMONE STIMULUS | 167 | 3.51e-01 | 4.19e-02 | 7.93e-01 |
| GOBP DETECTION OF EXTERNAL BIOTIC STIMULUS | 23 | 7.28e-01 | -4.18e-02 | 9.39e-01 |
| GOBP LEUKOCYTE PROLIFERATION | 283 | 2.26e-01 | 4.18e-02 | 6.99e-01 |
| GOBP MORPHOGENESIS OF AN EPITHELIAL FOLD | 11 | 8.10e-01 | 4.18e-02 | 9.61e-01 |
| GOBP CARDIAC VENTRICLE MORPHOGENESIS | 41 | 6.43e-01 | -4.18e-02 | 9.15e-01 |
| GOBP REGULATION OF DNA BIOSYNTHETIC PROCESS | 106 | 4.58e-01 | 4.17e-02 | 8.46e-01 |
| GOCC PRERIBOSOME | 105 | 4.60e-01 | -4.17e-02 | 8.47e-01 |
| GOBP LATERAL VENTRICLE DEVELOPMENT | 11 | 8.11e-01 | -4.17e-02 | 9.62e-01 |
| GOBP ORGANIC ACID TRANSPORT | 235 | 2.72e-01 | -4.16e-02 | 7.36e-01 |
| GOBP CELL GROWTH | 378 | 1.65e-01 | -4.16e-02 | 6.30e-01 |
| GOBP EXOCYTIC PROCESS | 67 | 5.56e-01 | 4.16e-02 | 8.87e-01 |
| GOMF TRANSFERASE ACTIVITY TRANSFERRING NITROGENOUS GROUPS | 20 | 7.48e-01 | -4.16e-02 | 9.43e-01 |
| GOBP POSITIVE REGULATION OF NEUTROPHIL MIGRATION | 29 | 6.99e-01 | 4.15e-02 | 9.28e-01 |
| GOBP NEGATIVE REGULATION OF PROTEIN POLYMERIZATION | 70 | 5.48e-01 | -4.15e-02 | 8.84e-01 |
| GOBP ASTROCYTE DIFFERENTIATION | 63 | 5.69e-01 | -4.15e-02 | 8.90e-01 |
| GOBP CELLULAR RESPONSE TO ATP | 17 | 7.67e-01 | 4.15e-02 | 9.50e-01 |
| GOCC DOPAMINERGIC SYNAPSE | 11 | 8.12e-01 | 4.15e-02 | 9.62e-01 |
| GOMF RNA NUCLEASE ACTIVITY | 117 | 4.39e-01 | 4.15e-02 | 8.39e-01 |
| GOBP PROTEIN POLYMERIZATION | 259 | 2.51e-01 | -4.15e-02 | 7.19e-01 |
| GOBP L CYSTINE TRANSPORT | 5 | 8.72e-01 | 4.15e-02 | 9.76e-01 |
| GOBP TRNA METHYLATION | 40 | 6.51e-01 | 4.14e-02 | 9.17e-01 |
| GOBP ENUCLEATE ERYTHROCYTE DIFFERENTIATION | 12 | 8.04e-01 | 4.14e-02 | 9.61e-01 |
| GOBP NETRIN ACTIVATED SIGNALING PATHWAY | 6 | 8.61e-01 | -4.14e-02 | 9.72e-01 |
| GOBP CARDIAC MUSCLE CELL PROLIFERATION | 36 | 6.68e-01 | 4.13e-02 | 9.22e-01 |
| GOCC CHOLINERGIC SYNAPSE | 7 | 8.50e-01 | -4.13e-02 | 9.68e-01 |
| GOBP REGULATION OF DENDRITIC CELL ANTIGEN PROCESSING AND PRESENTATION | 9 | 8.30e-01 | -4.13e-02 | 9.64e-01 |
| GOBP NEGATIVE REGULATION OF BONE REMODELING | 11 | 8.12e-01 | 4.13e-02 | 9.62e-01 |
| GOMF PHOSPHATIDYLINOSITOL 4 5 BISPHOSPHATE 5 PHOSPHATASE ACTIVITY | 9 | 8.30e-01 | -4.13e-02 | 9.64e-01 |
| GOCC SMN SM PROTEIN COMPLEX | 18 | 7.62e-01 | 4.13e-02 | 9.48e-01 |
| GOBP NEGATIVE REGULATION OF TRANSCRIPTION BY RNA POLYMERASE II | 702 | 6.29e-02 | -4.12e-02 | 4.63e-01 |
| GOBP PLACENTA BLOOD VESSEL DEVELOPMENT | 24 | 7.27e-01 | -4.12e-02 | 9.39e-01 |
| GOMF UBIQUITIN BINDING | 102 | 4.73e-01 | 4.11e-02 | 8.55e-01 |
| GOBP PURINE NUCLEOTIDE TRANSPORT | 35 | 6.74e-01 | -4.11e-02 | 9.23e-01 |
| GOBP ORGANIC CATION TRANSPORT | 78 | 5.30e-01 | 4.11e-02 | 8.78e-01 |
| GOBP MYELOID LEUKOCYTE MEDIATED IMMUNITY | 97 | 4.85e-01 | 4.11e-02 | 8.60e-01 |
| GOCC CELL POLE | 8 | 8.41e-01 | -4.10e-02 | 9.67e-01 |
| GOMF QUINONE BINDING | 16 | 7.77e-01 | -4.10e-02 | 9.54e-01 |
| GOMF PEPTIDYL PROLINE DIOXYGENASE ACTIVITY | 11 | 8.14e-01 | -4.10e-02 | 9.62e-01 |
| GOBP RESPONSE TO INTERLEUKIN 4 | 34 | 6.79e-01 | -4.10e-02 | 9.24e-01 |
| GOBP POSITIVE REGULATION OF STRESS FIBER ASSEMBLY | 42 | 6.46e-01 | -4.10e-02 | 9.15e-01 |
| GOBP CELLULAR RESPONSE TO POTASSIUM ION | 10 | 8.23e-01 | 4.10e-02 | 9.64e-01 |
| GOMF HEXOSYLTRANSFERASE ACTIVITY | 155 | 3.79e-01 | 4.09e-02 | 8.12e-01 |
| GOBP GLAND DEVELOPMENT | 307 | 2.18e-01 | 4.09e-02 | 6.93e-01 |
| GOBP REGULATION OF ACTIN FILAMENT LENGTH | 137 | 4.09e-01 | -4.09e-02 | 8.26e-01 |
| GOBP POSITIVE REGULATION OF PROTEIN TRANSPORT | 205 | 3.13e-01 | 4.09e-02 | 7.66e-01 |
| GOBP REGULATION OF PROTEIN TARGETING | 72 | 5.49e-01 | -4.09e-02 | 8.84e-01 |
| GOBP IMMUNOLOGICAL MEMORY PROCESS | 16 | 7.77e-01 | -4.09e-02 | 9.54e-01 |
| GOBP PROTEIN DNA COMPLEX ORGANIZATION | 786 | 5.16e-02 | 4.08e-02 | 4.33e-01 |
| GOBP VALINE METABOLIC PROCESS | 7 | 8.52e-01 | -4.08e-02 | 9.69e-01 |
| GOBP POSITIVE REGULATION OF PODOSOME ASSEMBLY | 9 | 8.32e-01 | 4.08e-02 | 9.64e-01 |
| GOMF PROMOTER SPECIFIC CHROMATIN BINDING | 57 | 5.94e-01 | -4.08e-02 | 9.00e-01 |
| GOMF CARGO ADAPTOR ACTIVITY | 21 | 7.46e-01 | 4.08e-02 | 9.43e-01 |
| GOBP NEGATIVE REGULATION OF T CELL DIFFERENTIATION | 37 | 6.68e-01 | -4.08e-02 | 9.22e-01 |
| GOMF TRANSITION METAL ION BINDING | 869 | 4.17e-02 | 4.07e-02 | 4.05e-01 |
| GOBP SEGMENTATION | 59 | 5.89e-01 | 4.07e-02 | 8.95e-01 |
| GOMF GLUTATHIONE TRANSFERASE ACTIVITY | 20 | 7.53e-01 | -4.07e-02 | 9.45e-01 |
| GOBP N GLYCAN PROCESSING | 15 | 7.85e-01 | 4.07e-02 | 9.57e-01 |
| GOBP ENDOPLASMIC RETICULUM TUBULAR NETWORK FORMATION | 5 | 8.75e-01 | -4.06e-02 | 9.76e-01 |
| GOBP MONOCARBOXYLIC ACID TRANSPORT | 113 | 4.56e-01 | -4.06e-02 | 8.44e-01 |
| GOBP REGULATION OF SMOOTH MUSCLE CONTRACTION | 38 | 6.65e-01 | -4.06e-02 | 9.22e-01 |
| GOBP MOTOR NEURON MIGRATION | 7 | 8.52e-01 | 4.06e-02 | 9.69e-01 |
| GOCC RUFFLE MEMBRANE | 88 | 5.10e-01 | -4.06e-02 | 8.70e-01 |
| GOBP LONG CHAIN FATTY ACID CATABOLIC PROCESS | 7 | 8.52e-01 | 4.06e-02 | 9.69e-01 |
| GOBP POTASSIUM ION HOMEOSTASIS | 23 | 7.36e-01 | -4.06e-02 | 9.42e-01 |
| GOBP POSITIVE REGULATION OF DEVELOPMENTAL GROWTH | 116 | 4.51e-01 | -4.06e-02 | 8.43e-01 |
| GOBP TISSUE REGENERATION | 55 | 6.03e-01 | -4.05e-02 | 9.03e-01 |
| GOMF NEUREXIN FAMILY PROTEIN BINDING | 10 | 8.25e-01 | -4.05e-02 | 9.64e-01 |
| GOCC PERIKARYON | 102 | 4.80e-01 | -4.05e-02 | 8.59e-01 |
| GOMF COBALAMIN BINDING | 9 | 8.34e-01 | 4.05e-02 | 9.64e-01 |
| GOMF STRUCTURAL CONSTITUENT OF MYELIN SHEATH | 9 | 8.34e-01 | -4.05e-02 | 9.64e-01 |
| GOBP REGULATION OF TRANSPORT | 1234 | 1.69e-02 | 4.05e-02 | 2.83e-01 |
| GOCC MANNOSYLTRANSFERASE COMPLEX | 5 | 8.76e-01 | -4.05e-02 | 9.76e-01 |
| GOBP PROTEIN LOCALIZATION TO PHOTORECEPTOR OUTER SEGMENT | 5 | 8.76e-01 | 4.04e-02 | 9.76e-01 |
| GOCC ORGANELLE INNER MEMBRANE | 508 | 1.20e-01 | -4.03e-02 | 5.82e-01 |
| GOBP LIPID DROPLET DISASSEMBLY | 5 | 8.76e-01 | 4.03e-02 | 9.76e-01 |
| GOMF GLUCOSE BINDING | 11 | 8.17e-01 | -4.03e-02 | 9.63e-01 |
| GOBP POSITIVE REGULATION OF CHROMOSOME SEGREGATION | 27 | 7.17e-01 | 4.03e-02 | 9.36e-01 |
| GOBP REGULATION OF EPITHELIAL CELL MIGRATION | 186 | 3.44e-01 | -4.02e-02 | 7.89e-01 |
| GOBP IRON ION TRANSMEMBRANE TRANSPORT | 19 | 7.62e-01 | -4.02e-02 | 9.48e-01 |
| GOBP REGULATION OF SECRETION | 439 | 1.49e-01 | 4.02e-02 | 6.13e-01 |
| GOBP RESPONSE TO COLD | 34 | 6.85e-01 | 4.02e-02 | 9.25e-01 |
| GOBP POSITIVE REGULATION OF CD4 POSITIVE ALPHA BETA T CELL DIFFERENTIATION | 34 | 6.86e-01 | -4.01e-02 | 9.25e-01 |
| GOBP DEOXYRIBONUCLEOSIDE MONOPHOSPHATE BIOSYNTHETIC PROCESS | 8 | 8.44e-01 | 4.01e-02 | 9.68e-01 |
| GOBP REGULATION OF VENTRICULAR CARDIAC MUSCLE CELL MEMBRANE REPOLARIZATION | 17 | 7.75e-01 | 4.01e-02 | 9.54e-01 |
| GOMF HISTONE H4 DEMETHYLASE ACTIVITY | 5 | 8.77e-01 | 4.01e-02 | 9.76e-01 |
| GOMF CARBON OXYGEN LYASE ACTIVITY | 65 | 5.76e-01 | -4.01e-02 | 8.92e-01 |
| GOBP REGULATION OF MICROTUBULE CYTOSKELETON ORGANIZATION | 142 | 4.10e-01 | 4.00e-02 | 8.26e-01 |
| GOBP NEGATIVE REGULATION OF CALCIUM ION TRANSMEMBRANE TRANSPORTER ACTIVITY | 15 | 7.88e-01 | -4.00e-02 | 9.58e-01 |
| GOBP SECONDARY METABOLIC PROCESS | 34 | 6.86e-01 | 4.00e-02 | 9.26e-01 |
| GOBP CELLULAR RESPONSE TO HORMONE STIMULUS | 468 | 1.38e-01 | 4.00e-02 | 6.04e-01 |
| GOMF FERROUS IRON BINDING | 21 | 7.51e-01 | 4.00e-02 | 9.45e-01 |
| GOBP POSITIVE REGULATION OF GRANULOCYTE CHEMOTAXIS | 22 | 7.46e-01 | 4.00e-02 | 9.43e-01 |
| GOCC DENDRITIC TREE | 451 | 1.46e-01 | -3.99e-02 | 6.13e-01 |
| GOBP NEGATIVE REGULATION OF LEUKOCYTE MEDIATED IMMUNITY | 64 | 5.81e-01 | 3.99e-02 | 8.93e-01 |
| GOBP COPPER ION HOMEOSTASIS | 19 | 7.63e-01 | -3.99e-02 | 9.49e-01 |
| GOBP REGULATION OF NUCLEOTIDE EXCISION REPAIR | 26 | 7.25e-01 | 3.99e-02 | 9.38e-01 |
| GOBP PHOTOTRANSDUCTION | 27 | 7.20e-01 | -3.99e-02 | 9.37e-01 |
| GOBP POSTSYNAPTIC CYTOSKELETON ORGANIZATION | 11 | 8.19e-01 | -3.99e-02 | 9.63e-01 |
| GOBP REGULATION OF APOPTOTIC SIGNALING PATHWAY | 322 | 2.18e-01 | 3.99e-02 | 6.93e-01 |
| GOBP NEGATIVE REGULATION OF TRANSCRIPTION REGULATORY REGION DNA BINDING | 6 | 8.66e-01 | -3.99e-02 | 9.74e-01 |
| GOBP LYMPHOCYTE MEDIATED IMMUNITY | 324 | 2.17e-01 | 3.99e-02 | 6.92e-01 |
| GOBP POSITIVE REGULATION OF HEART RATE | 16 | 7.82e-01 | 3.99e-02 | 9.56e-01 |
| GOBP ESTABLISHMENT OF PROTEIN LOCALIZATION TO MEMBRANE | 251 | 2.77e-01 | 3.99e-02 | 7.39e-01 |
| GOBP ANTIGEN PROCESSING AND PRESENTATION | 103 | 4.85e-01 | 3.99e-02 | 8.60e-01 |
| GOMF TRANSLATION INITIATION FACTOR BINDING | 30 | 7.06e-01 | -3.98e-02 | 9.32e-01 |
| GOBP POSITIVE REGULATION OF GENE EXPRESSION VIA CHROMOSOMAL CPG ISLAND DEMETHYLATION | 13 | 8.04e-01 | 3.98e-02 | 9.61e-01 |
| GOBP PEPTIDYL CYSTEINE MODIFICATION | 40 | 6.63e-01 | -3.98e-02 | 9.21e-01 |
| GOBP POSITIVE REGULATION OF ENDOTHELIAL CELL PROLIFERATION | 67 | 5.74e-01 | -3.97e-02 | 8.92e-01 |
| GOMF ENDONUCLEASE ACTIVITY ACTIVE WITH EITHER RIBO OR DEOXYRIBONUCLEIC ACIDS AND PRODUCING 5 PHOSPHOMONOESTERS | 40 | 6.64e-01 | -3.97e-02 | 9.22e-01 |
| GOBP STEROL METABOLIC PROCESS | 114 | 4.64e-01 | -3.97e-02 | 8.50e-01 |
| GOBP REGULATION OF TOLL LIKE RECEPTOR SIGNALING PATHWAY | 32 | 6.98e-01 | 3.97e-02 | 9.28e-01 |
| GOMF TRANSLATION ELONGATION FACTOR ACTIVITY | 20 | 7.59e-01 | -3.97e-02 | 9.47e-01 |
| GOBP REGULATION OF NUCLEOTIDE METABOLIC PROCESS | 77 | 5.47e-01 | -3.97e-02 | 8.84e-01 |
| GOMF NUCLEOBASE CONTAINING COMPOUND TRANSMEMBRANE TRANSPORTER ACTIVITY | 50 | 6.28e-01 | -3.96e-02 | 9.11e-01 |
| GOBP SEX DIFFERENTIATION | 187 | 3.50e-01 | 3.96e-02 | 7.93e-01 |
| GOBP ANTIGEN PROCESSING AND PRESENTATION OF EXOGENOUS PEPTIDE ANTIGEN VIA MHC CLASS II | 28 | 7.17e-01 | 3.96e-02 | 9.36e-01 |
| GOBP INTERLEUKIN 13 PRODUCTION | 17 | 7.78e-01 | 3.96e-02 | 9.54e-01 |
| GOBP PROGESTERONE METABOLIC PROCESS | 11 | 8.20e-01 | -3.95e-02 | 9.63e-01 |
| GOBP SKELETAL SYSTEM DEVELOPMENT | 333 | 2.15e-01 | -3.95e-02 | 6.91e-01 |
| GOMF PURINE NUCLEOTIDE BINDING | 1724 | 6.51e-03 | 3.95e-02 | 1.89e-01 |
| GOBP CELLULAR RESPONSE TO NUTRIENT | 39 | 6.70e-01 | -3.95e-02 | 9.22e-01 |
| GOBP EMBRYONIC ORGAN DEVELOPMENT | 286 | 2.51e-01 | -3.94e-02 | 7.20e-01 |
| GOMF INTRAMOLECULAR OXIDOREDUCTASE ACTIVITY | 44 | 6.51e-01 | -3.94e-02 | 9.17e-01 |
| GOBP REGULATION OF CELLULAR COMPONENT SIZE | 309 | 2.34e-01 | -3.94e-02 | 7.05e-01 |
| GOBP PHOSPHOLIPID BIOSYNTHETIC PROCESS | 227 | 3.07e-01 | 3.94e-02 | 7.61e-01 |
| GOCC ENDOSOME | 931 | 4.19e-02 | 3.94e-02 | 4.05e-01 |
| GOBP NEGATIVE REGULATION OF LEUKOCYTE CELL CELL ADHESION | 116 | 4.64e-01 | 3.94e-02 | 8.50e-01 |
| GOBP POSITIVE REGULATION OF DOUBLE STRAND BREAK REPAIR | 86 | 5.28e-01 | 3.94e-02 | 8.76e-01 |
| GOBP CYTOKINE PRODUCTION | 671 | 8.23e-02 | 3.94e-02 | 5.04e-01 |
| GOBP CARTILAGE DEVELOPMENT | 128 | 4.42e-01 | -3.93e-02 | 8.41e-01 |
| GOBP POSITIVE REGULATION OF MONONUCLEAR CELL MIGRATION | 77 | 5.51e-01 | 3.93e-02 | 8.85e-01 |
| GOBP REGULATION OF BONE RESORPTION | 30 | 7.09e-01 | -3.93e-02 | 9.33e-01 |
| GOMF CHROMATIN DNA BINDING | 111 | 4.75e-01 | -3.93e-02 | 8.56e-01 |
| GOBP DOPAMINE TRANSPORT | 26 | 7.29e-01 | 3.92e-02 | 9.40e-01 |
| GOBP T HELPER 2 CELL CYTOKINE PRODUCTION | 10 | 8.30e-01 | 3.92e-02 | 9.64e-01 |
| GOBP HIPPOCAMPUS DEVELOPMENT | 68 | 5.77e-01 | -3.91e-02 | 8.92e-01 |
| GOBP RESPONSE TO STARVATION | 184 | 3.60e-01 | 3.91e-02 | 8.00e-01 |
| GOCC SPECIFIC GRANULE MEMBRANE | 88 | 5.26e-01 | 3.91e-02 | 8.76e-01 |
| GOBP NEGATIVE REGULATION OF NON CANONICAL NF KAPPAB SIGNAL TRANSDUCTION | 24 | 7.40e-01 | 3.91e-02 | 9.42e-01 |
| GOMF ACTIVE TRANSMEMBRANE TRANSPORTER ACTIVITY | 348 | 2.11e-01 | -3.90e-02 | 6.84e-01 |
| GOBP EPITHELIAL CELL PROLIFERATION INVOLVED IN PROSTATE GLAND DEVELOPMENT | 9 | 8.39e-01 | 3.90e-02 | 9.66e-01 |
| GOMF O METHYLTRANSFERASE ACTIVITY | 22 | 7.51e-01 | -3.90e-02 | 9.45e-01 |
| GOCC CELL DIVISION SITE | 66 | 5.84e-01 | 3.90e-02 | 8.93e-01 |
| GOBP SENSORY ORGAN DEVELOPMENT | 360 | 2.04e-01 | -3.90e-02 | 6.78e-01 |
| GOBP LABYRINTHINE LAYER BLOOD VESSEL DEVELOPMENT | 15 | 7.94e-01 | 3.89e-02 | 9.59e-01 |
| GOBP MONOATOMIC CATION TRANSMEMBRANE TRANSPORT | 606 | 1.02e-01 | -3.89e-02 | 5.51e-01 |
| GOBP NEURON PROJECTION REGENERATION | 46 | 6.48e-01 | -3.89e-02 | 9.16e-01 |
| GOBP RESPONSE TO VITAMIN | 60 | 6.02e-01 | -3.89e-02 | 9.03e-01 |
| GOBP FACULTATIVE HETEROCHROMATIN FORMATION | 39 | 6.74e-01 | 3.89e-02 | 9.23e-01 |
| GOBP REGULATION OF MUSCLE CONTRACTION | 115 | 4.71e-01 | -3.89e-02 | 8.54e-01 |
| GOMF PHOSPHATIDYLINOSITOL 3 4 5 TRISPHOSPHATE BINDING | 36 | 6.87e-01 | 3.88e-02 | 9.26e-01 |
| GOBP PROTEIN LOCALIZATION TO MICROTUBULE | 17 | 7.82e-01 | 3.88e-02 | 9.56e-01 |
| GOCC SWR1 COMPLEX | 13 | 8.08e-01 | -3.88e-02 | 9.61e-01 |
| GOMF HISTONE H3K9 DEMETHYLASE ACTIVITY | 10 | 8.32e-01 | 3.88e-02 | 9.64e-01 |
| GOBP TRNA 5 LEADER REMOVAL | 13 | 8.09e-01 | 3.88e-02 | 9.61e-01 |
| GOMF GPI ANCHOR BINDING | 5 | 8.81e-01 | 3.88e-02 | 9.77e-01 |
| GOBP HEART PROCESS | 170 | 3.83e-01 | 3.88e-02 | 8.15e-01 |
| GOMF GLUTAMATE RECEPTOR BINDING | 33 | 7.00e-01 | 3.88e-02 | 9.28e-01 |
| GOBP GMP BIOSYNTHETIC PROCESS | 13 | 8.09e-01 | 3.88e-02 | 9.61e-01 |
| GOBP REGULATION OF REPRODUCTIVE PROCESS | 124 | 4.56e-01 | 3.88e-02 | 8.44e-01 |
| GOBP REGULATION OF ORGAN GROWTH | 63 | 5.95e-01 | -3.87e-02 | 9.01e-01 |
| GOMF SYNDECAN BINDING | 5 | 8.81e-01 | 3.87e-02 | 9.77e-01 |
| GOBP POSITIVE REGULATION OF PROTEIN DEPOLYMERIZATION | 15 | 7.95e-01 | 3.87e-02 | 9.59e-01 |
| GOMF VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR BINDING | 11 | 8.24e-01 | -3.87e-02 | 9.64e-01 |
| GOBP CATECHOLAMINE UPTAKE INVOLVED IN SYNAPTIC TRANSMISSION | 6 | 8.70e-01 | -3.87e-02 | 9.75e-01 |
| GOMF DNA ENDONUCLEASE ACTIVITY | 41 | 6.69e-01 | 3.86e-02 | 9.22e-01 |
| GOBP MESONEPHROS DEVELOPMENT | 61 | 6.02e-01 | -3.86e-02 | 9.03e-01 |
| GOBP ACTIN FILAMENT BUNDLE ORGANIZATION | 140 | 4.31e-01 | -3.86e-02 | 8.35e-01 |
| GOBP ICOSANOID TRANSPORT | 35 | 6.93e-01 | -3.85e-02 | 9.27e-01 |
| GOBP FACE DEVELOPMENT | 38 | 6.81e-01 | 3.85e-02 | 9.24e-01 |
| GOBP LYMPHOCYTE MIGRATION | 89 | 5.30e-01 | 3.85e-02 | 8.78e-01 |
| GOCC SMALL RIBOSOMAL SUBUNIT | 75 | 5.64e-01 | 3.85e-02 | 8.90e-01 |
| GOBP BIOLOGICAL PROCESS INVOLVED IN SYMBIOTIC INTERACTION | 256 | 2.90e-01 | 3.84e-02 | 7.47e-01 |
| GOBP STEROL HOMEOSTASIS | 66 | 5.89e-01 | -3.84e-02 | 8.96e-01 |
| GOBP REGULATION OF ENDOTHELIAL CELL DEVELOPMENT | 18 | 7.78e-01 | -3.84e-02 | 9.54e-01 |
| GOBP ADENYLATE CYCLASE ACTIVATING G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY | 98 | 5.11e-01 | -3.84e-02 | 8.70e-01 |
| GOBP ESTABLISHMENT OR MAINTENANCE OF BIPOLAR CELL POLARITY | 48 | 6.45e-01 | -3.84e-02 | 9.15e-01 |
| GOBP PROTEIN CONTAINING COMPLEX LOCALIZATION | 166 | 3.94e-01 | 3.83e-02 | 8.20e-01 |
| GOMF PLATELET DERIVED GROWTH FACTOR RECEPTOR BINDING | 13 | 8.11e-01 | -3.83e-02 | 9.62e-01 |
| GOBP RESPONSE TO INSULIN | 227 | 3.20e-01 | 3.83e-02 | 7.72e-01 |
| GOBP PROTON TRANSPORTING V TYPE ATPASE COMPLEX ASSEMBLY | 7 | 8.61e-01 | -3.83e-02 | 9.72e-01 |
| GOCC CHROMAFFIN GRANULE | 12 | 8.19e-01 | 3.82e-02 | 9.63e-01 |
| GOBP NEGATIVE REGULATION OF AXON EXTENSION INVOLVED IN AXON GUIDANCE | 7 | 8.61e-01 | 3.82e-02 | 9.72e-01 |
| GOBP RIBONUCLEOPROTEIN COMPLEX BIOGENESIS | 445 | 1.68e-01 | 3.81e-02 | 6.33e-01 |
| GOBP POSITIVE REGULATION OF MEIOTIC CELL CYCLE | 14 | 8.05e-01 | 3.80e-02 | 9.61e-01 |
| GOBP DETECTION OF MECHANICAL STIMULUS | 37 | 6.89e-01 | 3.80e-02 | 9.27e-01 |
| GOBP REGULATION OF TRANSPORTER ACTIVITY | 164 | 4.01e-01 | 3.80e-02 | 8.23e-01 |
| GOBP REGULATION OF IMMUNE EFFECTOR PROCESS | 337 | 2.31e-01 | 3.80e-02 | 7.03e-01 |
| GOBP PLASMA MEMBRANE PHOSPHOLIPID SCRAMBLING | 18 | 7.80e-01 | 3.80e-02 | 9.55e-01 |
| GOCC LUMENAL SIDE OF MEMBRANE | 40 | 6.78e-01 | -3.79e-02 | 9.24e-01 |
| GOBP BRANCHING INVOLVED IN BLOOD VESSEL MORPHOGENESIS | 20 | 7.69e-01 | 3.79e-02 | 9.51e-01 |
| GOMF OXIDOREDUCTASE ACTIVITY ACTING ON PAIRED DONORS WITH OXIDATION OF A PAIR OF DONORS RESULTING IN THE REDUCTION OF MOLECULAR OXYGEN TO TWO MOLECULES OF WATER | 9 | 8.44e-01 | -3.79e-02 | 9.68e-01 |
| GOBP BICARBONATE TRANSPORT | 27 | 7.33e-01 | 3.79e-02 | 9.41e-01 |
| GOBP REGULATION OF LYMPHOCYTE DIFFERENTIATION | 191 | 3.67e-01 | -3.79e-02 | 8.04e-01 |
| GOMF FOUR WAY JUNCTION DNA BINDING | 18 | 7.81e-01 | 3.78e-02 | 9.56e-01 |
| GOMF PROTEIN MEMBRANE ADAPTOR ACTIVITY | 37 | 6.91e-01 | 3.78e-02 | 9.27e-01 |
| GOBP MAMMARY GLAND DEVELOPMENT | 97 | 5.20e-01 | 3.78e-02 | 8.74e-01 |
| GOBP POSITIVE REGULATION OF POTASSIUM ION TRANSPORT | 31 | 7.16e-01 | 3.78e-02 | 9.36e-01 |
| GOBP PROTEIN DESTABILIZATION | 48 | 6.51e-01 | -3.78e-02 | 9.17e-01 |
| GOBP REGULATION OF RETINOIC ACID RECEPTOR SIGNALING PATHWAY | 11 | 8.28e-01 | 3.78e-02 | 9.64e-01 |
| GOBP CELLULAR RESPONSE TO ALCOHOL | 84 | 5.50e-01 | -3.78e-02 | 8.84e-01 |
| GOMF SEQUENCE SPECIFIC SINGLE STRANDED DNA BINDING | 14 | 8.07e-01 | 3.77e-02 | 9.61e-01 |
| GOBP TRANSEPITHELIAL CHLORIDE TRANSPORT | 7 | 8.63e-01 | 3.77e-02 | 9.74e-01 |
| GOBP AXONAL FASCICULATION | 16 | 7.94e-01 | -3.77e-02 | 9.59e-01 |
| GOMF MONOATOMIC CATION TRANSMEMBRANE TRANSPORTER ACTIVITY | 459 | 1.67e-01 | -3.77e-02 | 6.32e-01 |
| GOBP EPITHELIAL TO MESENCHYMAL TRANSITION | 129 | 4.60e-01 | 3.77e-02 | 8.47e-01 |
| GOBP DETECTION OF MOLECULE OF BACTERIAL ORIGIN | 11 | 8.29e-01 | 3.76e-02 | 9.64e-01 |
| GOBP NEURON PROJECTION EXTENSION | 124 | 4.70e-01 | -3.76e-02 | 8.54e-01 |
| GOBP PROTEIN K29 LINKED UBIQUITINATION | 10 | 8.37e-01 | -3.76e-02 | 9.66e-01 |
| GOBP SYNAPTONEMAL COMPLEX ORGANIZATION | 19 | 7.77e-01 | -3.75e-02 | 9.54e-01 |
| GOMF RNA POLYMERASE ACTIVITY | 32 | 7.13e-01 | -3.75e-02 | 9.35e-01 |
| GOBP VITAMIN METABOLIC PROCESS | 90 | 5.39e-01 | -3.75e-02 | 8.79e-01 |
| GOBP LEUKOCYTE MEDIATED IMMUNITY | 406 | 1.95e-01 | 3.75e-02 | 6.68e-01 |
| GOBP POSITIVE REGULATION OF PEPTIDE SECRETION | 76 | 5.73e-01 | -3.74e-02 | 8.92e-01 |
| GOBP REGULATION OF LEUKOCYTE PROLIFERATION | 222 | 3.37e-01 | 3.74e-02 | 7.86e-01 |
| GOMF UBIQUITIN LIKE LIGASE SUBSTRATE ADAPTOR ACTIVITY | 55 | 6.32e-01 | 3.73e-02 | 9.12e-01 |
| GOBP ACTIN FILAMENT ORGANIZATION | 385 | 2.09e-01 | -3.73e-02 | 6.82e-01 |
| GOCC PROTON TRANSPORTING ATP SYNTHASE COMPLEX CATALYTIC CORE F 1 | 5 | 8.85e-01 | -3.73e-02 | 9.78e-01 |
| GOBP GPI ANCHOR METABOLIC PROCESS | 31 | 7.19e-01 | -3.73e-02 | 9.36e-01 |
| GOBP NEGATIVE REGULATION OF ACTION POTENTIAL | 6 | 8.74e-01 | 3.73e-02 | 9.76e-01 |
| GOBP PHOSPHATIDYLSERINE METABOLIC PROCESS | 19 | 7.78e-01 | -3.73e-02 | 9.54e-01 |
| GOBP PYRIMIDINE NUCLEOSIDE MONOPHOSPHATE CATABOLIC PROCESS | 6 | 8.74e-01 | -3.72e-02 | 9.76e-01 |
| GOBP POSITIVE REGULATION OF MICROTUBULE POLYMERIZATION OR DEPOLYMERIZATION | 32 | 7.16e-01 | -3.72e-02 | 9.36e-01 |
| GOBP CATECHOLAMINE TRANSPORT | 39 | 6.88e-01 | -3.72e-02 | 9.27e-01 |
| GOBP POSITIVE REGULATION OF CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY | 114 | 4.93e-01 | 3.72e-02 | 8.62e-01 |
| GOMF PROTEIN HORMONE RECEPTOR ACTIVITY | 15 | 8.03e-01 | 3.72e-02 | 9.61e-01 |
| GOBP POSITIVE REGULATION OF B CELL MEDIATED IMMUNITY | 40 | 6.84e-01 | 3.72e-02 | 9.25e-01 |
| GOMF CYCLIN DEPENDENT PROTEIN KINASE ACTIVITY | 26 | 7.43e-01 | -3.71e-02 | 9.42e-01 |
| GOMF PHOSPHOLIPASE ACTIVITY | 82 | 5.62e-01 | -3.71e-02 | 8.89e-01 |
| GOBP PROTEIN LOCALIZATION TO MEMBRANE RAFT | 8 | 8.56e-01 | -3.71e-02 | 9.71e-01 |
| GOBP PEPTIDYL LYSINE TRIMETHYLATION | 10 | 8.39e-01 | 3.71e-02 | 9.66e-01 |
| GOBP PROTEIN K27 LINKED UBIQUITINATION | 12 | 8.24e-01 | 3.71e-02 | 9.64e-01 |
| GOBP POSITIVE REGULATION OF LIPID TRANSPORT | 63 | 6.11e-01 | 3.70e-02 | 9.04e-01 |
| GOBP VESICLE MEDIATED TRANSPORT IN SYNAPSE | 176 | 3.97e-01 | 3.70e-02 | 8.21e-01 |
| GOBP REGULATION OF RNA POLYMERASE II TRANSCRIPTION PREINITIATION COMPLEX ASSEMBLY | 6 | 8.75e-01 | -3.70e-02 | 9.76e-01 |
| GOBP NEGATIVE REGULATION OF CELL DEVELOPMENT | 186 | 3.85e-01 | -3.69e-02 | 8.15e-01 |
| GOBP WOUND HEALING INVOLVED IN INFLAMMATORY RESPONSE | 7 | 8.66e-01 | 3.69e-02 | 9.74e-01 |
| GOBP ANATOMICAL STRUCTURE ARRANGEMENT | 12 | 8.25e-01 | 3.68e-02 | 9.64e-01 |
| GOMF IRON ION BINDING | 101 | 5.23e-01 | 3.68e-02 | 8.75e-01 |
| GOBP REGULATION OF MIRNA METABOLIC PROCESS | 74 | 5.84e-01 | 3.68e-02 | 8.93e-01 |
| GOBP REGULATION OF BIOMINERAL TISSUE DEVELOPMENT | 69 | 5.97e-01 | -3.68e-02 | 9.02e-01 |
| GOMF NUCLEAR STEROID RECEPTOR ACTIVITY | 18 | 7.87e-01 | -3.68e-02 | 9.57e-01 |
| GOBP GRANULOCYTE ACTIVATION | 45 | 6.70e-01 | -3.67e-02 | 9.22e-01 |
| GOBP CEREBELLAR PURKINJE CELL LAYER DEVELOPMENT | 22 | 7.66e-01 | 3.67e-02 | 9.49e-01 |
| GOBP FAT CELL DIFFERENTIATION | 176 | 4.02e-01 | -3.66e-02 | 8.23e-01 |
| GOBP CELLULAR RESPONSE TO UV | 82 | 5.66e-01 | -3.66e-02 | 8.90e-01 |
| GOBP PYRIMIDINE DIMER REPAIR | 9 | 8.49e-01 | -3.66e-02 | 9.68e-01 |
| GOBP REGULATION OF ALPHA BETA T CELL DIFFERENTIATION | 68 | 6.02e-01 | -3.66e-02 | 9.03e-01 |
| GOMF S100 PROTEIN BINDING | 12 | 8.26e-01 | -3.66e-02 | 9.64e-01 |
| GOCC SET1C COMPASS COMPLEX | 13 | 8.20e-01 | 3.65e-02 | 9.63e-01 |
| GOBP HEART DEVELOPMENT | 422 | 1.98e-01 | -3.65e-02 | 6.70e-01 |
| GOBP BLOOD VESSEL MATURATION | 7 | 8.67e-01 | 3.65e-02 | 9.74e-01 |
| GOMF GLYCOGEN BINDING | 6 | 8.77e-01 | -3.65e-02 | 9.76e-01 |
| GOBP ADENYLATE CYCLASE MODULATING G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY | 154 | 4.34e-01 | -3.65e-02 | 8.36e-01 |
| GOBP REGULATION OF CHEMOTAXIS | 154 | 4.34e-01 | 3.65e-02 | 8.36e-01 |
| GOBP PROTEIN MATURATION | 456 | 1.82e-01 | 3.65e-02 | 6.54e-01 |
| GOBP NEGATIVE REGULATION OF INTERLEUKIN 12 PRODUCTION | 18 | 7.89e-01 | 3.65e-02 | 9.58e-01 |
| GOBP REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE BY RENIN ANGIOTENSIN | 16 | 8.01e-01 | -3.64e-02 | 9.60e-01 |
| GOBP CALCIUM ION TRANSPORT | 314 | 2.67e-01 | -3.64e-02 | 7.33e-01 |
| GOBP LOCALIZATION WITHIN MEMBRANE | 593 | 1.30e-01 | 3.64e-02 | 5.94e-01 |
| GOBP GLYCOPROTEIN METABOLIC PROCESS | 314 | 2.68e-01 | 3.64e-02 | 7.33e-01 |
| GOBP MEMBRANE DEPOLARIZATION | 60 | 6.26e-01 | -3.64e-02 | 9.10e-01 |
| GOBP NEGATIVE REGULATION OF CARTILAGE DEVELOPMENT | 13 | 8.21e-01 | -3.63e-02 | 9.64e-01 |
| GOMF CHONDROITIN SULFATE BINDING | 6 | 8.78e-01 | 3.63e-02 | 9.77e-01 |
| GOBP REGULATION OF ADENYLATE CYCLASE ACTIVATING G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY | 16 | 8.01e-01 | 3.63e-02 | 9.60e-01 |
| GOBP NEGATIVE REGULATION OF DNA BINDING TRANSCRIPTION FACTOR ACTIVITY | 117 | 4.97e-01 | -3.63e-02 | 8.62e-01 |
| GOBP POSITIVE REGULATION OF PHOSPHORUS METABOLIC PROCESS | 527 | 1.55e-01 | 3.62e-02 | 6.17e-01 |
| GOCC PAR POLARITY COMPLEX | 6 | 8.78e-01 | -3.62e-02 | 9.77e-01 |
| GOBP POSITIVE REGULATION OF STEROID HORMONE SECRETION | 7 | 8.68e-01 | 3.62e-02 | 9.75e-01 |
| GOBP VENTRICULAR CARDIAC MUSCLE CELL ACTION POTENTIAL | 27 | 7.45e-01 | 3.62e-02 | 9.42e-01 |
| GOMF MAP KINASE ACTIVITY | 14 | 8.15e-01 | 3.62e-02 | 9.62e-01 |
| GOBP CELLULAR RESPONSE TO VASCULAR ENDOTHELIAL GROWTH FACTOR STIMULUS | 46 | 6.71e-01 | -3.61e-02 | 9.22e-01 |
| GOBP SODIUM ION TRANSPORT | 166 | 4.22e-01 | -3.61e-02 | 8.30e-01 |
| GOMF GLUCURONOSYL N ACETYLGALACTOSAMINYL PROTEOGLYCAN 4 BETA N ACETYLGALACTOSAMINYLTRANSFERASE ACTIVITY | 5 | 8.89e-01 | -3.61e-02 | 9.79e-01 |
| GOMF L AMINO ACID TRANSMEMBRANE TRANSPORTER ACTIVITY | 46 | 6.72e-01 | 3.61e-02 | 9.22e-01 |
| GOBP POSITIVE REGULATION OF CELL CELL ADHESION MEDIATED BY CADHERIN | 7 | 8.69e-01 | -3.61e-02 | 9.75e-01 |
| GOBP NEURON MIGRATION | 126 | 4.84e-01 | 3.61e-02 | 8.60e-01 |
| GOBP ANTRAL OVARIAN FOLLICLE GROWTH | 9 | 8.51e-01 | -3.60e-02 | 9.69e-01 |
| GOCC LARGE RIBOSOMAL SUBUNIT | 110 | 5.14e-01 | -3.60e-02 | 8.71e-01 |
| GOBP REGULATION OF ACTIN FILAMENT ORGANIZATION | 231 | 3.46e-01 | -3.60e-02 | 7.90e-01 |
| GOBP LYTIC VACUOLE ORGANIZATION | 99 | 5.37e-01 | 3.59e-02 | 8.79e-01 |
| GOBP POSITIVE REGULATION OF APOPTOTIC SIGNALING PATHWAY | 119 | 4.98e-01 | 3.59e-02 | 8.63e-01 |
| GOBP POSITIVE REGULATION OF WNT SIGNALING PATHWAY | 112 | 5.11e-01 | 3.59e-02 | 8.70e-01 |
| GOBP REGULATION OF KIDNEY DEVELOPMENT | 20 | 7.81e-01 | -3.59e-02 | 9.56e-01 |
| GOBP CELLULAR RESPONSE TO CHEMICAL STRESS | 275 | 3.06e-01 | 3.59e-02 | 7.61e-01 |
| GOBP POSITIVE REGULATION OF DNA METABOLIC PROCESS | 272 | 3.08e-01 | 3.59e-02 | 7.62e-01 |
| GOMF TELOMERIC DNA BINDING | 38 | 7.02e-01 | 3.58e-02 | 9.30e-01 |
| GOBP MOLTING CYCLE | 68 | 6.10e-01 | 3.58e-02 | 9.03e-01 |
| GOCC EXTRINSIC COMPONENT OF PLASMA MEMBRANE | 78 | 5.85e-01 | -3.58e-02 | 8.93e-01 |
| GOMF ANTIOXIDANT ACTIVITY | 69 | 6.08e-01 | 3.58e-02 | 9.03e-01 |
| GOBP POSITIVE REGULATION OF UBIQUITIN DEPENDENT PROTEIN CATABOLIC PROCESS | 96 | 5.45e-01 | -3.57e-02 | 8.83e-01 |
| GOBP REGULATION OF GRANULOCYTE CHEMOTAXIS | 41 | 6.92e-01 | 3.57e-02 | 9.27e-01 |
| GOBP SECRETION | 712 | 1.04e-01 | 3.57e-02 | 5.56e-01 |
| GOBP ATRIAL CARDIAC MUSCLE CELL TO AV NODE CELL COMMUNICATION | 12 | 8.30e-01 | -3.57e-02 | 9.64e-01 |
| GOBP MACROPHAGE MIGRATION | 46 | 6.75e-01 | -3.57e-02 | 9.24e-01 |
| GOBP GLUCAN BIOSYNTHETIC PROCESS | 34 | 7.19e-01 | -3.57e-02 | 9.36e-01 |
| GOBP NUCLEOSIDE MONOPHOSPHATE METABOLIC PROCESS | 69 | 6.09e-01 | 3.56e-02 | 9.03e-01 |
| GOCC INTRACILIARY TRANSPORT PARTICLE B | 15 | 8.11e-01 | 3.56e-02 | 9.62e-01 |
| GOBP MIGRACYTOSIS | 5 | 8.90e-01 | 3.56e-02 | 9.79e-01 |
| GOBP SMOOTH MUSCLE CELL MIGRATION | 59 | 6.36e-01 | -3.56e-02 | 9.14e-01 |
| GOBP BILE ACID SIGNALING PATHWAY | 5 | 8.90e-01 | -3.56e-02 | 9.79e-01 |
| GOBP NEGATIVE REGULATION OF REACTIVE OXYGEN SPECIES METABOLIC PROCESS | 35 | 7.16e-01 | 3.55e-02 | 9.36e-01 |
| GOBP NEGATIVE REGULATION OF ACTIN FILAMENT DEPOLYMERIZATION | 41 | 6.94e-01 | 3.55e-02 | 9.27e-01 |
| GOBP RESPONSE TO HYDROGEN PEROXIDE | 88 | 5.65e-01 | 3.55e-02 | 8.90e-01 |
| GOBP NEGATIVE REGULATION OF PROTEIN CONTAINING COMPLEX DISASSEMBLY | 71 | 6.05e-01 | 3.55e-02 | 9.03e-01 |
| GOBP NEUROTRANSMITTER TRANSPORT | 148 | 4.56e-01 | 3.55e-02 | 8.44e-01 |
| GOBP REGULATION OF PROTEOLYSIS INVOLVED IN PROTEIN CATABOLIC PROCESS | 209 | 3.77e-01 | 3.54e-02 | 8.10e-01 |
| GOBP GLUTAMINE FAMILY AMINO ACID METABOLIC PROCESS | 58 | 6.41e-01 | 3.54e-02 | 9.15e-01 |
| GOCC PHOTORECEPTOR DISC MEMBRANE | 11 | 8.39e-01 | -3.54e-02 | 9.66e-01 |
| GOBP NEGATIVE REGULATION OF COLD INDUCED THERMOGENESIS | 40 | 6.99e-01 | 3.54e-02 | 9.28e-01 |
| GOBP MYELOID CELL DIFFERENTIATION | 369 | 2.44e-01 | 3.54e-02 | 7.13e-01 |
| GOBP POSITIVE REGULATION OF STEM CELL POPULATION MAINTENANCE | 42 | 6.92e-01 | 3.54e-02 | 9.27e-01 |
| GOBP AORTIC VALVE MORPHOGENESIS | 23 | 7.69e-01 | -3.53e-02 | 9.51e-01 |
| GOBP CELLULAR RESPONSE TO INORGANIC SUBSTANCE | 165 | 4.35e-01 | 3.53e-02 | 8.36e-01 |
| GOBP POSITIVE REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE | 8 | 8.63e-01 | -3.53e-02 | 9.74e-01 |
| GOBP CARBOHYDRATE TRANSPORT | 108 | 5.27e-01 | -3.52e-02 | 8.76e-01 |
| GOBP POSITIVE REGULATION OF T CELL RECEPTOR SIGNALING PATHWAY | 19 | 7.91e-01 | -3.50e-02 | 9.59e-01 |
| GOBP PRIMARY MIRNA PROCESSING | 16 | 8.09e-01 | 3.49e-02 | 9.61e-01 |
| GOBP REGULATION OF INSULIN LIKE GROWTH FACTOR RECEPTOR SIGNALING PATHWAY | 13 | 8.27e-01 | -3.49e-02 | 9.64e-01 |
| GOMF STAT FAMILY PROTEIN BINDING | 10 | 8.48e-01 | -3.49e-02 | 9.68e-01 |
| GOCC COMPACT MYELIN | 12 | 8.34e-01 | 3.49e-02 | 9.65e-01 |
| GOCC PRESYNAPSE | 406 | 2.28e-01 | -3.49e-02 | 7.01e-01 |
| GOBP REGULATION OF CELLULAR RESPONSE TO INSULIN STIMULUS | 64 | 6.30e-01 | 3.48e-02 | 9.11e-01 |
| GOBP HYDROGEN PEROXIDE BIOSYNTHETIC PROCESS | 12 | 8.35e-01 | 3.48e-02 | 9.65e-01 |
| GOMF TRANSCRIPTION FACTOR BINDING | 514 | 1.77e-01 | -3.48e-02 | 6.48e-01 |
| GOBP POSITIVE REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY | 44 | 6.90e-01 | 3.48e-02 | 9.27e-01 |
| GOBP ACTIN MODIFICATION | 5 | 8.93e-01 | -3.48e-02 | 9.80e-01 |
| GOBP POSITIVE REGULATION OF ANTIGEN RECEPTOR MEDIATED SIGNALING PATHWAY | 27 | 7.55e-01 | 3.47e-02 | 9.45e-01 |
| GOBP LUNG SACCULE DEVELOPMENT | 5 | 8.93e-01 | 3.47e-02 | 9.80e-01 |
| GOCC T CELL RECEPTOR COMPLEX | 119 | 5.13e-01 | -3.47e-02 | 8.71e-01 |
| GOBP INTRINSIC APOPTOTIC SIGNALING PATHWAY IN RESPONSE TO OSMOTIC STRESS | 8 | 8.65e-01 | 3.46e-02 | 9.74e-01 |
| GOMF LONG CHAIN FATTY ACID COA LIGASE ACTIVITY | 13 | 8.29e-01 | 3.46e-02 | 9.64e-01 |
| GOBP SULFUR AMINO ACID BIOSYNTHETIC PROCESS | 13 | 8.29e-01 | -3.46e-02 | 9.64e-01 |
| GOBP GASTRO INTESTINAL SYSTEM SMOOTH MUSCLE CONTRACTION | 8 | 8.65e-01 | 3.46e-02 | 9.74e-01 |
| GOBP REGULATION OF NEURON MIGRATION | 32 | 7.35e-01 | 3.46e-02 | 9.42e-01 |
| GOBP LONG CHAIN FATTY ACID TRANSPORT | 47 | 6.82e-01 | -3.46e-02 | 9.24e-01 |
| GOBP RECOMBINATIONAL REPAIR | 182 | 4.22e-01 | 3.45e-02 | 8.30e-01 |
| GOBP REGULATION OF PHOSPHORYLATION | 764 | 1.04e-01 | 3.45e-02 | 5.56e-01 |
| GOBP NEGATIVE REGULATION OF WNT SIGNALING PATHWAY | 116 | 5.21e-01 | -3.45e-02 | 8.74e-01 |
| GOBP G PROTEIN COUPLED PURINERGIC NUCLEOTIDE RECEPTOR SIGNALING PATHWAY | 12 | 8.36e-01 | -3.45e-02 | 9.65e-01 |
| GOMF G PROTEIN COUPLED PURINERGIC NUCLEOTIDE RECEPTOR ACTIVITY | 12 | 8.36e-01 | -3.45e-02 | 9.65e-01 |
| GOBP IMPORT INTO THE MITOCHONDRION | 49 | 6.76e-01 | 3.45e-02 | 9.24e-01 |
| GOBP NEGATIVE REGULATION OF CELLULAR SENESCENCE | 20 | 7.89e-01 | 3.45e-02 | 9.58e-01 |
| GOCC GOLGI APPARATUS | 1384 | 3.17e-02 | 3.45e-02 | 3.74e-01 |
| GOBP POSITIVE REGULATION OF MYELINATION | 15 | 8.17e-01 | -3.45e-02 | 9.63e-01 |
| GOBP FATTY ACID DERIVATIVE METABOLIC PROCESS | 64 | 6.34e-01 | -3.44e-02 | 9.13e-01 |
| GOBP NEUROINFLAMMATORY RESPONSE | 64 | 6.34e-01 | 3.44e-02 | 9.13e-01 |
| GOMF DNA NUCLEASE ACTIVITY | 63 | 6.37e-01 | -3.44e-02 | 9.14e-01 |
| GOMF OXIDOREDUCTASE ACTIVITY ACTING ON THE CH NH GROUP OF DONORS | 24 | 7.71e-01 | -3.44e-02 | 9.51e-01 |
| GOBP NEGATIVE REGULATION OF OSSIFICATION | 27 | 7.57e-01 | -3.44e-02 | 9.46e-01 |
| GOBP NEGATIVE REGULATION OF RNA SPLICING | 25 | 7.66e-01 | 3.44e-02 | 9.49e-01 |
| GOBP REGULATION OF MITOCHONDRIAL ELECTRON TRANSPORT NADH TO UBIQUINONE | 5 | 8.94e-01 | -3.44e-02 | 9.81e-01 |
| GOBP REGULATION OF EPITHELIAL CELL PROLIFERATION | 256 | 3.45e-01 | -3.43e-02 | 7.89e-01 |
| GOBP REGULATION OF MOLECULAR FUNCTION | 1572 | 2.34e-02 | 3.43e-02 | 3.32e-01 |
| GOBP REGULATION OF LIPASE ACTIVITY | 46 | 6.87e-01 | -3.43e-02 | 9.27e-01 |
| GOBP TISSUE REMODELING | 123 | 5.12e-01 | -3.43e-02 | 8.70e-01 |
| GOBP EPITHELIAL TUBE MORPHOGENESIS | 233 | 3.68e-01 | -3.43e-02 | 8.04e-01 |
| GOBP DNA DEAMINATION | 13 | 8.31e-01 | -3.42e-02 | 9.64e-01 |
| GOCC CYTOPLASMIC REGION | 226 | 3.75e-01 | 3.42e-02 | 8.09e-01 |
| GOBP NEUROTRANSMITTER REUPTAKE | 21 | 7.86e-01 | -3.42e-02 | 9.57e-01 |
| GOBP GRANULOCYTE MIGRATION | 110 | 5.37e-01 | 3.41e-02 | 8.79e-01 |
| GOMF RIBOSOMAL PROTEIN S6 KINASE ACTIVITY | 7 | 8.76e-01 | 3.41e-02 | 9.76e-01 |
| GOBP DETECTION OF BIOTIC STIMULUS | 32 | 7.39e-01 | 3.41e-02 | 9.42e-01 |
| GOBP NEGATIVE REGULATION OF MIRNA PROCESSING | 7 | 8.76e-01 | -3.41e-02 | 9.76e-01 |
| GOBP ADULT BEHAVIOR | 95 | 5.66e-01 | -3.41e-02 | 8.90e-01 |
| GOBP RESPONSE TO OXIDATIVE STRESS | 344 | 2.78e-01 | 3.40e-02 | 7.40e-01 |
| GOBP POSITIVE REGULATION OF MRNA PROCESSING | 30 | 7.47e-01 | 3.40e-02 | 9.43e-01 |
| GOBP PURINE CONTAINING COMPOUND SALVAGE | 14 | 8.26e-01 | -3.40e-02 | 9.64e-01 |
| GOCC NEURON PROJECTION MEMBRANE | 36 | 7.24e-01 | -3.40e-02 | 9.38e-01 |
| GOBP CARDIAC CHAMBER DEVELOPMENT | 106 | 5.46e-01 | -3.40e-02 | 8.84e-01 |
| GOBP CELLULAR RESPONSE TO NUTRIENT LEVELS | 206 | 4.01e-01 | 3.40e-02 | 8.23e-01 |
| GOBP VESICLE COATING | 39 | 7.14e-01 | 3.40e-02 | 9.35e-01 |
| GOBP SPERMINE METABOLIC PROCESS | 5 | 8.96e-01 | 3.39e-02 | 9.81e-01 |
| GOBP MISMATCH REPAIR | 33 | 7.36e-01 | -3.39e-02 | 9.42e-01 |
| GOCC CLATHRIN COATED ENDOCYTIC VESICLE | 70 | 6.24e-01 | -3.39e-02 | 9.09e-01 |
| GOBP MAMMALIAN OOGENESIS STAGE | 9 | 8.60e-01 | 3.39e-02 | 9.72e-01 |
| GOBP NEGATIVE REGULATION OF VIRAL LIFE CYCLE | 20 | 7.93e-01 | 3.38e-02 | 9.59e-01 |
| GOBP REGULATION OF PROTEIN CONTAINING COMPLEX DISASSEMBLY | 111 | 5.38e-01 | 3.38e-02 | 8.79e-01 |
| GOMF CHLORIDE TRANSMEMBRANE TRANSPORTER ACTIVITY | 68 | 6.30e-01 | -3.38e-02 | 9.11e-01 |
| GOBP CERAMIDE METABOLIC PROCESS | 86 | 5.88e-01 | 3.38e-02 | 8.95e-01 |
| GOBP POSITIVE REGULATION OF RHO PROTEIN SIGNAL TRANSDUCTION | 30 | 7.49e-01 | 3.38e-02 | 9.44e-01 |
| GOBP NEGATIVE REGULATION OF LYMPHOCYTE MEDIATED IMMUNITY | 55 | 6.65e-01 | 3.38e-02 | 9.22e-01 |
| GOBP THYROID HORMONE METABOLIC PROCESS | 17 | 8.10e-01 | -3.38e-02 | 9.61e-01 |
| GOBP INTERMEDIATE FILAMENT ORGANIZATION | 24 | 7.75e-01 | 3.37e-02 | 9.54e-01 |
| GOCC CORE MEDIATOR COMPLEX | 26 | 7.66e-01 | 3.37e-02 | 9.49e-01 |
| GOCC CILIARY BASE | 36 | 7.26e-01 | -3.37e-02 | 9.39e-01 |
| GOBP ANTEROGRADE AXONAL TRANSPORT | 47 | 6.90e-01 | 3.37e-02 | 9.27e-01 |
| GOBP CARDIOCYTE DIFFERENTIATION | 98 | 5.65e-01 | 3.37e-02 | 8.90e-01 |
| GOMF VOLUME SENSITIVE ANION CHANNEL ACTIVITY | 8 | 8.69e-01 | -3.36e-02 | 9.75e-01 |
| GOBP POSITIVE REGULATION OF PROTEIN MODIFICATION PROCESS | 598 | 1.60e-01 | 3.36e-02 | 6.27e-01 |
| GOBP MITOCHONDRIAL TRANSPORT | 167 | 4.54e-01 | -3.36e-02 | 8.43e-01 |
| GOBP POSITIVE REGULATION OF T HELPER CELL DIFFERENTIATION | 22 | 7.85e-01 | 3.36e-02 | 9.57e-01 |
| GOBP EPIDERMAL CELL DIFFERENTIATION | 131 | 5.07e-01 | -3.36e-02 | 8.68e-01 |
| GOMF FAD BINDING | 36 | 7.28e-01 | 3.35e-02 | 9.39e-01 |
| GOBP NADH DEHYDROGENASE COMPLEX ASSEMBLY | 59 | 6.56e-01 | -3.35e-02 | 9.18e-01 |
| GOBP EMBRYONIC PROCESS INVOLVED IN FEMALE PREGNANCY | 6 | 8.87e-01 | 3.35e-02 | 9.78e-01 |
| GOBP MONOCARBOXYLIC ACID METABOLIC PROCESS | 493 | 2.03e-01 | -3.35e-02 | 6.77e-01 |
| GOBP POSITIVE REGULATION OF CELLULAR COMPONENT BIOGENESIS | 421 | 2.39e-01 | 3.35e-02 | 7.08e-01 |
| GOBP NEGATIVE REGULATION OF ACTIN FILAMENT POLYMERIZATION | 57 | 6.62e-01 | -3.34e-02 | 9.21e-01 |
| GOBP NEGATIVE REGULATION OF HORMONE SECRETION | 50 | 6.83e-01 | -3.34e-02 | 9.24e-01 |
| GOBP NEGATIVE REGULATION OF AXON EXTENSION | 25 | 7.73e-01 | -3.34e-02 | 9.53e-01 |
| GOBP METENCEPHALON DEVELOPMENT | 88 | 5.89e-01 | -3.34e-02 | 8.95e-01 |
| GOBP COLUMNAR CUBOIDAL EPITHELIAL CELL MATURATION | 10 | 8.55e-01 | -3.34e-02 | 9.71e-01 |
| GOBP AMYLOID PRECURSOR PROTEIN METABOLIC PROCESS | 68 | 6.34e-01 | 3.33e-02 | 9.14e-01 |
| GOBP REGULATION OF PEPTIDASE ACTIVITY | 231 | 3.83e-01 | 3.33e-02 | 8.15e-01 |
| GOBP PYRIDINE CONTAINING COMPOUND METABOLIC PROCESS | 150 | 4.81e-01 | -3.33e-02 | 8.59e-01 |
| GOBP NUCLEOPHAGY | 22 | 7.87e-01 | -3.33e-02 | 9.57e-01 |
| GOBP CONNECTIVE TISSUE DEVELOPMENT | 196 | 4.22e-01 | -3.33e-02 | 8.30e-01 |
| GOBP FOREBRAIN GENERATION OF NEURONS | 33 | 7.41e-01 | 3.33e-02 | 9.42e-01 |
| GOBP PYRIMIDINE CONTAINING COMPOUND CATABOLIC PROCESS | 39 | 7.19e-01 | 3.33e-02 | 9.36e-01 |
| GOMF METALLOAMINOPEPTIDASE ACTIVITY | 23 | 7.82e-01 | -3.33e-02 | 9.56e-01 |
| GOBP NEGATIVE REGULATION OF PROTEIN SECRETION | 54 | 6.72e-01 | 3.33e-02 | 9.23e-01 |
| GOBP REGULATION OF POSTSYNAPTIC MEMBRANE NEUROTRANSMITTER RECEPTOR LEVELS | 75 | 6.19e-01 | -3.32e-02 | 9.07e-01 |
| GOMF OXIDOREDUCTASE ACTIVITY ACTING ON METAL IONS | 12 | 8.42e-01 | -3.32e-02 | 9.67e-01 |
| GOBP HEART VALVE DEVELOPMENT | 49 | 6.88e-01 | 3.32e-02 | 9.27e-01 |
| GOBP REGULATION OF DENDRITE DEVELOPMENT | 79 | 6.10e-01 | -3.32e-02 | 9.03e-01 |
| GOCC DENSE CORE GRANULE | 18 | 8.08e-01 | 3.32e-02 | 9.61e-01 |
| GOBP REGULATION OF IMMUNE SYSTEM PROCESS | 1331 | 4.25e-02 | 3.32e-02 | 4.07e-01 |
| GOCC PAM COMPLEX TIM23 ASSOCIATED IMPORT MOTOR | 5 | 8.98e-01 | 3.32e-02 | 9.81e-01 |
| GOBP INTEGRIN MEDIATED SIGNALING PATHWAY | 96 | 5.75e-01 | -3.31e-02 | 8.92e-01 |
| GOMF EPHRIN RECEPTOR ACTIVITY | 12 | 8.42e-01 | 3.31e-02 | 9.67e-01 |
| GOMF MONOATOMIC ION TRANSMEMBRANE TRANSPORTER ACTIVITY | 532 | 1.91e-01 | -3.31e-02 | 6.63e-01 |
| GOBP POSITIVE REGULATION OF VASCULATURE DEVELOPMENT | 132 | 5.11e-01 | 3.31e-02 | 8.70e-01 |
| GOBP AROMATIC AMINO ACID TRANSPORT | 11 | 8.49e-01 | 3.31e-02 | 9.68e-01 |
| GOBP MYELOID LEUKOCYTE MIGRATION | 176 | 4.49e-01 | 3.31e-02 | 8.43e-01 |
| GOBP POSITIVE REGULATION OF RECEPTOR CATABOLIC PROCESS | 7 | 8.80e-01 | 3.31e-02 | 9.77e-01 |
| GOBP NITRIC OXIDE TRANSPORT | 5 | 8.98e-01 | 3.31e-02 | 9.81e-01 |
| GOBP CELL CHEMOTAXIS | 236 | 3.82e-01 | 3.30e-02 | 8.14e-01 |
| GOBP REGULATION OF CARDIOCYTE DIFFERENTIATION | 15 | 8.25e-01 | 3.30e-02 | 9.64e-01 |
| GOBP REGULATION OF HYDROLASE ACTIVITY | 567 | 1.80e-01 | 3.30e-02 | 6.52e-01 |
| GOBP ARTERY MORPHOGENESIS | 43 | 7.08e-01 | -3.30e-02 | 9.33e-01 |
| GOBP RESPONSE TO INTERLEUKIN 7 | 16 | 8.20e-01 | 3.29e-02 | 9.63e-01 |
| GOBP RESPONSE TO HEAT | 83 | 6.04e-01 | 3.29e-02 | 9.03e-01 |
| GOBP NEGATIVE REGULATION OF HEART RATE | 8 | 8.72e-01 | -3.29e-02 | 9.76e-01 |
| GOBP POSITIVE REGULATION OF CYTOSKELETON ORGANIZATION | 153 | 4.83e-01 | -3.29e-02 | 8.60e-01 |
| GOBP POSITIVE REGULATION OF DNA BINDING TRANSCRIPTION FACTOR ACTIVITY | 179 | 4.48e-01 | -3.29e-02 | 8.43e-01 |
| GOBP PYRIMIDINE RIBONUCLEOSIDE TRIPHOSPHATE METABOLIC PROCESS | 16 | 8.20e-01 | -3.29e-02 | 9.63e-01 |
| GOBP POSITIVE REGULATION OF MIRNA METABOLIC PROCESS | 55 | 6.73e-01 | -3.29e-02 | 9.23e-01 |
| GOBP FATTY ACID METABOLIC PROCESS | 314 | 3.17e-01 | -3.28e-02 | 7.68e-01 |
| GOBP POSITIVE REGULATION OF SODIUM ION TRANSPORT | 28 | 7.64e-01 | 3.28e-02 | 9.49e-01 |
| GOBP RESPONSE TO ATP | 27 | 7.68e-01 | 3.28e-02 | 9.50e-01 |
| GOBP P38MAPK CASCADE | 46 | 7.00e-01 | 3.28e-02 | 9.28e-01 |
| GOMF PEPTIDE HORMONE RECEPTOR BINDING | 7 | 8.81e-01 | 3.27e-02 | 9.77e-01 |
| GOBP TRANSMEMBRANE TRANSPORT | 1137 | 6.32e-02 | -3.27e-02 | 4.63e-01 |
| GOMF POLYSACCHARIDE BINDING | 20 | 8.00e-01 | 3.27e-02 | 9.60e-01 |
| GOBP LIPID STORAGE | 73 | 6.30e-01 | 3.26e-02 | 9.11e-01 |
| GOBP ACTOMYOSIN STRUCTURE ORGANIZATION | 164 | 4.71e-01 | -3.26e-02 | 8.54e-01 |
| GOCC ENDONUCLEASE COMPLEX | 40 | 7.21e-01 | 3.26e-02 | 9.37e-01 |
| GOBP FOREBRAIN NEURON DIFFERENTIATION | 26 | 7.74e-01 | 3.26e-02 | 9.54e-01 |
| GOBP NEUTRAL LIPID BIOSYNTHETIC PROCESS | 43 | 7.12e-01 | -3.26e-02 | 9.35e-01 |
| GOBP APOPTOTIC SIGNALING PATHWAY | 525 | 2.02e-01 | 3.25e-02 | 6.75e-01 |
| GOBP NEGATIVE REGULATION OF FIBROBLAST PROLIFERATION | 31 | 7.54e-01 | -3.25e-02 | 9.45e-01 |
| GOBP CELLULAR RESPONSE TO INTERLEUKIN 1 | 64 | 6.53e-01 | -3.25e-02 | 9.18e-01 |
| GOBP CANONICAL NF KAPPAB SIGNAL TRANSDUCTION | 277 | 3.52e-01 | 3.25e-02 | 7.94e-01 |
| GOBP NEGATIVE REGULATION OF MOLECULAR FUNCTION | 555 | 1.91e-01 | 3.25e-02 | 6.63e-01 |
| GOMF MOLECULAR SEQUESTERING ACTIVITY | 43 | 7.13e-01 | 3.25e-02 | 9.35e-01 |
| GOBP CELLULAR RESPONSE TO RETINOIC ACID | 42 | 7.16e-01 | 3.25e-02 | 9.36e-01 |
| GOBP T CELL CYTOKINE PRODUCTION | 35 | 7.40e-01 | 3.25e-02 | 9.42e-01 |
| GOBP PHOSPHATIDYLINOSITOL METABOLIC PROCESS | 148 | 4.96e-01 | 3.24e-02 | 8.62e-01 |
| GOCC NUCLEAR EXOSOME RNASE COMPLEX | 16 | 8.22e-01 | 3.24e-02 | 9.64e-01 |
| GOMF RRNA BINDING | 64 | 6.54e-01 | -3.24e-02 | 9.18e-01 |
| GOBP CIRCADIAN RHYTHM | 158 | 4.82e-01 | 3.24e-02 | 8.60e-01 |
| GOBP POSITIVE REGULATION OF NEUROBLAST PROLIFERATION | 20 | 8.02e-01 | 3.24e-02 | 9.61e-01 |
| GOMF PROTEIN SERINE THREONINE TYROSINE KINASE ACTIVITY | 39 | 7.27e-01 | 3.24e-02 | 9.39e-01 |
| GOMF LIPASE ACTIVITY | 100 | 5.76e-01 | -3.23e-02 | 8.92e-01 |
| GOBP MALATE METABOLIC PROCESS | 7 | 8.82e-01 | 3.23e-02 | 9.78e-01 |
| GOBP NEGATIVE REGULATION OF ENDOCYTOSIS | 58 | 6.71e-01 | -3.23e-02 | 9.22e-01 |
| GOBP REGULATION OF PHOSPHORUS METABOLIC PROCESS | 898 | 1.01e-01 | 3.23e-02 | 5.49e-01 |
| GOBP REGULATION OF PEPTIDYL TYROSINE PHOSPHORYLATION | 161 | 4.80e-01 | 3.23e-02 | 8.59e-01 |
| GOBP NEGATIVE REGULATION OF TORC1 SIGNALING | 46 | 7.05e-01 | 3.23e-02 | 9.32e-01 |
| GOBP MONOATOMIC ION TRANSPORT | 870 | 1.07e-01 | -3.22e-02 | 5.59e-01 |
| GOBP GENOMIC IMPRINTING | 14 | 8.35e-01 | 3.22e-02 | 9.65e-01 |
| GOBP PHAGOCYTOSIS | 208 | 4.23e-01 | 3.22e-02 | 8.30e-01 |
| GOBP CELLULAR RESPONSE TO EPINEPHRINE STIMULUS | 9 | 8.67e-01 | -3.22e-02 | 9.74e-01 |
| GOBP AMIDE METABOLIC PROCESS | 362 | 2.93e-01 | 3.22e-02 | 7.50e-01 |
| GOBP POSITIVE REGULATION OF LEUKOCYTE CELL CELL ADHESION | 240 | 3.91e-01 | -3.21e-02 | 8.18e-01 |
| GOBP REGULATION OF CELL ADHESION | 640 | 1.65e-01 | -3.21e-02 | 6.30e-01 |
| GOBP REGULATION OF MITOCHONDRIAL FUSION | 14 | 8.35e-01 | 3.21e-02 | 9.65e-01 |
| GOBP REGULATION OF PROTEIN LOCALIZATION TO LYSOSOME | 5 | 9.01e-01 | -3.21e-02 | 9.82e-01 |
| GOBP POSITIVE REGULATION OF B CELL RECEPTOR SIGNALING PATHWAY | 8 | 8.75e-01 | -3.21e-02 | 9.76e-01 |
| GOBP POSITIVE REGULATION OF POTASSIUM ION TRANSMEMBRANE TRANSPORT | 24 | 7.86e-01 | -3.20e-02 | 9.57e-01 |
| GOBP HEPATICOBILIARY SYSTEM DEVELOPMENT | 112 | 5.58e-01 | 3.20e-02 | 8.88e-01 |
| GOMF PEPTIDE LYSINE N ACETYLTRANSFERASE ACTIVITY | 44 | 7.14e-01 | 3.20e-02 | 9.35e-01 |
| GOBP CELLULAR RESPONSE TO HYDROGEN PEROXIDE | 62 | 6.63e-01 | -3.20e-02 | 9.21e-01 |
| GOCC PHAGOPHORE ASSEMBLY SITE MEMBRANE | 21 | 8.00e-01 | -3.20e-02 | 9.60e-01 |
| GOCC ENDOCYTIC VESICLE LUMEN | 19 | 8.10e-01 | 3.19e-02 | 9.61e-01 |
| GOBP REGULATION OF TRANSMEMBRANE TRANSPORT | 336 | 3.15e-01 | 3.19e-02 | 7.67e-01 |
| GOCC CELL SURFACE | 657 | 1.63e-01 | 3.19e-02 | 6.30e-01 |
| GOBP ADAPTIVE THERMOGENESIS | 136 | 5.21e-01 | -3.19e-02 | 8.74e-01 |
| GOBP N ACETYLNEURAMINATE METABOLIC PROCESS | 11 | 8.55e-01 | 3.19e-02 | 9.71e-01 |
| GOMF HIGH DENSITY LIPOPROTEIN PARTICLE BINDING | 8 | 8.76e-01 | -3.19e-02 | 9.76e-01 |
| GOCC SMALL NUCLEAR RIBONUCLEOPROTEIN COMPLEX | 76 | 6.32e-01 | 3.18e-02 | 9.12e-01 |
| GOCC CHITOSOME | 16 | 8.26e-01 | 3.18e-02 | 9.64e-01 |
| GOBP REGULATION OF CELL CELL ADHESION | 406 | 2.72e-01 | -3.18e-02 | 7.36e-01 |
| GOBP DENDRITE DEVELOPMENT | 190 | 4.51e-01 | 3.17e-02 | 8.43e-01 |
| GOMF AMINO ACID BINDING | 30 | 7.64e-01 | -3.17e-02 | 9.49e-01 |
| GOBP CELLULAR RESPONSE TO OXIDATIVE STRESS | 218 | 4.21e-01 | 3.17e-02 | 8.30e-01 |
| GOBP REGULATION OF MACROPHAGE MIGRATION | 37 | 7.39e-01 | -3.16e-02 | 9.42e-01 |
| GOMF TAU PROTEIN BINDING | 42 | 7.23e-01 | 3.16e-02 | 9.38e-01 |
| GOMF TRANSFERASE ACTIVITY TRANSFERRING PHOSPHORUS CONTAINING GROUPS | 803 | 1.28e-01 | 3.16e-02 | 5.93e-01 |
| GOBP RRNA METABOLIC PROCESS | 259 | 3.81e-01 | -3.16e-02 | 8.14e-01 |
| GOBP RESPONSE TO XENOBIOTIC STIMULUS | 301 | 3.46e-01 | 3.16e-02 | 7.90e-01 |
| GOBP REGULATION OF PROTEIN OLIGOMERIZATION | 5 | 9.03e-01 | -3.16e-02 | 9.83e-01 |
| GOBP POSITIVE REGULATION OF AUTOPHAGOSOME MATURATION | 7 | 8.85e-01 | 3.15e-02 | 9.78e-01 |
| GOCC KERATIN FILAMENT | 15 | 8.33e-01 | -3.15e-02 | 9.64e-01 |
| GOBP NEGATIVE REGULATION OF T CELL PROLIFERATION | 63 | 6.65e-01 | 3.15e-02 | 9.22e-01 |
| GOBP DICARBOXYLIC ACID TRANSPORT | 72 | 6.44e-01 | 3.15e-02 | 9.15e-01 |
| GOBP REGULATION OF HORMONE BIOSYNTHETIC PROCESS | 20 | 8.07e-01 | 3.15e-02 | 9.61e-01 |
| GOBP ACTIN POLYMERIZATION OR DEPOLYMERIZATION | 176 | 4.71e-01 | -3.15e-02 | 8.54e-01 |
| GOMF NUCLEOTIDASE ACTIVITY | 15 | 8.33e-01 | 3.15e-02 | 9.64e-01 |
| GOMF TYPE II TRANSFORMING GROWTH FACTOR BETA RECEPTOR BINDING | 11 | 8.57e-01 | 3.15e-02 | 9.71e-01 |
| GOCC MKS COMPLEX | 13 | 8.44e-01 | 3.15e-02 | 9.68e-01 |
| GOBP MONOATOMIC ANION HOMEOSTASIS | 14 | 8.39e-01 | 3.15e-02 | 9.66e-01 |
| GOBP REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY VIA DEATH DOMAIN RECEPTORS | 36 | 7.44e-01 | -3.14e-02 | 9.42e-01 |
| GOBP REGULATION OF GROWTH | 454 | 2.52e-01 | -3.14e-02 | 7.20e-01 |
| GOMF NUCLEASE ACTIVITY | 204 | 4.41e-01 | 3.13e-02 | 8.41e-01 |
| GOBP INTERLEUKIN 17A MEDIATED SIGNALING PATHWAY | 5 | 9.04e-01 | 3.13e-02 | 9.83e-01 |
| GOCC PRESYNAPTIC CYTOSKELETON | 7 | 8.86e-01 | 3.13e-02 | 9.78e-01 |
| GOBP REGULATION OF SYNAPTIC TRANSMISSION GLUTAMATERGIC | 46 | 7.14e-01 | 3.13e-02 | 9.35e-01 |
| GOBP NEGATIVE REGULATION OF ENDOPLASMIC RETICULUM CALCIUM ION CONCENTRATION | 6 | 8.94e-01 | 3.13e-02 | 9.81e-01 |
| GOBP RESPONSE TO MISFOLDED PROTEIN | 19 | 8.14e-01 | -3.13e-02 | 9.62e-01 |
| GOBP SUPRAMOLECULAR FIBER ORGANIZATION | 670 | 1.68e-01 | -3.12e-02 | 6.33e-01 |
| GOBP POSITIVE REGULATION OF MITOCHONDRIAL DEPOLARIZATION | 5 | 9.04e-01 | -3.12e-02 | 9.83e-01 |
| GOMF STEROID DEHYDROGENASE ACTIVITY | 28 | 7.75e-01 | 3.12e-02 | 9.54e-01 |
| GOMF ENDOPEPTIDASE ACTIVITY | 264 | 3.84e-01 | -3.11e-02 | 8.15e-01 |
| GOBP POSITIVE REGULATION OF TRANSPORT | 662 | 1.73e-01 | 3.11e-02 | 6.40e-01 |
| GOBP COLUMNAR CUBOIDAL EPITHELIAL CELL DEVELOPMENT | 34 | 7.54e-01 | -3.11e-02 | 9.45e-01 |
| GOBP DICARBOXYLIC ACID CATABOLIC PROCESS | 14 | 8.41e-01 | -3.10e-02 | 9.67e-01 |
| GOBP STRIATED MUSCLE CELL DEVELOPMENT | 48 | 7.10e-01 | 3.10e-02 | 9.34e-01 |
| GOMF HYDRO LYASE ACTIVITY | 50 | 7.05e-01 | -3.10e-02 | 9.31e-01 |
| GOBP DEVELOPMENTAL GROWTH INVOLVED IN MORPHOGENESIS | 171 | 4.85e-01 | -3.10e-02 | 8.60e-01 |
| GOMF METAL ION TRANSMEMBRANE TRANSPORTER ACTIVITY | 300 | 3.56e-01 | -3.10e-02 | 7.97e-01 |
| GOCC MITOCHONDRIAL ENVELOPE | 748 | 1.50e-01 | -3.09e-02 | 6.13e-01 |
| GOBP POSITIVE REGULATION OF TOR SIGNALING | 68 | 6.59e-01 | -3.09e-02 | 9.19e-01 |
| GOBP REGULATION OF GLUCOCORTICOID METABOLIC PROCESS | 8 | 8.80e-01 | 3.09e-02 | 9.77e-01 |
| GOBP POSITIVE REGULATION OF SYNAPTIC TRANSMISSION | 108 | 5.79e-01 | -3.09e-02 | 8.92e-01 |
| GOCC TRANS GOLGI NETWORK MEMBRANE | 99 | 5.95e-01 | 3.09e-02 | 9.01e-01 |
| GOBP LIPID MODIFICATION | 163 | 4.96e-01 | -3.09e-02 | 8.62e-01 |
| GOBP POSITIVE REGULATION OF HEART GROWTH | 22 | 8.02e-01 | 3.09e-02 | 9.61e-01 |
| GOBP BODY MORPHOGENESIS | 39 | 7.39e-01 | -3.08e-02 | 9.42e-01 |
| GOBP REGULATION OF P38MAPK CASCADE | 34 | 7.56e-01 | -3.07e-02 | 9.46e-01 |
| GOBP RESPONSE TO MUSCLE ACTIVITY | 20 | 8.12e-01 | -3.07e-02 | 9.62e-01 |
| GOBP CAMP METABOLIC PROCESS | 17 | 8.26e-01 | 3.07e-02 | 9.64e-01 |
| GOBP EXPORT FROM CELL | 681 | 1.72e-01 | 3.07e-02 | 6.40e-01 |
| GOMF COMPLEMENT RECEPTOR ACTIVITY | 9 | 8.73e-01 | 3.07e-02 | 9.76e-01 |
| GOMF DENEDDYLASE ACTIVITY | 6 | 8.96e-01 | 3.07e-02 | 9.81e-01 |
| GOCC SYNAPSE | 1085 | 8.85e-02 | -3.06e-02 | 5.20e-01 |
| GOBP POSITIVE REGULATION OF GTPASE ACTIVITY | 171 | 4.89e-01 | -3.06e-02 | 8.61e-01 |
| GOBP POSITIVE REGULATION OF NERVOUS SYSTEM PROCESS | 22 | 8.04e-01 | -3.06e-02 | 9.61e-01 |
| GOBP REGULATION OF GLYCOPROTEIN METABOLIC PROCESS | 40 | 7.38e-01 | 3.06e-02 | 9.42e-01 |
| GOBP REGULATION OF KERATINOCYTE DIFFERENTIATION | 26 | 7.87e-01 | 3.06e-02 | 9.57e-01 |
| GOBP VASCULAR PROCESS IN CIRCULATORY SYSTEM | 189 | 4.69e-01 | 3.06e-02 | 8.53e-01 |
| GOBP ENERGY HOMEOSTASIS | 58 | 6.87e-01 | 3.06e-02 | 9.27e-01 |
| GOMF CARBOHYDRATE MONOATOMIC CATION SYMPORTER ACTIVITY | 13 | 8.49e-01 | -3.05e-02 | 9.68e-01 |
| GOBP GLUTAMINE FAMILY AMINO ACID BIOSYNTHETIC PROCESS | 14 | 8.43e-01 | 3.05e-02 | 9.68e-01 |
| GOBP NEGATIVE REGULATION OF CYTOSKELETON ORGANIZATION | 136 | 5.39e-01 | -3.05e-02 | 8.80e-01 |
| GOBP HEAD DEVELOPMENT | 557 | 2.19e-01 | 3.05e-02 | 6.93e-01 |
| GOBP SEMI LUNAR VALVE DEVELOPMENT | 29 | 7.76e-01 | 3.05e-02 | 9.54e-01 |
| GOBP REGULATION OF VASCULOGENESIS | 10 | 8.67e-01 | -3.05e-02 | 9.74e-01 |
| GOBP MONOATOMIC CATION TRANSPORT | 738 | 1.59e-01 | -3.05e-02 | 6.25e-01 |
| GOBP HORMONE MEDIATED SIGNALING PATHWAY | 145 | 5.27e-01 | 3.05e-02 | 8.76e-01 |
| GOBP CELLULAR CATABOLIC PROCESS | 984 | 1.06e-01 | 3.05e-02 | 5.59e-01 |
| GOBP AMINO ACID ACTIVATION | 45 | 7.24e-01 | 3.04e-02 | 9.38e-01 |
| GOBP REGULATION OF RESTING MEMBRANE POTENTIAL | 6 | 8.97e-01 | 3.04e-02 | 9.81e-01 |
| GOMF PEPTIDE BINDING | 212 | 4.45e-01 | 3.04e-02 | 8.41e-01 |
| GOBP TORC2 SIGNALING | 13 | 8.50e-01 | -3.04e-02 | 9.68e-01 |
| GOBP RETINA MORPHOGENESIS IN CAMERA TYPE EYE | 39 | 7.43e-01 | -3.04e-02 | 9.42e-01 |
| GOCC NEURON SPINE | 130 | 5.50e-01 | -3.04e-02 | 8.84e-01 |
| GOBP AROMATIC AMINO ACID METABOLIC PROCESS | 24 | 7.97e-01 | -3.03e-02 | 9.59e-01 |
| GOBP REELIN MEDIATED SIGNALING PATHWAY | 8 | 8.82e-01 | -3.03e-02 | 9.78e-01 |
| GOBP REGULATION OF MICROGLIAL CELL ACTIVATION | 14 | 8.44e-01 | 3.03e-02 | 9.68e-01 |
| GOBP PROTEIN O LINKED GLYCOSYLATION | 86 | 6.27e-01 | 3.03e-02 | 9.11e-01 |
| GOBP LYMPHOCYTE ACTIVATION | 699 | 1.73e-01 | 3.02e-02 | 6.40e-01 |
| GOBP MUSCLE CELL DIFFERENTIATION | 298 | 3.69e-01 | -3.02e-02 | 8.06e-01 |
| GOBP POSITIVE REGULATION OF RESPONSE TO TYPE II INTERFERON | 6 | 8.98e-01 | -3.02e-02 | 9.81e-01 |
| GOMF ELECTRON TRANSFER ACTIVITY | 111 | 5.83e-01 | -3.02e-02 | 8.93e-01 |
| GOBP POSITIVE REGULATION OF T CELL DIFFERENTIATION IN THYMUS | 8 | 8.83e-01 | 3.02e-02 | 9.78e-01 |
| GOBP ESTABLISHMENT OF TISSUE POLARITY | 27 | 7.86e-01 | -3.02e-02 | 9.57e-01 |
| GOBP MONOATOMIC ANION TRANSPORT | 114 | 5.78e-01 | 3.01e-02 | 8.92e-01 |
| GOMF MOLECULAR TRANSDUCER ACTIVITY | 792 | 1.50e-01 | 3.01e-02 | 6.13e-01 |
| GOBP FATTY ACID BIOSYNTHETIC PROCESS | 126 | 5.60e-01 | -3.01e-02 | 8.88e-01 |
| GOBP PROTEIN K11 LINKED DEUBIQUITINATION | 9 | 8.76e-01 | 3.01e-02 | 9.76e-01 |
| GOBP NEURON PROJECTION EXTENSION INVOLVED IN NEURON PROJECTION GUIDANCE | 14 | 8.46e-01 | 3.01e-02 | 9.68e-01 |
| GOBP INFLAMMATORY RESPONSE | 658 | 1.89e-01 | 3.01e-02 | 6.62e-01 |
| GOBP REGULATION OF STEROID BIOSYNTHETIC PROCESS | 52 | 7.08e-01 | 3.00e-02 | 9.33e-01 |
| GOBP POSITIVE REGULATION OF EPITHELIAL CELL APOPTOTIC PROCESS | 30 | 7.76e-01 | -3.00e-02 | 9.54e-01 |
| GOCC CLATHRIN COATED VESICLE | 181 | 4.87e-01 | 3.00e-02 | 8.60e-01 |
| GOBP POSTSYNAPSE ORGANIZATION | 149 | 5.28e-01 | 3.00e-02 | 8.76e-01 |
| GOBP PROTEIN TARGETING TO PEROXISOME | 9 | 8.76e-01 | 3.00e-02 | 9.76e-01 |
| GOMF MICROTUBULE MOTOR ACTIVITY | 60 | 6.88e-01 | 2.99e-02 | 9.27e-01 |
| GOBP EMBRYO IMPLANTATION | 42 | 7.37e-01 | 2.99e-02 | 9.42e-01 |
| GOBP NEGATIVE REGULATION OF T CELL RECEPTOR SIGNALING PATHWAY | 25 | 7.96e-01 | 2.99e-02 | 9.59e-01 |
| GOBP REGULATION OF NMDA RECEPTOR ACTIVITY | 10 | 8.70e-01 | 2.99e-02 | 9.75e-01 |
| GOBP REGULATION OF NITRIC OXIDE METABOLIC PROCESS | 52 | 7.09e-01 | -2.99e-02 | 9.33e-01 |
| GOMF EXOPEPTIDASE ACTIVITY | 78 | 6.48e-01 | 2.99e-02 | 9.17e-01 |
| GOBP LIPID LOCALIZATION | 353 | 3.35e-01 | -2.99e-02 | 7.84e-01 |
| GOBP EPIDERMIS DEVELOPMENT | 214 | 4.52e-01 | -2.98e-02 | 8.43e-01 |
| GOBP ENDOCRINE SYSTEM DEVELOPMENT | 72 | 6.62e-01 | 2.98e-02 | 9.21e-01 |
| GOBP MUSCLE ORGAN MORPHOGENESIS | 42 | 7.39e-01 | -2.97e-02 | 9.42e-01 |
| GOBP ANIMAL ORGAN MORPHOGENESIS | 651 | 1.96e-01 | -2.97e-02 | 6.68e-01 |
| GOBP TELOMERE CAPPING | 37 | 7.55e-01 | 2.97e-02 | 9.45e-01 |
| GOBP HEART VALVE MORPHOGENESIS | 40 | 7.45e-01 | -2.97e-02 | 9.43e-01 |
| GOBP EMBRYONIC MORPHOGENESIS | 413 | 3.01e-01 | -2.97e-02 | 7.57e-01 |
| GOBP RETICULOPHAGY | 20 | 8.18e-01 | 2.96e-02 | 9.63e-01 |
| GOBP REGULATION OF DNA BINDING TRANSCRIPTION FACTOR ACTIVITY | 290 | 3.86e-01 | -2.96e-02 | 8.16e-01 |
| GOBP REGULATION OF LEUKOCYTE DIFFERENTIATION | 275 | 3.99e-01 | -2.96e-02 | 8.22e-01 |
| GOBP CELLULAR RESPIRATION | 224 | 4.46e-01 | 2.96e-02 | 8.41e-01 |
| GOCC JUXTAPARANODE REGION OF AXON | 9 | 8.78e-01 | -2.95e-02 | 9.77e-01 |
| GOBP ACTIN FILAMENT BASED MOVEMENT | 101 | 6.08e-01 | 2.95e-02 | 9.03e-01 |
| GOCC DNA POLYMERASE COMPLEX | 20 | 8.19e-01 | -2.95e-02 | 9.63e-01 |
| GOMF POTASSIUM ION LEAK CHANNEL ACTIVITY | 8 | 8.85e-01 | -2.95e-02 | 9.78e-01 |
| GOBP LIPOPHAGY | 7 | 8.92e-01 | 2.95e-02 | 9.80e-01 |
| GOBP POSITIVE REGULATION OF NERVOUS SYSTEM DEVELOPMENT | 212 | 4.59e-01 | -2.95e-02 | 8.47e-01 |
| GOBP NEGATIVE REGULATION OF POST TRANSLATIONAL PROTEIN MODIFICATION | 83 | 6.42e-01 | 2.95e-02 | 9.15e-01 |
| GOBP REGULATION OF MEMBRANE REPOLARIZATION | 25 | 7.99e-01 | -2.95e-02 | 9.60e-01 |
| GOMF PROTEIN SERINE KINASE ACTIVITY | 329 | 3.59e-01 | 2.95e-02 | 7.99e-01 |
| GOBP CELLULAR RESPONSE TO KETONE | 82 | 6.45e-01 | 2.94e-02 | 9.15e-01 |
| GOCC CLUSTER OF ACTIN BASED CELL PROJECTIONS | 125 | 5.70e-01 | -2.94e-02 | 8.90e-01 |
| GOMF BUBBLE DNA BINDING | 7 | 8.93e-01 | -2.94e-02 | 9.80e-01 |
| GOBP POSITIVE REGULATION OF INTRACELLULAR SIGNAL TRANSDUCTION | 830 | 1.51e-01 | 2.94e-02 | 6.13e-01 |
| GOBP REGULATION OF WNT SIGNALING PATHWAY | 246 | 4.29e-01 | 2.93e-02 | 8.34e-01 |
| GOBP MEMBRANE ORGANIZATION | 694 | 1.88e-01 | 2.93e-02 | 6.62e-01 |
| GOBP STEROID METABOLIC PROCESS | 226 | 4.48e-01 | -2.93e-02 | 8.43e-01 |
| GOMF MOLECULAR FUNCTION ACTIVATOR ACTIVITY | 815 | 1.56e-01 | -2.93e-02 | 6.20e-01 |
| GOBP POTASSIUM ION IMPORT ACROSS PLASMA MEMBRANE | 26 | 7.96e-01 | 2.92e-02 | 9.59e-01 |
| GOBP POSTSYNAPTIC SIGNAL TRANSDUCTION | 30 | 7.82e-01 | 2.92e-02 | 9.56e-01 |
| GOBP CELLULAR RESPONSE TO REACTIVE NITROGEN SPECIES | 14 | 8.50e-01 | 2.92e-02 | 9.68e-01 |
| GOBP TANGENTIAL MIGRATION FROM THE SUBVENTRICULAR ZONE TO THE OLFACTORY BULB | 6 | 9.01e-01 | -2.92e-02 | 9.82e-01 |
| GOBP GLOMERULAR EPITHELIUM DEVELOPMENT | 20 | 8.21e-01 | -2.92e-02 | 9.64e-01 |
| GOBP RESPONSE TO MACROPHAGE COLONY STIMULATING FACTOR | 14 | 8.50e-01 | 2.92e-02 | 9.69e-01 |
| GOBP REGULATION OF STEROID HORMONE BIOSYNTHETIC PROCESS | 12 | 8.61e-01 | 2.91e-02 | 9.73e-01 |
| GOBP POSITIVE REGULATION OF AUTOPHAGY | 145 | 5.45e-01 | 2.91e-02 | 8.83e-01 |
| GOMF MITOCHONDRIAL RIBOSOME BINDING | 8 | 8.87e-01 | -2.91e-02 | 9.78e-01 |
| GOBP INTRACILIARY ANTEROGRADE TRANSPORT | 16 | 8.40e-01 | 2.91e-02 | 9.67e-01 |
| GOBP REGULATION OF DENDRITE MORPHOGENESIS | 52 | 7.17e-01 | 2.91e-02 | 9.36e-01 |
| GOBP POSITIVE REGULATION OF REGULATED SECRETORY PATHWAY | 36 | 7.63e-01 | -2.91e-02 | 9.48e-01 |
| GOBP SKIN DEVELOPMENT | 179 | 5.02e-01 | 2.91e-02 | 8.66e-01 |
| GOBP REGULATION OF MODIFICATION OF POSTSYNAPTIC STRUCTURE | 9 | 8.80e-01 | 2.91e-02 | 9.77e-01 |
| GOBP SEROTONIN UPTAKE | 10 | 8.74e-01 | -2.91e-02 | 9.76e-01 |
| GOCC WEIBEL PALADE BODY | 5 | 9.10e-01 | 2.90e-02 | 9.83e-01 |
| GOBP REGULATION OF PROTEOLYSIS | 497 | 2.68e-01 | 2.90e-02 | 7.33e-01 |
| GOBP RETINOIC ACID METABOLIC PROCESS | 12 | 8.62e-01 | 2.90e-02 | 9.73e-01 |
| GOBP DEOXYRIBONUCLEOSIDE MONOPHOSPHATE CATABOLIC PROCESS | 11 | 8.68e-01 | -2.90e-02 | 9.74e-01 |
| GOBP INTRINSIC APOPTOTIC SIGNALING PATHWAY BY P53 CLASS MEDIATOR | 76 | 6.63e-01 | 2.89e-02 | 9.21e-01 |
| GOBP RIBOSE PHOSPHATE BIOSYNTHETIC PROCESS | 210 | 4.71e-01 | -2.88e-02 | 8.54e-01 |
| GOBP RESPONSE TO ISOQUINOLINE ALKALOID | 7 | 8.95e-01 | -2.87e-02 | 9.81e-01 |
| GOBP NEGATIVE REGULATION OF ANTIGEN PROCESSING AND PRESENTATION | 9 | 8.81e-01 | 2.87e-02 | 9.78e-01 |
| GOBP COMPLEMENT ACTIVATION CLASSICAL PATHWAY | 33 | 7.75e-01 | 2.87e-02 | 9.54e-01 |
| GOCC FICOLIN 1 RICH GRANULE MEMBRANE | 57 | 7.08e-01 | 2.87e-02 | 9.33e-01 |
| GOCC RIBBON SYNAPSE | 11 | 8.69e-01 | -2.87e-02 | 9.75e-01 |
| GOBP BLOOD VESSEL ENDOTHELIAL CELL DIFFERENTIATION | 7 | 8.96e-01 | 2.86e-02 | 9.81e-01 |
| GOBP REGULATION OF PROTEIN STABILITY | 293 | 4.00e-01 | 2.86e-02 | 8.23e-01 |
| GOBP POSITIVE REGULATION OF DOUBLE STRAND BREAK REPAIR VIA HOMOLOGOUS RECOMBINATION | 41 | 7.52e-01 | -2.85e-02 | 9.45e-01 |
| GOBP PROTEOGLYCAN BIOSYNTHETIC PROCESS | 50 | 7.27e-01 | -2.85e-02 | 9.39e-01 |
| GOBP NEGATIVE REGULATION OF CATABOLIC PROCESS | 302 | 3.94e-01 | 2.85e-02 | 8.20e-01 |
| GOBP CELLULAR RESPONSE TO ORGANIC CYCLIC COMPOUND | 415 | 3.19e-01 | 2.85e-02 | 7.70e-01 |
| GOBP POSITIVE REGULATION OF LEUKOCYTE MIGRATION | 116 | 5.96e-01 | 2.85e-02 | 9.01e-01 |
| GOBP HOMOLOGOUS CHROMOSOME PAIRING AT MEIOSIS | 34 | 7.74e-01 | 2.84e-02 | 9.54e-01 |
| GOBP POSTSYNAPTIC MEMBRANE ORGANIZATION | 28 | 7.95e-01 | -2.84e-02 | 9.59e-01 |
| GOMF ISOCITRATE DEHYDROGENASE NAD P PLUS ACTIVITY | 5 | 9.13e-01 | 2.84e-02 | 9.83e-01 |
| GOMF DEAMINASE ACTIVITY | 29 | 7.92e-01 | 2.83e-02 | 9.59e-01 |
| GOBP POSITIVE REGULATION OF BLOOD PRESSURE | 16 | 8.45e-01 | 2.83e-02 | 9.68e-01 |
| GOBP NEGATIVE REGULATION OF EPITHELIAL CELL DIFFERENTIATION | 27 | 7.99e-01 | 2.83e-02 | 9.60e-01 |
| GOBP CORTICAL CYTOSKELETON ORGANIZATION | 49 | 7.32e-01 | -2.83e-02 | 9.41e-01 |
| GOBP REGULATION OF MYOBLAST PROLIFERATION | 9 | 8.83e-01 | -2.83e-02 | 9.78e-01 |
| GOMF PHOSPHATIDYLSERINE BINDING | 53 | 7.22e-01 | 2.83e-02 | 9.38e-01 |
| GOBP ENDOTHELIAL CELL PROLIFERATION | 117 | 5.98e-01 | -2.82e-02 | 9.02e-01 |
| GOBP PHOSPHATIDYLSERINE ACYL CHAIN REMODELING | 7 | 8.97e-01 | 2.82e-02 | 9.81e-01 |
| GOBP MITOCHONDRIAL TRNA PROCESSING | 14 | 8.55e-01 | 2.82e-02 | 9.71e-01 |
| GOBP REGULATION OF CARDIAC MUSCLE ADAPTATION | 9 | 8.84e-01 | -2.82e-02 | 9.78e-01 |
| GOBP NEGATIVE REGULATION BY HOST OF VIRAL PROCESS | 13 | 8.61e-01 | -2.81e-02 | 9.72e-01 |
| GOBP REGULATION OF EPITHELIAL CELL DIFFERENTIATION | 106 | 6.17e-01 | -2.81e-02 | 9.06e-01 |
| GOBP RIBONUCLEOSIDE MONOPHOSPHATE METABOLIC PROCESS | 55 | 7.18e-01 | 2.81e-02 | 9.36e-01 |
| GOBP CARDIAC MUSCLE TISSUE MORPHOGENESIS | 33 | 7.80e-01 | -2.81e-02 | 9.55e-01 |
| GOCC ESCRT I COMPLEX | 10 | 8.78e-01 | 2.80e-02 | 9.77e-01 |
| GOMF BETA 1 3 GALACTOSYLTRANSFERASE ACTIVITY | 11 | 8.72e-01 | 2.80e-02 | 9.76e-01 |
| GOBP POSITIVE REGULATION OF TRANSCRIPTION BY RNA POLYMERASE I | 32 | 7.84e-01 | -2.80e-02 | 9.57e-01 |
| GOBP POSITIVE REGULATION OF SODIUM ION TRANSMEMBRANE TRANSPORTER ACTIVITY | 14 | 8.56e-01 | 2.80e-02 | 9.71e-01 |
| GOBP RESPONSE TO ESTRADIOL | 83 | 6.60e-01 | -2.79e-02 | 9.20e-01 |
| GOBP POSITIVE REGULATION OF CATECHOLAMINE SECRETION | 7 | 8.98e-01 | -2.79e-02 | 9.81e-01 |
| GOBP LIVER REGENERATION | 25 | 8.09e-01 | 2.79e-02 | 9.61e-01 |
| GOCC MOTILE CILIUM | 181 | 5.17e-01 | -2.79e-02 | 8.72e-01 |
| GOBP POSITIVE REGULATION OF AMINE METABOLIC PROCESS | 6 | 9.06e-01 | 2.79e-02 | 9.83e-01 |
| GOBP GROOMING BEHAVIOR | 9 | 8.85e-01 | -2.78e-02 | 9.78e-01 |
| GOBP REGULATION OF CANONICAL WNT SIGNALING PATHWAY | 189 | 5.10e-01 | 2.78e-02 | 8.69e-01 |
| GOBP RESPONSE TO LIGHT STIMULUS | 262 | 4.38e-01 | -2.78e-02 | 8.39e-01 |
| GOBP REGULATION OF TRIGLYCERIDE METABOLIC PROCESS | 31 | 7.89e-01 | -2.78e-02 | 9.58e-01 |
| GOBP REGULATION OF DEVELOPMENTAL GROWTH | 222 | 4.76e-01 | -2.77e-02 | 8.57e-01 |
| GOBP CARDIAC SEPTUM MORPHOGENESIS | 46 | 7.45e-01 | 2.77e-02 | 9.42e-01 |
| GOBP REGULATION OF PROTEIN CATABOLIC PROCESS | 324 | 3.91e-01 | 2.77e-02 | 8.18e-01 |
| GOBP MUSCLE CELL PROLIFERATION | 159 | 5.47e-01 | 2.77e-02 | 8.84e-01 |
| GOBP POSITIVE REGULATION OF ESTABLISHMENT OF PROTEIN LOCALIZATION | 277 | 4.28e-01 | 2.77e-02 | 8.34e-01 |
| GOBP REGULATION OF MEGAKARYOCYTE DIFFERENTIATION | 27 | 8.04e-01 | 2.76e-02 | 9.61e-01 |
| GOBP REACTIVE OXYGEN SPECIES METABOLIC PROCESS | 192 | 5.10e-01 | 2.76e-02 | 8.69e-01 |
| GOBP ORGANIC CYCLIC COMPOUND CATABOLIC PROCESS | 543 | 2.72e-01 | 2.75e-02 | 7.36e-01 |
| GOBP BRUSH BORDER ASSEMBLY | 5 | 9.15e-01 | 2.75e-02 | 9.84e-01 |
| GOBP ISOCITRATE METABOLIC PROCESS | 6 | 9.07e-01 | -2.75e-02 | 9.83e-01 |
| GOBP POSITIVE REGULATION OF MAPK CASCADE | 334 | 3.88e-01 | -2.75e-02 | 8.17e-01 |
| GOMF PROTEIN SEQUESTERING ACTIVITY | 27 | 8.05e-01 | 2.75e-02 | 9.61e-01 |
| GOCC RNA POLYMERASE II TRANSCRIPTION REGULATOR COMPLEX | 217 | 4.86e-01 | 2.75e-02 | 8.60e-01 |
| GOBP LIPID DIGESTION | 12 | 8.69e-01 | 2.75e-02 | 9.75e-01 |
| GOBP MATURE B CELL DIFFERENTIATION INVOLVED IN IMMUNE RESPONSE | 25 | 8.12e-01 | 2.75e-02 | 9.62e-01 |
| GOMF NEUROTROPHIN BINDING | 7 | 9.00e-01 | -2.74e-02 | 9.82e-01 |
| GOBP POSITIVE REGULATION OF PROTEIN TARGETING TO MEMBRANE | 26 | 8.09e-01 | -2.74e-02 | 9.61e-01 |
| GOCC NUCLEAR PERIPHERY | 141 | 5.74e-01 | 2.74e-02 | 8.92e-01 |
| GOBP REGULATION OF CELL GROWTH INVOLVED IN CARDIAC MUSCLE CELL DEVELOPMENT | 12 | 8.70e-01 | -2.74e-02 | 9.75e-01 |
| GOBP SERINE FAMILY AMINO ACID BIOSYNTHETIC PROCESS | 13 | 8.64e-01 | -2.74e-02 | 9.74e-01 |
| GOBP RNA GUANINE N7 METHYLATION | 6 | 9.08e-01 | -2.73e-02 | 9.83e-01 |
| GOBP NEURAL RETINA DEVELOPMENT | 45 | 7.51e-01 | -2.73e-02 | 9.45e-01 |
| GOBP RESPONSE TO ETHANOL | 84 | 6.66e-01 | -2.73e-02 | 9.22e-01 |
| GOBP CARDIAC CHAMBER MORPHOGENESIS | 74 | 6.86e-01 | -2.72e-02 | 9.25e-01 |
| GOBP LYSINE METABOLIC PROCESS | 6 | 9.08e-01 | -2.72e-02 | 9.83e-01 |
| GOCC PLASMA MEMBRANE REGION | 879 | 1.72e-01 | -2.72e-02 | 6.40e-01 |
| GOBP NEGATIVE REGULATION OF ORGANELLE ORGANIZATION | 323 | 4.02e-01 | 2.72e-02 | 8.23e-01 |
| GOBP PURINE NUCLEOSIDE CATABOLIC PROCESS | 7 | 9.01e-01 | 2.72e-02 | 9.82e-01 |
| GOBP POSITIVE REGULATION OF SIGNALING | 1396 | 8.97e-02 | 2.71e-02 | 5.24e-01 |
| GOBP REGULATION OF NEURON PROJECTION DEVELOPMENT | 343 | 3.88e-01 | -2.71e-02 | 8.17e-01 |
| GOBP CD40 SIGNALING PATHWAY | 14 | 8.61e-01 | -2.71e-02 | 9.72e-01 |
| GOBP DEMETHYLATION | 36 | 7.78e-01 | -2.71e-02 | 9.54e-01 |
| GOBP SIGNAL TRANSDUCTION IN ABSENCE OF LIGAND | 52 | 7.35e-01 | -2.71e-02 | 9.42e-01 |
| GOBP OSSIFICATION | 293 | 4.25e-01 | 2.71e-02 | 8.32e-01 |
| GOBP CELLULAR RESPONSE TO MOLECULE OF BACTERIAL ORIGIN | 185 | 5.26e-01 | -2.71e-02 | 8.76e-01 |
| GOBP SEROTONIN TRANSPORT | 16 | 8.51e-01 | -2.71e-02 | 9.69e-01 |
| GOBP REGULATION OF MYELOID LEUKOCYTE DIFFERENTIATION | 94 | 6.51e-01 | 2.70e-02 | 9.17e-01 |
| GOBP MUSCLE STRUCTURE DEVELOPMENT | 502 | 3.01e-01 | -2.70e-02 | 7.57e-01 |
| GOCC SUPRAMOLECULAR POLYMER | 711 | 2.21e-01 | -2.70e-02 | 6.94e-01 |
| GOBP MEMBRANE REPOLARIZATION DURING ACTION POTENTIAL | 18 | 8.43e-01 | -2.70e-02 | 9.68e-01 |
| GOMF DNA BINDING TRANSCRIPTION FACTOR BINDING | 402 | 3.55e-01 | -2.69e-02 | 7.96e-01 |
| GOBP REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY | 123 | 6.07e-01 | 2.69e-02 | 9.03e-01 |
| GOBP POSITIVE REGULATION OF PROTEIN METABOLIC PROCESS | 1020 | 1.47e-01 | 2.69e-02 | 6.13e-01 |
| GOBP RESPONSE TO ALKALOID | 71 | 6.96e-01 | 2.69e-02 | 9.27e-01 |
| GOBP REGULATION OF POSITIVE CHEMOTAXIS | 15 | 8.57e-01 | 2.69e-02 | 9.71e-01 |
| GOBP NEGATIVE REGULATION OF DNA BIOSYNTHETIC PROCESS | 29 | 8.02e-01 | -2.68e-02 | 9.61e-01 |
| GOMF PEPTIDASE ACTIVATOR ACTIVITY | 56 | 7.28e-01 | 2.68e-02 | 9.39e-01 |
| GOBP NEGATIVE REGULATION OF ATP DEPENDENT ACTIVITY | 13 | 8.67e-01 | -2.68e-02 | 9.74e-01 |
| GOBP MACROPHAGE ACTIVATION | 91 | 6.58e-01 | 2.68e-02 | 9.19e-01 |
| GOBP NEGATIVE REGULATION OF OXIDOREDUCTASE ACTIVITY | 13 | 8.67e-01 | 2.68e-02 | 9.74e-01 |
| GOBP DEVELOPMENT OF PRIMARY SEXUAL CHARACTERISTICS | 160 | 5.59e-01 | 2.68e-02 | 8.88e-01 |
| GOMF SPHINGOLIPID TRANSFER ACTIVITY | 8 | 8.96e-01 | 2.68e-02 | 9.81e-01 |
| GOCC TERTIARY GRANULE | 154 | 5.66e-01 | -2.68e-02 | 8.90e-01 |
| GOBP NUCLEOSIDE BISPHOSPHATE METABOLIC PROCESS | 108 | 6.31e-01 | 2.68e-02 | 9.12e-01 |
| GOBP REGULATION OF FAT CELL PROLIFERATION | 7 | 9.02e-01 | 2.68e-02 | 9.83e-01 |
| GOBP DNA TEMPLATED TRANSCRIPTION ELONGATION | 130 | 5.98e-01 | 2.68e-02 | 9.02e-01 |
| GOBP REGULATION OF LONG TERM SYNAPTIC DEPRESSION | 10 | 8.84e-01 | -2.68e-02 | 9.78e-01 |
| GOBP NEGATIVE REGULATION OF TUBULIN DEACETYLATION | 5 | 9.17e-01 | -2.68e-02 | 9.85e-01 |
| GOBP REGULATION OF ACTIN FILAMENT BASED PROCESS | 315 | 4.15e-01 | -2.67e-02 | 8.29e-01 |
| GOCC CLATHRIN COAT OF COATED PIT | 16 | 8.53e-01 | 2.67e-02 | 9.70e-01 |
| GOBP REGULATION OF JNK CASCADE | 120 | 6.13e-01 | -2.67e-02 | 9.04e-01 |
| GOBP FORMATION OF PRIMARY GERM LAYER | 91 | 6.60e-01 | -2.67e-02 | 9.20e-01 |
| GOBP REGULATION OF B CELL ACTIVATION | 122 | 6.10e-01 | 2.67e-02 | 9.03e-01 |
| GOCC SODIUM CHANNEL COMPLEX | 17 | 8.49e-01 | -2.67e-02 | 9.68e-01 |
| GOBP MODULATION OF PROCESS OF ANOTHER ORGANISM | 12 | 8.73e-01 | -2.66e-02 | 9.76e-01 |
| GOBP REGULATION OF CALCIUM ION TRANSPORT | 180 | 5.38e-01 | -2.66e-02 | 8.79e-01 |
| GOBP T CELL MEDIATED IMMUNITY | 120 | 6.15e-01 | 2.66e-02 | 9.05e-01 |
| GOBP LEARNING | 109 | 6.32e-01 | -2.66e-02 | 9.12e-01 |
| GOMF INOSITOL PHOSPHATE KINASE ACTIVITY | 9 | 8.90e-01 | 2.65e-02 | 9.79e-01 |
| GOBP NEGATIVE REGULATION OF MYELOID CELL DIFFERENTIATION | 70 | 7.01e-01 | -2.65e-02 | 9.29e-01 |
| GOBP ACTIVATION INDUCED CELL DEATH OF T CELLS | 9 | 8.91e-01 | -2.65e-02 | 9.79e-01 |
| GOBP GLYCOSPHINGOLIPID METABOLIC PROCESS | 50 | 7.46e-01 | 2.65e-02 | 9.43e-01 |
| GOCC CALCIUM CHANNEL COMPLEX | 53 | 7.39e-01 | -2.64e-02 | 9.42e-01 |
| GOBP BRANCHED CHAIN AMINO ACID METABOLIC PROCESS | 27 | 8.12e-01 | 2.64e-02 | 9.62e-01 |
| GOBP RESPONSE TO ORGANIC CYCLIC COMPOUND | 661 | 2.48e-01 | 2.63e-02 | 7.17e-01 |
| GOBP DETECTION OF OTHER ORGANISM | 18 | 8.47e-01 | -2.63e-02 | 9.68e-01 |
| GOBP NEUROTRANSMITTER RECEPTOR TRANSPORT ENDOSOME TO POSTSYNAPTIC MEMBRANE | 10 | 8.85e-01 | 2.63e-02 | 9.78e-01 |
| GOBP BIOMINERAL TISSUE DEVELOPMENT | 118 | 6.22e-01 | -2.63e-02 | 9.09e-01 |
| GOBP NEGATIVE REGULATION OF LYASE ACTIVITY | 12 | 8.75e-01 | -2.63e-02 | 9.76e-01 |
| GOBP MUSCLE CELL APOPTOTIC PROCESS | 63 | 7.18e-01 | -2.63e-02 | 9.36e-01 |
| GOBP CATECHOLAMINE SECRETION | 30 | 8.03e-01 | -2.63e-02 | 9.61e-01 |
| GOBP PROTEIN EXPORT FROM NUCLEUS | 58 | 7.29e-01 | 2.63e-02 | 9.40e-01 |
| GOBP NEGATIVE REGULATION OF TELOMERE MAINTENANCE VIA TELOMERE LENGTHENING | 28 | 8.10e-01 | -2.63e-02 | 9.61e-01 |
| GOBP NEGATIVE REGULATION OF RESPONSE TO EXTERNAL STIMULUS | 316 | 4.23e-01 | 2.62e-02 | 8.30e-01 |
| GOBP STEROID HORMONE BIOSYNTHETIC PROCESS | 29 | 8.07e-01 | 2.62e-02 | 9.61e-01 |
| GOBP REGULATION OF CELL CELL ADHESION MEDIATED BY INTEGRIN | 10 | 8.86e-01 | -2.62e-02 | 9.78e-01 |
| GOBP REGULATION OF LYMPHOCYTE APOPTOTIC PROCESS | 54 | 7.39e-01 | 2.62e-02 | 9.42e-01 |
| GOBP POSITIVE REGULATION OF SPROUTING ANGIOGENESIS | 18 | 8.47e-01 | -2.62e-02 | 9.68e-01 |
| GOBP NEGATIVE REGULATION OF INTERFERON BETA PRODUCTION | 14 | 8.65e-01 | -2.62e-02 | 9.74e-01 |
| GOBP PEPTIDYL ARGININE MODIFICATION | 12 | 8.75e-01 | -2.62e-02 | 9.76e-01 |
| GOBP SYNAPTIC VESICLE BUDDING | 10 | 8.86e-01 | -2.61e-02 | 9.78e-01 |
| GOBP ORGANOPHOSPHATE ESTER TRANSPORT | 129 | 6.08e-01 | -2.61e-02 | 9.03e-01 |
| GOCC SOMATODENDRITIC COMPARTMENT | 608 | 2.71e-01 | -2.61e-02 | 7.35e-01 |
| GOBP CYCLIC NUCLEOTIDE METABOLIC PROCESS | 29 | 8.08e-01 | 2.61e-02 | 9.61e-01 |
| GOBP REGULATION OF CORTICOSTEROID HORMONE SECRETION | 10 | 8.86e-01 | -2.61e-02 | 9.78e-01 |
| GOBP CIRCULATORY SYSTEM PROCESS | 415 | 3.63e-01 | 2.61e-02 | 8.02e-01 |
| GOBP SLEEP | 14 | 8.66e-01 | -2.61e-02 | 9.74e-01 |
| GOBP REGULATION OF TRANSCRIPTION REGULATORY REGION DNA BINDING | 24 | 8.25e-01 | -2.60e-02 | 9.64e-01 |
| GOMF SNRNA BINDING | 46 | 7.60e-01 | 2.60e-02 | 9.48e-01 |
| GOBP MONOATOMIC ION TRANSMEMBRANE TRANSPORT | 712 | 2.37e-01 | -2.60e-02 | 7.08e-01 |
| GOCC RECYCLING ENDOSOME | 185 | 5.42e-01 | -2.60e-02 | 8.81e-01 |
| GOBP L ALPHA AMINO ACID TRANSMEMBRANE TRANSPORT | 52 | 7.46e-01 | 2.60e-02 | 9.43e-01 |
| GOBP NEGATIVE REGULATION OF HEMOPOIESIS | 87 | 6.75e-01 | -2.60e-02 | 9.24e-01 |
| GOMF BICARBONATE TRANSMEMBRANE TRANSPORTER ACTIVITY | 23 | 8.29e-01 | 2.60e-02 | 9.64e-01 |
| GOBP AXIS SPECIFICATION | 58 | 7.32e-01 | 2.60e-02 | 9.41e-01 |
| GOBP PYRUVATE FAMILY AMINO ACID CATABOLIC PROCESS | 7 | 9.05e-01 | -2.60e-02 | 9.83e-01 |
| GOMF ATP DEPENDENT DNA DAMAGE SENSOR ACTIVITY | 18 | 8.49e-01 | -2.59e-02 | 9.68e-01 |
| GOBP REGULATION OF PLASMA MEMBRANE REPAIR | 7 | 9.05e-01 | -2.59e-02 | 9.83e-01 |
| GOCC LEADING EDGE MEMBRANE | 141 | 5.95e-01 | -2.59e-02 | 9.01e-01 |
| GOBP LENS DEVELOPMENT IN CAMERA TYPE EYE | 56 | 7.37e-01 | -2.59e-02 | 9.42e-01 |
| GOBP NEGATIVE REGULATION OF RECEPTOR SIGNALING PATHWAY VIA JAK STAT | 16 | 8.58e-01 | 2.59e-02 | 9.71e-01 |
| GOBP MICROTUBULE POLYMERIZATION OR DEPOLYMERIZATION | 121 | 6.22e-01 | -2.59e-02 | 9.09e-01 |
| GOBP TUBE MORPHOGENESIS | 642 | 2.63e-01 | -2.59e-02 | 7.30e-01 |
| GOBP POSITIVE REGULATION OF ACTIN FILAMENT DEPOLYMERIZATION | 12 | 8.77e-01 | 2.59e-02 | 9.76e-01 |
| GOBP NUCLEOSIDE MONOPHOSPHATE CATABOLIC PROCESS | 16 | 8.58e-01 | 2.59e-02 | 9.71e-01 |
| GOBP APOPTOTIC CHROMOSOME CONDENSATION | 6 | 9.13e-01 | -2.59e-02 | 9.83e-01 |
| GOBP GLUCAN METABOLIC PROCESS | 69 | 7.10e-01 | 2.59e-02 | 9.34e-01 |
| GOBP MESODERMAL CELL FATE COMMITMENT | 7 | 9.06e-01 | -2.58e-02 | 9.83e-01 |
| GOMF PROTEIN TYROSINE KINASE ACTIVATOR ACTIVITY | 22 | 8.34e-01 | 2.58e-02 | 9.65e-01 |
| GOBP DIGESTIVE SYSTEM DEVELOPMENT | 79 | 6.92e-01 | 2.58e-02 | 9.27e-01 |
| GOBP NEGATIVE REGULATION OF APOPTOTIC SIGNALING PATHWAY | 194 | 5.36e-01 | 2.58e-02 | 8.79e-01 |
| GOBP POSITIVE REGULATION OF MOLECULAR FUNCTION | 954 | 1.78e-01 | 2.58e-02 | 6.49e-01 |
| GOBP ASSOCIATIVE LEARNING | 61 | 7.28e-01 | -2.57e-02 | 9.39e-01 |
| GOBP EPITHELIUM DEVELOPMENT | 803 | 2.15e-01 | -2.57e-02 | 6.91e-01 |
| GOBP NEGATIVE REGULATION OF RESPONSE TO TYPE II INTERFERON | 6 | 9.13e-01 | -2.57e-02 | 9.83e-01 |
| GOBP EPIGENETIC PROGRAMMING OF GENE EXPRESSION | 25 | 8.24e-01 | -2.57e-02 | 9.64e-01 |
| GOBP PROTEIN TETRAMERIZATION | 78 | 6.95e-01 | -2.57e-02 | 9.27e-01 |
| GOBP REGULATION OF FATTY ACID TRANSPORT | 25 | 8.24e-01 | -2.56e-02 | 9.64e-01 |
| GOBP REGULATION OF UBIQUITIN DEPENDENT PROTEIN CATABOLIC PROCESS | 155 | 5.82e-01 | 2.56e-02 | 8.93e-01 |
| GOBP NEGATIVE REGULATION OF MUSCLE CONTRACTION | 18 | 8.51e-01 | -2.56e-02 | 9.69e-01 |
| GOMF FK506 BINDING | 10 | 8.88e-01 | -2.56e-02 | 9.79e-01 |
| GOCC ORGANELLAR RIBOSOME | 89 | 6.77e-01 | -2.56e-02 | 9.24e-01 |
| GOBP RIBONUCLEOSIDE DIPHOSPHATE BIOSYNTHETIC PROCESS | 10 | 8.89e-01 | 2.56e-02 | 9.79e-01 |
| GOBP MAINTENANCE OF CELL POLARITY | 16 | 8.59e-01 | -2.56e-02 | 9.72e-01 |
| GOBP REGULATION OF OSTEOBLAST DIFFERENTIATION | 89 | 6.77e-01 | 2.55e-02 | 9.24e-01 |
| GOBP REGULATION OF INTRACELLULAR SIGNAL TRANSDUCTION | 1489 | 9.98e-02 | 2.55e-02 | 5.47e-01 |
| GOBP PULMONARY VALVE MORPHOGENESIS | 10 | 8.89e-01 | -2.55e-02 | 9.79e-01 |
| GOBP POSITIVE REGULATION OF AMIDE METABOLIC PROCESS | 25 | 8.25e-01 | -2.55e-02 | 9.64e-01 |
| GOBP HYPOTHALAMUS DEVELOPMENT | 12 | 8.78e-01 | 2.55e-02 | 9.77e-01 |
| GOBP PEPTIDYL THREONINE MODIFICATION | 91 | 6.75e-01 | 2.55e-02 | 9.23e-01 |
| GOCC BRUSH BORDER | 79 | 6.97e-01 | -2.54e-02 | 9.28e-01 |
| GOBP TRNA METABOLIC PROCESS | 200 | 5.37e-01 | 2.53e-02 | 8.79e-01 |
| GOMF FILAMIN BINDING | 10 | 8.90e-01 | -2.53e-02 | 9.79e-01 |
| GOBP NEUTROPHIL MIGRATION | 87 | 6.83e-01 | 2.53e-02 | 9.24e-01 |
| GOBP OUTER EAR MORPHOGENESIS | 5 | 9.22e-01 | 2.53e-02 | 9.86e-01 |
| GOBP RESPONSE TO MECHANICAL STIMULUS | 170 | 5.69e-01 | -2.53e-02 | 8.90e-01 |
| GOCC CELL LEADING EDGE | 365 | 4.06e-01 | -2.53e-02 | 8.26e-01 |
| GOBP POSITIVE REGULATION OF NEUROEPITHELIAL CELL DIFFERENTIATION | 6 | 9.15e-01 | -2.53e-02 | 9.84e-01 |
| GOBP NEGATIVE REGULATION OF CELL MATRIX ADHESION | 28 | 8.17e-01 | -2.53e-02 | 9.63e-01 |
| GOBP POSITIVE REGULATION OF PROGRAMMED CELL DEATH | 453 | 3.57e-01 | 2.53e-02 | 7.98e-01 |
| GOBP STRIATED MUSCLE CELL APOPTOTIC PROCESS | 32 | 8.05e-01 | 2.52e-02 | 9.61e-01 |
| GOCC CILIARY PLASM | 120 | 6.33e-01 | 2.52e-02 | 9.13e-01 |
| GOBP LEUKOCYTE DIFFERENTIATION | 526 | 3.23e-01 | 2.52e-02 | 7.74e-01 |
| GOBP NEGATIVE REGULATION OF MIRNA METABOLIC PROCESS | 23 | 8.35e-01 | -2.52e-02 | 9.65e-01 |
| GOCC SUPRAMOLECULAR COMPLEX | 1043 | 1.71e-01 | 2.51e-02 | 6.38e-01 |
| GOBP INTRACELLULAR MRNA LOCALIZATION | 15 | 8.66e-01 | -2.51e-02 | 9.74e-01 |
| GOBP VERY LONG CHAIN FATTY ACID CATABOLIC PROCESS | 7 | 9.08e-01 | -2.51e-02 | 9.83e-01 |
| GOBP CARDIAC LEFT VENTRICLE MORPHOGENESIS | 8 | 9.02e-01 | -2.51e-02 | 9.83e-01 |
| GOBP REGULATION OF ALDOSTERONE METABOLIC PROCESS | 6 | 9.15e-01 | -2.51e-02 | 9.84e-01 |
| GOCC EUKARYOTIC TRANSLATION INITIATION FACTOR 3 COMPLEX EIF3M | 7 | 9.09e-01 | 2.51e-02 | 9.83e-01 |
| GOBP ENERGY DERIVATION BY OXIDATION OF ORGANIC COMPOUNDS | 302 | 4.54e-01 | 2.51e-02 | 8.43e-01 |
| GOBP PEROXISOME ORGANIZATION | 36 | 7.95e-01 | 2.50e-02 | 9.59e-01 |
| GOBP PHAGOSOME MATURATION | 27 | 8.22e-01 | 2.50e-02 | 9.64e-01 |
| GOBP SKELETAL SYSTEM MORPHOGENESIS | 135 | 6.16e-01 | -2.50e-02 | 9.06e-01 |
| GOBP MEMBRANE RAFT ORGANIZATION | 22 | 8.39e-01 | -2.50e-02 | 9.66e-01 |
| GOBP AGGREPHAGY | 16 | 8.63e-01 | -2.49e-02 | 9.74e-01 |
| GOBP DEFENSE RESPONSE TO BACTERIUM | 210 | 5.34e-01 | -2.49e-02 | 8.79e-01 |
| GOBP CYTOPLASMIC SEQUESTERING OF PROTEIN | 14 | 8.72e-01 | -2.49e-02 | 9.76e-01 |
| GOBP SKELETAL MUSCLE SATELLITE CELL DIFFERENTIATION | 8 | 9.03e-01 | 2.49e-02 | 9.83e-01 |
| GOBP GUANINE NUCLEOTIDE TRANSPORT | 10 | 8.92e-01 | -2.49e-02 | 9.80e-01 |
| GOBP LAMELLIPODIUM ORGANIZATION | 81 | 6.99e-01 | -2.49e-02 | 9.28e-01 |
| GOBP NUCLEOTIDE SUGAR METABOLIC PROCESS | 38 | 7.91e-01 | 2.49e-02 | 9.59e-01 |
| GOBP POSITIVE REGULATION OF ACTIN FILAMENT BUNDLE ASSEMBLY | 50 | 7.61e-01 | -2.49e-02 | 9.48e-01 |
| GOBP ESTABLISHMENT OF GOLGI LOCALIZATION | 7 | 9.09e-01 | 2.49e-02 | 9.83e-01 |
| GOBP POLARIZED EPITHELIAL CELL DIFFERENTIATION | 20 | 8.47e-01 | 2.48e-02 | 9.68e-01 |
| GOCC PHAGOCYTIC VESICLE | 137 | 6.16e-01 | 2.48e-02 | 9.06e-01 |
| GOCC SHELTERIN COMPLEX | 6 | 9.16e-01 | 2.48e-02 | 9.85e-01 |
| GOMF ADENYL NUCLEOTIDE BINDING | 1429 | 1.17e-01 | 2.48e-02 | 5.76e-01 |
| GOBP NEGATIVE REGULATION OF ACTIN FILAMENT BUNDLE ASSEMBLY | 26 | 8.27e-01 | -2.48e-02 | 9.64e-01 |
| GOBP REGULATION OF PROTEIN CONTAINING COMPLEX ASSEMBLY | 368 | 4.15e-01 | -2.47e-02 | 8.29e-01 |
| GOBP VASCULAR ENDOTHELIAL GROWTH FACTOR SIGNALING PATHWAY | 31 | 8.12e-01 | 2.47e-02 | 9.62e-01 |
| GOBP ESTABLISHMENT OF LYMPHOCYTE POLARITY | 13 | 8.77e-01 | 2.47e-02 | 9.77e-01 |
| GOBP CELL MOTILITY | 1286 | 1.37e-01 | -2.47e-02 | 6.02e-01 |
| GOBP REGULATION OF STEM CELL DIFFERENTIATION | 67 | 7.27e-01 | 2.47e-02 | 9.39e-01 |
| GOBP POSITIVE REGULATION OF GLUCONEOGENESIS | 17 | 8.60e-01 | -2.47e-02 | 9.72e-01 |
| GOBP LENS FIBER CELL DIFFERENTIATION | 29 | 8.18e-01 | -2.47e-02 | 9.63e-01 |
| GOCC FIBRILLAR CENTER | 138 | 6.17e-01 | 2.47e-02 | 9.06e-01 |
| GOBP REGULATION OF CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY INVOLVED IN APOPTOTIC PROCESS | 141 | 6.13e-01 | 2.47e-02 | 9.04e-01 |
| GOBP CARDIAC CELL DEVELOPMENT | 57 | 7.48e-01 | 2.46e-02 | 9.44e-01 |
| GOBP POSITIVE REGULATION OF INTERLEUKIN 23 PRODUCTION | 5 | 9.24e-01 | -2.46e-02 | 9.86e-01 |
| GOBP ESTABLISHMENT OF PROTEIN LOCALIZATION TO MITOCHONDRIAL MEMBRANE | 35 | 8.01e-01 | 2.46e-02 | 9.60e-01 |
| GOBP REGULATION OF CHRONIC INFLAMMATORY RESPONSE | 9 | 8.98e-01 | -2.46e-02 | 9.81e-01 |
| GOBP PHOSPHATIDYLINOSITOL BIOSYNTHETIC PROCESS | 119 | 6.44e-01 | 2.46e-02 | 9.15e-01 |
| GOBP REGULATION OF NUCLEOTIDE CATABOLIC PROCESS | 45 | 7.76e-01 | -2.45e-02 | 9.54e-01 |
| GOCC TRAPPIII PROTEIN COMPLEX | 12 | 8.83e-01 | -2.45e-02 | 9.78e-01 |
| GOMF NITRITE REDUCTASE ACTIVITY | 5 | 9.25e-01 | -2.45e-02 | 9.86e-01 |
| GOBP ZYMOGEN ACTIVATION | 44 | 7.79e-01 | -2.45e-02 | 9.54e-01 |
| GOCC INTERCALATED DISC | 39 | 7.92e-01 | 2.44e-02 | 9.59e-01 |
| GOBP POSITIVE REGULATION OF ENDOTHELIAL CELL CHEMOTAXIS | 9 | 8.99e-01 | -2.44e-02 | 9.82e-01 |
| GOBP SKELETAL MUSCLE ORGAN DEVELOPMENT | 122 | 6.42e-01 | -2.44e-02 | 9.15e-01 |
| GOBP PHOSPHOLIPID CATABOLIC PROCESS | 46 | 7.75e-01 | 2.44e-02 | 9.54e-01 |
| GOBP PROTEIN DNA COVALENT CROSS LINKING REPAIR | 9 | 8.99e-01 | 2.44e-02 | 9.82e-01 |
| GOBP NATURAL KILLER CELL CYTOKINE PRODUCTION | 7 | 9.11e-01 | 2.44e-02 | 9.83e-01 |
| GOBP SPERM AXONEME ASSEMBLY | 22 | 8.43e-01 | 2.43e-02 | 9.68e-01 |
| GOBP CELLULAR EXTRAVASATION | 61 | 7.42e-01 | 2.43e-02 | 9.42e-01 |
| GOBP CD4 POSITIVE ALPHA BETA T CELL ACTIVATION | 112 | 6.56e-01 | 2.43e-02 | 9.18e-01 |
| GOBP INTERLEUKIN 6 PRODUCTION | 130 | 6.32e-01 | -2.43e-02 | 9.12e-01 |
| GOBP POSITIVE REGULATION OF DEPHOSPHORYLATION | 48 | 7.71e-01 | 2.43e-02 | 9.51e-01 |
| GOBP REGULATION OF PHOSPHOLIPASE ACTIVITY | 37 | 7.98e-01 | -2.43e-02 | 9.59e-01 |
| GOBP PYRIMIDINE RIBONUCLEOTIDE METABOLIC PROCESS | 28 | 8.24e-01 | 2.43e-02 | 9.64e-01 |
| GOBP REGULATION OF NUCLEOTIDE BIOSYNTHETIC PROCESS | 21 | 8.47e-01 | 2.43e-02 | 9.68e-01 |
| GOBP BONE CELL DEVELOPMENT | 17 | 8.62e-01 | -2.43e-02 | 9.73e-01 |
| GOBP INSULIN SECRETION INVOLVED IN CELLULAR RESPONSE TO GLUCOSE STIMULUS | 52 | 7.62e-01 | -2.43e-02 | 9.48e-01 |
| GOMF CO RECEPTOR BINDING | 5 | 9.25e-01 | -2.42e-02 | 9.86e-01 |
| GOMF IONOTROPIC GLUTAMATE RECEPTOR BINDING | 19 | 8.55e-01 | 2.42e-02 | 9.71e-01 |
| GOBP PHOSPHORYLATION | 1124 | 1.73e-01 | 2.41e-02 | 6.40e-01 |
| GOMF MYOSIN PHOSPHATASE ACTIVITY | 65 | 7.37e-01 | -2.41e-02 | 9.42e-01 |
| GOBP MACROPHAGE CHEMOTAXIS | 32 | 8.14e-01 | -2.41e-02 | 9.62e-01 |
| GOBP PYRIMIDINE CONTAINING COMPOUND BIOSYNTHETIC PROCESS | 38 | 7.97e-01 | -2.41e-02 | 9.59e-01 |
| GOBP TUBE DEVELOPMENT | 791 | 2.50e-01 | -2.41e-02 | 7.18e-01 |
| GOBP REGULATION OF GAMMA AMINOBUTYRIC ACID SECRETION | 6 | 9.19e-01 | -2.41e-02 | 9.85e-01 |
| GOBP PROTEIN CONTAINING COMPLEX ASSEMBLY | 1385 | 1.34e-01 | 2.41e-02 | 5.99e-01 |
| GOBP MOTILE CILIUM ASSEMBLY | 53 | 7.62e-01 | -2.41e-02 | 9.48e-01 |
| GOBP NUCLEOTIDE SUGAR TRANSMEMBRANE TRANSPORT | 12 | 8.85e-01 | 2.41e-02 | 9.78e-01 |
| GOBP NEGATIVE REGULATION OF IMMUNE EFFECTOR PROCESS | 109 | 6.64e-01 | 2.41e-02 | 9.22e-01 |
| GOBP B CELL MEDIATED IMMUNITY | 174 | 5.85e-01 | 2.40e-02 | 8.94e-01 |
| GOMF TELOMERASE INHIBITOR ACTIVITY | 5 | 9.26e-01 | -2.40e-02 | 9.86e-01 |
| GOBP POSITIVE REGULATION OF CELL GROWTH | 124 | 6.44e-01 | -2.40e-02 | 9.15e-01 |
| GOBP POSITIVE REGULATION OF INFLAMMATORY RESPONSE TO ANTIGENIC STIMULUS | 13 | 8.81e-01 | 2.39e-02 | 9.78e-01 |
| GOCC CILIARY BASAL BODY | 152 | 6.11e-01 | 2.39e-02 | 9.04e-01 |
| GOBP LYMPHOID PROGENITOR CELL DIFFERENTIATION | 21 | 8.50e-01 | 2.39e-02 | 9.68e-01 |
| GOMF HYDROLASE ACTIVITY ACTING ON CARBON NITROGEN BUT NOT PEPTIDE BONDS | 120 | 6.52e-01 | -2.39e-02 | 9.18e-01 |
| GOBP POSITIVE REGULATION OF MYOBLAST PROLIFERATION | 8 | 9.07e-01 | 2.39e-02 | 9.83e-01 |
| GOMF C4 DICARBOXYLATE TRANSMEMBRANE TRANSPORTER ACTIVITY | 12 | 8.86e-01 | -2.38e-02 | 9.78e-01 |
| GOBP RNA METHYLATION | 78 | 7.16e-01 | 2.38e-02 | 9.36e-01 |
| GOBP NEGATIVE REGULATION OF AXONOGENESIS | 40 | 7.95e-01 | -2.38e-02 | 9.59e-01 |
| GOBP REGENERATION | 153 | 6.12e-01 | -2.38e-02 | 9.04e-01 |
| GOBP CELL MATURATION | 131 | 6.40e-01 | -2.37e-02 | 9.15e-01 |
| GOMF TROPOMYOSIN BINDING | 12 | 8.87e-01 | 2.37e-02 | 9.78e-01 |
| GOBP POSITIVE REGULATION OF CATALYTIC ACTIVITY | 690 | 2.90e-01 | 2.37e-02 | 7.47e-01 |
| GOBP STRIATED MUSCLE CONTRACTION | 132 | 6.39e-01 | 2.37e-02 | 9.15e-01 |
| GOCC PLATELET ALPHA GRANULE | 73 | 7.27e-01 | -2.36e-02 | 9.39e-01 |
| GOBP REGULATION OF ACTOMYOSIN STRUCTURE ORGANIZATION | 82 | 7.11e-01 | -2.36e-02 | 9.35e-01 |
| GOBP LIPID IMPORT INTO CELL | 18 | 8.62e-01 | -2.36e-02 | 9.73e-01 |
| GOBP REGULATION OF BLOOD CIRCULATION | 164 | 6.02e-01 | 2.36e-02 | 9.03e-01 |
| GOBP XENOBIOTIC METABOLIC PROCESS | 79 | 7.17e-01 | -2.36e-02 | 9.36e-01 |
| GOCC INTRACILIARY TRANSPORT PARTICLE | 22 | 8.48e-01 | -2.36e-02 | 9.68e-01 |
| GOMF TAU PROTEIN KINASE ACTIVITY | 21 | 8.52e-01 | -2.36e-02 | 9.69e-01 |
| GOBP EMBRYONIC VISCEROCRANIUM MORPHOGENESIS | 6 | 9.21e-01 | -2.35e-02 | 9.86e-01 |
| GOBP ORGANIC ACID METABOLIC PROCESS | 741 | 2.76e-01 | -2.35e-02 | 7.39e-01 |
| GOBP REGULATION OF AXON EXTENSION INVOLVED IN AXON GUIDANCE | 11 | 8.93e-01 | -2.35e-02 | 9.80e-01 |
| GOBP CELL CELL ADHESION MEDIATED BY INTEGRIN | 15 | 8.75e-01 | 2.35e-02 | 9.76e-01 |
| GOBP GOLGI LOCALIZATION | 13 | 8.83e-01 | 2.35e-02 | 9.78e-01 |
| GOBP REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY | 158 | 6.11e-01 | 2.35e-02 | 9.04e-01 |
| GOBP ANTIGEN RECEPTOR MEDIATED SIGNALING PATHWAY | 197 | 5.71e-01 | 2.34e-02 | 8.90e-01 |
| GOCC SYNAPTONEMAL STRUCTURE | 29 | 8.28e-01 | 2.34e-02 | 9.64e-01 |
| GOCC GAMMA TUBULIN COMPLEX | 19 | 8.60e-01 | 2.33e-02 | 9.72e-01 |
| GOBP CELLULAR RESPONSE TO NITROGEN COMPOUND | 493 | 3.75e-01 | 2.33e-02 | 8.09e-01 |
| GOMF ANAPHASE PROMOTING COMPLEX BINDING | 9 | 9.04e-01 | 2.33e-02 | 9.83e-01 |
| GOMF PROTON TRANSPORTING ATP SYNTHASE ACTIVITY ROTATIONAL MECHANISM | 16 | 8.72e-01 | 2.33e-02 | 9.76e-01 |
| GOBP REGULATION OF OXIDATIVE STRESS INDUCED INTRINSIC APOPTOTIC SIGNALING PATHWAY | 35 | 8.12e-01 | -2.33e-02 | 9.62e-01 |
| GOCC PROTON TRANSPORTING TWO SECTOR ATPASE COMPLEX | 46 | 7.85e-01 | -2.33e-02 | 9.57e-01 |
| GOBP REGULATION OF MICROTUBULE BINDING | 7 | 9.15e-01 | 2.33e-02 | 9.84e-01 |
| GOBP MORPHOGENESIS OF AN EPITHELIUM | 342 | 4.60e-01 | -2.33e-02 | 8.47e-01 |
| GOBP REGULATION OF MIRNA TRANSCRIPTION | 62 | 7.52e-01 | 2.33e-02 | 9.45e-01 |
| GOBP POSITIVE REGULATION OF ALPHA BETA T CELL DIFFERENTIATION | 49 | 7.78e-01 | 2.32e-02 | 9.54e-01 |
| GOCC PLASMA MEMBRANE PROTEIN COMPLEX | 527 | 3.62e-01 | -2.32e-02 | 8.01e-01 |
| GOBP EOSINOPHIL MIGRATION | 13 | 8.85e-01 | 2.32e-02 | 9.78e-01 |
| GOBP INTERLEUKIN 1 MEDIATED SIGNALING PATHWAY | 26 | 8.38e-01 | -2.32e-02 | 9.66e-01 |
| GOBP STRIATED MUSCLE CELL DIFFERENTIATION | 212 | 5.60e-01 | -2.32e-02 | 8.88e-01 |
| GOBP NEGATIVE REGULATION OF INFLAMMATORY RESPONSE | 132 | 6.46e-01 | -2.32e-02 | 9.15e-01 |
| GOMF CHLORIDE CHANNEL REGULATOR ACTIVITY | 12 | 8.89e-01 | 2.32e-02 | 9.79e-01 |
| GOCC TERMINAL BOUTON | 25 | 8.41e-01 | -2.32e-02 | 9.67e-01 |
| GOBP REGULATION OF MEMBRANE LIPID DISTRIBUTION | 51 | 7.75e-01 | 2.31e-02 | 9.54e-01 |
| GOBP REGULATION OF CARBOHYDRATE CATABOLIC PROCESS | 53 | 7.71e-01 | -2.31e-02 | 9.51e-01 |
| GOCC SARCOPLASMIC RETICULUM | 58 | 7.61e-01 | 2.31e-02 | 9.48e-01 |
| GOBP PROTEIN STABILIZATION | 189 | 5.84e-01 | 2.31e-02 | 8.93e-01 |
| GOBP MULTICELLULAR ORGANISMAL LEVEL IRON ION HOMEOSTASIS | 23 | 8.48e-01 | 2.31e-02 | 9.68e-01 |
| GOBP REGULATION OF SUPEROXIDE METABOLIC PROCESS | 24 | 8.45e-01 | -2.31e-02 | 9.68e-01 |
| GOBP CHONDROCYTE HYPERTROPHY | 5 | 9.29e-01 | 2.30e-02 | 9.88e-01 |
| GOBP CELLULAR COMPONENT DISASSEMBLY | 479 | 3.88e-01 | 2.30e-02 | 8.17e-01 |
| GOBP REGULATION OF DENDRITE EXTENSION | 18 | 8.66e-01 | 2.30e-02 | 9.74e-01 |
| GOCC TRANSLOCON COMPLEX | 6 | 9.22e-01 | 2.30e-02 | 9.86e-01 |
| GOBP ADULT HEART DEVELOPMENT | 5 | 9.29e-01 | 2.30e-02 | 9.88e-01 |
| GOBP NEGATIVE REGULATION OF REPRODUCTIVE PROCESS | 42 | 7.97e-01 | 2.30e-02 | 9.59e-01 |
| GOBP POSITIVE REGULATION OF CELL MIGRATION INVOLVED IN SPROUTING ANGIOGENESIS | 16 | 8.74e-01 | 2.29e-02 | 9.76e-01 |
| GOBP REGULATION OF HEART GROWTH | 42 | 7.97e-01 | -2.29e-02 | 9.59e-01 |
| GOMF MONOATOMIC ANION CHANNEL ACTIVITY | 55 | 7.69e-01 | -2.29e-02 | 9.51e-01 |
| GOBP OOCYTE MATURATION | 24 | 8.46e-01 | 2.29e-02 | 9.68e-01 |
| GOBP REGULATION OF HEMOPOIESIS | 352 | 4.61e-01 | -2.29e-02 | 8.48e-01 |
| GOMF DOPAMINE RECEPTOR BINDING | 11 | 8.95e-01 | -2.29e-02 | 9.81e-01 |
| GOCC SITE OF POLARIZED GROWTH | 137 | 6.44e-01 | -2.29e-02 | 9.15e-01 |
| GOBP GLYCEROL ETHER METABOLIC PROCESS | 19 | 8.63e-01 | 2.29e-02 | 9.74e-01 |
| GOMF 1 ALKYL 2 ACETYLGLYCEROPHOSPHOCHOLINE ESTERASE ACTIVITY | 6 | 9.23e-01 | -2.29e-02 | 9.86e-01 |
| GOBP IMMUNE EFFECTOR PROCESS | 592 | 3.42e-01 | 2.29e-02 | 7.89e-01 |
| GOBP POSITIVE REGULATION OF CHROMOSOME CONDENSATION | 8 | 9.11e-01 | 2.29e-02 | 9.83e-01 |
| GOCC CONDENSIN COMPLEX | 8 | 9.11e-01 | 2.29e-02 | 9.83e-01 |
| GOMF OXIDIZED DNA BINDING | 11 | 8.96e-01 | -2.29e-02 | 9.81e-01 |
| GOBP REGULATION OF HEART CONTRACTION | 133 | 6.49e-01 | 2.29e-02 | 9.17e-01 |
| GOCC GTPASE COMPLEX | 34 | 8.18e-01 | 2.28e-02 | 9.63e-01 |
| GOMF PROTEIN KINASE ACTIVITY | 500 | 3.83e-01 | 2.28e-02 | 8.15e-01 |
| GOBP NOTOCHORD MORPHOGENESIS | 7 | 9.17e-01 | 2.27e-02 | 9.85e-01 |
| GOBP MACROPHAGE ACTIVATION INVOLVED IN IMMUNE RESPONSE | 17 | 8.71e-01 | 2.27e-02 | 9.76e-01 |
| GOBP RESPONSE TO HORMONE | 651 | 3.24e-01 | 2.27e-02 | 7.75e-01 |
| GOBP CORONARY VASCULATURE DEVELOPMENT | 36 | 8.14e-01 | 2.26e-02 | 9.62e-01 |
| GOMF PHOSPHATIDYLINOSITOL PHOSPHATE 5 PHOSPHATASE ACTIVITY | 12 | 8.92e-01 | -2.26e-02 | 9.80e-01 |
| GOBP CHROMATIN REMODELING | 565 | 3.59e-01 | 2.26e-02 | 7.99e-01 |
| GOBP PYRUVATE METABOLIC PROCESS | 101 | 6.95e-01 | -2.26e-02 | 9.27e-01 |
| GOBP REGULATION OF MICROTUBULE BASED PROCESS | 216 | 5.67e-01 | 2.26e-02 | 8.90e-01 |
| GOCC SPLICEOSOMAL TRI SNRNP COMPLEX | 37 | 8.12e-01 | -2.26e-02 | 9.62e-01 |
| GOBP REGULATION OF DENDRITIC CELL CHEMOTAXIS | 9 | 9.07e-01 | 2.26e-02 | 9.83e-01 |
| GOBP REGULATION OF NEURAL PRECURSOR CELL PROLIFERATION | 63 | 7.57e-01 | 2.26e-02 | 9.46e-01 |
| GOBP UROGENITAL SYSTEM DEVELOPMENT | 43 | 7.98e-01 | 2.25e-02 | 9.59e-01 |
| GOBP REGULATION OF CELL SHAPE | 117 | 6.74e-01 | -2.25e-02 | 9.23e-01 |
| GOCC SPERM MIDPIECE | 34 | 8.20e-01 | 2.25e-02 | 9.63e-01 |
| GOBP POSITIVE REGULATION OF TOLL LIKE RECEPTOR 4 SIGNALING PATHWAY | 12 | 8.93e-01 | -2.25e-02 | 9.80e-01 |
| GOBP NEGATIVE REGULATION OF TELOMERE MAINTENANCE | 36 | 8.16e-01 | -2.25e-02 | 9.62e-01 |
| GOMF CYTOCHROME B5 REDUCTASE ACTIVITY ACTING ON NAD P H | 6 | 9.24e-01 | -2.25e-02 | 9.86e-01 |
| GOCC SIDE OF MEMBRANE | 577 | 3.57e-01 | 2.24e-02 | 7.98e-01 |
| GOBP REGULATION OF VESICLE MEDIATED TRANSPORT | 421 | 4.31e-01 | 2.24e-02 | 8.35e-01 |
| GOBP POSITIVE REGULATION OF INTRACELLULAR TRANSPORT | 127 | 6.63e-01 | 2.24e-02 | 9.21e-01 |
| GOMF PHOSPHATIDYLINOSITOL 3 PHOSPHATE BINDING | 43 | 8.00e-01 | -2.24e-02 | 9.60e-01 |
| GOBP REGULATION OF LEUKOCYTE DEGRANULATION | 41 | 8.05e-01 | -2.23e-02 | 9.61e-01 |
| GOBP NEGATIVE REGULATION OF T CELL MEDIATED IMMUNITY | 29 | 8.35e-01 | -2.23e-02 | 9.65e-01 |
| GOBP PEPTIDYL TYROSINE MODIFICATION | 203 | 5.84e-01 | 2.23e-02 | 8.93e-01 |
| GOBP FEMALE MEIOSIS I | 10 | 9.03e-01 | 2.23e-02 | 9.83e-01 |
| GOBP NEUROTRANSMITTER RECEPTOR TRANSPORT | 19 | 8.66e-01 | -2.23e-02 | 9.74e-01 |
| GOCC CELL BODY | 401 | 4.44e-01 | -2.23e-02 | 8.41e-01 |
| GOBP MOLTING CYCLE PROCESS | 58 | 7.69e-01 | 2.23e-02 | 9.51e-01 |
| GOBP RESPONSE TO ACTINOMYCIN D | 5 | 9.31e-01 | 2.23e-02 | 9.88e-01 |
| GOBP REGULATION OF HYDROGEN PEROXIDE METABOLIC PROCESS | 14 | 8.85e-01 | 2.22e-02 | 9.78e-01 |
| GOBP NEGATIVE REGULATION OF CELL ADHESION | 239 | 5.54e-01 | -2.22e-02 | 8.86e-01 |
| GOMF DISORDERED DOMAIN SPECIFIC BINDING | 25 | 8.48e-01 | -2.22e-02 | 9.68e-01 |
| GOBP PEPTIDE ANTIGEN ASSEMBLY WITH MHC PROTEIN COMPLEX | 19 | 8.67e-01 | 2.21e-02 | 9.74e-01 |
| GOBP SINGLE FERTILIZATION | 91 | 7.15e-01 | 2.21e-02 | 9.36e-01 |
| GOBP LIPID BIOSYNTHETIC PROCESS | 595 | 3.57e-01 | 2.21e-02 | 7.98e-01 |
| GOBP RESPONSE TO INORGANIC SUBSTANCE | 396 | 4.50e-01 | 2.21e-02 | 8.43e-01 |
| GOBP POSITIVE REGULATION OF ORGANELLE ORGANIZATION | 446 | 4.24e-01 | 2.21e-02 | 8.31e-01 |
| GOMF PROTEIN TRANSPORTER ACTIVITY | 38 | 8.14e-01 | 2.21e-02 | 9.62e-01 |
| GOMF CADHERIN BINDING INVOLVED IN CELL CELL ADHESION | 14 | 8.86e-01 | -2.21e-02 | 9.78e-01 |
| GOBP PROSTATE GLAND DEVELOPMENT | 31 | 8.32e-01 | 2.20e-02 | 9.64e-01 |
| GOBP CARBOHYDRATE DERIVATIVE BIOSYNTHETIC PROCESS | 579 | 3.66e-01 | 2.20e-02 | 8.04e-01 |
| GOBP CYTOCHROME COMPLEX ASSEMBLY | 37 | 8.17e-01 | 2.20e-02 | 9.63e-01 |
| GOCC CELL TIP | 6 | 9.26e-01 | -2.20e-02 | 9.86e-01 |
| GOBP GLYCEROPHOSPHOLIPID CATABOLIC PROCESS | 28 | 8.41e-01 | 2.20e-02 | 9.67e-01 |
| GOBP LYSOSOMAL PROTEIN CATABOLIC PROCESS | 20 | 8.65e-01 | -2.19e-02 | 9.74e-01 |
| GOMF EXCITATORY EXTRACELLULAR LIGAND GATED MONOATOMIC ION CHANNEL ACTIVITY | 16 | 8.79e-01 | 2.19e-02 | 9.77e-01 |
| GOBP C TERMINAL PROTEIN AMINO ACID MODIFICATION | 13 | 8.91e-01 | 2.19e-02 | 9.80e-01 |
| GOBP REGULATION OF MYELOID CELL DIFFERENTIATION | 168 | 6.24e-01 | 2.19e-02 | 9.09e-01 |
| GOCC CENTRIOLAR SATELLITE | 115 | 6.85e-01 | 2.19e-02 | 9.25e-01 |
| GOBP NEGATIVE REGULATION OF CARDIAC MUSCLE ADAPTATION | 6 | 9.26e-01 | -2.19e-02 | 9.86e-01 |
| GOBP SPLEEN DEVELOPMENT | 30 | 8.36e-01 | -2.19e-02 | 9.65e-01 |
| GOMF LIGASE ACTIVITY | 156 | 6.37e-01 | 2.19e-02 | 9.14e-01 |
| GOMF SOLUTE INORGANIC ANION ANTIPORTER ACTIVITY | 23 | 8.56e-01 | -2.19e-02 | 9.71e-01 |
| GOCC RECEPTOR COMPLEX | 387 | 4.61e-01 | -2.18e-02 | 8.48e-01 |
| GOBP POSITIVE REGULATION OF ALPHA BETA T CELL ACTIVATION | 67 | 7.57e-01 | -2.18e-02 | 9.46e-01 |
| GOBP NEGATIVE REGULATION OF TUMOR NECROSIS FACTOR SUPERFAMILY CYTOKINE PRODUCTION | 54 | 7.82e-01 | -2.18e-02 | 9.56e-01 |
| GOBP NEGATIVE REGULATION OF LEUKOCYTE CHEMOTAXIS | 20 | 8.66e-01 | -2.18e-02 | 9.74e-01 |
| GOBP DETECTION OF ABIOTIC STIMULUS | 90 | 7.21e-01 | -2.18e-02 | 9.37e-01 |
| GOBP ENERGY RESERVE METABOLIC PROCESS | 74 | 7.46e-01 | 2.17e-02 | 9.43e-01 |
| GOBP RESPONSE TO BACTERIUM | 523 | 3.95e-01 | 2.17e-02 | 8.20e-01 |
| GOBP NEGATIVE REGULATION OF TRANSCRIPTION BY COMPETITIVE PROMOTER BINDING | 10 | 9.05e-01 | 2.17e-02 | 9.83e-01 |
| GOMF DNA DIRECTED DNA POLYMERASE ACTIVITY | 22 | 8.60e-01 | 2.17e-02 | 9.72e-01 |
| GOBP REGULATION OF LIPID LOCALIZATION | 124 | 6.77e-01 | -2.17e-02 | 9.24e-01 |
| GOBP RESPONSE TO AXON INJURY | 61 | 7.71e-01 | -2.16e-02 | 9.51e-01 |
| GOBP REGULATION OF DNA BINDING | 61 | 7.71e-01 | -2.16e-02 | 9.51e-01 |
| GOBP TELENCEPHALON DEVELOPMENT | 201 | 5.98e-01 | 2.16e-02 | 9.02e-01 |
| GOBP CELL FATE COMMITMENT | 158 | 6.40e-01 | -2.15e-02 | 9.15e-01 |
| GOBP SECONDARY METABOLITE BIOSYNTHETIC PROCESS | 17 | 8.78e-01 | 2.15e-02 | 9.77e-01 |
| GOBP PIGMENT ACCUMULATION | 10 | 9.06e-01 | 2.15e-02 | 9.83e-01 |
| GOBP PIGMENT GRANULE MATURATION | 10 | 9.06e-01 | 2.15e-02 | 9.83e-01 |
| GOBP TOR SIGNALING | 154 | 6.46e-01 | 2.15e-02 | 9.15e-01 |
| GOBP ORGANIC HYDROXY COMPOUND METABOLIC PROCESS | 412 | 4.55e-01 | -2.15e-02 | 8.44e-01 |
| GOMF SCAFFOLD PROTEIN BINDING | 58 | 7.78e-01 | -2.14e-02 | 9.54e-01 |
| GOBP DIGESTIVE SYSTEM PROCESS | 69 | 7.59e-01 | -2.14e-02 | 9.47e-01 |
| GOBP TISSUE MORPHOGENESIS | 408 | 4.59e-01 | -2.14e-02 | 8.47e-01 |
| GOBP PROSTANOID METABOLIC PROCESS | 38 | 8.20e-01 | -2.14e-02 | 9.63e-01 |
| GOBP ACTIN NUCLEATION | 51 | 7.92e-01 | 2.14e-02 | 9.59e-01 |
| GOMF TRANSCRIPTION REGULATOR ACTIVATOR ACTIVITY | 8 | 9.17e-01 | 2.13e-02 | 9.85e-01 |
| GOBP REGULATION OF BEHAVIOR | 50 | 7.94e-01 | 2.13e-02 | 9.59e-01 |
| GOBP SYNAPSE ASSEMBLY | 131 | 6.74e-01 | -2.13e-02 | 9.23e-01 |
| GOBP PHENOL CONTAINING COMPOUND METABOLIC PROCESS | 72 | 7.55e-01 | -2.13e-02 | 9.45e-01 |
| GOMF TRANSFERASE ACTIVITY TRANSFERRING ALKYL OR ARYL OTHER THAN METHYL GROUPS | 52 | 7.91e-01 | -2.13e-02 | 9.59e-01 |
| GOBP TORC1 SIGNALING | 100 | 7.13e-01 | -2.13e-02 | 9.35e-01 |
| GOMF L ASCORBIC ACID BINDING | 19 | 8.73e-01 | -2.12e-02 | 9.76e-01 |
| GOBP GLYCOPHAGY | 12 | 8.99e-01 | 2.12e-02 | 9.82e-01 |
| GOBP LYMPHOCYTE COSTIMULATION | 44 | 8.08e-01 | -2.12e-02 | 9.61e-01 |
| GOBP POSITIVE REGULATION OF PROTEIN LOCALIZATION TO CELL PERIPHERY | 61 | 7.74e-01 | -2.12e-02 | 9.54e-01 |
| GOBP REGULATION OF CARDIAC MUSCLE CELL PROLIFERATION | 26 | 8.51e-01 | 2.12e-02 | 9.69e-01 |
| GOBP REGULATION OF CYTOSKELETON ORGANIZATION | 445 | 4.43e-01 | -2.12e-02 | 8.41e-01 |
| GOMF PEPTIDE HORMONE BINDING | 27 | 8.49e-01 | -2.12e-02 | 9.68e-01 |
| GOCC CUL4 RING E3 UBIQUITIN LIGASE COMPLEX | 33 | 8.33e-01 | 2.12e-02 | 9.64e-01 |
| GOMF PSEUDOURIDINE SYNTHASE ACTIVITY | 13 | 8.95e-01 | -2.12e-02 | 9.81e-01 |
| GOMF PHOSPHOLIPID BINDING | 397 | 4.69e-01 | -2.12e-02 | 8.54e-01 |
| GOBP LYMPHOCYTE APOPTOTIC PROCESS | 75 | 7.51e-01 | 2.12e-02 | 9.45e-01 |
| GOMF ESTRADIOL 17 BETA DEHYDROGENASE NAD P ACTIVITY | 15 | 8.87e-01 | -2.12e-02 | 9.78e-01 |
| GOBP PROLINE METABOLIC PROCESS | 8 | 9.18e-01 | -2.11e-02 | 9.85e-01 |
| GOBP REGULATION OF NATURAL KILLER CELL DIFFERENTIATION | 13 | 8.95e-01 | 2.11e-02 | 9.81e-01 |
| GOBP POSITIVE REGULATION OF PHOSPHORYLATION | 469 | 4.34e-01 | 2.11e-02 | 8.36e-01 |
| GOBP CARDIAC MUSCLE CELL CARDIAC MUSCLE CELL ADHESION | 5 | 9.35e-01 | 2.11e-02 | 9.89e-01 |
| GOMF CELL ADHESIVE PROTEIN BINDING INVOLVED IN BUNDLE OF HIS CELL PURKINJE MYOCYTE COMMUNICATION | 5 | 9.35e-01 | 2.11e-02 | 9.89e-01 |
| GOBP BARBED END ACTIN FILAMENT CAPPING | 24 | 8.58e-01 | -2.11e-02 | 9.72e-01 |
| GOCC SARCOLEMMA | 110 | 7.03e-01 | 2.11e-02 | 9.30e-01 |
| GOBP CELL KILLING | 175 | 6.31e-01 | 2.10e-02 | 9.12e-01 |
| GOBP REGULATION OF GTPASE ACTIVITY | 230 | 5.83e-01 | -2.10e-02 | 8.93e-01 |
| GOBP CARDIAC MUSCLE CELL DIFFERENTIATION | 78 | 7.48e-01 | 2.10e-02 | 9.44e-01 |
| GOMF R SMAD BINDING | 22 | 8.64e-01 | -2.10e-02 | 9.74e-01 |
| GOMF HISTONE H3K4 METHYLTRANSFERASE ACTIVITY | 16 | 8.84e-01 | -2.10e-02 | 9.78e-01 |
| GOCC CHROMATIN SILENCING COMPLEX | 13 | 8.96e-01 | -2.10e-02 | 9.81e-01 |
| GOBP POSITIVE REGULATION OF ERK1 AND ERK2 CASCADE | 126 | 6.84e-01 | -2.10e-02 | 9.25e-01 |
| GOBP REGULATION OF MONONUCLEAR CELL MIGRATION | 120 | 6.92e-01 | 2.10e-02 | 9.27e-01 |
| GOMF STEROL TRANSFER ACTIVITY | 18 | 8.78e-01 | -2.09e-02 | 9.77e-01 |
| GOBP DNA UNWINDING INVOLVED IN DNA REPLICATION | 21 | 8.68e-01 | -2.09e-02 | 9.75e-01 |
| GOMF EPHRIN RECEPTOR BINDING | 24 | 8.59e-01 | 2.09e-02 | 9.72e-01 |
| GOBP ACYLGLYCEROL HOMEOSTASIS | 28 | 8.48e-01 | 2.09e-02 | 9.68e-01 |
| GOCC INTERSTITIAL MATRIX | 5 | 9.36e-01 | 2.09e-02 | 9.89e-01 |
| GOBP REACTIVE NITROGEN SPECIES METABOLIC PROCESS | 69 | 7.64e-01 | 2.09e-02 | 9.49e-01 |
| GOBP REGULATION OF ANOIKIS | 19 | 8.75e-01 | 2.09e-02 | 9.76e-01 |
| GOBP REGULATION OF SKELETAL MUSCLE CONTRACTION BY CALCIUM ION SIGNALING | 6 | 9.30e-01 | 2.09e-02 | 9.88e-01 |
| GOBP G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY | 574 | 3.94e-01 | -2.08e-02 | 8.20e-01 |
| GOBP LIPID CATABOLIC PROCESS | 264 | 5.60e-01 | -2.08e-02 | 8.88e-01 |
| GOBP DIGESTION | 76 | 7.54e-01 | -2.08e-02 | 9.45e-01 |
| GOBP NEGATIVE REGULATION OF ERK1 AND ERK2 CASCADE | 54 | 7.91e-01 | -2.08e-02 | 9.59e-01 |
| GOMF EXOGENOUS PROTEIN BINDING | 68 | 7.67e-01 | 2.08e-02 | 9.50e-01 |
| GOBP LEUKOCYTE MIGRATION | 314 | 5.26e-01 | 2.08e-02 | 8.76e-01 |
| GOBP POSITIVE REGULATION OF FATTY ACID BIOSYNTHETIC PROCESS | 15 | 8.89e-01 | 2.08e-02 | 9.79e-01 |
| GOBP REGULATION OF PROTEIN DEACETYLATION | 28 | 8.49e-01 | 2.08e-02 | 9.68e-01 |
| GOBP NEGATIVE REGULATION OF MAPK CASCADE | 130 | 6.83e-01 | 2.07e-02 | 9.24e-01 |
| GOCC NEURON PROJECTION | 950 | 2.80e-01 | -2.07e-02 | 7.41e-01 |
| GOBP LEFT RIGHT AXIS SPECIFICATION | 10 | 9.10e-01 | 2.07e-02 | 9.83e-01 |
| GOBP NEGATIVE REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY | 94 | 7.30e-01 | -2.06e-02 | 9.40e-01 |
| GOMF ATPASE COUPLED MONOATOMIC CATION TRANSMEMBRANE TRANSPORTER ACTIVITY | 41 | 8.20e-01 | -2.05e-02 | 9.63e-01 |
| GOBP CILIUM ORGANIZATION | 369 | 4.99e-01 | 2.05e-02 | 8.64e-01 |
| GOBP NEGATIVE REGULATION OF SUPRAMOLECULAR FIBER ORGANIZATION | 136 | 6.80e-01 | -2.05e-02 | 9.24e-01 |
| GOCC ATPASE COMPLEX | 140 | 6.76e-01 | -2.05e-02 | 9.24e-01 |
| GOBP NUCLEOSIDE TRIPHOSPHATE METABOLIC PROCESS | 239 | 5.86e-01 | -2.05e-02 | 8.94e-01 |
| GOMF N METHYLTRANSFERASE ACTIVITY | 90 | 7.37e-01 | -2.05e-02 | 9.42e-01 |
| GOBP REGULATION OF AMIDE METABOLIC PROCESS | 59 | 7.86e-01 | -2.04e-02 | 9.57e-01 |
| GOBP REGULATION OF INSULIN SECRETION INVOLVED IN CELLULAR RESPONSE TO GLUCOSE STIMULUS | 43 | 8.17e-01 | -2.04e-02 | 9.63e-01 |
| GOBP POSITIVE REGULATION OF CD4 POSITIVE ALPHA BETA T CELL ACTIVATION | 43 | 8.17e-01 | -2.04e-02 | 9.63e-01 |
| GOBP POLYSACCHARIDE METABOLIC PROCESS | 86 | 7.44e-01 | 2.04e-02 | 9.42e-01 |
| GOMF TRANSFERRIN RECEPTOR BINDING | 10 | 9.11e-01 | -2.03e-02 | 9.83e-01 |
| GOMF CALCIUM ION BINDING | 470 | 4.50e-01 | -2.03e-02 | 8.43e-01 |
| GOBP MACROMOLECULE METHYLATION | 122 | 6.98e-01 | 2.03e-02 | 9.28e-01 |
| GOBP POSITIVE REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY | 53 | 7.98e-01 | 2.03e-02 | 9.59e-01 |
| GOCC GRANULAR COMPONENT | 7 | 9.26e-01 | 2.03e-02 | 9.86e-01 |
| GOBP ORGANOPHOSPHATE BIOSYNTHETIC PROCESS | 524 | 4.28e-01 | 2.02e-02 | 8.34e-01 |
| GOMF CARBOHYDRATE BINDING | 216 | 6.09e-01 | 2.02e-02 | 9.03e-01 |
| GOBP NEGATIVE REGULATION OF CELLULAR CATABOLIC PROCESS | 100 | 7.28e-01 | -2.02e-02 | 9.39e-01 |
| GOBP PEROXISOMAL TRANSPORT | 21 | 8.73e-01 | -2.02e-02 | 9.76e-01 |
| GOBP REGULATION OF REGULATED SECRETORY PATHWAY | 98 | 7.31e-01 | 2.01e-02 | 9.40e-01 |
| GOBP REGULATION OF CILIUM ASSEMBLY | 89 | 7.43e-01 | 2.01e-02 | 9.42e-01 |
| GOBP SMALL MOLECULE METABOLIC PROCESS | 1490 | 1.96e-01 | -2.01e-02 | 6.68e-01 |
| GOBP MAMMARY GLAND MORPHOGENESIS | 30 | 8.49e-01 | 2.01e-02 | 9.68e-01 |
| GOBP SENSORY PERCEPTION | 359 | 5.14e-01 | 2.00e-02 | 8.71e-01 |
| GOBP REGULATION OF RAS PROTEIN SIGNAL TRANSDUCTION | 40 | 8.26e-01 | 2.00e-02 | 9.64e-01 |
| GOMF NARROW PORE CHANNEL ACTIVITY | 10 | 9.13e-01 | -2.00e-02 | 9.83e-01 |
| GOBP ENDOCHONDRAL BONE MORPHOGENESIS | 38 | 8.31e-01 | 2.00e-02 | 9.64e-01 |
| GOBP SIGNAL RELEASE | 348 | 5.23e-01 | 2.00e-02 | 8.75e-01 |
| GOCC ACTIN BASED CELL PROJECTION | 177 | 6.47e-01 | 1.99e-02 | 9.16e-01 |
| GOCC ARYL HYDROCARBON RECEPTOR COMPLEX | 5 | 9.38e-01 | 1.99e-02 | 9.89e-01 |
| GOBP CIRCULATORY SYSTEM DEVELOPMENT | 828 | 3.31e-01 | -1.99e-02 | 7.82e-01 |
| GOMF SYMPORTER ACTIVITY | 101 | 7.30e-01 | -1.99e-02 | 9.40e-01 |
| GOBP POSITIVE REGULATION OF HEPATOCYTE PROLIFERATION | 7 | 9.27e-01 | 1.99e-02 | 9.87e-01 |
| GOBP TRNA PSEUDOURIDINE SYNTHESIS | 6 | 9.33e-01 | 1.98e-02 | 9.89e-01 |
| GOCC GAMMA TUBULIN RING COMPLEX | 9 | 9.18e-01 | 1.98e-02 | 9.85e-01 |
| GOBP HETEROTYPIC CELL CELL ADHESION | 50 | 8.09e-01 | -1.98e-02 | 9.61e-01 |
| GOBP REGULATION OF INCLUSION BODY ASSEMBLY | 14 | 8.98e-01 | 1.98e-02 | 9.81e-01 |
| GOBP BILE ACID AND BILE SALT TRANSPORT | 15 | 8.95e-01 | 1.98e-02 | 9.81e-01 |
| GOMF CYCLASE ACTIVATOR ACTIVITY | 6 | 9.33e-01 | -1.97e-02 | 9.89e-01 |
| GOBP POSITIVE REGULATION OF SMOOTH MUSCLE CELL APOPTOTIC PROCESS | 13 | 9.02e-01 | 1.97e-02 | 9.83e-01 |
| GOBP RESPONSE TO KETONE | 158 | 6.70e-01 | 1.96e-02 | 9.22e-01 |
| GOBP DEOXYRIBONUCLEOSIDE MONOPHOSPHATE METABOLIC PROCESS | 21 | 8.76e-01 | 1.96e-02 | 9.76e-01 |
| GOBP ENDOCYTOSIS | 588 | 4.17e-01 | 1.96e-02 | 8.30e-01 |
| GOBP REGULATION OF G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY | 105 | 7.28e-01 | 1.96e-02 | 9.39e-01 |
| GOBP REGULATION OF B CELL APOPTOTIC PROCESS | 19 | 8.83e-01 | -1.96e-02 | 9.78e-01 |
| GOBP PROTON TRANSMEMBRANE TRANSPORT | 131 | 6.99e-01 | -1.96e-02 | 9.28e-01 |
| GOBP POSITIVE REGULATION OF NON CANONICAL NF KAPPAB SIGNAL TRANSDUCTION | 56 | 8.01e-01 | 1.95e-02 | 9.60e-01 |
| GOBP NEGATIVE REGULATION OF GLUCOSE TRANSMEMBRANE TRANSPORT | 16 | 8.93e-01 | -1.95e-02 | 9.80e-01 |
| GOMF LEUKOTRIENE C4 SYNTHASE ACTIVITY | 5 | 9.40e-01 | -1.95e-02 | 9.89e-01 |
| GOBP POSITIVE REGULATION OF DEVELOPMENTAL PROCESS | 990 | 3.00e-01 | -1.95e-02 | 7.56e-01 |
| GOMF APOLIPOPROTEIN BINDING | 13 | 9.03e-01 | -1.95e-02 | 9.83e-01 |
| GOBP REGULATION OF HYDROGEN PEROXIDE MEDIATED PROGRAMMED CELL DEATH | 9 | 9.19e-01 | 1.95e-02 | 9.86e-01 |
| GOBP REGULATION OF PRESYNAPTIC CYTOSOLIC CALCIUM ION CONCENTRATION | 10 | 9.15e-01 | -1.94e-02 | 9.84e-01 |
| GOBP REGULATION OF INSULIN RECEPTOR SIGNALING PATHWAY | 59 | 7.97e-01 | -1.94e-02 | 9.59e-01 |
| GOMF MODIFICATION DEPENDENT PROTEIN BINDING | 181 | 6.53e-01 | -1.94e-02 | 9.18e-01 |
| GOBP POSITIVE REGULATION OF HEMOPOIESIS | 164 | 6.68e-01 | -1.94e-02 | 9.22e-01 |
| GOMF OXIDOREDUCTASE ACTIVITY ACTING ON NAD P H OXYGEN AS ACCEPTOR | 12 | 9.07e-01 | 1.94e-02 | 9.83e-01 |
| GOBP POSITIVE CHEMOTAXIS | 38 | 8.36e-01 | 1.94e-02 | 9.65e-01 |
| GOBP EMBRYONIC PLACENTA DEVELOPMENT | 62 | 7.92e-01 | 1.94e-02 | 9.59e-01 |
| GOBP NEGATIVE REGULATION OF CANONICAL NF KAPPAB SIGNAL TRANSDUCTION | 53 | 8.08e-01 | 1.93e-02 | 9.61e-01 |
| GOBP REGULATION OF TESTOSTERONE BIOSYNTHETIC PROCESS | 5 | 9.40e-01 | -1.93e-02 | 9.89e-01 |
| GOBP MITOCHONDRIAL FUSION | 35 | 8.43e-01 | 1.93e-02 | 9.68e-01 |
| GOBP REGULATION OF ORGANELLE ORGANIZATION | 1063 | 2.88e-01 | 1.93e-02 | 7.47e-01 |
| GOBP MITOCHONDRIAL GENE EXPRESSION | 167 | 6.67e-01 | 1.93e-02 | 9.22e-01 |
| GOBP REGULATION OF GAMMA DELTA T CELL DIFFERENTIATION | 9 | 9.20e-01 | 1.93e-02 | 9.86e-01 |
| GOBP AMINO ACID BIOSYNTHETIC PROCESS | 62 | 7.93e-01 | -1.93e-02 | 9.59e-01 |
| GOBP NEGATIVE REGULATION OF CHEMOKINE MEDIATED SIGNALING PATHWAY | 6 | 9.35e-01 | -1.93e-02 | 9.89e-01 |
| GOBP DNA STRAND ELONGATION | 37 | 8.40e-01 | 1.92e-02 | 9.66e-01 |
| GOCC TRANSCRIPTION REPRESSOR COMPLEX | 66 | 7.87e-01 | 1.92e-02 | 9.57e-01 |
| GOBP ACTIN FILAMENT BASED TRANSPORT | 10 | 9.16e-01 | -1.92e-02 | 9.85e-01 |
| GOBP RNA SURVEILLANCE | 18 | 8.88e-01 | -1.92e-02 | 9.79e-01 |
| GOBP AROMATIC AMINO ACID FAMILY CATABOLIC PROCESS | 13 | 9.05e-01 | 1.92e-02 | 9.83e-01 |
| GOBP AMINO SUGAR METABOLIC PROCESS | 36 | 8.43e-01 | 1.91e-02 | 9.67e-01 |
| GOBP ACTIVATION OF TRANSMEMBRANE RECEPTOR PROTEIN TYROSINE KINASE ACTIVITY | 5 | 9.41e-01 | -1.91e-02 | 9.89e-01 |
| GOMF HYDROLASE ACTIVITY ACTING ON ESTER BONDS | 648 | 4.10e-01 | 1.90e-02 | 8.26e-01 |
| GOBP MITOCHONDRIAL RESPIRATORY CHAIN COMPLEX ASSEMBLY | 97 | 7.47e-01 | 1.90e-02 | 9.43e-01 |
| GOBP THYMOCYTE APOPTOTIC PROCESS | 16 | 8.95e-01 | -1.90e-02 | 9.81e-01 |
| GOBP POLYOL METABOLIC PROCESS | 89 | 7.58e-01 | 1.89e-02 | 9.46e-01 |
| GOBP GLYCOLIPID CATABOLIC PROCESS | 16 | 8.96e-01 | -1.89e-02 | 9.81e-01 |
| GOBP REGULATION OF ALCOHOL BIOSYNTHETIC PROCESS | 35 | 8.46e-01 | -1.89e-02 | 9.68e-01 |
| GOBP DEVELOPMENTAL GROWTH | 481 | 4.78e-01 | 1.89e-02 | 8.57e-01 |
| GOBP POSITIVE REGULATION OF MACROPHAGE MIGRATION | 20 | 8.84e-01 | 1.89e-02 | 9.78e-01 |
| GOBP MEMBRANE BIOGENESIS | 53 | 8.12e-01 | 1.89e-02 | 9.62e-01 |
| GOBP MACROPHAGE INFLAMMATORY PROTEIN 1 ALPHA PRODUCTION | 5 | 9.42e-01 | -1.89e-02 | 9.89e-01 |
| GOBP RAS PROTEIN SIGNAL TRANSDUCTION | 107 | 7.37e-01 | -1.88e-02 | 9.42e-01 |
| GOBP LAMELLIPODIUM ASSEMBLY | 63 | 7.96e-01 | 1.88e-02 | 9.59e-01 |
| GOBP REGULATION OF PROTEIN LOCALIZATION TO MEMBRANE | 149 | 6.94e-01 | 1.87e-02 | 9.27e-01 |
| GOCC OUTER MEMBRANE | 227 | 6.28e-01 | -1.87e-02 | 9.11e-01 |
| GOBP RESPONSE TO ABIOTIC STIMULUS | 894 | 3.44e-01 | 1.87e-02 | 7.89e-01 |
| GOBP POSITIVE REGULATION OF MYELOID LEUKOCYTE MEDIATED IMMUNITY | 20 | 8.85e-01 | -1.87e-02 | 9.78e-01 |
| GOBP APPENDAGE MORPHOGENESIS | 92 | 7.57e-01 | 1.87e-02 | 9.46e-01 |
| GOBP POSITIVE REGULATION OF TRANSCRIPTION ELONGATION BY RNA POLYMERASE II | 49 | 8.22e-01 | 1.86e-02 | 9.64e-01 |
| GOBP HEMOPOIESIS | 814 | 3.67e-01 | 1.86e-02 | 8.04e-01 |
| GOCC PROTEIN DNA COMPLEX | 1033 | 3.13e-01 | -1.86e-02 | 7.65e-01 |
| GOCC BETA CATENIN TCF COMPLEX | 13 | 9.08e-01 | 1.86e-02 | 9.83e-01 |
| GOBP MICROTUBULE BASED MOVEMENT | 329 | 5.63e-01 | 1.85e-02 | 8.90e-01 |
| GOBP POSITIVE REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY BY P53 CLASS MEDIATOR | 6 | 9.37e-01 | 1.85e-02 | 9.89e-01 |
| GOBP NEGATIVE REGULATION OF MACROPHAGE DERIVED FOAM CELL DIFFERENTIATION | 11 | 9.15e-01 | -1.85e-02 | 9.84e-01 |
| GOBP CYTOSKELETON ORGANIZATION | 1221 | 2.77e-01 | -1.85e-02 | 7.39e-01 |
| GOBP LEYDIG CELL DIFFERENTIATION | 7 | 9.32e-01 | 1.85e-02 | 9.89e-01 |
| GOMF HSP90 PROTEIN BINDING | 38 | 8.44e-01 | 1.85e-02 | 9.68e-01 |
| GOBP MAPK CASCADE | 576 | 4.49e-01 | 1.85e-02 | 8.43e-01 |
| GOBP ANAPHASE PROMOTING COMPLEX DEPENDENT CATABOLIC PROCESS | 23 | 8.78e-01 | 1.84e-02 | 9.77e-01 |
| GOBP ASTROCYTE CELL MIGRATION | 7 | 9.33e-01 | 1.84e-02 | 9.89e-01 |
| GOBP RETROGRADE TRANSPORT VESICLE RECYCLING WITHIN GOLGI | 9 | 9.24e-01 | 1.84e-02 | 9.86e-01 |
| GOMF EFFLUX TRANSMEMBRANE TRANSPORTER ACTIVITY | 11 | 9.16e-01 | -1.84e-02 | 9.84e-01 |
| GOBP RESPONSE TO ZINC ION | 31 | 8.59e-01 | -1.84e-02 | 9.72e-01 |
| GOBP POSITIVE REGULATION OF OSSIFICATION | 36 | 8.48e-01 | -1.84e-02 | 9.68e-01 |
| GOBP MITOCHONDRIAL GENOME MAINTENANCE | 29 | 8.64e-01 | 1.84e-02 | 9.74e-01 |
| GOBP FATTY ACID ELONGATION | 13 | 9.09e-01 | -1.84e-02 | 9.83e-01 |
| GOMF CYTOSKELETAL ANCHOR ACTIVITY | 23 | 8.79e-01 | 1.84e-02 | 9.77e-01 |
| GOBP DETECTION OF MECHANICAL STIMULUS INVOLVED IN SENSORY PERCEPTION OF SOUND | 13 | 9.09e-01 | -1.83e-02 | 9.83e-01 |
| GOBP CARDIAC MUSCLE CELL MEMBRANE REPOLARIZATION | 27 | 8.69e-01 | -1.83e-02 | 9.75e-01 |
| GOBP REGULATION OF STEROID METABOLIC PROCESS | 68 | 7.94e-01 | -1.83e-02 | 9.59e-01 |
| GOMF ASPARTIC ENDOPEPTIDASE ACTIVITY INTRAMEMBRANE CLEAVING | 7 | 9.33e-01 | 1.83e-02 | 9.89e-01 |
| GOBP ANIMAL ORGAN MATURATION | 22 | 8.82e-01 | 1.83e-02 | 9.78e-01 |
| GOBP TRNA THREONYLCARBAMOYLADENOSINE MODIFICATION | 5 | 9.44e-01 | 1.82e-02 | 9.89e-01 |
| GOMF SULFATIDE BINDING | 5 | 9.44e-01 | -1.82e-02 | 9.89e-01 |
| GOMF MODIFIED AMINO ACID BINDING | 79 | 7.80e-01 | -1.82e-02 | 9.55e-01 |
| GOBP POSITIVE REGULATION OF CELLULAR EXTRAVASATION | 17 | 8.97e-01 | -1.82e-02 | 9.81e-01 |
| GOBP AV NODE CELL TO BUNDLE OF HIS CELL COMMUNICATION | 8 | 9.29e-01 | -1.81e-02 | 9.88e-01 |
| GOBP MEDIUM CHAIN FATTY ACYL COA METABOLIC PROCESS | 6 | 9.39e-01 | 1.81e-02 | 9.89e-01 |
| GOMF CYTOSKELETAL PROTEIN BINDING | 832 | 3.76e-01 | 1.81e-02 | 8.10e-01 |
| GOBP ALCOHOL METABOLIC PROCESS | 284 | 6.00e-01 | -1.81e-02 | 9.03e-01 |
| GOBP REGULATION OF VIRAL TRANSCRIPTION | 18 | 8.95e-01 | 1.80e-02 | 9.81e-01 |
| GOBP EMBRYONIC HEART TUBE DEVELOPMENT | 53 | 8.20e-01 | 1.80e-02 | 9.63e-01 |
| GOBP MAINTENANCE OF BLOOD BRAIN BARRIER | 32 | 8.60e-01 | -1.80e-02 | 9.72e-01 |
| GOBP NEUROTRANSMITTER GATED ION CHANNEL CLUSTERING | 10 | 9.21e-01 | 1.80e-02 | 9.86e-01 |
| GOBP MESENCHYMAL CELL DIFFERENTIATION | 176 | 6.81e-01 | 1.80e-02 | 9.24e-01 |
| GOBP POSITIVE REGULATION OF PROTEIN LOCALIZATION TO CILIUM | 6 | 9.39e-01 | -1.80e-02 | 9.89e-01 |
| GOBP WATER SOLUBLE VITAMIN BIOSYNTHETIC PROCESS | 11 | 9.18e-01 | -1.80e-02 | 9.85e-01 |
| GOBP ANGIOGENESIS INVOLVED IN WOUND HEALING | 22 | 8.84e-01 | 1.80e-02 | 9.78e-01 |
| GOBP CELL MORPHOGENESIS INVOLVED IN NEURON DIFFERENTIATION | 415 | 5.30e-01 | -1.80e-02 | 8.78e-01 |
| GOBP MINERALOCORTICOID METABOLIC PROCESS | 8 | 9.30e-01 | -1.80e-02 | 9.88e-01 |
| GOBP PEPTIDYL AMINO ACID MODIFICATION | 695 | 4.20e-01 | 1.79e-02 | 8.30e-01 |
| GOMF DEOXYRIBONUCLEASE I ACTIVITY | 5 | 9.45e-01 | 1.79e-02 | 9.90e-01 |
| GOBP GLIAL CELL ACTIVATION | 46 | 8.33e-01 | -1.79e-02 | 9.64e-01 |
| GOCC PROTON TRANSPORTING V TYPE ATPASE COMPLEX | 24 | 8.79e-01 | 1.79e-02 | 9.77e-01 |
| GOMF OXIDOREDUCTASE ACTIVITY | 593 | 4.58e-01 | -1.79e-02 | 8.46e-01 |
| GOBP ACUTE PHASE RESPONSE | 27 | 8.73e-01 | 1.78e-02 | 9.76e-01 |
| GOCC CLATHRIN COATED ENDOCYTIC VESICLE MEMBRANE | 57 | 8.17e-01 | -1.78e-02 | 9.63e-01 |
| GOBP AMINO SUGAR BIOSYNTHETIC PROCESS | 11 | 9.19e-01 | 1.77e-02 | 9.86e-01 |
| GOBP ACTIVATED T CELL PROLIFERATION | 40 | 8.46e-01 | -1.77e-02 | 9.68e-01 |
| GOBP CARBOHYDRATE DERIVATIVE CATABOLIC PROCESS | 237 | 6.38e-01 | -1.77e-02 | 9.15e-01 |
| GOMF HYDROLASE ACTIVITY ACTING ON CARBON NITROGEN BUT NOT PEPTIDE BONDS IN CYCLIC AMIDES | 11 | 9.19e-01 | 1.77e-02 | 9.86e-01 |
| GOBP REGULATION OF CELL DEVELOPMENT | 649 | 4.42e-01 | -1.77e-02 | 8.41e-01 |
| GOBP POSITIVE REGULATION OF BLOOD VESSEL ENDOTHELIAL CELL MIGRATION | 47 | 8.34e-01 | 1.77e-02 | 9.65e-01 |
| GOBP POSITIVE REGULATION OF MEIOTIC NUCLEAR DIVISION | 7 | 9.35e-01 | 1.77e-02 | 9.89e-01 |
| GOBP IMMUNE RESPONSE REGULATING CELL SURFACE RECEPTOR SIGNALING PATHWAY INVOLVED IN PHAGOCYTOSIS | 21 | 8.89e-01 | -1.77e-02 | 9.79e-01 |
| GOMF SPHINGOLIPID TRANSPORTER ACTIVITY | 18 | 8.97e-01 | 1.77e-02 | 9.81e-01 |
| GOBP NEGATIVE REGULATION OF OSTEOBLAST DIFFERENTIATION | 35 | 8.57e-01 | -1.77e-02 | 9.71e-01 |
| GOBP MITOCHONDRION ORGANIZATION | 481 | 5.08e-01 | -1.76e-02 | 8.68e-01 |
| GOBP REGULATION OF CELL MORPHOGENESIS | 205 | 6.63e-01 | -1.76e-02 | 9.21e-01 |
| GOBP SENSORY PERCEPTION OF TEMPERATURE STIMULUS | 16 | 9.03e-01 | 1.76e-02 | 9.83e-01 |
| GOBP SIGNAL TRANSDUCTION INVOLVED IN REGULATION OF GENE EXPRESSION | 13 | 9.12e-01 | 1.76e-02 | 9.83e-01 |
| GOBP PEPTIDYL TYROSINE DEPHOSPHORYLATION | 26 | 8.77e-01 | 1.76e-02 | 9.76e-01 |
| GOBP HIPPOCAMPAL NEURON APOPTOTIC PROCESS | 5 | 9.46e-01 | 1.76e-02 | 9.90e-01 |
| GOBP CELLULAR HOMEOSTASIS | 634 | 4.50e-01 | -1.76e-02 | 8.43e-01 |
| GOBP AUTOCRINE SIGNALING | 5 | 9.46e-01 | 1.76e-02 | 9.90e-01 |
| GOBP CELLULAR RESPONSE TO COPPER ION | 14 | 9.09e-01 | -1.75e-02 | 9.83e-01 |
| GOBP ACTION POTENTIAL | 111 | 7.50e-01 | 1.75e-02 | 9.44e-01 |
| GOBP LIPOSACCHARIDE METABOLIC PROCESS | 89 | 7.75e-01 | 1.75e-02 | 9.54e-01 |
| GOMF G PROTEIN COUPLED SEROTONIN RECEPTOR ACTIVITY | 7 | 9.36e-01 | 1.75e-02 | 9.89e-01 |
| GOMF LAMININ BINDING | 23 | 8.84e-01 | 1.75e-02 | 9.78e-01 |
| GOBP POSITIVE REGULATION OF MIRNA TRANSCRIPTION | 47 | 8.35e-01 | -1.75e-02 | 9.65e-01 |
| GOBP BERGMANN GLIAL CELL DIFFERENTIATION | 10 | 9.24e-01 | -1.75e-02 | 9.86e-01 |
| GOBP POLYSACCHARIDE BIOSYNTHETIC PROCESS | 49 | 8.32e-01 | -1.75e-02 | 9.64e-01 |
| GOBP ADHESION OF SYMBIONT TO HOST | 10 | 9.24e-01 | -1.75e-02 | 9.86e-01 |
| GOBP PEROXISOME FISSION | 10 | 9.24e-01 | 1.74e-02 | 9.86e-01 |
| GOBP NERVOUS SYSTEM PROCESS | 730 | 4.23e-01 | 1.74e-02 | 8.30e-01 |
| GOBP ORGANELLE DISASSEMBLY | 171 | 6.94e-01 | 1.74e-02 | 9.27e-01 |
| GOBP PROTEIN INSERTION INTO MITOCHONDRIAL INNER MEMBRANE | 13 | 9.14e-01 | 1.73e-02 | 9.84e-01 |
| GOBP NEGATIVE REGULATION OF GENE EXPRESSION VIA CHROMOSOMAL CPG ISLAND METHYLATION | 14 | 9.11e-01 | -1.73e-02 | 9.83e-01 |
| GOCC MICROTUBULE MINUS END | 7 | 9.37e-01 | 1.73e-02 | 9.89e-01 |
| GOBP RESPONSE TO INTERLEUKIN 1 | 83 | 7.85e-01 | -1.73e-02 | 9.57e-01 |
| GOCC FIBRILLAR COLLAGEN TRIMER | 6 | 9.41e-01 | -1.73e-02 | 9.89e-01 |
| GOBP POSITIVE REGULATION OF VASCULAR ASSOCIATED SMOOTH MUSCLE CELL PROLIFERATION | 31 | 8.68e-01 | -1.73e-02 | 9.74e-01 |
| GOBP CELLULAR RESPONSE TO CADMIUM ION | 27 | 8.76e-01 | 1.73e-02 | 9.76e-01 |
| GOMF KINASE ACTIVITY | 650 | 4.53e-01 | 1.73e-02 | 8.43e-01 |
| GOBP REGULATION OF HEMATOPOIETIC STEM CELL DIFFERENTIATION | 15 | 9.08e-01 | 1.73e-02 | 9.83e-01 |
| GOBP POSITIVE REGULATION OF SMOOTHENED SIGNALING PATHWAY | 27 | 8.77e-01 | 1.73e-02 | 9.76e-01 |
| GOBP AMINO ACID CATABOLIC PROCESS | 82 | 7.87e-01 | -1.72e-02 | 9.57e-01 |
| GOBP CEREBELLAR CORTEX DEVELOPMENT | 41 | 8.49e-01 | -1.72e-02 | 9.68e-01 |
| GOBP ENDODERM FORMATION | 46 | 8.40e-01 | -1.72e-02 | 9.67e-01 |
| GOBP G2 MI TRANSITION OF MEIOTIC CELL CYCLE | 6 | 9.42e-01 | 1.72e-02 | 9.89e-01 |
| GOBP DEOXYRIBONUCLEOTIDE CATABOLIC PROCESS | 25 | 8.82e-01 | -1.72e-02 | 9.78e-01 |
| GOBP SIGNAL TRANSDUCTION BY P53 CLASS MEDIATOR | 161 | 7.07e-01 | 1.72e-02 | 9.32e-01 |
| GOMF DEUBIQUITINASE ACTIVATOR ACTIVITY | 7 | 9.37e-01 | 1.72e-02 | 9.89e-01 |
| GOBP PHOSPHATIDYLSERINE EXPOSURE ON APOPTOTIC CELL SURFACE | 6 | 9.42e-01 | -1.71e-02 | 9.89e-01 |
| GOBP REGULATION OF STORE OPERATED CALCIUM ENTRY | 12 | 9.18e-01 | -1.71e-02 | 9.85e-01 |
| GOBP CALCIUM ION TRANSMEMBRANE TRANSPORT VIA HIGH VOLTAGE GATED CALCIUM CHANNEL | 15 | 9.09e-01 | 1.71e-02 | 9.83e-01 |
| GOBP POSITIVE REGULATION OF IMMUNOGLOBULIN PRODUCTION | 47 | 8.39e-01 | 1.71e-02 | 9.66e-01 |
| GOBP CHAPERONE MEDIATED AUTOPHAGY | 15 | 9.09e-01 | 1.71e-02 | 9.83e-01 |
| GOBP REGULATION OF ESTABLISHMENT OF T CELL POLARITY | 6 | 9.42e-01 | -1.71e-02 | 9.89e-01 |
| GOBP PROTEIN LOCALIZATION TO PLASMA MEMBRANE | 242 | 6.48e-01 | 1.70e-02 | 9.16e-01 |
| GOBP INTEGRATED STRESS RESPONSE SIGNALING | 47 | 8.40e-01 | 1.70e-02 | 9.67e-01 |
| GOBP NEGATIVE REGULATION OF BLOOD PRESSURE | 32 | 8.68e-01 | 1.70e-02 | 9.74e-01 |
| GOMF KINASE BINDING | 693 | 4.48e-01 | -1.69e-02 | 8.43e-01 |
| GOCC CLATHRIN VESICLE COAT | 31 | 8.71e-01 | -1.69e-02 | 9.75e-01 |
| GOBP REGULATION OF CLATHRIN DEPENDENT ENDOCYTOSIS | 16 | 9.07e-01 | 1.69e-02 | 9.83e-01 |
| GOBP REGULATION OF CELLULAR RESPONSE TO VASCULAR ENDOTHELIAL GROWTH FACTOR STIMULUS | 17 | 9.04e-01 | 1.69e-02 | 9.83e-01 |
| GOBP NEURON DEVELOPMENT | 833 | 4.08e-01 | 1.69e-02 | 8.26e-01 |
| GOMF CATALYTIC ACTIVITY ACTING ON A GLYCOPROTEIN | 18 | 9.01e-01 | -1.69e-02 | 9.82e-01 |
| GOBP NON PROTEINOGENIC AMINO ACID METABOLIC PROCESS | 56 | 8.27e-01 | -1.68e-02 | 9.64e-01 |
| GOBP REGULATION OF MYELINATION | 37 | 8.59e-01 | 1.68e-02 | 9.72e-01 |
| GOBP CELLULAR RESPONSE TO ALKALOID | 30 | 8.73e-01 | 1.68e-02 | 9.76e-01 |
| GOBP REGULATION OF DNA TEMPLATED TRANSCRIPTION ELONGATION | 98 | 7.74e-01 | 1.68e-02 | 9.54e-01 |
| GOBP NEURAL TUBE PATTERNING | 22 | 8.92e-01 | -1.68e-02 | 9.80e-01 |
| GOBP POSITIVE REGULATION OF REPRODUCTIVE PROCESS | 49 | 8.39e-01 | -1.67e-02 | 9.66e-01 |
| GOBP EPITHELIAL CILIUM MOVEMENT INVOLVED IN DETERMINATION OF LEFT RIGHT ASYMMETRY | 11 | 9.23e-01 | -1.67e-02 | 9.86e-01 |
| GOBP MAINTENANCE OF LOCATION IN CELL | 185 | 6.95e-01 | -1.67e-02 | 9.27e-01 |
| GOBP CARBOHYDRATE DERIVATIVE METABOLIC PROCESS | 939 | 3.86e-01 | 1.67e-02 | 8.16e-01 |
| GOBP RESPONSE TO NUTRIENT | 120 | 7.52e-01 | -1.67e-02 | 9.45e-01 |
| GOBP REGULATION OF FLAGELLATED SPERM MOTILITY | 5 | 9.49e-01 | 1.67e-02 | 9.91e-01 |
| GOBP EMBRYO DEVELOPMENT ENDING IN BIRTH OR EGG HATCHING | 491 | 5.28e-01 | -1.66e-02 | 8.76e-01 |
| GOBP CRANIAL NERVE FORMATION | 7 | 9.39e-01 | 1.66e-02 | 9.89e-01 |
| GOCC CELL SUBSTRATE JUNCTION | 396 | 5.70e-01 | 1.66e-02 | 8.90e-01 |
| GOBP EPITHELIAL CELL DEVELOPMENT | 164 | 7.13e-01 | 1.66e-02 | 9.35e-01 |
| GOCC SCHAFFER COLLATERAL CA1 SYNAPSE | 70 | 8.10e-01 | 1.66e-02 | 9.61e-01 |
| GOBP DOPAMINE METABOLIC PROCESS | 25 | 8.86e-01 | -1.66e-02 | 9.78e-01 |
| GOBP NUCLEOBASE CONTAINING SMALL MOLECULE METABOLIC PROCESS | 593 | 4.90e-01 | 1.66e-02 | 8.61e-01 |
| GOBP REGULATION OF NEUTROPHIL ACTIVATION | 5 | 9.49e-01 | -1.66e-02 | 9.91e-01 |
| GOBP POSITIVE REGULATION OF NEURAL PRECURSOR CELL PROLIFERATION | 35 | 8.65e-01 | -1.66e-02 | 9.74e-01 |
| GOMF ATP GATED ION CHANNEL ACTIVITY | 6 | 9.44e-01 | -1.66e-02 | 9.89e-01 |
| GOMF CLATHRIN LIGHT CHAIN BINDING | 6 | 9.44e-01 | -1.66e-02 | 9.89e-01 |
| GOBP BASEMENT MEMBRANE ORGANIZATION | 31 | 8.73e-01 | -1.66e-02 | 9.76e-01 |
| GOBP BLOOD VESSEL MORPHOGENESIS | 463 | 5.41e-01 | -1.66e-02 | 8.81e-01 |
| GOBP POSITIVE REGULATION OF GROWTH | 186 | 6.97e-01 | -1.65e-02 | 9.28e-01 |
| GOBP REGULATION OF CIRCADIAN RHYTHM | 89 | 7.88e-01 | -1.65e-02 | 9.57e-01 |
| GOMF CARBONYL REDUCTASE NADPH ACTIVITY | 9 | 9.32e-01 | -1.65e-02 | 9.88e-01 |
| GOMF MALATE DEHYDROGENASE ACTIVITY | 6 | 9.44e-01 | -1.65e-02 | 9.90e-01 |
| GOMF MONOATOMIC ANION TRANSMEMBRANE TRANSPORTER ACTIVITY | 89 | 7.88e-01 | -1.65e-02 | 9.58e-01 |
| GOCC HEMIDESMOSOME | 7 | 9.40e-01 | -1.64e-02 | 9.89e-01 |
| GOMF CALCIUM DEPENDENT PHOSPHOLIPID BINDING | 39 | 8.59e-01 | 1.64e-02 | 9.72e-01 |
| GOBP REGULATION OF GLUCOCORTICOID SECRETION | 7 | 9.40e-01 | -1.64e-02 | 9.89e-01 |
| GOBP LACTATE METABOLIC PROCESS | 15 | 9.12e-01 | -1.64e-02 | 9.83e-01 |
| GOBP FACIAL NERVE MORPHOGENESIS | 7 | 9.40e-01 | 1.64e-02 | 9.89e-01 |
| GOBP NEGATIVE REGULATION OF DNA METABOLIC PROCESS | 122 | 7.55e-01 | -1.64e-02 | 9.45e-01 |
| GOBP NUCLEOSIDE BISPHOSPHATE CATABOLIC PROCESS | 12 | 9.22e-01 | 1.64e-02 | 9.86e-01 |
| GOBP COENZYME A METABOLIC PROCESS | 18 | 9.05e-01 | 1.63e-02 | 9.83e-01 |
| GOBP CALCIUM ION TRANSPORT INTO CYTOSOL | 17 | 9.07e-01 | -1.63e-02 | 9.83e-01 |
| GOBP SODIUM DEPENDENT PHOSPHATE TRANSPORT | 7 | 9.40e-01 | -1.63e-02 | 9.89e-01 |
| GOBP POSITIVE REGULATION OF MACROPHAGE CHEMOTAXIS | 15 | 9.13e-01 | -1.63e-02 | 9.83e-01 |
| GOBP SECRETION OF LYSOSOMAL ENZYMES | 7 | 9.41e-01 | -1.63e-02 | 9.89e-01 |
| GOBP GERMINAL CENTER B CELL DIFFERENTIATION | 5 | 9.50e-01 | 1.63e-02 | 9.91e-01 |
| GOBP CELLULAR RESPONSE TO CALCIUM ION | 56 | 8.33e-01 | -1.63e-02 | 9.64e-01 |
| GOBP XENOBIOTIC CATABOLIC PROCESS | 18 | 9.05e-01 | 1.63e-02 | 9.83e-01 |
| GOBP POSITIVE REGULATION OF INTERLEUKIN 6 PRODUCTION | 83 | 7.98e-01 | -1.62e-02 | 9.59e-01 |
| GOBP NEGATIVE REGULATION OF DNA RECOMBINATION | 45 | 8.51e-01 | -1.62e-02 | 9.69e-01 |
| GOBP NEGATIVE REGULATION OF CELLULAR COMPONENT ORGANIZATION | 599 | 4.98e-01 | 1.62e-02 | 8.62e-01 |
| GOBP PURINE CONTAINING COMPOUND TRANSMEMBRANE TRANSPORT | 31 | 8.76e-01 | 1.62e-02 | 9.76e-01 |
| GOMF CHROMATIN PROTEIN ADAPTOR ACTIVITY | 30 | 8.78e-01 | 1.62e-02 | 9.77e-01 |
| GOBP REGULATION OF PROTEASOMAL UBIQUITIN DEPENDENT PROTEIN CATABOLIC PROCESS | 118 | 7.62e-01 | 1.62e-02 | 9.48e-01 |
| GOBP CARDIAC VENTRICLE DEVELOPMENT | 80 | 8.03e-01 | -1.62e-02 | 9.61e-01 |
| GOBP REGULATION OF CHOLESTEROL BIOSYNTHETIC PROCESS | 14 | 9.17e-01 | -1.62e-02 | 9.85e-01 |
| GOCC AZUROPHIL GRANULE | 151 | 7.32e-01 | -1.61e-02 | 9.41e-01 |
| GOBP T CELL APOPTOTIC PROCESS | 53 | 8.39e-01 | 1.61e-02 | 9.66e-01 |
| GOCC SARCOPLASM | 73 | 8.12e-01 | -1.61e-02 | 9.62e-01 |
| GOBP IN UTERO EMBRYONIC DEVELOPMENT | 321 | 6.21e-01 | -1.61e-02 | 9.09e-01 |
| GOBP CELL CELL RECOGNITION | 44 | 8.54e-01 | -1.60e-02 | 9.70e-01 |
| GOBP CARDIAC ATRIUM MORPHOGENESIS | 14 | 9.17e-01 | 1.60e-02 | 9.85e-01 |
| GOBP REGULATION OF ENDOCYTOSIS | 238 | 6.71e-01 | 1.60e-02 | 9.22e-01 |
| GOBP LIMBIC SYSTEM DEVELOPMENT | 79 | 8.06e-01 | -1.60e-02 | 9.61e-01 |
| GOBP SPECIFICATION OF SYMMETRY | 96 | 7.87e-01 | -1.60e-02 | 9.57e-01 |
| GOBP PALLIUM DEVELOPMENT | 141 | 7.43e-01 | 1.60e-02 | 9.42e-01 |
| GOCC SWI SNF SUPERFAMILY TYPE COMPLEX | 90 | 7.94e-01 | -1.60e-02 | 9.59e-01 |
| GOBP SOMITE DEVELOPMENT | 52 | 8.42e-01 | 1.59e-02 | 9.67e-01 |
| GOBP CARNITINE TRANSMEMBRANE TRANSPORT | 5 | 9.51e-01 | 1.59e-02 | 9.91e-01 |
| GOBP CELLULAR MODIFIED AMINO ACID METABOLIC PROCESS | 144 | 7.42e-01 | 1.59e-02 | 9.42e-01 |
| GOBP CELLULAR RESPONSE TO ACID CHEMICAL | 71 | 8.17e-01 | 1.59e-02 | 9.63e-01 |
| GOBP POSITIVE REGULATION OF NEUROTRANSMITTER TRANSPORT | 19 | 9.05e-01 | -1.59e-02 | 9.83e-01 |
| GOBP MACROPHAGE CYTOKINE PRODUCTION | 33 | 8.75e-01 | 1.59e-02 | 9.76e-01 |
| GOBP COMPLEMENT ACTIVATION | 45 | 8.54e-01 | -1.59e-02 | 9.70e-01 |
| GOBP POSTSYNAPSE TO NUCLEUS SIGNALING PATHWAY | 5 | 9.51e-01 | -1.59e-02 | 9.91e-01 |
| GOMF TRANSFORMING GROWTH FACTOR BETA RECEPTOR ACTIVITY | 11 | 9.28e-01 | -1.58e-02 | 9.87e-01 |
| GOBP IMPORT ACROSS PLASMA MEMBRANE | 137 | 7.51e-01 | 1.57e-02 | 9.45e-01 |
| GOBP EXPLORATION BEHAVIOR | 22 | 8.99e-01 | 1.57e-02 | 9.82e-01 |
| GOCC ENDOCYTIC VESICLE MEMBRANE | 169 | 7.25e-01 | 1.57e-02 | 9.38e-01 |
| GOBP POSITIVE REGULATION OF CELL ACTIVATION | 329 | 6.26e-01 | -1.56e-02 | 9.10e-01 |
| GOBP L AMINO ACID METABOLIC PROCESS | 141 | 7.49e-01 | -1.56e-02 | 9.44e-01 |
| GOCC LAMELLIPODIUM MEMBRANE | 18 | 9.09e-01 | -1.56e-02 | 9.83e-01 |
| GOBP REGULATION OF SMALL GTPASE MEDIATED SIGNAL TRANSDUCTION | 263 | 6.64e-01 | -1.56e-02 | 9.22e-01 |
| GOBP ROOF OF MOUTH DEVELOPMENT | 61 | 8.34e-01 | 1.56e-02 | 9.64e-01 |
| GOBP NEGATIVE REGULATION OF RNA BIOSYNTHETIC PROCESS | 984 | 4.09e-01 | -1.55e-02 | 8.26e-01 |
| GOBP NEUROTRANSMITTER UPTAKE | 30 | 8.83e-01 | 1.55e-02 | 9.78e-01 |
| GOBP POLYAMINE BIOSYNTHETIC PROCESS | 14 | 9.20e-01 | -1.55e-02 | 9.86e-01 |
| GOBP ALPHA BETA T CELL ACTIVATION | 169 | 7.29e-01 | 1.55e-02 | 9.39e-01 |
| GOBP FATTY ACYL COA METABOLIC PROCESS | 38 | 8.69e-01 | 1.55e-02 | 9.75e-01 |
| GOCC STRIATED MUSCLE THIN FILAMENT | 14 | 9.20e-01 | -1.54e-02 | 9.86e-01 |
| GOBP REGULATION OF SYNAPTIC VESICLE TRANSPORT | 5 | 9.52e-01 | -1.54e-02 | 9.92e-01 |
| GOBP ADAPTIVE IMMUNE RESPONSE BASED ON SOMATIC RECOMBINATION OF IMMUNE RECEPTORS BUILT FROM IMMUNOGLOBULIN SUPERFAMILY DOMAINS | 334 | 6.29e-01 | 1.54e-02 | 9.11e-01 |
| GOBP INTRACELLULAR IRON ION HOMEOSTASIS | 64 | 8.32e-01 | -1.54e-02 | 9.64e-01 |
| GOBP SMOOTH MUSCLE TISSUE DEVELOPMENT | 13 | 9.24e-01 | -1.53e-02 | 9.86e-01 |
| GOBP MAINTENANCE OF PROTEIN LOCATION | 78 | 8.15e-01 | 1.53e-02 | 9.62e-01 |
| GOBP SODIUM ION TRANSMEMBRANE TRANSPORT | 128 | 7.65e-01 | -1.53e-02 | 9.49e-01 |
| GOCC PLASMA MEMBRANE RAFT | 89 | 8.03e-01 | -1.53e-02 | 9.61e-01 |
| GOBP NEGATIVE REGULATION OF CELLULAR RESPONSE TO VASCULAR ENDOTHELIAL GROWTH FACTOR STIMULUS | 9 | 9.37e-01 | -1.53e-02 | 9.89e-01 |
| GOMF PHOSPHATASE ACTIVATOR ACTIVITY | 18 | 9.11e-01 | 1.53e-02 | 9.83e-01 |
| GOCC PERICENTRIC HETEROCHROMATIN | 28 | 8.89e-01 | 1.53e-02 | 9.79e-01 |
| GOBP MORPHOGENESIS OF A POLARIZED EPITHELIUM | 48 | 8.55e-01 | -1.52e-02 | 9.71e-01 |
| GOBP MONONUCLEAR CELL DIFFERENTIATION | 450 | 5.80e-01 | 1.52e-02 | 8.93e-01 |
| GOMF TRANSCRIPTION COREGULATOR ACTIVITY | 456 | 5.78e-01 | -1.52e-02 | 8.92e-01 |
| GOMF PHOSPHOTYROSINE RESIDUE BINDING | 45 | 8.60e-01 | -1.52e-02 | 9.72e-01 |
| GOBP POSITIVE REGULATION OF GLIOGENESIS | 53 | 8.49e-01 | -1.52e-02 | 9.68e-01 |
| GOBP CELLULAR RESPONSE TO EXTERNAL STIMULUS | 65 | 8.33e-01 | -1.52e-02 | 9.64e-01 |
| GOBP POSITIVE REGULATION OF MYOBLAST DIFFERENTIATION | 33 | 8.81e-01 | 1.51e-02 | 9.77e-01 |
| GOMF VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR 2 BINDING | 9 | 9.38e-01 | -1.50e-02 | 9.89e-01 |
| GOBP REGULATION OF DOUBLE STRAND BREAK REPAIR | 133 | 7.65e-01 | -1.50e-02 | 9.49e-01 |
| GOBP NEGATIVE REGULATION OF CYCLIN DEPENDENT PROTEIN SERINE THREONINE KINASE ACTIVITY | 18 | 9.12e-01 | -1.50e-02 | 9.83e-01 |
| GOBP CELL MORPHOGENESIS | 721 | 4.93e-01 | 1.50e-02 | 8.62e-01 |
| GOMF AMYLOID BETA BINDING | 70 | 8.28e-01 | 1.50e-02 | 9.64e-01 |
| GOBP REGULATION OF HORMONE LEVELS | 360 | 6.26e-01 | -1.50e-02 | 9.10e-01 |
| GOBP EPIGENETIC PROGRAMMING IN THE ZYGOTIC PRONUCLEI | 11 | 9.32e-01 | 1.50e-02 | 9.88e-01 |
| GOBP PHOSPHOLIPASE C ACTIVATING G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY | 70 | 8.29e-01 | 1.49e-02 | 9.64e-01 |
| GOCC LOW DENSITY LIPOPROTEIN PARTICLE | 9 | 9.38e-01 | -1.49e-02 | 9.89e-01 |
| GOBP REGULATION OF INTEGRIN MEDIATED SIGNALING PATHWAY | 19 | 9.10e-01 | 1.49e-02 | 9.83e-01 |
| GOBP REGULATION OF LIPID TRANSPORT | 102 | 7.95e-01 | -1.49e-02 | 9.59e-01 |
| GOMF ANTIPORTER ACTIVITY | 108 | 7.90e-01 | 1.48e-02 | 9.59e-01 |
| GOBP SYNAPTIC SIGNALING | 520 | 5.63e-01 | 1.48e-02 | 8.90e-01 |
| GOBP EMBRYONIC APPENDAGE MORPHOGENESIS | 73 | 8.27e-01 | -1.48e-02 | 9.64e-01 |
| GOBP ESTABLISHMENT OR MAINTENANCE OF CELL POLARITY | 194 | 7.23e-01 | -1.48e-02 | 9.38e-01 |
| GOBP STEM CELL DIFFERENTIATION | 169 | 7.42e-01 | 1.47e-02 | 9.42e-01 |
| GOMF ACTIVE MONOATOMIC ION TRANSMEMBRANE TRANSPORTER ACTIVITY | 218 | 7.09e-01 | -1.47e-02 | 9.33e-01 |
| GOBP POSITIVE REGULATION OF MONOATOMIC ION TRANSPORT | 152 | 7.55e-01 | -1.47e-02 | 9.45e-01 |
| GOBP POSITIVE REGULATION OF CELLULAR CATABOLIC PROCESS | 194 | 7.26e-01 | 1.46e-02 | 9.38e-01 |
| GOMF AZOLE TRANSMEMBRANE TRANSPORTER ACTIVITY | 10 | 9.36e-01 | -1.46e-02 | 9.89e-01 |
| GOBP CELL PROLIFERATION IN BONE MARROW | 6 | 9.51e-01 | -1.46e-02 | 9.91e-01 |
| GOBP T CELL ACTIVATION | 497 | 5.79e-01 | 1.46e-02 | 8.92e-01 |
| GOBP TRNA WOBBLE BASE MODIFICATION | 20 | 9.10e-01 | 1.46e-02 | 9.83e-01 |
| GOBP REGULATION OF PROTEIN KINASE C SIGNALING | 15 | 9.22e-01 | 1.45e-02 | 9.86e-01 |
| GOBP ALPHA BETA T CELL DIFFERENTIATION | 114 | 7.89e-01 | 1.45e-02 | 9.58e-01 |
| GOBP RESPONSE TO ESTROGEN | 45 | 8.66e-01 | 1.45e-02 | 9.74e-01 |
| GOBP POSITIVE REGULATION OF STRIATED MUSCLE CELL APOPTOTIC PROCESS | 9 | 9.40e-01 | -1.45e-02 | 9.89e-01 |
| GOBP REGULATION OF MEMBRANE DEPOLARIZATION | 32 | 8.87e-01 | -1.45e-02 | 9.78e-01 |
| GOMF U6 SNRNA BINDING | 14 | 9.25e-01 | 1.45e-02 | 9.86e-01 |
| GOMF BICARBONATE MONOATOMIC ANION ANTIPORTER ACTIVITY | 7 | 9.47e-01 | 1.44e-02 | 9.91e-01 |
| GOBP POSITIVE REGULATION OF PEPTIDASE ACTIVITY | 143 | 7.66e-01 | 1.44e-02 | 9.49e-01 |
| GOCC ROUGH ENDOPLASMIC RETICULUM | 53 | 8.56e-01 | 1.44e-02 | 9.71e-01 |
| GOBP REGULATION OF BARBED END ACTIN FILAMENT CAPPING | 5 | 9.56e-01 | -1.43e-02 | 9.94e-01 |
| GOBP REGULATION OF CD4 POSITIVE ALPHA BETA T CELL ACTIVATION | 74 | 8.31e-01 | 1.43e-02 | 9.64e-01 |
| GOBP ENZYME LINKED RECEPTOR PROTEIN SIGNALING PATHWAY | 721 | 5.13e-01 | -1.43e-02 | 8.71e-01 |
| GOBP NEGATIVE REGULATION OF ACTIVATED T CELL PROLIFERATION | 14 | 9.26e-01 | -1.43e-02 | 9.86e-01 |
| GOBP RESPONSE TO GROWTH FACTOR | 523 | 5.77e-01 | -1.43e-02 | 8.92e-01 |
| GOBP MONOCYTE ACTIVATION | 10 | 9.38e-01 | -1.43e-02 | 9.89e-01 |
| GOBP PROTEIN IMPORT INTO PEROXISOME MEMBRANE | 6 | 9.52e-01 | 1.42e-02 | 9.92e-01 |
| GOMF PROTEIN HETERODIMERIZATION ACTIVITY | 239 | 7.05e-01 | 1.42e-02 | 9.32e-01 |
| GOBP MULTICELLULAR ORGANISMAL LEVEL HOMEOSTASIS | 642 | 5.39e-01 | 1.42e-02 | 8.80e-01 |
| GOBP REGULATION OF ANATOMICAL STRUCTURE SIZE | 395 | 6.29e-01 | -1.42e-02 | 9.11e-01 |
| GOBP MITOCHONDRION LOCALIZATION | 45 | 8.69e-01 | 1.42e-02 | 9.75e-01 |
| GOCC VACUOLAR MEMBRANE | 460 | 6.02e-01 | 1.42e-02 | 9.03e-01 |
| GOMF O ACYLTRANSFERASE ACTIVITY | 45 | 8.69e-01 | 1.42e-02 | 9.75e-01 |
| GOBP OLIGOSACCHARIDE BIOSYNTHETIC PROCESS | 21 | 9.11e-01 | 1.42e-02 | 9.83e-01 |
| GOBP NEGATIVE REGULATION OF CYCLASE ACTIVITY | 10 | 9.38e-01 | 1.41e-02 | 9.89e-01 |
| GOMF CELL ADHESION MOLECULE BINDING | 452 | 6.07e-01 | -1.41e-02 | 9.03e-01 |
| GOMF PRERIBOSOME BINDING | 6 | 9.52e-01 | 1.41e-02 | 9.92e-01 |
| GOBP POSITIVE REGULATION OF ATTACHMENT OF SPINDLE MICROTUBULES TO KINETOCHORE | 11 | 9.36e-01 | -1.41e-02 | 9.89e-01 |
| GOBP LUNG CELL DIFFERENTIATION | 16 | 9.22e-01 | 1.41e-02 | 9.86e-01 |
| GOMF TRANSFORMING GROWTH FACTOR BETA BINDING | 22 | 9.09e-01 | -1.41e-02 | 9.83e-01 |
| GOMF PROTEIN DOMAIN SPECIFIC BINDING | 570 | 5.66e-01 | 1.41e-02 | 8.90e-01 |
| GOCC PRE SNORNP COMPLEX | 7 | 9.49e-01 | 1.41e-02 | 9.91e-01 |
| GOMF OSMOSENSOR ACTIVITY | 5 | 9.57e-01 | 1.41e-02 | 9.94e-01 |
| GOBP REGULATION OF MULTICELLULAR ORGANISMAL DEVELOPMENT | 1063 | 4.39e-01 | -1.41e-02 | 8.39e-01 |
| GOBP TRANSCRIPTION ELONGATION BY RNA POLYMERASE I | 7 | 9.49e-01 | -1.41e-02 | 9.91e-01 |
| GOCC ORGANELLE ENVELOPE | 1175 | 4.18e-01 | 1.40e-02 | 8.30e-01 |
| GOBP RESPIRATORY SYSTEM PROCESS | 34 | 8.87e-01 | -1.40e-02 | 9.78e-01 |
| GOMF 3 5 DNA HELICASE ACTIVITY | 15 | 9.25e-01 | 1.40e-02 | 9.86e-01 |
| GOBP SNRNA 3 END PROCESSING | 21 | 9.12e-01 | 1.40e-02 | 9.83e-01 |
| GOBP APPENDAGE DEVELOPMENT | 117 | 7.94e-01 | -1.40e-02 | 9.59e-01 |
| GOBP REGULATION OF MONOATOMIC ION TRANSMEMBRANE TRANSPORT | 233 | 7.14e-01 | 1.39e-02 | 9.35e-01 |
| GOBP EMBRYONIC CAMERA TYPE EYE MORPHOGENESIS | 12 | 9.34e-01 | 1.39e-02 | 9.89e-01 |
| GOBP MUSCLE ADAPTATION | 78 | 8.32e-01 | -1.39e-02 | 9.64e-01 |
| GOCC CYTOSOLIC SMALL RIBOSOMAL SUBUNIT | 43 | 8.75e-01 | 1.39e-02 | 9.76e-01 |
| GOBP OXIDATIVE PHOSPHORYLATION | 138 | 7.79e-01 | -1.39e-02 | 9.54e-01 |
| GOBP REGULATION OF CALCIUM MEDIATED SIGNALING | 73 | 8.38e-01 | 1.39e-02 | 9.66e-01 |
| GOBP NEGATIVE REGULATION OF INTRACELLULAR ESTROGEN RECEPTOR SIGNALING PATHWAY | 12 | 9.34e-01 | 1.38e-02 | 9.89e-01 |
| GOMF SECONDARY ACTIVE TRANSMEMBRANE TRANSPORTER ACTIVITY | 204 | 7.34e-01 | -1.38e-02 | 9.41e-01 |
| GOBP EMBRYONIC HEART TUBE MORPHOGENESIS | 46 | 8.71e-01 | 1.38e-02 | 9.76e-01 |
| GOBP FATTY ACID DERIVATIVE BIOSYNTHETIC PROCESS | 41 | 8.79e-01 | 1.38e-02 | 9.77e-01 |
| GOBP TRANSCRIPTION BY RNA POLYMERASE III | 61 | 8.52e-01 | 1.38e-02 | 9.69e-01 |
| GOMF HISTONE H3K9 METHYLTRANSFERASE ACTIVITY | 11 | 9.37e-01 | 1.37e-02 | 9.89e-01 |
| GOBP VENTRICULAR CARDIAC MUSCLE TISSUE MORPHOGENESIS | 28 | 9.00e-01 | -1.37e-02 | 9.82e-01 |
| GOBP ANIMAL ORGAN REGENERATION | 57 | 8.58e-01 | -1.37e-02 | 9.72e-01 |
| GOMF PROTEIN CONTAINING COMPLEX BINDING | 1475 | 3.79e-01 | -1.37e-02 | 8.12e-01 |
| GOBP TRANSITION METAL ION TRANSPORT | 83 | 8.29e-01 | -1.37e-02 | 9.64e-01 |
| GOBP PROTEIN KINASE C SIGNALING | 25 | 9.06e-01 | -1.37e-02 | 9.83e-01 |
| GOBP ASPARTATE FAMILY AMINO ACID BIOSYNTHETIC PROCESS | 18 | 9.20e-01 | 1.37e-02 | 9.86e-01 |
| GOBP REGULATION OF BROWN FAT CELL DIFFERENTIATION | 18 | 9.20e-01 | 1.37e-02 | 9.86e-01 |
| GOMF HISTONE MODIFYING ACTIVITY | 193 | 7.44e-01 | 1.36e-02 | 9.42e-01 |
| GOBP CELL ACTIVATION | 947 | 4.79e-01 | 1.36e-02 | 8.58e-01 |
| GOBP CELLULAR RESPONSE TO CORTICOSTEROID STIMULUS | 47 | 8.72e-01 | 1.36e-02 | 9.76e-01 |
| GOBP VACUOLAR LOCALIZATION | 76 | 8.38e-01 | 1.36e-02 | 9.66e-01 |
| GOBP REGULATION OF ESTABLISHMENT OF PROTEIN LOCALIZATION TO MITOCHONDRION | 44 | 8.76e-01 | -1.36e-02 | 9.76e-01 |
| GOCC GTPASE ACTIVATOR COMPLEX | 11 | 9.38e-01 | 1.36e-02 | 9.89e-01 |
| GOCC BRUSH BORDER MEMBRANE | 41 | 8.81e-01 | -1.36e-02 | 9.77e-01 |
| GOBP EAR DEVELOPMENT | 128 | 7.93e-01 | -1.35e-02 | 9.59e-01 |
| GOBP FATTY ACID HOMEOSTASIS | 12 | 9.36e-01 | -1.34e-02 | 9.89e-01 |
| GOBP VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR SIGNALING PATHWAY | 44 | 8.78e-01 | -1.34e-02 | 9.77e-01 |
| GOMF ACYLTRANSFERASE ACTIVITY TRANSFERRING GROUPS OTHER THAN AMINO ACYL GROUPS | 193 | 7.49e-01 | 1.34e-02 | 9.44e-01 |
| GOBP REGULATION OF LYMPHOCYTE ACTIVATION | 442 | 6.30e-01 | 1.34e-02 | 9.12e-01 |
| GOBP REGULATION OF LIPID METABOLIC PROCESS | 234 | 7.25e-01 | -1.33e-02 | 9.38e-01 |
| GOBP SELF PROTEOLYSIS | 9 | 9.45e-01 | 1.33e-02 | 9.90e-01 |
| GOBP REGULATION OF CHOLESTEROL STORAGE | 15 | 9.29e-01 | 1.32e-02 | 9.88e-01 |
| GOBP NON CANONICAL NF KAPPAB SIGNAL TRANSDUCTION | 110 | 8.11e-01 | -1.32e-02 | 9.62e-01 |
| GOBP MITOCHONDRIAL CALCIUM ION HOMEOSTASIS | 23 | 9.13e-01 | 1.32e-02 | 9.83e-01 |
| GOBP RESPONSE TO RADIATION | 358 | 6.68e-01 | 1.32e-02 | 9.22e-01 |
| GOBP POSITIVE REGULATION OF PROTEIN LOCALIZATION | 409 | 6.47e-01 | 1.32e-02 | 9.16e-01 |
| GOMF PROTEIN PHOSPHATASE 1 BINDING | 23 | 9.13e-01 | -1.32e-02 | 9.83e-01 |
| GOBP GASTRULATION | 144 | 7.85e-01 | -1.32e-02 | 9.57e-01 |
| GOCC NEURON PROJECTION TERMINUS | 81 | 8.38e-01 | -1.31e-02 | 9.66e-01 |
| GOBP POSITIVE REGULATION OF HORMONE SECRETION | 96 | 8.24e-01 | 1.31e-02 | 9.64e-01 |
| GOBP REGULATION OF ATP BIOSYNTHETIC PROCESS | 12 | 9.37e-01 | -1.31e-02 | 9.89e-01 |
| GOMF METHYLATION DEPENDENT PROTEIN BINDING | 78 | 8.42e-01 | 1.31e-02 | 9.67e-01 |
| GOCC CYTOSOLIC REGION | 19 | 9.21e-01 | -1.31e-02 | 9.86e-01 |
| GOBP IMPORT INTO CELL | 735 | 5.47e-01 | 1.31e-02 | 8.84e-01 |
| GOBP REGULATION OF OXIDATIVE PHOSPHORYLATION | 22 | 9.16e-01 | 1.31e-02 | 9.84e-01 |
| GOBP REGULATION OF VASCULATURE DEVELOPMENT | 227 | 7.35e-01 | 1.30e-02 | 9.42e-01 |
| GOCC MHC CLASS I PROTEIN COMPLEX | 9 | 9.46e-01 | 1.30e-02 | 9.90e-01 |
| GOBP REGULATION OF PHOSPHATIDYLCHOLINE BIOSYNTHETIC PROCESS | 5 | 9.60e-01 | 1.30e-02 | 9.94e-01 |
| GOBP REGULATION OF CYTOPLASMIC TRANSLATIONAL INITIATION | 8 | 9.49e-01 | -1.30e-02 | 9.91e-01 |
| GOBP POSITIVE REGULATION OF INTEGRIN MEDIATED SIGNALING PATHWAY | 12 | 9.38e-01 | -1.29e-02 | 9.89e-01 |
| GOBP REGULATION OF NEUTROPHIL CHEMOTAXIS | 29 | 9.04e-01 | 1.29e-02 | 9.83e-01 |
| GOBP POSITIVE REGULATION OF HEAT GENERATION | 8 | 9.50e-01 | -1.29e-02 | 9.91e-01 |
| GOMF PHOSPHATIDYLCHOLINE BINDING | 24 | 9.13e-01 | 1.29e-02 | 9.83e-01 |
| GOMF RNA ENDONUCLEASE ACTIVITY PRODUCING 5 PHOSPHOMONOESTERS | 31 | 9.01e-01 | -1.29e-02 | 9.82e-01 |
| GOBP DOUBLE STRAND BREAK REPAIR VIA SINGLE STRAND ANNEALING | 8 | 9.50e-01 | -1.29e-02 | 9.91e-01 |
| GOBP DNA TEMPLATED TRANSCRIPTION INITIATION | 182 | 7.65e-01 | 1.28e-02 | 9.49e-01 |
| GOBP KIDNEY MORPHOGENESIS | 59 | 8.65e-01 | -1.28e-02 | 9.74e-01 |
| GOBP MRNA SPLICE SITE RECOGNITION | 30 | 9.04e-01 | 1.27e-02 | 9.83e-01 |
| GOCC SPERM PRINCIPAL PIECE | 22 | 9.18e-01 | -1.27e-02 | 9.85e-01 |
| GOMF PROTEOGLYCAN BINDING | 28 | 9.07e-01 | 1.27e-02 | 9.83e-01 |
| GOBP FOAM CELL DIFFERENTIATION | 29 | 9.06e-01 | -1.27e-02 | 9.83e-01 |
| GOMF GLUTATHIONE PEROXIDASE ACTIVITY | 18 | 9.26e-01 | 1.27e-02 | 9.86e-01 |
| GOBP ENDOCRINE PROCESS | 60 | 8.65e-01 | -1.27e-02 | 9.74e-01 |
| GOBP LYMPHOCYTE DIFFERENTIATION | 375 | 6.73e-01 | 1.27e-02 | 9.23e-01 |
| GOBP RRNA PROCESSING | 218 | 7.47e-01 | -1.27e-02 | 9.43e-01 |
| GOMF TAT PROTEIN BINDING | 10 | 9.45e-01 | -1.26e-02 | 9.90e-01 |
| GOBP T HELPER 1 CELL DIFFERENTIATION | 21 | 9.21e-01 | -1.26e-02 | 9.86e-01 |
| GOBP RESPONSE TO REACTIVE OXYGEN SPECIES | 170 | 7.77e-01 | 1.26e-02 | 9.54e-01 |
| GOBP ACETYL COA METABOLIC PROCESS | 28 | 9.09e-01 | -1.25e-02 | 9.83e-01 |
| GOBP MONOCARBOXYLIC ACID BIOSYNTHETIC PROCESS | 171 | 7.78e-01 | -1.25e-02 | 9.54e-01 |
| GOBP POSITIVE REGULATION OF MYOBLAST FUSION | 13 | 9.38e-01 | 1.25e-02 | 9.89e-01 |
| GOBP AXON DEVELOPMENT | 352 | 6.88e-01 | -1.25e-02 | 9.27e-01 |
| GOBP NEGATIVE REGULATION OF DENDRITE MORPHOGENESIS | 5 | 9.62e-01 | -1.25e-02 | 9.95e-01 |
| GOCC LIPID DROPLET | 87 | 8.41e-01 | 1.25e-02 | 9.67e-01 |
| GOBP REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE MEDIATED BY A CHEMICAL SIGNAL | 28 | 9.09e-01 | 1.25e-02 | 9.83e-01 |
| GOBP RESPONSE TO OXYGEN GLUCOSE DEPRIVATION | 7 | 9.55e-01 | 1.24e-02 | 9.93e-01 |
| GOBP REGULATION OF CARDIAC EPITHELIAL TO MESENCHYMAL TRANSITION | 11 | 9.43e-01 | 1.24e-02 | 9.89e-01 |
| GOBP REGULATION OF CELL MATRIX ADHESION | 99 | 8.31e-01 | -1.24e-02 | 9.64e-01 |
| GOBP CELL RECOGNITION | 97 | 8.33e-01 | -1.24e-02 | 9.64e-01 |
| GOCC INTEGRIN COMPLEX | 27 | 9.11e-01 | -1.24e-02 | 9.83e-01 |
| GOBP HINDBRAIN MORPHOGENESIS | 37 | 8.96e-01 | -1.24e-02 | 9.81e-01 |
| GOBP NEGATIVE REGULATION OF BONE MINERALIZATION | 14 | 9.36e-01 | -1.23e-02 | 9.89e-01 |
| GOBP SYNAPTIC VESICLE EXOCYTOSIS | 72 | 8.56e-01 | 1.23e-02 | 9.71e-01 |
| GOBP RESPONSE TO WOUNDING | 442 | 6.58e-01 | -1.23e-02 | 9.19e-01 |
| GOBP POSITIVE REGULATION OF MYELOID LEUKOCYTE DIFFERENTIATION | 43 | 8.89e-01 | -1.23e-02 | 9.79e-01 |
| GOBP REGULATION OF NEUTROPHIL MIGRATION | 39 | 8.95e-01 | -1.23e-02 | 9.81e-01 |
| GOBP REGULATION OF LOCOMOTION | 808 | 5.54e-01 | -1.23e-02 | 8.86e-01 |
| GOBP MESODERM DEVELOPMENT | 84 | 8.46e-01 | -1.22e-02 | 9.68e-01 |
| GOBP PURINE CONTAINING COMPOUND METABOLIC PROCESS | 489 | 6.43e-01 | 1.22e-02 | 9.15e-01 |
| GOMF PORIN ACTIVITY | 6 | 9.59e-01 | 1.22e-02 | 9.94e-01 |
| GOBP RESPONSE TO CADMIUM ION | 48 | 8.84e-01 | 1.22e-02 | 9.78e-01 |
| GOBP PHOTOTRANSDUCTION VISIBLE LIGHT | 12 | 9.42e-01 | 1.22e-02 | 9.89e-01 |
| GOCC CLATHRIN ADAPTOR COMPLEX | 25 | 9.16e-01 | -1.22e-02 | 9.85e-01 |
| GOBP EMBRYONIC SKELETAL SYSTEM DEVELOPMENT | 60 | 8.70e-01 | -1.22e-02 | 9.75e-01 |
| GOBP CELL PROJECTION MORPHOGENESIS | 478 | 6.49e-01 | 1.21e-02 | 9.17e-01 |
| GOBP CENTRAL NERVOUS SYSTEM DEVELOPMENT | 729 | 5.77e-01 | 1.21e-02 | 8.92e-01 |
| GOMF UDP GLYCOSYLTRANSFERASE ACTIVITY | 107 | 8.29e-01 | 1.21e-02 | 9.64e-01 |
| GOBP ENDOCRINE HORMONE SECRETION | 38 | 8.97e-01 | -1.21e-02 | 9.81e-01 |
| GOBP SKIN EPIDERMIS DEVELOPMENT | 77 | 8.54e-01 | -1.21e-02 | 9.71e-01 |
| GOBP REFLEX | 7 | 9.56e-01 | 1.21e-02 | 9.94e-01 |
| GOCC CAVEOLA | 66 | 8.65e-01 | -1.21e-02 | 9.74e-01 |
| GOBP NEGATIVE REGULATION OF LIPID CATABOLIC PROCESS | 21 | 9.24e-01 | 1.21e-02 | 9.86e-01 |
| GOBP REGULATION OF ANGIOTENSIN LEVELS IN BLOOD | 7 | 9.56e-01 | 1.20e-02 | 9.94e-01 |
| GOMF SMALL MOLECULE SENSOR ACTIVITY | 45 | 8.89e-01 | 1.20e-02 | 9.79e-01 |
| GOBP REGULATION OF HIGH VOLTAGE GATED CALCIUM CHANNEL ACTIVITY | 8 | 9.53e-01 | -1.20e-02 | 9.93e-01 |
| GOBP INTRACELLULAR SIGNALING CASSETTE | 1557 | 4.32e-01 | 1.20e-02 | 8.35e-01 |
| GOMF AMIDE BINDING | 200 | 7.71e-01 | -1.19e-02 | 9.51e-01 |
| GOBP AMYLOID PRECURSOR PROTEIN CATABOLIC PROCESS | 52 | 8.82e-01 | -1.19e-02 | 9.78e-01 |
| GOMF SUMO LIGASE ACTIVITY | 13 | 9.41e-01 | 1.19e-02 | 9.89e-01 |
| GOBP REGULATION OF CYTOSOLIC CALCIUM ION CONCENTRATION | 33 | 9.06e-01 | -1.19e-02 | 9.83e-01 |
| GOBP ATP SYNTHESIS COUPLED ELECTRON TRANSPORT | 93 | 8.44e-01 | -1.18e-02 | 9.68e-01 |
| GOBP POSITIVE REGULATION OF CALCIUM ION TRANSMEMBRANE TRANSPORTER ACTIVITY | 25 | 9.19e-01 | 1.18e-02 | 9.86e-01 |
| GOBP SNO S RNA METABOLIC PROCESS | 15 | 9.37e-01 | -1.17e-02 | 9.89e-01 |
| GOBP ENDOCYTIC RECYCLING | 80 | 8.57e-01 | 1.17e-02 | 9.71e-01 |
| GOBP POSITIVE REGULATION OF CELLULAR COMPONENT ORGANIZATION | 918 | 5.49e-01 | 1.17e-02 | 8.84e-01 |
| GOBP CHEMICAL HOMEOSTASIS | 769 | 5.82e-01 | -1.17e-02 | 8.93e-01 |
| GOBP REGULATION OF THYMOCYTE APOPTOTIC PROCESS | 11 | 9.47e-01 | 1.16e-02 | 9.90e-01 |
| GOBP REGULATION OF BINDING | 197 | 7.78e-01 | -1.16e-02 | 9.54e-01 |
| GOMF CARD DOMAIN BINDING | 14 | 9.40e-01 | -1.16e-02 | 9.89e-01 |
| GOBP POSITIVE REGULATION OF CELL POPULATION PROLIFERATION | 689 | 6.04e-01 | 1.16e-02 | 9.03e-01 |
| GOMF PROTEIN SERINE THREONINE KINASE ACTIVITY | 383 | 6.97e-01 | 1.16e-02 | 9.28e-01 |
| GOBP LYSOSOMAL LUMEN ACIDIFICATION | 24 | 9.22e-01 | 1.16e-02 | 9.86e-01 |
| GOBP RESPONSE TO CALCIUM ION | 99 | 8.42e-01 | -1.16e-02 | 9.67e-01 |
| GOCC RECYCLING ENDOSOME MEMBRANE | 99 | 8.42e-01 | -1.16e-02 | 9.67e-01 |
| GOCC TRANSCRIPTION FACTOR TFTC COMPLEX | 18 | 9.32e-01 | -1.16e-02 | 9.89e-01 |
| GOMF L LEUCINE TRANSMEMBRANE TRANSPORTER ACTIVITY | 6 | 9.61e-01 | 1.15e-02 | 9.95e-01 |
| GOMF ORGANIC ACID SODIUM SYMPORTER ACTIVITY | 18 | 9.33e-01 | -1.15e-02 | 9.89e-01 |
| GOMF OPSIN BINDING | 5 | 9.65e-01 | -1.14e-02 | 9.95e-01 |
| GOMF OXIDOREDUCTASE ACTIVITY ACTING ON NAD P H HEME PROTEIN AS ACCEPTOR | 10 | 9.50e-01 | 1.14e-02 | 9.91e-01 |
| GOBP MYOBLAST FUSION | 39 | 9.02e-01 | -1.14e-02 | 9.82e-01 |
| GOBP MEMBRANE REPOLARIZATION | 33 | 9.10e-01 | 1.14e-02 | 9.83e-01 |
| GOBP POSITIVE REGULATION OF PROTEIN CATABOLIC PROCESS | 183 | 7.90e-01 | 1.14e-02 | 9.59e-01 |
| GOBP INORGANIC ION HOMEOSTASIS | 389 | 7.00e-01 | -1.14e-02 | 9.28e-01 |
| GOBP POSITIVE REGULATION OF TUMOR NECROSIS FACTOR MEDIATED SIGNALING PATHWAY | 13 | 9.43e-01 | -1.14e-02 | 9.89e-01 |
| GOBP CELL PROJECTION ASSEMBLY | 540 | 6.52e-01 | 1.13e-02 | 9.18e-01 |
| GOBP ADIPONECTIN ACTIVATED SIGNALING PATHWAY | 7 | 9.59e-01 | -1.13e-02 | 9.94e-01 |
| GOCC PARASPECKLES | 9 | 9.53e-01 | 1.13e-02 | 9.93e-01 |
| GOMF PEPTIDE N ACETYLTRANSFERASE ACTIVITY | 48 | 8.92e-01 | 1.13e-02 | 9.80e-01 |
| GOCC CELL PROJECTION MEMBRANE | 273 | 7.48e-01 | -1.13e-02 | 9.44e-01 |
| GOBP SENSORY PERCEPTION OF LIGHT STIMULUS | 116 | 8.33e-01 | 1.13e-02 | 9.64e-01 |
| GOBP CHLORIDE TRANSPORT | 75 | 8.66e-01 | 1.13e-02 | 9.74e-01 |
| GOBP KERATINOCYTE DEVELOPMENT | 10 | 9.51e-01 | -1.13e-02 | 9.91e-01 |
| GOBP CENP A CONTAINING CHROMATIN ASSEMBLY | 9 | 9.53e-01 | 1.13e-02 | 9.93e-01 |
| GOCC SARCOPLASMIC RETICULUM MEMBRANE | 30 | 9.15e-01 | 1.13e-02 | 9.84e-01 |
| GOMF NERVE GROWTH FACTOR BINDING | 6 | 9.62e-01 | 1.13e-02 | 9.95e-01 |
| GOBP POSITIVE REGULATION OF LAMELLIPODIUM ORGANIZATION | 33 | 9.11e-01 | 1.13e-02 | 9.83e-01 |
| GOBP REGULATION OF BONE MINERALIZATION | 57 | 8.83e-01 | -1.13e-02 | 9.78e-01 |
| GOCC TETRASPANIN ENRICHED MICRODOMAIN | 9 | 9.54e-01 | -1.12e-02 | 9.93e-01 |
| GOBP POSITIVE REGULATION OF LYMPHOCYTE DIFFERENTIATION | 123 | 8.30e-01 | -1.12e-02 | 9.64e-01 |
| GOMF PROTEIN SERINE THREONINE PHOSPHATASE ACTIVITY | 84 | 8.59e-01 | -1.12e-02 | 9.72e-01 |
| GOMF GTPASE BINDING | 291 | 7.42e-01 | 1.12e-02 | 9.42e-01 |
| GOBP REGULATION OF EPITHELIAL CELL APOPTOTIC PROCESS | 77 | 8.65e-01 | 1.12e-02 | 9.74e-01 |
| GOBP POSITIVE REGULATION OF DIGESTIVE SYSTEM PROCESS | 9 | 9.54e-01 | 1.12e-02 | 9.93e-01 |
| GOBP CELL PROJECTION ORGANIZATION | 1261 | 5.05e-01 | 1.12e-02 | 8.66e-01 |
| GOCC CYTOSOLIC LARGE RIBOSOMAL SUBUNIT | 53 | 8.88e-01 | -1.12e-02 | 9.79e-01 |
| GOMF G PROTEIN BETA GAMMA SUBUNIT COMPLEX BINDING | 19 | 9.33e-01 | -1.12e-02 | 9.89e-01 |
| GOBP REGULATION OF CHOLESTEROL METABOLIC PROCESS | 26 | 9.22e-01 | -1.12e-02 | 9.86e-01 |
| GOMF TRANSCRIPTION COACTIVATOR BINDING | 39 | 9.04e-01 | 1.12e-02 | 9.83e-01 |
| GOBP NEGATIVE REGULATION OF DEVELOPMENTAL PROCESS | 644 | 6.29e-01 | -1.12e-02 | 9.11e-01 |
| GOMF TETRAPYRROLE BINDING | 99 | 8.48e-01 | 1.11e-02 | 9.68e-01 |
| GOBP POSITIVE REGULATION OF NEUROTRANSMITTER SECRETION | 15 | 9.41e-01 | -1.11e-02 | 9.89e-01 |
| GOBP NEGATIVE REGULATION OF CELL ACTIVATION | 178 | 7.98e-01 | 1.11e-02 | 9.59e-01 |
| GOMF P TYPE CALCIUM TRANSPORTER ACTIVITY | 7 | 9.59e-01 | -1.11e-02 | 9.94e-01 |
| GOBP PHOSPHATIDYLCHOLINE ACYL CHAIN REMODELING | 13 | 9.45e-01 | 1.11e-02 | 9.90e-01 |
| GOCC CATENIN COMPLEX | 17 | 9.37e-01 | -1.11e-02 | 9.89e-01 |
| GOBP MAMMARY GLAND EPITHELIUM DEVELOPMENT | 53 | 8.89e-01 | -1.11e-02 | 9.79e-01 |
| GOBP CELLULAR RESPONSE TO XENOBIOTIC STIMULUS | 128 | 8.29e-01 | -1.11e-02 | 9.64e-01 |
| GOBP RESPONSE TO MUSCLE INACTIVITY | 8 | 9.57e-01 | 1.11e-02 | 9.94e-01 |
| GOCC CILIARY MEMBRANE | 63 | 8.79e-01 | 1.11e-02 | 9.77e-01 |
| GOBP TYPE II INTERFERON PRODUCTION | 105 | 8.46e-01 | -1.10e-02 | 9.68e-01 |
| GOBP NEGATIVE REGULATION OF NUCLEASE ACTIVITY | 7 | 9.60e-01 | 1.10e-02 | 9.94e-01 |
| GOBP METHYLATION | 200 | 7.90e-01 | -1.09e-02 | 9.59e-01 |
| GOMF SOLUTE MONOATOMIC CATION SYMPORTER ACTIVITY | 76 | 8.70e-01 | -1.09e-02 | 9.75e-01 |
| GOBP REGULATION OF TUMOR NECROSIS FACTOR MEDIATED SIGNALING PATHWAY | 54 | 8.90e-01 | -1.09e-02 | 9.79e-01 |
| GOMF PROTEIN METHYLTRANSFERASE ACTIVITY | 87 | 8.61e-01 | -1.09e-02 | 9.72e-01 |
| GOBP NUCLEOTIDE BINDING OLIGOMERIZATION DOMAIN CONTAINING 2 SIGNALING PATHWAY | 18 | 9.36e-01 | 1.09e-02 | 9.89e-01 |
| GOBP INTERMEDIATE FILAMENT BUNDLE ASSEMBLY | 5 | 9.67e-01 | -1.08e-02 | 9.95e-01 |
| GOBP CELLULAR RESPONSE TO OXYGEN LEVELS | 131 | 8.31e-01 | 1.08e-02 | 9.64e-01 |
| GOBP NEGATIVE REGULATION OF BMP SIGNALING PATHWAY | 41 | 9.05e-01 | -1.08e-02 | 9.83e-01 |
| GOBP POSITIVE REGULATION OF CELL MATRIX ADHESION | 44 | 9.01e-01 | -1.08e-02 | 9.82e-01 |
| GOBP ORGANIC HYDROXY COMPOUND TRANSPORT | 186 | 8.00e-01 | 1.08e-02 | 9.60e-01 |
| GOBP MODULATION BY SYMBIONT OF ENTRY INTO HOST | 42 | 9.04e-01 | 1.08e-02 | 9.83e-01 |
| GOBP MITOCHONDRIAL TRANSLATION | 130 | 8.32e-01 | 1.08e-02 | 9.64e-01 |
| GOBP MEMBRANE RAFT LOCALIZATION | 7 | 9.61e-01 | 1.07e-02 | 9.94e-01 |
| GOBP NEGATIVE REGULATION OF MYELOID LEUKOCYTE MEDIATED IMMUNITY | 9 | 9.55e-01 | 1.07e-02 | 9.94e-01 |
| GOBP POSITIVE REGULATION OF CELL DEVELOPMENT | 361 | 7.26e-01 | -1.07e-02 | 9.39e-01 |
| GOCC PHOTORECEPTOR INNER SEGMENT | 47 | 8.99e-01 | 1.07e-02 | 9.82e-01 |
| GOBP REGULATION OF LEUKOCYTE MIGRATION | 185 | 8.02e-01 | 1.07e-02 | 9.60e-01 |
| GOMF HYALURONIC ACID BINDING | 16 | 9.41e-01 | -1.07e-02 | 9.89e-01 |
| GOBP REGULATION OF DNA TEMPLATED DNA REPLICATION | 47 | 9.00e-01 | -1.06e-02 | 9.82e-01 |
| GOCC DESMOSOME | 18 | 9.38e-01 | -1.06e-02 | 9.89e-01 |
| GOCC MULTIVESICULAR BODY | 54 | 8.93e-01 | 1.06e-02 | 9.80e-01 |
| GOBP POSITIVE REGULATION OF PEPTIDYL SERINE PHOSPHORYLATION | 53 | 8.94e-01 | 1.06e-02 | 9.81e-01 |
| GOBP CELLULAR RESPONSE TO RADIATION | 152 | 8.23e-01 | 1.05e-02 | 9.64e-01 |
| GOBP SENSORY PERCEPTION OF BITTER TASTE | 16 | 9.42e-01 | -1.05e-02 | 9.89e-01 |
| GOBP LOCOMOTION | 946 | 5.85e-01 | -1.05e-02 | 8.94e-01 |
| GOBP REGULATION OF JUN KINASE ACTIVITY | 36 | 9.14e-01 | 1.04e-02 | 9.84e-01 |
| GOBP IMMUNE RESPONSE TO TUMOR CELL | 25 | 9.28e-01 | -1.04e-02 | 9.87e-01 |
| GOBP PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR SIGNALING PATHWAY | 17 | 9.41e-01 | 1.04e-02 | 9.89e-01 |
| GOBP MUSCLE CELL DEVELOPMENT | 130 | 8.38e-01 | -1.04e-02 | 9.66e-01 |
| GOBP REGULATION OF TOLL SIGNALING PATHWAY | 5 | 9.68e-01 | -1.04e-02 | 9.95e-01 |
| GOBP REGULATION OF HORMONE SECRETION | 178 | 8.11e-01 | -1.04e-02 | 9.62e-01 |
| GOBP DEVELOPMENTAL MATURATION | 232 | 7.86e-01 | 1.03e-02 | 9.57e-01 |
| GOBP SNRNA PROCESSING | 27 | 9.26e-01 | -1.03e-02 | 9.86e-01 |
| GOBP REGULATION OF LIPOPOLYSACCHARIDE MEDIATED SIGNALING PATHWAY | 23 | 9.32e-01 | 1.03e-02 | 9.88e-01 |
| GOBP NEGATIVE REGULATION OF TOLL LIKE RECEPTOR 2 SIGNALING PATHWAY | 5 | 9.68e-01 | 1.03e-02 | 9.95e-01 |
| GOBP REGULATION OF PROTEIN LOCALIZATION TO CELL PERIPHERY | 114 | 8.50e-01 | -1.03e-02 | 9.68e-01 |
| GOBP REGULATION OF CELL PROJECTION ORGANIZATION | 552 | 6.80e-01 | 1.03e-02 | 9.24e-01 |
| GOBP CANONICAL WNT SIGNALING PATHWAY | 235 | 7.87e-01 | 1.02e-02 | 9.57e-01 |
| GOMF PROTEIN CONTAINING COMPLEX DESTABILIZING ACTIVITY | 12 | 9.51e-01 | -1.02e-02 | 9.91e-01 |
| GOBP EPITHELIAL CELL PROLIFERATION | 310 | 7.58e-01 | -1.02e-02 | 9.46e-01 |
| GOBP MITOCHONDRIAL TRANSCRIPTION | 22 | 9.34e-01 | 1.01e-02 | 9.89e-01 |
| GOMF HISTONE H3K4ME H3K4ME2 H3K4ME3 DEMETHYLASE ACTIVITY | 5 | 9.69e-01 | 1.01e-02 | 9.95e-01 |
| GOMF NEUROTROPHIN RECEPTOR BINDING | 8 | 9.60e-01 | -1.01e-02 | 9.94e-01 |
| GOBP REGULATION OF OSSIFICATION | 85 | 8.72e-01 | 1.01e-02 | 9.76e-01 |
| GOBP REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY IN ABSENCE OF LIGAND | 33 | 9.20e-01 | 1.01e-02 | 9.86e-01 |
| GOBP REGULATION OF LONG TERM NEURONAL SYNAPTIC PLASTICITY | 20 | 9.38e-01 | 1.01e-02 | 9.89e-01 |
| GOCC PRONUCLEUS | 12 | 9.52e-01 | 1.01e-02 | 9.92e-01 |
| GOBP NEGATIVE REGULATION OF STRIATED MUSCLE CELL DIFFERENTIATION | 30 | 9.24e-01 | -1.01e-02 | 9.86e-01 |
| GOBP CYTOKINETIC PROCESS | 46 | 9.06e-01 | 1.01e-02 | 9.83e-01 |
| GOBP MUSCLE TISSUE DEVELOPMENT | 283 | 7.71e-01 | 1.01e-02 | 9.51e-01 |
| GOBP POSITIVE REGULATION OF CELL DIFFERENTIATION | 643 | 6.64e-01 | -1.00e-02 | 9.22e-01 |
| GOMF CYTOKINE RECEPTOR BINDING | 164 | 8.25e-01 | 1.00e-02 | 9.64e-01 |
| GOMF N ACYLTRANSFERASE ACTIVITY | 77 | 8.80e-01 | -9.97e-03 | 9.77e-01 |
| GOBP PROTEIN HISTIDYL MODIFICATION TO DIPHTHAMIDE | 7 | 9.64e-01 | -9.95e-03 | 9.95e-01 |
| GOBP TONGUE DEVELOPMENT | 10 | 9.57e-01 | 9.94e-03 | 9.94e-01 |
| GOBP CD4 POSITIVE ALPHA BETA T CELL DIFFERENTIATION | 87 | 8.73e-01 | -9.94e-03 | 9.76e-01 |
| GOBP CELLULAR RESPONSE TO BIOTIC STIMULUS | 212 | 8.04e-01 | -9.90e-03 | 9.61e-01 |
| GOCC TERTIARY GRANULE MEMBRANE | 70 | 8.86e-01 | 9.89e-03 | 9.78e-01 |
| GOBP POSITIVE REGULATION OF LEUKOCYTE DEGRANULATION | 22 | 9.36e-01 | 9.84e-03 | 9.89e-01 |
| GOBP RESPIRATORY CHAIN COMPLEX IV ASSEMBLY | 27 | 9.30e-01 | 9.81e-03 | 9.88e-01 |
| GOBP NUCLEOSIDE DIPHOSPHATE METABOLIC PROCESS | 113 | 8.57e-01 | -9.80e-03 | 9.71e-01 |
| GOBP EMBRYO DEVELOPMENT | 817 | 6.36e-01 | -9.75e-03 | 9.14e-01 |
| GOBP POSITIVE REGULATION OF PHOSPHATIDYLINOSITOL 3 KINASE PROTEIN KINASE B SIGNAL TRANSDUCTION | 135 | 8.46e-01 | 9.70e-03 | 9.68e-01 |
| GOBP REGULATION OF MITOCHONDRIAL MEMBRANE POTENTIAL | 63 | 8.94e-01 | 9.68e-03 | 9.81e-01 |
| GOBP EXTRACELLULAR TRANSPORT | 34 | 9.23e-01 | -9.59e-03 | 9.86e-01 |
| GOBP EPIGENETIC REGULATION OF GENE EXPRESSION | 223 | 8.07e-01 | 9.49e-03 | 9.61e-01 |
| GOBP POSITIVE REGULATION OF MONOATOMIC ION TRANSMEMBRANE TRANSPORT | 107 | 8.65e-01 | -9.48e-03 | 9.74e-01 |
| GOBP FERTILIZATION | 122 | 8.56e-01 | 9.48e-03 | 9.71e-01 |
| GOBP HEMATOPOIETIC STEM CELL HOMEOSTASIS | 22 | 9.39e-01 | 9.48e-03 | 9.89e-01 |
| GOBP ANATOMICAL STRUCTURE FORMATION INVOLVED IN MORPHOGENESIS | 861 | 6.37e-01 | -9.47e-03 | 9.15e-01 |
| GOBP NEGATIVE REGULATION OF TELOMERE MAINTENANCE VIA TELOMERASE | 21 | 9.40e-01 | -9.47e-03 | 9.89e-01 |
| GOBP MINERALOCORTICOID BIOSYNTHETIC PROCESS | 7 | 9.65e-01 | 9.47e-03 | 9.95e-01 |
| GOMF CELL ADHESION MEDIATOR ACTIVITY | 46 | 9.12e-01 | -9.43e-03 | 9.83e-01 |
| GOMF TRANSCRIPTION REGULATOR INHIBITOR ACTIVITY | 25 | 9.35e-01 | 9.43e-03 | 9.89e-01 |
| GOBP HORMONE TRANSPORT | 224 | 8.08e-01 | -9.40e-03 | 9.61e-01 |
| GOBP TYPE 2 IMMUNE RESPONSE | 38 | 9.20e-01 | -9.40e-03 | 9.86e-01 |
| GOBP GLUCOSE IMPORT | 58 | 9.02e-01 | 9.39e-03 | 9.82e-01 |
| GOMF TRANSFERASE ACTIVITY TRANSFERRING ONE CARBON GROUPS | 196 | 8.21e-01 | -9.38e-03 | 9.64e-01 |
| GOMF D1 DOPAMINE RECEPTOR BINDING | 5 | 9.71e-01 | -9.34e-03 | 9.95e-01 |
| GOBP PROTEIN INSERTION INTO ER MEMBRANE | 30 | 9.30e-01 | -9.32e-03 | 9.88e-01 |
| GOBP BINDING OF SPERM TO ZONA PELLUCIDA | 20 | 9.43e-01 | 9.31e-03 | 9.89e-01 |
| GOBP T CELL RECEPTOR SIGNALING PATHWAY | 140 | 8.49e-01 | -9.30e-03 | 9.68e-01 |
| GOBP GOLGI TO VACUOLE TRANSPORT | 19 | 9.44e-01 | 9.29e-03 | 9.90e-01 |
| GOBP REGULATION OF GAMMA DELTA T CELL ACTIVATION | 11 | 9.58e-01 | 9.28e-03 | 9.94e-01 |
| GOBP KETONE CATABOLIC PROCESS | 13 | 9.54e-01 | 9.27e-03 | 9.93e-01 |
| GOBP RESPONSE TO PROGESTERONE | 31 | 9.29e-01 | 9.26e-03 | 9.88e-01 |
| GOBP CELLULAR RESPONSE TO NICOTINE | 7 | 9.66e-01 | 9.21e-03 | 9.95e-01 |
| GOBP MESODERM MORPHOGENESIS | 48 | 9.12e-01 | -9.20e-03 | 9.83e-01 |
| GOMF NAD P H OXIDASE H2O2 FORMING ACTIVITY | 7 | 9.66e-01 | -9.17e-03 | 9.95e-01 |
| GOBP SYNAPSE ORGANIZATION | 338 | 7.72e-01 | -9.17e-03 | 9.52e-01 |
| GOBP SMALL MOLECULE BIOSYNTHETIC PROCESS | 478 | 7.32e-01 | -9.15e-03 | 9.41e-01 |
| GOBP RESPONSE TO EPIDERMAL GROWTH FACTOR | 37 | 9.23e-01 | -9.12e-03 | 9.86e-01 |
| GOBP REGULATION OF CELLULAR COMPONENT BIOGENESIS | 849 | 6.52e-01 | 9.11e-03 | 9.18e-01 |
| GOMF TRANSCRIPTION COACTIVATOR ACTIVITY | 250 | 8.04e-01 | -9.10e-03 | 9.61e-01 |
| GOBP XENOBIOTIC EXPORT FROM CELL | 12 | 9.56e-01 | 9.10e-03 | 9.94e-01 |
| GOBP DEDIFFERENTIATION | 6 | 9.69e-01 | 9.10e-03 | 9.95e-01 |
| GOBP NEGATIVE REGULATION OF DNA TEMPLATED DNA REPLICATION | 10 | 9.60e-01 | -9.09e-03 | 9.94e-01 |
| GOBP BODY FLUID SECRETION | 62 | 9.01e-01 | 9.09e-03 | 9.82e-01 |
| GOBP PROTEIN AUTOPHOSPHORYLATION | 170 | 8.38e-01 | 9.07e-03 | 9.66e-01 |
| GOCC MEMBRANE PROTEIN COMPLEX | 1115 | 6.10e-01 | 9.07e-03 | 9.03e-01 |
| GOBP ANATOMICAL STRUCTURE MATURATION | 178 | 8.36e-01 | -9.02e-03 | 9.65e-01 |
| GOMF MOLECULAR ADAPTOR ACTIVITY | 1072 | 6.19e-01 | 9.01e-03 | 9.07e-01 |
| GOMF HISTONE H4K12 ACETYLTRANSFERASE ACTIVITY | 12 | 9.57e-01 | -9.01e-03 | 9.94e-01 |
| GOBP TRANSCRIPTION INITIATION AT RNA POLYMERASE II PROMOTER | 146 | 8.51e-01 | 9.00e-03 | 9.69e-01 |
| GOBP STEROL TRANSPORT | 86 | 8.85e-01 | -9.00e-03 | 9.78e-01 |
| GOBP REGULATION OF KERATINOCYTE MIGRATION | 11 | 9.59e-01 | 9.00e-03 | 9.94e-01 |
| GOBP NEGATIVE REGULATION OF LYMPHOCYTE APOPTOTIC PROCESS | 34 | 9.28e-01 | -8.98e-03 | 9.87e-01 |
| GOBP PROTEIN COMPLEX OLIGOMERIZATION | 212 | 8.22e-01 | 8.95e-03 | 9.64e-01 |
| GOBP DEVELOPMENTAL CELL GROWTH | 167 | 8.42e-01 | -8.95e-03 | 9.67e-01 |
| GOBP REGULATION OF SODIUM ION TRANSPORT | 63 | 9.02e-01 | 8.94e-03 | 9.83e-01 |
| GOMF DNA BINDING TRANSCRIPTION REPRESSOR ACTIVITY | 198 | 8.29e-01 | -8.92e-03 | 9.64e-01 |
| GOCC ASTROCYTE END FOOT | 6 | 9.70e-01 | 8.90e-03 | 9.95e-01 |
| GOMF SYNTAXIN BINDING | 52 | 9.12e-01 | 8.88e-03 | 9.83e-01 |
| GOBP LUNG EPITHELIUM DEVELOPMENT | 27 | 9.36e-01 | -8.87e-03 | 9.89e-01 |
| GOCC METHYLOSOME | 12 | 9.58e-01 | -8.87e-03 | 9.94e-01 |
| GOBP SNORNA LOCALIZATION | 6 | 9.70e-01 | -8.86e-03 | 9.95e-01 |
| GOMF MODIFIED AMINO ACID TRANSMEMBRANE TRANSPORTER ACTIVITY | 25 | 9.39e-01 | -8.86e-03 | 9.89e-01 |
| GOCC EXTRINSIC COMPONENT OF MEMBRANE | 144 | 8.54e-01 | -8.85e-03 | 9.71e-01 |
| GOMF ACETYLCHOLINE RECEPTOR BINDING | 7 | 9.68e-01 | 8.85e-03 | 9.95e-01 |
| GOMF PHOSPHATIDYLINOSITOL PHOSPHATE BINDING | 156 | 8.49e-01 | 8.84e-03 | 9.68e-01 |
| GOCC MYOFILAMENT | 17 | 9.50e-01 | -8.84e-03 | 9.91e-01 |
| GOBP L AMINO ACID BIOSYNTHETIC PROCESS | 49 | 9.15e-01 | -8.84e-03 | 9.84e-01 |
| GOBP RESPONSE TO COCAINE | 35 | 9.28e-01 | -8.82e-03 | 9.87e-01 |
| GOBP NEURAL CREST CELL DIFFERENTIATION | 56 | 9.10e-01 | -8.78e-03 | 9.83e-01 |
| GOCC ENDOPLASMIC RETICULUM PLASMA MEMBRANE CONTACT SITE | 9 | 9.64e-01 | -8.76e-03 | 9.95e-01 |
| GOBP RESPONSE TO MOLECULE OF BACTERIAL ORIGIN | 287 | 7.99e-01 | -8.75e-03 | 9.60e-01 |
| GOBP REGULATION OF NEUROGENESIS | 272 | 8.04e-01 | 8.73e-03 | 9.61e-01 |
| GOBP WOUND HEALING | 337 | 7.84e-01 | 8.71e-03 | 9.57e-01 |
| GOBP INTRINSIC APOPTOTIC SIGNALING PATHWAY IN RESPONSE TO ENDOPLASMIC RETICULUM STRESS | 58 | 9.09e-01 | 8.70e-03 | 9.83e-01 |
| GOBP RESPONSE TO TUMOR NECROSIS FACTOR | 187 | 8.38e-01 | -8.69e-03 | 9.66e-01 |
| GOBP REGULATION OF SYNAPSE STRUCTURE OR ACTIVITY | 182 | 8.42e-01 | 8.57e-03 | 9.67e-01 |
| GOMF PROTEIN GLUTAMINE GAMMA GLUTAMYLTRANSFERASE ACTIVITY | 6 | 9.71e-01 | -8.57e-03 | 9.95e-01 |
| GOBP ALKANESULFONATE TRANSMEMBRANE TRANSPORT | 6 | 9.71e-01 | -8.55e-03 | 9.95e-01 |
| GOCC TELOMERASE HOLOENZYME COMPLEX | 21 | 9.46e-01 | -8.48e-03 | 9.90e-01 |
| GOBP POSITIVE REGULATION OF MACROPHAGE DERIVED FOAM CELL DIFFERENTIATION | 11 | 9.61e-01 | 8.47e-03 | 9.95e-01 |
| GOBP HEART TRABECULA FORMATION | 7 | 9.69e-01 | -8.47e-03 | 9.95e-01 |
| GOBP ANTIGEN PROCESSING AND PRESENTATION OF EXOGENOUS ANTIGEN | 47 | 9.20e-01 | 8.47e-03 | 9.86e-01 |
| GOBP NEUTROPHIL DIFFERENTIATION | 10 | 9.63e-01 | 8.46e-03 | 9.95e-01 |
| GOMF QUATERNARY AMMONIUM GROUP BINDING | 32 | 9.34e-01 | 8.44e-03 | 9.89e-01 |
| GOBP RESPONSE TO PURINE CONTAINING COMPOUND | 109 | 8.80e-01 | -8.40e-03 | 9.77e-01 |
| GOBP METHIONINE BIOSYNTHETIC PROCESS | 10 | 9.63e-01 | 8.38e-03 | 9.95e-01 |
| GOBP MITOCHONDRIAL ELECTRON TRANSPORT NADH TO UBIQUINONE | 50 | 9.19e-01 | -8.36e-03 | 9.85e-01 |
| GOMF PHOSPHATIDYLINOSITOL 3 4 BISPHOSPHATE BINDING | 25 | 9.42e-01 | -8.36e-03 | 9.89e-01 |
| GOBP POSITIVE REGULATION OF BLOOD BRAIN BARRIER PERMEABILITY | 5 | 9.74e-01 | -8.34e-03 | 9.95e-01 |
| GOBP PROTEIN INSERTION INTO MEMBRANE FROM INNER SIDE | 5 | 9.74e-01 | 8.32e-03 | 9.95e-01 |
| GOBP RIBOSOMAL LARGE SUBUNIT BIOGENESIS | 64 | 9.09e-01 | 8.30e-03 | 9.83e-01 |
| GOBP EXTRINSIC APOPTOTIC SIGNALING PATHWAY | 191 | 8.44e-01 | -8.28e-03 | 9.68e-01 |
| GOBP NEGATIVE REGULATION OF GLIAL CELL PROLIFERATION | 14 | 9.57e-01 | -8.26e-03 | 9.94e-01 |
| GOBP B CELL APOPTOTIC PROCESS | 25 | 9.43e-01 | -8.25e-03 | 9.89e-01 |
| GOMF NUCLEOTIDE RECEPTOR ACTIVITY | 17 | 9.53e-01 | -8.25e-03 | 9.93e-01 |
| GOBP CELLULAR RESPONSE TO OSMOTIC STRESS | 49 | 9.21e-01 | 8.24e-03 | 9.86e-01 |
| GOBP LIMB BUD FORMATION | 5 | 9.75e-01 | 8.23e-03 | 9.95e-01 |
| GOBP REGULATION OF GLUTAMATE RECEPTOR SIGNALING PATHWAY | 6 | 9.72e-01 | 8.21e-03 | 9.95e-01 |
| GOBP TRACHEA FORMATION | 6 | 9.72e-01 | -8.21e-03 | 9.95e-01 |
| GOBP TRACHEA MORPHOGENESIS | 6 | 9.72e-01 | -8.21e-03 | 9.95e-01 |
| GOBP TELOMERASE RNA LOCALIZATION | 19 | 9.51e-01 | 8.19e-03 | 9.91e-01 |
| GOBP POSITIVE REGULATION OF PROTEIN SECRETION | 109 | 8.83e-01 | 8.19e-03 | 9.78e-01 |
| GOBP DNA INTEGRATION | 7 | 9.70e-01 | -8.18e-03 | 9.95e-01 |
| GOCC MIGRASOME | 5 | 9.75e-01 | 8.17e-03 | 9.95e-01 |
| GOBP REGULATION OF ACTIN FILAMENT BUNDLE ASSEMBLY | 87 | 8.96e-01 | -8.13e-03 | 9.81e-01 |
| GOBP BONE MINERALIZATION | 89 | 8.95e-01 | -8.09e-03 | 9.81e-01 |
| GOBP CLEARANCE OF FOREIGN INTRACELLULAR NUCLEIC ACIDS | 6 | 9.73e-01 | -8.06e-03 | 9.95e-01 |
| GOMF CARBON NITROGEN LIGASE ACTIVITY WITH GLUTAMINE AS AMIDO N DONOR | 9 | 9.67e-01 | -8.04e-03 | 9.95e-01 |
| GOBP REGULATION OF PROTEIN SECRETION | 192 | 8.48e-01 | -8.03e-03 | 9.68e-01 |
| GOCC MICROTUBULE | 390 | 7.86e-01 | -8.02e-03 | 9.57e-01 |
| GOBP POSITIVE REGULATION OF PEPTIDYL TYROSINE PHOSPHORYLATION | 114 | 8.83e-01 | 7.95e-03 | 9.78e-01 |
| GOBP NEGATIVE REGULATION OF CYTOKINE PRODUCTION | 252 | 8.28e-01 | 7.94e-03 | 9.64e-01 |
| GOBP POSITIVE REGULATION OF HORMONE BIOSYNTHETIC PROCESS | 8 | 9.69e-01 | 7.93e-03 | 9.95e-01 |
| GOBP RESPONSE TO CORTISOL | 5 | 9.76e-01 | 7.91e-03 | 9.95e-01 |
| GOCC LUMENAL SIDE OF ENDOPLASMIC RETICULUM MEMBRANE | 31 | 9.39e-01 | -7.88e-03 | 9.89e-01 |
| GOBP REGULATION OF NON CANONICAL NF KAPPAB SIGNAL TRANSDUCTION | 84 | 9.01e-01 | 7.83e-03 | 9.82e-01 |
| GOBP REGULATION OF CELL DIFFERENTIATION | 1153 | 6.55e-01 | -7.82e-03 | 9.18e-01 |
| GOMF MHC CLASS IB PROTEIN BINDING | 8 | 9.70e-01 | -7.80e-03 | 9.95e-01 |
| GOBP MALE SEX DIFFERENTIATION | 118 | 8.84e-01 | 7.79e-03 | 9.78e-01 |
| GOBP REGULATION OF CORTISOL BIOSYNTHETIC PROCESS | 5 | 9.76e-01 | 7.77e-03 | 9.95e-01 |
| GOBP NEGATIVE REGULATION OF NEURON MIGRATION | 6 | 9.74e-01 | 7.75e-03 | 9.95e-01 |
| GOBP RETROGRADE TRANS SYNAPTIC SIGNALING | 8 | 9.70e-01 | 7.74e-03 | 9.95e-01 |
| GOBP NEGATIVE REGULATION OF NF KAPPAB TRANSCRIPTION FACTOR ACTIVITY | 68 | 9.12e-01 | -7.74e-03 | 9.83e-01 |
| GOBP MUSCLE CONTRACTION | 237 | 8.38e-01 | 7.72e-03 | 9.66e-01 |
| GOBP RIBOSOME BIOGENESIS | 306 | 8.17e-01 | 7.71e-03 | 9.63e-01 |
| GOBP T CELL DIFFERENTIATION INVOLVED IN IMMUNE RESPONSE | 77 | 9.07e-01 | 7.71e-03 | 9.83e-01 |
| GOBP NATURAL KILLER CELL ACTIVATION INVOLVED IN IMMUNE RESPONSE | 16 | 9.57e-01 | -7.70e-03 | 9.94e-01 |
| GOCC TRANSCRIPTION REGULATOR COMPLEX | 404 | 7.91e-01 | -7.70e-03 | 9.59e-01 |
| GOBP TAXIS | 344 | 8.07e-01 | 7.67e-03 | 9.61e-01 |
| GOBP MUSCLE SYSTEM PROCESS | 307 | 8.17e-01 | 7.66e-03 | 9.63e-01 |
| GOBP REGULATION OF TELOMERE CAPPING | 24 | 9.48e-01 | -7.66e-03 | 9.91e-01 |
| GOBP REGULATION OF OXIDOREDUCTASE ACTIVITY | 49 | 9.26e-01 | 7.65e-03 | 9.86e-01 |
| GOBP SMOOTH MUSCLE CELL PROLIFERATION | 114 | 8.88e-01 | -7.64e-03 | 9.79e-01 |
| GOBP REGULATION OF EPITHELIAL CELL DIFFERENTIATION INVOLVED IN KIDNEY DEVELOPMENT | 8 | 9.70e-01 | -7.61e-03 | 9.95e-01 |
| GOMF METALLOPEPTIDASE ACTIVITY | 129 | 8.81e-01 | -7.61e-03 | 9.78e-01 |
| GOCC CHROMOCENTER | 13 | 9.62e-01 | 7.59e-03 | 9.95e-01 |
| GOMF NUCLEOSOMAL DNA BINDING | 45 | 9.30e-01 | 7.56e-03 | 9.88e-01 |
| GOBP REGULATION OF OSTEOCLAST DEVELOPMENT | 9 | 9.69e-01 | 7.55e-03 | 9.95e-01 |
| GOBP REGULATION OF ODONTOGENESIS | 9 | 9.69e-01 | -7.54e-03 | 9.95e-01 |
| GOBP POSITIVE REGULATION OF NUCLEOTIDE BIOSYNTHETIC PROCESS | 9 | 9.69e-01 | -7.50e-03 | 9.95e-01 |
| GOMF PROTEIN DEMETHYLASE ACTIVITY | 28 | 9.45e-01 | -7.49e-03 | 9.90e-01 |
| GOBP POSITIVE REGULATION OF SODIUM ION TRANSMEMBRANE TRANSPORT | 18 | 9.56e-01 | -7.47e-03 | 9.94e-01 |
| GOBP POSITIVE REGULATION OF PROTEASOMAL PROTEIN CATABOLIC PROCESS | 100 | 8.97e-01 | 7.47e-03 | 9.81e-01 |
| GOMF HISTONE H3K14 ACETYLTRANSFERASE ACTIVITY | 9 | 9.69e-01 | -7.44e-03 | 9.95e-01 |
| GOMF 2 OXOGLUTARATE DEPENDENT DIOXYGENASE ACTIVITY | 55 | 9.24e-01 | -7.43e-03 | 9.86e-01 |
| GOBP NEUTRAL LIPID CATABOLIC PROCESS | 26 | 9.48e-01 | 7.40e-03 | 9.91e-01 |
| GOMF ARP2 3 COMPLEX BINDING | 13 | 9.63e-01 | 7.38e-03 | 9.95e-01 |
| GOBP NEGATIVE REGULATION OF SMOOTH MUSCLE CONTRACTION | 11 | 9.66e-01 | -7.38e-03 | 9.95e-01 |
| GOMF PHOSPHOLIPID TRANSPORTER ACTIVITY | 56 | 9.24e-01 | 7.36e-03 | 9.86e-01 |
| GOBP REGULATION OF BLOOD PRESSURE | 122 | 8.88e-01 | 7.35e-03 | 9.79e-01 |
| GOBP NEGATIVE REGULATION OF LOCOMOTION | 257 | 8.39e-01 | 7.34e-03 | 9.66e-01 |
| GOBP TRABECULA MORPHOGENESIS | 31 | 9.44e-01 | 7.33e-03 | 9.89e-01 |
| GOBP REGULATION OF PROTEIN LOCALIZATION TO PLASMA MEMBRANE | 89 | 9.05e-01 | -7.32e-03 | 9.83e-01 |
| GOBP CELLULAR RESPONSE TO OXYGEN CONTAINING COMPOUND | 899 | 7.10e-01 | 7.32e-03 | 9.34e-01 |
| GOBP REGULATION OF CARDIAC CONDUCTION | 18 | 9.57e-01 | 7.31e-03 | 9.94e-01 |
| GOBP RETINAL ROD CELL DEVELOPMENT | 5 | 9.77e-01 | -7.29e-03 | 9.95e-01 |
| GOBP GENERATION OF PRECURSOR METABOLITES AND ENERGY | 413 | 8.01e-01 | -7.22e-03 | 9.60e-01 |
| GOMF N ACETYLTRANSFERASE ACTIVITY | 61 | 9.22e-01 | -7.22e-03 | 9.86e-01 |
| GOBP REGULATION OF ALPHA BETA T CELL ACTIVATION | 107 | 8.97e-01 | -7.21e-03 | 9.81e-01 |
| GOBP TRNA AMINOACYLATION FOR MITOCHONDRIAL PROTEIN TRANSLATION | 8 | 9.72e-01 | -7.20e-03 | 9.95e-01 |
| GOMF ACYL COA BINDING | 19 | 9.57e-01 | -7.20e-03 | 9.94e-01 |
| GOMF DNA BINDING TRANSCRIPTION ACTIVATOR ACTIVITY | 319 | 8.25e-01 | 7.20e-03 | 9.64e-01 |
| GOBP REGULATION OF MOTOR NEURON APOPTOTIC PROCESS | 14 | 9.63e-01 | -7.19e-03 | 9.95e-01 |
| GOBP SMALL GTPASE MEDIATED SIGNAL TRANSDUCTION | 442 | 7.96e-01 | -7.17e-03 | 9.59e-01 |
| GOMF STRUCTURAL CONSTITUENT OF RIBOSOME | 158 | 8.77e-01 | -7.14e-03 | 9.76e-01 |
| GOBP T CELL MIGRATION | 62 | 9.23e-01 | -7.14e-03 | 9.86e-01 |
| GOCC H4 HISTONE ACETYLTRANSFERASE COMPLEX | 37 | 9.40e-01 | -7.13e-03 | 9.89e-01 |
| GOCC GLYCOGEN GRANULE | 6 | 9.76e-01 | 7.12e-03 | 9.95e-01 |
| GOCC MICROTUBULE ASSOCIATED COMPLEX | 136 | 8.86e-01 | 7.12e-03 | 9.78e-01 |
| GOBP REGULATION OF STEM CELL PROLIFERATION | 48 | 9.32e-01 | -7.12e-03 | 9.89e-01 |
| GOBP LIPID METABOLIC PROCESS | 1075 | 6.94e-01 | -7.11e-03 | 9.27e-01 |
| GOBP GLUTAMINE FAMILY AMINO ACID CATABOLIC PROCESS | 18 | 9.59e-01 | -7.06e-03 | 9.94e-01 |
| GOBP RENAL VESICLE DEVELOPMENT | 9 | 9.71e-01 | -7.05e-03 | 9.95e-01 |
| GOBP RESPONSE TO UV | 141 | 8.85e-01 | -7.05e-03 | 9.78e-01 |
| GOBP NEGATIVE REGULATION OF CELL CELL ADHESION | 161 | 8.78e-01 | -6.99e-03 | 9.77e-01 |
| GOBP RESPONSE TO FIBROBLAST GROWTH FACTOR | 75 | 9.17e-01 | 6.98e-03 | 9.85e-01 |
| GOCC IMMUNOLOGICAL SYNAPSE | 45 | 9.36e-01 | -6.95e-03 | 9.89e-01 |
| GOBP DNA REPLICATION SYNTHESIS OF PRIMER | 7 | 9.75e-01 | 6.95e-03 | 9.95e-01 |
| GOBP ESTABLISHMENT OF CELL POLARITY | 132 | 8.90e-01 | 6.95e-03 | 9.79e-01 |
| GOBP WNT SIGNALING PATHWAY | 345 | 8.25e-01 | 6.93e-03 | 9.64e-01 |
| GOMF ENZYME REGULATOR ACTIVITY | 1100 | 6.98e-01 | 6.93e-03 | 9.28e-01 |
| GOCC CELL TRAILING EDGE | 15 | 9.63e-01 | -6.92e-03 | 9.95e-01 |
| GOCC TRAPP COMPLEX | 17 | 9.61e-01 | -6.92e-03 | 9.94e-01 |
| GOBP GLOMERULUS DEVELOPMENT | 52 | 9.31e-01 | 6.92e-03 | 9.88e-01 |
| GOBP POSITIVE REGULATION OF TYPE II INTERFERON PRODUCTION | 68 | 9.22e-01 | -6.89e-03 | 9.86e-01 |
| GOBP WNT PROTEIN SECRETION | 6 | 9.77e-01 | -6.89e-03 | 9.95e-01 |
| GOBP MUSCLE ORGAN DEVELOPMENT | 242 | 8.54e-01 | -6.88e-03 | 9.70e-01 |
| GOBP PROTEIN METHYLATION | 46 | 9.36e-01 | 6.87e-03 | 9.89e-01 |
| GOBP TRANSFORMING GROWTH FACTOR BETA RECEPTOR SIGNALING PATHWAY | 170 | 8.78e-01 | -6.85e-03 | 9.77e-01 |
| GOCC CELL CELL CONTACT ZONE | 61 | 9.26e-01 | -6.84e-03 | 9.86e-01 |
| GOCC AP TYPE MEMBRANE COAT ADAPTOR COMPLEX | 39 | 9.41e-01 | 6.82e-03 | 9.89e-01 |
| GOMF MONOOXYGENASE ACTIVITY | 56 | 9.30e-01 | 6.79e-03 | 9.88e-01 |
| GOBP REGULATION OF BRANCHING INVOLVED IN SALIVARY GLAND MORPHOGENESIS | 7 | 9.75e-01 | -6.78e-03 | 9.95e-01 |
| GOBP MAINTENANCE OF LOCATION | 271 | 8.48e-01 | -6.76e-03 | 9.68e-01 |
| GOBP TISSUE HOMEOSTASIS | 192 | 8.72e-01 | 6.75e-03 | 9.76e-01 |
| GOBP FATTY ACID BETA OXIDATION USING ACYL COA DEHYDROGENASE | 12 | 9.68e-01 | 6.74e-03 | 9.95e-01 |
| GOBP OLFACTORY BEHAVIOR | 8 | 9.74e-01 | 6.71e-03 | 9.95e-01 |
| GOBP REGULATION OF T HELPER 2 CELL DIFFERENTIATION | 12 | 9.68e-01 | 6.66e-03 | 9.95e-01 |
| GOBP LEUKOTRIENE SIGNALING PATHWAY | 5 | 9.80e-01 | -6.63e-03 | 9.96e-01 |
| GOBP POSITIVE REGULATION OF MITOTIC NUCLEAR DIVISION | 33 | 9.47e-01 | -6.63e-03 | 9.91e-01 |
| GOBP ANTIGEN PROCESSING AND PRESENTATION OF ENDOGENOUS PEPTIDE ANTIGEN | 19 | 9.60e-01 | 6.62e-03 | 9.94e-01 |
| GOBP NEGATIVE REGULATION OF MUSCLE HYPERTROPHY | 22 | 9.57e-01 | -6.61e-03 | 9.94e-01 |
| GOBP POSITIVE REGULATION OF PROTEOLYSIS INVOLVED IN PROTEIN CATABOLIC PROCESS | 119 | 9.01e-01 | -6.61e-03 | 9.82e-01 |
| GOBP REGULATION OF AEROBIC RESPIRATION | 31 | 9.49e-01 | 6.58e-03 | 9.91e-01 |
| GOBP REGULATION OF EPITHELIAL TO MESENCHYMAL TRANSITION | 82 | 9.19e-01 | -6.52e-03 | 9.85e-01 |
| GOBP REGULATION OF TYPE 2 IMMUNE RESPONSE | 30 | 9.51e-01 | 6.51e-03 | 9.91e-01 |
| GOCC NUCLEOSOME | 77 | 9.21e-01 | -6.51e-03 | 9.86e-01 |
| GOBP LIPOPROTEIN BIOSYNTHETIC PROCESS | 94 | 9.14e-01 | -6.45e-03 | 9.84e-01 |
| GOBP NEGATIVE REGULATION OF PRODUCTION OF MOLECULAR MEDIATOR OF IMMUNE RESPONSE | 38 | 9.45e-01 | -6.44e-03 | 9.90e-01 |
| GOMF ISOMERASE ACTIVITY | 151 | 8.92e-01 | -6.42e-03 | 9.80e-01 |
| GOBP BONE MORPHOGENESIS | 62 | 9.30e-01 | 6.42e-03 | 9.88e-01 |
| GOBP REGULATION OF STRIATED MUSCLE CONTRACTION | 67 | 9.28e-01 | -6.40e-03 | 9.87e-01 |
| GOBP PURINE CONTAINING COMPOUND CATABOLIC PROCESS | 134 | 8.98e-01 | -6.40e-03 | 9.81e-01 |
| GOCC SECONDARY LYSOSOME | 21 | 9.60e-01 | -6.40e-03 | 9.94e-01 |
| GOBP SULFUR AMINO ACID METABOLIC PROCESS | 24 | 9.57e-01 | -6.36e-03 | 9.94e-01 |
| GOBP POSITIVE REGULATION OF DNA RECOMBINATION | 72 | 9.26e-01 | 6.36e-03 | 9.86e-01 |
| GOBP POSITIVE REGULATION OF TRANSCRIPTION BY RNA POLYMERASE II | 939 | 7.42e-01 | -6.35e-03 | 9.42e-01 |
| GOBP REGULATED EXOCYTOSIS | 178 | 8.84e-01 | 6.34e-03 | 9.78e-01 |
| GOBP RESPONSE TO INTERLEUKIN 12 | 11 | 9.71e-01 | 6.33e-03 | 9.95e-01 |
| GOBP PROTEIN HOMOOLIGOMERIZATION | 156 | 8.91e-01 | -6.33e-03 | 9.80e-01 |
| GOCC CLATHRIN COATED VESICLE MEMBRANE | 112 | 9.08e-01 | -6.32e-03 | 9.83e-01 |
| GOBP MODIFICATION OF SYNAPTIC STRUCTURE | 25 | 9.57e-01 | -6.27e-03 | 9.94e-01 |
| GOBP POSITIVE REGULATION OF SMOOTH MUSCLE CELL PROLIFERATION | 69 | 9.28e-01 | -6.26e-03 | 9.87e-01 |
| GOBP REGULATION OF POTASSIUM ION TRANSPORT | 61 | 9.33e-01 | 6.21e-03 | 9.89e-01 |
| GOBP REGULATION OF LAMELLIPODIUM ORGANIZATION | 45 | 9.43e-01 | 6.18e-03 | 9.89e-01 |
| GOBP RESPIRATORY CHAIN COMPLEX III ASSEMBLY | 9 | 9.75e-01 | 6.13e-03 | 9.95e-01 |
| GOCC H4 H2A HISTONE ACETYLTRANSFERASE COMPLEX | 24 | 9.59e-01 | -6.13e-03 | 9.94e-01 |
| GOMF ALCOHOL DEHYDROGENASE NAD P PLUS ACTIVITY | 13 | 9.70e-01 | -6.09e-03 | 9.95e-01 |
| GOMF TRNA SPECIFIC RIBONUCLEASE ACTIVITY | 16 | 9.66e-01 | 6.09e-03 | 9.95e-01 |
| GOBP ADAPTIVE IMMUNE RESPONSE | 618 | 7.97e-01 | 6.08e-03 | 9.59e-01 |
| GOBP PEPTIDE ANTIGEN ASSEMBLY WITH MHC CLASS II PROTEIN COMPLEX | 14 | 9.69e-01 | -6.06e-03 | 9.95e-01 |
| GOCC MICROVILLUS MEMBRANE | 23 | 9.60e-01 | -6.05e-03 | 9.94e-01 |
| GOCC CMG COMPLEX | 11 | 9.72e-01 | 6.03e-03 | 9.95e-01 |
| GOMF PROTON TRANSMEMBRANE TRANSPORTER ACTIVITY | 155 | 8.97e-01 | -6.00e-03 | 9.81e-01 |
| GOBP POSITIVE REGULATION OF RNA METABOLIC PROCESS | 1458 | 7.03e-01 | 5.98e-03 | 9.30e-01 |
| GOBP LIPOPROTEIN METABOLIC PROCESS | 121 | 9.10e-01 | -5.96e-03 | 9.83e-01 |
| GOBP REGULATION OF CALCIUM ION TRANSMEMBRANE TRANSPORT | 121 | 9.10e-01 | -5.95e-03 | 9.83e-01 |
| GOCC SPECTRIN | 9 | 9.75e-01 | -5.93e-03 | 9.95e-01 |
| GOMF ATPASE COUPLED ION TRANSMEMBRANE TRANSPORTER ACTIVITY | 20 | 9.64e-01 | 5.91e-03 | 9.95e-01 |
| GOBP EPITHELIAL CELL DIFFERENTIATION | 459 | 8.28e-01 | -5.90e-03 | 9.64e-01 |
| GOBP POSITIVE REGULATION OF SEQUESTERING OF CALCIUM ION | 13 | 9.71e-01 | -5.82e-03 | 9.95e-01 |
| GOMF CHROMATIN BINDING | 515 | 8.22e-01 | -5.80e-03 | 9.64e-01 |
| GOBP REGULATION OF CD8 POSITIVE ALPHA BETA T CELL ACTIVATION | 19 | 9.65e-01 | 5.80e-03 | 9.95e-01 |
| GOMF PEPTIDASE ACTIVITY | 426 | 8.37e-01 | 5.80e-03 | 9.66e-01 |
| GOMF RNA POLYMERASE II SPECIFIC DNA BINDING TRANSCRIPTION FACTOR BINDING | 288 | 8.66e-01 | 5.77e-03 | 9.74e-01 |
| GOBP NEGATIVE REGULATION OF PROTEIN ACETYLATION | 7 | 9.79e-01 | -5.77e-03 | 9.96e-01 |
| GOBP NEUROGENESIS | 1245 | 7.32e-01 | -5.77e-03 | 9.41e-01 |
| GOBP G PROTEIN COUPLED RECEPTOR INTERNALIZATION | 8 | 9.77e-01 | -5.77e-03 | 9.95e-01 |
| GOBP REGULATION OF INFLAMMATORY RESPONSE TO ANTIGENIC STIMULUS | 39 | 9.50e-01 | 5.76e-03 | 9.91e-01 |
| GOBP RENAL SYSTEM DEVELOPMENT | 220 | 8.83e-01 | -5.74e-03 | 9.78e-01 |
| GOMF ENZYME ACTIVATOR ACTIVITY | 537 | 8.20e-01 | 5.74e-03 | 9.63e-01 |
| GOBP REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE BY HORMONE | 23 | 9.62e-01 | 5.72e-03 | 9.95e-01 |
| GOBP REGULATION OF BONE REMODELING | 34 | 9.54e-01 | -5.71e-03 | 9.93e-01 |
| GOBP POSITIVE REGULATION OF MUSCLE CELL APOPTOTIC PROCESS | 22 | 9.63e-01 | 5.69e-03 | 9.95e-01 |
| GOBP T CELL PROLIFERATION | 184 | 8.95e-01 | 5.66e-03 | 9.81e-01 |
| GOCC NUCLEAR UBIQUITIN LIGASE COMPLEX | 45 | 9.48e-01 | -5.66e-03 | 9.91e-01 |
| GOBP GLYCEROLIPID CATABOLIC PROCESS | 48 | 9.46e-01 | 5.64e-03 | 9.90e-01 |
| GOBP POSITIVE REGULATION OF MACROPHAGE CYTOKINE PRODUCTION | 22 | 9.64e-01 | -5.61e-03 | 9.95e-01 |
| GOBP POSITIVE REGULATION OF PROTEIN CONTAINING COMPLEX ASSEMBLY | 175 | 8.99e-01 | -5.59e-03 | 9.82e-01 |
| GOMF S ADENOSYLMETHIONINE DEPENDENT METHYLTRANSFERASE ACTIVITY | 149 | 9.07e-01 | -5.57e-03 | 9.83e-01 |
| GOBP T HELPER 1 CELL CYTOKINE PRODUCTION | 8 | 9.78e-01 | 5.53e-03 | 9.95e-01 |
| GOBP RESPONSE TO METAL ION | 258 | 8.79e-01 | 5.50e-03 | 9.77e-01 |
| GOBP PROTEIN TRANSPORT TO VACUOLE INVOLVED IN UBIQUITIN DEPENDENT PROTEIN CATABOLIC PROCESS VIA THE MULTIVESICULAR BODY SORTING PATHWAY | 14 | 9.72e-01 | -5.50e-03 | 9.95e-01 |
| GOMF RACEMASE AND EPIMERASE ACTIVITY ACTING ON CARBOHYDRATES AND DERIVATIVES | 10 | 9.76e-01 | -5.49e-03 | 9.95e-01 |
| GOBP PROTEIN LOCALIZATION TO CHROMATIN | 48 | 9.48e-01 | 5.45e-03 | 9.91e-01 |
| GOBP LIPID HOMEOSTASIS | 126 | 9.17e-01 | -5.41e-03 | 9.85e-01 |
| GOBP MONONUCLEAR CELL MIGRATION | 181 | 9.00e-01 | -5.40e-03 | 9.82e-01 |
| GOBP ATP EXPORT | 6 | 9.82e-01 | -5.40e-03 | 9.97e-01 |
| GOBP TELENCEPHALON GLIAL CELL MIGRATION | 22 | 9.65e-01 | 5.39e-03 | 9.95e-01 |
| GOBP POSITIVE REGULATION OF HYDROLASE ACTIVITY | 373 | 8.59e-01 | 5.36e-03 | 9.72e-01 |
| GOBP MONOATOMIC ION HOMEOSTASIS | 458 | 8.45e-01 | 5.32e-03 | 9.68e-01 |
| GOCC MON1 CCZ1 COMPLEX | 5 | 9.84e-01 | 5.31e-03 | 9.97e-01 |
| GOBP REGULATION OF T CELL ACTIVATION | 330 | 8.69e-01 | 5.30e-03 | 9.75e-01 |
| GOCC SECRETORY GRANULE | 723 | 8.09e-01 | 5.29e-03 | 9.61e-01 |
| GOBP REGULATION OF STEM CELL POPULATION MAINTENANCE | 60 | 9.44e-01 | -5.28e-03 | 9.89e-01 |
| GOMF CALCIUM DEPENDENT PROTEIN BINDING | 59 | 9.44e-01 | -5.25e-03 | 9.90e-01 |
| GOBP POSITIVE REGULATION OF NITRIC OXIDE METABOLIC PROCESS | 34 | 9.58e-01 | -5.23e-03 | 9.94e-01 |
| GOBP POLYOL CATABOLIC PROCESS | 9 | 9.78e-01 | 5.23e-03 | 9.95e-01 |
| GOMF LYSOPHOSPHOLIPASE ACTIVITY | 24 | 9.65e-01 | 5.23e-03 | 9.95e-01 |
| GOBP NEGATIVE REGULATION OF TRANSMEMBRANE RECEPTOR PROTEIN SERINE THREONINE KINASE SIGNALING PATHWAY | 115 | 9.23e-01 | -5.20e-03 | 9.86e-01 |
| GOBP NEGATIVE REGULATION OF LIPID METABOLIC PROCESS | 72 | 9.39e-01 | 5.20e-03 | 9.89e-01 |
| GOBP REGULATION OF TRANS SYNAPTIC SIGNALING | 336 | 8.70e-01 | -5.18e-03 | 9.75e-01 |
| GOBP STRIATED MUSCLE TISSUE DEVELOPMENT | 167 | 9.10e-01 | 5.08e-03 | 9.83e-01 |
| GOBP REGULATION OF MACROPHAGE DERIVED FOAM CELL DIFFERENTIATION | 22 | 9.67e-01 | -5.03e-03 | 9.95e-01 |
| GOCC L TYPE VOLTAGE GATED CALCIUM CHANNEL COMPLEX | 7 | 9.82e-01 | -5.03e-03 | 9.97e-01 |
| GOMF PHOSPHATIDYLINOSITOL 3 KINASE BINDING | 22 | 9.67e-01 | 5.03e-03 | 9.95e-01 |
| GOBP REGULATION OF GENERATION OF PRECURSOR METABOLITES AND ENERGY | 119 | 9.25e-01 | 5.00e-03 | 9.86e-01 |
| GOBP POSITIVE REGULATION OF NOTCH SIGNALING PATHWAY | 37 | 9.58e-01 | -4.99e-03 | 9.94e-01 |
| GOBP CELLULAR RESPONSE TO LIPID | 472 | 8.53e-01 | 4.98e-03 | 9.70e-01 |
| GOCC VACUOLE | 774 | 8.14e-01 | -4.98e-03 | 9.62e-01 |
| GOBP T CELL DIFFERENTIATION IN THYMUS | 78 | 9.40e-01 | -4.91e-03 | 9.89e-01 |
| GOCC RUFFLE | 166 | 9.13e-01 | -4.90e-03 | 9.83e-01 |
| GOCC CATALYTIC STEP 1 SPLICEOSOME | 12 | 9.77e-01 | -4.81e-03 | 9.95e-01 |
| GOBP FORMATION OF EXTRACHROMOSOMAL CIRCULAR DNA | 15 | 9.74e-01 | -4.81e-03 | 9.95e-01 |
| GOCC SECRETORY VESICLE | 849 | 8.12e-01 | 4.81e-03 | 9.62e-01 |
| GOBP POSITIVE REGULATION OF CELL FATE COMMITMENT | 8 | 9.81e-01 | -4.79e-03 | 9.97e-01 |
| GOMF COPPER ION BINDING | 47 | 9.55e-01 | -4.78e-03 | 9.93e-01 |
| GOCC KINESIN COMPLEX | 43 | 9.57e-01 | 4.74e-03 | 9.94e-01 |
| GOBP PURINERGIC NUCLEOTIDE RECEPTOR SIGNALING PATHWAY | 28 | 9.65e-01 | 4.74e-03 | 9.95e-01 |
| GOBP PIECEMEAL MICROAUTOPHAGY OF THE NUCLEUS | 17 | 9.73e-01 | -4.72e-03 | 9.95e-01 |
| GOBP BONE REMODELING | 63 | 9.48e-01 | -4.72e-03 | 9.91e-01 |
| GOMF PHOSPHATIDIC ACID BINDING | 21 | 9.70e-01 | -4.71e-03 | 9.95e-01 |
| GOBP ANTERIOR POSTERIOR PATTERN SPECIFICATION | 116 | 9.31e-01 | -4.67e-03 | 9.88e-01 |
| GOBP PYRIMIDINE NUCLEOSIDE TRIPHOSPHATE METABOLIC PROCESS | 22 | 9.70e-01 | 4.66e-03 | 9.95e-01 |
| GOBP VASCULATURE DEVELOPMENT | 553 | 8.52e-01 | -4.65e-03 | 9.69e-01 |
| GOBP MULTI MULTICELLULAR ORGANISM PROCESS | 143 | 9.24e-01 | -4.64e-03 | 9.86e-01 |
| GOBP REGULATION OF GRANULOCYTE DIFFERENTIATION | 13 | 9.77e-01 | 4.61e-03 | 9.95e-01 |
| GOBP REGULATION OF ANATOMICAL STRUCTURE MORPHOGENESIS | 645 | 8.42e-01 | 4.61e-03 | 9.67e-01 |
| GOBP RESPONSE TO STEROID HORMONE | 251 | 9.01e-01 | 4.57e-03 | 9.82e-01 |
| GOCC MITOCHONDRION | 1531 | 7.65e-01 | -4.57e-03 | 9.49e-01 |
| GOBP NEGATIVE REGULATION OF CELL DIFFERENTIATION | 458 | 8.67e-01 | 4.56e-03 | 9.74e-01 |
| GOBP POSITIVE REGULATION OF PROTEIN CONTAINING COMPLEX DISASSEMBLY | 32 | 9.65e-01 | -4.52e-03 | 9.95e-01 |
| GOCC DENDRITE TERMINUS | 12 | 9.78e-01 | -4.51e-03 | 9.95e-01 |
| GOCC MIB COMPLEX | 13 | 9.78e-01 | 4.49e-03 | 9.95e-01 |
| GOBP PROTEIN ACYLATION | 86 | 9.43e-01 | 4.49e-03 | 9.89e-01 |
| GOBP REGULATION OF GOLGI ORGANIZATION | 17 | 9.74e-01 | 4.48e-03 | 9.95e-01 |
| GOMF OXIDOREDUCTASE ACTIVITY ACTING ON PAIRED DONORS WITH INCORPORATION OR REDUCTION OF MOLECULAR OXYGEN | 123 | 9.32e-01 | 4.46e-03 | 9.89e-01 |
| GOMF G PROTEIN COUPLED RECEPTOR ACTIVITY | 289 | 8.97e-01 | 4.45e-03 | 9.81e-01 |
| GOBP REGULATION OF CELLULAR RESPONSE TO TRANSFORMING GROWTH FACTOR BETA STIMULUS | 119 | 9.34e-01 | 4.42e-03 | 9.89e-01 |
| GOBP REGULATION OF PROTEIN LOCALIZATION TO NUCLEOLUS | 9 | 9.82e-01 | 4.41e-03 | 9.97e-01 |
| GOBP DNA DEMETHYLATION | 20 | 9.73e-01 | -4.40e-03 | 9.95e-01 |
| GOBP GLYCEROPHOSPHOLIPID METABOLIC PROCESS | 268 | 9.01e-01 | -4.40e-03 | 9.82e-01 |
| GOBP RESPONSE TO OXYGEN LEVELS | 262 | 9.04e-01 | 4.35e-03 | 9.83e-01 |
| GOCC MEIOTIC COHESIN COMPLEX | 6 | 9.85e-01 | -4.35e-03 | 9.98e-01 |
| GOBP CARDIAC SEPTUM DEVELOPMENT | 75 | 9.48e-01 | -4.34e-03 | 9.91e-01 |
| GOCC AXONEMAL MICROTUBULE | 22 | 9.72e-01 | 4.33e-03 | 9.95e-01 |
| GOBP IMP METABOLIC PROCESS | 16 | 9.76e-01 | 4.33e-03 | 9.95e-01 |
| GOBP MESENCHYME DEVELOPMENT | 212 | 9.14e-01 | 4.32e-03 | 9.84e-01 |
| GOCC CHLORIDE CHANNEL COMPLEX | 27 | 9.69e-01 | -4.30e-03 | 9.95e-01 |
| GOMF CHLORIDE CHANNEL INHIBITOR ACTIVITY | 6 | 9.85e-01 | -4.30e-03 | 9.98e-01 |
| GOCC RIBOSOMAL SUBUNIT | 182 | 9.21e-01 | -4.28e-03 | 9.86e-01 |
| GOBP REGULATION OF T CELL PROLIFERATION | 151 | 9.28e-01 | 4.27e-03 | 9.87e-01 |
| GOBP POSITIVE REGULATION OF PROTEIN DEACETYLATION | 7 | 9.85e-01 | -4.24e-03 | 9.97e-01 |
| GOBP VASCULAR ASSOCIATED SMOOTH MUSCLE CELL PROLIFERATION | 51 | 9.58e-01 | -4.23e-03 | 9.94e-01 |
| GOMF DAMAGED DNA BINDING | 70 | 9.51e-01 | 4.23e-03 | 9.91e-01 |
| GOBP MULTICELLULAR ORGANISMAL RESPONSE TO STRESS | 61 | 9.55e-01 | -4.22e-03 | 9.93e-01 |
| GOBP REGULATION OF BODY FLUID LEVELS | 282 | 9.03e-01 | -4.22e-03 | 9.83e-01 |
| GOBP PHOSPHATIDYLCHOLINE BIOSYNTHETIC PROCESS | 25 | 9.71e-01 | -4.19e-03 | 9.95e-01 |
| GOBP RESPONSE TO LIPID | 693 | 8.51e-01 | 4.18e-03 | 9.69e-01 |
| GOBP REGULATION OF PROTEIN ADP RIBOSYLATION | 8 | 9.84e-01 | 4.17e-03 | 9.97e-01 |
| GOBP POSITIVE REGULATION OF NEURON PROJECTION DEVELOPMENT | 118 | 9.38e-01 | -4.13e-03 | 9.89e-01 |
| GOMF LIGASE ACTIVITY FORMING CARBON OXYGEN BONDS | 41 | 9.64e-01 | -4.11e-03 | 9.95e-01 |
| GOCC U7 SNRNP | 7 | 9.85e-01 | -4.06e-03 | 9.98e-01 |
| GOBP ORGANOPHOSPHATE METABOLIC PROCESS | 891 | 8.39e-01 | 4.02e-03 | 9.66e-01 |
| GOMF STRUCTURAL CONSTITUENT OF CYTOSKELETON | 78 | 9.51e-01 | -4.01e-03 | 9.91e-01 |
| GOBP REGULATION OF MAP KINASE ACTIVITY | 106 | 9.43e-01 | -4.00e-03 | 9.89e-01 |
| GOBP RESPONSE TO TRANSFORMING GROWTH FACTOR BETA | 217 | 9.19e-01 | -4.00e-03 | 9.86e-01 |
| GOBP MITOTIC SPINDLE ELONGATION | 11 | 9.82e-01 | 3.99e-03 | 9.97e-01 |
| GOBP DNA PROTECTION | 6 | 9.87e-01 | -3.97e-03 | 9.98e-01 |
| GOCC METHYLTRANSFERASE COMPLEX | 98 | 9.46e-01 | 3.95e-03 | 9.90e-01 |
| GOBP MATING BEHAVIOR | 23 | 9.74e-01 | 3.90e-03 | 9.95e-01 |
| GOBP UDP N ACETYLGLUCOSAMINE BIOSYNTHETIC PROCESS | 9 | 9.84e-01 | -3.88e-03 | 9.97e-01 |
| GOMF RNA POLYMERASE II CTD HEPTAPEPTIDE REPEAT MODIFYING ACTIVITY | 17 | 9.78e-01 | -3.84e-03 | 9.95e-01 |
| GOBP ERYTHROCYTE DEVELOPMENT | 39 | 9.67e-01 | 3.84e-03 | 9.95e-01 |
| GOBP JNK CASCADE | 151 | 9.37e-01 | 3.75e-03 | 9.89e-01 |
| GOBP REGULATION OF HORMONE METABOLIC PROCESS | 31 | 9.71e-01 | -3.75e-03 | 9.95e-01 |
| GOBP T HELPER 1 TYPE IMMUNE RESPONSE | 44 | 9.66e-01 | 3.71e-03 | 9.95e-01 |
| GOBP MONOSACCHARIDE TRANSMEMBRANE TRANSPORT | 94 | 9.51e-01 | -3.70e-03 | 9.91e-01 |
| GOBP PEPTIDYL TYROSINE DEPHOSPHORYLATION INVOLVED IN INACTIVATION OF PROTEIN KINASE ACTIVITY | 5 | 9.89e-01 | 3.69e-03 | 9.98e-01 |
| GOBP ORNITHINE METABOLIC PROCESS | 8 | 9.86e-01 | -3.67e-03 | 9.98e-01 |
| GOBP REGULATION OF BASEMENT MEMBRANE ORGANIZATION | 11 | 9.83e-01 | -3.66e-03 | 9.97e-01 |
| GOBP POSITIVE REGULATION OF DNA BINDING | 29 | 9.73e-01 | -3.65e-03 | 9.95e-01 |
| GOBP NEGATIVE REGULATION OF INFLAMMATORY RESPONSE TO ANTIGENIC STIMULUS | 24 | 9.76e-01 | 3.61e-03 | 9.95e-01 |
| GOBP AMINO ACID TRANSMEMBRANE TRANSPORT | 71 | 9.58e-01 | -3.59e-03 | 9.94e-01 |
| GOBP ALPHA BETA T CELL PROLIFERATION | 44 | 9.67e-01 | 3.59e-03 | 9.95e-01 |
| GOBP RIBOSOMAL SMALL SUBUNIT BIOGENESIS | 103 | 9.50e-01 | -3.57e-03 | 9.91e-01 |
| GOBP DGMP METABOLIC PROCESS | 5 | 9.89e-01 | -3.56e-03 | 9.98e-01 |
| GOBP GLYCEROLIPID METABOLIC PROCESS | 329 | 9.12e-01 | -3.53e-03 | 9.83e-01 |
| GOBP CELL COMMUNICATION INVOLVED IN CARDIAC CONDUCTION | 35 | 9.71e-01 | -3.50e-03 | 9.95e-01 |
| GOMF CALCIUM INDUCED CALCIUM RELEASE ACTIVITY | 6 | 9.88e-01 | -3.50e-03 | 9.98e-01 |
| GOBP CELLULAR RESPONSE TO GAMMA RADIATION | 24 | 9.76e-01 | 3.49e-03 | 9.95e-01 |
| GOMF G PROTEIN ALPHA SUBUNIT BINDING | 21 | 9.78e-01 | 3.49e-03 | 9.95e-01 |
| GOBP ESTABLISHMENT OF EPITHELIAL CELL APICAL BASAL POLARITY | 14 | 9.82e-01 | -3.48e-03 | 9.97e-01 |
| GOCC SMALL SUBUNIT PROCESSOME | 72 | 9.60e-01 | -3.45e-03 | 9.94e-01 |
| GOBP PEPTIDYL ARGININE METHYLATION | 9 | 9.86e-01 | 3.43e-03 | 9.98e-01 |
| GOBP REGULATION OF LIPID STORAGE | 41 | 9.70e-01 | 3.42e-03 | 9.95e-01 |
| GOMF PHOSPHATIDYLINOSITOL BINDING | 241 | 9.28e-01 | 3.40e-03 | 9.87e-01 |
| GOCC PEPTIDASE INHIBITOR COMPLEX | 9 | 9.86e-01 | 3.39e-03 | 9.98e-01 |
| GOBP POSITIVE REGULATION OF NEUROGENESIS | 183 | 9.37e-01 | 3.39e-03 | 9.89e-01 |
| GOBP HEART MORPHOGENESIS | 171 | 9.39e-01 | -3.38e-03 | 9.89e-01 |
| GOBP NECROPTOTIC PROCESS | 39 | 9.71e-01 | -3.36e-03 | 9.95e-01 |
| GOBP ALPHA AMINO ACID METABOLIC PROCESS | 169 | 9.40e-01 | 3.34e-03 | 9.89e-01 |
| GOBP LEUKOTRIENE D4 METABOLIC PROCESS | 6 | 9.89e-01 | 3.34e-03 | 9.98e-01 |
| GOBP POSITIVE REGULATION OF T CELL MEDIATED CYTOTOXICITY | 32 | 9.74e-01 | 3.33e-03 | 9.95e-01 |
| GOBP PHOSPHOLIPID TRANSPORT | 84 | 9.58e-01 | -3.33e-03 | 9.94e-01 |
| GOMF NEUREGULIN BINDING | 5 | 9.90e-01 | -3.29e-03 | 9.98e-01 |
| GOBP SULFUR COMPOUND METABOLIC PROCESS | 260 | 9.27e-01 | -3.29e-03 | 9.87e-01 |
| GOBP NUCLEOSOME ORGANIZATION | 94 | 9.56e-01 | -3.28e-03 | 9.94e-01 |
| GOBP CELLULAR RESPONSE TO ABIOTIC STIMULUS | 279 | 9.27e-01 | 3.20e-03 | 9.87e-01 |
| GOCC ENDOCYTIC VESICLE | 305 | 9.24e-01 | 3.18e-03 | 9.86e-01 |
| GOBP AMINO ACID TRANSPORT | 111 | 9.54e-01 | -3.18e-03 | 9.93e-01 |
| GOCC VCP NPL4 UFD1 AAA ATPASE COMPLEX | 8 | 9.88e-01 | -3.15e-03 | 9.98e-01 |
| GOBP METHIONINE METABOLIC PROCESS | 13 | 9.84e-01 | -3.15e-03 | 9.97e-01 |
| GOBP LONG TERM SYNAPTIC POTENTIATION | 64 | 9.65e-01 | 3.15e-03 | 9.95e-01 |
| GOBP REGULATION OF BIOLOGICAL PROCESS INVOLVED IN SYMBIOTIC INTERACTION | 46 | 9.71e-01 | -3.12e-03 | 9.95e-01 |
| GOBP SPINDLE ELONGATION | 13 | 9.85e-01 | 3.11e-03 | 9.97e-01 |
| GOBP NEGATIVE REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY IN RESPONSE TO DNA DAMAGE | 27 | 9.78e-01 | -3.11e-03 | 9.95e-01 |
| GOMF RACEMASE AND EPIMERASE ACTIVITY | 17 | 9.82e-01 | 3.09e-03 | 9.97e-01 |
| GOBP NEGATIVE REGULATION OF INTERLEUKIN 6 PRODUCTION | 42 | 9.73e-01 | 3.05e-03 | 9.95e-01 |
| GOCC CUL4B RING E3 UBIQUITIN LIGASE COMPLEX | 6 | 9.90e-01 | 3.04e-03 | 9.98e-01 |
| GOBP SPERM FLAGELLUM ASSEMBLY | 33 | 9.76e-01 | 3.04e-03 | 9.95e-01 |
| GOBP PROTEIN LOCALIZATION TO EXTRACELLULAR REGION | 281 | 9.30e-01 | -3.03e-03 | 9.88e-01 |
| GOBP POTASSIUM ION EXPORT ACROSS PLASMA MEMBRANE | 14 | 9.84e-01 | 3.03e-03 | 9.97e-01 |
| GOBP CHROMOSOME CONDENSATION | 37 | 9.75e-01 | 3.02e-03 | 9.95e-01 |
| GOBP POSITIVE REGULATION OF PROTEIN TYROSINE KINASE ACTIVITY | 19 | 9.82e-01 | 3.02e-03 | 9.97e-01 |
| GOBP 3 UTR MEDIATED MRNA STABILIZATION | 18 | 9.83e-01 | 2.96e-03 | 9.97e-01 |
| GOBP LEUKOCYTE ADHESION TO VASCULAR ENDOTHELIAL CELL | 39 | 9.75e-01 | 2.86e-03 | 9.95e-01 |
| GOBP POSITIVE REGULATION OF UBIQUITIN PROTEIN TRANSFERASE ACTIVITY | 18 | 9.83e-01 | -2.84e-03 | 9.97e-01 |
| GOBP MITOCHONDRIAL TRANSMEMBRANE TRANSPORT | 90 | 9.63e-01 | -2.83e-03 | 9.95e-01 |
| GOBP NEGATIVE REGULATION OF NERVOUS SYSTEM DEVELOPMENT | 94 | 9.62e-01 | 2.82e-03 | 9.95e-01 |
| GOBP MRNA CIS SPLICING VIA SPLICEOSOME | 29 | 9.79e-01 | 2.82e-03 | 9.96e-01 |
| GOBP INNER MITOCHONDRIAL MEMBRANE ORGANIZATION | 44 | 9.74e-01 | 2.79e-03 | 9.95e-01 |
| GOBP BLOOD VESSEL ENDOTHELIAL CELL PROLIFERATION INVOLVED IN SPROUTING ANGIOGENESIS | 14 | 9.86e-01 | -2.78e-03 | 9.98e-01 |
| GOBP CELL CELL SIGNALING | 845 | 8.92e-01 | 2.76e-03 | 9.80e-01 |
| GOBP STARTLE RESPONSE | 15 | 9.85e-01 | -2.76e-03 | 9.98e-01 |
| GOBP PRESYNAPTIC MODULATION OF CHEMICAL SYNAPTIC TRANSMISSION | 24 | 9.81e-01 | -2.76e-03 | 9.97e-01 |
| GOBP PEPTIDYL PROLINE HYDROXYLATION | 10 | 9.88e-01 | -2.74e-03 | 9.98e-01 |
| GOBP PLACENTA DEVELOPMENT | 109 | 9.61e-01 | 2.73e-03 | 9.94e-01 |
| GOMF FATTY ACID BINDING | 30 | 9.79e-01 | 2.73e-03 | 9.96e-01 |
| GOCC SMN COMPLEX | 11 | 9.88e-01 | 2.71e-03 | 9.98e-01 |
| GOBP CELL SURFACE RECEPTOR PROTEIN TYROSINE KINASE SIGNALING PATHWAY | 475 | 9.20e-01 | 2.69e-03 | 9.86e-01 |
| GOBP POSITIVE REGULATION OF TELOMERASE RNA LOCALIZATION TO CAJAL BODY | 15 | 9.86e-01 | 2.69e-03 | 9.98e-01 |
| GOBP INTRINSIC APOPTOTIC SIGNALING PATHWAY IN RESPONSE TO DNA DAMAGE | 96 | 9.64e-01 | 2.68e-03 | 9.95e-01 |
| GOBP CELLULAR RESPONSE TO INSULIN LIKE GROWTH FACTOR STIMULUS | 9 | 9.89e-01 | 2.68e-03 | 9.98e-01 |
| GOBP REGULATION OF PROTEIN COMPLEX STABILITY | 12 | 9.87e-01 | 2.67e-03 | 9.98e-01 |
| GOBP NEGATIVE REGULATION OF CHEMOTAXIS | 38 | 9.78e-01 | 2.62e-03 | 9.95e-01 |
| GOBP NEGATIVE REGULATION OF INTRACELLULAR SIGNAL TRANSDUCTION | 486 | 9.22e-01 | -2.61e-03 | 9.86e-01 |
| GOBP NUCLEOSIDE PHOSPHATE CATABOLIC PROCESS | 157 | 9.56e-01 | -2.55e-03 | 9.94e-01 |
| GOBP NEGATIVE REGULATION OF MULTICELLULAR ORGANISMAL PROCESS | 838 | 9.01e-01 | -2.54e-03 | 9.82e-01 |
| GOBP OOCYTE CONSTRUCTION | 5 | 9.92e-01 | 2.52e-03 | 9.99e-01 |
| GOBP DETECTION OF LIGHT STIMULUS INVOLVED IN SENSORY PERCEPTION | 15 | 9.87e-01 | -2.49e-03 | 9.98e-01 |
| GOBP N ACYLETHANOLAMINE METABOLIC PROCESS | 5 | 9.92e-01 | -2.47e-03 | 9.99e-01 |
| GOBP PYRIMIDINE NUCLEOTIDE METABOLIC PROCESS | 49 | 9.76e-01 | -2.45e-03 | 9.95e-01 |
| GOBP POSITIVE REGULATION OF PROTEOLYSIS | 299 | 9.42e-01 | -2.45e-03 | 9.89e-01 |
| GOMF I SMAD BINDING | 16 | 9.87e-01 | -2.43e-03 | 9.98e-01 |
| GOBP CELLULAR RESPONSE TO REACTIVE OXYGEN SPECIES | 130 | 9.62e-01 | 2.42e-03 | 9.95e-01 |
| GOBP REGULATION OF ERYTHROCYTE DIFFERENTIATION | 43 | 9.78e-01 | 2.42e-03 | 9.95e-01 |
| GOBP POSITIVE REGULATION OF STEM CELL PROLIFERATION | 24 | 9.84e-01 | 2.41e-03 | 9.97e-01 |
| GOCC ENDOPLASMIC RETICULUM LUMEN | 226 | 9.51e-01 | 2.38e-03 | 9.91e-01 |
| GOBP POSITIVE REGULATION OF NUCLEAR DIVISION | 40 | 9.79e-01 | -2.37e-03 | 9.96e-01 |
| GOMF HISTONE H3K36 DEMETHYLASE ACTIVITY | 10 | 9.90e-01 | -2.36e-03 | 9.98e-01 |
| GOBP RESPONSE TO ISCHEMIA | 47 | 9.78e-01 | 2.35e-03 | 9.95e-01 |
| GOBP POSITIVE REGULATION OF LIPID LOCALIZATION | 81 | 9.71e-01 | -2.33e-03 | 9.95e-01 |
| GOCC ORGANELLE ENVELOPE LUMEN | 88 | 9.70e-01 | 2.31e-03 | 9.95e-01 |
| GOCC APICAL CORTEX | 7 | 9.92e-01 | -2.26e-03 | 9.99e-01 |
| GOBP BIOLOGICAL PROCESS INVOLVED IN INTERACTION WITH SYMBIONT | 98 | 9.69e-01 | -2.25e-03 | 9.95e-01 |
| GOBP NEGATIVE REGULATION OF NUCLEOBASE CONTAINING COMPOUND METABOLIC PROCESS | 1188 | 8.96e-01 | -2.25e-03 | 9.81e-01 |
| GOBP RESPONSE TO LIGHT INTENSITY | 12 | 9.89e-01 | 2.25e-03 | 9.98e-01 |
| GOBP POSITIVE REGULATION OF CANONICAL WNT SIGNALING PATHWAY | 84 | 9.72e-01 | 2.23e-03 | 9.95e-01 |
| GOBP NEGATIVE REGULATION OF CELL POPULATION PROLIFERATION | 548 | 9.29e-01 | -2.22e-03 | 9.88e-01 |
| GOBP NEUTRAL LIPID METABOLIC PROCESS | 101 | 9.69e-01 | -2.21e-03 | 9.95e-01 |
| GOBP LEUKOCYTE CELL CELL ADHESION | 353 | 9.44e-01 | 2.19e-03 | 9.89e-01 |
| GOBP MITOCHONDRION DISTRIBUTION | 17 | 9.88e-01 | -2.17e-03 | 9.98e-01 |
| GOBP COLLATERAL SPROUTING | 24 | 9.85e-01 | 2.15e-03 | 9.98e-01 |
| GOBP PROTEIN LOCALIZATION TO CELL PERIPHERY | 290 | 9.51e-01 | -2.12e-03 | 9.91e-01 |
| GOBP GENERATION OF NEURONS | 1056 | 9.08e-01 | -2.10e-03 | 9.83e-01 |
| GOBP POLY A PLUS MRNA EXPORT FROM NUCLEUS | 20 | 9.87e-01 | -2.08e-03 | 9.98e-01 |
| GOBP POSITIVE REGULATION OF B CELL ACTIVATION | 79 | 9.75e-01 | 2.05e-03 | 9.95e-01 |
| GOBP LOCOMOTORY BEHAVIOR | 134 | 9.68e-01 | -2.03e-03 | 9.95e-01 |
| GOBP BONE DEVELOPMENT | 148 | 9.66e-01 | 2.03e-03 | 9.95e-01 |
| GOCC MITOCHONDRIAL MATRIX | 474 | 9.41e-01 | -1.99e-03 | 9.89e-01 |
| GOBP ELECTRON TRANSPORT CHAIN | 121 | 9.70e-01 | 1.99e-03 | 9.95e-01 |
| GOBP CONNECTIVE TISSUE REPLACEMENT INVOLVED IN INFLAMMATORY RESPONSE WOUND HEALING | 5 | 9.94e-01 | -1.96e-03 | 9.99e-01 |
| GOBP POSITIVE REGULATION OF PROTEIN LOCALIZATION TO MEMBRANE | 89 | 9.75e-01 | -1.95e-03 | 9.95e-01 |
| GOBP POSITIVE REGULATION OF MEMBRANE PROTEIN ECTODOMAIN PROTEOLYSIS | 15 | 9.90e-01 | 1.94e-03 | 9.98e-01 |
| GOBP T CELL DIFFERENTIATION | 279 | 9.56e-01 | 1.94e-03 | 9.94e-01 |
| GOBP EMBRYONIC HINDLIMB MORPHOGENESIS | 10 | 9.92e-01 | 1.90e-03 | 9.99e-01 |
| GOMF ARMADILLO REPEAT DOMAIN BINDING | 8 | 9.93e-01 | -1.87e-03 | 9.99e-01 |
| GOBP ACTIVATION OF PROTEIN KINASE B ACTIVITY | 12 | 9.91e-01 | 1.86e-03 | 9.99e-01 |
| GOMF METAL CLUSTER BINDING | 72 | 9.78e-01 | 1.86e-03 | 9.95e-01 |
| GOCC PARANODE REGION OF AXON | 10 | 9.92e-01 | 1.85e-03 | 9.99e-01 |
| GOBP REGULATION OF MUSCLE SYSTEM PROCESS | 169 | 9.67e-01 | -1.85e-03 | 9.95e-01 |
| GOBP REGULATION OF RECEPTOR INTERNALIZATION | 51 | 9.82e-01 | 1.83e-03 | 9.97e-01 |
| GOCC CYTOPLASMIC SIDE OF PLASMA MEMBRANE | 143 | 9.70e-01 | -1.83e-03 | 9.95e-01 |
| GOBP HORMONE METABOLIC PROCESS | 147 | 9.70e-01 | -1.82e-03 | 9.95e-01 |
| GOBP NEGATIVE REGULATION OF STRIATED MUSCLE CELL APOPTOTIC PROCESS | 19 | 9.89e-01 | 1.82e-03 | 9.98e-01 |
| GOMF GROWTH HORMONE RECEPTOR BINDING | 5 | 9.94e-01 | -1.81e-03 | 9.99e-01 |
| GOCC CYTOPLASMIC SIDE OF MEMBRANE | 183 | 9.66e-01 | 1.81e-03 | 9.95e-01 |
| GOBP POSITIVE REGULATION OF CELL CYCLE G2 M PHASE TRANSITION | 29 | 9.87e-01 | 1.80e-03 | 9.98e-01 |
| GOCC CILIUM | 561 | 9.42e-01 | 1.80e-03 | 9.89e-01 |
| GOMF NUCLEOSIDE DIPHOSPHATE PHOSPHATASE ACTIVITY | 15 | 9.90e-01 | -1.80e-03 | 9.98e-01 |
| GOBP PROTEIN PROCESSING | 183 | 9.67e-01 | 1.79e-03 | 9.95e-01 |
| GOCC 9PLUS2 MOTILE CILIUM | 121 | 9.73e-01 | 1.77e-03 | 9.95e-01 |
| GOBP REGULATION OF NEURON DIFFERENTIATION | 117 | 9.74e-01 | 1.76e-03 | 9.95e-01 |
| GOBP GRANULOCYTE DIFFERENTIATION | 35 | 9.86e-01 | -1.73e-03 | 9.98e-01 |
| GOBP REGULATION OF CELL ACTIVATION | 542 | 9.46e-01 | 1.71e-03 | 9.90e-01 |
| GOBP NUCLEOTIDE TRANSPORT | 41 | 9.85e-01 | 1.66e-03 | 9.98e-01 |
| GOBP REGULATION OF MEMBRANE REPOLARIZATION DURING CARDIAC MUSCLE CELL ACTION POTENTIAL | 5 | 9.95e-01 | 1.64e-03 | 9.99e-01 |
| GOBP REGULATION OF RHO PROTEIN SIGNAL TRANSDUCTION | 73 | 9.82e-01 | 1.56e-03 | 9.97e-01 |
| GOBP AMINE BIOSYNTHETIC PROCESS | 29 | 9.89e-01 | -1.53e-03 | 9.98e-01 |
| GOCC CILIARY TIP | 40 | 9.87e-01 | 1.50e-03 | 9.98e-01 |
| GOBP INTESTINAL LIPID ABSORPTION | 14 | 9.92e-01 | 1.49e-03 | 9.99e-01 |
| GOBP CELLULAR LIPID METABOLIC PROCESS | 804 | 9.43e-01 | -1.48e-03 | 9.89e-01 |
| GOBP POSITIVE THYMIC T CELL SELECTION | 13 | 9.93e-01 | -1.47e-03 | 9.99e-01 |
| GOBP ISOPRENOID METABOLIC PROCESS | 91 | 9.81e-01 | 1.45e-03 | 9.97e-01 |
| GOBP RESPONSE TO NUTRIENT LEVELS | 378 | 9.63e-01 | -1.39e-03 | 9.95e-01 |
| GOBP REGULATION OF ANIMAL ORGAN MORPHOGENESIS | 51 | 9.87e-01 | -1.34e-03 | 9.98e-01 |
| GOBP REGULATION OF SYSTEM PROCESS | 368 | 9.67e-01 | 1.26e-03 | 9.95e-01 |
| GOBP PHOSPHOLIPID METABOLIC PROCESS | 328 | 9.69e-01 | -1.26e-03 | 9.95e-01 |
| GOBP TUMOR NECROSIS FACTOR MEDIATED SIGNALING PATHWAY | 98 | 9.83e-01 | -1.22e-03 | 9.97e-01 |
| GOBP REGULATION OF MONOATOMIC ION TRANSPORT | 321 | 9.70e-01 | -1.22e-03 | 9.95e-01 |
| GOBP NEGATIVE REGULATION OF MICROTUBULE POLYMERIZATION OR DEPOLYMERIZATION | 33 | 9.90e-01 | 1.22e-03 | 9.98e-01 |
| GOBP GROWTH | 693 | 9.57e-01 | 1.21e-03 | 9.94e-01 |
| GOBP UTP METABOLIC PROCESS | 10 | 9.95e-01 | 1.18e-03 | 9.99e-01 |
| GOBP REGULATION OF DNA RECOMBINATION | 130 | 9.82e-01 | 1.17e-03 | 9.97e-01 |
| GOBP ACTIN FILAMENT DEPOLYMERIZATION | 54 | 9.88e-01 | -1.17e-03 | 9.98e-01 |
| GOBP GLYCEROLIPID BIOSYNTHETIC PROCESS | 223 | 9.76e-01 | -1.17e-03 | 9.95e-01 |
| GOBP REGULATION OF CELL POPULATION PROLIFERATION | 1264 | 9.45e-01 | -1.16e-03 | 9.90e-01 |
| GOBP RETINA DEVELOPMENT IN CAMERA TYPE EYE | 103 | 9.84e-01 | -1.16e-03 | 9.97e-01 |
| GOBP ENTRY OF BACTERIUM INTO HOST CELL | 7 | 9.96e-01 | -1.16e-03 | 1.00e+00 |
| GOBP EMBRYONIC CRANIAL SKELETON MORPHOGENESIS | 26 | 9.92e-01 | -1.16e-03 | 9.99e-01 |
| GOBP REPLICATIVE SENESCENCE | 16 | 9.94e-01 | -1.14e-03 | 9.99e-01 |
| GOBP NEGATIVE REGULATION OF CELLULAR RESPONSE TO GROWTH FACTOR STIMULUS | 74 | 9.87e-01 | 1.13e-03 | 9.98e-01 |
| GOBP GLYCINE METABOLIC PROCESS | 9 | 9.95e-01 | -1.13e-03 | 1.00e+00 |
| GOBP ORGANOPHOSPHATE CATABOLIC PROCESS | 205 | 9.79e-01 | -1.07e-03 | 9.96e-01 |
| GOBP SNRNA MODIFICATION | 7 | 9.96e-01 | -1.06e-03 | 1.00e+00 |
| GOBP CELLULAR LIPID CATABOLIC PROCESS | 194 | 9.80e-01 | -1.04e-03 | 9.96e-01 |
| GOBP VESICLE UNCOATING | 7 | 9.96e-01 | 1.04e-03 | 1.00e+00 |
| GOCC HIPPOCAMPAL MOSSY FIBER TO CA3 SYNAPSE | 24 | 9.93e-01 | -1.03e-03 | 9.99e-01 |
| GOBP POSITIVE REGULATION OF MULTICELLULAR ORGANISMAL PROCESS | 1278 | 9.52e-01 | 1.01e-03 | 9.92e-01 |
| GOCC IKAPPAB KINASE COMPLEX | 7 | 9.96e-01 | -1.01e-03 | 1.00e+00 |
| GOMF NADP BINDING | 46 | 9.91e-01 | 1.00e-03 | 9.98e-01 |
| GOBP ERK1 AND ERK2 CASCADE | 221 | 9.80e-01 | 9.95e-04 | 9.96e-01 |
| GOMF DNA RNA HYBRID BINDING | 5 | 9.97e-01 | -9.79e-04 | 1.00e+00 |
| GOBP POSITIVE REGULATION OF LEUKOCYTE PROLIFERATION | 134 | 9.84e-01 | 9.73e-04 | 9.97e-01 |
| GOBP T CELL ACTIVATION INVOLVED IN IMMUNE RESPONSE | 99 | 9.87e-01 | -9.67e-04 | 9.98e-01 |
| GOBP REGULATION OF DNA REPAIR | 208 | 9.81e-01 | 9.62e-04 | 9.97e-01 |
| GOMF MHC PROTEIN BINDING | 41 | 9.92e-01 | -9.38e-04 | 9.99e-01 |
| GOBP ASPARTATE FAMILY AMINO ACID METABOLIC PROCESS | 37 | 9.92e-01 | -9.17e-04 | 9.99e-01 |
| GOBP NEGATIVE REGULATION OF VASCULAR ASSOCIATED SMOOTH MUSCLE CELL PROLIFERATION | 18 | 9.95e-01 | -9.00e-04 | 9.99e-01 |
| GOBP POSITIVE REGULATION OF LOCOMOTION | 453 | 9.75e-01 | -8.71e-04 | 9.95e-01 |
| GOBP NEGATIVE REGULATION OF TRANSFORMING GROWTH FACTOR BETA RECEPTOR SIGNALING PATHWAY | 80 | 9.90e-01 | -8.37e-04 | 9.98e-01 |
| GOBP HEMOSTASIS | 193 | 9.84e-01 | -8.28e-04 | 9.97e-01 |
| GOBP HEMATOPOIETIC OR LYMPHOID ORGAN DEVELOPMENT | 77 | 9.90e-01 | -8.27e-04 | 9.98e-01 |
| GOBP POSITIVE REGULATION OF CALCIUM MEDIATED SIGNALING | 40 | 9.93e-01 | -8.04e-04 | 9.99e-01 |
| GOBP NEGATIVE REGULATION OF CANONICAL WNT SIGNALING PATHWAY | 92 | 9.89e-01 | -7.97e-04 | 9.98e-01 |
| GOMF HYDROLASE ACTIVITY ACTING ON GLYCOSYL BONDS | 106 | 9.89e-01 | -7.89e-04 | 9.98e-01 |
| GOBP POSITIVE REGULATION OF PROTEIN SERINE THREONINE KINASE ACTIVITY | 102 | 9.89e-01 | 7.86e-04 | 9.98e-01 |
| GOBP DENDRITE EXTENSION | 26 | 9.95e-01 | 7.79e-04 | 9.99e-01 |
| GOCC ASTROCYTE PROJECTION | 10 | 9.97e-01 | -7.44e-04 | 1.00e+00 |
| GOBP NEGATIVE REGULATION OF RESPONSE TO STIMULUS | 1356 | 9.65e-01 | 7.16e-04 | 9.95e-01 |
| GOBP RESPONSE TO ENDOGENOUS STIMULUS | 1217 | 9.67e-01 | -7.12e-04 | 9.95e-01 |
| GOBP VASCULOGENESIS | 55 | 9.93e-01 | -7.00e-04 | 9.99e-01 |
| GOBP REGULATION OF MACROPHAGE DIFFERENTIATION | 18 | 9.96e-01 | -6.85e-04 | 1.00e+00 |
| GOBP MUSCLE CELL MIGRATION | 69 | 9.92e-01 | -6.65e-04 | 9.99e-01 |
| GOBP NEGATIVE REGULATION OF BIOMINERAL TISSUE DEVELOPMENT | 20 | 9.96e-01 | -6.59e-04 | 1.00e+00 |
| GOBP HOMEOSTATIC PROCESS | 1321 | 9.70e-01 | -6.11e-04 | 9.95e-01 |
| GOBP AMYLOID BETA METABOLIC PROCESS | 49 | 9.95e-01 | -5.37e-04 | 9.99e-01 |
| GOBP NEGATIVE REGULATION OF CELL GROWTH INVOLVED IN CARDIAC MUSCLE CELL DEVELOPMENT | 9 | 9.98e-01 | 5.33e-04 | 1.00e+00 |
| GOBP MORPHOGENESIS OF A BRANCHING STRUCTURE | 128 | 9.92e-01 | 5.30e-04 | 9.99e-01 |
| GOBP POLYSACCHARIDE CATABOLIC PROCESS | 25 | 9.96e-01 | -5.28e-04 | 1.00e+00 |
| GOBP NEGATIVE REGULATION OF SIGNALING | 1135 | 9.77e-01 | -5.13e-04 | 9.95e-01 |
| GOBP REGULATION OF NEUROTRANSMITTER UPTAKE | 13 | 9.98e-01 | 4.93e-04 | 1.00e+00 |
| GOBP POSITIVE REGULATION OF ASTROCYTE DIFFERENTIATION | 7 | 9.98e-01 | -4.84e-04 | 1.00e+00 |
| GOBP AEROBIC RESPIRATION | 183 | 9.91e-01 | -4.69e-04 | 9.99e-01 |
| GOCC HISTONE PRE MRNA 3 END PROCESSING COMPLEX | 6 | 9.98e-01 | -4.55e-04 | 1.00e+00 |
| GOBP INORGANIC ION IMPORT ACROSS PLASMA MEMBRANE | 79 | 9.95e-01 | 4.14e-04 | 9.99e-01 |
| GOBP INTERLEUKIN 23 PRODUCTION | 8 | 9.98e-01 | 4.12e-04 | 1.00e+00 |
| GOCC PROTEIN PHOSPHATASE TYPE 2A COMPLEX | 17 | 9.98e-01 | 4.10e-04 | 1.00e+00 |
| GOBP REGULATION OF TETRAPYRROLE METABOLIC PROCESS | 8 | 9.98e-01 | -3.88e-04 | 1.00e+00 |
| GOMF ALPHA CATENIN BINDING | 7 | 9.99e-01 | 3.77e-04 | 1.00e+00 |
| GOCC ANAPHASE PROMOTING COMPLEX | 22 | 9.98e-01 | -3.64e-04 | 1.00e+00 |
| GOBP POSITIVE REGULATION OF CELL PROJECTION ORGANIZATION | 288 | 9.92e-01 | -3.55e-04 | 9.99e-01 |
| GOBP XENOBIOTIC TRANSPORT | 37 | 9.97e-01 | 3.29e-04 | 1.00e+00 |
| GOBP NUCLEOSIDE PHOSPHATE BIOSYNTHETIC PROCESS | 258 | 9.93e-01 | 3.27e-04 | 9.99e-01 |
| GOCC AGGRESOME | 30 | 9.98e-01 | 3.27e-04 | 1.00e+00 |
| GOBP AMINO ACID METABOLIC PROCESS | 248 | 9.93e-01 | 3.14e-04 | 9.99e-01 |
| GOBP NEGATIVE REGULATION OF STEM CELL PROLIFERATION | 15 | 9.98e-01 | 2.95e-04 | 1.00e+00 |
| GOMF ACTIN MONOMER BINDING | 25 | 9.98e-01 | 2.94e-04 | 1.00e+00 |
| GOCC RNA POLYMERASE I TRANSCRIPTION REGULATOR COMPLEX | 6 | 9.99e-01 | -2.82e-04 | 1.00e+00 |
| GOBP NEGATIVE REGULATION OF HYPOXIA INDUCED INTRINSIC APOPTOTIC SIGNALING PATHWAY | 6 | 9.99e-01 | -2.67e-04 | 1.00e+00 |
| GOBP REGULATION OF MACROPHAGE CHEMOTAXIS | 24 | 9.98e-01 | -2.55e-04 | 1.00e+00 |
| GOCC MYELIN SHEATH | 40 | 9.98e-01 | -2.52e-04 | 1.00e+00 |
| GOBP CALCIUM MEDIATED SIGNALING | 179 | 9.96e-01 | -2.12e-04 | 1.00e+00 |
| GOBP POSITIVE REGULATION OF AMYLOID PRECURSOR PROTEIN CATABOLIC PROCESS | 23 | 9.99e-01 | -1.93e-04 | 1.00e+00 |
| GOBP NEGATIVE REGULATION OF TYPE II INTERFERON PRODUCTION | 38 | 9.98e-01 | -1.79e-04 | 1.00e+00 |
| GOBP INTRACELLULAR DISTRIBUTION OF MITOCHONDRIA | 7 | 9.99e-01 | -1.61e-04 | 1.00e+00 |
| GOBP NEGATIVE REGULATION OF MHC CLASS II BIOSYNTHETIC PROCESS | 5 | 1.00e+00 | 1.32e-04 | 1.00e+00 |
| GOBP RESPONSE TO OXYGEN CONTAINING COMPOUND | 1252 | 9.94e-01 | -1.17e-04 | 9.99e-01 |
| GOBP RIBOSE PHOSPHATE METABOLIC PROCESS | 420 | 9.97e-01 | -1.16e-04 | 1.00e+00 |
| GOBP WATER SOLUBLE VITAMIN METABOLIC PROCESS | 60 | 9.99e-01 | -1.05e-04 | 1.00e+00 |
| GOBP CELLULAR RESPONSE TO ESTRADIOL STIMULUS | 28 | 9.99e-01 | -1.01e-04 | 1.00e+00 |
| GOBP ORGANIC ACID BIOSYNTHETIC PROCESS | 254 | 9.98e-01 | -1.00e-04 | 1.00e+00 |
| GOBP NEGATIVE REGULATION OF FATTY ACID METABOLIC PROCESS | 25 | 9.99e-01 | 8.67e-05 | 1.00e+00 |
| GOCC AXON | 467 | 9.98e-01 | 8.34e-05 | 1.00e+00 |
| GOBP HINDBRAIN DEVELOPMENT | 117 | 9.99e-01 | 7.12e-05 | 1.00e+00 |
| GOBP GLYCEROPHOSPHOLIPID BIOSYNTHETIC PROCESS | 190 | 9.99e-01 | -6.47e-05 | 1.00e+00 |
| GOBP REGULATION OF NERVOUS SYSTEM DEVELOPMENT | 326 | 9.99e-01 | -2.61e-05 | 1.00e+00 |
| GOBP NEGATIVE REGULATION OF LIPASE ACTIVITY | 11 | 1.00e+00 | -1.71e-05 | 1.00e+00 |
Detailed Gene set reports
GOBP REGULATION OF ENDOPLASMIC RETICULUM TUBULAR NETWORK ORGANIZATION
| set | GOBP REGULATION OF ENDOPLASMIC RETICULUM TUBULAR NETWORK ORGANIZATION |
| setSize | 6 |
| pANOVA | 0.000254 |
| s.dist | 0.862 |
| p.adjustANOVA | 0.0285 |
Top enriched genes
| GeneID | Gene Rank |
|---|---|
| TMEM33 | 10446 |
| RAB3GAP1 | 10360 |
| RAB3GAP2 | 10245 |
| LNPK | 10121 |
| ATL3 | 8522 |
| ARL6IP1 | 5547 |
Click HERE to show all gene set members
| GeneID | Gene Rank |
|---|---|
| TMEM33 | 10446 |
| RAB3GAP1 | 10360 |
| RAB3GAP2 | 10245 |
| LNPK | 10121 |
| ATL3 | 8522 |
| ARL6IP1 | 5547 |
GOCC PHAGOCYTIC VESICLE LUMEN
| set | GOCC PHAGOCYTIC VESICLE LUMEN |
| setSize | 5 |
| pANOVA | 0.00103 |
| s.dist | -0.848 |
| p.adjustANOVA | 0.0719 |
Top enriched genes
| GeneID | Gene Rank |
|---|---|
| PGLYRP1 | -10403 |
| LTF | -10062 |
| HGS | -9473 |
| MPO | -8990 |
| GNLY | -5862 |
Click HERE to show all gene set members
| GeneID | Gene Rank |
|---|---|
| PGLYRP1 | -10403 |
| LTF | -10062 |
| HGS | -9473 |
| MPO | -8990 |
| GNLY | -5862 |
GOBP ESTABLISHMENT OF MITOTIC SISTER CHROMATID COHESION
| set | GOBP ESTABLISHMENT OF MITOTIC SISTER CHROMATID COHESION |
| setSize | 7 |
| pANOVA | 0.000108 |
| s.dist | 0.845 |
| p.adjustANOVA | 0.0162 |
Top enriched genes
| GeneID | Gene Rank |
|---|---|
| STAG1 | 10330 |
| NAA50 | 10114 |
| NIPBL | 9912 |
| STAG2 | 9819 |
| SMC3 | 9544 |
| RAD21 | 9514 |
| SMC1A | 3907 |
Click HERE to show all gene set members
| GeneID | Gene Rank |
|---|---|
| STAG1 | 10330 |
| NAA50 | 10114 |
| NIPBL | 9912 |
| STAG2 | 9819 |
| SMC3 | 9544 |
| RAD21 | 9514 |
| SMC1A | 3907 |
GOCC GLYCOPROTEIN IB IX V COMPLEX
| set | GOCC GLYCOPROTEIN IB IX V COMPLEX |
| setSize | 5 |
| pANOVA | 0.00128 |
| s.dist | -0.831 |
| p.adjustANOVA | 0.0815 |
Top enriched genes
| GeneID | Gene Rank |
|---|---|
| GP1BA | -9974 |
| FLNA | -9719 |
| GP1BB | -8934 |
| GP9 | -8885 |
| GP5 | -6427 |
Click HERE to show all gene set members
| GeneID | Gene Rank |
|---|---|
| GP1BA | -9974 |
| FLNA | -9719 |
| GP1BB | -8934 |
| GP9 | -8885 |
| GP5 | -6427 |
GOBP ACROSOMAL VESICLE EXOCYTOSIS
| set | GOBP ACROSOMAL VESICLE EXOCYTOSIS |
| setSize | 5 |
| pANOVA | 0.00161 |
| s.dist | -0.814 |
| p.adjustANOVA | 0.0971 |
Top enriched genes
| GeneID | Gene Rank |
|---|---|
| ZP3 | -10397 |
| HYAL3 | -9965 |
| STXBP1 | -9516 |
| UNC13B | -7805 |
| RAB3A | -5342 |
Click HERE to show all gene set members
| GeneID | Gene Rank |
|---|---|
| ZP3 | -10397 |
| HYAL3 | -9965 |
| STXBP1 | -9516 |
| UNC13B | -7805 |
| RAB3A | -5342 |
GOCC SARCOPLASMIC RETICULUM LUMEN
| set | GOCC SARCOPLASMIC RETICULUM LUMEN |
| setSize | 5 |
| pANOVA | 0.00193 |
| s.dist | 0.801 |
| p.adjustANOVA | 0.109 |
Top enriched genes
| GeneID | Gene Rank |
|---|---|
| HSP90B1 | 10447 |
| CASQ1 | 9327 |
| CALU | 8754 |
| CALR | 8262 |
| MANF | 5975 |
Click HERE to show all gene set members
| GeneID | Gene Rank |
|---|---|
| HSP90B1 | 10447 |
| CASQ1 | 9327 |
| CALU | 8754 |
| CALR | 8262 |
| MANF | 5975 |
GOBP REGULATION OF MATRIX METALLOPEPTIDASE SECRETION
| set | GOBP REGULATION OF MATRIX METALLOPEPTIDASE SECRETION |
| setSize | 5 |
| pANOVA | 0.00204 |
| s.dist | 0.797 |
| p.adjustANOVA | 0.111 |
Top enriched genes
| GeneID | Gene Rank |
|---|---|
| RAP1GDS1 | 10318 |
| TLR2 | 8459 |
| CD200 | 8190 |
| SLC12A2 | 7870 |
| TLR4 | 7709 |
Click HERE to show all gene set members
| GeneID | Gene Rank |
|---|---|
| RAP1GDS1 | 10318 |
| TLR2 | 8459 |
| CD200 | 8190 |
| SLC12A2 | 7870 |
| TLR4 | 7709 |
GOBP INTERLEUKIN 27 MEDIATED SIGNALING PATHWAY
| set | GOBP INTERLEUKIN 27 MEDIATED SIGNALING PATHWAY |
| setSize | 7 |
| pANOVA | 0.000265 |
| s.dist | 0.796 |
| p.adjustANOVA | 0.0289 |
Top enriched genes
| GeneID | Gene Rank |
|---|---|
| OAS2 | 10625 |
| STAT1 | 10587 |
| IL6ST | 10507 |
| OAS1 | 10486 |
| MX1 | 10395 |
| OASL | 8310 |
| IL27RA | -1393 |
Click HERE to show all gene set members
| GeneID | Gene Rank |
|---|---|
| OAS2 | 10625 |
| STAT1 | 10587 |
| IL6ST | 10507 |
| OAS1 | 10486 |
| MX1 | 10395 |
| OASL | 8310 |
| IL27RA | -1393 |
GOBP MEIOTIC CYTOKINESIS
| set | GOBP MEIOTIC CYTOKINESIS |
| setSize | 6 |
| pANOVA | 0.00102 |
| s.dist | 0.774 |
| p.adjustANOVA | 0.0718 |
Top enriched genes
| GeneID | Gene Rank |
|---|---|
| ACTR3 | 10481 |
| ACTR2 | 9849 |
| ORC4 | 9486 |
| WASHC5 | 7925 |
| SPIRE1 | 6417 |
| SPIRE2 | 5474 |
Click HERE to show all gene set members
| GeneID | Gene Rank |
|---|---|
| ACTR3 | 10481 |
| ACTR2 | 9849 |
| ORC4 | 9486 |
| WASHC5 | 7925 |
| SPIRE1 | 6417 |
| SPIRE2 | 5474 |
GOMF HISTONE H2AX KINASE ACTIVITY
| set | GOMF HISTONE H2AX KINASE ACTIVITY |
| setSize | 5 |
| pANOVA | 0.00389 |
| s.dist | 0.745 |
| p.adjustANOVA | 0.15 |
Top enriched genes
| GeneID | Gene Rank |
|---|---|
| ATR | 10540 |
| ATM | 7863 |
| PRKDC | 7508 |
| BAZ1B | 7181 |
| VRK1 | 6735 |
Click HERE to show all gene set members
| GeneID | Gene Rank |
|---|---|
| ATR | 10540 |
| ATM | 7863 |
| PRKDC | 7508 |
| BAZ1B | 7181 |
| VRK1 | 6735 |
GOBP HYPOXIA INDUCIBLE FACTOR 1ALPHA SIGNALING PATHWAY
| set | GOBP HYPOXIA INDUCIBLE FACTOR 1ALPHA SIGNALING PATHWAY |
| setSize | 5 |
| pANOVA | 0.00399 |
| s.dist | 0.743 |
| p.adjustANOVA | 0.151 |
Top enriched genes
| GeneID | Gene Rank |
|---|---|
| HIF1A | 10075 |
| CYBB | 10049 |
| RWDD3 | 9478 |
| PDK3 | 5687 |
| PDK1 | 4429 |
Click HERE to show all gene set members
| GeneID | Gene Rank |
|---|---|
| HIF1A | 10075 |
| CYBB | 10049 |
| RWDD3 | 9478 |
| PDK3 | 5687 |
| PDK1 | 4429 |
GOMF UBIQUITIN LIKE PROTEIN SPECIFIC ENDOPEPTIDASE ACTIVITY
| set | GOMF UBIQUITIN LIKE PROTEIN SPECIFIC ENDOPEPTIDASE ACTIVITY |
| setSize | 5 |
| pANOVA | 0.00426 |
| s.dist | 0.738 |
| p.adjustANOVA | 0.158 |
Top enriched genes
| GeneID | Gene Rank |
|---|---|
| SENP2 | 9200 |
| SENP7 | 9091 |
| SENP6 | 8661 |
| SENP1 | 6385 |
| SENP5 | 6100 |
Click HERE to show all gene set members
| GeneID | Gene Rank |
|---|---|
| SENP2 | 9200 |
| SENP7 | 9091 |
| SENP6 | 8661 |
| SENP1 | 6385 |
| SENP5 | 6100 |
GOCC TUBULAR ENDOSOME
| set | GOCC TUBULAR ENDOSOME |
| setSize | 5 |
| pANOVA | 0.00492 |
| s.dist | 0.726 |
| p.adjustANOVA | 0.171 |
Top enriched genes
| GeneID | Gene Rank |
|---|---|
| VPS35 | 10321 |
| SNX5 | 9930 |
| SNX6 | 9754 |
| VPS26A | 9070 |
| ANKRD27 | -272 |
Click HERE to show all gene set members
| GeneID | Gene Rank |
|---|---|
| VPS35 | 10321 |
| SNX5 | 9930 |
| SNX6 | 9754 |
| VPS26A | 9070 |
| ANKRD27 | -272 |
GOBP INTERKINETIC NUCLEAR MIGRATION
| set | GOBP INTERKINETIC NUCLEAR MIGRATION |
| setSize | 5 |
| pANOVA | 0.00527 |
| s.dist | 0.721 |
| p.adjustANOVA | 0.177 |
Top enriched genes
| GeneID | Gene Rank |
|---|---|
| CEP120 | 9778 |
| PAX6 | 8885 |
| PCM1 | 7940 |
| HOOK3 | 6712 |
| DOCK7 | 5189 |
Click HERE to show all gene set members
| GeneID | Gene Rank |
|---|---|
| CEP120 | 9778 |
| PAX6 | 8885 |
| PCM1 | 7940 |
| HOOK3 | 6712 |
| DOCK7 | 5189 |
GOMF C PALMITOYLTRANSFERASE ACTIVITY
| set | GOMF C PALMITOYLTRANSFERASE ACTIVITY |
| setSize | 5 |
| pANOVA | 0.00558 |
| s.dist | 0.716 |
| p.adjustANOVA | 0.179 |
Top enriched genes
| GeneID | Gene Rank |
|---|---|
| SPTLC1 | 9980 |
| SPTLC2 | 9924 |
| SPTLC3 | 8460 |
| SPTSSB | 6907 |
| SPTSSA | 2971 |
Click HERE to show all gene set members
| GeneID | Gene Rank |
|---|---|
| SPTLC1 | 9980 |
| SPTLC2 | 9924 |
| SPTLC3 | 8460 |
| SPTSSB | 6907 |
| SPTSSA | 2971 |
GOBP PROTEIN FOLDING IN ENDOPLASMIC RETICULUM
| set | GOBP PROTEIN FOLDING IN ENDOPLASMIC RETICULUM |
| setSize | 11 |
| pANOVA | 5.25e-05 |
| s.dist | 0.704 |
| p.adjustANOVA | 0.00886 |
Top enriched genes
| GeneID | Gene Rank |
|---|---|
| HSP90B1 | 10447 |
| CANX | 10368 |
| PDIA3 | 10197 |
| DNAJC3 | 9791 |
| HSPA5 | 9424 |
| VAPA | 9269 |
| ERO1A | 9009 |
| CALR | 8262 |
| ERO1B | 4900 |
| DNAJC10 | 2927 |
| P4HB | -1824 |
Click HERE to show all gene set members
| GeneID | Gene Rank |
|---|---|
| HSP90B1 | 10447 |
| CANX | 10368 |
| PDIA3 | 10197 |
| DNAJC3 | 9791 |
| HSPA5 | 9424 |
| VAPA | 9269 |
| ERO1A | 9009 |
| CALR | 8262 |
| ERO1B | 4900 |
| DNAJC10 | 2927 |
| P4HB | -1824 |
GOCC BRCA1 C COMPLEX
| set | GOCC BRCA1 C COMPLEX |
| setSize | 6 |
| pANOVA | 0.00298 |
| s.dist | 0.7 |
| p.adjustANOVA | 0.129 |
Top enriched genes
| GeneID | Gene Rank |
|---|---|
| NBN | 10142 |
| RAD50 | 9723 |
| RBBP8 | 8771 |
| BRCA1 | 6573 |
| BARD1 | 5352 |
| MRE11 | 4342 |
Click HERE to show all gene set members
| GeneID | Gene Rank |
|---|---|
| NBN | 10142 |
| RAD50 | 9723 |
| RBBP8 | 8771 |
| BRCA1 | 6573 |
| BARD1 | 5352 |
| MRE11 | 4342 |
GOBP ONCOGENE INDUCED CELL SENESCENCE
| set | GOBP ONCOGENE INDUCED CELL SENESCENCE |
| setSize | 5 |
| pANOVA | 0.00703 |
| s.dist | -0.696 |
| p.adjustANOVA | 0.194 |
Top enriched genes
| GeneID | Gene Rank |
|---|---|
| HRAS | -9376 |
| HMGA1 | -8515 |
| SPI1 | -8432 |
| CDKN1A | -5506 |
| PML | -4916 |
Click HERE to show all gene set members
| GeneID | Gene Rank |
|---|---|
| HRAS | -9376 |
| HMGA1 | -8515 |
| SPI1 | -8432 |
| CDKN1A | -5506 |
| PML | -4916 |
GOMF LIGAND GATED MONOATOMIC ION CHANNEL ACTIVITY INVOLVED IN REGULATION OF PRESYNAPTIC MEMBRANE POTENTIAL
| set | GOMF LIGAND GATED MONOATOMIC ION CHANNEL ACTIVITY INVOLVED IN REGULATION OF PRESYNAPTIC MEMBRANE POTENTIAL |
| setSize | 5 |
| pANOVA | 0.00709 |
| s.dist | -0.695 |
| p.adjustANOVA | 0.194 |
Top enriched genes
| GeneID | Gene Rank |
|---|---|
| GRIN2D | -9967 |
| GRIK4 | -9835 |
| GRIN3B | -8360 |
| GRIK5 | -5548 |
| GRIA4 | -2995 |
Click HERE to show all gene set members
| GeneID | Gene Rank |
|---|---|
| GRIN2D | -9967 |
| GRIK4 | -9835 |
| GRIN3B | -8360 |
| GRIK5 | -5548 |
| GRIA4 | -2995 |
GOBP NEGATIVE REGULATION OF FIBROBLAST APOPTOTIC PROCESS
| set | GOBP NEGATIVE REGULATION OF FIBROBLAST APOPTOTIC PROCESS |
| setSize | 6 |
| pANOVA | 0.00352 |
| s.dist | 0.688 |
| p.adjustANOVA | 0.141 |
Top enriched genes
| GeneID | Gene Rank |
|---|---|
| PIK3CG | 10519 |
| PIK3CA | 9857 |
| CFDP1 | 9259 |
| API5 | 8729 |
| CHD8 | 2978 |
| GAS6 | 2785 |
Click HERE to show all gene set members
| GeneID | Gene Rank |
|---|---|
| PIK3CG | 10519 |
| PIK3CA | 9857 |
| CFDP1 | 9259 |
| API5 | 8729 |
| CHD8 | 2978 |
| GAS6 | 2785 |
GOBP REGULATION OF BLOOD VESSEL REMODELING
| set | GOBP REGULATION OF BLOOD VESSEL REMODELING |
| setSize | 6 |
| pANOVA | 0.0036 |
| s.dist | -0.686 |
| p.adjustANOVA | 0.142 |
Top enriched genes
| GeneID | Gene Rank |
|---|---|
| TGFB1 | -10090 |
| CST3 | -10051 |
| BCR | -7791 |
| CEACAM1 | -6685 |
| TMBIM1 | -5238 |
| FLT4 | -3613 |
Click HERE to show all gene set members
| GeneID | Gene Rank |
|---|---|
| TGFB1 | -10090 |
| CST3 | -10051 |
| BCR | -7791 |
| CEACAM1 | -6685 |
| TMBIM1 | -5238 |
| FLT4 | -3613 |
GOBP LOOP OF HENLE DEVELOPMENT
| set | GOBP LOOP OF HENLE DEVELOPMENT |
| setSize | 5 |
| pANOVA | 0.00789 |
| s.dist | -0.686 |
| p.adjustANOVA | 0.204 |
Top enriched genes
| GeneID | Gene Rank |
|---|---|
| AQP1 | -9830 |
| PKD1 | -9471 |
| JAG1 | -8247 |
| PKD2 | -6507 |
| DLL1 | -2157 |
Click HERE to show all gene set members
| GeneID | Gene Rank |
|---|---|
| AQP1 | -9830 |
| PKD1 | -9471 |
| JAG1 | -8247 |
| PKD2 | -6507 |
| DLL1 | -2157 |
GOBP 7 METHYLGUANOSINE RNA CAPPING
| set | GOBP 7 METHYLGUANOSINE RNA CAPPING |
| setSize | 7 |
| pANOVA | 0.00169 |
| s.dist | 0.685 |
| p.adjustANOVA | 0.1 |
Top enriched genes
| GeneID | Gene Rank |
|---|---|
| RNGTT | 10585 |
| CMTR2 | 9409 |
| RNMT | 9142 |
| RAMAC | 8154 |
| NCBP3 | 6556 |
| NCBP1 | 6101 |
| CMTR1 | 1325 |
Click HERE to show all gene set members
| GeneID | Gene Rank |
|---|---|
| RNGTT | 10585 |
| CMTR2 | 9409 |
| RNMT | 9142 |
| RAMAC | 8154 |
| NCBP3 | 6556 |
| NCBP1 | 6101 |
| CMTR1 | 1325 |
GOBP REGULATION OF TOLL LIKE RECEPTOR 7 SIGNALING PATHWAY
| set | GOBP REGULATION OF TOLL LIKE RECEPTOR 7 SIGNALING PATHWAY |
| setSize | 6 |
| pANOVA | 0.00459 |
| s.dist | 0.668 |
| p.adjustANOVA | 0.165 |
Top enriched genes
| GeneID | Gene Rank |
|---|---|
| LILRA4 | 10654 |
| RSAD2 | 10602 |
| TASL | 9728 |
| DDX3X | 5512 |
| SLC15A4 | 4898 |
| TREML4 | 1471 |
Click HERE to show all gene set members
| GeneID | Gene Rank |
|---|---|
| LILRA4 | 10654 |
| RSAD2 | 10602 |
| TASL | 9728 |
| DDX3X | 5512 |
| SLC15A4 | 4898 |
| TREML4 | 1471 |
GOBP HEPOXILIN METABOLIC PROCESS
| set | GOBP HEPOXILIN METABOLIC PROCESS |
| setSize | 7 |
| pANOVA | 0.00226 |
| s.dist | -0.667 |
| p.adjustANOVA | 0.117 |
Top enriched genes
| GeneID | Gene Rank |
|---|---|
| ALOX15B | -10492 |
| ALOX12 | -10327 |
| GSTM2 | -7785 |
| ALOX12B | -7377 |
| GSTP1 | -5988 |
| ALOX15 | -4265 |
| GSTM1 | -3011 |
Click HERE to show all gene set members
| GeneID | Gene Rank |
|---|---|
| ALOX15B | -10492 |
| ALOX12 | -10327 |
| GSTM2 | -7785 |
| ALOX12B | -7377 |
| GSTP1 | -5988 |
| ALOX15 | -4265 |
| GSTM1 | -3011 |
GOCC TORC1 COMPLEX
| set | GOCC TORC1 COMPLEX |
| setSize | 6 |
| pANOVA | 0.00481 |
| s.dist | -0.665 |
| p.adjustANOVA | 0.169 |
Top enriched genes
| GeneID | Gene Rank |
|---|---|
| AKT1S1 | -10441 |
| MTOR | -7798 |
| TTI1 | -7213 |
| RPTOR | -6339 |
| LARP1 | -5234 |
| MLST8 | -5067 |
Click HERE to show all gene set members
| GeneID | Gene Rank |
|---|---|
| AKT1S1 | -10441 |
| MTOR | -7798 |
| TTI1 | -7213 |
| RPTOR | -6339 |
| LARP1 | -5234 |
| MLST8 | -5067 |
GOCC MCRD MEDIATED MRNA STABILITY COMPLEX
| set | GOCC MCRD MEDIATED MRNA STABILITY COMPLEX |
| setSize | 5 |
| pANOVA | 0.0102 |
| s.dist | 0.664 |
| p.adjustANOVA | 0.227 |
Top enriched genes
| GeneID | Gene Rank |
|---|---|
| CSDE1 | 10204 |
| PAIP1 | 8436 |
| SYNCRIP | 7074 |
| HNRNPD | 5455 |
| PABPC1 | 4318 |
Click HERE to show all gene set members
| GeneID | Gene Rank |
|---|---|
| CSDE1 | 10204 |
| PAIP1 | 8436 |
| SYNCRIP | 7074 |
| HNRNPD | 5455 |
| PABPC1 | 4318 |
GOBP INTERLEUKIN 5 MEDIATED SIGNALING PATHWAY
| set | GOBP INTERLEUKIN 5 MEDIATED SIGNALING PATHWAY |
| setSize | 5 |
| pANOVA | 0.0112 |
| s.dist | 0.655 |
| p.adjustANOVA | 0.24 |
Top enriched genes
| GeneID | Gene Rank |
|---|---|
| LYN | 10508 |
| IL5RA | 10400 |
| CSF2RB | 8486 |
| JAK2 | 8416 |
| STAT5A | -2776 |
Click HERE to show all gene set members
| GeneID | Gene Rank |
|---|---|
| LYN | 10508 |
| IL5RA | 10400 |
| CSF2RB | 8486 |
| JAK2 | 8416 |
| STAT5A | -2776 |
GOBP MAINTENANCE OF PROTEIN LOCATION IN EXTRACELLULAR REGION
| set | GOBP MAINTENANCE OF PROTEIN LOCATION IN EXTRACELLULAR REGION |
| setSize | 6 |
| pANOVA | 0.00556 |
| s.dist | -0.654 |
| p.adjustANOVA | 0.179 |
Top enriched genes
| GeneID | Gene Rank |
|---|---|
| NRROS | -10345 |
| NBL1 | -9327 |
| LTBP1 | -7460 |
| MICOS10-NBL1 | -5439 |
| FBN1 | -4505 |
| FBN2 | -4306 |
Click HERE to show all gene set members
| GeneID | Gene Rank |
|---|---|
| NRROS | -10345 |
| NBL1 | -9327 |
| LTBP1 | -7460 |
| MICOS10-NBL1 | -5439 |
| FBN1 | -4505 |
| FBN2 | -4306 |
GOBP LOW DENSITY LIPOPROTEIN RECEPTOR PARTICLE METABOLIC PROCESS
| set | GOBP LOW DENSITY LIPOPROTEIN RECEPTOR PARTICLE METABOLIC PROCESS |
| setSize | 6 |
| pANOVA | 0.00571 |
| s.dist | -0.652 |
| p.adjustANOVA | 0.18 |
Top enriched genes
| GeneID | Gene Rank |
|---|---|
| PCSK9 | -9375 |
| ABCA2 | -9345 |
| MYLIP | -8813 |
| FURIN | -7871 |
| APOE | -7061 |
| ANXA2 | 1209 |
Click HERE to show all gene set members
| GeneID | Gene Rank |
|---|---|
| PCSK9 | -9375 |
| ABCA2 | -9345 |
| MYLIP | -8813 |
| FURIN | -7871 |
| APOE | -7061 |
| ANXA2 | 1209 |
GOBP CHROMOSOME MOVEMENT TOWARDS SPINDLE POLE
| set | GOBP CHROMOSOME MOVEMENT TOWARDS SPINDLE POLE |
| setSize | 6 |
| pANOVA | 0.00581 |
| s.dist | 0.65 |
| p.adjustANOVA | 0.18 |
Top enriched genes
| GeneID | Gene Rank |
|---|---|
| CENPE | 10556 |
| ACTR3 | 10481 |
| KPNB1 | 10329 |
| ACTR2 | 9849 |
| DLGAP5 | 8425 |
| KATNB1 | -7916 |
Click HERE to show all gene set members
| GeneID | Gene Rank |
|---|---|
| CENPE | 10556 |
| ACTR3 | 10481 |
| KPNB1 | 10329 |
| ACTR2 | 9849 |
| DLGAP5 | 8425 |
| KATNB1 | -7916 |
GOBP REGULATION OF TOOTH MINERALIZATION
| set | GOBP REGULATION OF TOOTH MINERALIZATION |
| setSize | 5 |
| pANOVA | 0.012 |
| s.dist | -0.649 |
| p.adjustANOVA | 0.243 |
Top enriched genes
| GeneID | Gene Rank |
|---|---|
| TGFB1 | -10090 |
| WNT6 | -9713 |
| SLC4A2 | -8955 |
| BCOR | -7158 |
| ENAM | 1667 |
Click HERE to show all gene set members
| GeneID | Gene Rank |
|---|---|
| TGFB1 | -10090 |
| WNT6 | -9713 |
| SLC4A2 | -8955 |
| BCOR | -7158 |
| ENAM | 1667 |
GOCC SIGNAL PEPTIDASE COMPLEX
| set | GOCC SIGNAL PEPTIDASE COMPLEX |
| setSize | 5 |
| pANOVA | 0.0125 |
| s.dist | 0.645 |
| p.adjustANOVA | 0.249 |
Top enriched genes
| GeneID | Gene Rank |
|---|---|
| SPCS2 | 9850 |
| SPCS3 | 8231 |
| SPCS1 | 6736 |
| SEC11C | 6179 |
| SEC11A | 3489 |
Click HERE to show all gene set members
| GeneID | Gene Rank |
|---|---|
| SPCS2 | 9850 |
| SPCS3 | 8231 |
| SPCS1 | 6736 |
| SEC11C | 6179 |
| SEC11A | 3489 |
GOCC MMXD COMPLEX
| set | GOCC MMXD COMPLEX |
| setSize | 5 |
| pANOVA | 0.0127 |
| s.dist | -0.643 |
| p.adjustANOVA | 0.249 |
Top enriched genes
| GeneID | Gene Rank |
|---|---|
| ERCC2 | -10565 |
| MMS19 | -10359 |
| CIAO1 | -4757 |
| CIAO2B | -4349 |
| SLC25A5 | -3920 |
Click HERE to show all gene set members
| GeneID | Gene Rank |
|---|---|
| ERCC2 | -10565 |
| MMS19 | -10359 |
| CIAO1 | -4757 |
| CIAO2B | -4349 |
| SLC25A5 | -3920 |
GOBP RENAL WATER ABSORPTION
| set | GOBP RENAL WATER ABSORPTION |
| setSize | 5 |
| pANOVA | 0.0138 |
| s.dist | -0.636 |
| p.adjustANOVA | 0.254 |
Top enriched genes
| GeneID | Gene Rank |
|---|---|
| AQP1 | -9830 |
| MLLT6 | -8862 |
| CTNS | -6587 |
| HYAL2 | -6000 |
| AQP3 | -2255 |
Click HERE to show all gene set members
| GeneID | Gene Rank |
|---|---|
| AQP1 | -9830 |
| MLLT6 | -8862 |
| CTNS | -6587 |
| HYAL2 | -6000 |
| AQP3 | -2255 |
GOBP REGULATION OF CELLULAR RESPONSE TO MACROPHAGE COLONY STIMULATING FACTOR STIMULUS
| set | GOBP REGULATION OF CELLULAR RESPONSE TO MACROPHAGE COLONY STIMULATING FACTOR STIMULUS |
| setSize | 5 |
| pANOVA | 0.0142 |
| s.dist | 0.633 |
| p.adjustANOVA | 0.257 |
Top enriched genes
| GeneID | Gene Rank |
|---|---|
| PTPN2 | 8905 |
| TLR2 | 8459 |
| TLR4 | 7709 |
| STAP1 | 5037 |
| CSF1 | 3757 |
Click HERE to show all gene set members
| GeneID | Gene Rank |
|---|---|
| PTPN2 | 8905 |
| TLR2 | 8459 |
| TLR4 | 7709 |
| STAP1 | 5037 |
| CSF1 | 3757 |
GOBP REGULATION OF PRESYNAPTIC MEMBRANE POTENTIAL
| set | GOBP REGULATION OF PRESYNAPTIC MEMBRANE POTENTIAL |
| setSize | 9 |
| pANOVA | 0.00101 |
| s.dist | -0.633 |
| p.adjustANOVA | 0.0718 |
Top enriched genes
| GeneID | Gene Rank |
|---|---|
| GABBR1 | -10550 |
| GRIN2D | -9967 |
| GRIK4 | -9835 |
| KCNMB4 | -8741 |
| GRIN3B | -8360 |
| KCNC1 | -7207 |
| GRIK5 | -5548 |
| GRIA4 | -2995 |
| KCNA2 | 3133 |
Click HERE to show all gene set members
| GeneID | Gene Rank |
|---|---|
| GABBR1 | -10550 |
| GRIN2D | -9967 |
| GRIK4 | -9835 |
| KCNMB4 | -8741 |
| GRIN3B | -8360 |
| KCNC1 | -7207 |
| GRIK5 | -5548 |
| GRIA4 | -2995 |
| KCNA2 | 3133 |
GOBP VESICLE FUSION WITH GOLGI APPARATUS
| set | GOBP VESICLE FUSION WITH GOLGI APPARATUS |
| setSize | 8 |
| pANOVA | 0.00212 |
| s.dist | 0.627 |
| p.adjustANOVA | 0.113 |
Top enriched genes
| GeneID | Gene Rank |
|---|---|
| BET1 | 10325 |
| USO1 | 10148 |
| YIPF5 | 10067 |
| SEC22B | 9709 |
| YIPF4 | 8312 |
| VTI1A | 6554 |
| VTI1B | 6060 |
| STX5 | -7485 |
Click HERE to show all gene set members
| GeneID | Gene Rank |
|---|---|
| BET1 | 10325 |
| USO1 | 10148 |
| YIPF5 | 10067 |
| SEC22B | 9709 |
| YIPF4 | 8312 |
| VTI1A | 6554 |
| VTI1B | 6060 |
| STX5 | -7485 |
GOMF CTPASE ACTIVITY
| set | GOMF CTPASE ACTIVITY |
| setSize | 6 |
| pANOVA | 0.00806 |
| s.dist | 0.625 |
| p.adjustANOVA | 0.206 |
Top enriched genes
| GeneID | Gene Rank |
|---|---|
| ENTPD7 | 9974 |
| ENTPD4 | 7960 |
| ENTPD1 | 5846 |
| ABCE1 | 5816 |
| DDX3X | 5512 |
| NTPCR | 4980 |
Click HERE to show all gene set members
| GeneID | Gene Rank |
|---|---|
| ENTPD7 | 9974 |
| ENTPD4 | 7960 |
| ENTPD1 | 5846 |
| ABCE1 | 5816 |
| DDX3X | 5512 |
| NTPCR | 4980 |
GOMF SUPEROXIDE GENERATING NADPH OXIDASE ACTIVATOR ACTIVITY
| set | GOMF SUPEROXIDE GENERATING NADPH OXIDASE ACTIVATOR ACTIVITY |
| setSize | 9 |
| pANOVA | 0.00136 |
| s.dist | -0.617 |
| p.adjustANOVA | 0.0858 |
Top enriched genes
| GeneID | Gene Rank |
|---|---|
| PDGFB | -10415 |
| NCF1C | -9665 |
| NOXA1 | -9309 |
| SH3PXD2A | -9081 |
| SH3PXD2B | -9001 |
| NCF1B | -8277 |
| NCF1 | -5500 |
| NCF4 | -3793 |
| NCF2 | 6505 |
Click HERE to show all gene set members
| GeneID | Gene Rank |
|---|---|
| PDGFB | -10415 |
| NCF1C | -9665 |
| NOXA1 | -9309 |
| SH3PXD2A | -9081 |
| SH3PXD2B | -9001 |
| NCF1B | -8277 |
| NCF1 | -5500 |
| NCF4 | -3793 |
| NCF2 | 6505 |
GOCC POSTSYNAPTIC ACTIN CYTOSKELETON
| set | GOCC POSTSYNAPTIC ACTIN CYTOSKELETON |
| setSize | 6 |
| pANOVA | 0.009 |
| s.dist | -0.616 |
| p.adjustANOVA | 0.219 |
Top enriched genes
| GeneID | Gene Rank |
|---|---|
| CTTNBP2 | -10382 |
| ACTN4 | -8390 |
| MYO9B | -7720 |
| KPTN | -7415 |
| MYH10 | -2740 |
| ACTB | -2324 |
Click HERE to show all gene set members
| GeneID | Gene Rank |
|---|---|
| CTTNBP2 | -10382 |
| ACTN4 | -8390 |
| MYO9B | -7720 |
| KPTN | -7415 |
| MYH10 | -2740 |
| ACTB | -2324 |
GOBP SEBACEOUS GLAND DEVELOPMENT
| set | GOBP SEBACEOUS GLAND DEVELOPMENT |
| setSize | 7 |
| pANOVA | 0.00492 |
| s.dist | 0.614 |
| p.adjustANOVA | 0.171 |
Top enriched genes
| GeneID | Gene Rank |
|---|---|
| ACER1 | 9854 |
| EXT1 | 9268 |
| RBPJ | 8788 |
| SMAD4 | 8688 |
| ASH1L | 5025 |
| ZDHHC21 | 4710 |
| WNT10A | -372 |
Click HERE to show all gene set members
| GeneID | Gene Rank |
|---|---|
| ACER1 | 9854 |
| EXT1 | 9268 |
| RBPJ | 8788 |
| SMAD4 | 8688 |
| ASH1L | 5025 |
| ZDHHC21 | 4710 |
| WNT10A | -372 |
GOCC CRD MEDIATED MRNA STABILITY COMPLEX
| set | GOCC CRD MEDIATED MRNA STABILITY COMPLEX |
| setSize | 5 |
| pANOVA | 0.0177 |
| s.dist | 0.613 |
| p.adjustANOVA | 0.288 |
Top enriched genes
| GeneID | Gene Rank |
|---|---|
| CSDE1 | 10204 |
| HNRNPU | 9466 |
| DHX9 | 8395 |
| SYNCRIP | 7074 |
| YBX1 | -2362 |
Click HERE to show all gene set members
| GeneID | Gene Rank |
|---|---|
| CSDE1 | 10204 |
| HNRNPU | 9466 |
| DHX9 | 8395 |
| SYNCRIP | 7074 |
| YBX1 | -2362 |
GOBP BRANCHING INVOLVED IN PROSTATE GLAND MORPHOGENESIS
| set | GOBP BRANCHING INVOLVED IN PROSTATE GLAND MORPHOGENESIS |
| setSize | 5 |
| pANOVA | 0.0186 |
| s.dist | 0.608 |
| p.adjustANOVA | 0.297 |
Top enriched genes
| GeneID | Gene Rank |
|---|---|
| FGFR2 | 10440 |
| FEM1B | 8483 |
| FRS2 | 7784 |
| NKX3-1 | 4989 |
| ESR1 | 808 |
Click HERE to show all gene set members
| GeneID | Gene Rank |
|---|---|
| FGFR2 | 10440 |
| FEM1B | 8483 |
| FRS2 | 7784 |
| NKX3-1 | 4989 |
| ESR1 | 808 |
GOMF NADPLUS NUCLEOTIDASE CYCLIC ADP RIBOSE GENERATING
| set | GOMF NADPLUS NUCLEOTIDASE CYCLIC ADP RIBOSE GENERATING |
| setSize | 13 |
| pANOVA | 0.000149 |
| s.dist | 0.607 |
| p.adjustANOVA | 0.0204 |
Top enriched genes
| GeneID | Gene Rank |
|---|---|
| BST1 | 10505 |
| IL18R1 | 10358 |
| IL1RL1 | 9682 |
| IL1RAP | 8936 |
| TLR2 | 8459 |
| TLR1 | 8229 |
| IL18RAP | 7727 |
| TLR4 | 7709 |
| TLR10 | 7584 |
| CD38 | 7141 |
| IL1R1 | 4896 |
| TLR6 | 1131 |
| SARM1 | -7896 |
Click HERE to show all gene set members
| GeneID | Gene Rank |
|---|---|
| BST1 | 10505 |
| IL18R1 | 10358 |
| IL1RL1 | 9682 |
| IL1RAP | 8936 |
| TLR2 | 8459 |
| TLR1 | 8229 |
| IL18RAP | 7727 |
| TLR4 | 7709 |
| TLR10 | 7584 |
| CD38 | 7141 |
| IL1R1 | 4896 |
| TLR6 | 1131 |
| SARM1 | -7896 |
GOCC GROWTH FACTOR COMPLEX
| set | GOCC GROWTH FACTOR COMPLEX |
| setSize | 5 |
| pANOVA | 0.0187 |
| s.dist | -0.607 |
| p.adjustANOVA | 0.298 |
Top enriched genes
| GeneID | Gene Rank |
|---|---|
| PDGFB | -10415 |
| IGFALS | -9802 |
| IGFBP3 | -8076 |
| PDGFA | -4541 |
| VEGFA | 820 |
Click HERE to show all gene set members
| GeneID | Gene Rank |
|---|---|
| PDGFB | -10415 |
| IGFALS | -9802 |
| IGFBP3 | -8076 |
| PDGFA | -4541 |
| VEGFA | 820 |
GOBP POSITIVE REGULATION OF PROTEIN LOCALIZATION TO SYNAPSE
| set | GOBP POSITIVE REGULATION OF PROTEIN LOCALIZATION TO SYNAPSE |
| setSize | 5 |
| pANOVA | 0.019 |
| s.dist | -0.605 |
| p.adjustANOVA | 0.301 |
Top enriched genes
| GeneID | Gene Rank |
|---|---|
| CLSTN3 | -10422 |
| DVL1 | -9483 |
| WNT7A | -9130 |
| MAPT | -1870 |
| NLGN2 | -1027 |
Click HERE to show all gene set members
| GeneID | Gene Rank |
|---|---|
| CLSTN3 | -10422 |
| DVL1 | -9483 |
| WNT7A | -9130 |
| MAPT | -1870 |
| NLGN2 | -1027 |
GOBP PHOSPHATIDYLINOSITOL ACYL CHAIN REMODELING
| set | GOBP PHOSPHATIDYLINOSITOL ACYL CHAIN REMODELING |
| setSize | 5 |
| pANOVA | 0.0195 |
| s.dist | 0.603 |
| p.adjustANOVA | 0.306 |
Top enriched genes
| GeneID | Gene Rank |
|---|---|
| LPGAT1 | 9004 |
| AGPAT5 | 6846 |
| MBOAT7 | 6764 |
| LCLAT1 | 6467 |
| PLA2G4D | 3186 |
Click HERE to show all gene set members
| GeneID | Gene Rank |
|---|---|
| LPGAT1 | 9004 |
| AGPAT5 | 6846 |
| MBOAT7 | 6764 |
| LCLAT1 | 6467 |
| PLA2G4D | 3186 |
GOBP PROTEIN O LINKED FUCOSYLATION
| set | GOBP PROTEIN O LINKED FUCOSYLATION |
| setSize | 5 |
| pANOVA | 0.0197 |
| s.dist | -0.602 |
| p.adjustANOVA | 0.306 |
Top enriched genes
| GeneID | Gene Rank |
|---|---|
| POFUT2 | -9986 |
| SLC35C1 | -8761 |
| SLC35C2 | -7946 |
| B3GLCT | -6785 |
| POFUT1 | 1710 |
Click HERE to show all gene set members
| GeneID | Gene Rank |
|---|---|
| POFUT2 | -9986 |
| SLC35C1 | -8761 |
| SLC35C2 | -7946 |
| B3GLCT | -6785 |
| POFUT1 | 1710 |
GOBP POSITIVE REGULATION OF TOLL LIKE RECEPTOR 7 SIGNALING PATHWAY
| set | GOBP POSITIVE REGULATION OF TOLL LIKE RECEPTOR 7 SIGNALING PATHWAY |
| setSize | 5 |
| pANOVA | 0.0197 |
| s.dist | 0.602 |
| p.adjustANOVA | 0.306 |
Top enriched genes
| GeneID | Gene Rank |
|---|---|
| RSAD2 | 10602 |
| TASL | 9728 |
| DDX3X | 5512 |
| SLC15A4 | 4898 |
| TREML4 | 1471 |
Click HERE to show all gene set members
| GeneID | Gene Rank |
|---|---|
| RSAD2 | 10602 |
| TASL | 9728 |
| DDX3X | 5512 |
| SLC15A4 | 4898 |
| TREML4 | 1471 |
Network diagram
Only used for one-dimensional analysis.
Here, the network diagram is used to depict the similarity between
some of the top ranked gene sets. It makes separate charts for up and
downregulated sets. It works best when prioritisation is done by effect
size during the mitch_calc() step. By default, we only show
the top 20 genes, but you can use the networkplot() command
yourself with other options. See ?networkplot for more
detail. There is an element of stochasticity with regard to the network
projection, so if you see a lot of overlapping labels or labels getting
cut off, you could repeat the chart generation until you get a nice
layout. See ?networkplot for more detail.
Below the network diagrams, you will see lists of genes that make up the up and downregulated sets respectively. For upregulated genes the score needs to be >2 and for downregulated genes it needs to be < -2. This is to remove genes that have uninteresting differential expression and do not contribute enrichment.
if (d==1) {
networkplot(eres=res,FDR=0.05,n_sets=20)
network_genes(eres=res,FDR=0.05,n_sets=20)
} else {
message("Network charts only generated in one-dimensional analysis.")
}
## Can't plot downregulated sets. Fewer than 5 found.## [[1]]
## [[1]]$`UP genesets.GOBP ATTACHMENT OF SPINDLE MICROTUBULES TO KINETOCHORE`
## [1] "ABRAXAS2" "CDK1" "CENPE" "SKA2"
##
## [[1]]$`UP genesets.GOBP DNA DOUBLE STRAND BREAK PROCESSING`
## [1] "HELQ" "NBN" "RAD50"
##
## [[1]]$`UP genesets.GOBP ESTABLISHMENT OF MITOTIC SISTER CHROMATID COHESION`
## [1] "NAA50" "NIPBL" "SMC3" "STAG1" "STAG2"
##
## [[1]]$`UP genesets.GOBP ESTABLISHMENT OF PROTEIN LOCALIZATION TO ENDOPLASMIC RETICULUM`
## [1] "RAB10" "RAB3GAP1" "RAB3GAP2" "SEC62" "SEC63" "SPCS2"
##
## [[1]]$`UP genesets.GOBP INTERLEUKIN 27 MEDIATED SIGNALING PATHWAY`
## [1] "IL6ST" "MX1" "OAS1" "OAS2" "STAT1"
##
## [[1]]$`UP genesets.GOBP MITOTIC SISTER CHROMATID COHESION`
## [1] "ATRX" "ESCO1" "NAA50" "NIPBL" "SLF1" "SMC3" "STAG1" "STAG2"
##
## [[1]]$`UP genesets.GOBP NEGATIVE REGULATION OF VIRAL GENOME REPLICATION`
## [1] "EIF2AK2" "IFI16" "IFIT1" "MX1" "OAS1" "OAS2" "OAS3"
## [8] "PLSCR1" "RESF1" "RNASEL" "RSAD2" "SRPK1" "SRPK2" "ZC3HAV1"
##
## [[1]]$`UP genesets.GOBP POSITIVE REGULATION OF NITRIC OXIDE SYNTHASE BIOSYNTHETIC PROCESS`
## [1] "AKAP12" "MAP2K4" "MAP2K6" "STAT1"
##
## [[1]]$`UP genesets.GOBP POSITIVE REGULATION OF PROTEIN POLYUBIQUITINATION`
## [1] "BIRC2" "NMI" "RIPK2" "UBE2D1"
##
## [[1]]$`UP genesets.GOBP PROTEIN DEUBIQUITINATION`
## [1] "ABRAXAS2" "BRCC3" "TANK" "USP32" "USP33" "USP47" "USP9X"
##
## [[1]]$`UP genesets.GOBP PROTEIN FOLDING IN ENDOPLASMIC RETICULUM`
## [1] "CANX" "DNAJC3" "HSP90B1" "PDIA3"
##
## [[1]]$`UP genesets.GOBP PROTEIN LOCALIZATION TO ENDOPLASMIC RETICULUM`
## [1] "BCAP29" "INSIG2" "MIA3" "RAB10" "RAB3GAP1" "RAB3GAP2" "SEC62"
## [8] "SEC63" "SPCS2"
##
## [[1]]$`UP genesets.GOBP REGULATION OF ENDOPLASMIC RETICULUM TUBULAR NETWORK ORGANIZATION`
## [1] "LNPK" "RAB3GAP1" "RAB3GAP2" "TMEM33"
##
## [[1]]$`UP genesets.GOBP REGULATION OF PROTEIN POLYUBIQUITINATION`
## [1] "BIRC2" "CEP63" "NMI" "PLAA" "RIPK2" "UBE2D1"
##
## [[1]]$`UP genesets.GOBP REGULATION OF VIRAL GENOME REPLICATION`
## [1] "EIF2AK2" "IFI16" "IFIT1" "MX1" "OAS1" "OAS2" "OAS3"
## [8] "PLSCR1" "PPID" "RESF1" "RNASEL" "RSAD2" "SRPK1" "SRPK2"
## [15] "TOP2A" "TOP2B" "ZC3HAV1"
##
## [[1]]$`UP genesets.GOBP RESPONSE TO INTERFERON ALPHA`
## [1] "EIF2AK2" "IFNAR1" "LAMP3" "MX2"
##
## [[1]]$`UP genesets.GOCC MITOCHONDRIA ASSOCIATED ENDOPLASMIC RETICULUM MEMBRANE CONTACT SITE`
## [1] "ACSL4" "CANX" "STX17" "TMX1"
##
## [[1]]$`UP genesets.GOMF DOUBLE STRANDED RNA BINDING`
## [1] "DDX60" "DDX60L" "EIF2AK2" "LSM14A" "MTDH" "OAS1" "OAS2"
## [8] "OAS3" "SIDT2"
##
## [[1]]$`UP genesets.GOMF GDP BINDING`
## [1] "ARL8B" "GNAI3" "GNAT1" "MRAS" "RAB10" "RAB14" "RAB21" "RAB22A"
## [9] "RAB27A" "RAB8B" "RAP1A" "RAP1B" "SUCLG2"
##
## [[1]]$`UP genesets.GOMF NADPLUS NUCLEOTIDASE CYCLIC ADP RIBOSE GENERATING`
## [1] "BST1" "IL18R1" "IL1RL1"
##
## [[1]]$`DOWN genesets.GOBP COLLAGEN METABOLIC PROCESS`
## [1] "ADAM15" "ADAMTS14" "ADAMTS2" "CBX8" "CIITA" "COL5A1"
## [7] "COL6A1" "CST3" "CTSB" "CTSK" "CTSL" "DDR2"
## [13] "EMILIN1" "ENG" "F2R" "FOSL2" "FURIN" "HDAC2"
## [19] "INHBA" "ITGA2" "ITGB1" "MFAP4" "MMP11" "MMP14"
## [25] "MMP15" "MMP17" "MMP19" "MMP21" "MMP23B" "MMP24"
## [31] "MMP25" "MMP28" "MMP7" "MMP8" "MMP9" "MRC2"
## [37] "MYB" "NAGLU" "NOTCH1" "P2RX7" "P3H1" "P3H3"
## [43] "P3H4" "PCOLCE" "PEPD" "PLOD3" "PRTN3" "RCN3"
## [49] "RETREG2" "RETREG3" "RGCC" "RUNX1" "SCX" "SERPINF2"
## [55] "SERPINH1" "SMPD3" "TGFB1" "TGFB3" "TMPRSS6" "TNS2"
## [61] "TNXB" "TRAM2" "UCN" "VIM" "VIPAS39" "VPS33B"
## [67] "VSIR" "WNT4"
##
## [[1]]$`DOWN genesets.GOCC COLLAGEN CONTAINING EXTRACELLULAR MATRIX`
## [1] "A1BG" "A2M" "ABI3BP" "ACTA2" "ADAM11" "ADAM19"
## [7] "ADAMDEC1" "ADAMTS1" "ADAMTS10" "ADAMTS2" "ADAMTS4" "ADAMTS5"
## [13] "ADAMTSL4" "AEBP1" "AGRN" "AGT" "ANG" "ANGPT1"
## [19] "ANGPT2" "ANGPT4" "ANGPTL1" "ANGPTL4" "ANGPTL6" "ANXA1"
## [25] "ANXA11" "ANXA2" "ANXA4" "ANXA5" "ANXA6" "ANXA7"
## [31] "ANXA8" "APOE" "BCAM" "C17orf58" "C1QA" "C1QB"
## [37] "C1QC" "CALR" "CASK" "CCN3" "CD151" "CDH13"
## [43] "CDON" "CFP" "CHADL" "CILP" "CLEC3B" "CLU"
## [49] "COCH" "COL10A1" "COL11A2" "COL13A1" "COL17A1" "COL18A1"
## [55] "COL19A1" "COL23A1" "COL24A1" "COL26A1" "COL27A1" "COL28A1"
## [61] "COL4A2" "COL4A3" "COL4A4" "COL4A5" "COL5A1" "COL5A2"
## [67] "COL5A3" "COL6A1" "COL6A2" "COL6A3" "COL7A1" "COL8A1"
## [73] "COL8A2" "COL9A2" "COL9A3" "COLEC12" "COLQ" "CRELD1"
## [79] "CSPG4" "CSTB" "CTSB" "CTSD" "CTSF" "CTSG"
## [85] "CTSH" "CTSL" "CTSZ" "DAG1" "DEFA1" "DEFA1B"
## [91] "DLG1" "DST" "ECM1" "EFEMP2" "EFNA5" "EGFL7"
## [97] "ELANE" "ELN" "EMILIN1" "EMILIN2" "ENTPD2" "EYS"
## [103] "F12" "F13A1" "FBLN1" "FBLN2" "FBLN5" "FBN1"
## [109] "FBN2" "FCN1" "FGFBP3" "FGL2" "FN1" "GDF15"
## [115] "GPC1" "GPC2" "GREM1" "HAPLN3" "HDGF" "HNRNPM"
## [121] "HPX" "HRNR" "HSP90AA1" "HSPG2" "HTRA1" "ICAM1"
## [127] "IGFBP7" "IGFBPL1" "IL7" "IMPG2" "ITGB4" "ITIH1"
## [133] "ITIH2" "ITIH4" "ITIH5" "KRT1" "L1CAM" "LAMA1"
## [139] "LAMA2" "LAMA5" "LAMB1" "LAMB2" "LAMB3" "LAMC1"
## [145] "LAMC3" "LGALS1" "LGALS3" "LGALS3BP" "LGALS4" "LGALS9"
## [151] "LMAN1" "LMAN1L" "LOX" "LOXL1" "LOXL2" "LOXL3"
## [157] "LOXL4" "LTBP1" "LTBP2" "LTBP3" "LTBP4" "MARCO"
## [163] "MATN1" "MATN2" "MDK" "MFAP4" "MFAP5" "MFGE8"
## [169] "MMP23B" "MMP28" "MMP8" "MMP9" "MMRN1" "MMRN2"
## [175] "MST1" "MXRA7" "NAV2" "NCAM1" "NID1" "NID2"
## [181] "NPPA" "NTN1" "NTN4" "ORM1" "ORM2" "P3H1"
## [187] "PCOLCE" "PCSK6" "PDGFB" "PF4" "PKM" "PLAT"
## [193] "PLG" "PLOD3" "PODN" "PRELP" "PRG4" "PRTN3"
## [199] "PSAP" "PXDN" "PZP" "RELL2" "S100A10" "S100A4"
## [205] "S100A6" "S100A8" "S100A9" "SBSPON" "SDC3" "SEMA3B"
## [211] "SEMA7A" "SERPINB6" "SERPINB8" "SERPINB9" "SERPINE1" "SERPINE2"
## [217] "SERPINF1" "SERPINF2" "SERPING1" "SERPINH1" "SLPI" "SNORC"
## [223] "SPARC" "SPN" "SPON1" "SSC5D" "TGFB1" "TGFB1I1"
## [229] "TGFB2" "TGFB3" "TGFBI" "TGM2" "TGM4" "THBS1"
## [235] "THBS3" "THBS4" "THSD4" "TIMP1" "TIMP2" "TINAGL1"
## [241] "TNC" "TNR" "TNXB" "VCAN" "VIT" "VTN"
## [247] "VWA2" "VWF" "WNT2B" "WNT5B" "ZP3"
##
## [[1]]$`DOWN genesets.GOCC EXTERNAL ENCAPSULATING STRUCTURE`
## [1] "A1BG" "A2M" "ABI3BP" "ACTA2" "ADAM11" "ADAM19"
## [7] "ADAMDEC1" "ADAMTS1" "ADAMTS10" "ADAMTS13" "ADAMTS14" "ADAMTS16"
## [13] "ADAMTS17" "ADAMTS2" "ADAMTS4" "ADAMTS5" "ADAMTS6" "ADAMTSL2"
## [19] "ADAMTSL4" "ADAMTSL5" "AEBP1" "AGRN" "AGT" "ALPL"
## [25] "ANG" "ANGPT1" "ANGPT2" "ANGPT4" "ANGPTL1" "ANGPTL4"
## [31] "ANGPTL6" "ANOS1" "ANXA1" "ANXA11" "ANXA2" "ANXA4"
## [37] "ANXA5" "ANXA6" "ANXA7" "ANXA8" "APOE" "BCAM"
## [43] "C17orf58" "C1QA" "C1QB" "C1QC" "CALR" "CASK"
## [49] "CCBE1" "CCN3" "CCN5" "CD151" "CD180" "CD248"
## [55] "CDH13" "CDON" "CFP" "CHAD" "CHADL" "CHI3L1"
## [61] "CILP" "CLEC3B" "CLIC3" "CLU" "COCH" "COL10A1"
## [67] "COL11A2" "COL13A1" "COL17A1" "COL18A1" "COL19A1" "COL23A1"
## [73] "COL24A1" "COL26A1" "COL27A1" "COL28A1" "COL4A2" "COL4A3"
## [79] "COL4A4" "COL4A5" "COL5A1" "COL5A2" "COL5A3" "COL6A1"
## [85] "COL6A2" "COL6A3" "COL7A1" "COL8A1" "COL8A2" "COL9A2"
## [91] "COL9A3" "COLEC12" "COLQ" "CPN2" "CRELD1" "CRISP3"
## [97] "CRISPLD2" "CSPG4" "CSTB" "CTSB" "CTSD" "CTSF"
## [103] "CTSG" "CTSH" "CTSL" "CTSZ" "DAG1" "DEFA1"
## [109] "DEFA1B" "DGCR6" "DLG1" "DST" "ECM1" "EFEMP2"
## [115] "EFNA5" "EGFL7" "ELANE" "ELN" "EMID1" "EMILIN1"
## [121] "EMILIN2" "ENAM" "ENTPD2" "EYS" "F12" "F13A1"
## [127] "FBLN1" "FBLN2" "FBLN5" "FBLN7" "FBN1" "FBN2"
## [133] "FCGBP" "FCN1" "FGFBP3" "FGL2" "FLRT1" "FLRT2"
## [139] "FN1" "GDF15" "GFOD2" "GLG1" "GP1BA" "GPC1"
## [145] "GPC2" "GPLD1" "GREM1" "HAPLN3" "HDGF" "HNRNPM"
## [151] "HPSE" "HPX" "HRNR" "HSD17B12" "HSP90AA1" "HSPG2"
## [157] "HTRA1" "ICAM1" "IGFALS" "IGFBP7" "IGFBPL1" "IL7"
## [163] "IMPG2" "ITGB4" "ITIH1" "ITIH2" "ITIH4" "ITIH5"
## [169] "KRT1" "L1CAM" "LAMA1" "LAMA2" "LAMA5" "LAMB1"
## [175] "LAMB2" "LAMB3" "LAMC1" "LAMC3" "LGALS1" "LGALS3"
## [181] "LGALS3BP" "LGALS4" "LGALS9" "LINGO2" "LINGO3" "LMAN1"
## [187] "LMAN1L" "LOX" "LOXL1" "LOXL2" "LOXL3" "LOXL4"
## [193] "LRIG1" "LRIG2" "LRRC24" "LRRC32" "LRRN1" "LRRN2"
## [199] "LRRN3" "LTBP1" "LTBP2" "LTBP3" "LTBP4" "MARCO"
## [205] "MATN1" "MATN2" "MDK" "MFAP1" "MFAP4" "MFAP5"
## [211] "MFGE8" "MMP11" "MMP14" "MMP15" "MMP17" "MMP19"
## [217] "MMP21" "MMP23B" "MMP24" "MMP25" "MMP28" "MMP7"
## [223] "MMP8" "MMP9" "MMRN1" "MMRN2" "MST1" "MUC4"
## [229] "MUC5B" "MUC6" "MXRA7" "NAV2" "NCAM1" "NID1"
## [235] "NID2" "NPPA" "NTN1" "NTN4" "OLFML2A" "OLFML2B"
## [241] "ORM1" "ORM2" "OVGP1" "P3H1" "PCOLCE" "PCSK6"
## [247] "PDGFB" "PF4" "PHOSPHO1" "PI3" "PKHD1L1" "PKM"
## [253] "PLAT" "PLG" "PLOD3" "PODN" "PRELP" "PRG4"
## [259] "PRTN3" "PSAP" "PTX3" "PXDN" "PZP" "RELL2"
## [265] "RELN" "RTN4RL1" "RTN4RL2" "S100A10" "S100A4" "S100A6"
## [271] "S100A8" "S100A9" "SBSPON" "SDC3" "SEMA3B" "SEMA7A"
## [277] "SERAC1" "SERPINB6" "SERPINB8" "SERPINB9" "SERPINE1" "SERPINE2"
## [283] "SERPINF1" "SERPINF2" "SERPING1" "SERPINH1" "SLPI" "SNED1"
## [289] "SNORC" "SPARC" "SPN" "SPOCK2" "SPON1" "SPON2"
## [295] "SSC5D" "SSPOP" "TECTA" "TFIP11" "TGFB1" "TGFB1I1"
## [301] "TGFB2" "TGFB3" "TGFBI" "TGM2" "TGM4" "THBS1"
## [307] "THBS3" "THBS4" "THSD4" "TIMP1" "TIMP2" "TINAGL1"
## [313] "TLR3" "TNC" "TNR" "TNXB" "VASN" "VCAN"
## [319] "VEGFA" "VIT" "VTN" "VWA2" "VWF" "WNT11"
## [325] "WNT2B" "WNT3" "WNT4" "WNT5B" "WNT6" "WNT7A"
## [331] "ZP3"Session information
Here is the session info with all the versions of packages used.
sessionInfo()## R version 4.5.2 (2025-10-31)
## Platform: x86_64-pc-linux-gnu
## Running under: Ubuntu 24.04.4 LTS
##
## Matrix products: default
## BLAS: /usr/lib/x86_64-linux-gnu/openblas-pthread/libblas.so.3
## LAPACK: /usr/lib/x86_64-linux-gnu/openblas-pthread/libopenblasp-r0.3.26.so; LAPACK version 3.12.0
##
## locale:
## [1] LC_CTYPE=en_US.UTF-8 LC_NUMERIC=C
## [3] LC_TIME=en_US.UTF-8 LC_COLLATE=en_US.UTF-8
## [5] LC_MONETARY=en_US.UTF-8 LC_MESSAGES=en_US.UTF-8
## [7] LC_PAPER=en_US.UTF-8 LC_NAME=en_US.UTF-8
## [9] LC_ADDRESS=en_US.UTF-8 LC_TELEPHONE=en_US.UTF-8
## [11] LC_MEASUREMENT=en_US.UTF-8 LC_IDENTIFICATION=en_US.UTF-8
##
## time zone: Etc/UTC
## tzcode source: system (glibc)
##
## attached base packages:
## [1] stats4 stats graphics grDevices utils datasets methods
## [8] base
##
## other attached packages:
## [1] gtools_3.9.5 xlsx_0.6.5
## [3] DT_0.34.0 ggplot2_4.0.3
## [5] kableExtra_1.4.0 limma_3.66.0
## [7] RhpcBLASctl_0.23-42 beeswarm_0.4.0
## [9] eulerr_7.1.0 MASS_7.3-65
## [11] mitch_1.22.1 DESeq2_1.50.2
## [13] SummarizedExperiment_1.40.0 Biobase_2.70.0
## [15] MatrixGenerics_1.22.0 matrixStats_1.5.0
## [17] GenomicRanges_1.62.1 Seqinfo_1.0.0
## [19] IRanges_2.44.0 S4Vectors_0.48.1
## [21] BiocGenerics_0.56.0 generics_0.1.4
## [23] dplyr_1.2.1 WGCNA_1.74
## [25] fastcluster_1.3.0 dynamicTreeCut_1.63-1
## [27] reshape2_1.4.5 gplots_3.3.0
##
## loaded via a namespace (and not attached):
## [1] RColorBrewer_1.1-3 rstudioapi_0.17.1 jsonlite_2.0.0
## [4] magrittr_2.0.4 farver_2.1.2 rmarkdown_2.30
## [7] vctrs_0.7.3 base64enc_0.1-3 progress_1.2.3
## [10] htmltools_0.5.8.1 S4Arrays_1.10.1 SparseArray_1.10.10
## [13] Formula_1.2-5 sass_0.4.10 KernSmooth_2.23-26
## [16] bslib_0.9.0 htmlwidgets_1.6.4 plyr_1.8.9
## [19] echarts4r_0.5.0 impute_1.84.0 cachem_1.1.0
## [22] mime_0.13 lifecycle_1.0.5 iterators_1.0.14
## [25] pkgconfig_2.0.3 Matrix_1.7-4 R6_2.6.1
## [28] fastmap_1.2.0 shiny_1.11.1 digest_0.6.39
## [31] colorspace_2.1-2 GGally_2.4.0 textshaping_1.0.4
## [34] Hmisc_5.2-5 labeling_0.4.3 polyclip_1.10-7
## [37] abind_1.4-8 compiler_4.5.2 withr_3.0.2
## [40] doParallel_1.0.17 htmlTable_2.5.0 S7_0.2.2
## [43] backports_1.5.1 BiocParallel_1.44.0 ggstats_0.13.0
## [46] DelayedArray_0.36.1 caTools_1.18.3 tools_4.5.2
## [49] foreign_0.8-90 otel_0.2.0 httpuv_1.6.16
## [52] nnet_7.3-20 glue_1.8.0 promises_1.5.0
## [55] grid_4.5.2 polylabelr_1.0.0 checkmate_2.3.4
## [58] cluster_2.1.8.1 gtable_0.3.6 preprocessCore_1.72.0
## [61] tidyr_1.3.2 hms_1.1.4 data.table_1.18.4
## [64] xml2_1.5.1 XVector_0.50.0 foreach_1.5.2
## [67] pillar_1.11.1 stringr_1.6.0 later_1.4.4
## [70] rJava_1.0-18 splines_4.5.2 lattice_0.22-7
## [73] survival_3.8-3 tidyselect_1.2.1 locfit_1.5-9.12
## [76] knitr_1.50 gridExtra_2.3 svglite_2.2.2
## [79] xfun_0.54 statmod_1.5.2 stringi_1.8.7
## [82] statnet.common_4.13.0 yaml_2.3.11 evaluate_1.0.5
## [85] codetools_0.2-20 xlsxjars_0.9.0 tibble_3.3.0
## [88] cli_3.6.5 rpart_4.1.24 xtable_1.8-4
## [91] systemfonts_1.3.1 jquerylib_0.1.4 network_1.20.0
## [94] Rcpp_1.1.1-1.1 coda_0.19-4.1 parallel_4.5.2
## [97] prettyunits_1.2.0 bitops_1.0-9 viridisLite_0.4.3
## [100] scales_1.4.0 crayon_1.5.3 purrr_1.2.0
## [103] rlang_1.2.0END of report